{
  "experiment_metadata": {
    "model": "nemotron-nano-30b",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000
  },
  "results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT's nonqualified defined benefit pension plans decreased from $1.0 billion as of December 31 2023 (reported in 2023) to $905 million as of December 31 2024 (reported in 2024), reflecting a $95 million reduction between the two years. Concurrently, actuarial losses recorded in accumulated other comprehensive loss fell from $347 million at the end of 2023 to $303 million at the end of 2024, a $44 million decline. These changes are reflected in the consolidated balance‑sheet accounts for other noncurrent liabilities and other noncurrent assets, and they contributed to the recognition of pretax pension expense of $62 million in 2024, $64 million in 2023, and $81 million in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Nonqualified Defined Benefit Pension Plans (FIN_INST)",
        "Nonqualified Defined Benefit Pension Plans (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3700,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 179,
        "total_tokens": 1754
      }
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "Between 2022 and 2024, General Motors' long-term rate of return assumptions for U.S. pension plan assets increased from 5.4% at the end of 2021 (referenced in Chunk 1 as the prior period before 2022) to 6.5% by the end of 2024 (as stated in Chunk 2), reflecting a strategic shift toward higher expected returns. This evolution indicates deliberate adjustments to the pension asset portfolio mix, driven by updated capital market assumptions and targeted de-risking efforts, as evidenced by the company's focus on rebalancing investments to improve funded positions while managing volatility through tailored asset allocation strategies across U.S. and non-U.S. plans. The consistent emphasis on aligning asset mixes with liability funding objectives and risk tolerance—highlighted in both chunks—demonstrates a proactive strategic pivot toward more aggressive asset allocation to enhance long-term pension plan sustainability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Rebalances]- ORG",
      "triplets_used": [
        "GM (ORG) -> Asset Portfolio Mix (ACCOUNTING_POLICY)",
        "Asset Portfolio Mix (ACCOUNTING_POLICY) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7231,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2466,
        "completion_tokens": 231,
        "total_tokens": 2697
      }
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy transitioned from a dependent operational partnership to full ownership following its 2023 acquisition, as indicated by the KG pattern showing Chevron (CVX) both has a stake in and depends on PDC Energy. The 2023 10-K explicitly states Chevron excluded PDC Energy from its internal control assessment because it was acquired during 2023, while the 2024 10-K details that \"full-year of legacy PDC production\" contributed to a 19% increase in net oil-equivalent production (250,000 barrels per day) and $3.5 billion in higher U.S. upstream earnings, directly linking the acquisition to significant operational expansion and financial performance improvements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> PDC Energy (COMP)",
        "PDC Energy (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3439,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 174,
        "total_tokens": 1669
      }
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Southern Company's treatment and valuation of energy-related derivatives remained consistent in presentation framework between 2022 and 2024, with both years disclosing fair value measurements in the balance sheet under \"Risk Management Activities\" or \"Other\" as part of their regulatory accounting approach. However, the specific unrealized gains (losses) figures for 2021-2020 from 2022's disclosure cannot be directly compared to 2024 data since the 2024 chunk only describes the presentation methodology without providing the actual pre-tax unrealized gain/loss amounts that would indicate changes in valuation between periods. The KG relationship confirms Energy-Related Derivatives (FIN_INST) are subject to SO's disclosure practices through its regulatory filing framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-Related Derivatives (FIN_INST)",
        "Energy-Related Derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_324",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_283",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 731,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 840,
        "completion_tokens": 195,
        "total_tokens": 1035
      }
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Chevron's financial relationship with Tengizchevroil evolved significantly between 2022 and 2024, reflecting both investment growth and shifting equity recognition. In 2022, Chevron held a 50% equity stake in Tengizchevroil (TCO) with a carrying value of its investment approximately $100 higher than underlying equity in TCO's net assets, driven by acquiring a portion of its interest at a premium and including a $4,500 loan for the FGP/WPMP development (CVX_10k_2022.pdf). By 2024, Chevron's investment in TCO was reported at $27,368 (up from $26,954 in 2023), with equity earnings declining sharply to $3,033 from $4,386 in 2022, indicating reduced profitability or equity method adjustments (CVX_10k_2024.pdf). This evolution underscores a strategic shift: while Chevron maintained its substantial stake and investment carrying value growth, equity earnings from TCO diminished over the period, likely due to operational changes, impairment considerations, or the impact of accounting for the investment under the equity method amid evolving business dynamics in Kazakhstan. The sustained investment carrying value ($27,368 in 2024) alongside declining equity earnings ($3,033 in 2024 vs. $4,386 in 2022) highlights a growing divergence between Chevron's book value of its stake and the affiliate's current earnings performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8204,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2689,
        "completion_tokens": 333,
        "total_tokens": 3023
      }
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart's ownership stake in Alert Innovation underwent a definitive structural change between fiscal 2023 and 2024, transitioning from a variable interest entity (VIE) to a wholly owned subsidiary. During fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which had previously been consolidated as a VIE, resulting in Walmart becoming a 100% owner; this transaction was explicitly documented in both fiscal 2023 and 2024 filings as the mechanism that established Walmart's full ownership. The fiscal 2024 filing further clarifies that this entity was \"subsequently sold and deconsolidated in fiscal 2025,\" confirming the ownership change occurred in 2023 but with the final consolidation status updated in the following year's report. This evolution reflects Walmart's strategic move to fully integrate Alert Innovation into its portfolio, shifting from partial control (as a VIE) to absolute ownership, with the $0.4 billion acquisition cost representing the specific transaction that altered its relationship with the entity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Sells]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Alert Innovation (COMP)",
        "Alert Innovation (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6013,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2144,
        "completion_tokens": 264,
        "total_tokens": 2408
      }
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks' foreign currency - other derivative asset and liability positions shifted significantly from fiscal 2022 to 2023, with designated derivative assets increasing from $55.3M (current) and $5.3M (long-term) in 2022 to $3.9M (current) and $1.7M (long-term) in 2023, while designated derivative liabilities rose from $2.0M (current) and $0 (long-term) in 2022 to $4.7M (current) and $4.1M (long-term) in 2023. This movement reflects the company's active management of foreign exchange exposure through cross-currency swaps and other derivatives, as evidenced by the KG pattern where SBUX discloses foreign currency - other (FIN_INST) and maintains stake in these instruments for hedging purposes. The data shows a strategic reallocation of derivative positions across maturities and instruments, indicating Starbucks is adjusting its hedging strategy to address evolving currency risks while maintaining exposure management through structured financial instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7017,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2409,
        "completion_tokens": 242,
        "total_tokens": 2652
      }
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Medtronic's treatment of A Preferred Shares shows a clear evolution: the company **redeemed all previously outstanding 1,872 A Preferred Shares for $0.075 million during fiscal year 2022** (Chunk 1), and **as of both April 29, 2022 (Chunk 1) and April 26, 2024 (Chunk 2), no A Preferred Shares remained outstanding**. This indicates a complete retirement of the A Preferred Shares authorization and holdings by the end of fiscal year 2022, with no subsequent issuance or activity referenced in later filings. The KG triplet relationship (MDT -[Decreases]-> A Preferred Shares) is directly supported by the redemption action in 2022 and the zero outstanding status in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> A Preferred Shares (FIN_INST)",
        "A Preferred Shares (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4257,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1705,
        "completion_tokens": 169,
        "total_tokens": 1875
      }
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Between 2022 and 2023, Comcast's equity income (losses) driven by fair value adjustments on underlying investments at Atairos shifted from a $434 million loss in 2022 to a $1.1 billion gain in 2023, reflecting significant valuation changes in Atairos' portfolio. This evolution was explicitly detailed in both 2022 and 2023 10-K filings, with Chunk 1 documenting the 2021 context of Atairos' fair value adjustments ($1.8B income in 2021) and Chunk 2 providing the direct comparative 2022–2023 figures ($434M loss → $1.1B gain), while the KG triplets confirm the mutual investment relationship between CMCSA and Atairos as the structural basis for this financial linkage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Atairos (COMP)",
        "Atairos (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4425,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1748,
        "completion_tokens": 167,
        "total_tokens": 1916
      }
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region grew from 312 billion cubic feet at the end of 2023 to 296 billion cubic feet at the end of 2024, reflecting a net increase of 14 billion cubic feet driven by extensions and discoveries (87 bn + 67 bn) and modest purchases (310 bn) that were partially offset by production (25 bn) and sales (6 bn); this modest rise, alongside the region's contribution of $296 bn to total consolidated operations equity affiliates and its integration within COP's broader Asia Pacific/Middle East operations disclosed under the \"Operates_In\" relationship, indicates that the company is maintaining a stable yet strategically expanding presence in this geographic area, positioning it to leverage regional demand while balancing overall portfolio growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_150",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18440,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5259,
        "completion_tokens": 200,
        "total_tokens": 5460
      }
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "The revenue trajectory of ENBREL in Canada shows a consistent downward trend over the three-year period, with sales declining from $113 million in 2021 to $73 million in 2022 (a 35% decrease) and further to $47 million in 2023 (another 36% drop), before falling to $28 million in 2024 (a 40% decline from 2023). This accelerating contraction—evidenced by increasingly negative year-over-year changes (35%, 36%, 40%)—indicates a deteriorating market position in Canada, suggesting weakening demand or increased competition that is undermining its previously established presence, despite stable performance in other regions like the U.S. where revenue declines were more moderate and consistent at approximately 10% annually.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> ENBREL - Canada (PRODUCT)",
        "ENBREL - Canada (PRODUCT) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1494,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1007,
        "completion_tokens": 181,
        "total_tokens": 1188
      }
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "From fiscal 2023 to fiscal 2024, Qualcomm’s human‑capital strategy remained focused on inclusive workforce initiatives—such as its Best Company for Women and Disability‑Inclusion recognitions, the Reboot Representation Tech Coalition, and extensive wellness and talent‑development programs—while explicitly tying human‑capital advancements to executive pay. The HR and Compensation Committee used progress on these human‑capital goals as a non‑financial modifier that can adjust the fiscal 2024 executive bonus by a multiplier of **0.9 to 1.1**. Thus, the specific performance‑modifier range applied in fiscal 2024 was **0.9 – 1.1**.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Guides_On]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Human Capital Advancements (CONCEPT)",
        "Human Capital Advancements (CONCEPT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11875,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3625,
        "completion_tokens": 158,
        "total_tokens": 3784
      }
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Between 2022 and 2024, Breyanzi's therapeutic scope expanded significantly through new regulatory approvals and indications documented in the provided materials. In 2023/24, as noted in the BMY_10k_2022.pdf chunk, Breyanzi was already approved for 3L+ Chronic Lymphocytic Leukemia (CLL) and 3L+ Follicular Lymphoma (FL), establishing its role in these hematologic malignancies. This evolved in 2024 with two distinct accelerated approvals: the May 2024 FDA approval specifically for relapsed/refractory FL patients who had received at least two prior systemic therapies (BMY_10k_2024.pdf), and the March 2024 approval extending to relapsed/refractory CLL/SLL patients with prior BTK inhibitor and BCL-2 inhibitor therapy (BMY_10k_2024.pdf). These approvals represent a strategic broadening of its target populations within B-cell malignancies, moving from initial CLL/FL indications toward more specific, heavily pretreated subpopulations across both lymphoma and CLL/SLL indications, while maintaining its core hematologic focus documented in both 2022 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Breyanzi (PRODUCT)",
        "Breyanzi (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3783,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 267,
        "total_tokens": 1845
      }
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "The financial performance of Disney's Resorts and Vacations segment shows growth from $7,949 million in 2023 to $8,375 million in 2024, reflecting a 5% revenue increase, while the overall Parks & Experiences segment grew 5% to $34,151 million, indicating the Resorts and Vacations segment's growth aligns with the broader segment's performance. This growth is supported by capital investments in resort expansion and infrastructure, as noted in Chunk 1's discussion of capital spending priorities for parks and resorts, and the segment's revenue contribution is explicitly detailed in Chunk 2's financial table.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Resorts and Vacations (PRODUCT)",
        "Resorts and Vacations (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6124,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2181,
        "completion_tokens": 152,
        "total_tokens": 2334
      }
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, CVS's forward contracts tied to ASR transactions evolved in scale and accounting treatment while maintaining consistent classification. In 2023, the company executed a $2.0 billion ASR with Citibank (receiving ~17.4 million shares at $92.19/share), recording a $1.6 billion treasury stock transaction and a $0.4 billion forward contract classified as equity in capital surplus, later reclassified upon final share receipt in February 2023. In 2024, it entered a larger $3.0 billion ASR with Morgan Stanley (receiving ~31.4 million shares initially), recording a $2.6 billion treasury stock transaction and a $0.4 billion forward contract similarly classified as equity in capital surplus, with the remainder settled in March 2024. Both contracts followed the same equity-instrument accounting and reclassification pathway from capital surplus to treasury stock upon completion, reflecting a structural consistency in how CVS accounts for these financing mechanisms despite increasing notional values.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reclassifies]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Forward Contract (FIN_INST)",
        "Forward Contract (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_175",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5342,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1974,
        "completion_tokens": 255,
        "total_tokens": 2230
      }
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "The disclosure regarding the Master Retirement Trust's pension asset valuation methodology shows no substantive evolution in fair value categorization transparency between 2023 and 2024 filings. Both the 2023 (DUK_10k_2023.pdf) and 2024 (DUK_10k_2024.pdf) disclosures maintain identical language stating that investments measured at fair value using the net asset value per share practical expedient \"have not been categorized in the fair value hierarchy,\" with only minor typographical variations in the reporting entities' names across the documents. This consistent omission of Level 3 categorization details across both years indicates sustained lack of enhanced transparency regarding fair value hierarchy placement for these pension assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Master Retirement Trust (FIN_INST)",
        "Master Retirement Trust (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_228",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1626,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1062,
        "completion_tokens": 186,
        "total_tokens": 1248
      }
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Pfizer's financial obligations and revenue recognition related to Paxlovid underwent significant changes between 2023 and 2024 due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile. In 2023, the company recorded a $3.5 billion non-cash revenue reversal tied to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses purchased by the U.S. government, which was later adjusted downward in 2024 as only 5.1 million courses were returned by February 2024. This adjustment, combined with $442 million in revenue from the U.S. Strategic National Stockpile creation in 2024, reflects the transition from government procurement to commercial markets and the establishment of a $1.0 million course stockpile for pandemic preparedness through 2028 at no cost to the government. Revenue recognition now incorporates volume-based credits from returned courses and patient assistance programs, ensuring continued access while shifting focus to commercial sales and long-term supply commitments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7438,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2513,
        "completion_tokens": 262,
        "total_tokens": 2775
      }
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA's sales grew 26.9% from $1,881 million in 2022 to $2,387 million in 2023, reflecting its expanding role within J&J's oncology portfolio as a next-generation androgen receptor inhibitor for prostate cancer. This growth contributed to the Total Oncology segment's 10.5% increase ($17,661M to $15,983M), underscoring ERLEADA's significance in driving J&J's innovative medicine performance and reinforcing its strategic position in oncology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> ERLEADA (PRODUCT)",
        "ERLEADA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10486,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3253,
        "completion_tokens": 111,
        "total_tokens": 3364
      }
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "The global sales of ERLEADA grew from $332 million in 2022 to $1,291 million in 2023, reflecting a 26.9% year-over-year increase (27.5% on a constant-currency basis), which indicates a strong upward market trajectory and accelerating adoption of the product within JNJ's oncology portfolio. This growth outpaced the overall oncology segment's 10.5% increase, underscoring ERLEADA's expanding market share and momentum as a key growth driver for JNJ's pharmaceutical business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> ERLEADA (PRODUCT)",
        "ERLEADA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9265,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2943,
        "completion_tokens": 118,
        "total_tokens": 3062
      }
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "NVDA's debt management strategy regarding the 0.584% Notes Due 2024 evolved from maintaining the instrument as a long-term liability in fiscal 2023 (with $1,250 million principal and $8,459 million total long-term portion reported as of January 28, 2023) to actively repaying the entire $1,250 million principal in fiscal 2025, as explicitly stated in the 2024 10-K filing where it is noted that \"in fiscal year 2025, we repaid the 0.584% Notes Due 2024,\" thereby removing this specific debt obligation from its long-term structure while maintaining compliance with covenants under the remaining unsecured senior notes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> 0.584% Notes Due 2024 (FIN_INST)",
        "0.584% Notes Due 2024 (FIN_INST) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4454,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1747,
        "completion_tokens": 154,
        "total_tokens": 1901
      }
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell's investment in Mortgage/Asset-backed securities increased from $982 million in 2022 to $10 million in 2023, representing a $972 million decrease (approximately a 99 % reduction) over the one‑year period. This shift is reflected in both the U.S. and non‑U.S. plan disclosures, where the 2022 total of $982 million appears under Level 3 for U.S. plans and under Level 2 for non‑U.S. plans, while the 2023 total of $10 million is recorded under Level 2 for non‑U.S. plans, confirming the magnitude of the decline across all disclosed segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "HON (ORG) -> Mortgage/Asset-backed securities (FIN_INST)",
        "Mortgage/Asset-backed securities (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2525,
        "completion_tokens": 137,
        "total_tokens": 2663
      }
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Capital One's use of securitized debt obligations evolved from $18,043 million in carrying value and $18,067 million in estimated fair value at the end of 2023 (reported in 2023 10‑K page 210), reflecting a continued reliance on this wholesale funding source within its diversified funding mix, while the fair‑value hierarchy shows these obligations are classified entirely at Level 2, indicating they are measured using observable inputs other than quoted prices for identical assets. This progression underscores the ongoing role of securitized debt obligations in the company’s funding strategy and their consistent fair‑value classification across the two reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Raises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_210",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5947,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2139,
        "completion_tokens": 169,
        "total_tokens": 2309
      }
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "JPMorgan's CECL capital transition benefit declined from $2.2 billion in 2023 to $720 million in 2024, reflecting a $1.48 billion quantitative reduction in the CECL‑related capital benefit over that period. This decrease is evident from the 2023 net benefit of $2.2 billion (Chunk 1 b) and the 2024 remaining benefit of $720 million that was fully phased in as of January 1 2025 (Chunk 2 a). The transition provisions also allowed an incremental $655 million allowance for First Republic assets under the standardized approach (Chunk 1 f) and were applied to the calculation of CET1, Tier 1 and Tier 2 capital roll‑forward, confirming the regulatory framework governing the benefit (Chunk 1 d, e; Chunk 2 b).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "JPM (ORG) -> U.S. Capital Rules (REGULATORY_REQUIREMENT)",
        "U.S. Capital Rules (REGULATORY_REQUIREMENT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2938,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 177,
        "total_tokens": 1577
      }
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "The Revolving Loan Credit Agreement evolved from a $3.0 billion facility maturing in December 2025 (as disclosed in the 2023 filing) to a $5.0 billion facility with a new maturity in October 2029, reflecting an expansion of capacity and a later maturity date. This amendment, noted in both the 2023 and 2024 documents, also replaced the prior December 2020 agreement and removed the $1.0 billion of senior notes due within the next 12 months from the 2024 debt disclosure, underscoring the updated credit structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Revolving Loan Credit Agreement (FIN_INST)",
        "Revolving Loan Credit Agreement (FIN_INST) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7228,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2446,
        "completion_tokens": 128,
        "total_tokens": 2575
      }
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "UPS's relationship with Coyote evolved from a strategic partnership to a divestiture, as evidenced by the KG pattern showing UPS partnered with Coyote and subsequently divested from it. In 2024, UPS completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax), which was recognized in other expenses and excluded from ongoing operating metrics to reflect its non-recurring nature. This transaction marked the end of UPS's operational relationship with Coyote, shifting from partnership to exit, and the financial impact was a one-time gain that contributed to UPS's 2024 results while also triggering related transformation costs under its broader efficiency initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Divests]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Coyote (COMP)",
        "Coyote (COMP) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9280,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2945,
        "completion_tokens": 178,
        "total_tokens": 3123
      }
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific's relationship with chassis underwent a significant shift in both scale and ownership structure. In 2023, Union Pacific operated 48,340 total chassis units (30,635 owned and 17,705 leased), but by 2024, this had sharply declined to 5,553 total chassis units (4,356 owned and 1,197 leased), reflecting a reduction of over 88% in total chassis inventory. This contraction is further underscored by the ownership shift: while Union Pacific owned 63.8% of its chassis fleet in 2023, it owned only 78.4% of the much smaller 2024 fleet, indicating a relative increase in leased proportion despite the dramatic overall reduction. The data reveals a strategic pivot away from maintaining large owned/leased chassis fleets toward a more asset-light model, with the company now operating just 5,553 total chassis units compared to 48,340 the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Chassis (PRODUCT)",
        "Chassis (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 991,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 879,
        "completion_tokens": 220,
        "total_tokens": 1099
      }
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Boeing's aluminum agreements have evolved from being disclosed as non-hedge derivatives in 2022 to continuing as non-designated derivatives in 2024, with fair value changes recorded directly in earnings rather than comprehensive income. These agreements, classified as derivatives for accounting purposes but not designated for hedge accounting, involve quantities offset at prevailing market prices to address long-term strategic sourcing needs and non-U.S. business requirements, with no specified time horizon beyond their contractual terms. The 2024 filing confirms these instruments remain non-hedge derivatives where fair value fluctuations impact earnings immediately, consistent with the 2022 treatment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Aluminum Agreements (FIN_INST)",
        "Aluminum Agreements (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4847,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1863,
        "completion_tokens": 177,
        "total_tokens": 2041
      }
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Based on the provided 10-K filings and KG triplets, Procter & Gamble's exposure to currency rate risk has remained consistent between fiscal years ended June 30, 2023 and June 30, 2024, with no material change in hedging instruments or confidence levels. The company continues to primarily use forward contracts and currency swaps with maturities under 18 months to manage currency exposure, and explicitly states that at a 95% confidence level based on historical movements, near-term currency rate changes would not materially affect its financial statements—mirroring the same language and risk assessment approach in both filings. This consistency reflects stable hedging practices and confidence in mitigating exchange rate fluctuations through its diversified portfolio and centralized risk management strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "PG (ORG) -> Currency Rate Exposure (RISK_FACTOR)",
        "Currency Rate Exposure (RISK_FACTOR) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11256,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3479,
        "completion_tokens": 204,
        "total_tokens": 3684
      }
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Adobe's integration of Frame.io has significantly expanded functionally and technically between 2022 and 2024, evolving from a standalone collaboration platform into a deeply embedded component of its ecosystem. Initially referenced in Adobe's 2022 10-K as part of its trademark portfolio (Chunk 1), Frame.io was positioned as a cloud-native tool for real-time creative asset production, with direct integrations into Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront to enable frame-specific feedback and Camera to Cloud workflows (Chunk 2). By 2024, Frame.io's role was further solidified through its inclusion in Adobe G Studio alongside Adobe Express and Firefly Services, enabling enterprise-scale content production, while its integration with Adobe Stock and Creative Cloud Apps allowed seamless asset access and workflow continuity across the suite (Chunk 2). This evolution reflects Adobe's strategic move to unify creative workflows—from asset creation and editing to collaboration and distribution—within a single, AI-enhanced ecosystem, where Frame.io now serves as a critical nexus for production pipelines rather than a standalone product.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Frame.io (COMP)",
        "Frame.io (COMP) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5921,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2117,
        "completion_tokens": 293,
        "total_tokens": 2411
      }
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between fiscal years 2022 and 2023, AMD's financial relationship with the ATMP JV evolved in two key aspects: First, the carrying value of AMD's 15% equity investment in the ATMP JV increased from $69 million at December 25, 2021 (reported in 2022 10-K) to $63 million at December 26, 2020 (reported in 2021 10-K), indicating a $6 million increase year-over-year in the investment's book value. Second, while AMD continues to account for this investment using the equity method of accounting and reports related-party transactions (including $1.1 billion in purchases and $28 million in resales during 2021) within its consolidated financial statements without impacting net income, the 2023 10-K filing specifically notes that during the second quarter of fiscal 2022, AMD reassigned goodwill balances among updated reportable segments reflecting structural changes, though this reorganization does not alter the fundamental nature of its ATMP JV relationship or equity accounting treatment. The disclosures maintain consistency in highlighting the non-controlling nature of the investment ($69M → $63M carrying value), the absence of funding obligations, and the continued use of equity method accounting despite segment realignment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5282,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1966,
        "completion_tokens": 308,
        "total_tokens": 2275
      }
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell's revenue from Commercial Aviation Original Equipment declined from $2,397 million in 2023 to $2,223 million in 2024, representing a $174 million decrease year-over-year. This reduction occurs within a broader aerospace context where Honeywell's total aerospace sales grew from $13,624 million (2023) to $15,458 million (2024), indicating the company is expanding its aerospace footprint despite this specific product line contraction. The decline in Original Equipment revenue contrasts with growth in Aftermarket ($7,144 million in 2024 vs. $6,241 million in 2023) and Defense & Space ($6,091 million in 2024 vs. $4,986 million in 2023), suggesting Honeywell is strategically shifting toward higher-margin aerospace services and defense segments to maintain its sector position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "HON (ORG) -> Commercial Aviation Original Equipment (PRODUCT)",
        "Commercial Aviation Original Equipment (PRODUCT) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6716,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2332,
        "completion_tokens": 197,
        "total_tokens": 2530
      }
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, reflecting a 10.2% total change (10.3% excluding exchange impact). This growth was driven by a 10.2% increase in the Heart Failure segment revenue, as reported in the 2024 financial data showing $1,279 million for 2024 versus $1,161 million for 2023, with the percentage change explicitly stated in the 2024 financial disclosure. The segment's performance was further contextualized by its inclusion within the broader Medical Devices portfolio, which reported total revenue of $16,887 million in 2023 and $16,887 million in 2023 (with 2024 figures showing progression toward $16,887 million in the context of the segment's growth trajectory).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Heart Failure Devices (PRODUCT)",
        "Heart Failure Devices (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7231,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2450,
        "completion_tokens": 191,
        "total_tokens": 2642
      }
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "IBM's treatment of the 0.300% Notes due 2028 evolved from being designated as Exhibit 4.1 to Form 8-K filings in 2020 (as documented in the 2022 10-K filing on page 35, which references the February 10, 2020 Form 8-K incorporating Exhibits 4.1–4.3 for these notes) to being explicitly listed as a registered debt instrument under IBM's 2023 10-K filing (on page 1, where \"0.300% Notes due 2028\" appears under \"Title of each class\" with trading symbol IBM 28B on the New York Stock Exchange), reflecting a formal transition from private placement documentation to public market registration. This progression is reinforced by the knowledge graph relationship where IBM (ORG) has a stake in the 0.300% Notes due 2028 (FIN_INST), which in turn introduces IBM as its issuer, confirming the notes' ongoing structural linkage to IBM across both filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.300% Notes due 2028 (FIN_INST)",
        "0.300% Notes due 2028 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8968,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2869,
        "completion_tokens": 211,
        "total_tokens": 3081
      }
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region improved from 2022 to 2023, with net sales increasing from $29,375 million to $30,658 million and operating income rising from $11,569 million to $13,062 million. This growth reflects positive regional momentum, as highlighted by the geographic segmentation reporting structure where Rest of Asia Pacific (GPE) is managed separately within Apple's organizational framework (ORG), enabling targeted assessment of its distinct market dynamics and customer base.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Rest of Asia Pacific (GPE)",
        "Rest of Asia Pacific (GPE) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3664,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 131,
        "total_tokens": 1685
      }
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The vesting period for stock options issued under the 2007 Omnibus Incentive Plan has shortened from a five-year pro rata schedule for grants prior to 2022 to a four-year pro rata schedule for grants made after December 31, 2021, as disclosed in both the 2022 and 2024 10‑K filings. This change applies to options (and similarly to RSUs and PSUs) granted under the amended and restated plan, while options awarded to outside directors remain fully vested at grant. The evolution reflects the Company's updated equity compensation framework, which also extends the total authorized share reserve from roughly 127 million shares (as of 2021) to about 135 million shares authorized by 2024, with approximately 47 million shares still available for future issuance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> 2007 Omnibus Incentive Plan (ACCOUNTING_POLICY)",
        "2007 Omnibus Incentive Plan (ACCOUNTING_POLICY) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7170,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2462,
        "completion_tokens": 190,
        "total_tokens": 2653
      }
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "From 2022 to 2023, CVS maintained its Level 2 debt securities validation methodology with no material changes to price adjustment practices. The company continued its quarterly secondary source price comparisons and internal fair value assessments across both years, explicitly stating it \"did not adjust any of those prices at December 31, 2023 or 2022\" (Chunk 2), mirroring the 2021/2020 practice noted in Chunk 1. While both filings describe identical validation processes involving observable market inputs, methodology reviews, and internal/external price cross-checks, Chunk 1 specifically references 2021/2020 as the period when no price adjustments occurred, establishing that the no-adjustment practice was consistent through 2023. The KG triplet connections (CVS → Level 2 Debt Securities Prices ← Discloses CVS) confirm this validation framework remained unchanged year-over-year, with no incremental details about 2023-specific adjustments provided in either chunk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Obtains]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Level 2 Debt Securities Prices (FIN_INST)",
        "Level 2 Debt Securities Prices (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_153",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5606,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2057,
        "completion_tokens": 244,
        "total_tokens": 2301
      }
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "CVS maintained the same classification methodology for privately-placed equity securities in both 2022 and 2023, consistently categorizing them as Level 3 due to the absence of an active market and reliance on internal pricing through financial statement and cash flow analysis. The company's valuation approach remained unchanged, continuing to use significant unobservable inputs such as earnings and revenue multiples, discount for lack of marketability, and comparability adjustments to determine fair value. While the specific unobservable inputs and their directional impacts were detailed for 2022, the 2023 disclosure confirms the methodology persisted without modification, with fair value determinations still driven by internal analysis of comparable public bonds and sector indices for Level 3 securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Classifies]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Privately-Placed Equity Securities (FIN_INST)",
        "Privately-Placed Equity Securities (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_153",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5606,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2060,
        "completion_tokens": 204,
        "total_tokens": 2264
      }
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue from Alphagan/Combigan decreased by $24 million (8.8%) from $272 million in 2023 to $248 million in 2024, with international revenue showing a 1.5% increase ($151 million to $153 million) while U.S. revenue declined 21.8% ($121 million to $95 million). This aligns with the KG pattern where ABBV discloses Alphagan/Combigan as its product, and the international revenue trend shows growth (20.2% in 2023 to 24.4% in 2024 at constant currency) despite overall revenue decline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Alphagan/Combigan (PRODUCT)",
        "Alphagan/Combigan (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14548,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4276,
        "completion_tokens": 124,
        "total_tokens": 4400
      }
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy transitioned from a dependent operational partnership to full ownership following its 2023 acquisition, eliminating the prior \"Depends_On\" linkage and establishing Chevron as the sole controlling entity. This strategic integration directly contributed to Chevron's 7% year-over-year increase in worldwide oil-equivalent production to 3.3 million barrels per day in 2024, as explicitly attributed to \"the full-year of legacy PDC Energy production\" within its consolidated operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> PDC Energy (COMP)",
        "PDC Energy (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3485,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 130,
        "total_tokens": 1640
      }
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "From 2023 to 2024, UPS expanded its cold-chain logistics capabilities through strategic acquisitions, specifically adding Bomi Group and MNX Global Logistics in 2023 to strengthen its healthcare logistics infrastructure, and later acquiring Frigo-Trans and Biotech & Pharma Logistics in January 2025 for approximately $440 million to further enhance its international complex healthcare logistics reach, as evidenced by the KG pattern where Cold-Chain Logistics Capabilities (PRODUCT) is enhanced by UPS (ORG) and these acquisitions directly contributed to this capability evolution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enhances]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Cold-Chain Logistics Capabilities (PRODUCT)",
        "Cold-Chain Logistics Capabilities (PRODUCT) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3584,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 145,
        "total_tokens": 1686
      }
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Linde plc's non-employee director restricted stock unit (RSU) award program has evolved through a series of governance and shareholder alignment enhancements, as evidenced by its accounting policy disclosures and plan documentation across multiple filings. The 2021 Linde plc Long Term Incentive Plan (Exhibit 10.02 in the 2021 10-Q) introduced standardized RSU awards for directors, explicitly linking compensation to long-term value creation and aligning director interests with shareholders through performance-based equity components. This was expanded in 2024 with the adoption of the Linde plc Non-employee Director Deferral Program (Exhibit 10.16), which institutionalizes deferred compensation and reinforces long-term stewardship by requiring directors to hold deferred equity until post-retirement, thereby deepening alignment with enduring shareholder value. The program’s evolution is further anchored in its disclosure within the 2022 10-K (Item 4.08–4.11) and 2024 10-K (Exhibit 10.10i), which collectively show the transition from legacy Praxair plans to unified, performance-metric-driven RSU frameworks under the 2021 Plan, reflecting a deliberate governance shift toward accountability and sustained shareholder confidence.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Non-Employee Director Restricted Stock Unit Award (ACCOUNTING_POLICY)",
        "Non-Employee Director Restricted Stock Unit Award (ACCOUNTING_POLICY) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15105,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4450,
        "completion_tokens": 310,
        "total_tokens": 4760
      }
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors' legal relationship with Stellantis remained anchored in indemnification obligations stemming from the 2017 sale of Opel/Vauxhall, as detailed in GM's 2024 10-K (Chunk 2). GM continues to indemnify Stellantis for losses arising from breaches of representations, warranties, or covenants in the sale agreement—including costs related to emissions claims, recalls (such as Takata inflators in legacy Opel vehicles), and regulatory actions like the European Commission and UK CMA investigations into end-of-life vehicle coordination (which involve Opel, a former GM subsidiary now owned by Stellantis). While GM accrued an immaterial amount for these matters as of December 31, 2024, and cannot estimate potential losses, the indemnification framework persists with time limitations and caps, though no material liability has materialized recently.  \n\nThis legal dynamic is financially contextualized by GM's non-operating income in 2021, which included $0.2 billion in gains from Stellantis warrants (Chunk 1), reflecting early investment upside. However, by 2024, GM's focus shifted to resolving legacy liabilities—such as the $2.6 billion accrual for the Chevrolet Bolt recall and associated reimbursements from LG Energy Solution (Chunk 2)—while disentangling itself from Stellantis-related obligations. The absence of recent gains from Stellantis in GM's 2024 filings underscores a strategic and financial evolution: where 2021 featured active investment upside, 2022–2024 centered on indemnification risk management and operational cleanup, with no material gains or losses directly tied to Stellantis in GM's current financial position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Guarantees]- ORG",
      "triplets_used": [
        "GM (ORG) -> Stellantis (COMP)",
        "Stellantis (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6494,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2261,
        "completion_tokens": 419,
        "total_tokens": 2681
      }
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "Southern Company's treatment of energy-related derivatives shifted from explicit disclosure of pre-tax effects on income in its 2022 filing (Chunk 1) to integrated presentation within broader risk management disclosures in its 2024 filing (Chunk 2), reflecting a move from standalone income statement reporting to combined balance sheet categorization under \"Risk Management Activities\" while maintaining consistent financial instrument classification as disclosed through the ORG-FIN_INST dependency pattern.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-Related Derivatives (FIN_INST)",
        "Energy-Related Derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_327",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_283",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 630,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 808,
        "completion_tokens": 127,
        "total_tokens": 935
      }
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, GILD's strategic relationship with Arcus evolved significantly through increased equity ownership and governance influence. In 2023, GILD owned 14.8 million shares representing 19.9% of Arcus' voting stock and held two board designees. Following a $320 million equity investment in January 2024 that amended their Collaboration Agreement, GILD's ownership increased to 33% and its board representation expanded to three designees, reflecting strengthened strategic control and partnership. This progression aligns with the KG pattern showing mutual investment and dependency between GILD and Arcus as both ORG entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Arcus (COMP)",
        "Arcus (COMP) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11277,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3448,
        "completion_tokens": 160,
        "total_tokens": 3609
      }
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "Between 2022 and 2023, the maturity date of the 2021 Multicurrency Credit Facility was extended from June 30, 2025 (as amended in December 2021) to July 1, 2026 (per the June 29, 2023 amendment disclosed in Chunk 2), while its borrowing capacity remained unchanged at $6.0 billion (consistent with the December 2021 amendment and confirmed in both Chunk 1 and Chunk 2 as of December 31, 2023). Additionally, the facility’s sublimit for multicurrency borrowings stayed at $3.5 billion, and borrowing activity shifted from significant draws in 2021 ($7.8 billion borrowed, $3.4 billion repaid) to net repayments in 2023 ($3.0 billion borrowed, $6.1 billion repaid), reflecting strategic deleveraging using facility proceeds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Modifies]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 Multicurrency Credit Facility (FIN_INST)",
        "2021 Multicurrency Credit Facility (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7740,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2574,
        "completion_tokens": 180,
        "total_tokens": 2754
      }
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron's utilization of imported crude oil in U.S. refining operations remained steady at approximately 60% of refinery inputs in both 2023 and 2024, with no significant shift in its share of crude oil inputs despite evolving refinery capacity utilization trends. This consistency occurred alongside a decline in U.S. refinery capacity utilization, which dropped from 90.8% in 2023 to 86.6% in 2024 at Chevron-operated refineries, while overall crude unit distillation utilization across the company's network also decreased from 89.8% in 2023 to 87.9% in 2024. The Pasadena Refinery upgrade, completed in 2024 with phased operation through Q1 2025, aims to enhance light crude throughput capacity to 125,000 barrels per day, enabling increased processing of Permian Basin equity crude and improved product supply to the U.S. Gulf Coast, though this advancement does not alter the fundamental 60% imported crude dependency pattern observed in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Processes]-> RAW_MATERIAL <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Imported Crude Oil (RAW_MATERIAL)",
        "Imported Crude Oil (RAW_MATERIAL) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6572,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2293,
        "completion_tokens": 238,
        "total_tokens": 2532
      }
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS reduced its British Pound Sterling hedging position from $663 million in 2023 to $536 million in 2024, a decrease of $127 million, while simultaneously increasing hedges in other currencies such as the Euro and Hong Kong Dollar. This shift reflects a strategic rebalancing of currency exposure, indicating that UPS is actively managing its GBP risk—likely by scaling back GBP hedges as the pound’s volatility changed or as the company reallocates capital to other foreign‑exchange positions to optimize overall currency risk management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "UPS (ORG) -> British Pound Sterling Hedges (FIN_INST)",
        "British Pound Sterling Hedges (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1096,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 924,
        "completion_tokens": 135,
        "total_tokens": 1059
      }
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "The fair value of Bank of America's money market investments increased from $1.2 billion at December 31, 2023 to $1.3 billion at December 31, 2024, reflecting a $100 million rise that indicates a modest strategic shift toward higher-yielding short-term instruments amid evolving interest rate conditions. This evolution aligns with the bank's disclosed investment pattern of holding money market investments as part of its broader portfolio of debt and equity securities, where fair value changes are reported in market making and similar activities, and is consistent with the knowledge graph relationship showing Bank of America (BAC) invests in money market instruments disclosed through regulatory filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Money Market Investments (FIN_INST)",
        "Money Market Investments (FIN_INST) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5496,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2026,
        "completion_tokens": 177,
        "total_tokens": 2203
      }
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell-back options has declined across Southern Company's subsidiaries from 26 million mmBtu in 2022 (comprising 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power) to 15 million mmBtu in 2024 (allocated as 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power), reflecting a reduction of 11 million mmBtu in total expected sell-back volume over the two-year period. This change is documented in both the 2022 and 2024 10-K filings, with the 2024 disclosure specifying the updated volume distribution across subsidiaries while maintaining the same contractual feature of allowing sell-back due to operational constraints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Physical Natural Gas Supply Contracts (FIN_INST)",
        "Physical Natural Gas Supply Contracts (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_319",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_281",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4520,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1785,
        "completion_tokens": 224,
        "total_tokens": 2009
      }
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "The Firefly Vector Model’s integration has expanded from a standalone feature in Adobe Illustrator and Fresco (2023) to a core, AI‑enhanced capability embedded across the entire Creative Cloud suite by 2024, powering Generative Recolor in Illustrator, AI‑driven tools in Premiere Pro and After Effects, and enabling text‑to‑vector generation directly within InDesign, Adobe Express, and Firefly‑powered services, thereby unifying vector creation, design templates, and commercial‑safe AI workflows across all Adobe products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Firefly Vector Model (PRODUCT)",
        "Firefly Vector Model (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10426,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3240,
        "completion_tokens": 131,
        "total_tokens": 3371
      }
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "From 2023 to 2024, the commercial significance of Biktarvy for GILD evolved from being a dominant HIV revenue driver to facing significant competitive and strategic challenges. In 2023, Biktarvy generated $11,850 million in total sales (U.S.: $9,692M, Europe: $1,253M, Other Int’l: $905M), representing a substantial portion of GILD’s $18,175M total HIV revenue, but by 2024, its market position was threatened by generic competition and shifting treatment paradigms, as highlighted in the 2024 10-K risk factors noting that \"we may be unable to sustain or increase sales of our HIV products... including the inability to introduce new HIV medications necessary to remain competitive.\" This directly impacts GILD's HIV business strategy, which must now prioritize pipeline innovation and differentiation to maintain revenue, rather than relying on Biktarvy's historical dominance, as evidenced by the 2023 data showing Biktarvy's $11,850M contribution to a total HIV market of $18,175M, while the 2024 risks explicitly warn that \"nucleoside-based therapeutics do not remain the preferred regimen\" could \"adversely impact\" sales. Consequently, GILD's HIV strategy must shift toward developing next-generation therapies to offset Biktarvy's declining commercial relevance, as the company's future growth increasingly depends on mitigating this specific risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 32241,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 8696,
        "completion_tokens": 339,
        "total_tokens": 9035
      }
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "The Series 2018-1A Securities maintained a consistent interest rate of 3.652% from 2018 through 2023, with outstanding principal declining slightly from $496.8 million (as of December 31, 2022) to $496.1 million (as of December 31, 2023), reflecting ongoing amortization of the original $500.0 million issuance. This structure remained distinct from other financing arrangements, including the Series 2023-1A Securities issued in 2023 with a higher 5.490% rate and different maturity profile, while the underlying Loan securing the 2018 Securities continued to be backed by tower assets and cash flows subject to DSCR requirements that influenced distributions to the Company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Series 2018-1A Securities (FIN_INST)",
        "Series 2018-1A Securities (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8440,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2756,
        "completion_tokens": 169,
        "total_tokens": 2925
      }
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "From 2023 to 2024, UPS's strategic relationship with Coyote underwent a material shift driven by financial performance and corporate restructuring. In 2023, UPS recorded an $111 million goodwill impairment charge on the Coyote trade name following declining brokerage revenues and initiated strategic alternatives evaluation, with the trade name's carrying value at $89 million as of December 31, 2023 (Chunk 1). By 2024, UPS completed the divestiture of Coyote in September 2024, directly contributing to a $976 million revenue decline in Forwarding businesses within Supply Chain Solutions, while simultaneously reporting $510 million in growth from Logistics acquisitions like MNX Global (Chunk 2). This transaction marked a strategic pivot away from Coyote's brokerage model toward integrated logistics growth, as evidenced by the $163 million revenue increase in digital businesses driven by Roadie and Happy Returns acquisitions, demonstrating UPS's reallocation of resources toward more profitable segments (Chunk 2). The financial impact thus evolved from significant impairment risk in 2023 to complete divestiture and revenue reallocation in 2024, reflecting a deliberate shift in strategic direction toward scalable logistics capabilities rather than brokerage operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Announces]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Coyote (COMP)",
        "Coyote (COMP) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7376,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2466,
        "completion_tokens": 320,
        "total_tokens": 2787
      }
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "Linde plc's Performance Share Unit Awards structure evolved from its 2019 inception through 2024, maintaining the dual performance metric framework initially established under Praxair's 2009 Long Term Incentive Plan. As documented in both 2018 and 2024 filings, the awards continued to utilize Return on Capital and Total Shareholder Return performance metrics for grants beginning in 2019, with no indication of metric changes in subsequent years including up to 2024. The consistent reference to these specific metrics across exhibits in Linde plc's 2018 Annual Report (Exhibits 10.11k and 10.11l) and their recurrence in the 2024 filing (Exhibits 10.10l and 10.10m) confirms the structural continuity of the Performance Share Unit Awards framework without modification to the underlying performance criteria.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Performance Share Unit Award (FIN_INST)",
        "Performance Share Unit Award (FIN_INST) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15302,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4476,
        "completion_tokens": 202,
        "total_tokens": 4678
      }
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "The regulatory trajectory of Trodelvy has evolved from its initial FDA approval for metastatic triple-negative breast cancer (as detailed in Chunk 1) to receiving a second Breakthrough Therapy designation in 2024 for extensive-stage small cell lung cancer (SCLC), specifically following progression on platinum-based chemotherapy (as documented in Chunk 2). This progression indicates a strategic expansion of Trodelvy's development pathway beyond its original oncology indication into hematologic malignancies, leveraging accelerated clinical validation to support multiple high-unmet-need cancer types under the FDA's expedited review framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9246,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2941,
        "completion_tokens": 161,
        "total_tokens": 3102
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "From 2023 to 2024, Vertex AI's role within Google Cloud has evolved from a general platform for AI development to a specialized, generative AI-focused hub deeply integrated with Google's latest models like Gemini. Chunk 2 confirms Vertex AI enables developers to \"train, tune, augment, test, and deploy applications using Gemini and other leading generative AI models,\" while Chunk 1 establishes Gemini as Google's \"most capable and general model\" launched in December 2023, explicitly designed to be \"multimodal\" for understanding text, code, audio, images, and video. This integration allows Vertex AI to serve as the primary conduit for delivering Gemini's capabilities to cloud customers, moving beyond foundational AI infrastructure (mentioned in Chunk 1's \"AI-optimized infrastructure\" and \"mature AI platform\") to become the central engine for enterprise generative AI innovation, as emphasized in Chunk 2's description of Vertex AI providing \"the ability to train, tune, augment, test, and deploy applications using Gemini.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Vertex AI Platform (PRODUCT)",
        "Vertex AI Platform (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10709,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3322,
        "completion_tokens": 258,
        "total_tokens": 3580
      }
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "From 2022 to 2024, Southern Company (SO) has consistently treated weather derivatives as immaterial instruments that are excluded from formal derivative valuations and disclosures. As noted in SO’s 2022 10-K (page 122), the company omits the premium and intrinsic value of weather derivatives from its fair‑value calculations, describing those amounts as immaterial for all periods presented, and it also excludes cash collateral held in broker margin accounts from the derivative balance‑sheet totals. The 2024 10‑K (page 285) confirms this approach, stating that net amounts of derivative instruments outstanding likewise exclude the immaterial premium and intrinsic value of weather derivatives for all periods, while reporting gross collateral of $17 million (2024) and $62 million (2023) held in broker accounts. Thus, the treatment and valuation of these derivatives have remained unchanged: they are consistently regarded as immaterial, excluded from derivative fair‑value measurements, and only the related collateral is disclosed.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Weather Derivatives (FIN_INST)",
        "Weather Derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_285",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 969,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 897,
        "completion_tokens": 259,
        "total_tokens": 1157
      }
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Based on GILD's disclosures, Biktarvy's regulatory evolution between 2023 and 2024 reflects a strategic expansion of its market positioning. In 2023, Biktarvy was projected to maintain exclusivity through 2033 in both U.S. and EU markets (Chunk 1), establishing its long-term commercial foundation. By 2024, the FDA significantly broadened its scope: approving an expanded indication for Biktarvy to treat HIV patients with M184V/I resistance mutations and updating its label to include safety/efficacy data for pregnant individuals (Chunk 2). This regulatory advancement not only extends Biktarvy's therapeutic reach but also reinforces its market leadership by addressing unmet needs in resistant and vulnerable patient populations, directly building upon its established 2033 exclusivity timeline while enhancing its clinical value proposition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4580,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1770,
        "completion_tokens": 211,
        "total_tokens": 1981
      }
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "Between 2022 and 2023, AMT's utilization of the 2021 Multicurrency Credit Facility shifted significantly in both borrowing volume and facility structure. While the company borrowed $3.0 billion and repaid $6.1 billion (including €842.6 million/EUR) under the facility during 2023, this activity occurred within the context of a key amendment on June 29, 2023, which extended the facility's maturity to July 1, 2026, increased commitments to $6.0 billion, and replaced LIBOR with SOFR as the pricing benchmark. The 2022 10-K (Chunk 1) notes net borrowings of $850.0 million under this facility subsequent to December 31, 2021, primarily for debt repayment and general corporate purposes, establishing a baseline for its strategic use. By 2023, as detailed in the 10-K (Chunk 2), AMT actively leveraged the amended facility for substantial revolving indebtedness repayments—including the full repayment of the 2021 USD Two Year Delayed Draw Term Loan—while simultaneously extending maturities and increasing available capacity, demonstrating a marked evolution in how the facility was deployed to manage liquidity and optimize debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> 2021 Multicurrency Credit Facility (FIN_INST)",
        "2021 Multicurrency Credit Facility (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3354,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1489,
        "completion_tokens": 285,
        "total_tokens": 1774
      }
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "The role of Google Ad Manager in Alphabet's advertising revenue recognition strategy has evolved significantly between 2023 and 2024 through enhanced integration with revenue reporting models. In 2023, Alphabet recognized advertising revenues from Google Network properties on a gross basis for ads placed through Google Ad Manager, recording billed amounts as revenue and payments to partners as cost of revenue, while also recognizing performance advertising revenue upon user engagement and brand advertising revenue upon ad display. By 2024, this model remained consistent but was further clarified in the context of Google Ad Manager's function within the broader advertising ecosystem, where it serves as a key platform for delivering inventory that is monetized through Google Ads, Google Display & Video 360, and Google Marketing Platform, with Alphabet maintaining principal status and control over the advertising inventory before transfer to customers, thereby reinforcing gross revenue recognition for network property ads. This evolution reflects a sustained, strategically integrated approach to revenue recognition centered on Google Ad Manager's role in delivering and monetizing advertising inventory across Alphabet's platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Ad Manager (PRODUCT)",
        "Google Ad Manager (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8532,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2782,
        "completion_tokens": 311,
        "total_tokens": 3094
      }
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "Between 2023 and 2024, UPS's financial exposure and strategic positioning regarding Roadie evolved significantly, particularly in terms of goodwill impairment and risk assessment. While UPS did not record any goodwill impairments in 2024, it had previously recorded $56 million in impairment charges related to Roadie in 2023, indicating prior financial strain. The 2024 annual impairment testing revealed that Roadie, along with two other reporting units, exhibited limited excess of fair value above carrying value, making them more susceptible to future impairment risks—especially if cost of capital increases or cash flows decline. This heightened risk is underscored by the fact that approximately $1.1 billion of UPS’s $4.3 billion consolidated goodwill balance is tied to these three high-risk reporting units, including Roadie, which was acquired in 2021 for an undisclosed purchase price allocation (as detailed in Chunk 1). Furthermore, the strategic integration of Roadie within UPS’s Supply Chain Solutions segment reflects a deliberate effort to leverage its technology platform for scalable same-day delivery, but its ongoing vulnerability to impairment—despite no 2024 charges—highlights the financial and operational risks associated with its performance and market positioning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Roadie (COMP)",
        "Roadie (COMP) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5395,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1984,
        "completion_tokens": 323,
        "total_tokens": 2308
      }
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "Linde's helium supply relationship has evolved from a supplier role in 2022 to a more complex operational dynamic by 2024, where helium is now recognized as a raw material whose scarcity and cost pressures negatively impact the company's helium-related businesses. This shift is quantitatively reflected in the 2024 financial results showing a $32 million (2%) decline in \"Other\" sales—primarily driven by lower helium volumes—while operating profit in this segment increased $19 million (44%) due to insurance recoveries offsetting higher helium costs, demonstrating that despite volume reductions, strategic management of helium-related expenses improved profitability. The KG triplet relationship (LIN -[Supplies]-> Helium <-[Negatively_Impacts]- LIN) directly explains this paradox, as helium's status as a critical raw material whose supply constraints and price volatility simultaneously depress sales volumes yet elevate operating costs, requiring nuanced financial management to achieve net profit growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> RAW_MATERIAL <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Helium (RAW_MATERIAL)",
        "Helium (RAW_MATERIAL) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1321,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 971,
        "completion_tokens": 253,
        "total_tokens": 1224
      }
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long-term credit protection agreements with FNMA and FHLMC increased from $8.7 billion at December 31 2023 to $8.0 billion at December 31 2024, reflecting a modest rise in the protected portfolio. This growth indicates that the Corporation’s credit‑risk exposure on residential mortgage loans is expanding, as a larger pool of insured mortgages is now subject to full credit protection, thereby increasing the potential magnitude of future loss‑absorbing obligations despite the absence of an allowance for credit losses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Credit Protection Agreements (ACCOUNTING_POLICY)",
        "Credit Protection Agreements (ACCOUNTING_POLICY) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6407,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2273,
        "completion_tokens": 140,
        "total_tokens": 2413
      }
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Adobe's strategic positioning of Adobe Firefly has evolved from a generative AI capability natively integrated into Creative Cloud and Document Cloud (as noted in Chunk 1's emphasis on \"generative AI capabilities that are natively integrated into our products and designed to be safe for commercial use\") to a central differentiator in its 2024 AI strategy, explicitly highlighted as a response to rapid industry shifts in generative AI that could disrupt Adobe's core markets (Chunk 2's discussion of AI innovation risks and the need to \"invest or adapt\" to avoid business harm). While Firefly's commercial safety and integration were initially positioned as competitive advantages, its 2024 regulatory landscape introduces significant new risks, including potential non-compliance with emerging AI regulations like the EU AI Act (2024), which could force costly changes to development practices, delay AI offerings, or create liability exposure—risks Adobe acknowledges as material enough to be detailed in its 2024 10-K risk factors (Chunk 2's \"Issues relating to the development and use of AI\" section). This evolution reflects a dual shift: Firefly's role has expanded from a feature to a strategic pillar for differentiation, but its associated regulatory risks have intensified, requiring Adobe to balance innovation with compliance in an increasingly complex global AI governance environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Firefly (PRODUCT)",
        "Adobe Firefly (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9173,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2934,
        "completion_tokens": 350,
        "total_tokens": 3284
      }
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "The financial performance and regulatory trajectory of Trodelvy evolved significantly between 2023 and 2024, with both dimensions clearly reflected across the provided data. Financially, Trodelvy generated $1,063 million in product sales during 2023, up 56% from $680 million in 2022, demonstrating strong growth that was further reinforced by its inclusion in GILD's total revenue stream of $27,116 million in 2023 (Chunk 1). This growth trajectory continued into 2024 as evidenced by regulatory momentum: Trodelvy received a second Breakthrough Therapy designation from the FDA for adult patients with extensive-stage small cell lung cancer whose disease has progressed on or after platinum-based chemotherapy (Chunk 2), building upon its prior Breakthrough Therapy designation. This regulatory advancement not only underscores the drug's clinical potential but also positions it for potential future revenue expansion, aligning with GILD's strategic focus on oncology innovations that complement its established HIV and liver disease portfolios.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8693,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2794,
        "completion_tokens": 262,
        "total_tokens": 3056
      }
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "From 2022 to 2024, Chevron's financial involvement in Angola LNG evolved from a $3,968 million equity‑affiliate earnings contribution in 2019 to a $5,657 million gain in 2021, reflecting improved upstream earnings and the absence of prior impairments, and by 2024 Chevron holds a 36.4 percent stake in Angola LNG Limited, with its investment balance supported by a $4,500 million loan for the Wellhead Pressure Management and Future Growth Projects, while its total share of equity‑affiliate earnings and net loans to affiliates reached $4,731 million at year‑end 2024, underscoring a strategic deepening of its equity position and financing role in the venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Angola LNG (COMP)",
        "Angola LNG (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3547,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 165,
        "total_tokens": 1696
      }
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, META's Fixed-Rate Senior Unsecured Notes increased from $18.50 billion to $29.0 billion, reflecting the $10.5 billion of new notes issued in August 2024 in addition to the $7.5 billion of existing notes carried forward. This issuance activity raised the total outstanding balance by roughly $10.5 billion, underscoring META's continued reliance on debt capital to fund operations and strategic initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Fixed-Rate Senior Unsecured Notes (FIN_INST)",
        "Fixed-Rate Senior Unsecured Notes (FIN_INST) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1777,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1081,
        "completion_tokens": 106,
        "total_tokens": 1187
      }
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "Based on the KG pattern showing LIN's dual relationship with Helium (Supplies/Depends_On) and the disclosures across both filings, LIN's financial exposure to helium shifted from a passive supply relationship in 2023 to an active operational dependency in 2024, as evidenced by the 2024 filing's explicit cost and sourcing language. While the 2023 10-K (Chunk 1) only notes helium as a \"supply\" without cost implications, the 2024 10-K (Chunk 2) reveals that helium now \"constitutes a critical dependency\" with \"significant cost increases\" directly tied to supply chain constraints, transforming it from a mere input into a material financial risk driver affecting production economics. This evolution is underscored by the reciprocal KG triplets (LIN→Helium and Helium→LIN), confirming the mutual operational and financial entanglement that intensified year-over-year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> RAW_MATERIAL <-[Depends_On]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Helium (RAW_MATERIAL)",
        "Helium (RAW_MATERIAL) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 94,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 672,
        "completion_tokens": 217,
        "total_tokens": 889
      }
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "Between 2022 and 2023, PayPal's utilization of European customer balances for credit activities was reduced from $3.8 billion (approved in 2022) to $3.0 billion (approved in 2023), reflecting a decrease of $0.8 billion. This represents a percentage change of approximately –21% (calculated as (3.0 – 3.8) / 3.8 × 100). The change aligns with the KG pattern ORG‑[Increases]-> FIN_INST ←‑[Depends_On]‑ORG, showing how PayPal (PYPL) adjusts the amount of European customer balances it can designate for credit activities over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Credit Activities (FIN_INST)",
        "Credit Activities (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9746,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3085,
        "completion_tokens": 132,
        "total_tokens": 3217
      }
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Starbucks' exposure to foreign currency - other instruments decreased from $1,164 million at September 29 2024 to $920 million at October 1 2023, reflecting a reduction in the fair‑value amount of these instruments.  The 2024 10‑K shows that $9.5 million of gains previously recorded in AOCI are expected to be reclassified into earnings within the next 12 months, while the remaining $39.6 million of gains remain in AOCI and will affect earnings as the underlying hedges mature.  This reclassification, together with the lower fair‑value balance, indicates a modest unwind of the company’s foreign‑currency hedging position between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1666,
        "completion_tokens": 162,
        "total_tokens": 1828
      }
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "Based on the comparative fair value disclosures across both years and entities, Alabama Power's energy-related derivatives increased from a $55 million asset to a $15 million asset, reflecting a $40 million decrease in fair value. Georgia Power's energy-related derivatives shifted from an $8 million liability to a $13 million asset, indicating a $21 million directional change from liability to asset. This represents a net directional evolution where Alabama Power moved from a smaller asset position to a smaller asset position (net decrease), while Georgia Power transitioned from a liability to an asset position (net increase of $21 million), demonstrating divergent evolutionary paths in their derivative valuations from 2022 to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-related derivatives (FIN_INST)",
        "Energy-related derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_311",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_281",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 23085,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6426,
        "completion_tokens": 185,
        "total_tokens": 6611
      }
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "The asset allocation strategy for the U.S. Retiree Health Care Plan shifted significantly from 2022 to 2023, with fixed income securities and cash equivalents increasing from 65% to 80% of the portfolio, while equity securities decreased from 35% to 20%. This reallocation reflects a strategic emphasis on capital preservation and income generation, as evidenced by the plan's enhanced fixed income position and reduced equity exposure compared to the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> U.S. Retiree Health Care Plan (FIN_INST)",
        "U.S. Retiree Health Care Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3222,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 115,
        "total_tokens": 1581
      }
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy evolved from receiving FDA approval for metastatic urothelial cancer to gaining EC approval for HR+/HER2- metastatic breast cancer, with both approvals occurring in 2023. In 2023 specifically, Trodelvy received two key new indications: EC approval for HR+/HER2- metastatic breast cancer following endocrine therapy and at least two systemic treatments, and FDA approval for the same indication in the metastatic setting, expanding its use beyond urothelial cancer to include a significant new breast cancer population. This expansion was supported by GILD's strategic collaboration with Fosun Kite Biotechnology, which facilitated the China NMPA approval of axicabtagene ciloleucel (Yikaida) for relapsed/refractory LBCL, demonstrating complementary regulatory progress across their oncology portfolio. The approvals were secured through GILD's ongoing development of Trodelvy as a Trop-2 directed ADC, with the 2023 regulatory milestones marking critical expansion into breast cancer treatment while maintaining its existing urothelial cancer indication.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2891,
        "completion_tokens": 280,
        "total_tokens": 3171
      }
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Meta's disclosure regarding \"user perception\" as a risk factor has evolved significantly between 2023 and 2024, shifting from broad operational and engagement concerns to heightened regulatory and legal vulnerabilities that directly threaten business continuity. In 2023, the risk centered on user sentiment declines due to content quality, privacy concerns, and platform integrity issues (e.g., \"concerns about the nature of content made available on our products, or concerns related to privacy, safety, security, well-being\"), alongside challenges in maintaining user engagement amid legislative changes like GDPR and CCPA (e.g., \"decreased engagement with our products, or failure to accept our terms of service, as part of changes that we have implemented or may implement in the future, whether voluntarily, in connection with the GDPR, the European Union's ePrivacy Directive, the DMA, the DSA, U.S. state privacy and youth social media laws including the California Consumer Privacy Act (CCPA), as amended by the California Privacy Rights Act (CPRA)\"). By 2024, the risk explicitly expands to include *regulatory invalidation of data transfer mechanisms* as a critical threat, with the company warning that \"European courts invalidating the EU-U.S. DPF or regulators, courts, or legislative bodies determining that the legal bases we rely upon to transfer user data from the European Union to the United States are invalid\" would \"limit our business operations\" in Europe—a direct consequence of evolving data privacy enforcement. This shift underscores a transition from *user behavior-driven risks* (2023) to *structural regulatory risks* (2024) that could materially disrupt Meta's core advertising revenue model and global operations, as evidenced by the 2024 chunk's focus on \"exposure to greater than anticipated tax liabilities\" tied to intercompany arrangements and regulatory scrutiny of data practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> User Perception (RISK_FACTOR)",
        "User Perception (RISK_FACTOR) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9314,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2984,
        "completion_tokens": 480,
        "total_tokens": 3464
      }
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "Based on the provided disclosures, Lockheed Martin's notional amount of outstanding interest rate swaps increased from $572 million in 2020 to $500 million in 2021 (as reported in the 2021 context), then significantly grew to $1.3 billion by December 31, 2024 (as disclosed in the 2024 filing), reflecting a strategic expansion of its interest rate risk management program. This evolution indicates a deliberate scaling up of the company's use of variable interest rate swaps to hedge fixed-rate debt and fixed interest rate swaps to hedge variable-rate borrowings, demonstrating a more robust and comprehensive approach to managing interest rate exposure across its capital structure over the multi-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Variable Interest Rate Swaps (FIN_INST)",
        "Variable Interest Rate Swaps (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12505,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3779,
        "completion_tokens": 178,
        "total_tokens": 3957
      }
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "PayPal's approach to its Seller Protection Programs evolved between 2022 and 2023 by shifting from a general description of transaction loss exposure to more specific financial provisioning for losses. In 2022, the company noted that transaction loss rates ranged between 0.09% and 0.15% of TPV and emphasized monitoring macroeconomic risks to merchant solvency that could increase losses, while in 2023 it disclosed concrete allowance figures of $64 million for transaction losses and $218 million for negative customer balances as of December 31, 2023, directly linking these reserves to its protection programs. The KG pattern confirms this progression through the ORG-Has_Risk-ACCOUNTING_POLICY relationship, showing how the company moved from qualitative risk discussion in 2022 to quantitative loss provisions in 2023, with both chunks collectively demonstrating the transition from risk monitoring to specific financial accounting for Seller Protection Program losses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Risk]-> ACCOUNTING_POLICY <-[Provides]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Seller Protection Programs (ACCOUNTING_POLICY)",
        "Seller Protection Programs (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7727,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2583,
        "completion_tokens": 243,
        "total_tokens": 2827
      }
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks' foreign currency - other derivative asset position decreased from $920 million at fiscal year‑end 2023 to $920 million at fiscal year‑end 2024 (no change), while its derivative liability position increased from $4.7 million (accrued liabilities) + $4.1 million (other long‑term liabilities) = $8.8 million in 2023 to $4.7 million + $4.1 million = $8.8 million in 2024 (no net change), but the magnitude of the liability shift is reflected in the balance‑sheet line items showing $4.7 million and $4.1 million for 2024 versus $2.0 million and $0 million for 2023, indicating a $2.7 million increase in the current‑portion and a $4.1 million increase in the long‑term portion. Overall, the net effect on the balance sheet is an approximate $2.7 million rise in accrued liabilities and a $4.1 million rise in other long‑term liabilities for foreign‑currency derivatives, representing the change magnitude from FY2023 to FY2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4387,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1752,
        "completion_tokens": 233,
        "total_tokens": 1986
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "The financial impact of energy-related derivatives on natural gas cost and revenue hedging positions shifted significantly from 2022 to 2023, with the net gain (loss) from these non-designated hedging instruments moving from a $144 million loss in 2022 to a $76 million gain in 2023, reflecting a $220 million improvement year-over-year. This evolution is directly tied to the derivatives' role in hedging natural gas revenues and costs, as evidenced by the $117 million loss in 2022 (Chunk 1) and the corresponding $(11) million gain in 2023 (Chunk 2), demonstrating how the company's hedging strategy mitigated volatility in natural gas-related financial results across the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-related derivatives (FIN_INST)",
        "Energy-related derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_327",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_295",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2346,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 172,
        "total_tokens": 1399
      }
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Based on the KG pattern ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG and the provided triplets, Walmart Inc. (WMT) introduces and discloses its Deferred Compensation Matching Plan as an accounting policy in both 2023 and 2024 10-K filings. In the 2023 filing (Chunk 1), it was disclosed as \"amended and restated effective November 8, 2023\" (page 84), while the 2024 filing (Chunk 2) confirms it remains \"amended and restated effective November 8, 2023\" but now references the 2024 filing specifically, indicating no change to the effective date but a formal incorporation into the latest annual report. Both chunks confirm the plan's documentation status as \"amended and restated\" with the same effective date, demonstrating consistency in its treatment across filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Deferred Compensation Matching Plan (ACCOUNTING_POLICY)",
        "Deferred Compensation Matching Plan (ACCOUNTING_POLICY) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 19403,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5514,
        "completion_tokens": 195,
        "total_tokens": 5709
      }
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, the disclosure of LTIP Units remained consistent in noting that no securities had a material dilutive effect for the years ended December 31, 2023, 2024, and 2022, as stated in both Chunk 1 (SPG_10k_2023.pdf) and Chunk 2 (SPG_10k_2024.pdf). The treatment of LTIP Units evolved in terminology—referring to them as \"LTIP units\" in 2024 versus \"LTIP unit\" in 2023—but maintained the same accrual policy of recognizing distributions when declared, with no adjustment to net income or weighted average shares for units allocable to limited partners due to their non-dilutive impact. KG triplets confirm the bidirectional relationship between SPG (ORG) and LTIP Units (FIN_INST), reflecting ongoing disclosure and grant connections across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1235,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 942,
        "completion_tokens": 191,
        "total_tokens": 1134
      }
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) has evolved significantly between 2023 and 2024 in direct response to regulatory actions and decisions. Following the Irish Data Protection Committee's (IDPC) May 2023 Final Decision imposing a €1.2 billion fine and corrective orders requiring Meta Platforms Ireland to suspend data transfers and bring processing into GDPR compliance—currently appealed with an interim stay from the Irish High Court—Meta has actively engaged with regulators to implement corrective measures, including steps to comply with these orders while simultaneously advancing its reliance on the newly established EU-U.S. DPF as the replacement for invalidated frameworks like Privacy Shield and the prior SCC-based mechanisms. This regulatory evolution is further contextualized by Meta's 2024 acknowledgment that the EU-U.S. DPF's adequacy decision (adopted July 2023) is a \"welcome milestone,\" yet its implementation remains critical amid ongoing scrutiny, including the European Commission's March 2024 formal proceedings against Meta's \"subscription for no ads\" model under the Digital Markets Act (DMA), which issued preliminary findings in July 2024 indicating non-compliance and scheduled a conclusion in March 2025. The company's compliance strategy now integrates both the EU-U.S. DPF's new safeguards and the evolving enforcement landscape, as evidenced by its November 2024 expansion of user choices for ad personalization in Europe while navigating concurrent regulatory challenges from the European Data Protection Board and national privacy authorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "META (ORG) -> EU-U.S. DPF (REGULATORY_REQUIREMENT)",
        "EU-U.S. DPF (REGULATORY_REQUIREMENT) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13553,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4043,
        "completion_tokens": 405,
        "total_tokens": 4448
      }
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Linde's approach to green hydrogen production has evolved significantly between 2023 and 2024, with a clear strategic shift toward emphasizing renewable energy sources and expanding green hydrogen capabilities. In 2023, the company primarily produced gray hydrogen from natural gas via steam methane reforming, while explicitly developing both blue and green hydrogen technologies, with green hydrogen defined as being produced by electrolysis using renewable energy or from biomethane via steam methane reforming. By 2024, Linde refined its terminology and focus, explicitly distinguishing between \"renewable hydrogen\" (produced via electrolysis using renewable energy and water as feedstock) and \"low-carbon (blue) hydrogen\" (produced from methane with carbon capture and sequestration), while continuing to recover by-product hydrogen for ultrahigh-purity applications. This evolution reflects a strategic emphasis on renewable energy integration, as evidenced by the 2024 document's clarification that green hydrogen production specifically relies on renewable energy sources, marking a deliberate progression from foundational R&D in 2023 to commercial-scale deployment with a stronger renewable energy focus in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Green Hydrogen (PRODUCT)",
        "Green Hydrogen (PRODUCT) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10329,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3223,
        "completion_tokens": 305,
        "total_tokens": 3528
      }
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company's relationship with Sequent evolved from ownership to complete divestiture between 2021 and 2023, with significant financial implications. In 2021, Southern Company Gas sold Sequent to Williams Field Services Group for $159 million cash, generating a $121 million pre-tax gain ($92 million after tax), but this was offset by $85 million in additional tax expenses due to changes in state apportionment rates (Chunk 1, Chunk 2e, Chunk 2f). The 2023 financial statements reflect the aftermath of this transaction, showing a $96 million pre-tax charge ($72 million after tax) at Nicor Gas related to disallowed capital investments and $131 million in impairment charges for \"All Other\" items, including the PennEast Pipeline investment that was abandoned after Southern Company Gas's equity method investment (Chunk 2b, Chunk 2c, Chunk 2d). These entries demonstrate that while Sequent itself was sold in 2021, its financial legacy continued to impact Southern Company's 2023 results through residual tax effects and ongoing portfolio impairments (Chunk 1 sale details, Chunk 2 tax/impairment disclosures).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> COMP <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "SO (ORG) -> Sequent (COMP)",
        "Sequent (COMP) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_302",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5551,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2016,
        "completion_tokens": 280,
        "total_tokens": 2296
      }
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Walmart's relationship with the Allswell brand has evolved from its initial introduction as a private brand under the \"Brand name merchandise\" portfolio in 2023 to continued prominence in 2024, where it remains explicitly listed among key private brands alongside \"bettergoods\" and other proprietary lines, indicating its strategic role in Walmart's private brand portfolio as a premium offering within the home and lifestyle category. This sustained inclusion across both 2023 and 2024 filings—despite the addition of newer private brands like \"bettergoods\"—demonstrates Walmart's deliberate curation of Allswell as a differentiated, higher-end private label designed to compete in the premium segment while leveraging its proprietary brand architecture to enhance margin and customer loyalty within its core merchandise units.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Allswell (PRODUCT)",
        "Allswell (PRODUCT) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5366,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1984,
        "completion_tokens": 207,
        "total_tokens": 2191
      }
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "Based on the strategic emphasis and revenue composition detailed across both filings, TXN's Embedded Processing products have evolved from a secondary growth lever to a critical pillar of its long-term strategy, as evidenced by explicit strategic prioritization in the 2023 filing and revenue dynamics described in both years. While Analog revenue declined 12.5% year-over-year in 2023 (driving overall revenue down to $17.52B), Embedded Processing revenue increased sufficiently to partially offset this drop, underscoring its rising contribution to the company's core growth narrative. This strategic shift is further reinforced by TXN's 2023 focus on \"designing and selling products into industrial and automotive markets\" – which it identifies as the \"best long-term growth opportunities\" – with Embedded Processing products serving as the digital \"brains\" for these high-priority applications, directly aligning with their role in generating strong operational cash flow ($6.42B) and justifying significant R&D/sales investments ($3.69B) to strengthen competitive advantages in this segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Focuses_On]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Embedded Processing Products (PRODUCT)",
        "Embedded Processing Products (PRODUCT) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7049,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2405,
        "completion_tokens": 274,
        "total_tokens": 2679
      }
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "Chevron's involvement in Angola LNG has evolved from a 36.4% equity stake in Angola LNG Limited (as disclosed in the 2024 10-K notes to consolidated financial statements) to a position where its share of production volumes is explicitly tracked alongside other key assets like Tengizchevroil in Kazakhstan, with natural gas consumption volumes reported at 592–603 million cubic feet per day in recent years. This strategic partnership, confirmed through the KG relationship pattern ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG connecting CVX and Angola LNG, underscores Chevron's deliberate focus on securing long-term, high-value LNG supply chains to strengthen its market position amid growing global demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Angola LNG (COMP)",
        "Angola LNG (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3759,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1572,
        "completion_tokens": 178,
        "total_tokens": 1750
      }
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "The CH-53K program has evolved from generating $540 million in net sales and contributing roughly $140 million of operating profit in 2021 (driven by higher production volume and lower risk retirements) to becoming a key growth driver for Lockheed Martin’s RMS division, accounting for about $1.1 billion of the $3.0 billion product‑sales increase in 2024 through higher production volume and new program ramp‑up. This trajectory underscores its strategic importance within RMS, positioning the CH‑53K as a primary engine for revenue and profit expansion in the division’s portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> CH-53K (PRODUCT)",
        "CH-53K (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3423,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 145,
        "total_tokens": 1643
      }
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "PayPal’s loss curves for revolving consumer credit products incorporated macroeconomic forecasts that were updated between 2022 and 2023. In 2022, the reasonable and supportable forecast period for revolving products was approximately 2 years, whereas in 2023 it was extended to approximately 5 years and 7 months to 3.5 years, reflecting longer projected loan lives and updated macroeconomic assumptions such as household disposable income and retail e‑commerce sales trends. These updated macroeconomic factors were sourced externally and applied to the principal amount of consumer receivables, with the 2023 loss curves also integrating qualitative adjustments and a single scenario deemed most appropriate for current economic conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Loss Curves (ACCOUNTING_POLICY)",
        "Loss Curves (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12137,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3672,
        "completion_tokens": 185,
        "total_tokens": 3858
      }
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "From 2023 to 2024, Starbucks' foreign currency debt-related gains or losses included in AOCI shifted from a $19.1 million gain in 2023 to a $135.2 million gain in 2024, reflecting a significant increase in unrealized hedging gains tied to foreign currency fluctuations. This change indicates that the company's exposure to foreign currency movements has intensified, particularly through its foreign currency debt and net investment hedges, which are now generating substantially higher unrealized gains in AOCI—suggesting greater sensitivity to currency volatility in its international operations and debt management strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency debt (FIN_INST)",
        "Foreign currency debt (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9712,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3081,
        "completion_tokens": 156,
        "total_tokens": 3237
      }
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "The fair value of energy-related derivatives for Alabama Power increased from $110 million in 2022 to $124 million in 2023, while Georgia Power’s fair‑value derivative liability rose from $110 million to $124 million as well, indicating a $14 million increase for each company. Consequently, the combined liabilities for these derivatives grew from $220 million in 2022 to $248 million in 2023, reflecting an upward trend in their total exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-related derivatives (FIN_INST)",
        "Energy-related derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_327",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_281",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13881,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4129,
        "completion_tokens": 111,
        "total_tokens": 4241
      }
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Walmart's financial relationship with Alert Innovation evolved through a strategic acquisition followed by disposition: In fiscal 2023, Walmart acquired 100% ownership of Alert Innovation for $0.4 billion as part of its broader subsidiary consolidation, bringing its stake to full control. However, by fiscal 2024, Alert Innovation was subsequently sold and deconsolidated, indicating a reversal of this ownership stake. This transaction pattern—initially acquiring full control (via the $0.4B buyout) and later disposing of the entity—reflects a deliberate financial maneuver where Walmart invested in Alert Innovation (per the ORG-Invests_In-COMP relationship) but ultimately divested through sale, as evidenced by the fiscal 2024 disposition activity noted in both chunks. The $0.4B acquisition cost in 2023 was distinct from the $3.5B Flipkart-related transaction in 2024, confirming Alert Innovation's exit from Walmart's portfolio by the end of fiscal 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Acquires]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Alert Innovation (COMP)",
        "Alert Innovation (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3893,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 250,
        "total_tokens": 1866
      }
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's regulatory pathway evolved from receiving **FDA approval for metastatic HR+/HER2- breast cancer** (Chunk 2) to securing **EC (European Commission) approval as monotherapy** for the same indication (Chunk 2), marking a significant expansion of its global footprint in oncology. This dual approval—first in the U.S. and later in Europe—demonstrates Gilead's strategic focus on advancing Trodelvy as a differentiated antibody-drug conjugate in multiple high-need cancer settings, reinforcing its commitment to building a robust oncology pipeline beyond its virology roots. The approvals, coupled with the acquisition of XinThera and Tmunity (Chunk 1), highlight Gilead's deliberate investment in next-generation oncology assets, including PARP1 inhibitors and armored CAR-T platforms, to diversify its portfolio and drive long-term growth in targeted cancer therapies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8160,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2671,
        "completion_tokens": 224,
        "total_tokens": 2896
      }
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Simon Property Group's financial relationship with ABG has evolved through strategic capital transactions that strengthened their partnership over time. In 2023, ABG completed two significant capital transactions resulting in SPG recognizing noncash pre-tax gains of $36.4 million (Q2) and $145.8 million (Q3), while simultaneously recording deferred tax expenses of $9.1 million and $36.9 million respectively, reflecting the financial impact of ownership dilution and strategic repositioning. This pattern continued SPG's historical trend of capitalizing on ABG transactions for strategic gains, as evidenced by the 2022 acquisition of Reebok assets and long-term partnership with ABG as core licensee, which established the foundation for their collaborative growth. By 2024, SPG maintained its focus on capital allocation, with $552 million in remaining net cash funding required for development projects under construction, funded through operational cash flows, while continuing to leverage its ABG partnership for strategic expansion in global markets. The consistent pattern of capital transactions—ranging from initial 2021 sales to 2023 dilutive events—demonstrates a deliberate evolution toward deeper strategic alignment, where financial gains from equity disposals and acquisitions are systematically integrated into SPG's capital strategy and long-term value creation framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> ABG (COMP)",
        "ABG (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6534,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2266,
        "completion_tokens": 348,
        "total_tokens": 2614
      }
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Chevron's relationship with Chevron Phillips Chemical Company LLC evolved from a significant equity method investment generating $867 million in earnings in 2022 (Note 8, Chunk 1) to $608 million in 2023 and $903 million in 2024 (Chunk 2), reflecting both financial growth and sustained strategic importance. The KG triplets confirm this is a core investment relationship where Chevron (CVX) discloses and invests in Chevron Phillips Chemical Company LLC (COMP), with the 2024 data showing $8,571 million in investments and advances to the entity—up from $7,765 million in 2023—demonstrating increased capital commitment while maintaining equity method accounting that directly impacts Chevron's reported earnings and balance sheet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Chevron Phillips Chemical Company LLC (COMP)",
        "Chevron Phillips Chemical Company LLC (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8317,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2729,
        "completion_tokens": 183,
        "total_tokens": 2912
      }
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "The Facilities Consolidation Strategy, classified as an accounting policy under Note 3 Restructuring, evolved from being substantially completed as of December 31, 2023 —when the data‑center initiatives and employee layoffs were finished — to being fully completed as of December 31, 2024, when the company reported that all 2022 restructuring initiatives, including the facilities consolidation measures, had been completed. This progression reflects a transition from ongoing implementation and partial execution in late 2023 to finalization by the end of 2024, indicating that the strategic realignment and associated financial actions were fully realized within the 2024 reporting period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> Facilities Consolidation Strategy (ACCOUNTING_POLICY)",
        "Facilities Consolidation Strategy (ACCOUNTING_POLICY) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1634,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1058,
        "completion_tokens": 173,
        "total_tokens": 1231
      }
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "Lockheed Martin's strategic focus on hypersonics has evolved from a broad, multi-program development effort in 2022 to a more targeted emphasis on hypersonic strike weapons within its Aeronautics advanced development portfolio by 2024, as evidenced by its explicit inclusion of \"hypersonics programs\" alongside other next-generation capabilities like unmanned systems and air dominance in its 2024 10-K. While the company maintained its core role in hypersonics development and production through contracts with the U.S. Air Force and Army, the shift is reflected in its 2024 focus on integrating hypersonics into broader system architectures and advancing toward production readiness, moving beyond the 2022 emphasis on foundational research and program exploration as described in the 2022 risk factors regarding budget uncertainties and program transitions. This evolution is further contextualized by the continued centrality of the F-35 program (which remained at 26% of consolidated sales in 2024) and the broader defense budget environment, where hypersonics development is positioned as a critical, but increasingly focused, component of Lockheed's future growth strategy dependent on congressional funding and program maturation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Hypersonics Programs (PRODUCT)",
        "Hypersonics Programs (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11386,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3485,
        "completion_tokens": 309,
        "total_tokens": 3795
      }
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "Southern Company's treatment of energy-related derivatives shifted from regulatory hedging designation in 2021 (as noted in the 2021 annual report's pre-tax effects of designated hedging instruments) to explicit disclosure of non-hedging derivatives in its 2023 10-K (page 295), where it reported pre-tax effects of energy-related derivatives not designated as hedging instruments on income statements for 2023, 2022, and 2021. This evolution reflects a transition from managing derivatives primarily through regulatory rate recovery mechanisms to full transparency in income statement impacts, with the 2023 disclosure specifically quantifying the financial effects of derivatives no longer designated under hedge accounting frameworks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-Related Derivatives (FIN_INST)",
        "Energy-Related Derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_324",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_295",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 661,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 813,
        "completion_tokens": 184,
        "total_tokens": 997
      }
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Gilead's intellectual property strategy for Truvada shifted from active patent protection to expiration awareness between 2022 and 2023, as evidenced by its 2022 10-K filing (Chunk 1) which confirms Truvada's status as a key product in its portfolio while its 2023 10-K (Chunk 2) explicitly documents the patent expiration timeline for principal products including Truvada, showing the impending loss of exclusivity that was already impacting its business by 2021 as noted in the \"Business Highlights\" section of the 2021 report.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Truvada (PRODUCT)",
        "Truvada (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4842,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1840,
        "completion_tokens": 132,
        "total_tokens": 1973
      }
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "SPG utilized the Supplemental Facility through a two-phase borrowing and repayment strategy: initially drawing $1.05 billion in December 2021 to refinance nine mortgages, then fully retiring that balance on January 12 2022 via proceeds from a $1.2 billion senior note issuance; subsequently, the facility saw no further draws, and by November 17 2023 the remaining €750 million ($815.4 million) outstanding under the Supplemental Facility was repaid using proceeds from a €750 million bond issuance, culminating in the facility’s complete elimination through the redemption of its last tranche on October 1 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Supplemental Facility (FIN_INST)",
        "Supplemental Facility (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9600,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3037,
        "completion_tokens": 153,
        "total_tokens": 3190
      }
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife’s capital management strategy has increasingly tied cash buffer needs to capital allocation decisions, as highlighted in both filings. The 2022 10-K (Chunk 1) establishes that the company maintains a substantial liquidity buffer—$223.0 billion in liquid assets in 2021—and emphasizes that capital actions, including dividends and share repurchases, are contingent on preserving this buffer amid regulatory, market, and operational risks. This is reinforced in the 2024 10-K (Chunk 2), which explicitly states that \"cash buffer needs\" may restrict dividend payments or share repurchases, noting that increasing the buffer could reduce capital available for innovation, acquisitions, or shareholder returns. The KG triplet relationship—where **MET (ORG)** faces **Cash Buffer Needs (RISK_FACTOR)** that **negatively impacts** its capital allocation flexibility—demonstrates a strategic evolution: rather than treating liquidity as a standalone metric, MetLife now integrates cash buffer requirements into governance processes (e.g., Capital Management Committee and ERC reviews), ensuring that buffer levels directly constrain or enable capital decisions like buybacks and dividends. Consequently, while liquidity remains robust ($223B in 2021, with short-term liquidity at $12.4B), the *purpose* of that buffer has shifted from passive resilience to an active, risk-calibrated tool that prioritizes regulatory compliance and strategic restraint over aggressive capital deployment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MET (ORG) -> Cash Buffer Needs (RISK_FACTOR)",
        "Cash Buffer Needs (RISK_FACTOR) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_122",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10797,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3352,
        "completion_tokens": 376,
        "total_tokens": 3729
      }
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Starbucks' (SBUX) exposure to \"Foreign currency - other\" derivatives shifted significantly from 2022 to 2023, with the instrument moving from **liability classification** in 2022 to **asset classification** in 2023. In 2022 (Chunk 1), \"Foreign currency - other\" was recorded as a **$0.3 accrued liability** (short-term) and **$3.6 other long-term liability**, reflecting a net liability position. By 2023 (Chunk 2), the same instrument appeared as a **$1.9 prepaid expense** (current asset) and **$1.7 other long-term asset**, indicating a strategic shift to hedging foreign currency risks as an **asset**. This evolution aligns with the KG pattern where SBUX depends on the FIN_INST \"Foreign currency - other,\" showing a transformation from liability (2022) to asset (2023) classification across both designated and non-designated derivative instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5598,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2045,
        "completion_tokens": 213,
        "total_tokens": 2259
      }
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "From 2023 to 2024, The Coca-Cola Company's strategic engagement with Coca-Cola FEMSA shifted from a bottler partnership to a significant equity investment, reflecting a deeper financial integration. While maintaining contractual bottler agreements, the Company increased its equity stake in Coca-Cola FEMSA to 28% by 2024, positioning it as a key equity method investment that now contributes proportionally to earnings and carries a substantial valuation difference of $7,791 million from underlying net assets. This evolution underscores a strategic pivot toward shared financial objectives and long-term value creation, moving beyond traditional bottling relationships to a partnership grounded in equity ownership and collaborative growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola FEMSA (COMP)",
        "Coca-Cola FEMSA (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8009,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2641,
        "completion_tokens": 188,
        "total_tokens": 2829
      }
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Intel's strategic positioning of FPGAs has evolved from being a standalone product category to becoming an integrated component within adjacent product lines and broader production focus, particularly through its integration with AIPC (Artificial Intelligence Personal Computer) platforms and Data Center and Artificial Intelligence (DCAI) segments as reflected in the 2024 restructuring initiatives (Chunk 2). This evolution is underscored by the explicit linkage of FPGA (as a product) to Intel (ORG) in the knowledge graph pattern (KG Triplets), demonstrating its embedded role within Intel's core business architecture rather than operating as a discrete offering. Consequently, FPGAs now serve as critical enablers across multiple adjacent product categories—including AIPC, DCAI, and IOTG—while simultaneously supporting Intel's strategic shift toward higher-value, software-defined computing solutions that align with its CHIPSAct-driven production focus on AI and edge computing (Chunks 1 and 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> FPGA (PRODUCT)",
        "FPGA (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 32719,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 8817,
        "completion_tokens": 251,
        "total_tokens": 9068
      }
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips expanded its Lower 48 operations through the Concho acquisition, driving increased purchases in the region, while depreciation, depletion, and amortization expenses for Lower 48 rose to $5,729 million in 2023 from $4,854 million in 2022, reflecting growth in asset base and operational scale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_164",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2210,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 81,
        "total_tokens": 1276
      }
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson's relationship with AspenTech evolved from a strategic acquisition to a significant ownership stake and subsequent financial transactions that impacted gross margins. In 2022, Emerson acquired Heritage AspenTech for approximately $6.0 billion in cash, paying $87.69 per share and retaining $168 million in cash on AspenTech's balance sheet post-closing, while acquiring intangible assets that contributed to AspenTech's financials. By 2024, Emerson owned 55% of AspenTech's fully diluted shares, operating it under the name \"AspenTech\" with shares trading on NASDAQ as \"AZPN,\" though the acquisition's results were excluded from the first half of fiscal 2022. The financial impact on Emerson's gross margins was directly influenced by AspenTech's performance: in 2024, gross margin increased to 50.8% (up 1.8 points) due to the Test & Measurement acquisition and higher pricing, partially offset by $231 million in acquisition-related inventory step-up amortization that negatively impacted margins by 1.3 percentage points; this contrasted with 2023's 49.0% gross margin (up 3.3 points), which had previously benefited from the Heritage AspenTech acquisition by 0.6 percentage points. Additionally, Emerson's 2024 divestiture of its 40% stake in Copeland (selling equity for $1.5 billion and a note for $1.9 billion) and related accounting adjustments—reclassifying $279 pretax losses to discontinued operations—reflected the ongoing financial disentanglement of its former AspenTech-related investments, though the core AspenTech ownership and its margin contributions remained embedded in Emerson's industrial software segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5530,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2022,
        "completion_tokens": 415,
        "total_tokens": 2438
      }
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the treatment and availability of shares under the 2015 Director Stock Plan evolved through specific recovery and issuance mechanics detailed across the filings. While the 2015 Director Stock Plan allows for share recovery upon award termination, cash settlement, or tendering of shares for tax withholding (as noted in Chunk 1), the actual availability of shares for future issuance is tracked annually in the company's disclosures. Chunk 2 reveals that as of January 1, 2024, a total of 37,608,213 shares had been recovered for issuance since January 1, 2015, with 30,660,961 shares remaining available for future issuance under both the 2015 Stock Plan and 2015 Director Stock Plan combined. This indicates that recovered shares from prior periods (including those from 2022-2023) continue to replenish the pool of shares available for new awards under the 2015 Director Stock Plan, though the exact number of shares specifically attributable to the 2015 Director Stock Plan's recovery mechanics within 2022-2024 is not isolated in the provided data, only the aggregate recovery and remaining availability are disclosed.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> 2015 Director Stock Plan (ACCOUNTING_POLICY)",
        "2015 Director Stock Plan (ACCOUNTING_POLICY) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_335",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_311",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8115,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2684,
        "completion_tokens": 286,
        "total_tokens": 2971
      }
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "Starbucks' relationship with the Global Coffee Alliance has evolved from fiscal 2022 to fiscal 2023 with a strategic shift toward greater revenue diversification and operational integration. In fiscal 2022, Channel Development revenue grew 16% driven by higher product sales to and royalty payments from the Global Coffee Alliance, particularly Nestlé, while also contributing to margin pressures due to business mix shifts and supply chain constraints. By fiscal 2023, this relationship remained a key growth lever, with Channel Development revenues continuing to be bolstered by the Alliance, reflecting a sustained strategic emphasis on leveraging global partnerships to expand market reach and product distribution, even as macroeconomic challenges persisted. This evolution underscores a strategic pivot from isolated segment performance to integrated global commercial collaboration, where the Alliance serves as a critical channel for scalable growth and brand extension.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Global Coffee Alliance (COMP)",
        "Global Coffee Alliance (COMP) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10394,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3244,
        "completion_tokens": 244,
        "total_tokens": 3489
      }
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "NEE's financial stake in the Mountain Valley Pipeline decreased from approximately $6.582 billion at the end of 2022 to $6.156 billion at the end of 2023, reflecting a reduction in its equity‑method investment despite the pipeline remaining listed among its principal equity‑method investments. This decline indicates a strategic shift toward reallocating capital to other equity‑method assets (e.g., NEP and Sabal Trail) rather than maintaining or expanding its exposure to the Mountain Valley Pipeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Mountain Valley Pipeline (COMP)",
        "Mountain Valley Pipeline (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2293,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 126,
        "total_tokens": 1343
      }
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Medtronic's InterStim Therapy product line evolved between 2022 and 2024 through the introduction of next-generation neurostimulators and expanded therapeutic indications. According to the 2022 filing, the company advanced its InterStim II, InterStim Micro, and InterStim X platforms for treating overactive bladder, urinary retention, and bowel incontinence, while also obtaining FDA approval in January 2022 for Intellis and Vanta recharge-free systems specifically for Diabetic Peripheral Neuropathy (DPN) treatment. The 2024 filing confirms continued growth and innovation in this space, highlighting the Inceptiv closed-loop rechargeable SCS device that received U.S. FDA approval in April 2024, alongside ongoing advancements in pelvic health therapies using InterStim X and InterStim II recharge-free systems. This progression reflects Medtronic's strategic expansion of both hardware capabilities and therapeutic applications for neurostimulation within its Specialty Therapies division.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MDT (ORG) -> InterStim Therapy (PRODUCT)",
        "InterStim Therapy (PRODUCT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8060,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2651,
        "completion_tokens": 248,
        "total_tokens": 2900
      }
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolved significantly from 2022 to 2024 through deliberate acquisition, partial divestiture, and renewed partnership. In December 2021, SPG sold a portion of its ABG interest for $18.8 million pre-tax gain (later offset by $8.0 million tax expense), subsequently repurchasing additional interests for $100 million cash consideration in early 2022, while simultaneously establishing a long-term strategic partnership making SPG the core U.S. licensee and operating partner for Reebok. This sequence of transactions—documented in SPG's 2021 10-K (Chunk 1) and 2024 10-K (Chunk 2)—demonstrates a cyclical pattern of stake reduction followed by strategic reinvestment and deepened operational collaboration with ABG, directly reflecting the KG pattern of ORG-Partners_With-COMP and COMP-Discloses-ORG across both timeframes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> ABG (COMP)",
        "ABG (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6522,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2255,
        "completion_tokens": 230,
        "total_tokens": 2485
      }
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' investment activity in the Lower 48 region evolved significantly from 2021 to 2023, with depreciation, depletion, and amortization (DD&A) expenses reflecting this growth. In 2021, DD&A for the Lower 48 was $4,067 million; it increased to $4,854 million in 2022 and further to $5,729 million in 2023, as reported in the consolidated DD&A expenses of $8,284 million (2023), $7,492 million (2022), and $7,882 million (2021) in Chunk 2. This upward trend aligns with the expansion of developed reserves in the Lower 48, which grew from 2,431 million cubic feet at the end of 2018 to 4,658 million by the end of 2021, as detailed in Chunk 1, indicating increased capital investment and resource development in the region over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_158",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10872,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3353,
        "completion_tokens": 187,
        "total_tokens": 3540
      }
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon's (VZ) treatment of international bonds shifted from 2023 to 2024, with the 2023 10-K disclosing that these bonds were valued using matrix pricing inputs from independent third-party sources, while the 2024 filing explicitly reports $12 million in international bonds at Level 2 fair value (comprising $10 million from Level 1 inputs and $2 million from Level 2 inputs), reflecting a more granular classification of inputs but consistent valuation methodology. This evolution is underscored by the KG relationship where VZ discloses International Bonds (FIN_INST) as having a stake in VZ, confirming the asset category's relevance to the company's portfolio composition across both reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "VZ (ORG) -> International Bonds (FIN_INST)",
        "International Bonds (FIN_INST) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4354,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1725,
        "completion_tokens": 177,
        "total_tokens": 1902
      }
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Between 2022 and 2024, Emerson's relationship with AspenTech evolved from a strategic partnership into majority ownership and full operational integration. Initially, AspenTech was listed as a customer in Emerson's Automation Solutions segment (Chunk 1), with a balance of $1,044 million recorded as of September 30, 2021, reflecting ongoing business relationships. This transitioned significantly after Emerson acquired a 55% stake in AspenTech in 2023 (Chunk 2), investing approximately $6.0 billion in cash to acquire shares from Heritage AspenTech stockholders, which led to AspenTech operating under the name \"Aspen Technology, Inc.\" and becoming majority-owned by Emerson. The integration was further solidified through financial consolidation, as AspenTech's revenue and operations were fully incorporated into Emerson's financial statements, including impacts on cost of sales and SG&A expenses (Chunk 2). Additionally, Emerson's disposal of its remaining stake in Copeland (a related entity) in 2024 (Chunk 2) and reclassification of related gains/losses underscore the culmination of this relationship, shifting from equity investment to complete operational and financial integration under Emerson's control.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6658,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2295,
        "completion_tokens": 304,
        "total_tokens": 2600
      }
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' (SBUX) interest rate swap position shifted from a $34.0 million liability classified under \"Other long-term liabilities\" in 2022 (per Chunk 1) to a $19.2 million liability under \"Other long-term liabilities\" in 2023 (Chunk 2), while simultaneously gaining a $0.4 million derivative asset under \"Prepaid expenses and other current assets\" for interest rate swaps in 2023 (Chunk 2). This evolution reflects a reduction in net liability exposure, though the company maintained significant derivative liabilities tied to interest rate swaps, which are explicitly connected through the KG pattern ORG -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG, confirming SBUX's direct financial instrument stake in these swaps across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Interest rate swap (FIN_INST)",
        "Interest rate swap (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5598,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2040,
        "completion_tokens": 190,
        "total_tokens": 2231
      }
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "From 2022 to 2023, NextEra Energy Resources' involvement in the Mountain Valley Pipeline shifted dramatically from active investment to near-total exit due to persistent regulatory setbacks. In early 2022, following the U.S. Court of Appeals for the Fourth Circuit vacatur of the Mountain Valley Pipeline's Biological Opinion and the U.S. Forest Service right-of-way grant (January 2022), NextEra Energy Resources reevaluated its investment and determined a \"very low probability of pipeline completion\" due to ongoing legal and regulatory challenges. This led to a $0.8 billion impairment charge in Q1 2022, completely writing off its $0.6 billion equity method investment and establishing a $0.2 billion liability for future ARO costs. By 2023, as reflected in NEE's 2023 10-K disclosures, NextEra Energy Resources' stake was reduced to a passive contractual commitment within a joint venture agreement (with a 32.8% equity investment remaining only as a formal structure), while its financial exposure shifted to non-refundable transportation agreement obligations tied to construction completion. The company no longer held significant operational or financial influence over the pipeline's development, marking a definitive end to its active financial commitment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Mountain Valley Pipeline (COMP)",
        "Mountain Valley Pipeline (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8175,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2678,
        "completion_tokens": 317,
        "total_tokens": 2995
      }
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The Coca-Cola Company’s investment in equity and debt securities linked to its captive insurance company’s solvency capital for reinsuring group annuity contracts grew from $1,378 million in 2022 to $1,643 million in 2023, and further increased to $1,643 million in equity and $1,883 million in debt securities as of December 31, 2024 (up from $1,378 million in debt securities as of December 31, 2023), reflecting a continued expansion of the portfolio that backs these reinsurance obligations. This evolution demonstrates a strategic reinforcement of the captive’s capital base through market‑linked securities over the 2023‑2024 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Group Annuity Insurance Contracts (FIN_INST)",
        "Group Annuity Insurance Contracts (FIN_INST) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12383,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3751,
        "completion_tokens": 159,
        "total_tokens": 3911
      }
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node has evolved from a strategic ramp-up in 2022–2023 to full high-volume manufacturing in Ireland by 2024, positioning it as a foundational node for key products like the Core Ultra processors and enabling its shift toward a foundry model with external customer adoption of Intel 3 and 18A. While Intel 4 was initially referenced in 2021 financial disclosures (Chunk 1) as a driver of ramp-up costs and margin pressures, its successful transition to high-volume production in 2024 (Chunk 2) now supports Intel's broader roadmap, including Intel 3's HVM shift to Ireland in 2025 and Intel 18A's upcoming 2025 Panther Lake launch, cementing Intel 4's role in enabling density and performance scaling while reducing reliance on legacy nodes like 14nm. This progression reflects Intel's deliberate investment in EUV lithography and advanced packaging to regain foundry relevance, with Intel 4 serving as the critical bridge to next-gen nodes like 18A and 14A.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Intel 4 (PRODUCT)",
        "Intel 4 (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10236,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3199,
        "completion_tokens": 249,
        "total_tokens": 3448
      }
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved from a partnership into a significant ownership and operational integration. In 2022, Emerson held a minority stake in AspenTech, which was later increased to 55% ownership following the acquisition of Heritage AspenTech in 2024, as noted in Chunk 2 where Emerson acquired approximately $6.0 billion in cash and stock to create \"New AspenTech,\" resulting in Emerson owning 55% of AspenTech's shares. This acquisition, detailed in Chunk 1 as part of Heritage AspenTech's business areas including asset performance management, integrated AspenTech's software solutions into Emerson's operations, with Heritage AspenTech's technologies like AI-driven analytics and sustainability-focused modeling becoming core to Emerson's industrial software portfolio. Financially, the integration was reflected in Chunk 2's cost and margin data, where the Heritage AspenTech acquisition contributed to improved gross margins (increasing 0.6 percentage points in 2023 due to the acquisition) and influenced SG&A expenses, while Chunk 1's description of AspenTech's business model and geographic sales (55% Americas, 21% Asia-Pacific, 24% Europe in 2022) provided context for the strategic alignment. The ownership shift culminated in Emerson's 55% stake and operational control, with AspenTech continuing under Heritage AspenTech's branding and NASDAQ ticker 'AZPN' as confirmed in Chunk 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9337,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2968,
        "completion_tokens": 363,
        "total_tokens": 3331
      }
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "Intel's Intel 4 process node has evolved from its initial announcement in 2021 (Chunk 1) to become a mature, high-volume manufacturing technology by 2024, with production shifted to Ireland and significant adoption in client products like the Core Ultra processors (Chunk 2). The node demonstrated approximately 20% performance-per-watt improvements over Intel 7 and served as the foundation for Intel 3, which added further scaling and up to 18% performance-per-watt gains while expanding to external foundry customers and data center applications (Chunk 2). Intel's strategic pivot from canceled nodes like Intel 20A to focus on the next-generation Intel 18A—featuring breakthrough gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia)—highlights its iterative approach to maintaining manufacturing readiness and performance leadership, with high-volume production of Panther Lake processors scheduled for 2025 (Chunk 2). This progression reflects Intel's broader commitment to advancing EUV lithography, incremental node refinement, and competitive density/performance scaling to meet both internal product and external foundry demands (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Intel 4 (PRODUCT)",
        "Intel 4 (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6531,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2268,
        "completion_tokens": 293,
        "total_tokens": 2562
      }
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "Between 2022 and 2024, InterStim Micro evolved from a recharge-free neuromodulation device within Medtronic's Pelvic Health portfolio to a strategically emphasized, rechargeable solution positioned alongside InterStim X and II for overactive bladder, urinary retention, and fecal incontinence therapies. The 2024 10-K explicitly highlights \"continued acceptance and growth of our Pelvic Health therapies, including our InterStim therapy with InterStim X and InterStim II recharge-free neurostimulators and InterStim Micro rechargeable neurostimulator\" as a key growth driver, directly integrating it into Medtronic's Neuromodulation (NM) performance within Specialty Therapies. This reflects a deliberate shift toward emphasizing the Micro's rechargeable technology—contrasting with the recharge-free X and II models—while maintaining its core clinical indications, as evidenced by its inclusion in the Neuromodulation sales growth narrative alongside other advanced therapies like the Inceptiv SCS.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MDT (ORG) -> InterStim Micro (PRODUCT)",
        "InterStim Micro (PRODUCT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7269,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2446,
        "completion_tokens": 249,
        "total_tokens": 2695
      }
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "From 2022 through 2024, SPG consistently reports that LTIP Units are classified as potentially dilutive securities but, as disclosed in both the 2022 and 2024 10‑K filings, they have not had a material dilutive effect on net income or earnings per share for any of the reported periods (2021‑2024). Consequently, the evolution of the disclosure shows a stable pattern: each year’s filing notes that LTIP Units are included among potentially dilutive instruments yet explicitly states that no securities, including the LTIP Units, materially impacted dilution across the respective reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 993,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 885,
        "completion_tokens": 149,
        "total_tokens": 1034
      }
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "MetLife's approach to managing cash buffer needs in relation to stock repurchases has evolved from a $3.0 billion authorization announced in August 2021 with $1.5 billion remaining at December 31, 2021 (Chunk 1), to a more constrained position by 2024 where legal and regulatory restrictions or cash buffer needs may preclude repurchases (Chunk 2). The company explicitly states that its ability to pay dividends or repurchase stock is subject to these risks, and it maintains a cash buffer that may be increased, potentially reducing capital available for share repurchases (Chunk 2). This reflects a strategic shift toward prioritizing liquidity resilience over aggressive buybacks, as evidenced by the 2021 authorization's partial utilization and the 2024 emphasis on regulatory and operational constraints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MET (ORG) -> Cash Buffer Needs (RISK_FACTOR)",
        "Cash Buffer Needs (RISK_FACTOR) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7908,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2632,
        "completion_tokens": 202,
        "total_tokens": 2835
      }
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "Starbucks' foreign currency derivative positions shifted significantly from fiscal 2022 to 2023, with designated hedging instruments moving from a net asset of $103.9 million (2022) to $183.3 million (2023) in other long-term assets, while designated liabilities increased from $2.3 million to $37.4 million across accrued liabilities and other long-term liabilities. Non-designated derivatives also changed substantially, with derivative assets declining from $32.0 million to $1.9 million in prepaid expenses and other current assets, and derivative liabilities rising from $2.0 million to $7.5 million in accrued liabilities, reflecting a strategic reclassification of balance sheet positions that reduced short-term derivative assets but expanded long-term hedging coverage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9670,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3072,
        "completion_tokens": 194,
        "total_tokens": 3266
      }
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Procter & Gamble's global cash management strategy has evolved in direct response to its restructuring activities and corporate-level financial performance between fiscal 2022 and 2024, as evidenced by the interconnected disclosures across both 10-K filings. The strategy explicitly integrates restructuring costs—funded within Corporate and tied to cash management decisions—into its financial framework, with fiscal 2022 showing $250–$500 million in restructuring spending that contributed to $872 million in improved corporate net earnings through tax benefits and reduced charges, while fiscal 2024 saw a significant increase to $659 million in restructuring costs (including $216 million in non-cash foreign currency translation losses from market exits in Nigeria and Argentina), which drove a $1 billion decline in corporate net earnings due to asset impairments and higher charges. This escalation in restructuring activity directly impacted cash allocation, as the company used operating cash flow—funded by its global cash management strategy—to finance these initiatives, while simultaneously adjusting its cash position to account for liquidity management, economic factors, and tax considerations, ultimately reflecting how restructuring-driven financial performance necessitated strategic shifts in cash deployment across both fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "PG (ORG) -> Global Cash Management Strategy (ACCOUNTING_POLICY)",
        "Global Cash Management Strategy (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7376,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2505,
        "completion_tokens": 338,
        "total_tokens": 2844
      }
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "NVIDIA's Omniverse platform evolved from a standalone virtual world simulation tool into a core enterprise integration layer between 2022 and 2023, explicitly positioned as the foundational operating system for industrial digital twins and simulation workflows. The company strengthened its enterprise integration by embedding Omniverse within automotive solutions (notably through DRIVE Software's Chauffeur and Avatar components) and expanded its simulation ecosystem via DRIVE Constellation for autonomous vehicle validation, while simultaneously advancing its full-stack computing platform to support Omniverse's resource-intensive workloads through GPU-accelerated AI and DPUs. This strategic evolution enabled Omniverse to become the central hub for enterprise 3D workflows—from automotive digital twins and robotics testing to professional visualization—leveraging NVIDIA's unified AI computing architecture to deliver scalable, real-time simulation capabilities across industries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Omniverse (PRODUCT)",
        "Omniverse (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11394,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3490,
        "completion_tokens": 247,
        "total_tokens": 3737
      }
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "From 2023 to 2024, AMT's financial commitments related to communications sites evolved from an anticipated spend of approximately $450 million in 2023 (as disclosed in the 2023 10-K for constructing 2,500–3,500 global communications sites) to a significant increase in future obligations, including $4.5 billion in estimated undiscounted asset retirement costs for removing and remediating leased sites as of December 31, 2024 (per the 2024 10-K). This reflects not only expanded infrastructure investment but also binding financial and operational commitments under loan agreements that require ongoing maintenance and potential renewal of site leases to avoid revenue loss, while also underscoring the company's long-term capital allocation priorities—evidenced by its $3.2 billion 2025 distribution target—balancing shareholder returns with substantial debt management and covenant compliance to sustain its infrastructure-driven revenue model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Communications Sites (PRODUCT)",
        "Communications Sites (PRODUCT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3496,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 236,
        "total_tokens": 1752
      }
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "ExxonMobil's 2023 and 2024 disclosures reveal a consistent accounting policy where assets divested are explicitly characterized as \"no longer contributing to the Corporation's strategic objectives\" or \"worth considerably more to others,\" reflecting a deliberate evolution in framing divestitures as strategic portfolio optimization rather than reactive measures. Both years emphasize that proceeds from asset sales are intentionally presented alongside operating cash flow to illustrate \"total sources of cash\" for investment and financing, with the 2024 language reinforcing this by linking divestitures to the ongoing \"long-standing and regular disciplined review process\" that ensures assets align with strategic goals—demonstrating a mature, systematic approach to portfolio management where divestiture proceeds are framed as value-enhancing capital generated through proactive strategic realignment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Assets Contributing to Strategic Objectives (ACCOUNTING_POLICY)",
        "Assets Contributing to Strategic Objectives (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2616,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 226,
        "total_tokens": 1556
      }
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "From 2022 to 2023, Comcast's financial exposure to Universal Beijing Resort decreased as reflected in the consolidation of its assets and liabilities. In 2022, Universal Beijing Resort contributed $9.7 billion in assets and $8.1 billion in liabilities to Comcast's consolidated balance sheet, while by 2023, these figures declined to $7.8 billion in assets and $7.2 billion in liabilities. This reduction indicates a lower absolute financial exposure, though the 30% ownership stake and consolidation of the VIE remain unchanged, with no new liquidity arrangements or guarantees affecting Comcast's risk exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Consolidates]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5527,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2024,
        "completion_tokens": 153,
        "total_tokens": 2178
      }
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "The nature of Customer Demand Volatility as a risk factor for Caterpillar has intensified between 2023 and 2024, with both 2023 and 2024 10-K filings explicitly linking heightened macroeconomic uncertainty to increased demand volatility that directly threatens financial performance and supply chain stability. While 2023's disclosure emphasized how economic weakness in key industries like energy, transportation, and mining could reduce capital expenditures and trigger supply chain constraints, the 2024 filing amplifies this by explicitly connecting commodity price volatility, material cost inflation, and pandemic-driven demand uncertainty to \"significant disruptions to our supply chains or significant shortages of labor and material\" that now \"adversely impact financial results\" – demonstrating an evolved risk where volatile demand no longer merely affects sales but actively jeopardizes Caterpillar's ability to fulfill orders and maintain stable cash flows through interconnected supply chain vulnerabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Customer Demand Volatility (RISK_FACTOR)",
        "Customer Demand Volatility (RISK_FACTOR) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11056,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3425,
        "completion_tokens": 255,
        "total_tokens": 3680
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "From 2022 to 2024, the fair value of Net derivative assets (liabilities) increased from $31 million (with a $(43) million unrealized loss) in 2022 to $58 million (with a $(20) million unrealized loss) in 2024, reflecting a net gain of $27 million over the two‑year period. This evolution is driven by the same Level‑3 valuation methodology—discounted cash‑flow techniques using observable inputs such as swap rates (3‑5 % with a weighted average of 4 %) and significant unobservable inputs (e.g., prepayment, default, and loss‑severity rates)—as disclosed in both the 2022 and 2024 10‑K filings, and the change is captured within net income (and OCI) as part of the “Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities.”",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Included_in_Net_Income]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Net derivative assets (liabilities) (FIN_INST)",
        "Net derivative assets (liabilities) (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_220",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_217",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13042,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3901,
        "completion_tokens": 188,
        "total_tokens": 4090
      }
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 by deepening its integration within the company's broader GPU and cloud platform ecosystem, transitioning from a standalone gaming service to a core component of NVIDIA's full-stack accelerated computing strategy. This evolution is reflected in the 2023 10-K's emphasis on GeForce NOW as part of the \"gaming\" segment alongside GeForce RTX GPUs and SoCs, while the 2022 filing explicitly positioned it within the cloud platforms category enabling \"interactive graphics applications... to be accessed by almost any device, almost anywhere\" through vGPU and GeForce NOW. Crucially, the 2023 document reinforces this by detailing how NVIDIA's cloud gaming offering leverages its RTX GPU technology (including ray tracing and DLSS) and software stack, directly tying it to the company's AI and graphics leadership that drives the entire ecosystem—from AI supercomputing and CUDA software to Omniverse and automotive solutions—thereby positioning GeForce NOW not just as a gaming service but as a strategic extension of NVIDIA's core GPU and cloud computing platform to expand its reach across devices and industries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> GeForce NOW (PRODUCT)",
        "GeForce NOW (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11421,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3493,
        "completion_tokens": 295,
        "total_tokens": 3788
      }
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "The revenue performance of Inlyta showed growth between 2022 and 2023, with worldwide revenue increasing from $1,003 million to $1,036 million (a 3% operational increase), driven by continued growth in emerging markets and adoption of Inlyta in combination with immune checkpoint inhibitors for first-line treatment of advanced RCC, partially offset by lower volumes and net price pressures in certain European markets. This performance aligns with the patent expiration timeline for Inlyta (2025 in U.S., Europe, and Japan as shown in Chunk 1), ensuring ongoing market protection through 2025, while Chunk 2 details the specific revenue figures and growth drivers across regions and products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Inlyta (PRODUCT)",
        "Inlyta (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22484,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6243,
        "completion_tokens": 173,
        "total_tokens": 6416
      }
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, the treatment of network location intangibles remained consistent in amortization methodology—both years use straight-line amortization over estimated useful lives, generally up to 20 years, with the 2023 weighted average remaining period at 15 years (Chunk 1). However, the 2024 disclosure introduces a key evolution in impairment review: assets are now evaluated on an individual tower basis for recoverability via projected undiscounted cash flows, with impairment measured using discounted cash flows or market-based fair value comparisons (Chunk 2). Additionally, the 2024 filing details a significant change in asset retirement obligation estimates, extending settlement dates based on 20 years of operating history, which increased the liability by $470 million and the undiscounted cash outlay by $875 million, while reducing accretion expense by $75 million—demonstrating how valuation assumptions now directly impact cash flow projections and impairment assessments for these intangibles (Chunk 2). This reflects a maturation in how the Company evaluates both the economic life and recoverability of network location intangibles, moving from a portfolio-level approach to granular, cash flow-driven impairment triggers tied to tenant-specific risks and revised retirement assumptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amortizes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Network Location Intangibles (FIN_INST)",
        "Network Location Intangibles (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8046,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2662,
        "completion_tokens": 328,
        "total_tokens": 2990
      }
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has intensified through 2023-2024 with significant upstream expansion, as evidenced by four 2023 discoveries on the Stabroek Block and the operational launch of the Prosperity FPSO vessel in November 2023 that reached nameplate capacity by January 2024, contributing to combined gross production exceeding 390,000 barrels per day in 2023 and nearly 440,000 barrels per day in Q4 2023, with plans for six FPSO vessels by year-end 2027 and regulatory approvals underway for a sixth project at Whiptail. This growth is integrated into the company's Advantanced Volume Growth driver (encompassing Guyana alongside Permian and LNG) and reflects a strategic shift toward increased production from the Americas, particularly as the merger with Pioneer (closing May 3, 2024) expands the Permian Basin footprint while positioning Guyana as a key component of ExxonMobil's high-impact upstream portfolio to sustain production growth through 2027.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Guyana (GPE)",
        "Guyana (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8791,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2829,
        "completion_tokens": 244,
        "total_tokens": 3074
      }
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "The X1 platform's integration with third-party streaming services evolved significantly between 2022 and 2023, transitioning from foundational partnerships with Peacock, Disney+, and Netflix in 2022 to a more strategic, branded approach by 2023 that included the launch of the ad-supported Peacock tier, integrated access to Xumo Play, and the introduction of the standalone NOW streaming service targeting residential broadband customers. This evolution reflects Comcast's dual strategy of reducing cord-cutting through enhanced content aggregation and interactivity on X1 while simultaneously driving incremental ARPU growth via commission revenue from third-party DTC service sales and the monetization of integrated streaming features across its platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> X1 Platform (PRODUCT)",
        "X1 Platform (PRODUCT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11023,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3413,
        "completion_tokens": 190,
        "total_tokens": 3603
      }
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Caterpillar's relationship with FG Wilson has evolved significantly between 2023 and 2024 in terms of distribution network coverage for electric power generation systems, with measurable expansion documented across both years' financial disclosures. In 2023, FG Wilson-branded electric power generation systems were distributed through a worldwide network of 110 distributors covering 109 countries (Chunk 1), while by 2024 this coverage expanded to 108 distributors spanning 158 countries (Chunk 2), demonstrating a strategic increase in geographic reach despite a slight reduction in distributor count. This expansion reflects Caterpillar's ongoing investment in its electric power generation portfolio, as evidenced by the consistent branding of FG Wilson within its Machinery, Energy & Transportation (ME&T) business segment and the continued emphasis on dealer network support for these systems across both reporting periods. The distributor network growth—from 109 to 158 countries served—highlights a deliberate scaling of market penetration for FG Wilson's electric power solutions, directly enhancing Caterpillar's global distribution capabilities for this critical product line.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> FG Wilson (PRODUCT)",
        "FG Wilson (PRODUCT) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9052,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2899,
        "completion_tokens": 297,
        "total_tokens": 3196
      }
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One's exposure to securitized debt obligations declined modestly from 2022 to 2024, with the carrying value falling from $18,043 million (as reported in 2023) to $18,067 million when measured at fair value, indicating a slight increase in fair‑value exposure but essentially stable debt levels; the 2022 filing notes that these obligations are reported on the balance sheet as securitized debt obligations, while the 2024 filing provides a detailed table showing the carrying amount of $18,043 million and an estimated fair value of $18,067 million, reflecting minimal change in the overall exposure over the two‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reports]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_179",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_220",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2242,
        "completion_tokens": 158,
        "total_tokens": 2400
      }
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "McDonald's use of line of credit agreements evolved from 2023 to 2024 as reflected in its financing activities and cash flow management, with cash used for financing activities decreasing by $2.2 billion in 2023 (to $4.4 billion) due to increased bond issuances, but rising sharply to $7.5 billion in 2024 (an increase of $3.1 billion) driven by decreased bond issuances, while the company maintained substantial credit capacity through its line of credit agreements to fund debt service, dividends, share repurchases, and strategic growth initiatives like restaurant development. This shift underscores a strategic pivot toward relying more on internal cash generation and bond market access rather than credit facilities, even as cash and equivalents declined to $1.1 billion by year-end 2024 from $4.6 billion in 2023, though the company emphasized continued access to commercial paper and line of credit agreements for short-term funding needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Line of Credit Agreements (FIN_INST)",
        "Line of Credit Agreements (FIN_INST) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5345,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1978,
        "completion_tokens": 237,
        "total_tokens": 2215
      }
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Between 2022 and 2024, the Worldwide Business Conduct Manual remained a consistent cornerstone of Procter & Gamble's internal control framework, explicitly reinforcing governance through its integration into the Company's system of internal controls over financial reporting in both annual reports. This sustained emphasis indicates that P&G maintains a deliberate, policy-driven approach to governance where ethical conduct and compliance are foundational to financial control effectiveness, rather than relying on ad-hoc measures. The Manual's role evolved from being merely referenced in 2022 to being reaffirmed with identical language in 2024, demonstrating consistent institutional commitment to governance standards amid evolving operational landscapes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "PG (ORG) -> Worldwide Business Conduct Manual (ACCOUNTING_POLICY)",
        "Worldwide Business Conduct Manual (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7193,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2463,
        "completion_tokens": 190,
        "total_tokens": 2653
      }
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "Exxon's strategic positioning in Guyana has intensified through both asset growth and earnings recognition, as evidenced by its long-lived asset disclosures and updated earnings driver definitions. In 2023, Guyana's long-lived assets increased to $9,689 million (from $6,766 million in 2022 and $4,892 million in 2021), reflecting expanding upstream investments, while the 2024 earnings driver framework explicitly designates Guyana as an \"Advantaged Asset\" within its high-growth portfolio alongside Permian and LNG, underscoring its strategic importance to XOM's value creation narrative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Guyana (GPE)",
        "Guyana (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4108,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1659,
        "completion_tokens": 147,
        "total_tokens": 1806
      }
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One’s reliance on securitized debt obligations has expanded significantly from 2022 to 2024, with the carrying value of these obligations rising from $14,264 million in 2022 to $14,335 million in 2024, reflecting a modest but measurable increase in the use of this wholesale funding channel. This growth aligns with the firm’s broader strategy of maintaining a diversified funding mix, as highlighted by its disclosure of securitized debt obligations alongside deposits, senior notes, and other borrowings in both the 2022 and 2024 10‑K filings. The consistent reporting of securitized debt as a distinct liability in the balance‑sheet tables underscores that, while still a secondary source to deposits, securitized debt remains a key component of Capital One’s funding architecture over the three‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Raises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5947,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2131,
        "completion_tokens": 204,
        "total_tokens": 2336
      }
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "NVIDIA's Omniverse platform evolved from a real-time 3D design collaboration and virtual world simulation tool into a core enterprise offering for digital twin creation and industrial digitalization, as evidenced by its dedicated enterprise software subscription model and adoption by industrial enterprises to build digital replicas of factories, products, and autonomous systems. This strategic positioning was reinforced by the company's broader AI and computing platform expansion, including the launch of NVIDIA AI Enterprise software licenses and DGX Cloud service in fiscal 2024, which integrated Omniverse within a full-stack computing ecosystem leveraging GPUs, DPUs, and CPUs to deliver end-to-end enterprise AI solutions. The platform's enterprise adoption was further catalyzed by NVIDIA's established ecosystem of partnerships across automotive (via DRIVE AV solutions), gaming (RTX ray tracing and DLSS), and professional visualization (RTX-optimized design applications), enabling Omniverse to transition from a creative tool to a critical infrastructure component for industrial digital transformation, supported by its integration with NVIDIA's AI Enterprise suite and cloud services like vGPU for enterprise deployment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Omniverse (PRODUCT)",
        "Omniverse (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11421,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3483,
        "completion_tokens": 309,
        "total_tokens": 3792
      }
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Between 2022 and 2023, Pfizer's financial relationship with Viatris shifted from a $94 million net amount due to Viatris as of December 31, 2022 to a $33 million net amount due to Viatris as of December 31, 2023, reflecting the ongoing post‑separation agreements (MSAs, TSAs, and other arrangements) that were largely completed by the end of 2023. The cash flows tied to these agreements are reported in operating cash from continuing operations, while the $277 million payment made in 2021 remains a financing‑activity outflow recorded as a payable to Viatris. Thus, the net receivable/payable under the post‑separation contracts declined substantially over the two‑year period, moving from $94 million (2022) to $33 million (2023).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Viatris (COMP)",
        "Viatris (COMP) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6991,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2380,
        "completion_tokens": 183,
        "total_tokens": 2563
      }
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has intensified through a shift from exploratory drilling to active development and funding of specific projects, reflecting a more focused investment approach. In 2023, the company funded the Uaru project and advanced the Payara development with the Prosperity FPSO vessel, while also completing 12.6 exploration and development wells offshore Guyana, whereas in 2024, the Guyana asset was explicitly classified as an \"Advantaged Asset\" within its updated earnings drivers—highlighting its strategic priority for high-return growth—and the company emphasized continued development activities on the Yellowtail project, signaling a sustained and deepened commitment to Guyana's offshore potential beyond initial exploration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Guyana (GPE)",
        "Guyana (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5180,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1929,
        "completion_tokens": 191,
        "total_tokens": 2120
      }
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "The weighted-average interest rate for senior notes with maturities greater than 10 years increased from 3.67% in 2022 to 3.8% in 2023, while the face value decreased slightly from $52.8 billion to $53.4 billion (reported as $53.4 million in the chunk but consistent with billions context in financial statements). This evolution reflects a strategic shift in CMCSA's debt profile, as evidenced by the KG triplet relationship where CMCSA discloses these instruments and their rates increased year-over-year. The data from both chunks confirms this specific segment's metrics changed within the broader context of total debt increasing from $94.8 billion to $97.1 billion during the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Senior Notes Greater than 10 Years (FIN_INST)",
        "Senior Notes Greater than 10 Years (FIN_INST) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6215,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2198,
        "completion_tokens": 173,
        "total_tokens": 2371
      }
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, the nuclear decommissioning trusts managed by Alabama Power and Georgia Power increased their domestic equity Level 2 valuations from $169 million to $208 million (Alabama) and from $1 million to $1 million (Georgia), while shifting private‑equity classification from Level 3 ($161 million in 2023) to Level 3 ($169 million in 2024) with a corresponding rise in NAV‑based valuation from $178 million to $178 million. The trusts also expanded Level 2 inputs for domestic equity and other assets, reflected in higher total fair‑value measurements ($1,671 million to $1,435 million for Alabama and $1,415 million to $1,176 million for Georgia) and a notable increase in Level 2 corporate bond holdings ($225 million to $231 million for Alabama; $187 million to $158 million for Georgia). These changes illustrate a strategic reallocation toward Level 2 observable inputs and a modest shift in valuation methodology for private equity and domestic equity components across the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Nuclear decommissioning trusts (FIN_INST)",
        "Nuclear decommissioning trusts (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_284",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_277",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21769,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6113,
        "completion_tokens": 251,
        "total_tokens": 6365
      }
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "NVIDIA's strategic positioning of CUDA has evolved from 2022 to 2023 into a foundational pillar of its full-stack computing platform, deeply integrated across automotive, data center, and enterprise end markets through unified software ecosystems. In 2022, CUDA was central to automotive solutions like DRIVE Hyperion and Orin SoC, enabling AI-driven autonomous driving and cockpit experiences, while also powering Omniverse for industrial simulation; by 2023, this integration expanded to encompass a broader software-defined approach where CUDA underpinned not only automotive AI stacks (e.g., DRIVE Chauffeur and Drive Concierge) but also data center-scale AI infrastructure, enterprise AI platforms like NVIDIA AI Enterprise, and cross-industry workflows, as evidenced by the company's emphasis on \"full-stack innovation\" spanning silicon to software across all target markets. This evolution reflects CUDA's role as the unifying architecture enabling NVIDIA to deliver consistent performance advantages across diverse industries—from automotive (via DRIVE Sim and Orin) to data centers (via Grace CPU and AI Enterprise)—by leveraging its programmable foundation to support multi-billion-dollar markets through software stacks developed internally and by partners, thereby transforming CUDA from a graphics API into the core enabler of NVIDIA's end-to-end computing platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> CUDA (PRODUCT)",
        "CUDA (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11778,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3587,
        "completion_tokens": 344,
        "total_tokens": 3931
      }
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, Pfizer’s contractual and financial relationship with Viatris transitioned from active transitional agreements to settled arrangements, with net amounts owed decreasing significantly. In 2022, Pfizer recorded $94 million due to Viatris under the interim TSAs and MSAs that supported the Upjohn spin‑off, but by the end of 2023 those obligations were fully resolved, leaving only a $33 million receivable as of December 31, 2023, reflecting the completion of the transitional service agreements and the final settlement of amounts owed.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Viatris (COMP)",
        "Viatris (COMP) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8124,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2671,
        "completion_tokens": 138,
        "total_tokens": 2809
      }
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved such that deregulation pressures intensified competitive market risks (as documented in both 2022 and 2023 10-K filings), which directly amplified regulatory costs tied to environmental compliance. Specifically, while the 2022 filing highlighted stranded costs and asset impairments from potential deregulation as key financial threats, the 2023 filing expanded this to include how deregulation-related regulatory changes—particularly EPA emissions rules and state carbon reduction mandates—necessitated significant capital expenditures for environmental compliance, including CCR management and GHG restrictions, thereby linking deregulation-driven regulatory uncertainty to rising environmental compliance costs. This progression reflects a deepening interconnection where deregulation pressures (Retail Deregulation → DUK) not only threatened revenue streams but also catalyzed stricter environmental regulations (Environmental Regulations → DUK) that increased compliance costs, as evidenced by both documents' emphasis on EPA rules, state legislation, and the financial risks of meeting new environmental standards amid market restructuring.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Retail Deregulation (REGULATORY_REQUIREMENT)",
        "Retail Deregulation (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15162,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4442,
        "completion_tokens": 322,
        "total_tokens": 4764
      }
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products declined from 9.3% in 2023 to 7.6% in 2024, reflecting a 1.7 percentage point reduction that contrasts with the pricing strategy applied to Skoal during 2023. While the 2023 pricing strategy involved multiple list price increases—including a $0.11 per can increase effective January 23, 2024, affecting Skoal brands—this aggressive price adjustment coincided with a measurable erosion in Skoal’s retail share, suggesting that higher prices contributed to reduced market penetration despite the company’s efforts to maintain pricing discipline across its product portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Skoal (PRODUCT)",
        "Skoal (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5712,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2063,
        "completion_tokens": 155,
        "total_tokens": 2218
      }
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's investment in \"Other short-term interest-bearing securities\" remained unchanged at $138 million amortized cost and fair value from 2023 to 2024, indicating a stable short-term investment strategy focused on preserving capital rather than pursuing growth or yield expansion during this period. This consistency across both annual reports suggests the company maintained a conservative approach to its short-term liquidity management, prioritizing stability in its interest-bearing securities portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Other short-term interest-bearing securities (FIN_INST)",
        "Other short-term interest-bearing securities (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1776,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1106,
        "completion_tokens": 127,
        "total_tokens": 1233
      }
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "From 2022 to 2024, General Dynamics' involvement in Abrams Main Battle Tank Upgrades shifted from a $360 contract in 2021 (referenced in Chunk 1 as part of 2021 awards) to $350 in 2024 (Chunk 2), reflecting a continued but slightly reduced direct funding for upgrades, engineering, and logistics support. While Chunk 1 highlights the $360 Abrams upgrade award in 2021 as part of its Combat Systems segment backlog, Chunk 2 details the $350 2024 award specifically for Abrams upgrades alongside broader sustainment efforts, indicating an evolution toward integrated support services rather than just hardware production. The contract scope expanded to include system enhancement packages (e.g., SEPv3 for Romania, $285 in Chunk 2) and international partnerships, underscoring a strategic move from standalone upgrades to comprehensive, multi-year modernization programs with sustained technical support across multiple contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Receives]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Abrams Main Battle Tank Upgrades (PRODUCT)",
        "Abrams Main Battle Tank Upgrades (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2962,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 232,
        "total_tokens": 1620
      }
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG maintained its borrowing capacity with Corebridge through February 25, 2025, as noted in the 2023 filing, while the 2024 filing confirms that Corebridge generated pre‑tax income for June 10 – Dec 31 2024 and that AIG recognizes its equity‑method income from Corebridge as dividends received plus the appreciation of its investment, directly linking the two entities’ financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1022,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 887,
        "completion_tokens": 103,
        "total_tokens": 990
      }
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Tesla's Solar Roof evolution between 2022 and 2024 reveals significant production challenges and strategic dependencies documented in both filings. While Chunk 1 details the product's technical design - integrating solar tiles with power generation through proprietary inverters and seamless Powerwall integration - Chunk 2 explicitly identifies persistent manufacturing bottlenecks, noting that \"we have experienced, and may also experience similar future delays in launching and/or ramping production of our energy storage products and Solar Roof\" with construction timelines and quality control remaining critical dependencies. This confirms that despite continuous improvements to installation efficiency and collaboration with developers, the Solar Roof's production ramp has been constrained by supply chain vulnerabilities and factory construction complexities, directly impacting Tesla's ability to scale this strategic energy product commercially.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10512,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3263,
        "completion_tokens": 239,
        "total_tokens": 3502
      }
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "Based on the financial disclosures in both chunks, the retail share of Skoal in the U.S. oral tobacco market declined from 9.3% in 2023 to 7.6% in 2024, reflecting a 1.7 percentage point decrease. This reduction in market share indicates a weakening competitive positioning for Skoal relative to other oral tobacco products like Copenhagen (which also declined but from a higher base) and the growing on! brand, while the total oral tobacco market share fell from 42.5% to 37.5%, suggesting broader market pressures affecting the category. The data from Chunk 2's retail share table directly quantifies this decline, and Chunk 1's context on market dynamics—including inflation-driven discretionary income pressures and regulatory impacts on product adoption—provides the underlying reason for this shift, as consumers increasingly prioritize cost-sensitive purchasing behaviors that may be reshaping competitive hierarchies within the oral tobacco segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Skoal (PRODUCT)",
        "Skoal (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6604,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2284,
        "completion_tokens": 239,
        "total_tokens": 2523
      }
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The concentration of premium-tier device share among a few key customers—particularly Chinese OEMs and Apple—has intensified between 2023 and 2024, directly amplifying the risk factor tied to Qualcomm’s reliance on these entities. This concentration has eroded Qualcomm’s pricing power and revenue stability, as evidenced by the risk disclosures noting that \"the concentration of device share among a few companies, and the corresponding purchasing power of these companies, may result in lower prices for our products, which could have an adverse effect on our revenues and margins.\" In 2024, the trend accelerated with increased device share gains by Chinese OEMs and Apple’s continued reliance on lower-margin MDM products (which exclude Qualcomm’s integrated application processor technology), further pressuring margins and revenue resilience despite Qualcomm’s historical dominance in premium-tier modem and RF components. The risk explicitly links this dynamic to potential revenue declines from customer-driven pricing pressures and volatile purchase timing tied to competitors’ product cycles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Concentration_of_Device_Share (RISK_FACTOR)",
        "Concentration_of_Device_Share (RISK_FACTOR) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12852,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3879,
        "completion_tokens": 275,
        "total_tokens": 4154
      }
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million (fair value) as of December 31, 2023 and December 31, 2024, according to both the 2023 and 2024 10-K filings. This consistent allocation reflects the company's stable short-term liquidity management approach, with the money market mutual funds continuing to be classified as available-for-sale investments under the \"Types of securities\" disclosure in both filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Money market mutual funds (FIN_INST)",
        "Money market mutual funds (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1776,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 112,
        "total_tokens": 1197
      }
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "General Dynamics' participation in the Capital Construction Fund has evolved from $295 million of U.S. government accounts receivable pledged to the fund on December 31, 2021 (as reported in the 2022 filing) to $333 million pledged on December 31, 2024 (as reported in the 2024 filing), reflecting an increase of $38 million over the three‑year period. This growth demonstrates the company's continued reliance on the CCF program to finance eligible vessel‑construction activities and to defer taxable income, with the pledged receivables directly tied to its participation in the fund as captured by the KG relationship GD → Capital Construction Fund ← GD.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Participates_In]- ORG",
      "triplets_used": [
        "GD (ORG) -> Capital Construction Fund (FIN_INST)",
        "Capital Construction Fund (FIN_INST) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6703,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2331,
        "completion_tokens": 164,
        "total_tokens": 2495
      }
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "AIG's financial relationship with Corebridge evolved significantly between 2023 and 2024 through the tax implications of its IPO and subsequent deconsolidation. Following Corebridge's September 19, 2022 IPO, AIG's ownership dropped below 80%, triggering tax deconsolidation that removed Corebridge from AIG's consolidated U.S. federal tax group effective 2023, with a five-year restriction preventing American General Corporation and its life insurance subsidiaries from joining Corebridge's consolidated tax return. This deconsolidation preserved Corebridge's pre-tax operating losses and unused tax credit carryforwards within its own U.S. federal tax group for potential future utilization, while AIG's remaining stake continues to be impacted by CAMT under the Inflation Reduction Act's 15% corporate minimum tax on adjusted financial statement income exceeding $1 billion in average profits over three years. The effective tax rate implications are further shaped by AIG's use of item-by-item release of stranded tax effects in AOCI for available-for-sale securities and its policy of treating GILTI taxes as period charges, with Corebridge's post-IPO performance now reported separately as discontinued operations in AIG's financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_255",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4123,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1675,
        "completion_tokens": 312,
        "total_tokens": 1987
      }
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla's Solar Roof production strategy evolved from initial installation-focused scaling to a more integrated operational model emphasizing supply chain resilience and installer network expansion, while facing persistent component constraints and labor challenges. The company continued to emphasize cross-selling Solar Roof with residential solar and Powerwall products, but supply chain vulnerabilities—particularly for specialized roofing components and skilled electricians—remained critical bottlenecks requiring ongoing investment in installer training and developer collaborations to reduce deployment costs and timelines. This operational focus aligns with Tesla's broader capital expenditure strategy of simultaneously ramping multiple high-priority projects, including Solar Roof alongside Megapack and new vehicle models, where production ramp speeds directly depend on securing stable component supply and managing global trade-related cost pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12245,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3701,
        "completion_tokens": 245,
        "total_tokens": 3946
      }
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina decreased from approximately $9.5 billion–$10.5 billion (as projected in 2022) to about $7 billion–$8 billion by 2023, reflecting a reduction of roughly $1.5 billion after the 2019 settlement that lowered the incremental excavation cost for the remaining basins. This decline indicates that the company has made tangible progress under the Coal Ash Act—completing excavation at several sites and moving ash to lined landfills—while still facing a multi‑year spend of the remaining billions over the next decade.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Coal Ash Act (REGULATORY_REQUIREMENT)",
        "Coal Ash Act (REGULATORY_REQUIREMENT) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12682,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3837,
        "completion_tokens": 156,
        "total_tokens": 3993
      }
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The retail share of Altria's 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024, while the total oral tobacco segment's retail share declined from 42.5% to 37.5% during the same period. This growth in 'on!' share occurred despite a shrinking overall oral tobacco market, indicating that 'on!' is gaining relative market position within the segment, though it remains a smaller component of the broader oral tobacco category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> on! (PRODUCT)",
        "on! (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6604,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2297,
        "completion_tokens": 111,
        "total_tokens": 2408
      }
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "Qualcomm's reliance on Chinese OEMs for revenue has remained structurally concentrated but shows a shift in risk profile from 2023 to 2024: while both 2023 and 2024 filings confirm that \"certain Chinese OEMs have increased and may continue to increase their device share in China and in certain regions outside of China\" (Chunk 1) and that \"we derive a significant portion of our revenues from a small number of these OEMs\" (Chunk 1), the 2024 filing explicitly reinforces this trend by stating Chinese OEMs are continuing to expand share \"and may continue to increase\" (Chunk 2), indicating no meaningful reduction in dependence. This persistent concentration, however, carries heightened implications for business stability due to two compounding factors: first, the risk of revenue disruption from these OEMs is amplified by their potential to vertically integrate (develop their own integrated circuit products) or switch to competitors' technologies, as noted in both documents (Chunk 1 and Chunk 2); and second, the ongoing U.S./China trade and national security tensions—explicitly cited as exacerbating concentration risks in China (Chunk 1 and Chunk 2)—create regulatory volatility that could further restrict Qualcomm's ability to transact with these key customers, directly threatening the revenue stream that constitutes a \"significant portion\" of its business. Consequently, while the *magnitude* of reliance on Chinese OEMs appears stable year-over-year, the *stability* of this reliance is increasingly precarious due to intensifying geopolitical pressures and customer-driven technological disruption, making Qualcomm's revenue base more vulnerable to abrupt declines than in prior periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Derives_Revenues_From]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Chinese OEMs (COMP)",
        "Chinese OEMs (COMP) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12852,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3848,
        "completion_tokens": 426,
        "total_tokens": 4275
      }
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Between 2022 and 2023, Amgen's total available-for-sale investments decreased significantly from $4,335 million to $10,404 million (reflecting the ORG‑[Decreases]-> FIN_INST relationship), and the composition shifted to be primarily held in money market mutual funds ($10,266 million) and other short‑term interest‑bearing securities ($138 million), as disclosed in the 2023 balance sheet and security breakdown. This evolution shows a move away from traditional marketable securities toward cash‑equivalent money market instruments and short‑term securities within the available‑for‑sale portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> Total available-for-sale investments (FIN_INST)",
        "Total available-for-sale investments (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1261,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 964,
        "completion_tokens": 149,
        "total_tokens": 1113
      }
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Based on the provided data across both chunks, Shake Shack's presence as a tenant in SPG's premium outlet properties remained consistent between 2022 and 2023, appearing exclusively in properties with 100% occupancy and full ownership. In 2022, it was listed as a tenant at Woodbury Common Premium Outlets (NY) and Wrentham Village Premium Outlets (MA), both showing 98%+ occupancy, and was also present at Las Vegas Outlets (NV) with 99.5% occupancy. By 2023, Shake Shack continued to be a tenant only at Las Vegas Outlets (NV), which maintained 99.5% occupancy, while all other properties in the 2023 portfolio (including newly referenced sites like Folsom and Gilroy) did not list Shake Shack among their tenants. This indicates no expansion or contraction in its presence—its inclusion remained limited to high-occupancy, fully owned properties, with no new leases or removals observed across the portfolio between the two years. The KG relationship ORG-SPG → COMP-Shake Shack → ORG-SPG confirms this stable, exclusive tenant relationship within SPG's premium outlet assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Shake Shack (COMP)",
        "Shake Shack (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18229,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5181,
        "completion_tokens": 269,
        "total_tokens": 5450
      }
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, the classification of retirement annuity contracts within the fair value hierarchy remained consistently in Level 3 across both years, as explicitly stated in the 2022 and 2024 disclosures where these contracts are specifically identified as Level 3 assets alongside insurance deposit contracts and real estate funds. This consistent Level 3 classification indicates that GD maintains a stable valuation methodology for these assets, relying on unobservable inputs rather than quoted market prices or observable marketplace data, which aligns with the nature of retirement annuity contracts as non-traded, entity-specific instruments requiring internal valuation models. The persistence of this Level 3 categorization across both reporting periods confirms that GD's valuation approach for retirement annuity contracts has not materially changed, continuing to exclude them from the fair value hierarchy's Level 1 or Level 2 classifications while still requiring disclosure of their fair value in aggregate plan asset reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Consists_Of]- ORG",
      "triplets_used": [
        "GD (ORG) -> Retirement Annuity Contracts (FIN_INST)",
        "Retirement Annuity Contracts (FIN_INST) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3250,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 262,
        "total_tokens": 1731
      }
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent a structural shift that directly impacted both equity dilution and income recognition. Following the IPO closing on September 19, 2022, Blackstone's right to exchange its ownership stake in Corebridge for AIG common shares was terminated, eliminating potential dilution from that mechanism—this is reflected in the 4.4 million, 24.1 million, and 12.0 million potential shares excluded from diluted shares outstanding for 2023, 2022, and 2021, respectively, as noted in Chunk 1. Concurrently, Chunk 2 reveals that AIG now accounts for its investment in Corebridge using the equity method, recognizing income from dividends received and changes in the stock price since June 9, 2024, which marks a shift from prior consolidation and establishes a new income recognition pattern tied to Corebridge's performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_242",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1198,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 933,
        "completion_tokens": 221,
        "total_tokens": 1155
      }
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "From 2022 to 2024, Comcast's financial exposure to Universal Beijing Resort shifted from a disclosed debt balance of $3.6 billion (2022) to $3.4 billion (2024), reflecting both consolidation of the VIE and repayment of its debt, while the company maintains a 30% equity interest and consolidates the resort due to controlling financial power, as evidenced by the $7.3 billion in consolidated assets and $7.0 billion in liabilities reported for Universal Beijing Resort as of December 31, 2024, compared to $7.8 billion in assets and $7.2 billion in liabilities as of December 31, 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8064,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2656,
        "completion_tokens": 146,
        "total_tokens": 2802
      }
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "The structure of aircraft trade-in commitments has shifted significantly between 2022 and 2023, particularly regarding customer eligibility and risk exposure. In 2022, trade-in options were held by some customers in the Aerospace segment, generally establishing fair market value 45 or fewer days before delivery, with some structured to guarantee a pre-determined value that presented higher risk in adverse market conditions; by 2023, this evolved to involve \"some Gulfstream customers\" holding these options, maintaining the same structural approach but reflecting a more specific customer segment within the business. Crucially, the risk exposure profile remains consistent in its mechanics—any excess of the pre-established trade-in price over fair market value at delivery reduces new aircraft sales revenue—but the 2023 disclosure explicitly notes these commitments \"present more risk in the event of an adverse change in market conditions\" (Chunk 1), while the 2023 version (Chunk 2) confirms the same risk dynamic without material change in the estimated fair market value impact (\"estimated change in fair market values... was not material\" in both years). This evolution reflects a narrowing of eligible customers (from \"some customers\" to \"some Gulfstream customers\") but retains the core risk structure, with no material shift in how the financial impact is accounted for or assessed across the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Offers]- ORG",
      "triplets_used": [
        "GD (ORG) -> Aircraft Trade-ins (ACCOUNTING_POLICY)",
        "Aircraft Trade-ins (ACCOUNTING_POLICY) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8178,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2688,
        "completion_tokens": 354,
        "total_tokens": 3043
      }
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Tesla's approach to the Tesla Semi has evolved significantly between 2022 and 2024, transitioning from a planned future product to active development and pilot production. According to the 2022 10-K filing, the Semi was listed among \"Future Consumer and Commercial Electric Vehicles\" as part of Tesla's strategy to leverage advancements in Full Self-Driving, battery cells, and proprietary technologies, positioning it within the commercial electric vehicle segment of its automotive business. By 2024, the Semi had moved into tangible production phases, with \"Pilot production\" confirmed at the Nevada facility in the 2024 10-K's production status table, indicating progression beyond conceptual planning. This strategic shift aligns with Tesla's broader commercial vehicle ambitions while maintaining integration within its core automotive segment, as evidenced by the Semi's continued association with Tesla (TSLA) in the knowledge graph relationships. The vehicle remains a key component of Tesla's product lineup expansion, targeting commercial markets while building on its technological foundation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Tesla Semi (PRODUCT)",
        "Tesla Semi (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4713,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1819,
        "completion_tokens": 276,
        "total_tokens": 2096
      }
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million (2022) to $397 million (2023) and further to $402 million (2024), reflecting a continued need for a reserve against the realization of those deferred tax assets. This upward trend indicates that Altria continues to view the associated deferred tax assets as uncertain and expects limited likelihood of full realization in the near term.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Cronos Warrant (FIN_INST)",
        "Cronos Warrant (FIN_INST) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5510,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2033,
        "completion_tokens": 113,
        "total_tokens": 2146
      }
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "The financial treatment and valuation impact of Amgen's investment in BeiGene evolved significantly between 2023 and 2024 as reflected in both chunks and KG relationships. In 2023, Amgen changed its accounting method for the BeiGene investment from the equity method to fair value measurement, recognizing fair value changes directly in earnings - a shift that transformed prior-year losses into 2023 gains within Other income (expense), net, while 2022 had shown losses under the previous method. By 2024, this fair value approach continued but resulted in net unrealized losses on the BeiGene investment compared to 2023's gains, directly contributing to the change in Other income (expense), net, as noted in both Chunk 1 (describing the 2023 fair value transition) and Chunk 2 (documenting the 2024 reversal to losses). This valuation shift also connected to Amgen's broader tax strategy, as the fair value adjustments occurred within the investment structure that interacted with Puerto Rico tax reforms and global minimum tax implementations described in Chunk 1's tax discussion, ultimately affecting the taxable income recognition tied to this strategic investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Recognizes_Losses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> BeiGene Investment (FIN_INST)",
        "BeiGene Investment (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6605,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2283,
        "completion_tokens": 293,
        "total_tokens": 2577
      }
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's positioning evolved from a regionally branded service under Disney's direct-to-consumer strategy to a unified global offering. In 2023, it operated as a distinct DTC service in India with sports and general entertainment programming under the Disney+ Hotstar brand, while international Disney+ (excluding Hotstar) expanded in over 150 countries. By mid-2024, the company consolidated its Latin American offerings—previously including standalone Disney+ and Star+ services—into a single Disney+ product, signaling a strategic move toward standardized regional branding. This shift reflects Disney's broader DTC consolidation strategy, where Disney+ Hotstar's regional identity was integrated into a more cohesive global structure, though it remained a key market-specific offering within Disney's portfolio. The 2024 filing confirms that Disney+ Hotstar continues to operate as a separate service in India, but its structural integration into Disney's multi-product offerings (e.g., bundled with Hulu Live TV + SVOD in the U.S.) underscores a strategic emphasis on unified service architecture over distinct regional branding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Disney+ Hotstar (PRODUCT)",
        "Disney+ Hotstar (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7810,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2593,
        "completion_tokens": 291,
        "total_tokens": 2885
      }
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "PayPal's Protection Programs evolved between 2023 and 2024 by expanding their scope and formalizing loss recovery mechanisms, as evidenced by the 2024 disclosure that these programs now explicitly cover both merchant and consumer protections against fraud and counterparty performance failures, while the 2023 documentation established the foundational framework for recognizing associated costs in transaction and credit losses during payment processing. The 2024 filing details increased financial exposure through heightened emphasis on fraud detection complexities, potential inability to recover losses from merchants (e.g., due to insolvency or fraudulent activity), and regulatory shifts affecting chargeback requirements, directly linking to the 2023 acknowledgment that protection program costs are estimated and recorded at transaction time without material contract balances or capitalized costs. This evolution reflects a strategic shift toward more structured risk exposure management, where loss recovery now depends on active recovery efforts (e.g., from merchants) but remains inherently uncertain due to external factors like merchant viability and evolving fraud tactics, as underscored by the 2024 warning that allowances for transaction losses \"may be insufficient to cover incurred losses.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Protection Programs (ACCOUNTING_POLICY)",
        "Protection Programs (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11022,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3402,
        "completion_tokens": 327,
        "total_tokens": 3730
      }
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "From 2022 to 2024, NextEra Energy's relationship with solar generation facilities shifted from prior divestitures toward active consolidation and operational management, particularly through variable interest entities (VIEs) and partnerships like XPLR. While earlier transactions (e.g., 2020 sales of solar/wind assets to NEP subsidiaries, including a 90% stake in three solar facilities) involved significant ownership sales and gains, recent filings show NextEra consolidating VIEs that own substantial solar capacity—such as eight subsidiaries holding ~765 MW of solar assets and a consolidated VIE with ~10,446 MW of solar/wind/battery capacity—where NextEra Energy Resources operates and maintains the facilities, absorbing expected losses and controlling key activities. This evolution reflects a strategic move from outright sales to managing solar assets under VIE structures, where financial exposure is indirect but material, evidenced by $23.9 billion in total VIE assets and $1.5 billion in liabilities at December 2024, alongside $58 million in credit support obligations and $128 million in receivables from XPLR, underscoring ongoing operational and financial interdependence without majority ownership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Solar Generation Facilities (PRODUCT)",
        "Solar Generation Facilities (PRODUCT) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13983,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4142,
        "completion_tokens": 304,
        "total_tokens": 4446
      }
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "From 2022 to 2023, ACN's investment in Mutual Fund Debt Securities declined from $379,989 (reported at Level 2) to $253,025 (also at Level 2), reflecting a $126,964 reduction in fair value. The valuation methodology remained consistent with Level 2 inputs throughout both years, as evidenced by the fair value hierarchy disclosures in both chunks where Mutual Fund Debt Securities are explicitly categorized under Level 2 with no movement to Level 1 or Level 3. This indicates the change was driven by market valuations rather than a shift in reporting methodology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Mutual Fund Debt Securities (FIN_INST)",
        "Mutual Fund Debt Securities (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2576,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 141,
        "total_tokens": 1436
      }
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron's financial stake in Tengizchevroil increased from $23,727 million at the end of 2022 to $28,571 million at the end of 2023, reflecting a rise in its investment and advances within the upstream segment, while the underlying equity in TCO's net assets grew modestly to $80 million higher than Chevron's carrying value in 2023, driven by a $4,500 million loan to fund the FGP/WPMP development and a 50 percent equity ownership that also includes a $387 million loan for the Golden Triangle Polymers project; this evolution is underscored by the $13,623 million of sales and $7,404 million of crude oil purchases with affiliated companies in 2023, as well as the $1,480 million receivable and $591 million payable to affiliates, illustrating the deep financial integration and ongoing capital commitments between Chevron and Tengizchevroil.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8640,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2781,
        "completion_tokens": 211,
        "total_tokens": 2993
      }
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Disney's strategic positioning of ABC Network has deepened within its entertainment ecosystem through integrated distribution and content synergies, as evidenced by ABC's role as a key linear network asset owned 73% by Disney (DIS → ABC Network) and its content being leveraged across Disney's DTC platforms like Hulu and Disney+ (ABC Network → DIS). This evolution reflects Disney's consolidation of linear networks under its Entertainment segment, where ABC's affiliate fees and advertising revenues contribute to the segment's diverse revenue streams, while Disney's 2024 restructuring of its Latin American streaming services—merging standalone offerings into a unified Disney+ product—further aligns ABC's broadcast content with Disney's direct-to-consumer strategy, reinforcing cross-platform synergy and operational efficiency across the broader ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "DIS (ORG) -> ABC Network (COMP)",
        "ABC Network (COMP) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2801,
        "completion_tokens": 215,
        "total_tokens": 3017
      }
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics' Land Systems division maintained its strategic focus on tracked combat vehicles through the ASCOD platform, with production volume increasing from \"approximately 14,000\" LAVs globally in 2022 to \"399 new LAVs\" specifically for the Canadian Army in 2023, while simultaneously expanding its tracked vehicle portfolio to include the AJAX family and continuing development of the TRX prototype. This indicates a deliberate shift toward heavier, more advanced tracked systems—evidenced by the 2023 emphasis on AJAX variants and TRX development—suggesting a strategic reallocation of investment from lighter LAVs toward next-generation tracked platforms to address multi-domain battlefield demands, as underscored by the 2023 description of ASCOD's \"highly lethal, survivable and mobile\" design philosophy. The consistent mention of ASCOD across both years (including its Spanish Pizarro and Austrian Ulan variants) alongside the 2023 expansion of tracked vehicle production (399 new LAVs vs. 2022's 14,000 global LAV total) reveals a clear pivot from broad LAV market leadership toward targeted investment in high-value tracked combat vehicles for NATO allies, reflecting a production focus shift toward specialized, next-generation platforms rather than incremental LAV growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "GD (ORG) -> ASCOD (PRODUCT)",
        "ASCOD (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5611,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2050,
        "completion_tokens": 328,
        "total_tokens": 2379
      }
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit funding declined from $3.0 billion (39% of European balances) in 2023 to $2.0 billion (26% of balances) in 2024, reflecting a strategic shift toward external financing sources such as debt issuances and the sale of consumer installment receivables. This reduction—while still allowing up to 50% of those balances to be designated for credit activities—indicates the company is diversifying its credit‑funding mix and relying less on internally generated customer deposits to support its loan portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Credit Activities (FIN_INST)",
        "Credit Activities (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9836,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3108,
        "completion_tokens": 141,
        "total_tokens": 3249
      }
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, the valuation and categorization of equity securities within NEE's Special Use Funds evolved significantly, reflecting changes in transparency and investment composition. In 2022, equity securities in Special Use Funds were reported at $906 million in carrying amount and $907 million in estimated fair value for NEE, and $672 million for FPL, with no Level 2 or Level 3 categorization disclosed. By 2024, these funds expanded substantially to $6,164 million total for NEE and $4,219 million for FPL, with equity securities now categorized across Level 1 ($2,614M for NEE), Level 2 ($3,321M), and Level 3 ($229M), indicating increased transparency in fair value measurement and a more complex, diversified portfolio composition. This shift suggests a strategic move toward greater disclosure of valuation inputs and a potential reclassification of investments, possibly reflecting regulatory requirements, market conditions, or portfolio rebalancing toward more structured or illiquid assets requiring Level 2/3 inputs. The inclusion of detailed Level 2 and Level 3 components—such as corporate debt, asset-backed securities, and restricted assets—demonstrates enhanced granularity in reporting, signaling improved transparency but also a more intricate investment structure compared to the simpler, consolidated reporting in 2022. This evolution underscores both a maturation of NEE’s reporting practices and a likely transformation in the underlying asset mix toward higher-yielding, longer-duration, or less liquid instruments, which may carry different risk and return profiles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Special Use Funds (FIN_INST)",
        "Special Use Funds (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6167,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2194,
        "completion_tokens": 401,
        "total_tokens": 2595
      }
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Accenture's share purchase program expanded its total authorized share repurchase authority from $3,129 million (as of August 31 2022) to $6,129 million after the Board approved an additional $3 billion in September 2022, reflecting a broader scope of capital allocation. During fiscal 2022, 1,964,612 shares were acquired under the public open‑market program for $576 million, while 97,251 shares were obtained in employee‑related transactions that did not affect the public program’s authorization; the 2023 data shows continued use of employee‑related share withholding for payroll tax obligations, which likewise remains separate from the publicly announced program.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Share Purchase Program (FIN_INST)",
        "Share Purchase Program (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3066,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 175,
        "total_tokens": 1605
      }
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Between 2022 and 2023, Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC underwent a structural shift in consolidation status and accounting methodology. In 2022, Chevron Phillips Chemical Company LLC was explicitly listed as a separately reported reporting segment (Note 8 in CVX_10k_2022.pdf), indicating it was accounted for as a distinct business unit within Chevron's consolidated financial statements. However, in 2023, the reporting structure changed: Chevron Phillips Chemical Company LLC was no longer presented as a standalone segment but was instead integrated into the broader \"Summarized Financial Data\" for Chevron U.S.A. Inc. (CUSA), where it was disclosed as an equity method investment (Note 6 in CVX_10k_2023.pdf). This shift reflects a strategic realignment in reporting, where Chevron's investment in Chevron Phillips Chemical Company LLC is now treated as an equity investment within CUSA's operations rather than as a separate consolidated segment. Consequently, the company's financial reporting approach evolved from direct segment reporting to equity method accounting for this investment, aligning with the KG pattern of ORG -[Discloses]-> COMP and COMP -[Invests_In]-> ORG relationships being maintained but reinterpreted through the equity method framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Chevron Phillips Chemical Company LLC (COMP)",
        "Chevron Phillips Chemical Company LLC (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3497,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 330,
        "total_tokens": 1864
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "From 2022 to 2023, the role of Hydra-70 rockets in General Dynamics' Combat Systems segment shifted from a specific $175 contract award for production (Chunk 1) to expanded strategic importance through OTS's market leadership and capacity investments (Chunk 2). While Chunk 1 documents the 2021 $175 award for Hydra-70 production, Chunk 2 reveals that OTS—responsible for Hydra-70 supply as part of its munitions portfolio—is actively expanding production capacity from 18,000 to 86,000 rounds/month by 2025 to support the Army's artillery acceleration efforts, directly linking Hydra-70 production to broader Combat Systems growth. This evolution shows a transition from isolated contract execution to integrated, capacity-driven expansion within the segment's weapons systems portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Receives]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "GD (ORG) -> Hydra-70 Rockets (PRODUCT)",
        "Hydra-70 Rockets (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3126,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 197,
        "total_tokens": 1624
      }
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice has evolved from its initial 2015 filing (Exhibit 10.07+ in the 2023 10-K) to a refreshed 2024 version (Exhibit 10.07+ in the 2024 10-K), reflecting updates tied to the amended 2015 Equity Incentive Award Plan (10.03+ in 2024) and the 2024 Executive Severance Plan (10.05+). The 2023 filing referenced the original 2015 agreement forms, while the 2024 filing incorporates amendments to the underlying equity plan and includes updated exhibit numbering, underscoring a formalized evolution in documentation and governance under PayPal's current incentive framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Global Restricted Stock Unit Award Grant Notice (ACCOUNTING_POLICY)",
        "Global Restricted Stock Unit Award Grant Notice (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15868,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4640,
        "completion_tokens": 159,
        "total_tokens": 4800
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's portfolio has significantly evolved, as evidenced by its sustained revenue performance and strategic regulatory expansions. In 2022, Opdivo generated $7,523 million in revenue (Chunk 1), and by 2024, it received a key FDA approval for a first-line combination therapy in unresectable or metastatic urothelial carcinoma (Chunk 2), underscoring its growing clinical utility. This approval, alongside new launches for Breyanzi and Abecma in March 2024 (Chunk 2), reflects BMS's strategic focus on expanding Opdivo's therapeutic reach, while its revenue trajectory—though not explicitly stated for 2024—remains foundational to the portfolio, supported by its established $7.5B+ annual performance (Chunk 1) and continued regulatory momentum.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5880,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2103,
        "completion_tokens": 200,
        "total_tokens": 2303
      }
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolved significantly between 2022 and 2023 through targeted project funding and investment structures. In 2023, Chevron held a 50% stake in CPChem and included a $387 million loan to fund the Golden Triangle Polymers Project in Orange, Texas, directly supporting CPChem's expansion plans announced in 2021. This investment structure, detailed in the 2023 10-K, continued Chevron's strategic commitment to CPChem's growth, building on prior project approvals like the $266,000-ton/year 1-hexene unit at Old Ocean, Texas (targeted for 2023 start-up) and the $1 billion propylene capacity expansion at Cedar Bayou, which were central to CPChem's 2022-2023 operational roadmap. The financial ties were further reinforced through $13.6 billion in 2023 sales and $7.4 billion in crude oil purchases with affiliated entities, including CPChem, highlighting the deep integration of Chevron's investment in CPChem's manufacturing and project execution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Chevron Phillips Chemical Company LLC (COMP)",
        "Chevron Phillips Chemical Company LLC (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5365,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2000,
        "completion_tokens": 260,
        "total_tokens": 2260
      }
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "PayPal's protection programs evolved between 2023 and 2024 with increased financial commitments reflected in higher allowances for losses: transaction loss reserves rose from $64 million to $86 million, while negative customer balance reserves increased from $218 million to $256 million, indicating expanded risk coverage. The company continues to disclose these protections as assurance-type warrantants requiring real-time estimation and recording of associated costs during transaction completion, with no material changes to indemnification exposure ($2.9B outstanding as of 2024) despite growth in consumer receivables portfolios. This evolution demonstrates both quantitative expansion of loss reserves and continued transparency in accounting for protection program liabilities across all disclosed financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Protection Programs (ACCOUNTING_POLICY)",
        "Protection Programs (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7795,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2596,
        "completion_tokens": 207,
        "total_tokens": 2803
      }
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has reinforced its strategic framing of franchising as the core business model by emphasizing co-investment with franchisees as essential to performance and brand integrity. In its 2022 filing, the Company highlighted franchising as paramount to delivering quality food and driving profitability, noting that ownership of real estate combined with franchisee co-investment enables high restaurant performance. By 2024, this narrative was expanded to underscore that Company-owned operations enhance franchisor credibility and allow for testing innovations in collaboration with franchisees, while explicitly identifying co-investment in real estate and development as a key mechanism to align incentives and improve system-wide results. The 2024 filing further positions co-investment not just as a financial arrangement but as a strategic pillar for refining operations, marketing, and product strategies across the system, reflecting a deepened commitment to partnership as integral to the Company's business model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6573,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2291,
        "completion_tokens": 262,
        "total_tokens": 2553
      }
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "The FDA's authorization of Marlboro HeatSticks evolved from a January 2023 approval of three new tobacco‑flavored varieties (after earlier 2020/2022 authorizations of the IQOS system and IQOS 3) to continued regulatory scrutiny amid the ITC cease‑and‑desist order that forced removal of the products from the U.S. market in late 2021, while the company simultaneously pursued a strategic partnership with PMI to commercialize the IQOS system in the United States. This timeline illustrates Altria’s incremental regulatory progress—securing multiple PMTAs for HeatStick variants while navigating adverse ITC and FDA actions that could affect market availability—demonstrating both advances and ongoing challenges in its heated‑tobacco portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> FDA Authorization (REGULATORY_REQUIREMENT)",
        "FDA Authorization (REGULATORY_REQUIREMENT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11992,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3653,
        "completion_tokens": 186,
        "total_tokens": 3839
      }
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "Between 2022 and 2023, the valuation of mutual fund equity securities held by ACN increased significantly from $234,339 (Level 2) to $188,796 (Level 3) within the mutual fund equity securities category, though the total reported under this line item decreased slightly from $239,293 to $196,226 due to reclassification of non-U.S. corporate equity securities ($18,163) into a separate subcategory. This shift indicates ACN strategically reduced its exposure to broad mutual fund equity holdings while maintaining targeted investments in specific segments like non-U.S. corporate equities and mutual fund debt securities ($189,337 in 2023), reflecting a more refined investment positioning that emphasizes diversification across fixed income and regional exposures rather than traditional mutual fund equity dominance. The overall portfolio value remained nearly stable ($1.126B vs $1.126B), but the reallocation suggests a deliberate pivot toward higher-yielding fixed income instruments and non-equity assets to manage risk amid market volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Mutual Fund Equity Securities (FIN_INST)",
        "Mutual Fund Equity Securities (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2433,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 262,
        "total_tokens": 1525
      }
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "Chevron's involvement in Angola LNG Limited has evolved from a **36.4 percent equity interest** in 2022 (as noted in the 2022 filing describing the plant’s capacity and feedstock development) to a continued **36.4 percent stake** highlighted in the 2023 description of its major equity affiliates, underscoring a stable ownership level.  The 2023 text emphasizes that this interest is part of Chevron’s broader African upstream portfolio—particularly its participation in the **Angola LNG Limited** project, which processes natural gas from multiple fields and supports the **Sanha Lean Gas Connection Project** and ongoing non‑associated gas development.  Across both years, Chevron’s focus has been on **operational integration and investment in gas‑related infrastructure** (e.g., the SLGC platform and feedstock expansion) rather than on new equity increases, reflecting a sustained emphasis on leveraging its share in Angola LNG to grow gas production and LNG exports.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Angola LNG Limited (COMP)",
        "Angola LNG Limited (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7525,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2518,
        "completion_tokens": 243,
        "total_tokens": 2761
      }
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "From 2022 to 2023, MMM's investment in Certificates of Deposit/Time Deposits increased significantly, rising from $21 million to $49 million—a $28 million growth representing a substantial increase in this specific investment category. This change is clearly documented in both the 2022 and 2023 financial disclosures, with the 2023 10-K showing the current value at $49 million compared to $21 million in the prior year, demonstrating a notable expansion in MMM's holdings of these low-risk, short-term financial instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Certificates of Deposit/Time Deposits (FIN_INST)",
        "Certificates of Deposit/Time Deposits (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8270,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2711,
        "completion_tokens": 131,
        "total_tokens": 2843
      }
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Between 2021 and 2024, McDonald's franchised restaurant percentage increased from 93% to approximately 95%, reflecting a continued strategic emphasis on franchising as the primary ownership model. This evolution underscores the company's ongoing commitment to leveraging franchisee partnerships to drive brand growth, operational innovation, and profitability, while maintaining Company-owned operations to support system-wide development and standardization. The shift from 93% to 95% franchised locations demonstrates a deliberate expansion of the franchise model across its global footprint of over 100 countries, reinforcing the franchisee-franchisor relationship as central to McDonald's business strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12553,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3768,
        "completion_tokens": 177,
        "total_tokens": 3946
      }
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was first adopted in 2015 and subsequently amended and restated effective March 31 2021 (as noted in the 2021 Form 10‑Q) and then again amended and restated effective October 26 2022 (as disclosed in the 2022 Form 10‑Q), establishing the governing structure for director compensation through 2023. This evolution reflects a continuous refinement of the plan’s terms, with each amendment updating the effective date and scope of the plan to align with Altria’s evolving compensation policies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amends]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MO (ORG) -> 2015 Stock Compensation Plan for Non-Employee Directors (ACCOUNTING_POLICY)",
        "2015 Stock Compensation Plan for Non-Employee Directors (ACCOUNTING_POLICY) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16110,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4686,
        "completion_tokens": 137,
        "total_tokens": 4824
      }
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Based on the provided information, Accenture's financial relationship with Duck Creek Technologies evolved significantly between fiscal years 2022 and 2023, with the investment valuation and financial impact directly tied to a specific gain recorded in fiscal 2023. In fiscal 2022, Accenture held a 16% equity stake in Duck Creek Technologies, recorded using the equity method, with a carrying amount of $138,902 and an estimated fair value of $223,166 as of August 31, 2022 (Chunk 1). During fiscal 2023, Accenture recognized a $253 million investment gain related to its Duck Creek Technologies holding, which directly contributed to the adjusted diluted earnings per share increase of 2% to $11.95 compared to $11.67 in fiscal 2023 (Chunk 2). This gain, disclosed as part of business optimization costs exclusion in the key metrics, reflects the financial impact of the investment's appreciation, though the text does not specify a corresponding valuation change or new investment activity between the two fiscal years beyond this gain recognition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Duck Creek Technologies (COMP)",
        "Duck Creek Technologies (COMP) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5861,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2114,
        "completion_tokens": 262,
        "total_tokens": 2377
      }
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, Breyanzi's therapeutic application expanded significantly through new regulatory approvals that broadened its target indications and geographic reach. In 2024, it received FDA accelerated approval for relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after two prior lines of therapy including a BTK inhibitor and BCL-2 inhibitor (March 2024), and accelerated approval for relapsed/refractory follicular lymphoma (FL) after two prior systemic therapies (May 2024), while also securing EU approval for relapsed/refractory multiple myeloma after two prior lines of therapy (April 2024). These additions—particularly the CLL/SLL and FL approvals—substantially increased its addressable patient population and market potential by targeting additional hematologic malignancies beyond its initial large B-cell lymphoma indication launched in April 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Breyanzi (PRODUCT)",
        "Breyanzi (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6823,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2343,
        "completion_tokens": 226,
        "total_tokens": 2569
      }
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 has evolved in 2023 by incorporating more nuanced analysis of policy terms, case law, and claim-specific factors to determine recognizable insurance recoveries, particularly for respirator mask/asbestos litigation where the Company now faces approximately 4,042 claimants (up from 4,028 in 2022); this evolution reflects the Company's practice of recording receivables for the amount it concludes is recognizable under its insurance program even when no accrued liability exists (e.g., for non-probable or non-estimable losses), while also adjusting accruals based on reexamination of estimates each period, as detailed in Note 16 of both 2022 and 2023 filings where ASC 450 compliance is explicitly maintained through the ORG-MMM relationship under the regulatory framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "MMM (ORG) -> ASC 450, Contingencies (REGULATORY_REQUIREMENT)",
        "ASC 450, Contingencies (REGULATORY_REQUIREMENT) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9043,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2928,
        "completion_tokens": 220,
        "total_tokens": 3148
      }
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "PepsiCo's relationship with Naked evolved significantly between 2022 and 2023 through the sale of its juice portfolio, including Naked, to PAI Partners while retaining a 39% noncontrolling interest in the newly formed joint venture TBG, which operates across North America and Europe. This transaction, detailed in Note 13 of PepsiCo's consolidated financial statements, established a strategic distribution partnership where PepsiCo acts as the exclusive distributor for the joint venture's portfolio of brands in the U.S. small-format and foodservice channels, maintaining an operational and financial stake through its 39% ownership while divesting direct control of the Naked brand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Distributes]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Naked (PRODUCT)",
        "Naked (PRODUCT) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9032,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2888,
        "completion_tokens": 171,
        "total_tokens": 3060
      }
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "The accounting treatment for the ExtraBucks Rewards program has evolved from 2023 to 2024 in how revenue is allocated and recognized, particularly regarding performance obligations. In both years, the Company determined that ExtraBucks Rewards create an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices considering historical redemption patterns. Revenue for these rewards is recognized as they are redeemed, and unredeemed rewards are recorded as a contract liability at period-end. This treatment is consistent across both filings, with the 2024 chunk reinforcing that the rewards are tied to historical spending levels and require allocation of the transaction price between the initial purchase and the rewards obligation. The KG triplets confirm the mutual disclosure relationship between CVS and ExtraBucks Rewards, underscoring that the program's accounting is fully embedded within CVS's loyalty structure and revenue recognition framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> ExtraBucks Rewards (PRODUCT)",
        "ExtraBucks Rewards (PRODUCT) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_125",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8267,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2721,
        "completion_tokens": 260,
        "total_tokens": 2981
      }
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Netflix's reliance on integrated payment partners has remained consistently structured between 2023 and 2024, with both years explicitly identifying payment processing fees paid to integrated payment partners as a component of \"other operations costs\" within the cost of revenues section. While the 2023 chunk specifies these fees are paid \"to our integrated payment partners\" alongside customer service costs, and the 2024 chunk similarly notes \"payment processing fees, including those we pay to our integrated payment partners,\" neither year provides quantitative metrics or quantitative changes in this dependency, indicating the structural reliance has persisted without measurable evolution in payment partner integration during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Integrated Payment Partners (COMP)",
        "Integrated Payment Partners (COMP) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4442,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1757,
        "completion_tokens": 186,
        "total_tokens": 1944
      }
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M's approach to managing PFAS contamination in Minnesota evolved in response to increasingly stringent health-based standards and regulatory actions. In January 2024, the Minnesota Department of Health issued updated, more stringent Health-Based Values (HBVs) for PFOA and PFOS, prompting 3M to evaluate potential impacts on its obligations under the May 2007 Settlement Agreement and Consent Order (SACO) with the Minnesota Pollution Control Agency (MPCA) governing remediation at Oakdale, Woodbury, and Cottage Grove sites. This regulatory shift builds upon the ongoing remediation work previously completed or ongoing under the SACO framework, which requires 3M to address PFAS releases exceeding HBVs or Health Risk Limits (HRLs) and to remediate non-PFOA/PFOS PFAS sources. Concurrently, 3M faced new regulatory challenges, including a March 2023 Notice of Violation from MPCA alleging PFAS discharge in stormwater at its Hutchinson facility and a January 2024 draft Clean Water Act permit for the Cottage Grove facility with significantly revised, potentially unquantifiable PFAS limits, reflecting the broader trend of tightening environmental standards. These developments occurred within the context of 3M's continued operational and maintenance activities at remediation sites, as documented in both 2022 and 2023 filings, and its ongoing engagement with state and federal agencies to address compliance matters across its Minnesota operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Remediates]-> RISK_FACTOR <-[Treats]- ORG",
      "triplets_used": [
        "MMM (ORG) -> PFAS Sources (RISK_FACTOR)",
        "PFAS Sources (RISK_FACTOR) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12026,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3649,
        "completion_tokens": 368,
        "total_tokens": 4017
      }
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo's use of foreign currency derivatives increased significantly between 2022 and 2023, with notional value rising from $3.0 billion to $3.8 billion, indicating a more aggressive strategy to hedge foreign exchange exposure from international operations, net investments in subsidiaries, and currency-denominated transactions. This expansion, coupled with the company's disclosure of using forward contracts with maturities of no more than two years and net investment hedges to offset currency impacts, demonstrates a deliberate and scaled-up approach to managing foreign exchange risk, likely driven by heightened volatility in global currency markets during the period. The consistent use of derivatives aligned with underlying hedged items and the absence of material earnings impact from ineffective hedges further underscore a structured, risk-focused strategy to mitigate currency fluctuations across its global footprint.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Local Currency Contracts (ACCOUNTING_POLICY)",
        "Local Currency Contracts (ACCOUNTING_POLICY) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8617,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2806,
        "completion_tokens": 233,
        "total_tokens": 3040
      }
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "ExxonMobil's capital allocation strategy for chemical capacity expansion evolved from 2022 to 2023 by shifting focus from completing near-term U.S. Gulf Coast projects to advancing high-growth international initiatives, particularly in China. In 2022, the company restarted U.S. Gulf Coast growth projects (e.g., Baytown and Baton Rouge units) and launched advanced recycling capacity (500,000 metric tons/year by 2026), while finalizing a $10B+ chemical complex in China's Dayawan Industrial Park to capture domestic demand growth. By 2023, ExxonMobil had operationalized new performance polymers (400k tons/year Vistamaxx™/Exact™ in Baytown) and linear alpha olefins (350k tons/year in Baytown) units, but its strategic emphasis pivoted decisively to the Dayawan complex—set to become China's first 100% foreign-owned petrochemical facility with 2.5M+ tons/year capacity for high-performance polyethylene and polypropylene—reflecting a geographic prioritization of China to serve its expanding middle-class demand, while U.S. Gulf Coast investments transitioned to optimizing existing assets rather than new capacity. This progression demonstrates a deliberate evolution from incremental U.S. capacity additions to targeted, high-value international expansion aligned with improving living standards in key emerging markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> MACRO_CONDITION <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Improving Living Standards (MACRO_CONDITION)",
        "Improving Living Standards (MACRO_CONDITION) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6844,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2369,
        "completion_tokens": 331,
        "total_tokens": 2701
      }
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "3M's investment in Certificates of Deposit/Time Deposits increased from $21 million in 2022 to $49 million in 2023, reflecting a strategic shift toward higher‑yielding, short‑term instruments amid changing market conditions. This rise, highlighted by the KG pattern of “ORG Invests_In → FIN_INST Increases → ORG,” indicates that 3M is reallocating cash to more liquid, lower‑risk securities to optimize its short‑term investment portfolio while maintaining flexibility for operational needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Certificates of Deposit/Time Deposits (FIN_INST)",
        "Certificates of Deposit/Time Deposits (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1515,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1033,
        "completion_tokens": 122,
        "total_tokens": 1156
      }
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard's approach to proprietary insights has evolved from 2022 to 2023 by shifting from general references to \"proprietary insights\" in 2022 to explicitly emphasizing \"principled and responsible use of secure consumer and merchant data\" in 2023, reflecting a strengthened commitment to data responsibility and trust-building. This evolution is underscored by the company's framing of data practices as foundational to its franchise model and multi-layered security strategy, which collectively reinforce stakeholder confidence while maintaining interoperability across its global payments ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Proprietary Insights (PRODUCT)",
        "Proprietary Insights (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9128,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2921,
        "completion_tokens": 151,
        "total_tokens": 3072
      }
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "Between 2022 and 2023, the factors influencing accounting estimates for pension and retiree medical plans shifted from pandemic-related economic uncertainty to heightened geopolitical risks and macroeconomic pressures, specifically the \"ongoing conflicts in Ukraine and the Middle East\" and a \"high interest rate and inflationary cost environment.\" This evolution reflects a significant change in the external environment, as management now assesses estimates under substantially different global instability drivers while maintaining consistent application of critical accounting policies across periods. The transition underscores how evolving macroeconomic and geopolitical conditions directly impact the assumptions and judgments required for these long-term liability estimates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Pension and Retiree Medical Plans (ACCOUNTING_POLICY)",
        "Pension and Retiree Medical Plans (ACCOUNTING_POLICY) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4568,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1811,
        "completion_tokens": 195,
        "total_tokens": 2007
      }
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region declined slightly from 25,096 gross (11,977 net) thousand acres in 2022 to 24,221 gross (11,548 net) thousand acres in 2023, reflecting a reduction of 875 gross acres while maintaining net acreage levels. This evolution aligns with the company's practice of retaining acreage only when exploration potential is validated, as evidenced by its history of securing extensions for properties requiring additional evaluation time. The scheduled expiration of undeveloped leases over the next three years is not expected to have a material adverse impact, indicating that ExxonMobil's exploration potential in the region remains robust and strategically managed through disciplined evaluation and contractual flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Exploration Potential (RISK_FACTOR)",
        "Exploration Potential (RISK_FACTOR) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5981,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2149,
        "completion_tokens": 194,
        "total_tokens": 2343
      }
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, the treatment of non-functional currency denominated items shifted significantly in terms of associated foreign currency contracts. In 2022, as described in Chunk 1, the Company used foreign currency contracts not designated in hedging relationships specifically to offset changes in value of non-functional currency items, including intercompany financing balances, with fair value gains/losses recorded directly in earnings. By 2023, as detailed in Chunk 2, these previously designated cash flow hedge relationships were often de-designated, and such contracts continued to be used for non-hedging purposes, meaning their fair value changes now flow directly through the income statement without hedge accounting treatment. This evolution reflects a strategic shift where non-designated foreign currency contracts increasingly handled the financial impact of non-functional currency items, moving from potential hedge accounting (though sometimes de-designated) toward direct earnings impact, with the gross notional amount of such non-hedging contracts remaining substantial at $3.7 billion as of late 2021 (referenced in both chunks). The KG pattern ORG -[Hedges]-> FIN_INST <-[Impacts]- ORG underscores how MMM's derivative activity (Hedges) directly impacts the financial treatment of these specific FIN_INST items through non-designated contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Hedges]-> FIN_INST <-[Impacts]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Non-Functional Currency Denominated Items (FIN_INST)",
        "Non-Functional Currency Denominated Items (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6629,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2323,
        "completion_tokens": 343,
        "total_tokens": 2666
      }
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role of Cyber and Intelligence Solutions within Mastercard's value proposition evolved from being one component among several value-added services to a more strategically emphasized capability explicitly tied to security and trust in the payments ecosystem. As stated in the 2023 10-K, these solutions are described as \"designed to allow all parties to transact securely, easily and with confidence\" and are positioned alongside other critical offerings like consulting fees, loyalty programs, and gateway services, while also being highlighted as part of Mastercard's investments in \"new networks, such as open banking solutions and digital identity capabilities.\" This emphasis is reinforced by the company's multi-layered approach to protecting the global payments ecosystem, where cyber and intelligence solutions are presented as foundational to maintaining the safety and efficiency of their multi-rail payments network, directly supporting their franchise model's balance of value and risk across stakeholders. The consistent mention of these solutions across both 2022 and 2023 disclosures—alongside their explicit connection to secure transactions in the business overview—demonstrates a sustained and deepening integration of cyber and intelligence capabilities as a core differentiator within Mastercard's overall product portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Cyber and Intelligence Solutions (PRODUCT)",
        "Cyber and Intelligence Solutions (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4578,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1787,
        "completion_tokens": 342,
        "total_tokens": 2129
      }
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "The treatment and disclosure of Income Tax Expense and Accruals as a critical accounting policy remained consistent in both 2022 and 2023, as evidenced by its explicit inclusion in the list of critical accounting policies in both PEP_10k_2022.pdf (page 59) and PEP_10k_2023.pdf (page 58), with the 2023 filing specifically detailing its application under \"Note 5 - Income Taxes\" (page 84) and its continued prominence in the policy framework. While the 2022 chunk (Chunk 1) emphasizes the estimation methodology for income tax accruals—including reliance on forward-looking information and economic uncertainty assessments—the 2023 chunk (Chunk 2) confirms its structural placement within the critical policies list and references related disclosures in Note 5, indicating an evolution toward more structured, note-based elaboration of the policy without altering its fundamental criticality or disclosure requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Income Tax Expense and Accruals (ACCOUNTING_POLICY)",
        "Income Tax Expense and Accruals (ACCOUNTING_POLICY) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7073,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2419,
        "completion_tokens": 229,
        "total_tokens": 2649
      }
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Intel's Universal Chiplet Interconnect Express (UCIe) standard has evolved as a cornerstone of its systems-of-chips strategy, with the company demonstrating silicon validation of the standard in 2023 (INTC_10k_2023.pdf) and advancing its commercial readiness for broader adoption in 2024 through integration with Intel Foundry's advanced packaging capabilities (INTC_10k_2024.pdf). This development directly supports Intel's broader strategy of enabling optimized systems of chips through standardized interconnects, as highlighted in its IDM 2.0 roadmap and Open Foundry model, where UCIe facilitates chiplet-based system design across its ecosystem of customers and foundry partners (INTC_10k_2023.pdf, INTC_10k_2024.pdf). The standard's progression from demonstration to strategic implementation underscores Intel's leadership in establishing open standards that drive industry-wide systems innovation, particularly critical for AI workloads requiring heterogeneous chip integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Universal Chiplet Interconnect Express Standard (PRODUCT)",
        "Universal Chiplet Interconnect Express Standard (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6368,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2253,
        "completion_tokens": 246,
        "total_tokens": 2500
      }
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "The accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved significantly between the 2023 and 2024 10-K filings, reflecting a shift from initial execution to final settlement and enhanced disclosure of accounting mechanics. In the 2023 10-K, CVS disclosed initiating a $3.0 billion ASR with Morgan Stanley in January 2024 (settled in March 2024) and a $2.0 billion ASR with Citibank in January 2023 (settled in February 2023), describing the initial accounting as a treasury stock transaction for the upfront purchase price and a forward contract recorded in capital surplus, with final settlement involving reclassification to treasury stock upon receiving the remaining shares. The 2024 10-K provides critical updates: it confirms the $3.0 billion Morgan Stanley ASR was accounted for as a $2.6 billion treasury stock transaction and a $0.4 billion forward contract (equity instrument in capital surplus), with the forward contract reclassified to treasury stock in March 2024 upon receiving the final 8.3 million shares to complete the 15% settlement; similarly, the $2.0 billion Citibank ASR (executed January 4, 2023) was initially recorded as a $1.6 billion treasury stock transaction and $0.4 billion forward contract, with the forward contract reclassified to treasury stock in February 2023 after receiving the final 5.4 million shares. This progression demonstrates that the 2024 filing details the *completion* of these ASRs (including exact settlement dates and share counts), while the 2023 filing only described the *initiation* and structure, revealing a clear evolution from transaction launch to final accounting resolution across the two filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Repurchase Programs (ACCOUNTING_POLICY)",
        "Repurchase Programs (ACCOUNTING_POLICY) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6402,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2249,
        "completion_tokens": 429,
        "total_tokens": 2679
      }
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "UPS disclosed in its 2022 10-K that a $2.3 billion pre‑tax coordinating‑benefit estimate related to the Central States Pension Fund was recorded, reflecting the best estimate of additional payments required before adjusting for discount‑rate changes. In 2023 the company noted that a 25‑basis‑point shift in either the expected or actual return on pension assets would materially affect the liability for those coordinating benefits, as referenced in Note 5 of the audited financial statements. Consequently, while the 2022 filing detailed actuarial assumptions and sensitivity to discount‑rate changes, the 2023 filing highlighted a focus on how market‑return fluctuations influence the exposure and reporting of that same coordinating‑benefit liability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Central States Pension Fund (FIN_INST)",
        "Central States Pension Fund (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5558,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2044,
        "completion_tokens": 188,
        "total_tokens": 2233
      }
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Mastercard has strategically elevated its Cyber and Intelligence Solutions as a core differentiator in its value proposition, explicitly framing them as essential enablers of secure, confident transactions across its global payments ecosystem. In both 2022 and 2023, the company emphasized these solutions within its broader \"value-added services\" portfolio, positioning them as critical to its franchise model’s balance of value and risk while supporting interoperability and safety in an increasingly complex digital payments landscape. This evolution reflects a deliberate shift toward highlighting cybersecurity and data-driven intelligence as foundational to its growth strategy, directly tying to its mission of making payments \"safe, simple, smart, and accessible\" through integrated, proprietary insights drawn from its principled use of consumer and merchant data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Cyber and Intelligence Solutions (PRODUCT)",
        "Cyber and Intelligence Solutions (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6624,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2310,
        "completion_tokens": 218,
        "total_tokens": 2528
      }
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "PepsiCo's presentation of the 4.450% Senior Note due 2046 evolved from its initial disclosure in the 2022 filing (Chunk 1), where it was referenced as \"Form of 4.450% Senior Note due 2046, which is incorporated herein by reference to Exhibit 4.4 to PepsiCo, Inc.'s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 14, 2015\" (page 129), to its 2023 filing (Chunk 2), where the same note was re-referenced under \"Form of 4.450% Senior Note due 2046, which is incorporated herein by reference to Exhibit 4.4 to PepsiCo, Inc.'s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 24, 2016\" (page 126), indicating a shift in the cited filing date from 2015 to 2016 in the exhibit reference while maintaining the identical note description. This evolution reflects a retrospective update in the 2023 filing to align with the original 2016 Form 8-K filing date, ensuring consistency in the documentation trail for the long-term debt instrument.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 4.450% Senior Note due 2046 (FIN_INST)",
        "4.450% Senior Note due 2046 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12431,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3761,
        "completion_tokens": 253,
        "total_tokens": 4014
      }
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Between 2023 and 2024, Intel's engagement with Positive Technologies under OFAC licensing remained consistent with its prior pattern of sanctioned-era collaboration. The company continued authorized communications regarding IT security research and vulnerability coordination, explicitly permitted by OFAC's General License 1B, with no gross revenues or net profits generated from these activities (INTC_10k_2023.pdf, p.71; INTC_10k_2024.pdf, p.54). This engagement, initially established prior to Positive Technologies' April 15, 2021 designation as a sanctioned entity, persisted through 2024 under the same regulatory framework, maintaining compliance with OFAC terms while advancing security vulnerability disclosures (KG Triplets: INTC → Positive Technologies; Positive Technologies → INTC).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Positive Technologies (COMP)",
        "Positive Technologies (COMP) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3603,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 199,
        "total_tokens": 1745
      }
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "Between 2023 and 2024, CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million (as shown in both Chunk 1 and Chunk 2), indicating a stable long-term debt position for this specific tranche. However, the broader debt structure shows significant evolution: total long-term debt decreased from $21,351 million in 2023 (Chunk 1) to $19,922 million in 2024 (Chunk 2), driven by the maturity of $1,000 million of 5.25% notes due January 2029 and $1,250 million of 4.125% notes due April 2040, while new issuances like $1,000 million of 5.4% notes due June 2029 and $602 million of 4.125% notes due April 2040 partially offset these reductions. This shift reflects a strategic extension of maturity profiles and potential refinancing at lower rates, as evidenced by the replacement of older, higher-coupon notes with newer instruments carrying slightly different terms (e.g., 5.4% vs. 5.3% for 2043 maturities), suggesting CVS is actively managing its long-term debt structure to optimize future interest expense and liquidity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> 4.78% Senior Notes (FIN_INST)",
        "4.78% Senior Notes (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_168",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_161",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5996,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2142,
        "completion_tokens": 260,
        "total_tokens": 2403
      }
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 were registered with the SEC in both the 2022 filing (as shown in Chunk 1's table listing \"0.835% Notes due 2032\" under trading symbol XOM32 on the New York Stock Exchange) and the 2024 filing (where they are explicitly listed again in Chunk 2's table under \"0.835% Notes due 2032\" with trading symbol XOM32 on the New York Stock Exchange), confirming their continued registration and disclosure status across both filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> 0.835% Notes due 2032 (FIN_INST)",
        "0.835% Notes due 2032 (FIN_INST) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5212,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1937,
        "completion_tokens": 112,
        "total_tokens": 2049
      }
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "American Express's investment strategy toward U.S. Government treasury obligations has evolved significantly between 2022 and 2024, particularly in fair value allocation and maturity distribution. In 2022, the company held $477 million in U.S. Government treasury obligations with an estimated fair value, primarily classified as \"Less than 12 months\" maturity, reflecting a short-term positioning strategy. By 2024, this allocation expanded substantially to $287 million in total estimated fair value, with a more diversified maturity profile: $189 million due within 1 year, $98 million due after 1 year but within 5 years, and no holdings classified as \"Due after 10 years,\" indicating a strategic shift toward longer-term Treasury holdings while maintaining liquidity. This evolution is further contextualized by the broader investment portfolio, which now includes $764 million in foreign government bonds and $10 million in mortgage-backed securities, suggesting a more nuanced approach to fixed-income diversification that still prioritizes U.S. Government obligations as a core component. The weighted average yield of 4.98% across the total portfolio in 2024, compared to the 2022 fair value allocation, reflects a deliberate shift toward higher-yielding, longer-duration instruments within the Treasury segment to optimize returns amid changing interest rate environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> U.S. Government treasury obligations (FIN_INST)",
        "U.S. Government treasury obligations (FIN_INST) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2918,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 345,
        "total_tokens": 1734
      }
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced its $2.500 % Note due 2050 in its June 3 2020 filing (Chunk 1, 4.5; Chunk 2, 4.6), establishing the instrument as an Amazon‑issued financial security. Subsequent filings in 2021 and 2022 (Chunk 2, 4.7 and 4.8) added new notes but did not alter the terms of the 2050 note, indicating that Amazon continued to reference it unchanged through 2024. Thus, the note’s structure and existence remained consistent from its 2020 introduction through the 2022‑2024 period, with no reported modifications or early retirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> 2.500% Note due 2050 (FIN_INST)",
        "2.500% Note due 2050 (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12188,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3677,
        "completion_tokens": 133,
        "total_tokens": 3810
      }
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "Between 2022 and 2023, the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement increased from eight to eleven, reflecting a progression of contractual updates documented in both filings. This evolution is evidenced by the transition from the Eighth Amendment (filed in 2022) through the Eleventh Amendment (filed in 2023), with the Twelfth Amendment noted in the 2023 filing as occurring on 9/3/2023, confirming ongoing revisions beyond the initial eight amendments referenced in prior periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amends]-> FIN_INST <-[Amends_Agreement]- ORG",
      "triplets_used": [
        "COST (ORG) -> Co-Branded Credit Card Agreement (FIN_INST)",
        "Co-Branded Credit Card Agreement (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9474,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3007,
        "completion_tokens": 129,
        "total_tokens": 3137
      }
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "NVIDIA's CUDA evolution between 2022 and 2024 reflects a strategic expansion from its foundational role in accelerated computing to deep integration with next-generation architectures and enterprise software ecosystems. Building on its CUDA-based full-stack platform, NVIDIA launched the Blackwell architecture in 2025 (referenced in Chunk 2), which introduced the RTX 50 Series GPUs with neural graphics—combining AI models and traditional rendering—and transformer-based DLSS 3 technology, enabling up to 2x performance leaps for AI-driven graphics in gaming and professional visualization (Chunk 2). This advancement extends CUDA's reach into generative AI and real-time ray tracing, as seen in automotive applications where DRIVE Hyperion leverages CUDA-powered perception and planning stacks (Chunk 1). Simultaneously, NVIDIA expanded CUDA's ecosystem through enterprise AI software (e.g., NV IDIA AI Enterprise) and cloud services like DGX Cloud, while integrating with new hardware like DPUs and CPUs to optimize data center-scale computing (Chunk 2). Thus, CUDA's evolution is defined by its role as the unifying software layer enabling NVIDIA's unified architecture across gaming, data centers, and automotive, driving performance innovations from 2022 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Develops]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> CUDA (PRODUCT)",
        "CUDA (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11666,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3551,
        "completion_tokens": 317,
        "total_tokens": 3868
      }
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Pfizer's financial relationship with Paxlovid evolved significantly between 2023 and 2024, marked by a dramatic decline in revenue recognition tied to contractual obligations and inventory returns. In 2023, Paxlovid generated $1,279 million in revenue (down 92% operationally), driven by the return of 6.5 million EUA-labeled U.S. government treatment courses and lower international deliveries, partially offset by demand in China; this was reflected in the 2023 10-K showing $1,191 million in worldwide revenue and a $1,289 million operational decline due to lower net pricing and contract adjustments. By 2024, the company recognized a $771 million favorable adjustment to the $3.5 billion non-cash revenue reversal from 2023 (related to 5.1 million courses returned by February 2024 versus the original 6.5 million estimate), while remaining performance obligations for Paxlovid supply totaled approximately $1 billion in contracted revenue through 2028, with deliveries expected to renegotiate timing beyond 2024. This evolution underscores a strategic shift from pandemic-driven windfalls to managed contractual deliveries, with revenue recognition now governed by long-term supply agreements rather than emergency use inventory returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21959,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6126,
        "completion_tokens": 310,
        "total_tokens": 6437
      }
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "Based on the disclosed accounting policy and share availability data across both filings, the 2003 Incentive Program's share structure evolved significantly between 2022 and 2024 through specific changes in available shares and program integration. The program, which governs equity awards for ExxonMobil (XOM), maintained its core structure but saw a substantial reduction in available shares for new awards, decreasing from 65,754,069 shares available in 2022 to 47 million shares remaining at the end of 2024, as noted in the 2024 10-K (Chunk 2). This reduction reflects the program's ongoing use for grants, including the conversion of Pioneer restricted stock units following the May 2024 merger, which utilized shares from the Pioneer LTIP's remaining 9,362 thousand shares (Chunk 2). Additionally, the program's flexibility allows new awards until shares are depleted or terminated by the Board, with restricted stock units granted in 2024 totaling 10,393 thousand—demonstrating continued utilization of the remaining authorized shares despite the declining availability (Chunk 2). The 2022 data (Chunk 1) also confirms the program's role in granting restricted stock, including shares available under the 2004 Director Plan, but the 2024 disclosure clarifies the current scale of the 2003 Program's capacity, showing a clear evolution toward consolidation and adaptation post-merger.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "XOM (ORG) -> 2003 Incentive Program (ACCOUNTING_POLICY)",
        "2003 Incentive Program (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5080,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1908,
        "completion_tokens": 347,
        "total_tokens": 2256
      }
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "AdSense's role within Google's advertising revenue streams has evolved from being a foundational publisher-focused product (highlighted in 2022 as part of the Google Network's $8.6 billion growth driven by AdSense alongside AdMob and Google Ad Manager) to a more integrated component of Google's broader AI-powered advertising technology portfolio by 2024, where it operates within a sophisticated ecosystem of performance and brand advertising solutions like Demand Gen and Performance Max that leverage AI to optimize ad delivery across Google's platforms including Search, YouTube, and partner networks, while continuing to contribute to core revenue streams alongside other non-advertising businesses like Cloud, devices, and subscriptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Generates_Revenue_From]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> AdSense (PRODUCT)",
        "AdSense (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6306,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2223,
        "completion_tokens": 186,
        "total_tokens": 2409
      }
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "The UPS Retirement Plan ceased accruals of additional benefits for future service and compensation for non-union participants effective January 1 2023, a change that also applied to the UPS Excess Coordinating Benefit Plan, and the company re‑measured its pension obligations in 2021 and 2022, recognizing actuarial gains and plan‑amendment losses that impacted equity and earnings; however, the provided information does not specify any further specific modifications to future benefit accruals for non‑union participants beyond this cessation of accruals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "UPS (ORG) -> UPS Retirement Plan (FIN_INST)",
        "UPS Retirement Plan (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9326,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2979,
        "completion_tokens": 139,
        "total_tokens": 3118
      }
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Amazon's short-term credit capacity expanded significantly from 2022 to 2024, with its primary unsecured revolving facility growing from $7.0 billion (2022, maturing June 2023) to $15.0 billion (maturing November 2028), while adding a new $5.0 billion 364-day facility in October 2024 that matures in October 2025. The interest rate terms improved slightly, decreasing from 0.50% above benchmark to 0.45% above benchmark for both the long-term facility and the new short-term agreement, with commitment fees also declining from 0.04% to 0.03%. Outstanding borrowings remained consistently zero under these primary facilities through 2023 and 2024, though Amazon utilized other short-term facilities with $147 million and $151 million in borrowings outstanding as of December 31, 2023 and 2024, respectively, and maintained substantial unused capacity with $8.3 billion in unused letters of credit as of December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Borrows]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Short-Term Credit Facilities (FIN_INST)",
        "Short-Term Credit Facilities (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3733,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1589,
        "completion_tokens": 230,
        "total_tokens": 1819
      }
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Costco's use of variable-priced contracts for energy purchases remained consistent between 2022 and 2023, as evidenced by its continued reliance on index-based agreements for electricity, natural gas, and gas station fuel to partially mitigate commodity price risk—similar to its 2022 approach of using fixed-price contracts for warehouses while entering variable-priced contracts on an index basis for specific purchases. This strategy reflects a deliberate commodity price risk management approach focused on operational flexibility rather than speculative hedging, as indicated by the company's explicit statement that these contracts \"generally qualify for the 'normal purchases and normal sales' exception under authoritative guidance and require no mark-to-market adjustment,\" thereby avoiding formal hedge accounting while still economically hedging exposure to energy price fluctuations through market-indexed pricing mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "COST (ORG) -> Variable-Priced Contracts (FIN_INST)",
        "Variable-Priced Contracts (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8168,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2691,
        "completion_tokens": 234,
        "total_tokens": 2926
      }
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "Between 2022 and 2024, NVIDIA strategically elevated **NVIDIA AI Enterprise** from a niche software offering to the **core commercial engine of its data center platform**, reflecting a fundamental shift in how the company monetizes and positions its AI infrastructure.  \n\nIn 2022 (Chunk 1), NVIDIA AI Enterprise was explicitly categorized under its **Compute & Networking segment**—highlighted alongside Mellanox, automotive AI, and Jetson—as a key software component within data center solutions, but still positioned as part of a broader hardware-software stack. By 2024 (Chunk 2), this evolved dramatically: NVIDIA AI Enterprise transitioned from being *one element* of the data center platform to becoming the **central commercial offering** for enterprise AI adoption, explicitly marketed as a \"comprehensive suite of enterprise-grade AI software\" bundled with infrastructure (e.g., Blackwell architecture in 2025, though post-2024, its 2024 launch context is implied). Critically, the 2024 text emphasizes that NVIDIA now **sells paid licenses for NVIDIA AI Enterprise as a standalone product**—distinct from GPU hardware—directly targeting enterprise customers needing turnkey AI software for data centers, while integrating it with full-stack capabilities (CUDA, DGX Cloud, Blackwell).  \n\nThis evolution is underscored by the **strategic separation of AI software from hardware dependencies**: whereas 2022’s segment reporting grouped AI software under \"Compute & Networking\" as a feature of hardware systems, 2024’s narrative positions NVIDIA AI Enterprise as a **dedicated commercial product line** with its own revenue model (paid licenses), sales channels (direct enterprise sales), and integration into NVIDIA’s \"full-stack computing platform\" (encompassing DPUs, CPUs, and software). The KG triplets confirm this linkage (NVDA → NVIDIA AI Enterprise → NVDA), showing how the product is now a **core, standalone offering** driving revenue in the data center segment, not merely a software add-on. Thus, by 2024, NVIDIA AI Enterprise had evolved from a supporting component to the **central commercial pillar** of NVIDIA’s data center strategy, enabling recurring software revenue and deepening enterprise customer lock-in.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> NVIDIA AI Enterprise (PRODUCT)",
        "NVIDIA AI Enterprise (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2781,
        "completion_tokens": 558,
        "total_tokens": 3340
      }
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Pfizer's contractual obligations related to Paxlovid evolved significantly between 2023 and 2024, reflecting shifting demand and inventory management. In 2023, the company recorded a $3.5 billion non-cash revenue reversal due to anticipated returns of 6.5 million EUA-labeled treatment courses, indicating overestimation of sales. By early 2024, actual returns were lower than expected (5.1 million courses returned by February 2024), leading to a $771 million favorable adjustment that reversed part of this reversal and recognized previously reserved revenue. This adjustment, combined with $442 million in revenue from the U.S. Strategic National Stockpile (SNS) program, demonstrates a more accurate accounting of realized sales as government inventory levels stabilized. The 2024 Form 10-K further notes that remaining performance obligations for Paxlovid supply total approximately $1 billion through 2028, tied to long-term contracts with customers, though the timing of deliveries may be renegotiated. This indicates Pfizer expects a gradual decline in Paxlovid revenue beyond 2024 but maintains contractual commitments for future supply, suggesting cautious but sustained revenue expectations for the product in the medium term. The adjustments highlight a shift from aggressive pandemic-era sales projections to a more conservative, inventory-adjusted revenue recognition model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8243,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2701,
        "completion_tokens": 347,
        "total_tokens": 3048
      }
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google's exposure to new regulatory costs in international markets evolved from primarily data transfer and privacy challenges under evolving frameworks like the EU-UK data transfers to a broader, more volatile landscape encompassing sanctions, geopolitical conflict, and heightened anti-corruption enforcement. While 2022 highlighted \"new customer requirements\" and uncertainty around data transfers as part of an \"evolving foreign policy landscape,\" 2024 explicitly expanded the scope to include \"sanctions, import and export controls, other market access barriers, political unrest, geopolitical tensions, changes in regimes, or armed conflict\" as direct drivers of new regulatory costs and challenges, alongside \"new regulatory costs and challenges (including new customer requirements)\" that now carry \"uncertainty regarding regulatory outcomes\" and \"other liabilities under local laws.\" This progression reflects a shift from theoretical regulatory evolution to concrete, high-impact operational risks tied to active conflicts and enforcement actions, significantly increasing the scope and immediacy of compliance burdens across key international markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> New Regulatory Costs (RISK_FACTOR)",
        "New Regulatory Costs (RISK_FACTOR) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11079,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3425,
        "completion_tokens": 296,
        "total_tokens": 3722
      }
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "Between 2022 and 2023, UPS maintained its core funding approach for postretirement medical benefits but refined the sources used for expected benefit payments. While both years specify that these payments will be made from \"plan trusts and corporate assets,\" the 2023 filing (Chunk 2) explicitly reinforces this structure without introducing new funding sources, whereas the 2022 filing (Chunk 1) similarly identifies the same dual-source approach but with slightly different phrasing. The consistency across both filings, coupled with the regulatory context of applicable laws and regulations (as referenced in both chunks and connected through the KG pattern involving UPS and regulatory requirements), confirms that UPS continued to rely on plan trusts and corporate assets as the funding sources for postretirement medical benefits, with no indication of a structural shift in funding methodology between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "triplets_used": [
        "UPS (ORG) -> City Ordinances (REGULATORY_REQUIREMENT)",
        "City Ordinances (REGULATORY_REQUIREMENT) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1205,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 954,
        "completion_tokens": 230,
        "total_tokens": 1185
      }
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "From its 2022 launch as a specialized enterprise AI software suite within the broader NVIDIA ecosystem, NVIDIA AI Enterprise has evolved into a fully integrated, supply-chain-ready platform by 2024, now tightly coupled with NVIDIA's core GPU hardware and extended across all target markets. The KG pattern confirms this progression through the ORG-PRODUCT relationship (NVDA → NVIDIA AI Enterprise), while the 2024 context explicitly details its expanded scope: it now serves as the foundation for end-to-end AI infrastructure, supporting training/inferencing across GPUs, CPUs, and DPUs, and is bundled with tools like AI Enterprise (including NIM, NeMo, and AI Blueprints) for generative AI deployment. This evolution enables seamless integration into data centers, automotive systems (e.g., DRIVE Hyperion), and broader enterprise workflows, transforming it from a niche software offering into a central, supply-driven component of NVIDIA's accelerated computing platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> NVIDIA AI Enterprise (PRODUCT)",
        "NVIDIA AI Enterprise (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11151,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3423,
        "completion_tokens": 243,
        "total_tokens": 3667
      }
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "ExxonMobil's proved reserves through equity companies declined from 14 million barrels of oil-equivalent in 2021 to 1 million barrels in 2020 (Chunk 1), but grew significantly to 1,481 million barrels of oil-equivalent by 2024 (Chunk 2's \"Total Equity Company\" row under \"Total Developed\"). This represents a strategic shift toward consolidated operations in key regions like Canada (472 million bbls crude + 2,308 million bbls bitumen), Asia (1,923 million bbls crude + 4,242 million bbls natural gas), and the U.S. (1,874 million bbls crude + 11,671 billion cubic ft gas), where consolidated reserves now total 12,599 million barrels oil-equivalent—far exceeding equity company reserves. The data shows ExxonMobil is concentrating its reserve growth primarily within its consolidated subsidiaries, particularly in North America and Asia, while equity investments have diminished to a minor role (only 1 million bbls in 2021 vs. 1,481 million bbls in 2024), indicating a strategic pivot to direct ownership of high-value reserves in politically stable, resource-rich regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Equity Companies (COMP)",
        "Equity Companies (COMP) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10810,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3343,
        "completion_tokens": 269,
        "total_tokens": 3612
      }
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "The financial relationship with Google Network Partners has evolved significantly between 2022 and 2024, with their role in revenue generation and cost structure shifting in key ways. In 2022, Google Network Partners were integral to generating advertising revenue through platforms like AdMob and AdSense, where Google acted as the principal and recorded revenue gross while payments to partners were classified as cost of revenues, as noted in the 2022 10-K filing (Chunk 1). By 2024, this structure remained foundational, but cash flow dynamics reflected increased reliance on these partnerships—evidenced by higher cash payments to distribution and Google Network partners as a primary operating cash outflow (Chunk 2). Despite this, net cash from operations grew due to higher customer collections, indicating that while costs to partners rose, revenue generation from Network properties continued to expand, reinforcing their strategic role in Alphabet’s monetization model across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Supplies]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Network Partners (COMP)",
        "Google Network Partners (COMP) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7047,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2406,
        "completion_tokens": 249,
        "total_tokens": 2656
      }
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "Between 2022 and 2023, UPS's foreign currency exchange risk management strategy continued to utilize undesignated foreign currency forward contracts as economic offsets for remeasurement and settlement risk, with the key evolution being the explicit de-designation of original hedge relationships when terminating or offsetting positions with new counterparties. The financial impact of these contracts on earnings volatility is directly measured through fair value changes and settlements recorded in net income, as evidenced by the 2023 and 2022 amounts reported in the consolidated income statements for non-designated derivatives, where the 2023 figures (though not numerically specified in the chunk) represent the continued application of this same mechanism that generated measurable earnings volatility through fair value fluctuations, a practice maintained from prior periods as documented in both the 2022 and 2023 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Offsetting Foreign Currency Positions (FIN_INST)",
        "Offsetting Foreign Currency Positions (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_159",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2427,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 233,
        "total_tokens": 1504
      }
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Costco's profitability strategy has evolved from 2022 to 2023 by deepening the integration of its membership format as a core driver of both member loyalty and recurring fee revenue, with explicit emphasis on expanding Executive member penetration and sustaining high renewal rates across global operations. The KG pattern reveals that the Membership Format (ACCOUNTING_POLICY) is directly tied to COST as an accounting policy that \"depends on\" and \"reinforces\" member loyalty and fee revenue, while also being \"adversely impacted\" by warehouse openings in existing markets—a dynamic highlighted in both chunks as a key vulnerability to growth. Critically, Chunk 1 notes that \"the extent to which we achieve growth in our membership base, increase the penetration of our Executive members, and sustain high renewal rates materially influences our profitability,\" and Chunk 2 reinforces this by stating that \"the extent to which we achieve growth in our membership base, increase the penetration of Executive memberships, and sustain high renewal rates materially influences our profitability\" and that \"our worldwide renewal rate may be adversely impacted by lower renewal rates in newer markets.\" This strategic focus on loyalty and fee stability is further contextualized by the membership format's role in offsetting lower-margin business segments like gasoline (which \"generally has a lower gross margin percentage and lower SG&A expense relative to our non-gasoline businesses\" per Chunk 2), allowing Costco to maintain its low-margin operating model while generating disproportionate profitability from membership fees—making the format not just a revenue stream but a structural pillar of its overall financial resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "COST (ORG) -> Membership Format (ACCOUNTING_POLICY)",
        "Membership Format (ACCOUNTING_POLICY) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9415,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3007,
        "completion_tokens": 432,
        "total_tokens": 3439
      }
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "NVIDIA's CUDA evolution between 2022 and 2024 reflects a strategic expansion from a standalone parallel computing platform into the core of a full-stack data center ecosystem, deeply integrated with hardware and software components across its portfolio. Building on its foundational role—evidenced by nearly 3 million global developers using CUDA in 2022 (Chunk 1)—the company advanced CUDA’s integration within its broader platform, culminating in the 2025 launch of the Blackwell architecture, which encompasses GPUs, CPUs, DPUs, and networking as a unified data center infrastructure (Chunk 2). This progression is underscored by NVIDIA’s emphasis on CUDA as the \"large body of software\" enabling optimization across the entire computing stack, including its expansion into DPUs (2022) and CPUs (2024), while enterprise software offerings like NV IDIA AI Enterprise and DGX Cloud now provide licensed, managed AI development environments that rely on CUDA’s underlying architecture (Chunk 2). Concurrently, CUDA’s ecosystem has been reinforced through deep partnerships with cloud providers, server manufacturers, and developers via initiatives like the NVIDIA Inception program and Deep Learning Institute, ensuring its role as the central programming model for AI workloads—from autonomous vehicles (Chunk 1) to generative AI and high-performance computing (Chunk 2)—thereby transforming CUDA from a developer tool into the connective tissue of NVIDIA’s end-to-end computing platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Develops]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> CUDA (PRODUCT)",
        "CUDA (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11693,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3559,
        "completion_tokens": 372,
        "total_tokens": 3931
      }
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid has evolved significantly from 2023 to 2024, with remaining performance obligations for Paxlovid supply contracts totaling approximately $1 billion in contracted revenue as of December 31, 2024, reflecting expected deliveries through 2028 under agreements that may be renegotiated (Chunk 2). This follows the $3.5 billion non-cash revenue reversal in 2023 related to anticipated returns of 6.5 million treatment courses, which was partially offset in 2024 by a $771 million favorable adjustment based on only 5.1 million courses actually returned by February 2024 (Chunk 2). The contractual obligations tied to Paxlovid delivery are further contextualized by its production relationship with Pfizer as the originating organization (PFE -> Paxlovid), while the product's revenue recognition is directly linked to U.S. government inventory adjustments and supply agreements governed by Manufacturing Supply Agreements (MSA) (Chunk 1, Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14180,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4188,
        "completion_tokens": 245,
        "total_tokens": 4434
      }
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has intensified significantly between 2022 and 2024, as evidenced by its evolving classification of Guyana within \"Advantaged Assets\" under the new 2024 earnings driver framework. While Chunk 1 details Guyana's role in adding approximately 1.3 GOEB of proved undeveloped reserves in 2021 through development activities and highlights ongoing investment requirements for undeveloped reserves (including $8.0 billion in 2021 for reserve development), Chunk 2 explicitly elevates Guyana to a core component of its \"Advantaged Volume Growth\" strategy, specifically listing it alongside Permian and LNG as a key driver of earnings from advantaged assets. This strategic shift is further reinforced by the company's disclosure of Guyana's reserves development in both 2022 and 2024 filings, demonstrating a sustained and escalating focus on Guyana as a high-return, advantaged asset critical to its growth narrative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Guyana (GPE)",
        "Guyana (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8770,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2825,
        "completion_tokens": 238,
        "total_tokens": 3063
      }
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "The planned utilization of the ATR 72-600F aircraft decreases from 11 units in 2023 (Chunk 1) to 6 units in 2024 (Chunk 1), then stabilizes at 6 units in 2025 (Chunk 1) before further declining to 3 units in 2026 (Chunk 2), reflecting a strategic shift toward reduced reliance on this regional freighter model. This evolution—from 11 in 2023 to 6 in 2024 and 3 in 2026—indicates a deliberate fleet optimization, where the ATR 72-600F's role is being scaled back in favor of newer or more efficient assets like the Cessna SkyCourier (increasing from 12 to 14 units in 2026 per Chunk 1 and 17 in 2025 per Chunk 2), signaling a transition toward modernized regional cargo capabilities aligned with evolving operational and strategic priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> ATR 72-600F (PRODUCT)",
        "ATR 72-600F (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1669,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1054,
        "completion_tokens": 185,
        "total_tokens": 1240
      }
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "NVIDIA's approach to Omniverse has evolved from a standalone virtual world simulation platform in 2022 to a deeply integrated AI and simulation hub by 2024, explicitly designed to connect with broader AI ecosystems. The 2022 documentation (Chunk 1) established Omniverse as a free-for-individuals, enterprise-subscription platform for 3D workflows, emphasizing its role in automotive simulation (e.g., DRIVE Concierge integration for real-time conversational AI in vehicles) and industrial digital twins. By 2024 (Chunk 2), Omniverse became a core component of NVIDIA's full-stack AI platform, explicitly enabling integration with AI models and workflows—such as supporting generative AI applications and leveraging Blackwell architecture for enhanced AI processing—while expanding its ecosystem through partnerships like DRIVE Sim for autonomous vehicle validation. This evolution reflects a strategic shift from Omniverse as a standalone tool to the central operating system for AI-driven simulation, where it now seamlessly connects with NVIDIA's AI software stack (e.g., NV IDIA AI Enterprise, Blackwell GPUs) and external platforms to power use cases from automotive co-pilots to industrial digital twins.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Omniverse (PRODUCT)",
        "Omniverse (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11666,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3551,
        "completion_tokens": 302,
        "total_tokens": 3854
      }
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's role in generating non-advertising revenue evolved from being primarily a source of app and in-app purchase sales (highlighted in Chunk 1's discussion of non-advertising revenue growth drivers) to being explicitly structured as a distinct revenue segment within Google's broader \"Subscriptions, Platforms, and Devices\" category, where it contributed to the \"platforms\" revenue stream alongside YouTube subscriptions and device sales (as detailed in Chunk 2's classification of Google Play under \"platforms\" revenue). This evolution reflects a strategic expansion of Google Play's contribution to non-advertising revenue, moving beyond its initial focus on app sales to become a key component of Google's diversified non-advertising portfolio, which also includes YouTube subscriptions, Google Cloud, and hardware, all of which are subject to fluctuating margins and regulatory impacts as noted across both chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Play (PRODUCT)",
        "Google Play (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8270,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2690,
        "completion_tokens": 237,
        "total_tokens": 2928
      }
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "AIG has refined its expected loss ratio reserving methodology for workers' compensation between 2022 and 2023 by increasingly applying these methods to the most recent five accident years for excess of deductible business, while continuing to rely on them only for the most recent accident year in guaranteed cost business, reflecting a strategic shift toward more recent data-driven estimates for the former and sustained focus on recent-year weighting for the latter. This evolution aligns with AIG's operational segmentation of these business lines, where excess of deductible claims face slower reporting patterns due to increased large deductible proportions, necessitating greater reliance on projected ultimate loss ratios adjusted for inflation and market conditions, while guaranteed cost business maintains its historical emphasis on recent-year expected loss ratios amid ongoing mix shifts toward risk-retention structures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_260",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6056,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2176,
        "completion_tokens": 233,
        "total_tokens": 2409
      }
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco's product category segmentation evolved from the 2022 categories of Secure, Agile Networks; Internet for the Future; Collaboration; End-to-End Security; Optimized Application Experiences; and Other Products to the 2024 categories of Networking, Security, Collaboration, and Observability, with prior periods conformed to this new presentation. The Collaboration category remained a consistent reporting segment across both fiscal years, indicating its continued strategic importance despite the broader restructuring of product classifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Webex (PRODUCT)",
        "Webex (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1425,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 987,
        "completion_tokens": 137,
        "total_tokens": 1125
      }
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen’s 3.125% 2025 Notes were disclosed in both 2022 and 2023 with a consistent notional amount of $1,000 million, but the financial presentation and interest rate framework evolved to reflect updated market-based benchmarks. In the 2022 filing, the notes were listed with a fixed coupon rate of 3.125% and no explicit reference to a floating-rate structure, while the 2023 disclosure specifies an effective interest rate of SOFR + 2.1%, indicating a shift toward a variable-rate benchmark tied to the Secured Overnight Financing Rate. This evolution aligns with broader trends in debt issuance, where fixed-rate instruments are increasingly replaced or supplemented with floating-rate structures to mitigate interest rate risk, as evidenced by the 2023 notes’ linkage to SOFR across multiple maturities including the 2025 tranche. The consistent notional value across both years underscores the enduring scale of Amgen’s long-term debt obligations, while the updated rate framework reflects strategic refinements in capital management and market-aligned financing practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.125% 2025 Notes (FIN_INST)",
        "3.125% 2025 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5559,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2031,
        "completion_tokens": 269,
        "total_tokens": 2300
      }
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region have grown significantly from 326 billion cubic feet at the end of 2022 to 296 billion cubic feet by the end of 2024, reflecting an upward trend in its strategic focus on this geographic area. This expansion, driven by extensions and discoveries (e.g., 121 billion cubic feet in 2023 and 87 billion cubic feet in 2024) and modest revisions, underscores the company's intent to strengthen its presence and investment in the Asia Pacific/Middle East market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_174",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21358,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5989,
        "completion_tokens": 130,
        "total_tokens": 6119
      }
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Between 2022 and 2023, Alphabet's repurchase activity for Class C Capital Stock increased from $17.1 billion (as reflected in the 2022 balance sheet showing $(17,102) million in treasury stock related to repurchases) to $62.2 billion disclosed in the 2023 share repurchase statement, indicating a significant escalation in its capital allocation strategy through aggressive share buybacks. This upward trend in repurchases—from $59.3 billion total repurchases in 2022 (encompassing both Class A and Class C shares) to $62.2 billion in 2023—demonstrates the company's prioritization of returning capital to shareholders via equity retirement, supported by the Board's expanded $70 billion repurchase authorization and the remaining $36.3 billion availability as of December 31, 2023, reflecting a deliberate strategy to deploy excess cash toward stock retirement rather than reinvestment or debt reduction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class C Capital Stock (FIN_INST)",
        "Class C Capital Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10082,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3168,
        "completion_tokens": 226,
        "total_tokens": 3395
      }
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "AIG's use of frequency/severity methods evolved between 2022 and 2023 primarily in its application to long-tail lines of business, particularly U.S. Workers' Compensation, where the methodology was explicitly expanded to include frequency/severity techniques alongside loss development and expected loss ratio methods due to the line's decades-long loss emergence patterns and increasing complexity from risk-sharing structures like high deductibles and self-insured retentions. While frequency/severity methods were not used for shorter-tail lines like aviation (which relies on loss development and expected loss ratios due to high severity) or U.S. Property (which uses them alone or in combination for short-tail classes), the 2023 disclosure confirms their continued and enhanced application to Workers' Compensation, reflecting a strategic focus on accurately modeling the delayed and complex claim reporting inherent in that long-tail business, as evidenced by the detailed segmentation by deductible size, handling method, and state/industry subsets to address evolving reporting patterns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Frequency/Severity Methods (ACCOUNTING_POLICY)",
        "Frequency/Severity Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_273",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5417,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2014,
        "completion_tokens": 274,
        "total_tokens": 2288
      }
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "From 2022 to 2023, Amgen’s financial relationship with BeiGene shifted toward greater cost recovery and product sales, while profit and loss sharing remained equal during the initial commercialization period. In 2023, Amgen recovered $109 million of BeiGene‑borne oncology R&D costs (offsetting R&D expense), received $125 million of product sales from BeiGene, and shared profits and losses equally—recording $40 million of related expenses in SG&A. The collaboration also includes ongoing royalty payments by Amgen on China sales and a $1.25 billion cost‑sharing arrangement for joint R&D, underscoring a continued but evolving financial interdependence.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> BeiGene (COMP)",
        "BeiGene (COMP) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8678,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2803,
        "completion_tokens": 164,
        "total_tokens": 2967
      }
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 764 billion cubic feet at the end of 2021 to 296 billion cubic feet by the end of 2024, reflecting a net decline of 468 billion cubic feet over the three‑year period.  This evolution includes upward revisions of 102 billion cubic feet in 2024, purchases of 47 billion cubic feet in 2024 (and earlier purchases of 4 billion in 2022 and 23 billion in 2023), and extensions/discoveries adding 87 billion cubic feet in 2024, while production reductions of 78 billion cubic feet occurred in 2024.  Across the period, revisions contributed positively (e.g., 361 billion in 2022, 521 billion in 2023, and 356 billion in 2024), whereas sales and production consistently subtracted from reserves, resulting in the final 2024 figure of 296 billion cubic feet for the Asia Pacific/Middle East region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_166",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18705,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5328,
        "completion_tokens": 217,
        "total_tokens": 5545
      }
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "FedEx's planned usage of the B767F aircraft declines from 14 units in 2023 (per Chunk 1) to 11 units in 2025 (per Chunk 2), reflecting a strategic shift toward newer, more fuel-efficient aircraft types like the Cessna SkyCourier and ATR 72-600F for regional delivery needs. This reduction—from 38 total aircraft in 2023 to 14 in 2025 (Chunk 1) and further to 11 in 2025 (Chunk 2)—demonstrates a deliberate fleet optimization strategy focused on modernizing operations and reducing reliance on older widebody freighters, while maintaining core capacity through targeted investments in complementary aircraft types.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> B767F (PRODUCT)",
        "B767F (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1668,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1045,
        "completion_tokens": 153,
        "total_tokens": 1198
      }
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "AIG applied Expected Loss Ratio Methods to determine loss reserves for the latest accident year across both U.S. Property and Aviation lines of business in 2022, using these methods alongside development techniques for program business and liability classes, while continuing to rely on them for Aviation exposures where severity-driven claims necessitate a combination of development and expected loss ratio approaches; in 2023, the company maintained this application for U.S. Workers' Compensation, explicitly grouping risk-sharing programs and analyzing subsets by deductible size and handling method, but expanded its use to include ground-up claim projections from claims staff to assist in reserve development, reflecting an evolution in methodology that integrates both traditional expected loss ratios and enhanced projection techniques across long-tail lines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_273",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5417,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2010,
        "completion_tokens": 217,
        "total_tokens": 2227
      }
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Cisco's positioning around Enterprise Data Center Transformation has evolved from a focus on foundational technology convergence in 2022 to a more strategic, alliance-driven approach by 2024, as evidenced by its explicit emphasis on strategic partnerships in the context of this transformation. While both 2022 and 2024 documents highlight the competitive pressures of the data center market—including competition from alliance partners like Microsoft and Amazon Web Services—Cisco's 2024 filing specifically underscores that \"companies that are strategic alliance partners in some areas of our business may acquire or form alliances with our competitors, thereby reducing their business with us,\" indicating a more nuanced and potentially precarious alliance landscape. This evolution reflects Cisco's need to navigate a competitive environment where strategic partners can simultaneously be rivals, particularly as the enterprise data center undergoes \"fundamental transformation\" driven by converging technologies, forcing Cisco to balance alliance management with heightened competition from both traditional rivals and former partners.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Enterprise Data Center Transformation (CONCEPT)",
        "Enterprise Data Center Transformation (CONCEPT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11532,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3539,
        "completion_tokens": 285,
        "total_tokens": 3824
      }
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The effective interest rate on the 3.125% 2025 Notes increased from SOFR + 2.1% in 2022 to SOFR + 2.1% in 2023 (no change), while the notional amount associated with those notes rose from $1,000 million in 2022 to $1,000 million in 2023 (no change). This shift reflects the company’s derivative‑hedging activity disclosed in the 2022 filing and the updated table of notes and hedging terms in the 2023 filing, illustrating how AMGN’s financing structure evolved over the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.125% 2025 Notes (FIN_INST)",
        "3.125% 2025 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1876,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1100,
        "completion_tokens": 120,
        "total_tokens": 1220
      }
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "Cisco's strategic positioning of AppDynamics within its product portfolio has evolved significantly from 2022 to 2024, with a clear and growing emphasis on its role within observability offerings. In 2022, AppDynamics was explicitly positioned as a key component of Cisco's full-stack observability strategy, alongside infrastructure optimization (Intersight), network monitoring (ThousandEyes), and security innovations, indicating its foundational role in monitoring application experiences across hybrid and multicloud environments. By 2024, this emphasis intensified as evidenced by the formal categorization of \"Observability\" as a distinct product revenue category alongside Networking, Security, and Collaboration in Cisco's financial reporting, underscoring AppDynamics' elevated strategic importance within Cisco's portfolio and its dedicated contribution to the company's observability narrative. This evolution reflects Cisco's deepening commitment to observability as a core growth driver, with AppDynamics no longer just a part of the portfolio but a recognized pillar driving customer outcomes in complex, modern IT environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> AppDynamics (PRODUCT)",
        "AppDynamics (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6162,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2182,
        "completion_tokens": 285,
        "total_tokens": 2468
      }
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The effective interest rate for the 4.663% 2051 Notes increased from 4.663% in 2022 to SOFR + 4.3% in 2023, while the notional amount associated with these notes rose from $1,500 million (as implied by the 2022 context and 2023 total of $6,650 million across all notes) to $1,500 million specifically, reflecting a strategic adjustment in hedging following interest rate swap terminations and reinvestment at current rates. This evolution was driven by the company's proactive management of debt structure, as evidenced by the termination of prior swaps and entry into new agreements on the same $5.2 billion principal amount, directly linking the 4.663% 2051 Notes (AMGN) to the updated financial terms disclosed in both 2022 and 2023 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 4.663% 2051 Notes (FIN_INST)",
        "4.663% 2051 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1876,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 186,
        "total_tokens": 1285
      }
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG continued applying expected loss ratio methods primarily within its long-tail lines of business, particularly U.S. Workers' Compensation, where it maintains a complex mix of risk-sharing structures and segmented reporting by state, industry, and deductible size. The 2023 disclosure confirms the ongoing use of these methods alongside development and frequency/severity approaches, with segmentation refined to isolate guaranteed cost and excess-of-deductible business—especially as large deductible programs expanded over time. This evolution reflects a persistent reliance on actuarial assumptions to estimate reserves, consistent with prior-year practices but further detailed in 2023 through enhanced disclosures of undiscounted losses and allocated adjustment expenses by accident year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2336,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 204,
        "total_tokens": 1442
      }
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolved as part of a strategic expansion in its long-term debt issuance program, reflecting a broader financing strategy to diversify maturity profiles and funding costs. In 2023, the 2.850% Senior Notes due 2026 were already established under prior indentures, as referenced in Chunk 1 through the 2013 Indenture and supplemental filings, indicating their role as a recurring component of PepsiCo's capital structure. By 2024, the company reinforced and expanded this strategy through the introduction of new debt instruments, including additional series of senior notes, as documented in Chunk 2 via the February 12, 2024 Indenture with U.S. Bank Trust Company—though this specific instrument pertains to PepsiCo Singapore Financing I Pte. Ltd., it underscores the company’s ongoing use of structured securitization and trust-based financing mechanisms to support global operations. This progression highlights PepsiCo’s systematic approach to debt management, where recurring note maturities like the 2.850% due 2026 are maintained and augmented within a larger framework of continuous capital market engagement, ensuring liquidity and funding flexibility across its enterprise.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 2.850% Senior Notes due 2026 (FIN_INST)",
        "2.850% Senior Notes due 2026 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6286,
        "completion_tokens": 315,
        "total_tokens": 6601
      }
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco's exposure to channel partner financing guarantees has remained relatively stable between fiscal years 2022 and 2024, with the balance of guarantees outstanding holding at approximately $1.3–1.4 billion in recent periods, as disclosed in both the 2022 and 2024 filings. This consistency indicates a controlled and disciplined approach to financial risk management, where the company facilitates third-party working capital solutions for channel partners without significant contingent liabilities. Despite the substantial volume of financing arrangements ($26.7–27.9 billion annually), Cisco's guarantees represent a small, monitored exposure, reflecting a strategic balance between supporting partner ecosystems and limiting direct financial risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Financing Guarantees (FIN_INST)",
        "Financing Guarantees (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6143,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2186,
        "completion_tokens": 188,
        "total_tokens": 2375
      }
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "Between 2022 and 2023, the 2.45% 2030 Notes underwent a structural evolution in both status and interest rate framework. In 2022, as disclosed in Chunk 1, these notes were issued as fixed-rate debt by AMGN and were later subject to partial redemption in 2021 (prior to 2022–2023), with associated interest rate swaps—specifically, a $750 million notional swap tied to the 3.625% 2022 Notes redemption—being terminated. By 2023, as shown in Chunk 2, the 2.45% 2030 Notes remained outstanding with a notional amount of $1,000 million and now carry a variable interest rate structure tied to SOFR + 1.3%, reflecting a shift from fixed to floating-rate economics. This transition was part of a broader strategy to manage interest rate risk, as evidenced by the interest rate swap activity described in Chunk 1, which converted fixed coupons on certain debt instruments into floating LIBOR-based payments. Thus, the evolution reflects both a change in redemption behavior and a strategic move toward floating-rate financing, with the notes continuing to exist but now embedded within a more dynamic interest rate environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 2.45% 2030 Notes (FIN_INST)",
        "2.45% 2030 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_131",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2023.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5375,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1969,
        "completion_tokens": 280,
        "total_tokens": 2249
      }
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Between 2022 and 2023, FedEx's relationship with Pass-Through Certificates remained structurally consistent but saw a notable shift in financial guarantees and obligations. While the 2022 10-K (Chunk 1) confirms FedEx Express issued $970 million of Pass-Through Certificates secured by aircraft, explicitly guaranteed by FedEx, and used for general corporate purposes, the 2023 10-K (Chunk 2) clarifies that these certificates are \"not direct obligations of, or guaranteed by, FedEx or FedEx Express\" in their current leveraged lease structure. This evolution reflects a strategic shift where FedEx Express now relies on third-party trusts to issue certificates (funded via undiscounted future payments of ~$0.9 billion from new leases), reducing its direct financial guarantee burden while maintaining operational use of the aircraft. The 2022 disclosures also detail the certificates' fixed 1.875% rate and collateralization, but the 2023 context reveals the guarantees are now indirect and contingent on lease payment flows rather than explicit FedEx backing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Pass-Through Certificates (FIN_INST)",
        "Pass-Through Certificates (FIN_INST) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3982,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1639,
        "completion_tokens": 265,
        "total_tokens": 1905
      }
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "Mastercard's gross settlement exposure increased from $75,023 million in 2023 to $78,385 million in 2024, while the amount of risk mitigation arrangements applied rose from $12,167 million to $13,466 million, resulting in a net settlement exposure of $64,919 million (2024) versus $62,856 million (2023). This evolution indicates a deliberate expansion of the company's risk management strategy, as it systematically applies risk mitigation arrangements—including cash collateral and credit enhancements—to manage settlement exposure, reflecting a proactive approach to maintaining financial stability and compliance amid evolving regulatory scrutiny.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR <-[Increases]- ORG",
      "triplets_used": [
        "MA (ORG) -> Risk Mitigation Arrangements (RISK_FACTOR)",
        "Risk Mitigation Arrangements (RISK_FACTOR) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4064,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1672,
        "completion_tokens": 162,
        "total_tokens": 1835
      }
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased from $48 million in 2022 to $146 million in 2024 (reflecting a $37 million increase in the 2024 balance sheet but a $48 million figure reported for 2022), indicating a shift in the company's hedging strategy and reduced reliance on such instruments to manage foreign‑exchange risk. This change suggests Nike is adjusting its exposure management, possibly by reallocating capital or employing alternative risk‑mitigation tactics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Foreign Exchange Forwards and Options (FIN_INST)",
        "Foreign Exchange Forwards and Options (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4733,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1846,
        "completion_tokens": 135,
        "total_tokens": 1981
      }
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "The representation of Bounty within P&G's Baby, Feminine & Family Care segment evolved from being mentioned as a key product in the 2022 10-K (described as part of the family care business alongside Pampers and Always brands) to being explicitly listed as a major brand under this segment in the 2023 10-K, where it appears alongside Always, Tampax, Charmin, and Puffs in the product categories and major brands table. This progression—from a general reference to a formally categorized major brand—indicates a significant increase in Bounty's strategic visibility and brand prominence within P&G's Baby, Feminine & Family Care portfolio between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Bounty (PRODUCT)",
        "Bounty (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6216,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2194,
        "completion_tokens": 165,
        "total_tokens": 2359
      }
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Oracle's approach to its hardware business, particularly Oracle Engineered Systems, underwent a strategic shift between fiscal 2022 and fiscal 2023, marked by a deliberate emphasis on revenue recognition practices and business focus. In fiscal 2022, Oracle recognized hardware revenue ratably over the contractual term for support services tied to Engineered Systems, reflecting a long-term service-oriented model, whereas by fiscal 2023, the company explicitly stated that hardware product revenues are recognized at the point in time when ownership transfers upon delivery, aligning with standard industry practice for perpetual licenses and tangible goods, while support services continue to be recognized ratably over the contract term. This evolution underscores a strategic refinement in how Oracle structures and accounts for its hardware offerings, with fiscal 2023 documentation reinforcing that Engineered Systems and related software are accounted for as a combined performance obligation, and revenues are primarily recognized upon delivery—indicating a shift toward clearer, more immediate revenue recognition for hardware sales, while still maintaining ratable recognition for support services. The company also emphasized ongoing investments in R&D to enhance hardware products and acknowledged that hardware business margins remain lower than cloud and license segments due to production and support costs, signaling a continued but restructured focus on hardware as a complementary, not core, growth driver within its broader portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Engineered Systems (PRODUCT)",
        "Oracle Engineered Systems (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7085,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2423,
        "completion_tokens": 388,
        "total_tokens": 2811
      }
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "The sales performance of ERLEADA shows a significant upward trajectory between 2022 and 2023, with revenue increasing from $1,291 million in 2022 to $2,387 million in 2023—a 26.9% total change and 27.5% operations growth, as reported in JNJ_10k_2023.pdf (Chunk 2). This growth is part of a broader oncology sales expansion, where Total Oncology rose from $14,548 million in 2022 to $17,661 million in 2023 (Chunk 1 and Chunk 2), driven by products like DARZALEX and ERLEADA. The consistent operations growth in ERLEADA (27.5% in 2023 vs. 70.0% in 2022) and its inclusion in the Total Innovative Medicine Sales ($54,759 million in 2023, up 4.2% from 2022) indicate a strengthening market position and positive momentum in oncology, suggesting sustained demand and potential for continued growth in its therapeutic segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> ERLEADA (PRODUCT)",
        "ERLEADA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7918,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2609,
        "completion_tokens": 205,
        "total_tokens": 2814
      }
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "From 2023 to 2024, CMCSA's relationship with local broadcast television stations has shifted from a more balanced competitive positioning to heightened dependency, particularly in content distribution. While CMCSA continues to compete for audience share and advertising revenue with local stations (as noted in Chunk 1's Media section), the 2024 filing (Chunk 2) reveals a critical evolution: CMCSA's linear television networks and Peacock increasingly depend on retransmission consent agreements with these stations to distribute programming, with the risk that failure to renew these agreements on acceptable terms could significantly reduce revenues and audience reach. This dependency is amplified by industry consolidation, which drives up programming costs as stations demand higher payments, creating a structural vulnerability where CMCSA's competitive position is now constrained by its reliance on these stations for essential content distribution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Local Broadcast Television Stations (COMP)",
        "Local Broadcast Television Stations (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11488,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3531,
        "completion_tokens": 239,
        "total_tokens": 3770
      }
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The value of Held-to-Maturity (HTM) securities held by MA decreased significantly from $306 million in 2023 to $38 million in 2024, representing a substantial reduction in this investment category. This shift indicates a strategic reallocation of capital, as MA reduced its HTM holdings while simultaneously decreasing total investments from $592 million (2023) to $330 million (2024), suggesting a deliberate contraction in long-term fixed-income investments and potentially a shift toward more liquid or shorter-term securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "MA (ORG) -> HTM securities (FIN_INST)",
        "HTM securities (FIN_INST) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 882,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 861,
        "completion_tokens": 132,
        "total_tokens": 994
      }
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand remained positioned within Procter & Gamble’s Baby, Feminine & Family Care segment but underwent a subtle evolution in categorization and sub-category alignment. In 2022, Always was explicitly grouped under Feminine Care within the segment, alongside Pampers and Tampax, with sub-categories including Adult Incontinence and Feminine Care (e.g., Always Discreet). By 2023, the segment’s reporting refined the categorization to explicitly list Feminine Care as a standalone sub-category under Baby, Feminine & Family Care, with Always and Always Discreet retained as key brands, while Tampax was moved to the Health Care segment—a shift reflected in the updated product categorization and brand groupings across both annual reports. This reclassification, tied to P&G’s evolving segment reporting structure, underscores a strategic repositioning of Always’s categorization within the broader portfolio, even as its core product lines (e.g., Always Discreet for incontinence) remained anchored in the Feminine Care sub-category under Baby, Feminine & Family Care. The KG triplets (PG → Always and Always → PG) confirm the enduring corporate relationship, while the textual evolution in segment reporting highlights the dynamic nature of product categorization within P&G’s disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Always (PRODUCT)",
        "Always (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5039,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1908,
        "completion_tokens": 330,
        "total_tokens": 2239
      }
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Oracle's positioning of Engineered Systems shifted from a standalone hardware revenue stream to a tightly integrated component of its broader cloud and license ecosystem between 2022 and 2023, with revenue recognition evolving to reflect this strategic emphasis. In 2022, Engineered Systems hardware revenue was explicitly categorized under \"hardware revenues\" alongside servers and storage, with support contracts priced as a percentage of net hardware fees and recognized ratably over contract terms (Chunk 1). By 2023, Oracle consolidated Engineered Systems within its \"Hardware Business,\" which represented 6% of total revenue, emphasizing that hardware products and related software are accounted for as a \"combined performance obligation\" with revenue recognized at point-of-delivery when ownership transfers (Chunk 2). Critically, the 2023 filing underscores that hardware revenue recognition is now explicitly tied to the delivery of integrated systems (including Engineered Systems) and their associated support, while simultaneously highlighting that this business has \"lower operating margins\" than cloud/license segments due to incremental production and support costs (Chunk 2). This strategic shift is further evidenced by the 2023 filing's focus on Engineered Systems as part of a \"broad selection of enterprise hardware products\" sold through indirect channels, where revenue recognition now depends on the combined delivery of hardware and software, rather than isolated hardware sales (Chunk 2). Consequently, while Engineered Systems revenue recognition remained fundamentally tied to support contracts (as in 2022), the 2023 context reveals a more pronounced integration into Oracle's cloud and license strategy, with the hardware business now explicitly positioned as a lower-margin, integrated offering dependent on the broader ecosystem's success (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Engineered Systems (PRODUCT)",
        "Oracle Engineered Systems (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9343,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2986,
        "completion_tokens": 470,
        "total_tokens": 3456
      }
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Comcast's advertising sales strategy has evolved through its representation firms as an extension of its sales force, with revenue recorded net of agency commissions in advertising revenue while related fees are classified under other operating and administrative expenses. This partnership structure, explicitly detailed in both 2023 and 2024 filings under \"Advertising\" and \"Business Services Connectivity\" segments, allows Comcast to leverage representation firms to sell allocated advertising units while maintaining principal accounting treatment for the revenue. The consistent reference to \"representation firms as an extension of our sales force\" across both years confirms this evolution is operational rather than structural, directly supporting the KG triplet relationship where Representation Firms (COMP) Partner_With CMCSA (ORG) and depend on its advertising sales framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Representation Firms (COMP)",
        "Representation Firms (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12107,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3659,
        "completion_tokens": 222,
        "total_tokens": 3882
      }
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle's approach to industry-specific hardware offerings shifted markedly between fiscal 2022 and 2023, with a strategic emphasis on integrating hardware with cloud and license revenues while maintaining a distinct recognition model for hardware support. In fiscal 2022, hardware revenue recognition was tied to combined performance obligations for interdependent hardware and software, recognized at delivery, and hardware support was described as ratable over contractual terms with renewal dependence; by fiscal 2023, the company explicitly tied hardware revenue recognition to the point of delivery and transfer of ownership, emphasized ongoing R&D investment to improve and develop new hardware products, and highlighted that hardware support contracts—priced as a percentage of net hardware fees—were renewed at customer option and recognized ratably, reflecting a more matured, support-driven revenue model. This evolution is underscored by the hardware business representing 6% of total revenue in both fiscal 2023 and 2024 (as noted in Chunk 2), while Chunk 1 establishes the foundational 2022 context of hardware support being ratable and tied to contractual terms, and the KG triplets confirm the ORG-PRODUCT relationship (ORCL produces Industry-Specific Hardware), making the shift in revenue timing and strategic focus on hardware support renewals and R&D critical to understanding the progression from fiscal 2022 to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Industry-Specific Hardware (PRODUCT)",
        "Industry-Specific Hardware (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7085,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2422,
        "completion_tokens": 359,
        "total_tokens": 2781
      }
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "The sales of IMBRUVICA (ibrutinib) declined 13.7% from $3,784 million in 2022 to $3,264 million in 2023, as reported in JNJ's 2023 10-K (Chunk 2). This decrease occurred despite overall oncology sales growth of 10.5%, with the document specifically noting that IMBRUVICA's growth was \"partially offset by competitive pressures from novel oral agents and COVID-19 related market dynamics including delays in new patient starts\" (Chunk 1). The decline reflects both market-specific challenges and broader competitive pressures impacting the product's performance during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> IMBRUVICA (PRODUCT)",
        "IMBRUVICA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7367,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2469,
        "completion_tokens": 145,
        "total_tokens": 2614
      }
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "From 2023 to 2024, Comcast's involvement with Universal Beijing Resort shifted from $3.5 billion of outstanding debt to $3.4 billion, reflecting a modest reduction in leverage, while Comcast maintains a 30 % ownership stake and consolidates the resort as a variable interest entity, exposing it to financial risk primarily through its equity interest rather than direct guarantees. The resort's debt is secured by its assets and the partners' equity interests, and Comcast's maximum risk of loss is limited to its 30 % share, even as the entity's asset base remains substantial (~$7.3 billion in assets and $7.0 billion in liabilities as of 2024). This structure means Comcast's financial exposure is tied to the resort's performance and any potential impairments on its equity investment, but it does not entail additional liquidity or guarantee obligations beyond its equity stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Constructs]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7190,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2440,
        "completion_tokens": 220,
        "total_tokens": 2661
      }
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "The financial commitment for future lease payments related to build-to-suit facilities and equipment decreased significantly from approximately $3.4 billion (undiscounted) in 2022 to about $0.9 billion (undiscounted) in 2023, reflecting a reduction of roughly $2.5 billion in planned lease obligations over the one‑year period. This decline indicates that FedEx is scaling back its build‑to‑suit leasing strategy, shifting toward fewer large‑scale facility commitments and likely focusing on more cost‑efficient or shorter‑term lease arrangements. The change aligns with the disclosed future minimum lease payments and the company’s continued use of leveraged operating leases that are funded through pass‑through certificates, underscoring a strategic adjustment in its overall leasing approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Pass-Through Certificates (FIN_INST)",
        "Pass-Through Certificates (FIN_INST) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3039,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 199,
        "total_tokens": 1612
      }
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard's relationship with Dynamic Yield LTD has evolved from a strategic acquisition in 2022 to deeper integration by 2024, reflecting a focused effort to expand its digital identity and fraud prevention capabilities within cybersecurity and identity verification. The company acquired Dynamic Yield LTD in April 2022 for $325 million, securing $200 million in goodwill tied to anticipated synergies, and by 2024, it continued to build on this foundation—evidenced by its $2.7 billion acquisition of Recorded Future in December 2024, which explicitly aims to enhance Mastercard’s threat intelligence and real-time decisioning services, further solidifying its strategic push into cybersecurity. This progression underscores Mastercard’s deliberate diversification into high-growth, technology-driven security solutions, leveraging acquisitions to expand its digital identity ecosystem beyond traditional payment infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MA (ORG) -> Dynamic Yield LTD (COMP)",
        "Dynamic Yield LTD (COMP) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7884,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2612,
        "completion_tokens": 233,
        "total_tokens": 2845
      }
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers at Lowe's was most recently amended and restated on May 26, 2022, as disclosed in Exhibit 10.28 of Lowe's 2022 10-Q filing (filed November 27, 2024), which explicitly references the May 26, 2022 amendment. This plan was initially introduced in the Lowe's 2020 10-K filing (Exhibit 10.29) as \"as amended and restated May 29, 2020,\" establishing the foundational framework that was later updated in 2022 and further incorporated into subsequent governance documents like the 2023 officer agreements (Exhibits 10.29-10.31 in the 2024 10-K).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Severance Plan for Senior Officers (ACCOUNTING_POLICY)",
        "Severance Plan for Senior Officers (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10034,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3166,
        "completion_tokens": 144,
        "total_tokens": 3310
      }
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million at December 31, 2021, to $872 million at December 31, 2023, reflecting a $127 million decline in fair value over the two-year period. This evolution indicates shifting market perceptions of the company's debt, as the fair value decrease suggests growing investor skepticism about the notes' attractiveness or perceived credit risk, particularly amid changing interest rate environments and evolving market conditions during this period. The consistent identification of these notes as a distinct financial instrument connected to Netflix through the KG pattern ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG confirms their significance as a key debt component in Netflix's capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> 6.375% Senior Notes (FIN_INST)",
        "6.375% Senior Notes (FIN_INST) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6978,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2401,
        "completion_tokens": 192,
        "total_tokens": 2593
      }
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "IMBRUVICA sales declined 13.7% year-over-year to $3,264 million in 2023 (down from $3,784 million in 2022), yet remained the second-largest oncology product at $3,264 million (representing 18.6% of total oncology sales of $17,661 million), indicating its continued but slightly eroding market position in oncology despite overall oncology growth of 10.5%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> IMBRUVICA (PRODUCT)",
        "IMBRUVICA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7918,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2613,
        "completion_tokens": 88,
        "total_tokens": 2701
      }
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "LOW's inventory LCNRV reserve decreased by $23 million to $222 million during fiscal 2024, while its inventory shrink reserve increased by $2 million to $427 million as of January 31 2025. These reserve changes, together with the related vendor‑fund accrual adjustments, impacted net earnings by roughly $17 million for a 10 % change in either the LCNRV reserve or the markdown inventory base, and by about $32 million for a 10 % change in the estimated shrinkage rate, highlighting how fluctuations in these reserves directly affect the company's profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Changes]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Accrual Rates (ACCOUNTING_POLICY)",
        "Accrual Rates (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9228,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2945,
        "completion_tokens": 140,
        "total_tokens": 3086
      }
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "Qulipta's commercialization progressed from initial market entry in 2022 to significant growth in 2023, with U.S. sales surging from $158 million to $405 million and international sales increasing from $408 million to $3 (though reported as $408 million in some contexts), reflecting its expanding adoption post-approval. This development aligns with AbbVie's strategic focus on neuroscience, where Qulipta is categorized alongside key products like Botox Therapeutic and Vraylar, contributing to the segment's overall growth. The product's inclusion in AbbVie's developed product rights portfolio—reclassified from indefinite-lived to definite-lived intangible assets upon regulatory approval—enabled its amortization over a 12-year useful life, directly impacting the $7.7 billion amortization expense reported in 2021 and supporting the company's financial reporting of product-specific revenue streams.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Qulipta (PRODUCT)",
        "Qulipta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10058,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3147,
        "completion_tokens": 226,
        "total_tokens": 3373
      }
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Between 2022 and 2023, Honeywell's financial dependency on its Resideo subsidiary for environmental liabilities remained structurally consistent, with the indemnification agreement maintaining the same terms: Resideo's subsidiary continues to reimburse Honeywell for 90% of annual net environmental spending at designated sites, capped at $140 million per year and extending until the earlier of December 31, 2043, or three consecutive years of sub-$25 million payments. This mechanism transfers a significant portion of environmental risk exposure from Honeywell to Resideo, effectively reducing Honeywell's direct financial liability while preserving contingent exposure through the capped reimbursement obligation. The repetition of identical language across both 10-K filings underscores that this risk mitigation framework was unchanged during this period, indicating Honeywell has stabilized its environmental liability exposure through this contractual arrangement rather than facing evolving or increasing financial risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Pays]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "HON (ORG) -> Resideo Subsidiary (COMP)",
        "Resideo Subsidiary (COMP) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2883,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 257,
        "total_tokens": 1622
      }
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of \"original maturity\" for cash equivalents has remained consistent between 2022 and 2024, continuing to specify \"highly liquid investments with an original maturity of three months or less from the time of purchase\" and including amounts due from third-party financial institutions for credit/debit card transactions that settle within five days. This unchanged treatment indicates Target maintains a stable cash management strategy focused on preserving liquidity through short-term, low-risk instruments without altering its threshold for classifying securities as cash equivalents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Defines]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Original Maturity (ACCOUNTING_POLICY)",
        "Original Maturity (ACCOUNTING_POLICY) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1000,
        "completion_tokens": 151,
        "total_tokens": 1152
      }
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "The valuation of NVDA's 3.50% Notes Due 2040 remained unchanged at $1,000 million in both 2023 and 2024 per the 10-K disclosures, but its effective interest rate increased from 3.50% to 3.54% in the 2024 filing, reflecting updated market-based discount rate calculations. This reclassification to Level 2 fair value measurement (consistent with other debt securities in Chunk 1) and the maintained $1,000 million carrying value indicate NVIDIA's strategic focus on long-term debt issuance with extended maturities (15.2-year remaining term in 2024) to manage capital structure while maintaining investment-grade flexibility, as evidenced by the $8.463 billion total long-term debt position and the absence of any principal repayment adjustments for this specific tranche.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> 3.50% Notes Due 2040 (FIN_INST)",
        "3.50% Notes Due 2040 (FIN_INST) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4823,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1852,
        "completion_tokens": 192,
        "total_tokens": 2045
      }
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Based on the financial data across both chunks, Venclexta's total global revenue grew from $2,009 million in 2022 to $2,288 million in 2023, representing a 13.9% year-over-year increase (15.0% at constant currency). This growth was driven by strong international performance, where revenue rose 20.1% in 2023 (24.6% at constant currency), significantly outpacing U.S. growth of 7.8% (8.0% at constant currency). The collaboration structure with Genentech, as detailed in Chunk 1, shows AbbVie shares equally with Genentech on U.S. profits and pays royalties on international net revenues, with Venclexta sales directly contributing to AbbVie's net revenue and cost of products sold. The KG triplets confirm the ORG-PRODUCT-ORG relationship between ABBV and Venclexta, establishing AbbVie as the global manufacturer and distributor responsible for commercialization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Venclexta (PRODUCT)",
        "Venclexta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10547,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3269,
        "completion_tokens": 216,
        "total_tokens": 3485
      }
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Based on the KG triplets and all provided chunks, Netflix's Executive Severance and Retention Incentive Plan (Exhibit 10.7 in 2022 filing and Exhibit 10.6 in 2023 filing) underwent a formal amendment effective January 1, 2024, as disclosed in the 2023 10-K (Chunk 2, Exhibit 10.16†). This amendment, filed as part of the company's ongoing governance updates, replaced the prior plan terms with a revised structure effective January 1, 2024, though the exact amendment date and specific changes to severance/retention terms are not detailed in the provided exhibits. The 2022 filing (Chunk 1, Exhibit 10.7†) referenced the original plan adopted September 10, 2021, while the 2023 filing (Chunk 2, Exhibit 10.16†) explicitly documents the amended and restated plan's effective date as December 8, 2023, with the implementation date of January 1, 2024, marking the evolution of the plan's operational terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Executive Severance and Retention Incentive Plan (ACCOUNTING_POLICY)",
        "Executive Severance and Retention Incentive Plan (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18633,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5329,
        "completion_tokens": 226,
        "total_tokens": 5555
      }
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "The Benefit Restoration Plan was first introduced in Lowe's 2022 10-K filing (Chunk 1), where it was described as a non-qualified plan supplementing 401(k) benefits for employees restricted by IRS Code provisions, providing salary deferrals and employer matching contributions. Its formal structure and amendment history are documented in the 2024 10-K filing (Chunk 2), which explicitly lists \"Lowe's Companies Benefit Restoration Plan, as amended and restated as of January 1, 2025\" as Exhibit 10.3, confirming its evolution through regulatory updates and restatements effective January 1, 2025. This progression—from initial disclosure in 2022 to formal restatement in 2025 (Chunk 2)—indicates Lowe's proactive approach to aligning retirement benefits with evolving IRS regulations and internal governance, ensuring compliance while maintaining robust supplemental retirement provisions for affected employees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Maintains]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Benefit Restoration Plan (ACCOUNTING_POLICY)",
        "Benefit Restoration Plan (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6816,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2362,
        "completion_tokens": 228,
        "total_tokens": 2591
      }
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA's financial obligations related to the 0.584% Notes Due 2024 decreased from $1,185 million (as of January 29, 2023) to $1,228 million (as of January 26, 2025), reflecting a $43 million increase in the liability balance over the fiscal year.  In fiscal 2025, NVDA repaid the entire 0.584% Notes Due 2024, as disclosed in the 2024 10‑K filing, thereby eliminating that specific debt obligation.  This repayment is consistent with the disclosed pattern of NVDA → 0.584% Notes Due 2024 (Discloses) and the noted decrease in the related liability figure across the two fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> 0.584% Notes Due 2024 (FIN_INST)",
        "0.584% Notes Due 2024 (FIN_INST) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4701,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1807,
        "completion_tokens": 145,
        "total_tokens": 1953
      }
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Based on the financial data in Chunk 2, Mavyret's global revenue declined by 7.2% at actual currency rates from $1,541 million in 2022 to $1,430 million in 2023, with a more pronounced 9.9% drop in constant currency. In the United States, revenue fell 12.7% to $659 million, while international markets showed a minimal 1.9% decrease to $771 million, indicating relative stability in global performance with the U.S. market driving the overall decline. This trend aligns with the broader revenue contraction observed across AbbVie's portfolio, where total net revenues decreased 6.4% year-over-year, reflecting challenging market conditions that specifically impacted Mavyret's U.S. sales while international revenues remained relatively flat.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Decreases]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Mavyret (PRODUCT)",
        "Mavyret (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11942,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3623,
        "completion_tokens": 185,
        "total_tokens": 3809
      }
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix's compliance with covenant limitations related to its Senior Notes remained consistent, with no material breaches reported in 2022, 2023, or 2024, as explicitly stated in both the 2022 and 2024 10-K filings. While the 2024 filing notes the repayment of $400 million in 5.750% Senior Notes upon maturity, this action did not disrupt compliance, as the remaining notes—including the €470 million, €1.3 billion, €1.1 billion, €1.2 billion, and €1.1 billion euro-denominated tranches—continued to adhere to all covenants governing restricted activities such as additional indebtedness, asset sales, and mergers, with compliance confirmed as of December 31, 2023, and December 31, 2024. The core covenant framework, including change-of-control repayment triggers (101% of principal plus interest) and redemption terms, remained unchanged, ensuring that repayment obligations were managed within the broader context of ongoing covenant restrictions, which were consistently met across all reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Covenant Limitations (REGULATORY_REQUIREMENT)",
        "Covenant Limitations (REGULATORY_REQUIREMENT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3000,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 258,
        "total_tokens": 1670
      }
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Honeywell's Safety and Retail product line underwent a structural evolution in 2023, marked by the realignment of its Safety and Productivity Solutions segment. As stated in Chunk 2, the Safety and Retail business unit—encompassing gas detection and safety—was combined with the Advanced Sensing Technologies unit to form the new Sensing and Safety Technologies business unit, reflecting a strategic consolidation of safety-related offerings. This change is directly supported by Chunk 1's 2022 financial data showing Safety and Retail sales at $2,387 million, which was reclassified under the newly structured Sensing and Safety Technologies unit in 2023, indicating the product line's evolution into a more integrated safety technology offering.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "HON (ORG) -> Safety and Retail (PRODUCT)",
        "Safety and Retail (PRODUCT) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5818,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2098,
        "completion_tokens": 186,
        "total_tokens": 2285
      }
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "The status and role of Class B-2 Common Stock have undergone significant evolution between 2023 and 2024, particularly regarding convertibility and corporate governance. In 2023, Class B-2 Common Stock was explicitly designated as convertible into Class A Common Stock under Visa’s Europe retrospective responsibility plan, with conversion tied to litigation developments and subject to a holdback for pending claims, while also carrying voting rights on key corporate actions like mergers or exiting the core payments business — features that directly linked it to governance dynamics and potential dilution of Class A voting power upon conversion. By 2024, the absence of any outstanding Class B-2 Common Stock prior to the Class B-1 Common Stock exchange offer (as noted in Note 15 of the 2024 10-K) indicates that all Class B-2 shares had been converted or retired, effectively removing their convertibility and governance influence; this transition reflects a structural simplification of Visa’s capital hierarchy, where the elimination of Class B-2’s convertible rights and voting mechanisms likely strengthened Class A Common Stockholders' relative control by removing a distinct class with potentially conflicting interests, as highlighted by the 2023 disclosures about divergent incentives among non-Class A shareholders. Consequently, the evolution from an active, convertible, and governance-impacting Class B-2 Common Stock in 2023 to its complete absence in 2024 underscores a strategic move to consolidate voting power and streamline corporate governance under a single class of common stock, directly addressing the conflicts of interest described in the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class B-2 Common Stock (FIN_INST)",
        "Class B-2 Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4441,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1754,
        "completion_tokens": 420,
        "total_tokens": 2174
      }
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "The Home Depot's approach to enhancing the ease of shopping experience has evolved significantly between 2023 and 2024 through strategic investments in both digital and in-store capabilities, as evidenced by its interconnected shopping experience strategy. In 2023, the company focused on integrating physical and digital channels by improving mobile app functionality, enhancing online product \"shopability\" with richer content and fulfillment options, and implementing in-store innovations like self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to streamline the customer journey. By 2024, these efforts were explicitly framed as part of a broader \"interconnected shopping experience\" that spans stores, online, job sites, and homes, with continued investments in website and mobile app enhancements to deliver personalized, seamless engagement across channels—particularly through improved search capabilities, site functionality, and data-driven personalized marketing. This evolution reflects a sustained commitment to unifying digital and physical retail touchpoints, ensuring customers can research products online, access real-time inventory and reviews in-store, and complete purchases with greater convenience through omnichannel fulfillment options.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Impacted_By]- ORG",
      "triplets_used": [
        "HD (ORG) -> Ease of Shopping Experience (CONCEPT)",
        "Ease of Shopping Experience (CONCEPT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10770,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3340,
        "completion_tokens": 328,
        "total_tokens": 3669
      }
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "From 2022 to 2024, the Target Corporation Long-Term Incentive Plan evolved to incorporate a broader range of equity awards, as evidenced by the expanded list of plan documents and agreements disclosed across the filings. Building on the foundational structures outlined in the 2022 plan (Chunk 1), the 2024 disclosures (Chunk 2) specifically highlight the inclusion of new forms such as the \"Form of Cliff-Vested Restricted Stock Unit Agreement\" (10.4.5*) and \"Form of Performance Award Performance Share Unit Agreement\" (10.4.6*), which were not explicitly detailed in the 2022 version but are now formally part of the plan’s framework. Additionally, the continued use and amendment of prior components—such as the Target Corporation SPP I and SPP II (2022 Plan Statement) (10.5*, 10.6*) and the 2020 Long-Term Incentive Plan (10.4*)—demonstrate a strategic evolution in equity compensation design, with enhanced emphasis on performance-based and director-specific equity awards. These changes reflect Target’s ongoing refinement of its long-term incentive structure to align with governance best practices and shareholder expectations over the multi-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "TGT (ORG) -> LT Incentive Plan (ACCOUNTING_POLICY)",
        "LT Incentive Plan (ACCOUNTING_POLICY) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16997,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4903,
        "completion_tokens": 291,
        "total_tokens": 5194
      }
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta's commercial performance evolved from its September 2021 FDA approval through 2023, demonstrating significant growth across all regions. In 2023, total sales reached $405 million in the United States and $408 million internationally, representing over 100% growth compared to 2022 ($158 million US, $158 million international), with AbbVie reporting \" >100.0% \" growth rates for both segments in its 2023 financial disclosures (ABBV_10k_2023.pdf, p.42). This expansion occurred within the broader context of AbbVie's overall revenue trajectory, where Neuroscience (including Qulipta) grew 10.0% in 2023 to $2,991 million total sales, driven by strong uptake of Qulipta for migraine prevention following its 2021 approval (ABBV_10k_2023.pdf, p.42; Chunk 1). The product's performance was particularly notable as it contributed to AbbVie's Neuroscience portfolio growth, which outpaced many other therapeutic areas during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Qulipta (PRODUCT)",
        "Qulipta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11236,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3437,
        "completion_tokens": 235,
        "total_tokens": 3672
      }
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Netflix's 2020 Stock Plan has evolved from its initial disclosure in the 2022 filing (where it was presented as part of the \"2020 Stock Plan\" exhibit within its 10-K filing, alongside related equity compensation documents like the Form of Stock Option Agreement under the 2020 Stock Plan) to a more structured and expanded description in the 2024 filing, which explicitly details its components including time-based and performance-based restricted stock unit awards with specific vesting mechanics tied to executive employment and market-based performance targets, while maintaining its foundational role in equity compensation activities that also encompassed prior plans like the 2011 Stock Plan and ongoing stock option exercises under both the 2011 and 2020 frameworks as evidenced by the continued inclusion of related agreements (e.g., 10.12† for 2020 Stock Plan options) in its filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> 2020 Stock Plan (ACCOUNTING_POLICY)",
        "2020 Stock Plan (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11437,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3519,
        "completion_tokens": 223,
        "total_tokens": 3743
      }
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, the company's aluminum purchase agreements remained classified as derivative instruments not receiving hedge accounting treatment, as evidenced by their consistent disclosure in the \"Derivative Instruments Not Receiving Hedge Accounting Treatment\" section across both filings. While the 2022 filing (Chunk 1) identifies these agreements as derivative instruments used for long-term strategic sourcing and non-U.S. business requirements, the 2023 filing (Chunk 2) explicitly reiterates this classification without hedge accounting, noting they are \"derivative instruments for accounting purposes\" with quantities offsetting and priced at prevailing market prices. This consistent classification across both years reflects a strategic use of derivative instruments to manage aluminum price exposure through non-hedge accounting treatment, with the 2023 disclosure further detailing their notional amounts and fair values in the consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Aluminum Purchase Agreements (FIN_INST)",
        "Aluminum Purchase Agreements (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2422,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 245,
        "total_tokens": 1503
      }
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "The Directors' Code of Conduct has been consistently maintained in scope—applying to all directors of BNY Mellon—and its accessibility remains via the same dedicated webpage on the company’s website, though the URL was updated from the 2023 PDF location to a 2024 PDF location. Disclosure practices have not changed materially: the Code is still posted on the corporate site and any amendments or waivers (including those relating to executive officers) will continue to be disclosed on the website, mirroring the prior year’s approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5018,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1904,
        "completion_tokens": 134,
        "total_tokens": 2038
      }
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "Based on the provided information, HD's 4.95% Senior Notes issued in September 2026 (referenced in both chunks) represent a key component of its long-term debt strategy. The 2023 filings detail the issuance of multiple tranches including the $750 million 4.95% notes due September 30, 2026 (Chunk 1), while the 2024 filing shows these notes carried a carrying amount of $747 million as of February 2, 2025 and $745 million as of January 28, 2024 (Chunk 2). This indicates the notes are trading at a slight discount to par value, consistent with the $1.6 million discount noted in the original issuance. The company maintains flexibility in debt management through its indentures, which allow for redemption at par or present value of remaining payments, and the 4.95% notes are part of a broader portfolio that includes other senior notes maturing across 2024-2054. This structure reflects a strategic approach to long-term financing with staggered maturities and manageable interest costs, supporting HD's capital allocation priorities while maintaining investment-grade flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "HD (ORG) -> 4.95% Senior Notes (FIN_INST)",
        "4.95% Senior Notes (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12604,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3793,
        "completion_tokens": 271,
        "total_tokens": 4064
      }
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Between 2021 and 2023, Intel's financial treatment of its investment in Beijing Unisoc Technology Ltd. evolved through observable price adjustments and net book value changes, as detailed across the provided documents. In 2021, Intel recognized $471 million in observable price adjustments for its investment in Unisoc, a non-marketable equity security, with the net book value of the investment standing at $1.1 billion as of December 30, 2023 (and $1.1 billion as of December 31, 2022), indicating a stable valuation despite market fluctuations. This adjustment was part of broader equity investment accounting practices, where Intel recorded fair value changes for strategic investments, though the specific impact on Intel's overall financials was contextualized within its larger portfolio movements, such as the $4.6 billion gain from the McAfee consumer business sale in 2022, which reflected the broader strategic divestiture activity influencing Intel's investment strategy and valuation approach during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Holds]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Beijing Unisoc Technology Ltd (COMP)",
        "Beijing Unisoc Technology Ltd (COMP) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2513,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 256,
        "total_tokens": 1539
      }
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "From 2022 to 2023, AbbVie advanced Qulipta’s regulatory and commercial trajectory through key milestones: in 2023, the FDA approved Qulipta for preventive migraine treatment in adults (April), followed by European Commission approval (August), marking significant commercial expansion beyond its initial launch. This regulatory progress was highlighted alongside AbbVie’s broader neuroscience portfolio developments, including the Phase 3 success of BoNT/E (trenibotulinumtoxinE) for glabellar lines and the EU launch of Produodopa (ABBV-951) for Parkinson’s disease, underscoring Qulipta’s role in a growing therapeutic pipeline. The KG triplets confirm Qulipta’s direct development link to AbbVie (ABBV → Qulipta), with regulatory approvals (FDA, EC) and commercial launches (EU) representing critical evolution in its status from 2022’s pending approvals to 2023’s market-ready product.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Qulipta (PRODUCT)",
        "Qulipta (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2977,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 222,
        "total_tokens": 1597
      }
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Based on the 10-K filings and KG relationships, Boeing's framing of \"upgrades and conversions\" within Global Services remained consistent between 2022 and 2023, with identical language in both years describing it as part of a \"full spectrum of products and services\" that sustains aerospace platforms through \"engineering, maintenance and modifications, upgrades and conversions, spare parts\" and related offerings. The company continued to position these capabilities as critical to sustaining both commercial and defense customers globally, maintaining the same strategic emphasis on supporting existing fleets through technical enhancements rather than new aircraft production.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "BA (ORG) -> Upgrades and Conversions (PRODUCT)",
        "Upgrades and Conversions (PRODUCT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6855,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2364,
        "completion_tokens": 170,
        "total_tokens": 2534
      }
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel's investment in Beijing Unisoc Technology Ltd. evolved from a $658 million carrying amount as of December 26 2020 to $1.1 billion as of December 30 2023, reflecting $471 million of observable price adjustments recognized in 2021 and continued growth to $1.1 billion by the end of 2023. This increase is documented in Intel’s 2023 10‑K, which notes that the net book value of the investment was $1.1 billion at the end of 2023, underscoring a significant valuation rise over the 2021‑2023 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Holds]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Beijing Unisoc Technology Ltd (COMP)",
        "Beijing Unisoc Technology Ltd (COMP) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6804,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2349,
        "completion_tokens": 125,
        "total_tokens": 2474
      }
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, Self-Service Lockers evolved from a discrete convenience feature into a core component of Home Depot’s interconnected shopping experience, directly enabling faster, more reliable fulfillment within its omni-channel supply chain. As explicitly detailed in Chunk 1 (HD_10k_2023.pdf), the company invested in self-service lockers, online order storage areas, and curb-side service to enable convenient online order pickup options, explicitly linking these to the broader goal of enhancing the \"interconnected shopping experience\" across stores, online, and job sites. This investment was part of a strategic focus on improving delivery and pickup times, options, and costs, which depend on supply chain success. Crucially, Chunk 2 (HD_10k_2024.pdf) reveals that these lockers are now an integral node in Home Depot’s fulfillment network, specifically enabling \"four interconnected retail programs\" (BOSS, BOPIS, BODFS, BORIS) and serving as a primary pickup channel—evidenced by the fact that \"approximately 50% of U.S. online orders were fulfilled through a store\" in fiscal 2024, with self-service lockers positioned at store entrances to complement BOPIS. The KG triplet relationship (HD -> Self-Service Lockers -> HD) confirms this product is not just sold by HD but is a strategic enabler of HD’s supply chain and customer experience, directly supporting the company’s investment in supply chain automation and fulfillment speed to meet customer expectations for convenience and reliability. Thus, the lockers’ role shifted from a tactical add-on to a foundational element of Home Depot’s integrated commerce strategy, directly tied to its supply chain investments and omni-channel fulfillment architecture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "HD (ORG) -> Self-Service Lockers (PRODUCT)",
        "Self-Service Lockers (PRODUCT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10628,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3290,
        "completion_tokens": 433,
        "total_tokens": 3723
      }
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "The level of detail and specificity in Costco’s disclosure regarding estimation methods for Insurance/Self-insurance Liabilities increased significantly from 2023 to 2024, as evidenced by the inclusion of specific actuarial assumptions (historical claims experience, demographic and severity factors) and explicit acknowledgment of inflation, regulatory, and legal drivers of claim fluctuations in the 2024 filing (Chunk 2), while the 2023 disclosure (Chunk 1) only noted that retained-risk liabilities were \"not discounted\" without detailing estimation methodologies; this evolution is further reinforced by the structural KG relationship where Insurance/Self-insurance Liabilities (ACCOUNTING_POLICY) are subject to Costco’s estimation process (ORG → ACCOUNTING_POLICY ←[Discloses]- ORG), confirming that the 2024 enhancements represent a deliberate expansion in methodological transparency across all disclosed estimation practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "COST (ORG) -> Insurance/Self-insurance Liabilities (ACCOUNTING_POLICY)",
        "Insurance/Self-insurance Liabilities (ACCOUNTING_POLICY) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5195,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1958,
        "completion_tokens": 233,
        "total_tokens": 2192
      }
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory-related costs shifted from a $59 million increase in cost of sales in 2021 (due to fair‑value adjustments to inventory from the acquisition) to an $87 million charge in 2023 (reflecting excess inventory in the Biotechnology segment driven by reduced demand), illustrating a reversal in the trend of inventory‑related cost pressures after the acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Aldevron (COMP)",
        "Aldevron (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8652,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2783,
        "completion_tokens": 104,
        "total_tokens": 2887
      }
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Costco's treatment of shop card liabilities has remained consistent between 2023 and 2024, with both years recognizing revenue from shop cards upon redemption while accounting for estimated breakage, and maintaining shop card liabilities (net of breakage) within other current liabilities on the balance sheet. This approach indicates a deliberate strategy to record outstanding shop card balances as liabilities until redemption, reflecting a conservative accounting stance that acknowledges the financial obligation of unredeemed values while systematically recognizing revenue as cards are used, thereby demonstrating Costco's structured and prudent management of unclaimed balances through continuous estimation and liability accrual.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Sells]- ORG",
      "triplets_used": [
        "COST (ORG) -> Shop Cards (PRODUCT)",
        "Shop Cards (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8576,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2781,
        "completion_tokens": 184,
        "total_tokens": 2966
      }
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services evolved from establishing its IFS Accelerator Ecosystem Alliance (with over 40 strategic agreements including ARM and Synopsys) to actively securing high-value design wins and expanding partnerships under initiatives like RAMP-C, while leveraging its 18A process node and advanced packaging to attract customers such as Nvidia, IBM, Microsoft, Boeing, and Northrop Grumman, and forming a new commercial agreement with Tower for 300mm analog manufacturing in New Mexico.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Foundry Services (PRODUCT)",
        "Foundry Services (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7237,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2459,
        "completion_tokens": 128,
        "total_tokens": 2587
      }
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "The financial impact of DHR's relationship with Aldevron evolved significantly between 2022 and 2023, with goodwill and net cash consideration reflecting both the initial acquisition and subsequent adjustments. In 2022, DHR recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition, which was part of a larger transaction involving Cytiva (Cytiva Acquisition) that contributed $10.2 billion in goodwill overall. By 2023, the consolidated goodwill associated with Aldevron and other entities reached $7,187 million, with net cash consideration for the Aldevron transaction totaling $9,561 million after deducting noncash consideration of $23 million, as detailed in the consolidated balance sheet (Table of Assets and Liabilities Acquired). This represents a substantial increase in both goodwill recognition and cash outlay compared to the initial 2022 figures, driven by the integration of Aldevron into DHR's operations and the broader strategic acquisitions under the Life Sciences segment. The net cash consideration of $9,561 million for Aldevron (and related entities) in 2023 underscores the significant financial commitment to this relationship, building on the foundational $6.1 billion goodwill recorded in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Aldevron (COMP)",
        "Aldevron (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6133,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2166,
        "completion_tokens": 312,
        "total_tokens": 2478
      }
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of AT&T Inc.'s 1.800% Global Notes remains unchanged at September 14, 2039 between the 2022 and 2024 SEC filings, indicating consistent long-term debt structure with no modification to this specific tranche's maturity. This stability reflects AT&T's strategic approach to maintaining a portion of its debt at a fixed maturity date while extending overall maturity profiles through new issuances, as evidenced by the continued presence of this 2039 maturity in both filings despite the introduction of newer notes in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> 1.800% Global Notes due September 14,2039 (FIN_INST)",
        "1.800% Global Notes due September 14,2039 (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5851,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2121,
        "completion_tokens": 137,
        "total_tokens": 2258
      }
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target has maintained continuous compliance with its debt leverage covenant through both 2023 and 2024, as explicitly stated in disclosures from both years confirming the company \"is, and expect[s] to remain, in compliance with these covenants\" (TGT_10k_2023.pdf, page_54; TGT_10k_2024.pdf, page_35). The evolution of its credit facility structure—specifically the October 2023 amendment extending its $3.0 billion five-year revolving credit facility to October 2028 and the October 2024 replacement of its prior $1.0 billion 364-day facility with a new identical facility expiring in October 2025—has preserved and enhanced its liquidity backstop without altering debt levels or covenant terms (TGT_10k_2023.pdf, page_54; TGT_10k_2024.pdf, page_35). These structural changes, which included terminating older facilities and extending maturities, appear designed to reinforce financial flexibility while maintaining covenant compliance, with no balances outstanding under any facilities during 2023 or 2024 (TGT_10k_2023.pdf, page_54; TGT_10k_2024.pdf, page_35).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Debt Leverage Covenant (REGULATORY_REQUIREMENT)",
        "Debt Leverage Covenant (REGULATORY_REQUIREMENT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6752,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2346,
        "completion_tokens": 265,
        "total_tokens": 2611
      }
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "Intel's approach to expanding digital readiness has evolved significantly from 2022 to 2023 through deeper integration of its RISE strategy and expanded external collaborations. In 2022, the company emphasized RISE as a framework to \"expand digital readiness for millions of people around the world\" through partnerships like the Alliance for Global Inclusion, which developed a global inclusion index to benchmark industry progress. By 2023, Intel advanced this initiative by publishing the third annual inclusion index survey results, recognizing 18 participating organizations (including Intel) with scores of 50% or higher, and explicitly linking these efforts to \"expand digital readiness for millions of people around the world\" as a core RISE objective. This progression reflects a strategic shift from foundational partnership-building to measurable industry-wide impact, with the 2023 index serving as a tool to drive accountability and accelerate inclusive practices that directly support digital readiness expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enhances]-> CONCEPT <-[Expands]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Digital Readiness (CONCEPT)",
        "Digital Readiness (CONCEPT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11447,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3509,
        "completion_tokens": 256,
        "total_tokens": 3766
      }
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson's relationship with Micromine underwent a significant de-risking trajectory between 2023 and 2024, directly tied to AspenTech's failed acquisition attempt. While Emerson had previously acquired Micromine's parent entity (Afag) in 2023 as part of its $715M acquisition spree (noting Micromine was reported in the Discrete Automation segment), the pivotal shift occurred when AspenTech terminated its $900M agreement to acquire Micromine on August 1, 2023, due to unresolved Russian regulatory hurdles—this termination directly impacted Emerson's exposure to Micromine's parent structure. The financial implications were twofold: Emerson recognized a $48 pretax loss ($47 after-tax, $0.08/share) in 2023 from divesting its Russia-based Metran subsidiary (which had been tied to Micromine's operational footprint), and in 2024, it absorbed a $48 loss from divesting two small Final Control segment businesses—both losses reflecting the broader strategic exit from Russian-exposed assets. Crucially, the KG triplet pattern (ORG -[Depends_On]-> COMP) confirms Micromine's parent entity (Afag) was acquired by Emerson in 2023, but the termination of AspenTech's deal (a key external dependency) ultimately severed the transactional link, leading to Emerson's subsequent divestitures and associated losses as it disentangled from the Micromine ecosystem. This sequence underscores a clear evolution from acquisition-driven growth to active portfolio rationalization, with financial impacts quantified through discrete loss recognition in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Agreement]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "EMR (ORG) -> Micromine (COMP)",
        "Micromine (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4322,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1711,
        "completion_tokens": 387,
        "total_tokens": 2099
      }
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan decreased from approximately 17 million shares at January 30, 2022 (per 2022 filing) to approximately 15 million shares at January 28, 2024 (per 2023 filing), while the average purchase price of shares under the ESPPs increased from $305.14 during fiscal 2021 (noting the fiscal 2022 context) to $277.19 during fiscal 2023, reflecting a decline in average purchase price year-over-year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "HD (ORG) -> U.S. ESPP (FIN_INST)",
        "U.S. ESPP (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2845,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 117,
        "total_tokens": 1472
      }
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "The pattern of impairment triggers across DHR's business segments shifted significantly between 2022 and 2023 filings, reflecting evolving risks in its intangible asset portfolio. In 2022, impairment triggers were identified in the Diagnostics and Environmental & Applied Solutions segments during 2020 and 2021, resulting in $22 million in charges (2020) and $10 million (2021), primarily tied to long-lived assets from prior acquisitions. By 2023, triggers moved to the Biotechnology segment (second quarter), Diagnostics and Biotechnology segments (fourth quarter), and referenced 2021 triggers in Diagnostics, leading to $77 million in impairment charges for 2023—up from $10 million in 2021—indicating heightened risk in newer acquisitions like the Aldevron and Cytiva intangibles. This escalation in charges, coupled with increased amortization expenses ($1.491B in 2023 vs. $1.450B in 2021), underscores a strategic shift toward more frequent impairment testing in growth segments, signaling that DHR's intangible assets—particularly in Biotechnology—are increasingly exposed to market and operational volatility, demanding closer monitoring of finite-lived asset recoverability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Identifies]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Impairment Triggers (RISK_FACTOR)",
        "Impairment Triggers (RISK_FACTOR) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6390,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2257,
        "completion_tokens": 296,
        "total_tokens": 2554
      }
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "Between 2022 and 2023, the outstanding letters of credit related to trade contracts increased significantly from $362 million to $598 million, reflecting a $236 million rise that underscores the company’s expanding involvement in trade‑linked transactions. This growth, disclosed in both the 2022 and 2023 10‑K filings, indicates that the firm is increasingly leveraging trade contracts as a core component of its business dealings, while also maintaining related commitments to insurance programs and construction contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "HD (ORG) -> Trade Contracts (FIN_INST)",
        "Trade Contracts (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1946,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 131,
        "total_tokens": 1271
      }
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 transitioned from being disclosed as an unregistered financial instrument in IBM's 2023 filing (where it was listed among various debt instruments in exhibits to Form 8-K filings) to being formally registered and publicly traded under the ticker \"IBM28B\" in the 2024 filing, which explicitly lists it under \"Title of each class\" with associated exchange details. This evolution indicates IBM's financial instruments disclosures have become more transparent and standardized, reflecting a shift from merely referencing governing documents (e.g., indentures) to directly registering and identifying specific debt securities in its SEC filings, thereby enhancing investor clarity and regulatory compliance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.300% Notes due 2028 (FIN_INST)",
        "0.300% Notes due 2028 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10192,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3197,
        "completion_tokens": 182,
        "total_tokens": 3379
      }
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "IBM's treatment of the 1.750% Notes due 2031 has evolved from disclosure in multiple Form 8-K filings (2019, 2022, 2023, and 2024) to full registration and active trading on the New York Stock Exchange under trading symbol IBM31, as evidenced by its inclusion in the 2024 10-K's registered securities table alongside other debt instruments. The 2023 filing (Chunk 1) references the 1.750% Notes due 2031 within a list of debt securities whose rights are defined in Exhibits 4.1–4.9 of a February 3, 2023 Form 8-K, while the 2024 filing (Chunk 2) explicitly registers and lists \"1.750% Notes due 2031\" under IBM31 on the NYSE, confirming its formal exchange listing and ongoing disclosure compliance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 1.750% Notes due 2031 (FIN_INST)",
        "1.750% Notes due 2031 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10192,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3194,
        "completion_tokens": 174,
        "total_tokens": 3369
      }
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Eli Lilly’s financial relationship with Zyprexa shifted markedly between 2023 and 2024 as the company moved from recognizing Zyprexa sales as ordinary product revenue to treating the 2023 sale of the olanzapine portfolio—including Zyprexa—as a non‑ordinary collaboration and other‑arrangement revenue stream. In 2023, LLY disclosed $1.45 billion from the rights‑sale of the olanzapine portfolio (Chunk 1) and recognized that revenue within “collaboration and other revenue” alongside the Boehringer Ingelheim collaboration (Chunk 2), whereas prior years had recorded Zyprexa sales as standard product sales. By 2024, the revenue model had evolved to emphasize collaboration and other‑arrangement accounting, with substantially all remaining collaboration revenue tied to contracts with customers and only minimal prior‑period intellectual‑property licensing revenue (Chunk 2), reflecting a strategic shift away from routine product‑sale recognition toward partnership‑based revenue recognition for Zyprexa‑related assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Zyprexa (PRODUCT)",
        "Zyprexa (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2451,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 255,
        "total_tokens": 1501
      }
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "The Mobility Preferred Interests were fully repurchased in April 2023, eliminating any outstanding redemption obligations and removing the liability that had been recorded at fair value ($5,414) in 2022; consequently, there was no longer any adjustment to additional paid‑in capital or to earnings per share calculations from these interests in 2024. Because the reclassification from equity to liability in 2022 required a fair‑value adjustment that reduced net income by $663 in the basic EPS computation for 2022 (Note 16), the removal of the liability after repurchase meant that no further EPS impact occurred in 2023‑2024, and diluted EPS no longer needed to consider the antidilutive Mobility securities. This evolution reflects a shift from a potential cash‑or‑stock settlement that could affect EPS to a settled position with no ongoing redemption or distribution obligations, thereby stabilizing the company’s earnings per share presentation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reclassifies]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "T (ORG) -> Mobility Preferred Interests (FIN_INST)",
        "Mobility Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 24069,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6674,
        "completion_tokens": 238,
        "total_tokens": 6912
      }
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "IBM's treatment and disclosure of the 0.875% Notes due 2030 has evolved from being referenced in prior SEC filings to being explicitly listed in its 2024 Form 10-K as a registered security. In the 2023 10-K (Chunk 1), the instrument was disclosed as part of a group of debt securities under a 1993 Indenture, with its rights defined in Exhibits to Form 8-K filings, but it was not listed as a separately registered tradable security. By contrast, the 2024 10-K (Chunk 2) explicitly lists the 0.875% Notes due 2030 under \"Title of each class\" with the trading symbol IBM30A and confirms its registration and trading on the New York Stock Exchange, indicating a formal registration and market listing that was not present in prior disclosures. This progression reflects a shift from merely disclosing the debt instrument's terms to formally registering and listing it for public trading, consistent with the KG relationship where IBM discloses and issues the 0.875% Notes due 2030 as a financial instrument.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.875% Notes due 2030 (FIN_INST)",
        "0.875% Notes due 2030 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10192,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3195,
        "completion_tokens": 251,
        "total_tokens": 3446
      }
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "The Telco Preferred Interests underwent significant structural evolution from 2023 to 2024, reflecting AT&T's strategic refinement of its preferred equity financing approach. In 2023, AT&T issued $5.25 billion of additional Telco Class A-2 and A-3 preferred interests within Telco LLC, expanding the total Telco preferred interests to $7.25 billion, with the Class A-2 and A-3 carrying a 6.85% annual distribution rate subject to reset on November 1, 2027, and every seven years thereafter; this complemented the existing $2 billion Class A-1 interests issued in 2020. By 2024, AT&T further restructured its preferred equity portfolio through the Tower Holdings reorganization, amending the 2019 Tower preferred interests to convert them into Fixed Rate Class A Limited Membership Interests (paying 5.90% distributions) and Floating Rate Class A Limited Membership Interests (resetting to SOFR + 250 bps annually), while maintaining the Telco LLC structure with its $7.25 billion in cumulative preferred interests outstanding as of December 31, 2024. This evolution demonstrates AT&T's systematic use of preferred equity to secure stable, long-term capital with flexible redemption features—such as the ability to call interests after specified periods and the non-limiting nature of distribution defaults on cash movements or dividend repurchases—while strategically layering different tranches (e.g., Telco LLC's high-yield Class A-2/A-3 at 6.85% versus Tower's reset-rate structure) to optimize financing costs and align with operational needs across its subsidiaries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Telco Preferred Interests (FIN_INST)",
        "Telco Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9157,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2945,
        "completion_tokens": 392,
        "total_tokens": 3337
      }
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One's involvement in multifamily commercial real estate loans shifted from originating and selling these loans to government-sponsored enterprises (GSEs) under loss-sharing agreements in 2020, with the fair value option adopted for new agreements starting January 1, 2020. This resulted in unrealized gains and losses being recorded in non-interest income, while existing agreements (prior to 2019) required amortization of the liability into non-interest income as risk was released, with the liability balance declining from $137 million in 2022 to $82 million in 2023 as of December 31.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Originates]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Multifamily Commercial Real Estate Loans (FIN_INST)",
        "Multifamily Commercial Real Estate Loans (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_217",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6183,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2212,
        "completion_tokens": 149,
        "total_tokens": 2361
      }
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "Amazon's co-branded credit card programs shifted from a strategically significant growth lever in 2022 to a heightened regulatory liability in 2023, with new compliance obligations directly threatening operating results through potential termination of programs on unfavorable terms, increased fraud liabilities, and mandatory adherence to evolving payment card association rules that could force costly system changes or loss of payment processing capabilities—risks explicitly tied to third-party processor dependencies and data security failures that could materially reduce revenue streams while simultaneously amplifying exposure to regulatory penalties under expanded money transmission and consumer protection frameworks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Co-Branded Credit Card Programs (PRODUCT)",
        "Co-Branded Credit Card Programs (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11185,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3461,
        "completion_tokens": 182,
        "total_tokens": 3643
      }
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "PM's financial relationship with RBH underwent a structural shift from consolidation to deconsolidation beginning March 22 2019, when RBH entered CCAA protection and its results were removed from PM's consolidated statements; consequently, RBH's equity investment is now accounted for under the equity‑method, requiring PM to assess impairment and recognize a potential loss if fair‑value declines exceed cost. The 2024 audit discussion highlights that this investment is a critical audit matter because management must apply significant judgment in estimating RBH's fair value—using discounted cash‑flow assumptions tied to Canadian sales volumes, operating margins, discount rates, and the allocation of any global settlement payments—and evaluate the tax deductibility of related settlement amounts, all of which involve substantial auditor judgment and specialized expertise. Thus, between 2022 and 2024 the relationship moved from full consolidation to deconsolidation, shifting to equity‑method accounting and necessitating rigorous impairment testing and valuation scrutiny.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Deconsolidated From]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PM (ORG) -> RBH (COMP)",
        "RBH (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9712,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3069,
        "completion_tokens": 270,
        "total_tokens": 3340
      }
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Between 2023 and 2024, Baqsimi's revenue contribution evolved significantly within LLY's portfolio, growing from $677.6 million in 2023 to $677.6 million in 2024 (with 2024 data showing $31.9 million U.S. and $31.9 million outside U.S., though exact 2024 total revenue isn't explicitly stated in Chunk 2—only referenced in Note 4 as part of collaboration revenue from Baqsimi rights sales). This growth is contextualized by LLY's strategic portfolio shift, as evidenced by the $139.3 million total Baqsimi revenue in 2022 (Chunk 1) and the explicit mention in Chunk 2 of Baqsimi being part of the 2023 rights sales to Boehringer Ingelheim, which generated collaboration revenue. Consequently, Baqsimi transitioned from a standalone product with $677.6 million in 2023 revenue (Chunk 1) to a strategic asset contributing to collaboration revenue through rights licensing, positioning it as a key component in LLY's portfolio diversification beyond its core diabetes and immunology products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Baqsimi (PRODUCT)",
        "Baqsimi (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5070,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1910,
        "completion_tokens": 247,
        "total_tokens": 2157
      }
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, Union Pacific's Total Highway Revenue Equipment composition shifted significantly toward leased assets, with the owned-to-leased ratio declining across both containers and chassis. In 2022, containers had 48,962 owned versus 1,856 leased (96.2% owned), while chassis had 29,875 owned versus 14,148 leased (67.7% owned); by 2024, containers were 46,375 owned versus just 288 leased (99.38% owned), and chassis were 4,356 owned versus 1,197 leased (78.4% owned), though the total leased share rose sharply from 16,004 (16.9% of total) to 1,485 (2.8% of total) in absolute terms, reflecting a strategic pivot toward leased equipment despite the overwhelming majority ownership percentage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Leases]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Total Highway Revenue Equipment (PRODUCT)",
        "Total Highway Revenue Equipment (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_8",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 992,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 900,
        "completion_tokens": 176,
        "total_tokens": 1076
      }
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations remained a key component of its funding structure, as evidenced by the $18.0 billion carrying value and $18.1 billion fair value of these obligations reported in 2023 (Chunk 2). This aligns with the company's strategic reliance on securitization as a funding source, which is explicitly identified alongside deposits, senior notes, and other instruments in its funding profile (Chunk 1). The consistent presence of securitized debt obligations in both the 2022 and 2023 disclosures—despite growth in loan portfolios—demonstrates their enduring role in Capital One's broader funding mix, where they continue to serve as a structured financing tool to support liquidity needs while maintaining a deposit-centric primary funding strategy (Chunk 1).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Raises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_210",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1911,
        "completion_tokens": 204,
        "total_tokens": 2116
      }
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, LLY's Zyprexa revenue underwent a significant structural shift in both source and recognition method, as revealed by the integrated analysis of all provided chunks and KG relationships. While Chunk 1 (2023) explicitly states that Zyprexa revenue \"includes sale of the rights for the olanzapine portfolio\" (indicating revenue was derived from the *sale of intellectual property rights* to the olanzapine portfolio, including Zyprexa itself), Chunk 2 (2024) clarifies that in 2023, this was recognized as part of \"collaboration and other revenue\" stemming from the *sale of rights* for the olanzapine portfolio (including Zyprexa), which was accounted for under collaboration arrangements rather than as standard product sales. Consequently, the *source* of Zyprexa-related revenue transitioned from being tied to the *disposition of rights* (as a one-time collaboration revenue item in 2023) to being fully integrated into standard product sales revenue in 2024, with Chunk 2 confirming that \"substantially all of the remainder of collaboration and other revenue\" (including the olanzapine portfolio rights revenue) was now classified under \"collaboration and other revenue\" related to contracts with customers, but the *recognition method* shifted to being explicitly tied to *product sales to customers* (net product revenue) for the remainder of the portfolio, as evidenced by the 2024 revenue composition. This evolution reflects a move from recognizing Zyprexa revenue as a discrete collaboration milestone (from rights sale) to embedding it within the core product sales framework, with the 2023 rights sale revenue now fully accounted for under the collaboration revenue category in 2024's disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Zyprexa (PRODUCT)",
        "Zyprexa (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1806,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 432,
        "total_tokens": 1517
      }
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology for Federal Government Securities in the pension plan has evolved from Level 2 classification in 2022 to continued Level 2 classification in 2024, with the 2024 disclosure specifying that these securities are valued using a bid evaluation process with data from independent pricing sources and explicitly identified as Level 2 investments. This evolution reflects a consistent but more detailed disclosure in 2024 regarding the valuation approach, while maintaining the same Level 2 classification as referenced in both the 2022 financial statements (where Federal Government Securities were reported under \"Significant Other Observable Inputs (Level 2)\" with a carrying value of $742 million) and the 2024 valuation hierarchy description.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Federal Government Securities (FIN_INST)",
        "Federal Government Securities (FIN_INST) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6994,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2388,
        "completion_tokens": 191,
        "total_tokens": 2579
      }
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "From 2022 to 2023, Capital One maintained the use of borrower credit scores as a key driver for product segmentation decisions across its consumer loan portfolios, particularly for credit cards and auto loans, as explicitly stated in both the 2022 and 2023 10-K filings (Chunks 1 and 2). This consistent application of credit score data for subprime classification, competitive benchmarking, and segmentation decisions indicates that Capital One’s credit risk modeling strategy relies on granular borrower risk profiling to tailor product offerings and manage credit exposure, rather than shifting toward alternative risk indicators like internal risk ratings or nonperforming loan metrics. The repetition of this practice in both filings—despite the one-year temporal gap—demonstrates a sustained strategic emphasis on credit score-driven segmentation as a core component of their credit risk assessment framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Impacts]- ORG",
      "triplets_used": [
        "COF (ORG) -> Product Segmentation Decisions (ACCOUNTING_POLICY)",
        "Product Segmentation Decisions (ACCOUNTING_POLICY) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3551,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 228,
        "total_tokens": 1776
      }
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "Amazon's strategic positioning of AWS has evolved from 2022 to 2023 as a core growth engine integrated across its business segments, with increasing investment priorities reflected in both financial disclosures and operational focus. In 2022, AWS was highlighted as a key driver of technology and content investment, supporting geographic expansion and cross-functional system improvements, while in 2023 it was formally recognized as one of Amazon's three primary business segments alongside North America and International, explicitly serving developers and enterprises through on-demand services like compute, storage, and machine learning. This structural emphasis aligns with the KG relationship where AWS Services (PRODUCT) is both invested in by and offers services to AMZN (ORG), underscoring its dual role as a strategic investment and a revenue-generating platform. The company continues to allocate significant capital toward AWS infrastructure to enhance customer experience and operational efficiency, even as it manages shareholder dilution through equity compensation models like RSUs, ensuring long-term alignment of incentives across its global operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> AWS Services (PRODUCT)",
        "AWS Services (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9637,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3048,
        "completion_tokens": 293,
        "total_tokens": 3341
      }
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Between 2022 and 2024, PMI's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) underwent a material transformation due to the ongoing CCAA restructuring and resulting deconsolidation, which fundamentally altered its accounting treatment and exposed it to significant contingent liabilities. PMI had deconsolidated RBH from its consolidated financial statements as of March 22, 2019 following RBH's CCAA filing, meaning RBH's financial results no longer consolidated into PMI's statements; however, PMI maintained an equity investment in RBH, which became subject to impairment review. This culminated in a $2,316 million non-cash impairment charge recorded in 2024 (PM_10k_2024.pdf, p.30), driven by uncertainty around the allocation of a proposed CAD 32.5 billion global settlement amount among RBH, Imperial Tobacco Canada, and JTI Macdonald Corp. in the CCAA-mediated resolution of Canadian tobacco litigation, including the stayed smoking and health class actions (Chunk 1). While PMI's accounting for RBH's litigation exposure shifted to equity method accounting post-deconsolidation, the unresolved settlement allocation directly impacted the fair value assessment of its RBH investment, leading to the 2024 impairment. Critically, PMI's potential financial exposure remained tied to RBH's CCAA proceedings and the lingering liability from the CAD 15.5 billion Canadian class action judgment (where RBH was allocated ~CAD 3.1 billion, including interest), though the CCAA stay had initially shielded it from active litigation post-2019. Thus, the relationship evolved from consolidated subsidiary to equity investment with significant contingent liability exposure, culminating in a material impairment charge driven by the unresolved settlement dynamics within the CCAA process.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Deconsolidated From]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "PM (ORG) -> RBH (COMP)",
        "RBH (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9746,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3083,
        "completion_tokens": 450,
        "total_tokens": 3533
      }
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy's commercial significance for GILD has declined markedly in both revenue contribution and product risk exposure. In 2022, Biktarvy generated $8.624B in total sales (representing a substantial portion of GILD's $16.315B total HIV revenue), but by 2024 it had fallen to $7.259B (a 16% decrease), while its share of total HIV revenue dropped from 52.8% to 42.8% as newer products like Descovy and Genvoya gained traction. Critically, the FDA's January 2024 boxed warning for all CAR-T therapies (including GILD's Yescarta/Tecartus) and the heightened risks associated with HIV product dependency—particularly the potential loss of TAF-based regimens to newer paradigms—introduce significant commercial vulnerability that directly threatens Biktarvy's future revenue stability despite its historical dominance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 37170,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 9927,
        "completion_tokens": 208,
        "total_tokens": 10135
      }
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "From 2022 to 2024, Union Pacific Railroad's (UNP) financial stake and operational relationship with TTX evolved significantly, as reflected in the KG triplets and text chunks. In 2022, UPRR held a 37.03% economic interest in TTX and accounted for its investment using the equity method, with $1.6 billion recognized as an investment in 2021 (Chunk 1), which increased to $1.9 billion by 2024 (Chunk 2). This growth in investment value—from $1.6 billion (2021) to $1.9 billion (2024)—demonstrates a strengthening financial stake. Operationally, TTX car hire expenses rose from $407 million in 2019 to $432 million in 2024 (Chunk 2), reflecting increased utilization of TTX rail cars, while accounts payable to TTX also grew from $57 million (2021) to $70 million (2024) (Chunks 1 and 2), underscoring deeper operational and financial interdependence. These trends highlight both the expanding investment value and rising operational costs tied to TTX, driven by sustained collaboration across the railroad industry.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNP (ORG) -> TTX (COMP)",
        "TTX (COMP) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2836,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 253,
        "total_tokens": 1598
      }
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "Tesla's approach to scaling Solar Roof production evolved significantly from 2022 to 2023, with a strategic shift toward integrating installer training and supply chain risk management to support growth. In 2022, the company emphasized onboarding new installers and collaborating with real estate developers to reduce installation time and costs for Solar Roof, while explicitly identifying the need to hire skilled electricians and maintain adequate battery cell supply as critical dependencies for scaling (Chunk 1). By 2023, Tesla expanded this foundation by detailing how supply chain disruptions—such as semiconductor shortages, inflation-driven material cost increases, and supplier insolvency risks—could directly impact production ramps, necessitating proactive mitigation through diversified sourcing and inventory management (Chunk 2). This dual focus on workforce development and supply chain resilience ensured that Solar Roof scaling could proceed without the bottlenecks experienced in prior product launches, directly addressing the operational challenges highlighted in both chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12154,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3678,
        "completion_tokens": 274,
        "total_tokens": 3952
      }
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company's relationship with U.S. fountain retailers evolved through a strategic shift in syrup manufacturing and distribution, driven by contractual restructuring with bottling partners. While legacy agreements allowed certain bottlers to manufacture fountain syrups, the company increasingly centralized production under Comprehensive Beverage Agreements (CBAs), particularly with \"expanding participating bottlers\" (EPBs) who were granted exclusive territory rights and authorized to manufacture syrups for their own account and supply others. This transition replaced older legacy agreements—where pricing was tied to baseline formulas adjusted quarterly by sugar costs—and positioned Coca-Cola as the primary manufacturer of fountain syrups, which it sells directly to authorized fountain wholesalers and retailers (including some fountain retailers), rather than authorizing bottlers to produce them. As noted in Chunk 1, \"bottlers in the United States generally are not authorized to manufacture fountain syrups\" under modern CBAs, and Chunk 2 confirms that fountain syrup sales are included in the North America operating segment, reflecting this centralized model. Consequently, the relationship shifted from bottler-manufactured syrups under flexible legacy terms to company-controlled production and distribution via EPB CBAs and dedicated fountain syrup sales channels, ensuring tighter operational oversight and alignment with the company's broader concentrate operations strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Fountain Retailers (COMP)",
        "Fountain Retailers (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10338,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3233,
        "completion_tokens": 382,
        "total_tokens": 3615
      }
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "IBM's treatment and disclosure of the 0.950% Notes due 2025 has evolved from initial incorporation by reference in 2017 (as Exhibit 4.1 to the May 22, 2017 Form 8-K filing) to explicit registration details in its 2024 10-K, where the notes are identified under the trading symbol IBM25B with the New York Stock Exchange as the registered exchange (IBM_10k_2024.pdf, page_1). While the 2022 filing (IBM_10k_2022.pdf, page_33) lists the instrument defining the rights of the holders of the 0.950% Notes due 2025 as Exhibit 4.1 to the May 22, 2017 Form 8-K, the 2024 disclosure confirms their active registration and trading status under a distinct ISIN (IBM25B), reflecting a shift from passive incorporation to formal market registration and disclosure of trading details. This evolution underscores IBM's increasing transparency regarding the financial instrument's market presence, as evidenced by its inclusion in the 2024 list of registered securities with specific exchange and trading symbol details, while maintaining its original classification as a debt financial instrument issued by IBM (IBM (ORG) -> 0.950% Notes due 2025 (FIN_INST) <-[Issues_Financial_Instrument]- IBM (ORG)).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.950% Notes due 2025 (FIN_INST)",
        "0.950% Notes due 2025 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8912,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2881,
        "completion_tokens": 297,
        "total_tokens": 3178
      }
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "GILD's strategic positioning of Biktarvy has evolved from 2022 to 2024 by maintaining its central role in HIV treatment portfolios while shifting focus toward competitive differentiation through sustained market share leadership and reduced reliance on legacy TAF-based regimens amid evolving HIV paradigms. The 2022 10-K highlights Biktarvy's inclusion in a portfolio generating substantial revenue, with risk factors noting that sales could be impacted if nucleoside-based therapies like TAF fall out of favor, while the 2024 10-K explicitly identifies competitive pressures from generics and paradigm shifts as key threats requiring ongoing innovation to preserve its premium positioning. This strategic evolution reflects a calculated effort to leverage Biktarvy's established market dominance—rooted in its once-daily dosing and efficacy—to mitigate financial risk exposure from competitive erosion, as evidenced by its continued prominence in GILD's product portfolio despite the absence of direct triplet connections to newer therapies in the provided data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10222,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3199,
        "completion_tokens": 266,
        "total_tokens": 3465
      }
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Lockheed Martin's approach to defined contribution retirement savings plans evolved significantly between 2022 and 2023 through strategic transfers of defined benefit pension obligations to insurance companies, resulting in substantial financial impacts. In 2021, the company transferred $4.9 billion of pension obligations via group annuity contracts for approximately 18,000 retirees, recognizing a $1.7 billion noncash settlement charge in 2021 (related to accelerated AOCL recognition), followed by a $1.5 billion charge in 2022 for a $4.3 billion transfer affecting 13,600 retirees, and continued this strategy in 2023 with a $414 million voluntary settlement for 6,500 participants, thereby reducing net pension obligations and mitigating volatility in financial results through these noncash charges and obligation reductions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Defined Contribution Retirement Savings Plans (FIN_INST)",
        "Defined Contribution Retirement Savings Plans (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2827,
        "completion_tokens": 208,
        "total_tokens": 3035
      }
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "Between 2022 and 2024, IBM's debt composition maturing in 2025 underwent a structural evolution reflecting refinancing strategy and market conditions. In 2022, IBM had $1.0 billion principal amount of 2.875% Notes due 2025 (trading symbol IBM 25A) registered on the NYSE, alongside $700 million of 7.00% Debentures due 2025 (trading symbol IBM 25) also maturing that year. By 2024, the company maintained the same 2.875% Notes due 2025 (now listed as IBM 25A) but introduced updated terms reflected in the 2024 filing, while retaining the 7.00% Debentures due 2025 (IBM 25) as part of its long-term debt structure. This continuity with modified nomenclature and registration details indicates IBM's deliberate retention of these instruments within its 2025 maturity profile, supported by consistent NYSE registration across both filings. The evolution demonstrates IBM's strategy of managing near-term maturities through targeted refinancing while preserving key debt instruments with extended obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 2.875% Notes due 2025 (FIN_INST)",
        "2.875% Notes due 2025 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5845,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2105,
        "completion_tokens": 251,
        "total_tokens": 2357
      }
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "From 2022 to 2024, Biktarvy's strategic importance within Gilead's HIV portfolio has intensified amid growing competitive pressures and shifts in the treatment paradigm, as evidenced by its continued uptake across all geographies despite declines in legacy regimens like Truvada and Atripla due to generic competition. While Biktarvy remains a cornerstone of Gilead's HIV revenue—driven by its inclusion in preferred regimens and sustained market share—it faces heightened risk from evolving treatment paradigms, such as potential changes to nucleoside-based therapy preferences and regulatory scrutiny of HIV product classes, which could impact its long-term dominance if newer alternatives gain traction. This dynamic is underscored by Gilead's strategic focus on expanding its portfolio and ensuring patient access, as highlighted in its 2022 outlook, while simultaneously navigating risks tied to competitive threats and regulatory changes in the HIV space, as detailed in its 2024 risk factors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7413,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2500,
        "completion_tokens": 249,
        "total_tokens": 2750
      }
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The U.S. litigation escrow account balance increased from $1,449 million at the end of fiscal 2022 to $1,764 million at the end of fiscal 2023, reflecting a $1,000 million deposit during fiscal 2023 and a $1,500 million deposit during fiscal 2022, while net payments to opt‑out merchants were $685 million in fiscal 2023 and $175 million in fiscal 2022. These deposits and payments are disclosed in the 2023 10‑K as part of the escrow activity for the interchange multidistrict litigation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Deposits]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Litigation Escrow Account (FIN_INST)",
        "Litigation Escrow Account (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4465,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1770,
        "completion_tokens": 122,
        "total_tokens": 1892
      }
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, the role of fountain syrups within Coca-Cola's North America operating segment remained strategically consistent, with the company continuing to manufacture fountain syrups and sell them directly to fountain retailers, authorized fountain wholesalers, and bottling partners in the United States, as stated in both the 2022 and 2023 10-K filings. This responsibility is explicitly included in the North America operating segment, reflecting that manufacturing and distribution of fountain syrups are core to the segment's operations, while the company's concentrate operations—encompassing fountain syrups—are integral to its geographic operating segments and Global Ventures segment, as detailed in the structural descriptions of concentrate and finished product operations across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Fountain Syrups (PRODUCT)",
        "Fountain Syrups (PRODUCT) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6141,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2182,
        "completion_tokens": 203,
        "total_tokens": 2386
      }
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Between 2022 and 2024, IBM's debt composition maturing in 2025 underwent a structural evolution reflecting refinancing strategy and market conditions. In the 2022 filing (Chunk 1), IBM had two distinct 2025 maturities: 2.875% Notes due 2025 (IBM 25A) and 0.950% Notes due 2025 (IBM 25B), alongside 7.00% Debentures due 2025 (IBM 25). By the 2024 filing (Chunk 2), the 2.875% Notes due 2025 (now listed as IBM 25A) remained, but the 0.950% Notes due 2025 (IBM 25B) persisted as a separate instrument, while the 7.00% Debentures due 2025 retained their original designation (IBM 25). Critically, the 0.950% Notes due 2025 (IBM 25B) maintained its presence across both filings, indicating no retirement or restructuring of this specific tranche during the period, despite broader market shifts affecting debt issuance patterns. This consistency in the 0.950% Notes due 2025's structure—identified through its KG triplet connection to IBM (ORG) -> FIN_INST (0.950% Notes due 2025)—confirms its unchanged status as a key component of IBM's 2025 maturity profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.950% Notes due 2025 (FIN_INST)",
        "0.950% Notes due 2025 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5845,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2105,
        "completion_tokens": 264,
        "total_tokens": 2369
      }
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Disney's strategic approach to cruise ships has evolved through targeted investments and fleet expansion initiatives, as evidenced by its 2024 disclosure of plans to expand its cruise fleet and increase investments in the Experiences segment (Chunk 2), while simultaneously building on its historical operational foundation in cruise tourism (Chunk 1). This progression reflects a deliberate shift from leveraging cruise ships as part of its broader entertainment portfolio (as seen in the 2022 10-K's discussion of theme parks/resorts/cruise ships as interconnected offerings) to making explicit, multi-year capital commitments to scale this segment, including new ship construction and strategic positioning within its Experiences business line (Chunk 2), directly aligning with the KG pattern where Cruise Ships (PRODUCT) are both dependent on and invested in by DIS (ORG).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Cruise Ships (PRODUCT)",
        "Cruise Ships (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13096,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3903,
        "completion_tokens": 219,
        "total_tokens": 4122
      }
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "Lockheed Martin's pension risk transfer strategy evolved from executing a $4.9 billion group‑annuity transaction in August 2021 that eliminated obligations for roughly 18,000 retirees and generated a $1.7 billion noncash settlement charge, to continuing a broader program that has transferred about $11.6 billion of pension liabilities since 2018 and targets further transfers to reduce volatility and PBGC premiums; the 2023 filing confirms the company still plans to evaluate additional risk‑transfer transactions, which may trigger further noncash settlement charges and require extra pension‑trust contributions, while acknowledging that such actions mitigate earnings volatility but also expose the firm to insurance‑counterparty risk and ongoing funding sensitivity to market assumptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Pension Risk Transfer Transactions (FIN_INST)",
        "Pension Risk Transfer Transactions (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11741,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3585,
        "completion_tokens": 198,
        "total_tokens": 3783
      }
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Tesla's financing relationships with partners have evolved significantly between 2022 and 2023, with a strategic shift toward greater direct involvement in leasing and financing programs that introduces new risk exposures. While Chunk 1 reveals Tesla's accounts receivable includes amounts from financing institutions and leasing companies, particularly for regulatory credits and government rebates that can take up to a year to collect, Chunk 2 explicitly details the company's growing reliance on direct leasing arrangements where it retains residual value risk and depends on accurate residual value projections—risks amplified by market fluctuations in used vehicle values and pricing changes. Critically, Chunk 2 warns that if Tesla cannot adequately fund its leasing program through internal resources or partners, or if residual values decline due to supply/demand shifts or economic cycles, its ability to grow vehicle deliveries and manage \"greater levels of residual risk\" could be materially impaired, directly linking the evolution of financing partnerships to heightened credit and residual value risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Financing Partners (COMP)",
        "Financing Partners (COMP) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9113,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2919,
        "completion_tokens": 279,
        "total_tokens": 3199
      }
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola maintained its core bottler partnership model but refined the distribution architecture for fountain syrups and clarified the evolving roles of bottlers and wholesalers. The company continued to rely on bottlers for beverage production and distribution under Comprehensive Beverage Agreements (CBAs), while retaining exclusive rights to manufacture and sell fountain syrups directly to authorized fountain wholesalers—bypassing bottlers for this specific product line. This shift reinforced the separation between bottlers (who focus on finished beverage production and distribution) and fountain wholesalers (who exclusively handle syrup sales to foodservice accounts), as reflected in the persistent KG pattern where \"Fountain Wholesalers\" both partner with and depend on \"KO\" (The Coca-Cola Company). The 2023 filing confirms this structure remains unchanged from 2022, with no indication of strategic shifts in syrup distribution authority.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Fountain Wholesalers (COMP)",
        "Fountain Wholesalers (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10338,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3230,
        "completion_tokens": 244,
        "total_tokens": 3474
      }
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "AMD's financial relationship with the ATMP JV evolved significantly between 2023 and 2024, marked by increased receivables and new investment activities. In 2023, AMD held $9 million in receivables from the ATMP JV (as of Dec 30, 2023), which grew to $12 million by 2024 (as of Dec 28, 2024), reflecting higher outstanding balances tied to ongoing purchases and resales. Concurrently, AMD made a strategic $100 million term loan to the ATMP JV in October 2024, using the JV's receivables as collateral and bearing interest at SOFR + 50 bps, signaling deeper financial integration beyond passive equity investment. This loan, recorded within receivables from related parties, underscores a shift toward active capital support, while the JV's role expanded to include managing AMD's inventory and securing long-term supply chain partnerships, as evidenced by $1.7 billion in annual purchases and $121 million in resales to the JV during 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Receivables_From]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4998,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1882,
        "completion_tokens": 235,
        "total_tokens": 2117
      }
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolved significantly between 2022 and 2023 through additional pension obligation settlements that reduced financial volatility. In 2023, the company executed a voluntary settlement offering totaling $414 million for approximately 6,500 participants, resulting in a corresponding reduction in benefit obligations, while earlier settlements like the $1.5 billion noncash charge recognized in Q2 2022 (related to transferring $4.3 billion of obligations in 2022) and the $1.7 billion charge from the 2021 $4.9 billion transfer demonstrated a continued strategy of using group annuity contracts to offload liabilities. These settlements, which transferred obligations to insurance companies without requiring additional funding from Lockheed Martin, directly impacted financial results by accelerating the recognition of actuarial losses through noncash pension settlement charges, thereby reducing accumulated other comprehensive loss (AOCL) in stockholders' equity and mitigating the long-term volatility of net pension obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Nonqualified Defined Benefit Pension Plans (FIN_INST)",
        "Nonqualified Defined Benefit Pension Plans (FIN_INST) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2828,
        "completion_tokens": 279,
        "total_tokens": 3107
      }
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved significantly through increased investment and equity income. In 2023, AMD recorded $16 million in equity income from the ATMP JV, with a $99 million investment value as of December 30, 2023, supported by $363 million payables to the JV and $9 million receivables from it. By 2024, AMD increased its equity investment by $17 million (to $149 million total), directly correlating with a substantial rise in equity income to $33 million—up from $16 million in 2023—reflecting both the capital infusion and improved financial performance of the joint venture. This progression demonstrates a strategic deepening of AMD's engagement, transitioning from a $99 million investment position in late 2023 to $149 million by end-2024, while equity income nearly doubled to $33 million, underscoring the JV's growing contribution to AMD's financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Receivables_From]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4740,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1815,
        "completion_tokens": 230,
        "total_tokens": 2046
      }
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Johnson & Johnson's financial stake and ownership relationship with Kenvue underwent a significant evolution between 2023 and 2024, culminating in complete divestment. Immediately following the May 2023 IPO, JNJ retained an 89.6% stake in Kenvue, with a $1.3 billion non-controlling interest reflected in equity, and recognized a $2.5 billion gain on divested net assets. By August 23, 2023, JNJ executed an exchange offer that reduced its ownership to 9.5%, acquiring $31.4 billion in Kenvue shares (recorded as treasury stock) while retaining a $2.8 billion gain on the remaining stake, which was part of a $21 billion total gain from deconsolidation. However, by May 17, 2024, JNJ completed a Debt-for-Equity Exchange, surrendering its remaining 182.3 million shares of Kenvue Common Stock in exchange for $3.6 billion in commercial paper, resulting in full exit from Kenvue ownership and a $0.4 billion loss recorded in other expense. This sequence reflects a strategic shift from majority ownership to complete divestiture, with financial outcomes tied to non-controlling interest adjustments, treasury stock transactions, and gains/losses recognized across fiscal 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Kenvue (COMP)",
        "Kenvue (COMP) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7972,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2633,
        "completion_tokens": 296,
        "total_tokens": 2929
      }
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "Between 2022 and 2023, AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained formally intact through its inclusion in the continuing guaranty agreements referenced in both 2022 and 2023 filings, specifically under the \"Guaranty of certain obligations of Southwestern Bell Telephone Co.\" (Exhibit 4-b in both T_10k_2022.pdf and T_10k_2023.pdf), which is connected via the KG pattern ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG, confirming Southwestern Bell's ongoing role as a guaranteed entity within AT&T's broader guarantee structure across multiple subsidiaries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Southwestern Bell Telephone Co. (COMP)",
        "Southwestern Bell Telephone Co. (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5042,
        "completion_tokens": 150,
        "total_tokens": 5192
      }
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "Lockheed Martin's strategic positioning in hypersonics has evolved from 2022 to 2023 through expanded program development responsibilities, as evidenced by its role in the Hypersonics Programs product line (KG: LMT → Hypersonics Programs → LMT). In 2022, the company emphasized its reliance on U.S. government contracts for hypersonics development amid budget uncertainties, while the 2023 filing explicitly details active hypersonics programs under Space, including strike weapons development for the Army and Navy, demonstrating concrete progression in program execution. This evolution reflects a deepening integration of hypersonics within Lockheed's broader portfolio, where it now operates as a dedicated program area under Space, directly tied to national security priorities and subject to the same funding dynamics described in both chunks regarding congressional appropriations and budgetary risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Hypersonics Programs (PRODUCT)",
        "Hypersonics Programs (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10895,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3369,
        "completion_tokens": 227,
        "total_tokens": 3596
      }
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The U.S. litigation escrow account balance increased from $1.4 billion at the end of fiscal 2022 to $1.764 billion at the end of fiscal 2023, reflecting deposits of $850 million in fiscal 2022 and $1.0 billion in fiscal 2023, net of payments of $685 million and $175 million respectively. The account was initially funded with $850 million in fiscal 2022, and by the end of fiscal 2023 the balance had risen to $1.764 billion, indicating a net growth driven by the additional $1.0 billion deposit in fiscal 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Litigation Escrow Account (FIN_INST)",
        "Litigation Escrow Account (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6591,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2299,
        "completion_tokens": 128,
        "total_tokens": 2427
      }
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "From 2022 to 2024, Outdoor Garden's strategic positioning within HD's product portfolio shifted significantly, as evidenced by its classification changes and performance metrics across fiscal years. In 2022 (Chunk 1), Outdoor Garden was explicitly categorized under \"Indoor Garden\" with $15,546 million in net sales (10.3% of total), while 2024 data (Chunk 2) reclassifies it under \"Hardlines\" merchandising department alongside Hardware, Power, and Storage & Organization, indicating a strategic repositioning from a gardening-focused category to a broader hardlines segment. This evolution is further reflected in its financial trajectory: sales grew from $7,595 million in Fiscal 2019 to $9,602 million in Fiscal 2020 and $10,317 million in Fiscal 2021, demonstrating consistent performance that supported its expanded role in HD's product strategy, particularly as a key component within the Hardlines merchandising group that now encompasses critical business units like Electrical, Lumber, and Plumbing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "HD (ORG) -> Outdoor Garden (PRODUCT)",
        "Outdoor Garden (PRODUCT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2755,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 252,
        "total_tokens": 1578
      }
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD has sustained its emphasis on an engaging and open environment as its global workforce grew from approximately 26,000 employees in 2023 (AMD_10k_2023.pdf, Human Capital) to 28,000 employees in 2024 (AMD_10k_2024.pdf, Human Capital), explicitly linking this culture to its core mission of \"building great products that accelerate next-generation computing experiences\" through diverse, creative collaboration across global teams. This consistent focus—reinforced by its historical narrative of innovation since 1969 and ongoing investment in talent development—suggests a deliberate talent retention strategy centered on fostering a unique, inclusive culture that differentiates AMD in the competitive semiconductor industry, directly supporting its ability to attract and retain top engineering talent amid intense industry competition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Depends_On]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Engaging and Open Environment (CONCEPT)",
        "Engaging and Open Environment (CONCEPT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8816,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2869,
        "completion_tokens": 210,
        "total_tokens": 3079
      }
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "Between 2022 and 2023, AT&T's guarantee obligations toward The Ohio Bell Telephone Company remained formally intact but were effectively superseded by updated corporate structures and trust arrangements, as evidenced by the continued inclusion of Ohio Bell within the guaranty umbrella referenced in both 2022 and 2023 filings (Chunk 1: 4-c; Chunk 2: 4-c). While no new guarantees were executed during this period, the company maintained its historical commitment through existing instruments, including the master trust agreements and deferred compensation plans that indirectly supported obligations to subsidiaries like Ohio Bell (Chunk 1: 10-l; Chunk 2: 10-l, 10-q). The evolution reflects a consolidation of governance frameworks rather than a termination of AT&T's financial responsibilities, with the 2022 amendment to the Stock Purchase and Deferral Plan and the 2023 update to the Equity Retention Policy underscoring ongoing regulatory alignment (Chunk 2: 10-k, 10-q). Thus, AT&T's guarantee relationship with The Ohio Bell Telephone Company persisted through indirect mechanisms, anchored in longstanding debt instruments and trust structures, without material disruption in obligations despite evolving corporate documentation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> The Ohio Bell Telephone Company (COMP)",
        "The Ohio Bell Telephone Company (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5034,
        "completion_tokens": 309,
        "total_tokens": 5344
      }
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "The financial impact of GE's relationship with AerCap evolved significantly between 2023 and 2024, with gains on retained and sold ownership interests declining by $5.2 billion in 2024 compared to 2023, primarily due to reduced performance in the AerCap and GE HealthCare investments, as noted in the 2024 10-K filing. This decline was partially offset by other favorable factors including $1.6 billion in increased segment profit, $0.7 billion higher run-off insurance profits, and $0.5 billion gains from business interest sales, though these were insufficient to fully counteract the $5.2 billion reduction in gains tied to AerCap and GE HealthCare.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> AerCap (COMP)",
        "AerCap (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3460,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 163,
        "total_tokens": 1661
      }
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Home Depot's strategic use of HD Supply has evolved from its 2020 acquisition to a focused expansion of professional (Pro) services and MRO offerings through its subsidiary HD Supply, particularly to serve Pros who maintain residential and commercial properties. This evolution is evidenced by the 2024 acquisition of SRS to accelerate growth with Pros, the development of Pro-focused capabilities like the Pro Xtra loyalty program and trade credit offerings, and the explicit inclusion of MRO products and services for multifamily, hospitality, and government facilities—directly supporting HD Supply's historical role in serving professional customers while driving higher product sales and shareholder value through capital reinvestment and cost productivity initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "HD (ORG) -> HD Supply (COMP)",
        "HD Supply (COMP) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10159,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3174,
        "completion_tokens": 193,
        "total_tokens": 3367
      }
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "AMD's cross-licensing reliance has expanded modestly from 2023 to 2024, with its patent portfolio growing from approximately 18,500 worldwide matters (12,800 issued + 5,600 pending) in 2023 to 18,800 worldwide matters (13,200 issued + 5,600 pending) in 2024, reflecting a net increase of 300 matters while maintaining the same 5,600 pending applications. This incremental growth in patent assets supports continued technology exchange under cross-licensing agreements, which AMD views as non-material to its business despite the typical industry reliance on such arrangements for innovation sharing. The company's 2024 filing notes \"numerous cross-licensing and technology exchange agreements\" with other firms, underscoring that patent portfolio expansion directly enables ongoing technology transfer without significant disruption to its business model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Cross-Licensing Agreements (ACCOUNTING_POLICY)",
        "Cross-Licensing Agreements (ACCOUNTING_POLICY) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8816,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2860,
        "completion_tokens": 213,
        "total_tokens": 3074
      }
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "Johnson & Johnson's financial stake in Kenvue evolved from 89.6% ownership post-IPO (May 8 2023) to a 9.5% residual stake held in other assets (August 23 2023), which it then fully exited through a debt‑for‑equity exchange in the fiscal second quarter of 2024, swapping the remaining 182.3 million shares for $3.6 billion of commercial paper and recording a $0.4 billion loss in other expense; the 2023 separation generated a $21 billion non‑cash gain—including a $2.8 billion gain on the retained Kenvue stock—while the 2024 exchange marked the complete disposal of JNJ’s Kenvue holdings and the termination of related transition services and manufacturing agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Kenvue (COMP)",
        "Kenvue (COMP) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2734,
        "completion_tokens": 167,
        "total_tokens": 2901
      }
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "Between 2022 and 2023, AT&T's inclusion in guarantee disclosures remained consistent with prior years, as evidenced by the continued reference to Indiana Bell Telephone Co. Inc. within the guaranty of certain obligations described in Item 4-c of both the 2022 (T_10k_2022.pdf, page_141) and 2023 (T_10k_2023.pdf, page_103) filings—specifically, Indiana Bell is listed alongside other Bell operating companies as a subsidiary whose obligations are guaranteed by AT&T, reflecting a longstanding structural relationship preserved in regulatory disclosures. This pattern underscores that Indiana Bell continues to be a key entity in AT&T's guarantee framework, maintaining its inclusion in the disclosure of cross-guarantees among AT&T and its subsidiaries, as reinforced by the KG pattern ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG, which connects AT&T and Indiana Bell Telephone Co. Inc. through mutual financial responsibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Indiana Bell Telephone Co. Inc. (COMP)",
        "Indiana Bell Telephone Co. Inc. (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5034,
        "completion_tokens": 232,
        "total_tokens": 5267
      }
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE's financial relationship with AerCap shifted from active cash outflows to recognized investment gains. In 2023, GE paid $203 million in net cash to AerCap for ongoing services and lease activities (Chunk 1), while in 2024, AerCap's retained stake generated $5.2 billion in gains that were partially offset by other factors, contributing to a $1.8 billion increase in adjusted earnings (Chunk 2). This evolution reflects a transition from direct cash involvement to equity-based investment returns, with the 2024 gains directly tied to GE's stake in AerCap despite the reduced cash payment in the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> AerCap (COMP)",
        "AerCap (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2038,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 157,
        "total_tokens": 1293
      }
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "The Home Depot's approach to store appearance has evolved from 2022 to 2024 through intensified focus on enhancing the customer experience via digital integration, particularly through its interconnected shopping model that bridges physical stores with online platforms. While Chunk 1 details ongoing investments in store appearance to complement merchandising and service offerings like tool rentals and installation, Chunk 2 explicitly emphasizes how digital enhancements—such as improved mobile app functionality, streamlined online product presentation, and seamless transitions between in-store and online shopping—directly support store competitiveness by aligning with customer expectations for personalized, frictionless experiences across all touchpoints. This evolution reflects a strategic shift where store appearance is no longer isolated but is intrinsically linked to digital capabilities, as evidenced by Chunk 2's emphasis on \"interconnected retail strategy\" and the role of digital investments in driving conversion and sales growth, ultimately positioning store aesthetics as a critical component of a holistic, customer-centric ecosystem that competes on experience rather than just price or product alone.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Impacted_By]- ORG",
      "triplets_used": [
        "HD (ORG) -> Store Appearance (CONCEPT)",
        "Store Appearance (CONCEPT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11002,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3396,
        "completion_tokens": 306,
        "total_tokens": 3702
      }
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved through increased transaction volumes and new financial arrangements. The Company expanded its inventory management program with the ATMP JV, with purchases rising to $1.7 billion in 2024 (from prior year levels) and resales increasing to $121 million (up from $14 million in 2023), while receivables from the JV grew to $12 million. Additionally, on October 9, 2024, AMD entered a $100 million one-year term loan agreement with an ATMP JV subsidiary, secured by the JV's receivable balance from AMD, bearing interest at SOFR + 50 bps and repayable under potential 12-month extensions—marking the first explicit new financial arrangement beyond operational purchases/resales. This reflects a deepening financial integration, with the JV now holding $476 million payable to AMD (up from $363 million in 2023) and AMD's receivables from the JV increasing significantly.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3770,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 236,
        "total_tokens": 1809
      }
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Johnson & Johnson's privacy compliance programs have evolved from foundational frameworks to more sophisticated, globally integrated controls in response to escalating regulatory demands and cross-border data flow complexities. The 2024 filing explicitly details expanded obligations under new privacy laws, particularly emphasizing data localization requirements and international data transfer restrictions that directly challenge traditional compliance models. While the 2023 filing established privacy programs requiring global adherence, the 2024 update reveals heightened risks from evolving cyber threats and AI adoption that necessitate more dynamic, layered controls to manage cross-border data flows and prevent breaches impacting business operations or research. Critically, both filings underscore that inadequate controls—especially regarding third-party vendor management and international data transfers—could trigger substantial fines, reputational damage, or operational disruption, forcing JNJ to continuously adapt its compliance posture to address these dynamic regulatory and technological pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Privacy Compliance Programs (ACCOUNTING_POLICY)",
        "Privacy Compliance Programs (ACCOUNTING_POLICY) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6911,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2387,
        "completion_tokens": 280,
        "total_tokens": 2667
      }
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE's financial exposure to Bank BPH shifted significantly in relation to estimated borrower litigation losses and associated valuation allowances. In 2023, the valuation allowance against financing receivables held for sale included $1,712 million attributed to estimated borrower litigation losses on foreign currency-denominated mortgage portfolios, contributing to total estimated losses of $2,669 million. By 2024, this allowance decreased to $1,517 million for litigation-related losses, with total estimated losses narrowing to $2,461 million—a reduction of $208 million—indicating partial resolution or stabilization of litigation risks. This decline aligns with the restructuring of GE's financial services operations, as noted in Chunk 1, which acknowledges potential contingent liabilities but emphasizes strategic options to mitigate ongoing exposures. Concurrently, Chunk 2 confirms that $1,324 million in cash and equivalents were held for Bank BPH as of December 31, 2024, reflecting continued operational linkage despite asset disposals like the sale of GE HealthCare equity. Critically, the valuation allowance now \"completely offsets the financing receivables balance\" as of 2024 (Chunk 2), signaling a more conservative valuation approach that fully absorbs potential losses, whereas prior periods showed residual exposure. This evolution underscores a deliberate reduction in GE's direct financial risk to Bank BPH, driven by litigation settlements and allowance adjustments, though regulatory or market shocks could still materially impact future liabilities, as cautioned in Chunk 1's forward-looking disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> Bank BPH (COMP)",
        "Bank BPH (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7452,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2498,
        "completion_tokens": 414,
        "total_tokens": 2913
      }
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "HD's Indoor Garden product line has evolved from a standalone merchandising category in 2022 to being classified under the Hardlines department in 2024, reflecting a strategic repositioning within HD's product portfolio. While its financial contribution remained strong—accounting for 10.3% of net sales ($15,546 million) in 2022 and continuing growth through $14,649 million in 2021 ($11,261 million in 2020)—its categorization shifted from being grouped with Décor/Storage in 2022 to being explicitly included in the Hardlines department alongside Outdoor Garden, Power, and Storage & Organization in 2024, indicating a more distinct business unit focus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "HD (ORG) -> Indoor Garden (PRODUCT)",
        "Indoor Garden (PRODUCT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2755,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 164,
        "total_tokens": 1499
      }
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive has evolved its sourcing strategies from primarily relying on commodity hedging contracts to a more diversified approach that emphasizes cost efficiencies, productivity initiatives, and limited hedging to manage commodity price volatility, as evidenced by its 2024 disclosure that it now manages exposure through sourcing strategies, ongoing productivity initiatives, and the limited use of commodity hedging contracts rather than direct hedging of commodity costs. While the company previously faced significant inflationary pressure from raw material commodities like resins and tropical oils, its 2024 strategy explicitly integrates sourcing strategies as a core component of its \"funding-the-growth initiatives\" to offset cost increases, acknowledging that while commodity prices have retreated from peaks, they remain subject to future inflationary pressure from geopolitical conflicts and climatic events, requiring continuous adjustment of pricing and cost management tactics to protect margins.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Utilizes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "CL (ORG) -> Sourcing Strategies (ACCOUNTING_POLICY)",
        "Sourcing Strategies (ACCOUNTING_POLICY) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9301,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2974,
        "completion_tokens": 259,
        "total_tokens": 3234
      }
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "The sales of TREMFYA grew by 16.6% from $3,147 million in 2023 to $3,670 million in 2024, driven by market growth, continued strength in psoriasis and psoriatic arthritis, and a favorable patient mix (Chunk 1). This increase contributed to the overall Immunology portfolio rise of 0.4% and helped offset declines in other therapeutic areas, while the company’s biosimilar settlements and competition for infliximab and STELARA are expected to shape future sales dynamics (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> TREMFYA (PRODUCT)",
        "TREMFYA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8776,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2817,
        "completion_tokens": 120,
        "total_tokens": 2937
      }
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E shifted from a 50% ownership stake in A+E Networks (including A&E, HISTORY, and Lifetime) to reporting subscriber data separately for General Entertainment (240 million) and Family (200 million) channels, while the equity investment in A+E is now disclosed only as “Equity in the income of investees” on the consolidated income statement. Consequently, Disney no longer consolidates A+E’s subscriber counts in its core reporting, instead presenting them as part of internal management estimates for its own channel groups, and its financial stake in the partnership is reflected only through the equity‑in‑income line item rather than through direct subscriber figures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> A&E (COMP)",
        "A&E (COMP) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2356,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 181,
        "total_tokens": 1403
      }
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "The financial impact of GE's relationship with AerCap evolved significantly between 2023 and 2024, with realized and unrealized gains and losses directly tied to their investment stake. In 2023, GE reported a realized and unrealized gain of $129 million on its AerCap investment (up from a $865 million loss in 2022), while 2024 saw a substantial decline in gains on retained and sold ownership interests—specifically a $5.2 billion decrease driven primarily by AerCap and GE HealthCare investments—contributing to a $2.5 billion drop in continuing earnings despite other offsetting factors. This shift reflects a marked deterioration in the financial performance of GE's AerCap stake, transitioning from modest gains in 2023 to a major headwind in 2024, as explicitly linked to the company's investment in AerCap within its broader portfolio of strategic holdings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> AerCap (COMP)",
        "AerCap (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2450,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 216,
        "total_tokens": 1460
      }
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Mastercard's multi-layered security approach has evolved between 2022 and 2024 through enhanced integration of third-party risk management into its core network architecture, particularly by incorporating technical standards development and real-time fraud intelligence from external partners into its security framework. This strategic evolution—evidenced by the company's expanded collaboration with issuers, acquirers, and industry associations to establish EMV standards and leverage the Mastercard Intelligence Center—demonstrates a proactive response to emerging cyber threats, shifting from reactive network protection to a comprehensive ecosystem-centric security model that treats third-party service providers as integral components of its security architecture rather than isolated risk vectors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG",
      "triplets_used": [
        "MA (ORG) -> Multi-Layered Security Approach (ACCOUNTING_POLICY)",
        "Multi-Layered Security Approach (ACCOUNTING_POLICY) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10718,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3363,
        "completion_tokens": 201,
        "total_tokens": 3564
      }
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Between 2022 and 2023, Target Corporation maintained compliance with its debt leverage covenant through both years, as explicitly stated in the 2022 and 2023 Form 10-K filings (Chunks 1 and 2), which confirm the company was \"in compliance with these covenants\" and expected to remain so. The evolution of its credit facilities—replacing a $2.5 billion facility expiring in October 2023 with a new $1.0 billion 364-day facility in October 2023 (Chunk 2) and extending its $3.0 billion five-year facility to October 2028—demonstrates proactive management of liquidity, though the covenant itself remained unchanged in structure and the company continued meeting it without disruption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Debt Leverage Covenant (REGULATORY_REQUIREMENT)",
        "Debt Leverage Covenant (REGULATORY_REQUIREMENT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6366,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2246,
        "completion_tokens": 170,
        "total_tokens": 2417
      }
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "The nature of risks tied to Salesforce’s AI offerings—including generative AI and Agentforce—has shifted from 2023 to 2024 from primarily reputational and brand‑related concerns tied to third‑party developer reliance and general social/ethical issues (as noted in the 2023 10‑K discussion of AI‑related reputational harm) to a more acute focus on the technical and regulatory challenges of AI development itself. In 2024 the company explicitly warns that rapid AI evolution brings emerging ethical issues, heightened governmental and regulatory scrutiny, potential legal liability, and costly investments in compliance, governance, proprietary data, and testing for accuracy, bias, toxicity and security; these factors can directly impair adoption, trigger brand or reputational harm, and increase operating expenses, thereby materially affecting the business’s financial condition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Sales Cloud (PRODUCT)",
        "Sales Cloud (PRODUCT) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13117,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3913,
        "completion_tokens": 220,
        "total_tokens": 4133
      }
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal years 2023 and 2024, Lowe's evolved its delivery capability for parcel-eligible items through targeted improvements in its supply chain infrastructure and geographic expansion. As explicitly detailed in both chunks, the company expanded its market-based delivery model to additional geographic areas in 2024 (building on the 16 areas converted by fiscal 2023), enhanced distribution capacity for big and bulky products, and specifically accelerated parcel delivery speed—most parcel-eligible items now deliver within two business days or less at standard rates, with nationwide same-day delivery expansion via its gig provider network and next-day delivery for major appliances in nearly all U.S. zip codes. This evolution was enabled by the continued operation of its Total Home strategy, which relies on its network of over 120 supply chain facilities (including RDCs, FDCs, IDCs, BDCs, XDTs, and FCs), where Fulfillment Centers directly ship products to customers and the Pro fulfillment network handles larger orders, directly supporting the omnichannel customer experience described in both documents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Delivers]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Parcel-Eligible Items (PRODUCT)",
        "Parcel-Eligible Items (PRODUCT) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9879,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3107,
        "completion_tokens": 280,
        "total_tokens": 3388
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The financial impact of the Dermstore LLC sale on Target's consolidated revenues and operating income remained minimal and consistent from 2022 to 2023, as Dermstore represented less than 1 percent of consolidated revenues, operating income, and net assets at the time of its February 2021 sale (TGT_10k_2022.pdf, page 21; TGT_10k_2023.pdf, page 24). While Target recognized a $335 million pretax gain from the sale in 2021, this item was excluded from subsequent period analyses, and no further financial impact from the transaction was material to consolidated results in 2022 or 2023, with operating performance instead shaped by broader trends such as discretionary sales declines, freight cost reductions, and inventory management strategies (TGT_10k_2023.pdf, page 24; Chunk 2 analysis).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Dermstore LLC (COMP)",
        "Dermstore LLC (COMP) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4496,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1755,
        "completion_tokens": 198,
        "total_tokens": 1953
      }
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "The strategic positioning of Data Cloud has evolved from being a foundational data engine within Salesforce's Customer 360 suite in 2023 to a central, cross-offering capability that unifies and activates enterprise data across all Salesforce services—including Marketing, Commerce, Slack, and AI-driven workflows—while increasingly serving as a competitive differentiator in a crowded enterprise applications market where Data Cloud enables actionable, 360-degree customer insights that power personalized engagement and AI innovation, thereby strengthening Salesforce's integrated platform strategy amid intensifying competition from both established and emerging players in cloud services, productivity tools, and AI-enhanced solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Data Cloud (PRODUCT)",
        "Data Cloud (PRODUCT) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11885,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3614,
        "completion_tokens": 184,
        "total_tokens": 3798
      }
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, Lowe's treatment of forward interest rate swap contracts maintained consistent hedge accounting frameworks but shifted designation focus: in 2023, swaps were designated as cash flow hedges with gains/losses recorded in other comprehensive income and earnings (per 2023 10-K Note 3), while in 2024 they were explicitly accounted for as fair value hedges using the shortcut method, where derivative fair value changes offset hedged debt fair value changes with no net earnings impact (per 2024 10-K Note 3). Both years utilized identical notional amounts ($2.0B for 2023 Notes, $1.5B for 2022 Notes, $1.3B for 2022 Notes) and received comparable swap payments ($247M, $143M, $136M respectively), but the 2024 disclosure clarifies that hedge effectiveness is now assumed perfect under fair value hedge accounting, eliminating net earnings volatility from derivative valuations while preserving the same cash flow hedging disclosures for matured/outstanding contracts across both periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Settles]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Forward Interest Rate Swap Contracts (FIN_INST)",
        "Forward Interest Rate Swap Contracts (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2763,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 251,
        "total_tokens": 1595
      }
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "Target's owned brands strategy evolved from 2022 to 2023 by deepening portfolio emphasis on owned and exclusive brands as a core differentiator, with strategic objectives explicitly linking brand expansion to growth drivers like traffic, sales, and market share. The 2023 strategy explicitly states that strengthening owned brands portfolio, curating national brands, and expanding signature partnerships are central to delighting guests with newness, style, and value—directly building on the 2022 foundation where owned brands constituted approximately one-third of sales, as documented in Chunk 1's detailed brand list (including categories like A New Day™, Goodfellow & Co™, and exclusive beverage lines like California Roots™). This evolution is further reinforced by the 2023 strategy's focus on leveraging stores as fulfillment hubs (fulfilling over 96% of sales) and expanding capabilities like Roundel advertising, ensuring the owned brands strategy remains tightly integrated with Target's broader mission of being a \"favorite discovery destination\" through seamless omnichannel experiences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Expands]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Owned Brands (PRODUCT)",
        "Owned Brands (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5908,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2110,
        "completion_tokens": 275,
        "total_tokens": 2385
      }
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM evolved its software-enabled services from a foundational offering (highlighted in 2022's Note 1 as part of its broader AV and software-enabled services strategy) to a more integrated, scalable platform centered on its end-to-end software architecture. This is evidenced by the 2023 disclosure of a dedicated software platform enabling over-the-air updates, Super Cruise hands-free driving on 400,000+ miles of roads, and expanded features like security, climate control, and EV ownership experiences—deployed initially in 2024 models like the Cadillac LYRIQ and Chevrolet Silverado EV and rolling out across most vehicles. Concurrently, GM advanced its infrastructure strategy through the Cruise joint venture's safety pause and regulatory challenges, while simultaneously investing in scalable digital services via OnStar's global ecosystem (now in 15 markets) and the development of a 30,000-charger North American charging network through a new automaker collaboration. This progression demonstrates a clear strategic pivot toward embedding software as a core revenue driver, with deliberate investments in scalable, updatable platforms rather than standalone features, signaling GM's commitment to building a sustainable, software-defined vehicle ecosystem that supports long-term digital monetization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GM (ORG) -> Software-Enabled Services (PRODUCT)",
        "Software-Enabled Services (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9857,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3126,
        "completion_tokens": 332,
        "total_tokens": 3458
      }
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category grew from $75 million in fiscal 2022 to $80 million in fiscal 2023, reflecting a 14% increase driven by growth in ThousandEyes and related monitoring and analytics offerings, and then accelerated to $176 million in fiscal 2024, representing a 27% rise fueled by continued expansion of the ThousandEyes offering and contributions from the broader Observability suite.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> ThousandEyes (PRODUCT)",
        "ThousandEyes (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3849,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 121,
        "total_tokens": 1723
      }
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "The treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolved from explicit disclosure in the 2023 10-K (Chunk 1, page 104) as Amendment No. 4 to the Executive Severance Plan, referenced as part of the company's accounting policy framework, to its reclassification as Amendment No. 2 in the 2024 10-K (Chunk 2, page 105), where it is grouped with earlier amendments (Amendments No. 2 and No. 3) rather than highlighted as a distinct update. This shift indicates a strategic refinement in disclosure focus—from emphasizing the specific amendment (as in 2023) to integrating it within a broader sequence of plan modifications (as in 2024), reflecting a more consolidated approach to reporting executive compensation governance while maintaining full transparency through continued incorporation by reference to prior filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Amendment No. 4 to Executive Severance Plan (ACCOUNTING_POLICY)",
        "Amendment No. 4 to Executive Severance Plan (ACCOUNTING_POLICY) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10707,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3352,
        "completion_tokens": 212,
        "total_tokens": 3565
      }
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "JPMorgan's compliance with capital ratio requirements evolved significantly from 2023 to 2024, particularly in its leverage and CET1 capital ratios. In 2023, the company maintained a CET1 capital ratio of 15.0% and a Tier 1 capital ratio of 16.6%, with a Tier 1 leverage ratio of 7.2% (as reported in the 2023 10-K filing). By the end of 2024, the Standardized CET1 capital ratio remained at 15.0%, but the Tier 1 leverage ratio improved to 7.2% (up from 7.2% in the prior period, though the 2023 figure was also 7.2%—indicating stability in this metric), while the leverage-based requirement increased to 4.0% from 4.0% (no change in the threshold). The 2024 filing also shows a higher Tier 1 leverage ratio of 7.2% compared to the 2023 reported 7.2% (consistent but with stronger capital buffers), and the company continues to comfortably exceed regulatory requirements, with the leverage ratio well above the 4.0% minimum. Overall, JPMorgan maintained robust capital ratios, with its CET1 ratio holding steady at 15.0% and leverage ratio improving in absolute terms (though the ratio itself remained unchanged), reflecting sustained compliance and capital strength.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Capital Ratio Requirements (REGULATORY_REQUIREMENT)",
        "Capital Ratio Requirements (REGULATORY_REQUIREMENT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3176,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 292,
        "total_tokens": 1746
      }
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial's role evolved from being presented as a distinct segment within GM's consolidated financial statements to being formally integrated under the \"GM Financial\" segment designation in Note 1 of the 2023 filing, while maintaining its core function of providing automotive financing services through the same centralized structure. The 2023 Note 1 explicitly states that GM Financial's reported amounts are \"adjusted to reflect the impact on GM Financial's deferred tax positions and provision for income taxes resulting from the inclusion of GM Financial in our consolidated tax return and to eliminate the effect of transactions between GM Financial and other members of the consolidated group,\" confirming its continued operation as a dedicated financing segment now fully consolidated within GM's reporting structure. This integration is underscored by the consistent KG pattern of \"GM Financial\" (ORG) being connected to \"Automotive Financing Services\" (PRODUCT) through the \"Provides\" relationship, with both entities remaining central to GM's operational and financial presentation across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "GM (ORG) -> Automotive Financing Services (PRODUCT)",
        "Automotive Financing Services (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7712,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2584,
        "completion_tokens": 284,
        "total_tokens": 2868
      }
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "The treatment and disclosure of step-rent provisions in lease accounting have evolved between 2022 and 2024 in how periodic rent increases based on price indices or sales volume are recognized. Both the 2022 and 2024 filings (COST_10k_2022.pdf and COST_10k_2024.pdf) state that step-rent provisions, including those tied to price indices or sales volume, are recognized on a straight-line basis over the lease term and any extension options when reasonably certain of exercise, with such variable increases classified as variable lease payments (Chunks 1 and 2). This consistent accounting approach reflects ongoing adherence to ASC 842 principles, where the Company evaluates lease modifications and variable payments but maintains straight-line recognition for step-rent features tied to measurable factors like inflation or sales, ensuring comparability and transparency in financial reporting across the period (Chunks 1 and 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "COST (ORG) -> Step-Rent Provisions (ACCOUNTING_POLICY)",
        "Step-Rent Provisions (ACCOUNTING_POLICY) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6525,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2296,
        "completion_tokens": 233,
        "total_tokens": 2529
      }
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "The projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show an increase from $1,790 million in 2024 (Chunk 1) to $1,800 million expected to be paid in 2025 (Chunk 2), with long-term obligations aggregating $10,020 million over 2029-2033 (Chunk 1) and $9,990 million over 2030-2034 (Chunk 2). These amounts reflect the company's disclosed accounting policy for pension funding, where the projected payment schedule demonstrates a modest annual increase in near-term obligations ($1,790M → $1,800M for 2025) while the long-term aggregate decreases slightly ($10,020M → $9,990M) due to differing multi-year horizon calculations across the filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Increases]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Qualified defined benefit pension plans (ACCOUNTING_POLICY)",
        "Qualified defined benefit pension plans (ACCOUNTING_POLICY) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 976,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 924,
        "completion_tokens": 171,
        "total_tokens": 1095
      }
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "JPMorgan Chase's disclosures on resolution plan obligations and liquidity risk management show a clear evolution between 2023 and 2024, particularly in how it frames funding cost pressures and regulatory compliance. In both filings, the company consistently links its liquidity strategy to resolution plan obligations—highlighting that actions to meet regulatory requirements (such as pre-positioning liquidity in subsidiaries or satisfying coverage ratios) directly influence funding costs, with alternative sources becoming more expensive if stable funding declines. Critically, the 2024 filing expands on this by detailing how market stress or regulatory shifts could force reliance on costlier funding, while also emphasizing that credit rating downgrades (which could trigger higher funding costs) are monitored but not guaranteed, reflecting an evolved awareness of external risks. Furthermore, the 2024 text explicitly connects liquidity constraints to broader resolution plan obligations, noting that failure to manage liquidity could necessitate earlier resolution proceedings due to capital and liquidity thresholds at subsidiaries like the IHC, thereby tying funding cost considerations directly to the company’s ability to meet its regulatory commitments across jurisdictions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Resolution Plan Obligations (REGULATORY_REQUIREMENT)",
        "Resolution Plan Obligations (REGULATORY_REQUIREMENT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10270,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3238,
        "completion_tokens": 322,
        "total_tokens": 3560
      }
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Optum Rx's financial structure evolved significantly between 2022 and 2023, particularly in revenue recognition and accounts receivable. In 2023, Optum Rx recognized product revenue upon prescription dispensing through its contracted pharmacy network, while service revenue—including coordination of medical services and network access—was recognized over time as services were performed, reflecting a shift toward longer-term performance obligations. This evolution is underscored by the $11.8 billion in future revenue expected from remaining performance obligations (excluding short-term contracts), with approximately half to be recognized within the next three years, up from $7.1 billion in accounts receivable in 2022 to $8.6 billion in 2023, indicating growth in outstanding receivables tied to extended contractual arrangements. The absence of material bad-debt expenses and contract assets/liabilities further highlights the stability and predictability of these revenue streams under Optum's integrated pharmacy care model, which leverages UnitedHealthcare's extensive network and data analytics to manage costs and improve outcomes across its ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Controls]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Pharmacy Care Services (PRODUCT)",
        "Pharmacy Care Services (PRODUCT) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10403,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3245,
        "completion_tokens": 291,
        "total_tokens": 3536
      }
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "UPS's quantitative exposure to interest rate risk through Floating to Fixed Interest Rate Swaps has evolved significantly between 2022 and 2024, with the notional amount of such swaps decreasing substantially from $778 million in 2022 to $28 million in 2024, reflecting a strategic shift toward reducing reliance on floating-to-fixed hedges. This change aligns with the company's broader interest rate risk management approach, which involves using a combination of derivative instruments—including interest rate swaps designated as fair value or cash flow hedges—to manage the fixed and floating interest rate mix of its debt portfolio, as detailed in its 2024 risk management disclosures. The decline in Floating to Fixed swaps underscores a deliberate rebalancing of UPS's hedging strategy to better align with evolving market conditions and debt structure priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Designates]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Floating to Fixed Interest Rate Swaps (FIN_INST)",
        "Floating to Fixed Interest Rate Swaps (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_155",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4615,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1806,
        "completion_tokens": 217,
        "total_tokens": 2024
      }
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "GM's financial relationship with LG Energy Solution evolved significantly between 2022 and 2023 through both joint venture activities and recall-related costs. The two entities expanded their partnership with the creation of **Ultium Cells LLC**, an equally owned joint venture between GM and LG Energy Solution to mass-produce battery cells for GM's EVs at facilities in Lordstown, Ohio, Spring Hill, Tennessee, and Lansing, Michigan, with a fourth U.S. plant planned by mid-decade (Chunk 1). This collaboration became central to GM's EV strategy, directly supporting its goal of launching over 30 EVs globally by 2025 through the Ultium platform (Chunk 1). Concurrently, the financial impact of a major recall involving LG Energy Solution-supplied battery cells was substantial, with GM accruing **$2.6 billion** in total costs and recognizing **$1.6 billion in receivables** from LGES for reimbursement of recall expenses through December 31, 2023, while maintaining a remaining accrual of **$0.6 billion** for unresolved matters (Chunk 2). The recall, initially limited to 2017–2019 Bolt EVs but expanded to include 2022 model year vehicles and EUVs due to broader battery defect risks, underscored the financial interdependence between GM and LG Energy Solution, with LGES agreeing to cover certain costs amid ongoing regulatory and legal challenges (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Pays]- ORG",
      "triplets_used": [
        "GM (ORG) -> LG Energy Solution (COMP)",
        "LG Energy Solution (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11406,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3490,
        "completion_tokens": 341,
        "total_tokens": 3831
      }
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Observability product category grew from fiscal 2022 to fiscal 2023, increasing by $80 million (14%) as reported in fiscal 2023 versus fiscal 2022, and then accelerated to a $176 million (27%) rise in fiscal 2024 versus fiscal 2023, reflecting continued growth driven by ThousandEyes and the broader Observability suite. This upward trajectory underscores ThousandEyes’ expanding role in Cisco’s observability strategy, as highlighted by its inclusion in the Observability product category and its contribution to both the 14% and 27% revenue gains across the successive fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> ThousandEyes (PRODUCT)",
        "ThousandEyes (PRODUCT) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5925,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2112,
        "completion_tokens": 159,
        "total_tokens": 2271
      }
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS's relationship with the 7.620% Debentures has remained consistent in structure but evolved in disclosure detail between 2022 and 2024. The $276 million debentures, with a 2030 maturity, continue to be redeemable at UPS's option with a redemption price based on the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus 5 basis points, and interest remains payable semi-annually in April and October without sinking fund requirements. This redemption framework and interest payment structure, first noted in the 2022 filing (Chunk 1), was reaffirmed in the 2024 filing (Chunk 2) with updated context on callable features for other debt instruments, confirming no changes to the core terms while maintaining the same interest payment schedule and redemption mechanics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Pays_Interest_On]- ORG",
      "triplets_used": [
        "UPS (ORG) -> 7.620% Debentures (FIN_INST)",
        "7.620% Debentures (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9242,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2951,
        "completion_tokens": 212,
        "total_tokens": 3163
      }
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the composition of MET's Fixed Maturity Securities AFS shifted toward greater corporate and foreign bond exposure while U.S. government bond holdings remained relatively stable at $1,537 million in fair value (reported in Level 1 of the hierarchy). Total AFS fair value increased significantly from $2,164 million to $6,714 million, with corporate securities rising from $3,029 million to $3,083 million (though this appears inconsistent with the total breakdown) and foreign bonds growing from $810 million to $810 million (no change), while U.S. government bonds maintained $1,575 million in fair value. The total fair value of AFS securities grew from $2,164 million to $6,714 million, reflecting a substantial expansion in the portfolio, particularly in corporate and foreign bond categories, though the specific evolution of U.S. government bonds remained a consistent component at approximately $1,575 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Fixed Maturity Securities AFS (FIN_INST)",
        "Fixed Maturity Securities AFS (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8023,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2660,
        "completion_tokens": 235,
        "total_tokens": 2896
      }
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "From 2022 to 2023, General Motors' financial involvement with Ultium Cells LLC deepened through a $0.5 million investment recorded in its 2022 investing activities (Chunk 1), while regulatory scrutiny introduced significant implications: in February 2023, GM self-disclosed potential TSCA violations related to Ultium Cells LLC's chemical imports, leading to a settled EPA consent agreement in November 2023 requiring joint payment of approximately $5.1 million in civil penalties (Chunk 2). This regulatory matter, tied to GM's ownership stake in the joint venture, underscores how evolving compliance obligations directly impact GM's financial exposure and governance of the partnership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "GM (ORG) -> Ultium Cells LLC (COMP)",
        "Ultium Cells LLC (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4665,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1804,
        "completion_tokens": 172,
        "total_tokens": 1976
      }
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "The company's use of variable-priced contracts for natural gas and fuel purchases has evolved from being explicitly described in 2022 as meeting the characteristics of derivative instruments but qualifying for the \"normal purchases and normal sales\" exception (requiring no mark-to-market adjustments) to being referenced in 2024 as continuing to meet those characteristics under the same exception framework, with no indication of change in treatment. This consistent application across both years confirms a sustained reliance on index-based variable pricing for natural gas and fuel, primarily to mitigate energy price fluctuations while maintaining accounting simplicity through the normal purchases exception, as evidenced by the identical disclosure structure in both 2022 and 2024 filings regarding these contracts' classification and accounting treatment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "COST (ORG) -> Variable-Priced Contracts (FIN_INST)",
        "Variable-Priced Contracts (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9576,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3028,
        "completion_tokens": 215,
        "total_tokens": 3244
      }
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and fiscal 2023, continuing to exclude the same set of expenses from segment performance measurement. Both years' disclosures explicitly state that research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation, significant litigation settlements, asset impairment and restructuring charges, and certain other charges are not allocated to segments or included in gross margin calculations for performance measurement, as reflected in the internal management system used by the CODM.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> APJC (GPE)",
        "APJC (GPE) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3070,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 174,
        "total_tokens": 1585
      }
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "UNH's approach to managing medical cost trends evolved from 2022 to 2023 by shifting from broad risk-based cost management (emphasizing 80-85% premium utilization for care costs in risk products) to targeted strategies addressing rising outpatient procedure costs for seniors, as noted in Chunk 2's focus on \"increased care patterns, primarily related to outpatient procedures for seniors\" and efforts to \"engage physicians and consumers with information to help them make clinically sound choices.\" This evolution is further contextualized by Chunk 1's warning about \"increased medical care costs as people seek care which was deferred during the pandemic\" and the need to \"predict, price for and effectively manage medical costs\" to protect risk-based product profitability, while Chunk 2 details specific mitigation tactics like value-based care models, integrated care coordination technology, and physician engagement to improve outcomes and reduce costs in this high-growth area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Guides_On]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Medical Cost Management (PRODUCT)",
        "Medical Cost Management (PRODUCT) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10678,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3316,
        "completion_tokens": 246,
        "total_tokens": 3562
      }
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "UPS has strategically expanded and refined its time-definite delivery services between 2022 and 2024 by deepening integration across its global small package network while broadening service scope through supply chain solutions. The company enhanced its air and ground time-definite capabilities—including same-day, next-day, and three-day options in the U.S.—and strengthened international offerings like Worldwide Expedited and Express Freight, all managed through a unified global logistics network that optimizes asset utilization and reduces environmental impact. A pivotal 2024 development was the insourcing of UPS SurePost final delivery (previously handled by USPS), reflecting a strategic move to gain greater control over service quality and network cohesion, while divesting non-core segments like Coyote brokerage to sharpen focus on integrated logistics and forwarding services that support end-to-end supply chain solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Time-Definite Delivery (PRODUCT)",
        "Time-Definite Delivery (PRODUCT) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8448,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2751,
        "completion_tokens": 234,
        "total_tokens": 2986
      }
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "Based on the complete analysis of both 10-K filings and their corresponding supplemental indentures, Lowe's Companies, Inc.'s treatment of its 2.50% Notes maturing in April 2026 remained consistently recognized and referenced throughout both the 2022 and 2023 annual filings. The 2022 filing (Chunk 1) explicitly documents the 2.50% Notes as part of the Thirteenth Supplemental Indenture dated April 20, 2016 (Exhibit 4.14), while the 2023 filing (Chunk 2) similarly includes this same indenture (Exhibit 4.14) as part of its exhibit list, confirming ongoing legal and structural continuity. This consistent inclusion across both filings demonstrates that Lowe's maintained the same formal recognition and documentation of these notes without any material change in treatment or acknowledgment between the two reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues]- ORG",
      "triplets_used": [
        "LOW (ORG) -> 2.50% Notes (FIN_INST)",
        "2.50% Notes (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10519,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3264,
        "completion_tokens": 207,
        "total_tokens": 3471
      }
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "From 2022 to 2024, sovereign debt crises have increasingly pressured Costco’s merchandise sourcing and cost structure through heightened tariff exposure and inflationary cost pressures, as documented across both filings. While 2022 highlighted volatility in commodity prices and tariff impacts on key markets like China and the U.S., the 2024 filing explicitly expands this risk to include sovereign debt crises as a direct macroeconomic driver affecting inventory costs and pricing strategy—evidenced by the repeated linkage of \"sovereign debt crises\" to \"impact the cost of or ability to purchase inventory\" and \"adversely affect our results\" in both documents. This evolution reflects a deepening integration of sovereign debt risks into Costco’s supply chain vulnerability, where rising debt-related economic instability now compounds inflationary pressures on commodities like gasoline and consumables, forcing tighter cost management and limiting pricing flexibility without risking demand erosion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> MACRO_CONDITION <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "COST (ORG) -> Sovereign Debt Crises (MACRO_CONDITION)",
        "Sovereign Debt Crises (MACRO_CONDITION) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9275,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2960,
        "completion_tokens": 251,
        "total_tokens": 3211
      }
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "Between 2021 and 2023, the shares available for future grants under the 2020 Stock Incentive Plan increased from 64 million to 53 million (as reported in 2021) and then to 53 million shares available as of December 31, 2023 (Chunk 2), while the ESPP reserves also grew from 18 million shares in 2021 to 17 million shares available for future issuance in 2023 (though this reflects a slight reduction in ESPP reserves despite overall plan expansion). This indicates UnitedHealth Group maintains significant capacity for issuing new share-based awards, with the 2020 Stock Incentive Plan providing 53 million shares for future grants as of 2023, supporting ongoing equity compensation programs despite modest fluctuations in available reserves across the reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNH (ORG) -> 2020 Stock Incentive Plan (ACCOUNTING_POLICY)",
        "2020 Stock Incentive Plan (ACCOUNTING_POLICY) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2839,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 192,
        "total_tokens": 1570
      }
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "The IAM National Pension Fund / National Pension Plan relationship with UPS evolved from a 2023 expiration date in 2022 to a 2024 expiration date in 2024, and further extended to a 2029 expiration date in 2024, reflecting a multi-year extension of the collective bargaining agreement governing its participation. This progression demonstrates UPS's ongoing contribution significance to the pension fund, as evidenced by its sustained role as a contributor while maintaining compliance with multiemployer plan requirements across all three years. The fund's status as a material participant is reinforced by UPS's consistent reporting of contributions exceeding 5% of total plan funding in each fiscal year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Contributes_To]- ORG",
      "triplets_used": [
        "UPS (ORG) -> IAM National Pension Fund / National Pension Plan (FIN_INST)",
        "IAM National Pension Fund / National Pension Plan (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3491,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 176,
        "total_tokens": 1708
      }
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "The terms and availability under LOW's credit agreements evolved significantly between fiscal years 2022 and 2023, with the 2020 Credit Agreement being amended and restated in September 2023 to extend its maturity from March 2025 to September 2028 and maintain $2.0 billion aggregate availability, while the Third Amended and Restated Credit Agreement (entered into in December 2021) was also extended to September 2026 with $2.0 billion availability, and both agreements collectively supported a $4.0 billion combined availability as of February 2, 2024, with the Company retaining flexibility to increase this by an additional $1.0 billion subject to lender commitments and conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST <-[Amends]- ORG",
      "triplets_used": [
        "LOW (ORG) -> 2020 Credit Agreement (FIN_INST)",
        "2020 Credit Agreement (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4850,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1842,
        "completion_tokens": 171,
        "total_tokens": 2014
      }
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's notional amounts for Net Investment Hedge Derivative Contracts increased significantly, rising from $3,915 million (2021) to $8,647 million (2024), reflecting a substantial expansion in hedging activity. This growth is further supported by the inclusion of non-U.S. dollar debt designated as net investment hedges, where MDLZ increased its Euro notes notional from $3,622 million (2021) to $3,298 million (2024) and notably expanded Swiss franc notes from $811 million (2021) to $220 million (2024), while Canadian dollar notes remained relatively stable at $475 million (2021) and $869 million (2024). The KG pattern ORG-MDLZ → FIN_INST-Net Investment Hedge Derivative Contracts → ORG-MDLZ confirms the direct disclosure relationship, and the \"Increases\" connection between 2022 and 2024 underscores the upward trajectory in notional amounts across all hedge categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Net Investment Hedge Derivative Contracts (FIN_INST)",
        "Net Investment Hedge Derivative Contracts (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4419,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1753,
        "completion_tokens": 225,
        "total_tokens": 1978
      }
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Microsoft 365's integration with AI evolved from AI-backed capabilities in 2022 to a dedicated AI-first platform by 2024, with **Copilot for Microsoft 365** introduced as a core capability to combine AI with business data in Microsoft Graph and applications. In 2024, Microsoft launched **Copilot Pro** (a consumer subscription for faster, more powerful AI assistance), **Copilot Studio** (enabling customization of Copilot for Microsoft 365 or building custom Copilots), and **role-specific Copilots** (Copilot for Sales, Service, and Finance) to streamline workflows across business functions. These innovations, alongside Dynamics 365 and Power Platform enhancements, cemented Microsoft 365's role in boosting productivity and collaboration through AI-driven automation, insights, and personalized work experiences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Microsoft 365 (PRODUCT)",
        "Microsoft 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8721,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2829,
        "completion_tokens": 204,
        "total_tokens": 3034
      }
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "3M's approach to characterizing PFAS discharge at its Decatur, Alabama facility has evolved significantly between 2022 and 2024, reflecting deeper regulatory engagement and operational adjustments. In 2022, as documented in the 10-K, the Company acknowledged incomplete characterization of PFAS discharges in its NPDES permit, leading to the temporary idling of certain processes in September 2019 and the submission of an application to add unpermitted PFAS to its permit—though ADEM had not acted on this request by 2024. By 2024, the Company continued working with ADEM on this application while simultaneously navigating a grand jury subpoena related to compliance with the 2009 TSCA consent order and unpermitted discharges, underscoring ongoing regulatory scrutiny. Additionally, the 2024 disclosure of a grand jury subpoena and continued cooperation with federal authorities (as detailed in Chunk 2) confirms that the evolution involves not just technical remediation—such as installing and optimizing wastewater treatment controls—but also expanded legal and investigative dimensions, including EPA information requests and enforcement actions tied to both historical and evolving discharge characterization efforts. This progression illustrates a shift from initial remediation and disclosure (2022) to sustained regulatory dialogue and process modification (2024), with all actions rooted in the KG pattern of ORG disclosing RISK_FACTOR to address PFAS discharge characterization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discovers]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> PFAS Discharge (RISK_FACTOR)",
        "PFAS Discharge (RISK_FACTOR) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11709,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3568,
        "completion_tokens": 372,
        "total_tokens": 3940
      }
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe's Companies, Inc. issued its 4.550% Notes through the **Fifteenth Supplemental Indenture** (dated April 5, 2019), as documented in both 2022 and 2023 10-K filings (Chunk 1, Exhibit 4.16; Chunk 2, Exhibit 4.16), which established the $4.550\\%$ Notes due April 5, 2049 as a formal debt instrument under the trustee arrangement with U.S. Bank National Association. This issuance remained a consistent, long-term financing mechanism throughout 2022–2023, with no subsequent supplemental indentures modifying the 4.550% Notes' terms during this period, as evidenced by the unchanged Exhibit 4.16 references in both annual filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues]- ORG",
      "triplets_used": [
        "LOW (ORG) -> 4.550% Notes (FIN_INST)",
        "4.550% Notes (FIN_INST) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10519,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3250,
        "completion_tokens": 157,
        "total_tokens": 3407
      }
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Based on the provided information across all chunks and KG triplets, MDLZ's financial relationship with KDP evolved significantly between 2022 and 2024 through changes in accounting treatment and strategic equity transactions. The KG pattern shows mutual investment relationships (ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG) between MDLZ and KDP, with the critical evolution centered on MDLZ's shift from equity method accounting to recognizing gains on marketable securities. \n\nChunk 1 reveals that MDLZ initially held a 13.1% stake in KDP after a 2020 secondary offering, later reducing its stake in JDE Peet's (a related entity) to 22.9% through share sales, while maintaining significant influence and continuing equity method accounting for JDE Peet's. Crucially, Chunk 2 explicitly states that prior to the accounting change, MDLZ recorded a pre-tax gain of $493 million ($368 million after-tax) during 2023 from equity method transactions involving KDP, and that \"gain on marketable securities sold during the period reflects the difference between the sale proceeds and the carrying value of the equity securities at the date of the change of accounting for our investment in KDP.\" This indicates a fundamental shift in 2023 where MDLZ changed its accounting approach for the KDP investment, moving from equity method recognition to treating the investment as marketable securities, thereby recognizing gains based on fair value changes rather than equity method earnings. The $493 million gain in 2023 represents the cumulative effect of this accounting change, directly answering how the financial relationship evolved—specifically, the gains recognized from the change in accounting treatment for the KDP investment were a direct result of this strategic shift in how MDLZ accounted for its stake, transitioning from traditional equity method gains to gains on marketable securities sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> KDP (COMP)",
        "KDP (COMP) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5859,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2098,
        "completion_tokens": 476,
        "total_tokens": 2574
      }
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Microsoft's Xbox Game Pass has evolved significantly in scale and strategic positioning between 2022 and 2024, with its library expanding from \"over 100 first- and third-party console and PC titles\" (Chunk 1, 2022) to \"over 400 first- and third-party console and PC titles\" (Chunk 2, 2024), reflecting a substantial increase in available content. This growth is underpinned by Microsoft's strategic emphasis on expanding its gaming ecosystem through content acquisition (including Activision Blizzard), cloud gaming integration, and platform diversification across subscriptions, ads, and multiple devices, as highlighted in both chunks' descriptions of its \"curated library\" and \"expanding to new ecosystems\" strategy. The service's positioning has shifted from a community-focused offering to a core pillar of Microsoft's broader \"intelligent solutions\" and \"new gaming experiences\" agenda, explicitly tied to driving engagement with Windows, Microsoft 365, and cloud services, while competing directly with Sony, Nintendo, and major streaming platforms through its unique hardware-software-cloud integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Xbox Game Pass (PRODUCT)",
        "Xbox Game Pass (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9416,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2992,
        "completion_tokens": 277,
        "total_tokens": 3270
      }
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "The structure and disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan have remained consistent in format and incorporation method from 2022 to 2024, as evidenced by the unchanged reference language in both the 2022 and 2024 filings. Specifically, the 2022 filing (Chunk 1) discloses the agreement as incorporated by reference from the Form 10-K for the year ended December 31, 2018 (Item 10.8)*, while the 2024 filing (Chunk 2) maintains identical disclosure language but updates the plan amendment reference to May 8, 2023, and retains the same incorporation by reference from the Form 10-K for the year ended December 31, 2018 (Item 10.7)*, demonstrating continuity in regulatory disclosure practices without structural changes to the agreement's presentation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Deferred Stock Unit Award Agreement (FIN_INST)",
        "Deferred Stock Unit Award Agreement (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4880,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1883,
        "completion_tokens": 209,
        "total_tokens": 2093
      }
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024, Charles Schwab Bank's First Mortgages and HELOCs portfolio experienced a modest shift in geographic concentration, with California exposure declining slightly from 43% to 42% of the portfolio, while origination costs increased from $98 million to $100 million (reflecting higher direct origination expenses in 2024). The portfolio composition remained stable in performance and collateral structure, with both years showing no loans 90+ days past due and consistent pledging of the full loan balance to secure FHLB borrowing capacity under a blanket lien arrangement (as referenced in Notes 12 and 13).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> First Mortgages and HELOCs (FIN_INST)",
        "First Mortgages and HELOCs (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1664,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1072,
        "completion_tokens": 156,
        "total_tokens": 1229
      }
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Nike's strategic emphasis on Dri-FIT technology has evolved from being highlighted as a key innovation within its broader product research and development framework in fiscal 2023 to maintaining its prominence as part of a diversified portfolio of performance technologies—including Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React—in fiscal 2024. Both the 2023 and 2024 10-K filings underscore Dri-FIT's role in enhancing athletic performance, reducing injury, and maximizing comfort, while simultaneously emphasizing sustainability and global compliance in manufacturing. The consistent language across both filings, particularly in the product research and development sections, reflects a strategic continuity in leveraging Dri-FIT not as an isolated technology but as a foundational element integrated across categories and consumer applications, supported by extensive athlete testing and market-driven innovation. This evolution illustrates Nike's sustained commitment to embedding advanced material science—exemplified by Dri-FIT—into its product ecosystem as a driver of competitive differentiation and consumer engagement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Expands]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Dri-FIT (PRODUCT)",
        "Dri-FIT (PRODUCT) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7317,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2468,
        "completion_tokens": 287,
        "total_tokens": 2755
      }
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has systematically strengthened its backup and disaster recovery capabilities from 2022 to 2024 in direct response to escalating cybersecurity threats, as evidenced by its explicit focus on \"backup and disaster recovery\" within its cybersecurity risk disclosures across both filings. The company has intensified investments in this area by enhancing identity and access management, implementing multi-factor authentication, deploying advanced threat protection against sophisticated state-sponsored actors, and maintaining 24/7 security operations to improve threat monitoring and detection—particularly within its manufacturing and operational technology environments—while acknowledging that these measures, though critical, cannot guarantee absolute protection against increasingly frequent and complex cyber incidents. This evolution reflects a strategic response to heightened threats amplified by remote work, geopolitical instability (such as the Ukraine conflict), and the growing reliance on third-party technology providers, as detailed in both the 2022 and 2024 SEC filings where cybersecurity risks are explicitly linked to potential disruptions in business operations, data integrity, and financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enhances]-> RISK_FACTOR <-[Invests_In]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Backup and Disaster Recovery (RISK_FACTOR)",
        "Backup and Disaster Recovery (RISK_FACTOR) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8590,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2797,
        "completion_tokens": 311,
        "total_tokens": 3109
      }
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft's financial commitment to Black and African American-owned suppliers has significantly evolved from fiscal year 2022 to 2024, demonstrating sustained and measurable investment through its supplier diversity initiatives. In FY2022, the company reported having reached \"more than 90 percent of [its] goal to spend $500 million with double the number of Black and African American-owned suppliers\" and had increased transaction volumes with Black- and African American-owned financial institutions, while also advancing its $150 million investment in Minority Depository Institutions to support small business access to capital. By FY2024, Microsoft not only **achieved its $500 million spending goal with double the number of Black- and African American-owned suppliers** but also expanded its impact through $150 million in commitments to Minority Depository Institutions, 162 low- or no-interest loans via the Partner Capital Fund, and continued growth in the Black Partner Growth Initiative—directly enabling increased capital deployment into local communities and small business development. This progression reflects a deepening of Microsoft's engagement, transitioning from progress toward targets in FY2022 to concrete achievement of its $500 million supplier spending goal and expanded financial mechanisms in FY2024, all while maintaining accountability through ongoing reporting on representation goals (e.g., doubling Black and African American leaders by 2025) and community investments like the $150 million in racial equity initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Black and African American-Owned Suppliers (COMP)",
        "Black and African American-Owned Suppliers (COMP) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9989,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3147,
        "completion_tokens": 389,
        "total_tokens": 3536
      }
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "From 2022 to 2023 the number of common shares reserved for future issuance under Abbott Laboratories’ Employee Stock Purchase Plan for Non‑U.S. Employees declined from **10,638,639 shares** (as reported in the 2022 filing for the 2021 baseline) to **8,565,087 shares** (as reported in the 2023 filing for the 2023 baseline). This reduction reflects a deliberate contraction of the pool of shares available for future issuance under the plan.  \n\nThe decline indicates that Abbott is tightening its stock‑based incentive strategy—shifting resources away from the non‑U.S. employee purchase program and likely toward other components of its broader incentive framework (e.g., the 2017 Incentive Stock Program) or to preserve capital for other corporate purposes. The shrinkage in the available share reserve underscores a more conservative approach to equity compensation for its international workforce over the past year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Reacquired Shares (FIN_INST)",
        "Reacquired Shares (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9557,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3050,
        "completion_tokens": 230,
        "total_tokens": 3280
      }
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Nike's treatment of Nike Air technology has evolved from a foundational innovation to a core pillar of its product development strategy, as evidenced by its continued emphasis on technical innovation in design and manufacturing processes across both fiscal years 2023 and 2024. The company explicitly highlights Nike Air, alongside other technologies like Zoom, Free, and React, as typifying its dedication to designing innovative products through market intelligence and research, while maintaining its strategic focus on leveraging such technologies to enhance athletic performance and meet consumer preferences. This evolution is underscored by the consistent inclusion of Nike Air in its portfolio of proprietary technologies across both years, reflecting its central role in Nike's innovation narrative and product differentiation strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Expands]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Nike Air (PRODUCT)",
        "Nike Air (PRODUCT) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7317,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2455,
        "completion_tokens": 211,
        "total_tokens": 2667
      }
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Abbott's positioning of Osmolite within its Nutritional Products segment shifted significantly between 2022 and 2023, with the 2023 filing explicitly listing Osmotite alongside other key enteral feeding products like Glucerna 1.2 Cal, Glucerna 1.5 Cal, Jevity, Oxepa, Freego™ (Enteral Pump), Nepro, and Vital as core components of its institutional-focused nutritional portfolio for healthcare settings. This evolution reflects a strategic consolidation and emphasis on Osmotite's role within Abbott's broader enteral feeding product line strategy, as evidenced by its consistent inclusion in the 2023 Nutritional Products segment description alongside other specialized enteral formulas, underscoring its continued importance in Abbott's institutional nutrition offerings despite the segment's overall focus on diverse product lines like infant formula, adult nutrition, and medical foods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Osmolite (PRODUCT)",
        "Osmolite (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3307,
        "completion_tokens": 222,
        "total_tokens": 3530
      }
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M's regulatory engagement and remediation obligations related to PFAS discharge have evolved significantly in both Minnesota and Alabama, with developments reflecting expanded regulatory scrutiny and evolving compliance requirements across both states.\n\nIn Minnesota, 3M continued implementing remediation under the 2007 Settlement Agreement and Consent Order (SACO) with the MPCA, addressing PFAS at Oakdale, Woodbury, and Cottage Grove sites. The company completed remediation work at Oakdale and Woodbury and maintained operational monitoring, while Cottage Grove saw ongoing upgrades, including a new wastewater treatment system and engagement with MPCA over increasingly stringent health-based values (HBVs) for PFOA and PFOS issued in January 2024 and proposed health risk limits (HRLs) in October 2024. MPCA enforcement actions intensified, including a 2023 Notice of Violation for stormwater discharges in Hutchinson and a July 2024 draft Clean Water Act permit with significantly revised PFAS effluent limits for Cottage Grove, which 3M actively commented on and is negotiating to avoid operational disruption.\n\nIn Alabama, the evolution centered on the July 2020 interim Consent Order with ADEM, which formalized obligations for ongoing PFAS-related wastewater and air emissions monitoring, studies, and potential capital improvements at the Decatur facility. This followed earlier disclosures in 2019–2020 about incorrect NPDES reporting and halted operations due to PFAS releases, with full process controls restored by July 2019. The interim Consent Order, building on the 2009 TSCA consent order, requires sustained compliance efforts, including off-site investigations and remediation studies, with potential for additional costs over multiple years as investigations progress. 3M’s engagement with EPA and ADEM underscores a long-term regulatory framework for managing PFAS discharge at both sites, with Minnesota focusing on site-specific remediation and permit updates, and Alabama emphasizing structured consent-based obligations for ongoing operational compliance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discovers]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "MMM (ORG) -> PFAS Discharge (RISK_FACTOR)",
        "PFAS Discharge (RISK_FACTOR) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12050,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3653,
        "completion_tokens": 527,
        "total_tokens": 4180
      }
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "The Coca-Cola Company's financial relationship with Coca-Cola HBC AG has evolved from a disclosed equity investment to a significant equity method investment, with its stake percentage declining from 22% in 2022 to 19% by 2024, reflecting a strategic reduction in ownership while maintaining substantial influence over the joint venture's financial reporting. This transition is underscored by Coca-Cola HBC AG's continued classification as an equity method investee in KO's 2024 disclosures, where the company's 19% stake (down from prior years) is explicitly detailed alongside other key equity investments like CCEP and Monster, and the $7,791 million valuation difference between carrying value and net assets highlights the material financial interdependence between the entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola HBC AG (COMP)",
        "Coca-Cola HBC AG (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_118",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5451,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2005,
        "completion_tokens": 196,
        "total_tokens": 2201
      }
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments has intensified through targeted product development investment and integrated deployment model architecture between fiscal 2022 and 2024, with $7.2 billion allocated to R&D in fiscal 2022 specifically to enhance hybrid-capable offerings like Oracle Cloud@Customer and OCI-powered SaaS applications that enable seamless workload mobility across environments. The company continues to prioritize interoperability and flexibility as core differentiators, embedding hybrid deployment capabilities directly into product design—evidenced by its $6.5 billion (2021) and $6.1 billion (2020) R&D investments—while maintaining strategic alignment with its three-business model (cloud and license, hardware, and services) to ensure consistent innovation across all deployment modes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Hybrid Deployments (PRODUCT)",
        "Hybrid Deployments (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9682,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3069,
        "completion_tokens": 205,
        "total_tokens": 3275
      }
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The Mandatory Clawback Policy filing status remained unchanged between the 2023 and 2024 SEC 10-K filings, as evidenced by its consistent presence in both Exhibit 97 across both documents. In the 2023 filing (Chunk 1), it was explicitly listed as \"Filed herewith\" (Exhibit 97), while in the 2024 filing (Chunk 2), it was referenced as \"Incorporated by reference to Exhibit 97 to the Company's Annual Report on Form 10-K for the year ended December 31, 2023,\" confirming its continued use and formal incorporation into the 2024 disclosure without modification to its core policy framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Files]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "WFC (ORG) -> Mandatory Clawback Policy (ACCOUNTING_POLICY)",
        "Mandatory Clawback Policy (ACCOUNTING_POLICY) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WFC_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12150,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3683,
        "completion_tokens": 147,
        "total_tokens": 3830
      }
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher's relationship with CorEvitas, LLC evolved from an acquisition in August 2023—when it purchased the company for $0.91 billion within the Laboratory Products and Biopharma Services segment—to a continued strategic partnership that is highlighted by ongoing investments and financial commitments in 2024.  The 2023 10‑K notes that the acquisition generated $0.91 billion of cash outflow and created non‑tax‑deductible goodwill, and the 2024 filing confirms that the company’s investing activities now include “purchases of $1.48 billion of property, plant and equipment” and that it expects net PP&E expenditures of $1.3‑$1.5 billion for the full year, indicating sustained capital deployment tied to the CorEvitas integration.  Financially, the deal also impacted financing activities: the 2023 filing shows $5.94 billion of senior‑note issuance and $3.00 billion of common‑stock repurchases (including $3.00 billion repurchased early in Q1 2024), while the 2024 filing notes that $1.00 billion remained available for future repurchases under the new $4.00 billion authorization, underscoring how the acquisition influenced capital‑allocation decisions and shareholder‑return policies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Acquires]- ORG",
      "triplets_used": [
        "TMO (ORG) -> CorEvitas, LLC (COMP)",
        "CorEvitas, LLC (COMP) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6525,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2267,
        "completion_tokens": 299,
        "total_tokens": 2567
      }
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce, which are payable through June 2027 for V2500-powered aircraft flight hours, evolved from being accrued as liabilities to being capitalized as collaboration intangible assets over time. In 2022, these payments were initially accounted for as part of contractual commitments reflected in \"Other commercial aerospace commitments\" and were planned to be capitalized as collaboration intangible assets as payments were made, with the timing and amount contingent on flight hours flown. By 2023, the same obligations continued to be tied to flight hours through June 2027, with payments still treated as capital expenditures under \"Other commercial aerospace commitments\" and recorded as collaboration intangible assets upon payment, maintaining the same capitalization treatment described in both years. The timing of these obligations remained tied to actual flight hours flown, with no indication of a change in the capitalization policy between 2022 and 2023—both years consistently describe capitalizing such payments as they are made under the 2012 agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reflects]-> FIN_INST <-[Pays]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Flight Hour Payments (FIN_INST)",
        "Flight Hour Payments (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5296,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1975,
        "completion_tokens": 285,
        "total_tokens": 2260
      }
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "From 2022 to 2024, The Coca-Cola Company's financial relationship with fairlife has evolved from an initial acquisition stake (as noted in the KG pattern where KO acquires COMP and COMP has stake in KO) to a contingent payment structure tied to performance milestones. Specifically, as disclosed in Chunk 2, the $4,766 million acquisition of fairlife in 2020 included a legally enforceable milestone payment contingent on fairlife achieving specific financial targets through 2024, with the final payment due in 2025. This contingent obligation—referenced in Chunk 2 as \"the fair value of the remaining milestone payment related to our acquisition of fairlife in 2020, which is contingent on fairlife achieving certain financial targets through 2024\"—represents the direct financial linkage between Coca-Cola and fairlife, evolving from the initial ownership stake into a performance-based settlement. While Chunk 1 details Coca-Cola's broader supply chain financing (SCF) programs and factoring activities, it does not reference fairlife specifically, confirming that the contingent payment is a distinct, milestone-driven obligation separate from Coca-Cola's standard supplier financing mechanisms. Thus, the financial relationship has transitioned from equity ownership to a milestone-triggered contingent payment obligation, with the 2024 timeline now concluding the performance period for this contingent liability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> fairlife (COMP)",
        "fairlife (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6724,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2316,
        "completion_tokens": 355,
        "total_tokens": 2671
      }
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Oracle's strategic positioning of Oracle Cloud Services has evolved from a standalone cloud offering to a deeply integrated platform that unifies enterprise applications with infrastructure technologies across hybrid and cloud-native deployment models. As documented in both filings, Oracle Cloud Services (OCI) now serves as the central delivery mechanism for its comprehensive portfolio, enabling customers to access the latest versions of SaaS and OCI offerings through flexible, interoperable models that include cloud-based, hybrid, and on-premise environments—directly supporting the company's acquisition strategy (e.g., Cerner) to expand and enhance its cloud and license business while maintaining enterprise-grade scalability and reliability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud Services (PRODUCT)",
        "Oracle Cloud Services (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9708,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3077,
        "completion_tokens": 188,
        "total_tokens": 3265
      }
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "Based on the comparative analysis of the 2023 and 2024 SEC filings, the Key/Specified Employee Policy (Exhibit 10(r)) maintains identical documentation and incorporation status across both filings. In both the 2023 WFC_10k_2023.pdf (page 17) and 2024 WFC_10k_2024.pdf (page 20), the policy is explicitly referenced as \"Incorporated by reference to Exhibit 10(v) to the Company's Annual Report on Form 10-K for the year ended December 31, 2018\" – demonstrating consistent archival linkage without any documented evolution, amendment, or procedural change in its treatment or status between the two filings. The KG triplet relationship (Key/Specified Employee Policy → WFC) remains unchanged, confirming the policy's persistent incorporation by reference to the 2018 filing in both documents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "WFC (ORG) -> Key/Specified Employee Policy (ACCOUNTING_POLICY)",
        "Key/Specified Employee Policy (ACCOUNTING_POLICY) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WFC_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15378,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4505,
        "completion_tokens": 197,
        "total_tokens": 4703
      }
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of RTX's 6.700% notes due 2028 remained unchanged at $285 million between 2022 and 2023, indicating a stable debt management strategy focused on maintaining consistent long-term financing without active repayment or refinancing of this specific tranche during the period. This stability reflects RTX's disciplined approach to managing its debt maturities, preserving liquidity while maintaining a balanced capital structure across its diverse debt instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 6.700% notes due 2028 (FIN_INST)",
        "6.700% notes due 2028 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3585,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 123,
        "total_tokens": 1663
      }
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "Based on the comparative data across both filings, TMO's 1.95% 12-Year Senior Notes due July 24, 2029 exhibited the following evolution between 2023 and 2024:  \n\n1. **Carrying value increased** from **$773 million** (as of December 31, 2023, per Chunk 1) to **$725 million** (as of December 31, 2024, per Chunk 2), reflecting amortization of the unamortized discount and debt issuance costs over the note's life.  \n2. **Effective interest rate rose** from **2.08%** (2023, Chunk 1) to **2.07%** (2024, Chunk 2), indicating a marginal increase in the cost of borrowing due to accrual adjustments and refinancing dynamics.  \n\nThis evolution aligns with the KG relationship where TMO (ORG) issues and holds the 1.95% 12-Year Senior Notes (FIN_INST), with both chunks confirming the note's evolving financial metrics through updated carrying values and interest rate disclosures. The slight dip in carrying value despite the rising effective rate suggests ongoing discount amortization, while the rate increase reflects market-driven cost adjustments as reported in the latest 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG",
      "triplets_used": [
        "TMO (ORG) -> 1.95% 12-Year Senior Notes (FIN_INST)",
        "1.95% 12-Year Senior Notes (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14990,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4382,
        "completion_tokens": 271,
        "total_tokens": 4654
      }
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The corporate governance implications of BNY Mellon's change in presenting its Directors' Code of Conduct between its 2022 and 2024 SEC filings reflect a strategic shift in transparency and oversight practices. In the 2022 filing, the Directors' Code of Conduct was explicitly described as applying to all directors and accessible via a dedicated webpage, with disclosures about amendments and waivers intended for executive officers and directors, while the 2024 filing expands the scope of available governance materials by incorporating the Code of Conduct within a broader list of corporate governance documents available on its website, emphasizing its role alongside other key governance frameworks. This evolution underscores a more integrated approach to governance disclosures, where the Directors' Code of Conduct is positioned as a living, accessible component of BNY Mellon's corporate governance ecosystem rather than a standalone policy, potentially signaling enhanced stakeholder engagement and accountability in governance practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6959,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2390,
        "completion_tokens": 262,
        "total_tokens": 2653
      }
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon’s Short-Term Credit Agreement was first established in November 2023 with a $5.0 billion, 364‑day unsecured revolving facility that replaced the November 2022 agreement and matures in October 2024, later extended to October 2025 in the 2024 filing; its facility size remained $5.0 billion, but the maturity date shifted from October 2024 to October 2025, reflecting the 2024 amendment. The 2023 agreement was replaced by a new $5.0 billion 364‑day facility in October 2024, which retains the same $5.0 billion size but extends the maturity to October 2025 and continues to bear interest at SOFR + 0.45% with a 0.03% commitment fee.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Short-Term Credit Agreement (FIN_INST)",
        "Short-Term Credit Agreement (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4741,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1834,
        "completion_tokens": 159,
        "total_tokens": 1993
      }
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "AMD's APU strategy has evolved from 2022 to 2024 through deeper integration of AI capabilities and expanded target markets, positioning the company as a leader in AI PCs and data center solutions. In 2022, APUs were positioned for mainstream computing with basic AI features, but by 2024, AMD had integrated dedicated neural processing units (NPUs) into its APUs—making it the first company to pair an x86 CPU with an NPU on the same SoC—to accelerate AI workloads at the edge and in end devices. This shift is explicitly highlighted in Chunk 2, which states AMD \"was the first company to integrate a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs,\" directly enabling its AI PC strategy. Concurrently, the target market expanded from traditional consumer and embedded segments (as seen in Chunk 1's \"Embedded\" and \"Semi-Custom\" descriptions of low-power, 24/7 applications) to include high-growth AI PC and data center segments, where APUs now serve as central compute engines for AI-driven tasks. This evolution is reinforced by Chunk 2's emphasis on AMD's \"broad portfolio of high-performance compute engines spanning across...end devices\" and its 2024 focus on \"accelerating growth in our Data Center segment\" through AI accelerators like the Instinct MI300X, which complements APU-based AI PCs by extending AI capabilities to cloud and hyperscale deployments. The implications for revenue potential are substantial: Chunk 2 notes AMD's AI strategy targets \"the full potential of AI...perv asiv e across cloud, edge and end devices,\" with the company projecting leadership in \"end-to-end AI\" through its hardware-software ecosystem. This is supported by Chunk 1's mention of APUs being used in \"semi-custom\" solutions for gaming and embedded markets, now repurposed for AI workloads, while Chunk 2's acquisition of Silo AI and its software stack for training LLMs on AMD hardware underscores a strategic move to monetize AI software ecosystems. Consequently, AMD's APU strategy now drives revenue not only from traditional PC and embedded markets (Chunk 1) but also from high-margin AI PC and data center AI accelerator sales (Chunk 2), creating a multi-faceted revenue stream that leverages its integrated hardware-software approach to capture share in the burgeoning AI computing market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> APUs (PRODUCT)",
        "APUs (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10939,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3376,
        "completion_tokens": 581,
        "total_tokens": 3957
      }
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax liability for U.S. shareholders receiving Medtronic dividends has remained materially consistent in its core mechanics, though the 2024 filing explicitly reinforces the framework described in 2023. Both the 2023 and 2024 10-K filings confirm that Irish dividend withholding tax (currently 25%) generally applies to dividends paid by Medtronic, but U.S. residents are exempt from this tax if they meet specific documentation requirements—either through broker-reported U.S. addresses for DTC-held shares or by providing Form 6166 or Irish Non-Resident Form V2 to the transfer agent. Crucially, the 2024 filing reiterates that when withholding tax is imposed, it *discharges any Irish income tax liability* for the shareholder, provided they furnish a statement of the withheld tax to Irish Revenue authorities, and both years emphasize that reliance on the U.S.-Ireland Double Tax Treaty is generally unnecessary due to the broad exemptions under Irish domestic law. This consistency reflects a stable regulatory approach under the Irish dividend withholding tax regime, with no substantive evolution in the tax treatment itself between the two filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Irish Income Tax (REGULATORY_REQUIREMENT)",
        "Irish Income Tax (REGULATORY_REQUIREMENT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6744,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2347,
        "completion_tokens": 302,
        "total_tokens": 2650
      }
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "The risk disclosure around new products and services has evolved from 2022 to 2024 by explicitly linking transformational initiatives—particularly the platforms operating model—to heightened operational and strategic risks, as noted in both 2022 and 2024 filings where new lines of business and strategic projects are identified as sources of additional risk that could materially affect results of operations if not successfully implemented; this progression underscores a deepening emphasis on managing the complexities and uncertainties inherent in major operational transformations, with the 2024 disclosure further highlighting that failure to realize expected benefits from the platforms operating model could directly impact financial performance, thereby reflecting a more targeted and forward-looking risk narrative centered on this enterprise-wide initiative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Subject_To]- ORG",
      "triplets_used": [
        "BK (ORG) -> New Products and Services (PRODUCT)",
        "New Products and Services (PRODUCT) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6618,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2300,
        "completion_tokens": 217,
        "total_tokens": 2517
      }
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Between 2023 and 2024, Amazon's relationship with the 3.600% Note due 2032 remained consistent as a core component of its long-term debt financing strategy, as evidenced by its continued inclusion in both the 2023 and 2024 SEC filings. The note was originally established through the Supplemental Indenture dated April 13, 2022 (referenced in both Chunk 1 and Chunk 2 as part of the 2022 filing), which governs multiple tranches of senior unsecured notes including the 3.600% Note due 2032, and this structure was reaffirmed in the 2024 filing without modification. While Chunk 2 adds a new 5.200% Note due 2025 via the December 20, 2017 Officers' Certificate (4.5), this addition does not alter the status or terms of the existing 3.600% Note due 2032, which continues to be issued under the same indenture framework and remains a key long-dated instrument in Amazon's capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> 3.600% Note due 2032 (FIN_INST)",
        "3.600% Note due 2032 (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9540,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3024,
        "completion_tokens": 222,
        "total_tokens": 3246
      }
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "From 2023 to 2024, MDLZ's treatment of net investment hedge derivative contracts shifted from detailed quantitative disclosure in 2023 to qualitative emphasis on hedge effectiveness and presentation context in 2024. While 2023 explicitly detailed fair value measurements ($1,347M and $377M in other current assets; $1,209M and $421M in other current liabilities) and linked these contracts to non-U.S. debt in Note 9, 2024's 10-K (page 93) reframes their financial impact within \"Other income, net,\" explicitly excluding amounts related to hedge effectiveness assessment and foreign currency movements on assets/liabilities. This evolution reflects a strategic pivot toward integrating hedge results into broader income statement line items rather than standalone balance sheet presentations, with both years consistently disclosing the contracts as part of net investment hedges under the ORG-FIN_INST relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Net Investment Hedge Derivative Contracts (FIN_INST)",
        "Net Investment Hedge Derivative Contracts (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2183,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 229,
        "total_tokens": 1438
      }
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "The Abrams Main Battle Tank's modernization strategy has advanced significantly from 2023 to 2024, with GD (General Dynamics) continuing to integrate next-generation technologies into the M1A2 SEPv3 configuration—including enhanced communications, power generation, fuel efficiency, optics, and armor—while simultaneously developing the more transformative M1E3 variant featuring updated systems architecture for faster upgrades and reduced sustainment footprint. International demand remains robust, as evidenced by the \"growing installed base in Europe, the Middle East, North Africa and Indo-Pacific theaters\" and sustained procurement interest from NATO allies, directly supporting GD's strategy of leveraging its large global vehicle base and engineering expertise to deliver \"increased survivability, performance and lethality\" across its Combat Systems segment, which also encompasses the Stryker and M10 Booker platforms as core components of future warfare.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Upgrades]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Abrams Main Battle Tank (PRODUCT)",
        "Abrams Main Battle Tank (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7267,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2459,
        "completion_tokens": 241,
        "total_tokens": 2701
      }
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD's APU strategy evolved from primarily serving consumer desktop markets toward a more diversified segmentation that explicitly targets data center, embedded, and semi-custom applications. The company now positions APUs as core compute engines within its Data Center segment—highlighting AI accelerators, DPUs, and adaptive SoCs—while simultaneously leveraging the same APU IP in Embedded and Gaming segments to address high-performance networking, industrial workloads, and semi-custom solutions for gaming consoles and handheld PCs. This strategic expansion reflects a deliberate shift from traditional consumer segmentation to a broader portfolio where APUs enable power-efficient, integrated CPU/GPU solutions across enterprise infrastructure, specialized computing platforms, and custom silicon partnerships, as evidenced by their inclusion in AMD's 2024 reportable segments and IP licensing activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> APUs (PRODUCT)",
        "APUs (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7298,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2459,
        "completion_tokens": 233,
        "total_tokens": 2692
      }
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "From 2023 to 2024, Medtronic's disclosure regarding the Financial Transfers Act 1992 has remained consistent in its core description of the Act's scope and implications, with no substantive evolution noted in the provided text. Both the 2023 and 2024 filings (Chunks 1 and 2) reiterate that the Act empowers the Irish Minister for Finance to restrict financial transfers between Ireland and third countries, explicitly defining such transfers as movements of capital or payments akin to E.U. treaty contexts, and maintain the ongoing, non-exhaustive list of restricted third countries subject to change. Critically, the disclosures in both years uniformly state that financial transfers involving sanctioned countries, entities, or persons (including those acting on their behalf) may be restricted under Irish law, and this framework directly connects to Medtronic's regulatory disclosures as captured by the KG triplets linking MDT to the Financial Transfers Act 1992 (e.g., MDT → Financial Transfers Act 1992 and Financial Transfers Act 1992 → MDT). Thus, the evolution is characterized by continuity in the regulatory relationship and disclosure content, not by significant change in how the Act's implications are framed or applied.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Financial Transfers Act 1992 (REGULATORY_REQUIREMENT)",
        "Financial Transfers Act 1992 (REGULATORY_REQUIREMENT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6744,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2347,
        "completion_tokens": 309,
        "total_tokens": 2657
      }
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "Based on GD's disclosures across both chunks, the G700's status and production outlook evolved significantly from 2023 to 2024: In 2023 (Chunk 1), GD explicitly stated the G700 was \"expected to enter service following certification from the FAA in early 2024\" as the next model to join the lineup after the G500/G600, highlighting its ultra-long-range, ultra-large-cabin design with advanced Symmetry Flight Deck and new engines. By 2024 (Chunk 2), this timeline was confirmed with actual deliveries beginning in the second quarter of 2024, driven by increased production ramp-up and customer deposits tied to firm orders, directly linking the G700's certification milestone (2023 disclosure) to its commercial entry and production acceleration (2024 disclosure), while also enabling the company to expand its product portfolio and customer base as noted in the broader operational context.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> G700 (PRODUCT)",
        "G700 (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4704,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1797,
        "completion_tokens": 222,
        "total_tokens": 2020
      }
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "From 2023 to 2024, PMI's relationship with KT&G has transitioned from a newly established long-term exclusive commercialization partnership (announced January 30, 2023) to an operationalized strategic dependency where KT&G's smoke-free product pipeline and heat-not-burn technology are now core to PMI's global smoke-free growth strategy, as evidenced by PMI's 2024 financial disclosures identifying licensed KT&G heat-not-burn products as part of its net revenue streams and ongoing regulatory collaboration to bring these products to market worldwide (excluding South Korea). The partnership's structure, with 15-year term extending to January 2038 and performance-based volume commitments reviewed every three years, creates deep strategic interdependence, while PMI's 2024 documentation confirms KT&G's products are integral to its smoke-free portfolio expansion into low- and middle-income markets, requiring joint regulatory approvals and leveraging KT&G's innovation pipeline to enhance PMI's existing smoke-free offerings beyond its prior exclusive products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PM (ORG) -> KT&G (COMP)",
        "KT&G (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6338,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2215,
        "completion_tokens": 266,
        "total_tokens": 2481
      }
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "AMD's strategic evolution of semi-custom SoC products from 2022 to 2024 reflects a deliberate expansion of their role within broader product ecosystems, transitioning from a niche revenue stream to a core component of their adaptive computing strategy. While 2022 documentation emphasized the financial and operational risks tied to semi-custom SoC revenue—dependent on third-party adoption and market timing—2024 materials highlight their integration into AMD's AI-driven product portfolio, where these SoCs now serve as critical enablers for AI PCs (e.g., NPU integration), embedded platforms, and data center accelerators, directly supporting the company's ambition to become an \"end-to-end AI leader\" through partnerships and ecosystem-driven deployments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Semi-Custom SoC Products (PRODUCT)",
        "Semi-Custom SoC Products (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10912,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3376,
        "completion_tokens": 189,
        "total_tokens": 3566
      }
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "The treatment of Irish income tax on dividends paid to U.S. residents has evolved between 2023 and 2024 by clarifying exemption criteria and withholding obligations, ensuring U.S. shareholders who meet specific conditions are not subject to Irish dividend withholding tax or income tax. In 2023, exemptions were granted to U.S. shareholders holding shares through DTC with proper address verification, while 2024 explicitly states that such exemptions discharge Irish income tax liability upon providing documentation like Form 6166, and confirms that treaty provisions are generally unnecessary due to broad domestic exemptions. Both chunks confirm that U.S. residents receiving dividends subject to withholding tax are not liable for further Irish income tax, with 2024 detailing the documentation requirements (U.S. Certification of Residence or Form V2) that solidify this exemption, directly building on the 2023 framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Irish Income Tax (REGULATORY_REQUIREMENT)",
        "Irish Income Tax (REGULATORY_REQUIREMENT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8700,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2829,
        "completion_tokens": 232,
        "total_tokens": 3061
      }
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "General Dynamics' financial performance and strategic focus in ship construction shifted significantly from 2023 to 2024, with cost pressures on the Virginia-class and DDG-51 programs easing in 2024 while revenue outlook improved for the Columbia-class submarine initiative. In 2023, operating margin compression in the Marine Systems segment stemmed from supply chain impacts on the Virginia-class submarine schedule and cost growth on the Arleigh Burke-class (DDG-51) program, but 2024 revenue is projected to rise to $12.8–12.9 billion with a 7.6% operating margin, driven by increased volume on the Columbia-class submarine program. This strategic pivot reflects a deliberate shift toward higher-margin submarine construction, particularly the Columbia-class, which is now the primary growth driver for the Marine Systems segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Ship Construction (PRODUCT)",
        "Ship Construction (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3939,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1650,
        "completion_tokens": 208,
        "total_tokens": 1858
      }
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the financial disclosures in both chunks, BKNG's financial dependency on Booking.com has strengthened between 2022 and 2023, as evidenced by the consistent dominance of accommodation reservation services in its revenue mix. Specifically, approximately 89% of BKNG's 2023 revenue relates to online accommodation reservation services (up slightly from 89% in 2022 and 87% in 2021), with the majority of merchant revenues and substantially all agency revenues originating from Booking.com's accommodation reservations, confirming that Booking.com remains the primary revenue driver despite minor fluctuations in the exact percentage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> Booking.com (COMP)",
        "Booking.com (COMP) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7859,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2600,
        "completion_tokens": 159,
        "total_tokens": 2759
      }
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "The company's position with respect to its Swiss Franc note evolved from a $299 million liability on December 31, 2023, to full maturity and elimination by December 31, 2024, as evidenced by its complete absence in the 2024 foreign currency obligations schedule (Chunk 2). This reduction from $378 million in 2022 (Chunk 1) to $299 million in 2023 and then to zero in 2024 indicates the note was fully repaid or settled, demonstrating a deliberate reduction in foreign currency obligations over the period. Consequently, this evolution reflects a strategic decrease in the company's exposure to Swiss Franc-denominated debt, lowering its overall foreign currency obligations and associated exchange rate risk from $299 million to zero within one year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "PM (ORG) -> Swiss Franc Note (FIN_INST)",
        "Swiss Franc Note (FIN_INST) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4239,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1701,
        "completion_tokens": 187,
        "total_tokens": 1888
      }
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Between the 2023 and 2024 10-K filings, Goldman Sachs introduced and modified agreements related to Non-Employee Director RSU Award Agreements through specific updates to its equity compensation framework. The 2023 filing (GS_10k_2023.pdf) references the pre-2015 Form of Non-Employee Director RSU Award Agreement (Exhibit 10.8), establishing the baseline structure for these awards. In contrast, the 2024 filing (GS_10k_2024.pdf) explicitly documents amendments to these agreements via \"Amendments to Certain Non-Employee Director Equity Award Agreements\" (Exhibit 10.18), indicating a formal revision to the terms governing Non-Employee Director RSU awards. This evolution reflects a deliberate update to the accounting policy for Non-Employee Director RSU awards, as evidenced by the KG triplet relationship where GS adopts the accounting policy and introduces the modified agreement structure, directly connecting the 2023 baseline to the 2024 amendments across both filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "GS (ORG) -> Non-Employee Director RSU Award Agreement (ACCOUNTING_POLICY)",
        "Non-Employee Director RSU Award Agreement (ACCOUNTING_POLICY) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_246",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10010,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3167,
        "completion_tokens": 244,
        "total_tokens": 3412
      }
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Based on the financial disclosures and KG relationships, PM's financial relationship with Swedish Match AB evolved significantly between 2023 and 2024, particularly regarding long-term debt obligations tied to the acquisition. In 2023, goodwill related to the Swedish Match AB acquisition was reduced due to measurement period adjustments and impairment, while the 2024 debt schedule reveals a substantial decrease in the Euro credit facility borrowings specifically tied to this acquisition—from $6,121 million (2023) to $2,610 million (2024)—indicating active repayment or restructuring of acquisition-related financing. This reduction in debt, coupled with the goodwill adjustments noted in both years, demonstrates a deliberate evolution in PM's financial strategy to manage and settle the debt obligations incurred through the Swedish Match AB acquisition within the broader context of its four-segment reporting structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PM (ORG) -> Swedish Match AB (COMP)",
        "Swedish Match AB (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 232,
        "total_tokens": 1764
      }
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "BMY's strategic positioning around KRAS inhibition has evolved significantly from 2023 to 2024 through the acquisition of Mirati Therapeutics in January 2024, which brought Krazati - a best-in-class KRAS inhibitor approved for second-line NSCLC and now in pivotal first-line combination trials with PD-1 inhibitors - into its portfolio, while simultaneously advancing MRTX1719 (a PRMT5 inhibitor) through Phase I development as a potential first-in-class asset; this acquisition, valued at $4.8 billion total consideration including $1.0 billion in contingent value rights tied to FDA acceptance of the PRMT5 inhibitor NDA, strategically positions BMY to expand its KRAS inhibition pipeline beyond Krazati's existing approvals into new indications and combination therapies, directly leveraging Mirati's commercial infrastructure and clinical assets to accelerate growth in targeted oncology markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Adds]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Krazati (PRODUCT)",
        "Krazati (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6451,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2252,
        "completion_tokens": 225,
        "total_tokens": 2477
      }
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Goldman Sachs' Restricted Partner Compensation Plan (RPCP) was first adopted in 2006 and remains formally in place, but its operational relevance has diminished as newer governance frameworks have taken precedence. The firm has introduced and updated compensation governance policies during this period, including the Amended and Restated Clawback Policy effective December 1, 2023 (10.1 in 2024 filing), which supersedes older RPCP disclosures by incorporating stricter governance controls. While the RPCP is still referenced in current filings (10.4 in 2024), its standalone significance has evolved alongside these newer policies, reflecting a strategic shift toward integrated compensation governance rather than isolated RPCP administration. This transition aligns with the KG pattern where newer governance instruments (e.g., Clawback Policy) are formally adopted while maintaining connections to legacy plans like the RPCP.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "GS (ORG) -> Restricted Partner Compensation Plan (ACCOUNTING_POLICY)",
        "Restricted Partner Compensation Plan (ACCOUNTING_POLICY) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_246",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10010,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3174,
        "completion_tokens": 232,
        "total_tokens": 3406
      }
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, Philip Morris International refined its heat-not-burn product strategy by formally integrating these offerings under its broader smoke-free and wellness portfolio, as evidenced by the 2023 filing’s explicit categorization of heat-not-burn products—including licensed KT&G items—as part of its \"smoke-free products\" revenue stream alongside e-vapor and oral nicotine products, while also reflecting their inclusion within the operational scope of its Wellness and Healthcare business driven by acquisitions like Vectura Group PLC and Fertin Pharma A/S. This evolution signifies a strategic shift from standalone heat-not-burn commercialization (highlighted in 2022’s focus on IQOS Platform 1 and HEETS variants across 71 markets) to deeper business integration, where heat-not-burn products are now positioned not only as core smoke-free offerings but also as components of a diversified portfolio targeting reduced-risk and wellness markets, supported by cross-chunk evidence of regulatory authorization (2022), revenue segmentation (2023), and wellness expansion milestones (2021–2023).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PM (ORG) -> Heat-Not-Burn Products (PRODUCT)",
        "Heat-Not-Burn Products (PRODUCT) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6979,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2390,
        "completion_tokens": 276,
        "total_tokens": 2666
      }
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Based on the provided information, Bristol-Myers Squibb's approach to business risk governance evolved between 2023 and 2024 by formalizing and strengthening its compliance framework under the SEC Consent Order, particularly through the establishment and ongoing operation of a dedicated business risk and disclosure group. This group, explicitly referenced in both the 2023 and 2024 SEC Consent Order disclosures, serves as the central governance mechanism to monitor adherence to the Consent's sales limitation policies, escalate compliance concerns to management, and ensure timely resolution of issues related to direct customer sales practices. The 2024 filing confirms the continued implementation of this governance process, including regular monitoring of compliance, demonstrating an evolution from initial establishment (as noted in the 2023 filing) to sustained, integrated operational oversight directly tied to SEC-mandated risk management protocols.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Establishes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Business Risk Group (ACCOUNTING_POLICY)",
        "Business Risk Group (ACCOUNTING_POLICY) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10899,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3388,
        "completion_tokens": 240,
        "total_tokens": 3628
      }
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "UNP's treatment of the relationship between its pension plan's expected return and asset allocation mix remained consistent between 2023 and 2024, with both years explicitly defining the expected return as being based on the asset allocation mix and historical returns, adjusted for current and expected market conditions. While the 2023 10-K noted an actual return of approximately 6% in 2023 (compared to 15% in 2021 and -18% in 2022), the 2024 filing confirms the methodology—linking expected returns directly to the asset allocation strategy—without indicating any change in how this relationship is calculated or weighted, reflecting a stable accounting policy as reflected in the consistent KG triplet structure where Asset Allocation Mix (ACCOUNTING_POLICY) is considered by and depends on UNP (ORG) across both reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Considers]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Asset Allocation Mix (ACCOUNTING_POLICY)",
        "Asset Allocation Mix (ACCOUNTING_POLICY) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_9",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_9",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1082,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 916,
        "completion_tokens": 209,
        "total_tokens": 1125
      }
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "BNY Mellon's Directors' Code of Conduct remained consistently accessible via its dedicated webpage on the corporate site across both 2022 and 2023, with no indication of relocation or removal of the document in either filing. The 2022 filing explicitly stated the Code was posted online and intended for disclosure of amendments or waivers, while the 2023 filing confirmed its continued availability as part of the \"Corporate Governance Guidelines, Amended and Restated By-laws, Directors' Code of Conduct, and Committee Charters\" made publicly available on the company's website. This consistent presentation maintained the Code's integration within corporate governance reporting without structural changes to its accessibility or disclosure approach between the fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6873,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2380,
        "completion_tokens": 194,
        "total_tokens": 2575
      }
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database has evolved significantly between 2023 and 2024 by embedding the database within a broader hybrid cloud framework that emphasizes deployment flexibility and deep integration with engineered systems. In 2023, the focus was on enabling workloads to run across Oracle Cloud Infrastructure (OCI) and third-party clouds through hybrid and multicloud models, with key capabilities like Oracle Exadata Cloud@Customer, OCI Dedicated Region, and OCI Sovereign Cloud allowing databases to operate securely in on-premise data centers, at the network edge, or within regulated environments while maintaining centralized management by Oracle. By 2024, this evolved to explicitly position Oracle Database as part of a comprehensive engineered systems strategy—highlighted by the continued availability of Oracle Exadata Database Machine across on-premise, OCI, and hybrid deployments—where database performance, scalability, and security are tightly coupled with hardware and software integration to streamline maintenance and enhance operational efficiency in both cloud and on-premise environments. This progression demonstrates Oracle's deliberate approach to cloud migration and hybrid IT, prioritizing customer control over deployment locations (including sovereign and edge options), seamless integration across Oracle and non-Oracle ecosystems via middleware like Java and engineered systems, and enabling a gradual, flexible transition to the cloud without requiring complete re-architecture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Utilizes]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Database (PRODUCT)",
        "Oracle Database (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8463,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2782,
        "completion_tokens": 384,
        "total_tokens": 3166
      }
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "The formal review and certification process for annual and quarterly SEC reports was first established in 2004 as part of the Consent Order with the SEC, and its implementation has been continuously reinforced through governance procedures and risk monitoring mechanisms. According to the 2023 and 2024 10-K filings, the company maintains a company-wide policy with a structured governance process to escalate compliance concerns and regularly monitor adherence to the Consent’s sales limitation requirements, ensuring that the formal review and certification process remains a core component of its accounting controls and SEC reporting framework. This process, initially introduced under the Consent and further refined over time, continues to be supported by dedicated risk management practices and external consultant reviews to uphold compliance with regulatory expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Establishes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Formal Review Process (ACCOUNTING_POLICY)",
        "Formal Review Process (ACCOUNTING_POLICY) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10899,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3388,
        "completion_tokens": 220,
        "total_tokens": 3608
      }
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International refined its positioning of heat-not-burn products within the broader reduced-risk product (RRP) portfolio, explicitly categorizing them under \"smoke-free products\" alongside e-vapor and oral nicotine products in its revenue segmentation. The 2023 filing confirms that PMI's heat-not-burn offerings, including licensed KT&G products, are now distinctly reported as part of smoke-free revenue—not combustible tobacco—reflecting a strategic emphasis on these next-generation products as core growth drivers outside traditional smoking markets. This categorization aligns with PMI's stated focus on RRPs as a key pillar of its business, with the 2023 structure reinforcing their separation from combustion-based products and integration into the company's broader smoke-free innovation agenda.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PM (ORG) -> Heat-Not-Burn Products (PRODUCT)",
        "Heat-Not-Burn Products (PRODUCT) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2057,
        "completion_tokens": 209,
        "total_tokens": 2266
      }
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database has evolved to emphasize enhanced deployment flexibility through expanded cloud and hybrid options, as evidenced by its integration with Oracle Middleware and Engineered Systems that enable customers to deploy databases across on-premise, cloud, and hybrid environments while leveraging integrated Java and infrastructure technologies for streamlined application development and management. This evolution is underscored by the company's shift toward cloud services revenue growth—from 25% in fiscal 2022 to 37% in fiscal 2024—driven by customer migration to Oracle Cloud for new deployments and expansion of existing workloads, supported by flexible licensing models that include cloud-specific options and hybrid deployment capabilities for Oracle Engineered Systems like Exadata. The integration with Oracle Middleware and Java further strengthens this positioning by providing a unified ecosystem where database deployments are optimized within Oracle's broader cloud infrastructure, enabling customers to modernize applications with greater agility while maintaining compatibility across diverse IT environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Database (PRODUCT)",
        "Oracle Database (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9312,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2970,
        "completion_tokens": 291,
        "total_tokens": 3261
      }
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "BMY's strategic relationship with Krazati evolved from 2023 to 2024 through a transformative acquisition that elevated Krazati from a promising pipeline asset to a core commercial and strategic pillar of BMY's oncology portfolio. In 2023, Krazati was referenced as part of BMY's broader oncology expansion strategy, particularly following the acquisition of Mirati Therapeutics, but its commercial potential was still emerging. By 2024, the acquisition solidified BMY's full ownership of Krazati, including its FDA/EMA approvals for second-line NSCLC and KRAS-mutated colorectal cancer, and positioned it as a key growth driver alongside other assets like Opdivo and Sotyktu. The financial commitment in 2024 was substantial: BMY paid $4.8 billion in total consideration for Mirati (including $4.1 billion net of cash acquired and $1.0 billion in potential contingent value rights tied to FDA approval of the PRMT5 inhibitor), explicitly allocating $2.0 billion to R&D technology and $1.7 billion to indefinite-lived IPRD as intangible assets—reflecting a strategic investment in Krazati's pipeline and future innovation. This acquisition marked a decisive shift from 2023's exploratory partnership to 2024's full integration, with Krazati now directly contributing to BMY's growth strategy through expanded indications (e.g., first-line NSCLC with PD-1 inhibitors) and enhanced commercial execution, while the contingent consideration underscored BMY's commitment to advancing Krazati's clinical potential beyond its initial approvals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Krazati (PRODUCT)",
        "Krazati (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9016,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2890,
        "completion_tokens": 384,
        "total_tokens": 3274
      }
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Based on the SEC filings across both years, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV (trading as BK/P on the NYSE) maintained its registration status and guarantor relationship with The Bank of New York Mellon Corporation in both 2022 and 2023, as evidenced by identical disclosures in BK's 2022 and 2023 Form 10-K filings regarding this security's terms and NYSE listing. The consistent presentation of the security under BK's ticker \"BK/P\" and guarantor notation across both annual reports confirms its unchanged structural status during this period, with no material modifications to its registration details or guaranty terms disclosed in the 2023 filing compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "BK (ORG) -> 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV (FIN_INST)",
        "6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV (FIN_INST) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2314,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 181,
        "total_tokens": 1441
      }
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "From 2022 to 2023, the capacity of PMI's short-term credit arrangements increased from approximately $2.3 billion (as noted in the 2022 filing) to about $2.7 billion at year‑end 2023, reflecting an expansion of both the committed revolving facilities and uncommitted credit lines. Utilization shifted modestly downward: borrowings under these arrangements fell from $295 million in 2022 to $283 million in 2023, indicating that a larger portion of the expanded credit capacity remained unused. This combination of higher available capacity and lower outstanding borrowings suggests an improved near‑term liquidity posture, providing PMI with greater financial flexibility and a stronger buffer to meet working‑capital needs without relying heavily on external financing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Maintains]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "PM (ORG) -> Short-Term Credit Arrangements (FIN_INST)",
        "Short-Term Credit Arrangements (FIN_INST) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3147,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 192,
        "total_tokens": 1630
      }
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Oracle's Autonomous Database positioning evolved significantly between 2023 and 2024 by deepening integration with the broader Oracle Cloud ecosystem and expanding automation capabilities. In 2023, the database was positioned as a cloud-native service leveraging OCI infrastructure, emphasizing self-driving automation for routine tasks like patching, scaling, and security, while highlighting its role within Oracle's infrastructure technologies marketed through cloud and license businesses. By 2024, this evolved to explicitly integrate with complementary cloud services such as Java Cloud and Oracle APEX low-code platforms, enabling developers to build cloud-native applications on a unified platform, while also enhancing analytics integration with Oracle Analytics Cloud and third-party tools through Exadata's scale-out infrastructure. The 2024 iteration further emphasized consumption-based pricing, on-demand scaling, and expanded deployment flexibility—including OCI, on-premise via Exadata Cloud@Customer, and Dedicated Regions—while maintaining its core automation focus to reduce labor costs and human error through machine learning-driven operations across both database and analytics workloads.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Autonomous Database (PRODUCT)",
        "Oracle Autonomous Database (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9307,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2976,
        "completion_tokens": 302,
        "total_tokens": 3278
      }
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "General Motors's financial relationship with Ultium Cells Holdings LLC evolved significantly between 2023 and 2024 through increased capital commitments and strategic investment positioning. In 2023, GM had committed $0.8 billion to Ultium Cells Holdings LLC, with maximum exposure to loss at $3.5 billion related to its involvement with this nonconsolidated VIE, though it lacked controlling power over key economic activities. By 2024, GM's investment in Ultium Cells Holdings LLC increased to $0.7 billion (as disclosed in Note 12 of the 2024 10-K), reflecting continued strategic capital involvement despite the entity remaining a variable interest exception where GM does not directly control operations. This capital participation formed part of GM's broader investment portfolio that also included significant stakes in Cruise and Lithium Americas, demonstrating a diversified clean energy and mobility strategy through structured investments in key partnerships while maintaining exposure through both direct investments and potential capital calls.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GM (ORG) -> Ultium Cells Holdings LLC (COMP)",
        "Ultium Cells Holdings LLC (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2282,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 264,
        "total_tokens": 1479
      }
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the financial impact of the Litigation Management Deed evolved through two distinct anniversary releases of as-converted value from the series B and C preferred stock under Visa's Europe retrospective responsibility plan. In the 2022 sixth-anniversary release (June 21, 2022), $3.5 billion of as-converted value was released and 176,655 shares of series A preferred stock were issued (with $3 million paid in cash for fractional shares), while in the 2024 eighth-anniversary release (June 21, 2024), $2.7 billion of as-converted value was released and 99,264 shares of series A preferred stock were issued (with $5 million paid in cash for fractional shares), both following the same conversion mechanism where each series B/C share received series A shares equal to the conversion adjustment divided by 100. This pattern demonstrates a deliberate, scheduled reduction in the outstanding preferred stock exposure through these releases, directly tied to the litigation management deed's requirements and the company's right to recover VE territory covered losses via conversion rate adjustments, without impacting net income as long as the as-converted value remained above covered losses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "V (ORG) -> Litigation Management Deed (ACCOUNTING_POLICY)",
        "Litigation Management Deed (ACCOUNTING_POLICY) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10738,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3356,
        "completion_tokens": 303,
        "total_tokens": 3659
      }
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "The financial and strategic relationship between 3M and the Aearo Entities underwent a critical evolution between 2023 and 2024, marked by litigation resolution and structural adjustments. Following the June 2023 dismissal of the Aearo Entities' bankruptcy filings, 3M reconsolidated the previously deconsolidated Aearo Entities in Q2 2023, resulting in an immaterial income statement impact, while the subsequent CAE Settlement in August 2023—structured to resolve all Combat Arms Earplug litigation and future claims—eliminated ongoing legal exposure and enabled the dismissal of related appeals (including the Seventh Circuit case). This resolution directly influenced 3M's 2024 financial reporting, as evidenced by the Transportation and Electronics segment disclosures in MMM_10k_2024.pdf, which explicitly references \"divestiture and acquisition impacts\" tied to the Aearo Entities' deconsolidation (2022) and reconsolidation (2023), with segment operating income margins improving year-on-year due to productivity and non-PFAS growth, partially offset by dis-synergies from the Solventum spin. The reconsolidation also necessitated adjustments to segment performance metrics, as seen in the 2024 results where sales in Transportation and Electronics were adjusted for special items related to PFAS and Aearo-related divestiture impacts, while 2023 results reflected a 4.5% sales decline in the same segments before these adjustments. Consequently, the litigation resolution and reconsolidation allowed 3M to stabilize its business segment reporting, with the Aearo Entities' historical liabilities no longer requiring separate bankruptcy-related accounting, thereby shifting focus to operational performance in the post-litigation period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reconsolidates]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Aearo Entities (COMP)",
        "Aearo Entities (COMP) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8365,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2736,
        "completion_tokens": 436,
        "total_tokens": 3172
      }
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, Class C Common Stock maintained its distinct earnings per share profile and voting characteristics while evolving within V's capital structure. In 2023, Class C Common Stock demonstrated significantly higher earnings per share ($33.17 basic, $33.13 diluted) compared to Class A Common Stock ($8.29 basic, $8.28 diluted), reflecting its concentrated ownership among financial institution clients and different economic interests as noted in V's 2022 disclosure about divergent stakeholder incentives. The 2024 data shows Class C Common Stock continues to trade at a premium per share but with minimal share quantity (10 million shares), while its relationship to Class B and preferred stock remains governed by the same voting requirements for significant transactions—including mergers and core business exits—that require affirmative approval from these classes, preserving their collective influence over corporate actions despite Class A's market price sensitivity to potential conversions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class C Common Stock (FIN_INST)",
        "Class C Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7025,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2409,
        "completion_tokens": 254,
        "total_tokens": 2663
      }
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "From fiscal 2022 to 2024, Qualcomm's ADAS/AD development and commercialization evolved from a strategic investment focus (highlighted in Chunk 1's discussion of QSI's investments in automotive applications and enabling technologies like AI and sensor perception) to a clearly defined revenue stream within its QCT segment by 2024 (as detailed in Chunk 2, where ADAS/AD falls under \"products sold for use in automobiles\" alongside connectivity and digital cockpit, explicitly categorized as a distinct revenue driver). This progression is underscored by the shift in revenue categorization—from early-stage strategic investments supporting ADAS/AD development (Chunk 1) to its direct inclusion in product revenue streams under automotive applications by fiscal 2024 (Chunk 2), reflecting a matured commercialization strategy where ADAS/AD transitioned from a supported application area to a core revenue-generating product line within Qualcomm's broader automotive expansion beyond mobile handsets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> ADAS/AD (PRODUCT)",
        "ADAS/AD (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7353,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2488,
        "completion_tokens": 249,
        "total_tokens": 2738
      }
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Visa's U.S. Retrospective Responsibility Plan has evolved between 2022 and 2024 by expanding its mechanisms to address liability in covered litigation, particularly through the U.S. litigation escrow account and loss-sharing agreements, while maintaining its focus on settlements and final judgments. The 2024 disclosure emphasizes that the plan covers monetary liabilities from settled or substantially resolved matters like the Interchange Multidistrict Litigation, but explicitly excludes fines from European Commission proceedings, reflecting a more defined scope compared to the 2022 description where the plan's mechanisms were noted to potentially accrue amounts higher or lower than the escrow balance. This evolution suggests Visa is proactively managing litigation risk through structured financial safeguards and risk-sharing arrangements, though the core framework for addressing U.S. covered litigation liabilities remains consistent with prior years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "V (ORG) -> Retrospective Responsibility Plan (ACCOUNTING_POLICY)",
        "Retrospective Responsibility Plan (ACCOUNTING_POLICY) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7201,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2482,
        "completion_tokens": 241,
        "total_tokens": 2723
      }
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza remained strategically significant throughout 2023–2024, with alliance revenue growing 9% in 2024 driven by international demand and the January 2025 China NMPA approval for adjuvant treatment in BRCA-mutated breast cancer (Chunk 2), while the drug's inclusion in a collaboration with AstraZeneca (evidenced by the $1.5 billion intangible asset value in Chunk 1) underscores its ongoing strategic importance. This growth occurred alongside broader portfolio dynamics, such as the 75% increase in royalty revenue from Reblozyl (Chunk 1) and the expiration of Keytruda royalties in 2024–2025 (Chunk 2), which collectively highlight a shift toward newer pipeline assets like Lynparza as key growth drivers within Merck's collaboration strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5218,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1946,
        "completion_tokens": 194,
        "total_tokens": 2140
      }
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Skoal's market position within Altria's oral tobacco segment declined between 2022 and 2024, with its retail share decreasing from 9.3% to 7.6% as shown in the 2024 financial data (Chunk 2), while its key competitor Copenhagen also experienced a share reduction from 23.5% to 19.1% over the same period. Although USSTC (the segment's leading producer, including Skoal) maintained a dominant 37.5% combined retail share in 2024 (down from 42.5% in 2023, per Chunk 2), Skoal's specific share performance indicates a relative weakening in competitive position compared to both Copenhagen and the overall segment's downward trend. This decline occurred amid structural shifts in the oral tobacco market, including FDA regulatory changes affecting product authorization (such as the 2021 authorization of Verve products but not current sales, per Chunk 1) and intense competition in a highly regulated environment where brand loyalty, innovation, and distribution channels are critical success factors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Skoal (PRODUCT)",
        "Skoal (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6651,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2303,
        "completion_tokens": 249,
        "total_tokens": 2552
      }
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "Based on the financial disclosures across both filings, Microsoft Cloud revenue—including Dynamics 365—grew from $91.4 billion in fiscal 2022 to $111.6 billion in fiscal 2023, reflecting a $20.2 billion increase (approximately 22 % growth) year‑over‑year. This expansion underscores the rising contribution of Dynamics 365 within the broader Microsoft Cloud portfolio over the two fiscal periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Dynamics 365 (PRODUCT)",
        "Dynamics 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5436,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1986,
        "completion_tokens": 99,
        "total_tokens": 2085
      }
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "Merck's foreign exchange risk management program has expanded its hedging scope and refined its instrument usage between 2023 and 2024, with key developments detailed across both filings. In 2023, the program primarily utilized forward exchange contracts for balance sheet risk mitigation and net investment hedging, with forward contracts not designated as formal hedges for operating exposures and designated for net investment hedges (with unrealized gains/losses recorded in OCI and excluded components amortized into earnings). By 2024, Merck has significantly broadened its approach, implementing a structured revenue hedging program that layers in hedges over time using purchased local currency put options, forward contracts, and purchased collar options to protect against forecasted sales volatility in euros, yen, and renminbi, while continuing to use forwards for balance sheet risk and designating senior unsecured euro notes as economic hedges for net investment exposure. The 2024 filing explicitly details the use of \"purchased local currency put options, forward contracts, and purchased collar options\" for revenue hedging, marking a notable evolution from the 2023 focus on forwards alone, and confirms that cash flows from all derivative instruments are now reported as operating activities, reflecting a more comprehensive and stratified hedging strategy across both operational and investment exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Balance Sheet Risk Management Program (ACCOUNTING_POLICY)",
        "Balance Sheet Risk Management Program (ACCOUNTING_POLICY) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7383,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2520,
        "completion_tokens": 356,
        "total_tokens": 2876
      }
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal's involvement with merchant receivables has evolved significantly between 2022 and 2024 through both organic growth and expanded financing activities. The company increased its merchant receivables purchases from approximately $1.7 billion in 2023 to $1.8 billion in 2024, with outstanding balances growing from $1.2 billion to $1.5 billion net of participation interests, reflecting expanded direct investment in merchant financing products like PPWC and PPBL. While the allowance for credit losses on these receivables decreased from $380 million in 2023 to $348 million in 2024 due to improved credit quality in certain segments, this occurred alongside heightened macroeconomic uncertainty that PayPal explicitly acknowledges could materially impact future allowances - a risk underscored by its 2021 practice of incorporating externally sourced macroeconomic forecasts and qualitative adjustments for merchant-specific risks like payment holiday impacts and modification program effectiveness. The company's allowance methodology, which applies loss curves segmented by geography and delinquency while incorporating macroeconomic scenarios, has consistently required reactive updates as new data emerges, with 2021's allowance specifically accounting for volatility in merchant performance and uncertainty around loan modification program outcomes that could drive future adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Merchant Receivables (FIN_INST)",
        "Merchant Receivables (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9804,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3101,
        "completion_tokens": 349,
        "total_tokens": 3450
      }
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO has evolved through both goodwill allocation and operating income performance, as reflected across all provided data. While goodwill allocated to smokeable products remained stable at $99 million in both 2021 and 2022 (Chunk 1), their contribution to operating income grew substantially, rising from $10,670 million in 2023 to $10,821 million in 2024 (Chunk 2), despite a slight decline in net revenues from $21,756 million to $21,204 million over the same period. This indicates that although the goodwill allocation for smokeable products has been static, their operational profitability has increased in absolute terms and now represents a more significant portion of MO's overall operating income, accounting for approximately 96% of the $11,241 million total operating income in 2024 (Chunk 2), up from 92.4% in 2023 ($10,670 million / $11,547 million), demonstrating a strategic shift in financial emphasis toward smokeable products despite stable goodwill values.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Smokeable products (PRODUCT)",
        "Smokeable products (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3114,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 261,
        "total_tokens": 1680
      }
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "The commercial portion of LinkedIn contributed to Microsoft Cloud revenue, which increased from $91.2 billion in fiscal 2022 (Chunk 1) to $137.4 billion in fiscal 2024 (Chunk 2). Since the fiscal 2023 figure is reported as $111.6 billion for FY 2023 within the FY 2024 disclosure, LinkedIn’s commercial revenue grew by approximately $20.4 billion between fiscal 2022 and fiscal 2023. This growth reflects the expanding contribution of LinkedIn’s commercial segment to the overall Microsoft Cloud portfolio across the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> LinkedIn Commercial (PRODUCT)",
        "LinkedIn Commercial (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2435,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 131,
        "total_tokens": 1376
      }
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Based on the provided information, Lynparza's commercialization and market expansion between 2023 and 2024 involved significant geographic expansion and revenue growth. In May 2023, Lynparza received FDA approval for BRCA-mutated mCRPC (Chunk 1), followed by Japan's MHLW approval in August 2023 (Chunk 1). This was complemented by a 9% growth in alliance revenue for Lynparza in 2024, driven by higher international demand (Chunk 2). The product further expanded its geographic footprint with China's NMPA approval in January 2025 for adjuvant treatment of early breast cancer (Chunk 2), while its existing approvals in the U.S. and Japan continued to support market penetration. The revenue growth was specifically attributed to \"higher demand in most international markets,\" directly linking geographic expansion to commercial success.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10827,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3342,
        "completion_tokens": 209,
        "total_tokens": 3551
      }
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "RTX's financial treatment of Powder Metal Matter resulted in a $189 million decrease in future income tax benefits from $644 million in 2023 to $455 million in 2024, reflecting a $189 million reduction in the associated tax benefit component. This decline is consistent with the disclosed risk factor that Powder Metal Matter depends on RTX and is disclosed by RTX, indicating that the decrease directly impacts the company's future income tax benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Powder Metal Matter (RISK_FACTOR)",
        "Powder Metal Matter (RISK_FACTOR) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1772,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1086,
        "completion_tokens": 113,
        "total_tokens": 1199
      }
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "The borrowing capacity under PayPal's primary revolving credit facility remained unchanged at $5.0 billion from 2022 through 2024, with the agreement extending to a maturity of June 7 2028 (subject to early termination or extension).  Concurrently, the Paidy Credit Agreement—originally a ¥60 billion (≈$574 million) unsecured revolving facility that was expanded to ¥90 billion in September 2022—had its outstanding balance reduced to roughly $100 million by December 31 2021 and was scheduled to terminate in February 2027, after which no further borrowing would be permitted.  Thus, while PayPal’s global revolving capacity stayed at $5.0 billion and was set to expire in 2028, the Paidy‑specific facility evolved from a ¥60 billion limit (increased to ¥90 billion in 2022) to approximately $100 million of remaining capacity before its 2027 termination.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Assumes]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Paidy Credit Agreement (FIN_INST)",
        "Paidy Credit Agreement (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10551,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3265,
        "completion_tokens": 214,
        "total_tokens": 3479
      }
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Between 2022 and 2024, Altria's reliance on long-term senior unsecured notes as a capital resource remained structurally consistent but was quantitatively reduced in scale, reflecting a strategic shift toward greater use of internal cash flows and revolving credit facilities rather than new long-term debt issuances. In its 2022 filing (Chunk 1), Altria explicitly identified access to long-term senior unsecured notes as a key component of its capital markets access alongside its $3.0 billion Credit Agreement and commercial paper, with $4.5 billion in cash and equivalents reported at that time. By 2024 (Chunk 2), while reaffirming the availability of long-term senior unsecured notes as part of its capital resources, Altria reported a significantly lower cash and equivalents balance of $3.1 billion and emphasized broader reliance on operating cash flows from subsidiaries, dividend income, and its revolving credit facility—without any mention of new note issuances or increased dependence on this specific instrument. Critically, the Knowledge Graph pattern (ORG → FIN_INST ← Discloses ← ORG) confirms that \"Long-Term Senior Unsecured Notes\" are consistently disclosed by Altria (MO) as a financing channel, but the absence of any quantitative update or expansion in the 2024 filing suggests a deliberate de-emphasis of this tool in favor of more flexible, short-term liquidity sources, even as regulatory and operational conditions evolved across the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Long-Term Senior Unsecured Notes (FIN_INST)",
        "Long-Term Senior Unsecured Notes (FIN_INST) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7357,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2478,
        "completion_tokens": 367,
        "total_tokens": 2845
      }
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "RTX's financial treatment of Powder Metal Matter shifted from a $644 million benefit in 2023 to $455 million in 2024, reflecting a $189 million reduction in the future income‑tax benefit attributed to this item. This decline contributed to the overall decrease in total future income‑tax benefits from $5,190 million to $5,257 million, indicating that the diminishing tax advantage from Powder Metal Matter may modestly offset future income‑tax savings, but the net effect remains limited by other larger components such as capitalized R&D and valuation allowances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Powder Metal Matter (RISK_FACTOR)",
        "Powder Metal Matter (RISK_FACTOR) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2961,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 141,
        "total_tokens": 1526
      }
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "PayPal's utilization of the Paidy Credit Agreement evolved significantly between 2022 and 2024, transitioning from active borrowing to full drawdown and termination of capacity. In 2022, the agreement provided approximately $574 million in borrowing capacity (¥90 billion), with no amounts drawn as of December 31, 2021 (Chunk 1), though $98 million was outstanding at that time. By 2024, PayPal had fully drawn the $574 million facility (equivalent to ¥90 billion), exhausting all available borrowing capacity under the agreement, which subsequently terminated in October 2024 with no remaining availability (Chunk 2). This contrasts with the $5.0 billion revolving credit facility entered in June 2023, which remained fully available ($5.0 billion) as of December 31, 2024, with no borrowings outstanding (Chunk 2). Thus, while the Paidy facility's capacity was entirely consumed by 2024, PayPal maintained substantial liquidity through its newer, larger unsecured facility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Paidy Credit Agreement (FIN_INST)",
        "Paidy Credit Agreement (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7423,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2498,
        "completion_tokens": 244,
        "total_tokens": 2742
      }
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "The ownership structure between Accenture plc and Accenture Canada Holdings Inc. has remained stable from 2023 to 2024, with noncontrolling interests in Accenture Canada Holdings Inc. held by current and former members of Accenture Leadership remaining below 1% as of August 31, 2024 (Chunk 1). Exchangeable shares in Accenture Canada Holdings Inc. continue to be convertible one-for-one into Accenture plc Class A ordinary shares, maintaining the historical equity linkage where these shares entitle holders to distributions equivalent to Class A shares and may be exchanged or redeemed under specific terms (Chunks 1 and 2). While Class X ordinary shares (issued to original exchangeable share holders) lack dividend rights and have redemption restrictions to preserve the exchange ratio, the overall equity relationship—particularly the noncontrolling ownership stake and exchange mechanism—has not materially changed, though the aggregate authorization for share redemptions and purchases increased to $2.69 billion as of August 31, 2024 (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Accenture Canada Holdings Inc. (COMP)",
        "Accenture Canada Holdings Inc. (COMP) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4987,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1905,
        "completion_tokens": 263,
        "total_tokens": 2168
      }
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Merck's balance sheet risk management through forward exchange contracts has evolved from a broader currency hedging framework in 2022 to a more targeted approach by 2024, explicitly prioritizing cost-benefit analysis for developing market exposures like the Chinese renminbi while maintaining core developed currency hedges (euro, Japanese yen, British pound, Canadian dollar, Swiss franc). The 2022 document details the program's use of forward contracts to offset monetary asset/liability remeasurement exposure, with gains/losses recorded in \"Other (income) expense, net\" due to non-hedge accounting, while the 2024 update confirms this methodology persists but emphasizes that forward contracts are deployed \"when deemed economical\" based on exposure magnitude, volatility, and hedging costs—particularly for emerging markets. Both documents consistently show the Company layers hedges over time, uses short-term forwards (typically <1 year), and avoids speculative trading, with the 2024 filing additionally noting minimal reclassification impacts from discontinued hedges, reinforcing the program's operational and cost-conscious evolution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Establishes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Balance Sheet Risk Management Program (ACCOUNTING_POLICY)",
        "Balance Sheet Risk Management Program (ACCOUNTING_POLICY) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9251,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2979,
        "completion_tokens": 286,
        "total_tokens": 3266
      }
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The reduction in RTX's disclosed Powder Metal Matter charge from $644 million in 2023 to $455 million in 2024 reflects a smaller contingent liability that lessens the risk of future income‑tax benefit write‑downs, as shown by the decreasing balance in the “Powder Metal Matter” line of future tax benefits. Consequently, the lower exposure to this risk factor suggests that the ongoing financial impact on future income‑tax benefits will be less adverse, supporting a more stable outlook for tax‑related earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Powder Metal Matter (RISK_FACTOR)",
        "Powder Metal Matter (RISK_FACTOR) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3160,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 128,
        "total_tokens": 1566
      }
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal's merchant receivables involvement has expanded significantly from 2022 to 2024 through deeper integration with partner institutions and scaling of its finance offerings. The company continues to purchase merchant receivables under participation agreements with partners like WebBank in the U.S. and via its Luxembourg and Australian subsidiaries internationally, growing the outstanding balance in its merchant finance portfolio from $1.2 billion in 2023 to $1.5 billion in 2024 (net of $53 million and $44 million participation interests sold, respectively). While maintaining its core model of purchasing receivables from partner institutions and sharing credit and repayment risks on a pro rata basis, PayPal now generates revenue through fixed fees amortized into \"other value added services\" revenue, with repayment periods dynamically adjusted based on merchant payment processing volumes—requiring at least 10% of the loan plus fee to be repaid every 90 days for PPWC and ranging from 3-12 months for PPBL. This evolution reflects a strategic deepening of its relationship with partner institutions, shifting from passive financing to active portfolio management and revenue generation through structured participation arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Merchant Receivables (FIN_INST)",
        "Merchant Receivables (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9471,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3022,
        "completion_tokens": 311,
        "total_tokens": 3334
      }
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck's alliance revenue from Lynparza grew 9% in 2024, reaching $989 million (up from $725 million in 2023), driven primarily by higher demand across most international markets and the January 2025 Chinese NMPA approval for adjuvant treatment of germline BRCA‑mutated, HER2‑negative high‑risk early breast cancer based on the OlympiA trial. This expansion reflects both the continued uptake of Lynparza in existing indications and the added label in China, which together contributed to the revenue increase.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10544,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3261,
        "completion_tokens": 127,
        "total_tokens": 3388
      }
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's involvement in merchant receivables has expanded both in volume and operational complexity between 2022 and 2024, with financial exposure increasing through larger purchase volumes and evolving risk management under CECL. In 2024, PayPal purchased approximately $1.8 billion in merchant receivables—up from $1.7 billion in 2023—and held $1.5 billion in outstanding balances net of participation interests, up from $1.2 billion the prior year, reflecting growth in its merchant finance products like PPWC and PPBL. While the allowance for credit losses on its broader consumer portfolio decreased to $348 million from $380 million due to improved credit quality, the company continues to manage merchant receivables through active servicing, fixed fee recognition, and dynamic repayment assessments tied to merchant processing volumes, maintaining significant operational and financial responsibility despite transferring participation interests to partner institutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Merchant Receivables (FIN_INST)",
        "Merchant Receivables (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4152,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1679,
        "completion_tokens": 244,
        "total_tokens": 1923
      }
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "Merck's involvement in Lynparza's development and commercialization has progressed significantly from 2022 to 2024, with regulatory approvals expanding globally and revenue growth driven by international demand. In January 2025, China's NMPA approved Lynparza as an adjuvant treatment for BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial, building on the FDA's 2022 priority review for this indication and prior approvals in ovarian, breast, pancreatic, and prostate cancers. This follows the collaboration with AstraZeneca, where Lynparza revenue grew 9% in 2024 due to higher demand in international markets, including China's recent approval. While Merck's royalty expenses on Keytruda declined from 6.5% to 2.5% in 2024 (with one royalty expiring in September 2024), Lynparza's alliance revenue growth reflects its expanding commercial footprint, directly tied to regulatory milestones across multiple cancer types.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8863,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2854,
        "completion_tokens": 238,
        "total_tokens": 3093
      }
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Based on the provided SEC filings and knowledge graph relationships, Boeing's strategy with commodity purchase contracts has evolved to extend hedging horizons and manage financial exposure more strategically between 2022 and 2024. The 2022 filing (Chunk 1) explicitly details the use of commodity purchase contracts and swaps to hedge against price fluctuations for production materials, with exposure measured at a 10% market price change impacting unrealized losses by $46 million. By 2024, as reflected in Chunk 2's Note 20 disclosure, Boeing expanded its hedging scope to include commodity derivatives and purchase contracts extending through 2031, while also incorporating stricter criteria for cash flow hedge accounting—evidenced by $39 in losses being reclassified from AOCI to other income due to unlikelihood of forecasted transactions occurring. This progression demonstrates a deliberate shift toward longer-term risk management, enhanced hedge effectiveness monitoring, and more conservative hedge accounting practices to mitigate both commodity price volatility and potential financial losses from stranded hedges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Commodity Purchase Contracts (FIN_INST)",
        "Commodity Purchase Contracts (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4624,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1801,
        "completion_tokens": 282,
        "total_tokens": 2083
      }
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Schwab's exposure to Principal Accounting Loans (PALs) remained fully collateralized through 2021–2024, requiring no allowance for credit losses as of 2021 and 2020 due to securities collateral exceeding borrowings (Chunk 1), though PALs growth contributed to overall loan portfolio expansion in 2024 with a slight decline in 2023 (Chunk 2). While the allowance for credit losses on bank loans decreased in 2024 due to improved credit quality and lower projected loss rates (Chunk 2), the text does not specify changes in PAL-specific allowances post-2021, indicating sustained collateralization and minimal credit loss recognition despite macroeconomic shifts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> PALs (FIN_INST)",
        "PALs (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_142",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1776,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1081,
        "completion_tokens": 165,
        "total_tokens": 1246
      }
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024, Boeing's strategic and financial treatment of the 777X program underwent significant evolution marked by shifting cost dynamics and escalating R&D investments. In 2022, the 777X contributed to elevated cost of sales as a percentage of revenue due to reach-forward losses, pandemic-related disruptions, and the lingering impacts of the 737 MAX grounding, as noted in BA's 2022 10-K (Chunk 1). By 2023, R&D expenses increased by $525 million primarily due to intensified development spending on the 777X program (Chunk 1), and this trend accelerated in 2024 with a $435 million year-over-year rise in R&D costs, specifically attributed to the 777X program and broader enterprise product development initiatives (Chunk 2). Despite these rising investments, the program's cost structure remained under pressure, reflecting both the financial burden of advancing a next-generation aircraft and Boeing's sustained commitment to its development amid ongoing operational and market challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "BA (ORG) -> 777X Program (PRODUCT)",
        "777X Program (PRODUCT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1610,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1048,
        "completion_tokens": 252,
        "total_tokens": 1300
      }
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Schwab's exposure to Portfolio Against Loans (PALs) has evolved significantly between 2022 and 2024, with portfolio growth driven by client expansion and net new assets, though PALs declined slightly in 2023 before stabilizing. The credit loss allowance methodology for PALs remains anchored in collateralized risk mitigation—Schwab applies practical expedients leveraging over-collateralization and daily market value monitoring of pledged securities, which inherently limits credit losses, while applying loan-level simulations incorporating delinquency roll rates, loss severity, housing prices, interest rates, and unemployment to estimate expected losses. This methodology, consistent with its approach for First Mortgages and HELOCs but with HELOCs using higher loss severity estimates, has resulted in decreased allowance ratios in 2024 due to improved credit quality and lower projected loss rates, reflecting Schwab's proactive risk management through dynamic collateral oversight and macroeconomic forecasting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> PALs (FIN_INST)",
        "PALs (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_142",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6566,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2285,
        "completion_tokens": 255,
        "total_tokens": 2540
      }
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ's value of British pound sterling notes increased from $(8) million in 2022 (per 2022 10-K) to $45 million in 2023 (per 2023 10-K), representing a significant shift from a liability to a substantial asset position. This change indicates the company has become more exposed to GBP fluctuations, suggesting its foreign exchange risk management strategy now actively manages GBP denominated liabilities and receivables, potentially through hedging or strategic positioning to mitigate currency volatility impacts on financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> British pound sterling notes (FIN_INST)",
        "British pound sterling notes (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2398,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 134,
        "total_tokens": 1384
      }
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "The interest rate disclosures for Amgen's 3.125% 2025 Notes reveal a strategic shift in debt financing approach between 2022 and 2024 filings. In the 2022 filing (Chunk 1), the notes carried a fixed 3.125% interest rate with a $1,000 million notional amount, reflecting traditional fixed-rate borrowing at that time. By the 2024 filing (Chunk 2), the same instrument is now structured as a floating-rate note tied to SOFR+2.1%, indicating Amgen's proactive refinancing strategy to align with evolving market conditions and potentially reduce long-term interest cost volatility. This transition from fixed to floating-rate pricing demonstrates the company's adaptive approach to capital structure management, leveraging market-based benchmarks to optimize financing costs for this key debt instrument.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.125% 2025 Notes (FIN_INST)",
        "3.125% 2025 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2164,
        "completion_tokens": 200,
        "total_tokens": 2364
      }
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab's reliance on its Commercial Paper Issuance Program has evolved from a primary short-term funding source in 2022 to a more limited backup mechanism by 2024 due to market disruptions and rising interest rates. While the program remained part of its liquidity strategy as noted in both 2022 and 2024 filings, Schwab increasingly depended on higher-cost alternatives like FHLB advances and brokered CDs during periods of rapid rate increases, as explicitly stated in the 2024 10-K when describing how \"larger unrealized losses on our available for sale portfolio due to higher market interest rates negatively impact our capital position.\" This shift reflects how rising rates forced the company to supplement its CP program with more expensive funding sources when client cash outflows exceeded internal cash generation, directly linking the program's reduced role to both market volatility and the capital drag from interest rate-sensitive AFS securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Commercial Paper Issuance Program (ACCOUNTING_POLICY)",
        "Commercial Paper Issuance Program (ACCOUNTING_POLICY) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10980,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3400,
        "completion_tokens": 240,
        "total_tokens": 3641
      }
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625% Notes evolved from fixed-rate instruments in 2022 (carrying $750M face value in 2022) to floating-rate debt by 2024, where the $1.4B 2024 Notes now carry a SOFR+3.4% interest structure. This transition reflects a strategic shift toward market-responsive financing, reducing fixed-rate exposure and aligning debt costs with current interest rate environments. The company maintains a diversified debt maturity profile across multiple currencies and tenors, with total long-term debt increasing slightly to $33.2B in 2024 from $32.9B in 2022, indicating ongoing expansion of its capital structure while managing interest rate risk through both fixed and floating-rate instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.625% 2024 Notes (FIN_INST)",
        "3.625% 2024 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2157,
        "completion_tokens": 172,
        "total_tokens": 2329
      }
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Schwab's approach to supporting variable interest entities (VIEs) has shifted from a stance of non-provision of support to active, condition-dependent funding commitments, reflecting evolving intent and contractual obligations. In 2022, Schwab explicitly stated it did not provide or intend to provide financial or other support to VIEs beyond contractual requirements, but by 2024, it disclosed that its banking subsidiary (CSB) expects to fund substantially all remaining VIE commitments between 2022 and 2025, contingent on specific conditions, while still maintaining that such support is not provided unless required by contract. This evolution underscores a strategic shift from passive non-involvement to proactive, conditional financial engagement tied to timing and contractual triggers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Did_Not_Supply]-> FIN_INST <-[Provides]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Other Support (FIN_INST)",
        "Other Support (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2283,
        "completion_tokens": 199,
        "total_tokens": 2482
      }
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "Based on the provided information, MDLZ's financial relationship with JDE Peet's has evolved such that the investment provides strategic flexibility and additional liquidity resources without materially impacting MDLZ's overall liquidity position or capital structure. As stated in Chunk 2, \"Our investment in JDE Peet's provides us additional flexibility\" and \"we do not expect negative effects to our funding sources that would have a material effect on our liquidity,\" indicating the investment supports rather than strains MDLZ's financial flexibility. While Chunk 1 notes that JDE Peet's is an equity method investment requiring mark-to-market adjustments and inclusion of its operating results in MDLZ's financials (including potential impacts on operating income and interest expense), Chunk 2 confirms this investment is viewed as a strategic asset that enhances financial flexibility without altering MDLZ's capital structure or requiring equity financing for ongoing obligations. Consequently, the investment has not materially changed MDLZ's liquidity profile or debt-to-equity ratios between 2022 and 2023, instead serving as a source of operational and financial flexibility that complements MDLZ's existing capital resources.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> JDE Peet's (COMP)",
        "JDE Peet's (COMP) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4478,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1759,
        "completion_tokens": 309,
        "total_tokens": 2069
      }
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "Between 2022 and 2024, AMGN's hedging strategy for the 3.125% 2025 Notes evolved from a fixed-rate structure to a floating-rate swap tied to SOFR. As shown in Chunk 1, prior to 2020, the notes were hedged with terminated swaps at fixed rates (e.g., 3.125% coupon), but post-termination, new agreements established a variable rate of **SOFR + 2.1%** (Chunk 2, 2023–2024 disclosures). By 2024, the notional amount remained fixed at $1,000 million, with interest rates dynamically adjusting per SOFR, reflecting a shift from static hedging to market-responsive risk management. This transition reduced counterparty risk (Chunk 1) while aligning swap costs with current market conditions, as evidenced by the consistent $1,000 million notional and SOFR+2.1% rate across 2023–2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.125% 2025 Notes (FIN_INST)",
        "3.125% 2025 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2371,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 196,
        "total_tokens": 1433
      }
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $4,414 million in fiscal year 2023, a reduction of $1,405 million (approximately 24%). This decline reflects the downward movement captured by the KG pattern where the Level 2 financial instrument shows a decrease linked to Walmart.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Equity Investments Level 2 (FIN_INST)",
        "Equity Investments Level 2 (FIN_INST) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_8",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1382,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 994,
        "completion_tokens": 89,
        "total_tokens": 1083
      }
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Apple's characterization of its reliance on marketing abilities has remained consistent between its 2023 and 2024 10-K filings, explicitly identifying marketing and distribution capability as a principal competitive factor critical to its success in both periods. While the 2023 filing emphasizes marketing alongside design innovation and ecosystem strength as part of its competitive landscape, the 2024 filing retains identical language regarding marketing's role, reinforcing that Apple continues to view marketing abilities as foundational—not merely supportive—to its competitive strategy, even as it maintains parallel emphasis on innovation, supply chain resilience, and intellectual property protection across both disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Relies_On]-> CONCEPT <-[Depends_On]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> Marketing Abilities (CONCEPT)",
        "Marketing Abilities (CONCEPT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11793,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3579,
        "completion_tokens": 183,
        "total_tokens": 3763
      }
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "Between 2022 and 2024, the notional amount for the 3.625% 2024 Notes decreased from $1,400 million to $0, while the interest rate structure shifted from a fixed 3.625% rate to a floating rate of SOFR+3.4% (as disclosed in Chunk 2). This transition reflects Amgen's active hedging strategy, where it terminated prior fixed-rate swaps (notional $5.2 billion in 2020, per Chunk 1) and entered new swaps at then-current rates to manage interest rate risk, as evidenced by the updated swap agreements and notional values in Chunk 2. The change indicates a strategic pivot to floating-rate financing, likely responding to rising interest rate environments to mitigate future rate increases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMGN (ORG) -> 3.625% 2024 Notes (FIN_INST)",
        "3.625% 2024 Notes (FIN_INST) -> AMGN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMGN_10k_2022.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMGN_10k_2024.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2371,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 171,
        "total_tokens": 1407
      }
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "From 2022 to 2023, Schwab’s integration of the iRebal portfolio rebalancing solution evolved from a retained offering within its RIA-focused platform to a more prominently integrated component of its post-acquisition infrastructure, culminating in its explicit launch as part of the reimagined Schwab Trading Powered by Ameritrade experience. This progression—highlighted by the retention of TD Ameritrade Institutional’s iRebal solution and its incorporation into Schwab’s offerings for independent advisors—demonstrates a strategic leveraging of TD Ameritrade’s legacy technology to enhance Schwab’s competitive positioning in the RIA market, where scale, integrated platforms, and differentiated tools like iRebal are critical differentiators. The company’s ability to transition over $1.6 trillion in assets (including 7,000 RIAs) from TD Ameritrade to Schwab by 2023, while retaining and integrating key solutions like iRebal, underscores its operational efficiency and capacity to deliver cohesive, high-value services that reinforce its market leadership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Retains]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> iRebal (PRODUCT)",
        "iRebal (PRODUCT) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9938,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3124,
        "completion_tokens": 265,
        "total_tokens": 3389
      }
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Apple's iMac product line evolved between 2023 and 2024 through strategic product refreshes and integration of new technologies, as evidenced by its 10-K filings. In fiscal 2023 (ended September 2023), the iMac was listed as part of Apple's Mac product line in the 2023 10-K (Chunk 1), establishing its ongoing presence in the portfolio. By fiscal 2024, Apple explicitly announced new iMac models during its First Quarter 2024 product launch (Chunk 2), confirming active development and market introduction of updated iMac hardware within the year. This progression reflects Apple's continuous innovation cycle, where product lines like iMac are regularly refreshed with new models and technologies—such as the integration of Apple Intelligence™ and updated operating systems (Chunk 2)—to maintain competitive relevance, while operating within broader macroeconomic challenges that impact its business (Chunk 2). The KG triplets (AAPL → iMac ← ORG and iMac → AAPL) confirm the bidirectional relationship between Apple and the iMac product, underscoring its strategic role in the company's hardware ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> iMac (PRODUCT)",
        "iMac (PRODUCT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5961,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2118,
        "completion_tokens": 277,
        "total_tokens": 2395
      }
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX's relationship with the 2.820% Notes Due 2051 has remained structurally consistent between 2022 and 2024, as evidenced by the identical $1,000 million principal balance reported in both the 2022 issuance documentation (Chunk 1) and the 2024 long-term debt schedule (Chunk 2), where it continues to be explicitly listed as a distinct tranche within the total $41,078 million long-term debt portfolio. This stability in the specific tranche's size—despite the company's overall long-term debt decreasing from $43,638 million (2023) to $41,078 million (2024)—indicates that RTX has maintained this 2051 maturity debt as a fixed component of its capital structure, suggesting deliberate long-term financing strategy rather than opportunistic refinancing, with the note's original issuance in 2021 remaining a permanent fixture in the company's debt profile through at least 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 2.820% Notes Due 2051 (FIN_INST)",
        "2.820% Notes Due 2051 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4701,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1819,
        "completion_tokens": 219,
        "total_tokens": 2039
      }
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "Between 2022 and 2023, the terms of Schwab's IDA agreement evolved to address LIBOR transition risks, specifically reducing the service fee on client cash deposits held at TD Depository Institutions from 25 to 15 basis points (as disclosed in the pro forma financial information for the USAA-IMCO acquisition period). This adjustment, tied to the amended IDA agreement referenced in the 2020 pro forma results, reflects a material change in fee structure driven by regulatory shifts away from LIBOR, though no explicit 2022–2023 fee evolution details are provided beyond this structural transition. The KG pattern (SCHW → IDA Agreement → SCHW) confirms this agreement's centrality to Schwab's accounting policy, with the fee reduction directly linked to the LIBOR phaseout strategy described in the 2023 liquidity discussion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> IDA Agreement (ACCOUNTING_POLICY)",
        "IDA Agreement (ACCOUNTING_POLICY) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7540,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2526,
        "completion_tokens": 206,
        "total_tokens": 2732
      }
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The shift in Filorga's treatment from a standalone reporting unit with $221 million of goodwill in 2023 to inclusion within broader trademark groups in 2024 signals that management no longer views it as a distinct growth driver requiring separate valuation, reflecting a more consolidated, segment‑wide approach to intangible‑asset assessment; this is consistent with the qualitative brand‑life‑assessment factors and the use of multiple valuation methods described in the 2023 goodwill‑impairment discussion, and is further reinforced by the 2024 note that lists Filorga among the Company's principal global and regional trademarks across its product segments. Consequently, the company appears to be applying a unified market‑approach and royalty‑rate framework to all trademarks, implying that Filorga’s strategic importance is now evaluated collectively rather than as an isolated asset, and its valuation is likely integrated into the overall trademark portfolio rather than assessed independently.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CL (ORG) -> Filorga (PRODUCT)",
        "Filorga (PRODUCT) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6015,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2169,
        "completion_tokens": 250,
        "total_tokens": 2420
      }
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "The shift in Apple's 2024 10-K filing—from detailing the iPhone 16 Pro in the “Product, Service and Software Announcements” section of the 2023 filing to listing it among the “Fourth Quarter 2024” product releases—reflects a strategic evolution in both product development timing and reporting approach. By moving the iPhone 16 Pro from an early‑year announcement (Q1 2024) to a later‑quarter highlight (Q4 2024), Apple signals a more mature, market‑ready rollout and integrates the device into its broader fiscal‑year narrative, while also aligning its disclosure cadence with the expanded 52‑week fiscal calendar that now spans two consecutive 52‑week periods (2022‑2023) and a 53‑week 2023 year. This change underscores Apple’s intent to present product launches in sync with its fiscal period structure and to emphasize the iPhone 16 Pro’s role within the full‑year product portfolio alongside other 2024 releases such as the Apple Watch Series 10 and AirPods 4.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> iPhone 16 Pro (PRODUCT)",
        "iPhone 16 Pro (PRODUCT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5958,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2132,
        "completion_tokens": 241,
        "total_tokens": 2373
      }
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "The company's Economic Value of Equity (EVE) simulations have evolved between 2022 and 2023 in both modeling assumptions and balance sheet dynamics. In 2022, EVE calculations relied on historical behaviors and assumptions about non-maturity deposit behavior, prepayment speeds, and term structure models, with sensitivity analyses conducted under gradual parallel interest rate shifts while maintaining a static balance sheet structure. By 2023, the Company refined its approach by updating deposit beta assumptions in a declining rate environment and incorporating more sophisticated modeling of client cash allocation shifts, as evidenced by updated simulations showing net interest revenue impacts under various rate scenarios. This evolution reflects a deeper integration of balance sheet dynamics into EVE analysis, particularly in capturing the effects of changing liability composition and client behavior on long-term interest rate risk exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> EVE Simulations (ACCOUNTING_POLICY)",
        "EVE Simulations (ACCOUNTING_POLICY) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9293,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2982,
        "completion_tokens": 238,
        "total_tokens": 3221
      }
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm's 2022 strategic shift from merely enabling wireless access point technologies to directly producing them in 2023 fundamentally expanded its competitive positioning and product portfolio breadth in the broader networking market. By integrating Wi-Fi, Ethernet, and PON chips with its Snapdragon platform and RFFE components—highlighted in Chunk 2 as part of its \"networking products\" including wireless access points—QCOM now directly competes in edge networking infrastructure, moving beyond its prior role as a supplier of enabling technologies (as referenced in Chunk 1's discussion of Wi-Fi 6/6E access point demand). This vertical integration, supported by its fabless manufacturing model and dedicated back-end facilities in China and Singapore (Chunk 2), allows Qualcomm to offer end-to-end solutions for home and business networks, directly leveraging the 5G-driven growth in connected devices and edge networking demand described in Chunk 1. Consequently, its portfolio now spans from foundational RF components to full networking hardware, positioning it to capture more value in the $27B+ IoT and edge networking markets (Chunk 1) while competing directly with traditional networking hardware vendors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Wireless Access Points (PRODUCT)",
        "Wireless Access Points (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12952,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3897,
        "completion_tokens": 305,
        "total_tokens": 4202
      }
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "The interest-only payment structure of Schwab's HELOC has remained stable from 2022 to 2023, with the percentage of adjustable-rate mortgages featuring interest-only terms declining slightly from 28% (2021) to 27% (2023), and the proportion of these interest-only loans not scheduled to reset for three or more years decreasing marginally from 89% to 86%. This indicates minimal evolution in the product's core interest-only terms over the period, as Schwab continues to offer a 30-year HELOC with a 10-year interest-only draw period followed by a 20-year amortizing loan, where interest rates are floating (prime-based) and no temporary introductory rates are used, as explicitly stated in both 2022 and 2023 disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> HELOC Product (PRODUCT)",
        "HELOC Product (PRODUCT) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2818,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 180,
        "total_tokens": 1543
      }
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "Qualcomm's XR market involvement evolved from 2022 to 2023 through strategic investments and product revenue disclosures, with its XR segment explicitly identified as a target for expansion in both years' filings. In 2022, QSI allocated investments toward XR as part of its broader strategy to \"expand or open new opportunities for our technologies\" and support \"design and introduction of new products and services,\" including in early-stage XR companies, while 2023 revenue disclosures confirmed XR's inclusion under \"consumer (including PCs, tablets, voice and music and XR)\" applications within QCT's diversified product portfolio, demonstrating a direct evolution from investment focus to measurable revenue generation across XR devices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> XR (PRODUCT)",
        "XR (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7343,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2464,
        "completion_tokens": 185,
        "total_tokens": 2650
      }
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of RTX's 3.030% Notes Due 2052 remained unchanged at $1,100 million from 2022 through 2024, as evidenced by its consistent $1,100 value in both the 2022 issuance data (Chunk 1) and the 2024 long-term debt schedule (Chunk 2). This stability, alongside RTX's broader long-term debt structure showing a slight decrease from $43,697 million in 2023 to $41,078 million in 2024 (net of current portion), indicates a strategic focus on maintaining a stable, long-duration debt profile with minimal reliance on this specific 2052 instrument, while overall debt reduction suggests potential refinancing or repayment activities to optimize the company's capital structure over the long term.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 3.030% Notes Due 2052 (FIN_INST)",
        "3.030% Notes Due 2052 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4701,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1820,
        "completion_tokens": 178,
        "total_tokens": 1998
      }
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP has intensified its focus on corporate card solutions by explicitly evolving its card value propositions and expanding innovative products and features—including financing, banking, and payment solutions—for business customers, as highlighted in both the 2023 and 2024 strategic imperatives. This shift underscores a broader commercial payments strategy centered on deepening integrated network capabilities, merchant acceptance, and differentiated financial services to drive growth in high-value business segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enhances]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Corporate Card (PRODUCT)",
        "Corporate Card (PRODUCT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3629,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 130,
        "total_tokens": 1675
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "PCA SKIN's strategic positioning within Colgate-Palmolive's Oral, Personal and Home Care segment has evolved from being primarily sold through traditional retail channels and distributors to include targeted professional distribution, particularly skin health professionals, as evidenced by its explicit inclusion among \"skin health professionals\" in both 2023 and 2024 disclosures. This reflects a deliberate expansion of its distribution strategy to leverage specialized professional networks while maintaining its core retail and eCommerce presence, as highlighted by its consistent branding alongside other key oral and personal care trademarks across both filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CL (ORG) -> PCA SKIN (PRODUCT)",
        "PCA SKIN (PRODUCT) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3206,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 167,
        "total_tokens": 1611
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Based on the provided information, Opdivo's strategic evolution between 2022 and 2023 is characterized by a deliberate expansion of its oncology portfolio through new tumor indications and combination therapies, directly driving revenue growth. The 2023 strategy explicitly prioritizes \"expanding the use of Opdivo by expanding into additional indications and tumor types both as a monotherapy and in combination with Yervoy and other anti-cancer agents\" (Chunk 2), building on the 2022 foundation of multi-indication approvals (e.g., gastric/esophageal cancers, NSCLC, melanoma) and combination regimens like Opdivo + Yervoy and Opdivo + CABOMETYX (Chunk 1). This focus on broadening Opdivo's application across earlier therapy lines and new cancer types – supported by investigational subcutaneous formulations and pipeline assets like Opdualag – is positioned to sustain and accelerate revenue growth, as evidenced by the continued strong performance of Opdivo-related combinations (e.g., Yervoy's 36% international revenue growth in 2021 driven by Opdivo + Yervoy for NSCLC) and the company's commitment to advancing registrational trials for new indications (Chunk 2). Consequently, this strategic expansion directly underpins BMS's revenue trajectory, ensuring Opdivo remains a key growth engine amid patent expiries of other products, with the company actively working to \"drive adoption of Opdivo by expanding into additional indications\" to maintain its contribution to overall portfolio growth (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11274,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3473,
        "completion_tokens": 378,
        "total_tokens": 3851
      }
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express's investment in foreign government bonds and obligations decreased in fair value from $549 million in 2023 to $765 million in 2024 (when aggregated across maturity buckets), though this reflects a shift in distribution rather than a simple increase. In 2023, the entire $549 million was classified as \"Due after 5 years but within 10 years\" (per Chunk 1), while in 2024, $764 million of the $765 million total was due within 1 year and only $1 million was due after 1 year but within 5 years (per Chunk 2), indicating a significant shortening of the maturity profile with most holdings now maturing within one year. The fair value of foreign government bonds and obligations was $549 million at the end of 2023 and $765 million at the end of 2024, but the maturity structure evolved from a single long-term bucket to a predominantly short-term allocation with minimal exposure beyond one year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Foreign government bonds and obligations (FIN_INST)",
        "Foreign government bonds and obligations (FIN_INST) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4254,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1716,
        "completion_tokens": 227,
        "total_tokens": 1943
      }
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Walmart's intercompany financing arrangements have evolved to address evolving liquidity constraints across its global operations, with the amount of cash not freely transferable to the U.S. declining from $4.3 billion (2022) to $3.3 billion (2025), reflecting reduced restrictions on cash repatriation. The Company continues to utilize intercompany financing to optimize cash deployment globally, with transfers from restricted balances (e.g., $2.2 billion tied to Flipkart minority shareholder approval in 2022) now subject to fewer constraints under current laws, though local limitations and noncontrolling interest approvals still govern access to approximately $3.3 billion of restricted cash as of 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Intercompany Financing Arrangements (ACCOUNTING_POLICY)",
        "Intercompany Financing Arrangements (ACCOUNTING_POLICY) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7386,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2519,
        "completion_tokens": 177,
        "total_tokens": 2696
      }
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Based on the comparative data across both filings, the U.S. Retiree Health Care Plan's asset composition remained unchanged between 2023 and 2024, with fixed income securities and cash equivalents holding steady at $210 million (comprising $4 million in Level 1 and $206 million in other levels) and equity securities maintaining a consistent $54 million allocation. The KG triplet relationship confirms TXN's disclosure of the plan's assets, but the data reveals no evolution in the fixed income or equity securities allocation during this period, as both categories showed identical values in the 2023 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "TXN (ORG) -> U.S. Retiree Health Care Plan (FIN_INST)",
        "U.S. Retiree Health Care Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4217,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1713,
        "completion_tokens": 155,
        "total_tokens": 1868
      }
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Honeywell's 2006 Stock Plan for Non-Employee Directors has been amended through multiple omnibus amendments referenced in both 2022 (Chunk 1, Exhibit 10.29*) and 2024 filings (Chunk 2, Exhibit 10.29*), specifically introducing new Form of Restricted Unit Agreements (Exhibit 10.33* in 2021 and 2024) and Form of Option Agreement updates (Exhibit 10.30* in 2021 and 2024), while maintaining its core structure as an omnibus amendment to the original plan. This evolution—documented across Chunk 1's Exhibit 10.29* (2021) and Chunk 2's Exhibit 10.29* (2024) alongside related restricted unit and option agreement amendments—suggests a strategic shift toward more structured equity compensation for non-employee directors, moving from simplified option grants toward diversified award types including restricted stock units, likely to enhance retention and align director incentives with long-term shareholder value through more flexible, performance-oriented compensation components.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amends]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "HON (ORG) -> 2006 Stock Plan for Non-Employee Directors (ACCOUNTING_POLICY)",
        "2006 Stock Plan for Non-Employee Directors (ACCOUNTING_POLICY) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 20707,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5860,
        "completion_tokens": 245,
        "total_tokens": 6105
      }
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Walmart's ownership stake in Flipkart declined from approximately 83% to 75% following a $3.2 billion equity funding in fiscal 2022, a reduction that generated a significant cash inflow but also lowered its controlling interest in the subsidiary. This dilution exposes Walmart to heightened regulatory scrutiny in India, where the Directorate of Enforcement is investigating Flipkart for alleged Foreign Direct Investment rule violations dating back to 2009‑2015; a potential enforcement action could impose share‑ownership restrictions or other penalties that would affect Walmart’s financial position and cash‑flow outlook. Additionally, ongoing antitrust and driver‑classification matters in Mexico and the United States illustrate broader compliance risks that could materially impact Walmart’s consolidated results and financial condition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Flipkart (COMP)",
        "Flipkart (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7384,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2490,
        "completion_tokens": 211,
        "total_tokens": 2701
      }
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, HON's U.S. cash balances declined significantly in total holdings, decreasing from $11.5 billion (as reported for 2021 in Chunk 1, which serves as the closest prior benchmark to 2022) to $11.0 billion by the end of 2024 (Chunk 2), reflecting a strategic reduction in U.S. cash reserves over the period. Concurrently, the geographic distribution shifted meaningfully, with $8.0 billion—representing a substantial portion of the $11.0 billion total cash and cash equivalents held as of December 31, 2024—being deployed in non-U.S. subsidiaries (Chunk 2), indicating a deliberate move toward greater international cash deployment despite no material restrictions or tax barriers to repatriation. This evolution underscores a strategic emphasis on optimizing global liquidity, leveraging non-U.S. cash balances for operational flexibility while maintaining a conservative, safety-focused approach to principal preservation across all jurisdictions (Chunks 1 and 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "HON (ORG) -> U.S. Cash Balances (FIN_INST)",
        "U.S. Cash Balances (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3221,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 246,
        "total_tokens": 1700
      }
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "The Membership Rewards liability methodology remained consistent in structure from 2023 to 2024, continuing to estimate future redemption costs using the Unredeemed Rewards (URR) assumption and weighted average cost (WAC) per point applied to current enrollees' points, as evidenced by the KG pattern linking AXP and Membership Rewards as mutually dependent entities. While Chunk 1 confirms the inclusion of deferred fees for the program in 2023, Chunk 2 details the 2024 methodology where changes in URR (e.g., a 25 basis point increase estimated to raise liability and expense by $197 million) and WAC per point (e.g., a 1 basis point increase estimated to raise liability and expense by $220 million) directly impact current period expense through adjustments covering unredeemed points as of the reporting period end. This demonstrates the ongoing reliance on statistical models incorporating redemption trends, card product type, and partner costs, with liability adjustments driven by evolving assumptions about redemption patterns and contractual changes, while the core estimation approach—applying URR and WAC to outstanding points—persisted across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Membership Rewards (PRODUCT)",
        "Membership Rewards (PRODUCT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4993,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1900,
        "completion_tokens": 292,
        "total_tokens": 2192
      }
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe's strategic positioning of Frame.io has evolved from its 2021 integration into the Digital Media segment toward deeper ecosystem alignment by 2024, where Frame.io now serves as a core collaboration hub directly embedded within Adobe's Creative Cloud applications—including tight integration with Premiere Pro, After Effects, Photoshop, and Lightroom—to streamline workflows from production (via Camera to Cloud) through approval, while simultaneously powering enterprise-scale content creation via Adobe Express and Firefly Services. This evolution reflects Adobe's broader strategy of unifying creative workflows across its ecosystem, as evidenced by Frame.io's role in enabling end-to-end production pipelines that connect asset creation (using Adobe Stock and Firefly) with collaborative review and distribution, ultimately supporting Adobe's unified platform vision where Frame.io functions as the collaborative backbone for generating and managing creative assets within Adobe's integrated suite of tools like Document Cloud and Behance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Integrates]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Frame.io (COMP)",
        "Frame.io (COMP) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8871,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2855,
        "completion_tokens": 262,
        "total_tokens": 3117
      }
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "Between 2022 and 2023, the fair value of private alternative investments measured using significant unobservable inputs (Level 3) declined slightly from $15.4 million to $25.5 million in total, with equity‑like funds showing an increase in Level 3 inputs from $5.5 million to $25.4 million, while hedge funds remained at Level 3 $0 and other private‑alternative categories contributed minimal changes; this shift reflects a modest rise in valuation reliance on unobservable inputs across the equity‑like segment despite an overall reduction in the aggregate Level 3 exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Private Alternative Investments (FIN_INST)",
        "Private Alternative Investments (FIN_INST) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16009,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4661,
        "completion_tokens": 143,
        "total_tokens": 4805
      }
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Adobe's integration of Frame.io into its Digital Media portfolio has evolved from initial acquisition through deep technical embedding and expanded functionality by 2024. The company acquired Frame.io in October 2021 to enhance cloud-based video collaboration, and by 2024 it is directly integrated with core Creative Cloud applications like Premiere Pro, After Effects, and Photoshop, enabling frame-accurate commenting, Camera to Cloud uploads, and workflow integration within Adobe Express and Firefly Services [Chunk 1, Chunk 2]. This strategic positioning is underscored by Adobe's broader AI-driven content creation ecosystem, where Frame.io complements Firefly's generative capabilities and Adobe Stock's asset marketplace, forming a cohesive workflow from creation to collaboration to distribution [Chunk 2]. The integration supports Adobe's recurring revenue strategy, as evidenced by its use of ARR as a key performance metric to track Digital Media segment health, with Frame.io contributing to the expansion of subscription-based, cross-product engagement that drives predictable revenue growth [Chunk 1].",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Frame.io (COMP)",
        "Frame.io (COMP) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9998,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3124,
        "completion_tokens": 279,
        "total_tokens": 3403
      }
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "CVS has evolved its Medication Management approach between 2022 and 2024 by expanding clinical programs and digital tools to enhance adherence and cost efficiency. In 2022, the focus was on formulary management, utilization management (UM), and mail/order pharmacy services, including opioid utilization controls and adherence programs like Pharmacy Advisor. By 2024, these initiatives were strengthened through integrated digital strategies—such as expanded analytics for lower-cost alternatives, enhanced Disease Management for conditions like rheumatoid arthritis and MS, and value-based care integration via Oak Street Health’s primary care model. The Company also advanced its specialty pharmacy accreditation (URAC, Joint Commission) and introduced targeted programs like the CVS Weight Management initiative for GLP-1 drugs, alongside Group Purchasing Organization services to negotiate drug pricing. These efforts collectively aim to reduce costs while improving clinical outcomes through data-driven, patient-centered interventions across retail, mail order, and specialty pharmacy channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Medication Management (PRODUCT)",
        "Medication Management (PRODUCT) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3415,
        "completion_tokens": 275,
        "total_tokens": 3690
      }
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe's integration of Frame.io into Creative Cloud has evolved from initial acquisition in October 2021 through 2024 with progressive enhancements to collaboration capabilities. The company has deepened native integration by embedding Frame.io's review and approval workflows directly into Premiere Pro and After Effects, enabling frame-accurate commenting and annotations that streamline video production processes. By 2024, Frame.io's cloud-native platform had expanded beyond post-production to support end-to-end workflows including casting, location scouting, and marketing campaign management, while its Camera to Cloud functionality allowed automatic upload of footage from production devices. This integration is now positioned as a core component of Adobe's strategy to enable seamless collaboration across all stakeholders, with Frame.io's capabilities further strengthened through its incorporation into Adobe GenStudio and enhanced connectivity with Creative Cloud applications like Photoshop, Illustrator, and Adobe Express. The result is a more unified, efficient collaborative ecosystem where video creators can work natively within Adobe's applications while leveraging Frame.io's real-time review and approval tools.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Frame.io (COMP)",
        "Frame.io (COMP) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11569,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3539,
        "completion_tokens": 308,
        "total_tokens": 3848
      }
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "From 2023 to 2024, the valuation methodology for loans and other assets has increasingly emphasized recently executed transactions as key inputs for fair value determination, particularly for Level 3 classifications where observable market data are limited. In 2023, MS described using executed transactions alongside external benchmarks and discounted cash flow models, especially for mortgage and corporate loans, with valuation hierarchy levels assigned based on data observability. By 2024, this approach was formalized further, with nonrecurring fair value losses for held-for-sale loans explicitly calculated using recently executed transactions, market price quotations, and comparable debt pricing adjusted for basis differences and recovery analysis, reflecting a continued reliance on transactional data even when external inputs are unobservable. This evolution underscores a strategic shift toward grounding fair value assessments in real-time market transactional evidence, particularly for complex or illiquid assets, while maintaining rigorous documentation of inputs like credit spreads and collateral characteristics to support valuation legitimacy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MS (ORG) -> Recently Executed Transactions (FIN_INST)",
        "Recently Executed Transactions (FIN_INST) -> MS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MS_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MS_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_9",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7676,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2570,
        "completion_tokens": 291,
        "total_tokens": 2862
      }
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Adobe's approach to Substance 3D Stager has evolved from being positioned as a standalone 3D scene assembly tool within its broader Substance 3D ecosystem (as noted in Chunk 1's trademark list and Chunk 2's description of Substance 3D Collection components) to being tightly integrated with Adobe's generative AI capabilities, particularly Firefly, which is now embedded across Creative Cloud applications including those that interact with Substance 3D assets (Chunk 2 highlights Firefly's role in content generation and its integration with Frame.io and Creative Cloud Apps). This evolution reflects a strategic shift toward embedding Stager within Adobe's AI-driven workflow, where it now serves as a foundational component for creating and leveraging AI-generated 3D content—such as textures and materials derived from Firefly or Adobe Stock—while maintaining its core functionality for scene composition, thereby positioning it as a critical node in Adobe's end-to-end creative pipeline from AI generation to 3D assembly and collaboration (Chunk 2's details on Substance 3D Assets, Frame.io integration, and Firefly-powered workflows).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Substance 3D Stager (PRODUCT)",
        "Substance 3D Stager (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5921,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2125,
        "completion_tokens": 285,
        "total_tokens": 2410
      }
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE's strategic positioning regarding grid-scale batteries evolved from recognizing them as an emerging, complementary technology within its broader energy transition framework to explicitly integrating them as a critical component in achieving deep decarbonization goals for the power sector. While both the 2022 and 2023 filings emphasize that grid-scale batteries (alongside hydrogen, carbon capture, and advanced nuclear) are essential but not yet widely deployed technologies requiring significant investment and R&D, the 2023 filing specifically highlights their role within the context of the Inflation Reduction Act and other policy incentives, underscoring a more concrete strategic reliance on storage solutions to support renewable energy integration and grid reliability. This progression reflects a deepening strategic reliance, as GE explicitly connects grid-scale batteries to its Power business's resilience amid shifting market dynamics and positions them as part of the necessary infrastructure investments to navigate the energy transition, moving beyond mere acknowledgment of their future importance toward active navigation of these changes as a core element of its decarbonization strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GE (ORG) -> Grid-Scale Batteries (PRODUCT)",
        "Grid-Scale Batteries (PRODUCT) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12501,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3777,
        "completion_tokens": 307,
        "total_tokens": 4085
      }
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "Between 2022 and 2024, CVS's disclosure regarding broker-quoted debt securities in its fair value measurements underwent a significant shift in both presence and impact on financial reporting. In its 2022 filing (Chunk 1), the company explicitly stated it had **no broker quoted debt securities** for the years ended December 31, 2021 and 2020, indicating that such securities were not material to its Level 2 fair value hierarchy at that time. However, by the 2024 filing (Chunk 2), CVS reiterated that it **did not have any broker quoted debt securities** for the years ended December 31, 2024 and 2023, confirming a continued absence of these instruments in its valuation process. This consistent exclusion across all reported years suggests that broker-quoted debt securities never materialized as a component of CVS's fair value measurements during this period, rendering them immaterial to its financial reporting and regulatory disclosures. Consequently, there was no evolution in their presence or impact, as the company consistently reported zero reliance on broker quoted debt securities for fair value assessments in both 2022 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> Broker Quoted Debt Securities (FIN_INST)",
        "Broker Quoted Debt Securities (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2022.pdf",
          "page_id": "page_148",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5027,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1918,
        "completion_tokens": 288,
        "total_tokens": 2206
      }
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, BlackRock's Equity Securities at FVTNI underwent a significant shift in composition, particularly in equity securities/mutual funds and equity method investments. The 2023 data shows $1,211 million in equity securities/mutual funds and $181 million in equity method investments (comprising $181 million in mutual funds and $1,895 million total equity method), while 2024 reports $1,950 million in equity securities/mutual funds and $347 million in equity method investments (including $478 million in mutual funds and $2,783 million total equity method). This indicates a substantial increase in both categories, with equity method investments growing from $1,895 million to $2,783 million, driven by higher allocations to mutual funds ($347 million vs. $181 million), private equity ($1,060 million vs. $885 million), and real assets funds ($520 million vs. $304 million), alongside a notable rise in carried interest ($1,983 million vs. $1,550 million) and other investments ($445 million vs. $490 million, though the latter decreased slightly). The total equity method investments increased by $888 million, reflecting expanded holdings across multiple asset classes within the equity method category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Equity Securities at FVTNI (FIN_INST)",
        "Equity Securities at FVTNI (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21674,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6070,
        "completion_tokens": 306,
        "total_tokens": 6376
      }
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "UnitedHealth Group evaluated credit-related impairments for available-for-sale debt securities in 2022 with no material allowance for credit losses, as stated in its 2021 assessment where it concluded unrealized losses were temporary and not driven by credit quality deterioration, and this evaluation approach continued into 2024 with no indication of a material change in methodology or allowance requirements across the reporting periods described.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Evaluates]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Credit-Related Impairment (RISK_FACTOR)",
        "Credit-Related Impairment (RISK_FACTOR) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7394,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2512,
        "completion_tokens": 112,
        "total_tokens": 2625
      }
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Between 2022 and 2023, AMD's financial relationship with the ATMP JV evolved significantly in terms of investment value and equity income. The carrying value of AMD's investment in the ATMP JV increased from $83 million (as of December 31, 2022) to $99 million (as of December 30, 2023), reflecting growth in the equity stake's book value. Concurrently, equity income recognized from the ATMP JV rose substantially from $6 million in 2021 to $14 million in 2022 and $16 million in 2023, indicating stronger earnings generation from the joint venture over time. This progression demonstrates both an increasing financial commitment reflected in the investment's carrying value and improved equity method accounting results, with equity income showing a clear upward trend from $6 million (2021) to $16 million (2023).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMD (ORG) -> ATMP JV (COMP)",
        "ATMP JV (COMP) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6510,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2257,
        "completion_tokens": 204,
        "total_tokens": 2461
      }
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth Group's exposure to tort claims has increased in both scope and potential financial impact between 2022 and 2024, with claims evolving to include more complex medical malpractice allegations and broader liability theories that may circumvent damage caps, particularly in states where traditional limits are in place. The company remains largely self-insured for these risks and continues to record liabilities for estimated costs, but acknowledges that actual losses could significantly exceed recorded amounts, especially as litigation risks grow across its affiliated physician networks and healthcare delivery operations. This escalating exposure is underscored by ongoing legal challenges involving its subsidiaries, such as the antitrust indictment of Surgical Care Affiliates, which highlights how pre-acquisition liabilities can persist and create new financial and reputational risks post-integration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR <-[Faces]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Tort Claims (RISK_FACTOR)",
        "Tort Claims (RISK_FACTOR) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12689,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3813,
        "completion_tokens": 230,
        "total_tokens": 4044
      }
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "The structure and capacity of Boeing's revolving credit agreements have evolved significantly between 2023 and 2024, reflecting a strategic shift in its liquidity management. In 2023, Boeing held $10.0 billion of unused borrowing capacity across legacy agreements, including a $3.0 billion three-year facility expiring in August 2025 and a $3.2 billion five-year facility expiring in October 2024 (amended), alongside a newly entered $3.0 billion five-year facility expiring in August 2028 and a $0.8 billion 364-day facility expiring in August 2024 with a one-year extension option to August 2025. By 2024, the company terminated the $0.8 billion 364-day facility and the amended $3.2 billion five-year facility, while retaining the $3.0 billion three-year agreement (expiring August 2025) and adding a new $4.0 billion five-year revolving credit agreement expiring in May 2029, resulting in $10.0 billion of available capacity under the remaining facilities as of December 31, 2024. This transition—from reliance on shorter-term and legacy agreements to a more robust, longer-dated $4.0 billion five-year facility—indicates a deliberate liquidity strategy focused on enhancing long-term financial flexibility, reducing refinancing risks, and signaling confidence in sustained access to capital markets despite prior credit rating volatility, as underscored by the company's emphasis on maintaining \"substantial borrowing capacity\" and compliance with covenants to support operational needs and debt management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BA (ORG) -> Three-Year Revolving Credit Agreement (FIN_INST)",
        "Three-Year Revolving Credit Agreement (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2024.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7711,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2584,
        "completion_tokens": 378,
        "total_tokens": 2962
      }
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "The 2017 Performance-based Options vested $56 million in fair value during 2023 (Chunk 1) and $52 million in fair value during 2024 (Chunk 2), reflecting a modest decline in the fair value of options that vested year‑over‑year. In contrast, the intrinsic value realized from exercised options increased sharply, reaching $44 million in 2023 (Chunk 1) versus $373 million in 2024 (Chunk 2), indicating a substantially higher market price relative to the $513.50 strike price in 2024. Both years show that the three tranches of the 2017 awards vested in equal installments—2022, 2023 and 2024—completing the final tranche in 2024 (Chunks 1 & 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> 2017 Performance-based Options (FIN_INST)",
        "2017 Performance-based Options (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2813,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 160,
        "total_tokens": 1521
      }
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD refined its methodology for estimating adjustments related to product return rights and variable consideration under contracts with OEMs and distributors. In both years, the company based these estimates on trended historical return rate data, adjusted for known events or conditions, and utilized internal and external market data to project future pricing trends, rebate program attainment, and incentive program outcomes. However, the 2023 disclosure emphasizes a more structured application of ASC 606-10-32-8 through 14 to evaluate the net consideration to which AMD expects to be entitled, explicitly incorporating adjustments for return rights, rebates, and price protection into the estimation of variable consideration. This reflects a continued reliance on historical activity and market analysis, but with greater clarity on the timing of revenue reductions for cooperative advertising and marketing incentives, as well as enhanced consideration of contractual return limitations and potential additional returns beyond standard percentages. AMD maintains that its estimates have been materially consistent with actual results, though they remain subject to management judgment and could vary based on future economic conditions or changes in assumptions regarding demand, pricing, or return patterns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Provides]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Product Return Rights (ACCOUNTING_POLICY)",
        "Product Return Rights (ACCOUNTING_POLICY) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10399,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3255,
        "completion_tokens": 334,
        "total_tokens": 3590
      }
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The number of shares under the 2017 Performance-based Options decreased from **625,825 outstanding at December 31, 2023** (per Chunk 2) to **766,970 outstanding at December 31, 2024** for the 2023 tranche (Chunk 2), but this reflects a *net increase* in the 2023 tranche’s outstanding shares year-over-year due to fewer forfeitures ($40,725 forfeited in 2023 vs. $26,705 in 2024) and no exercises during 2023 (Chunk 2). However, the *core 2017 tranche* (awarded in 2017) saw its outstanding shares decline from **1,549,080 (2023)** to **625,825 (2024)** due to **exercised shares (905,219)** and **forfeited shares (18,036)** (Chunk 2), indicating that the original 2017 Performance-based Options were largely exhausted through exercise and forfeiture by 2024, with only a small residual balance remaining. This trend—driven by the achievement of performance hurdles (as noted in Chunk 1’s vesting schedule where \"the first two tranches vested at the end of 2022 and 2023\")—signals that the 2017 Performance-based Options are nearing completion, with minimal forfeiture in 2024 ($18,036 vs. $40,725 in 2023) suggesting stable retention of remaining eligible employees, while the exercised portion ($44 million intrinsic value in 2023, per Chunk 1) confirms significant market value realization for participants.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> 2017 Performance-based Options (FIN_INST)",
        "2017 Performance-based Options (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_108",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3138,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 327,
        "total_tokens": 1767
      }
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx’s role evolved from a pharmacy benefits manager into a core, data-driven engine of UnitedHealth Group’s integrated health‑care ecosystem.  Powered by the “Pharmacy Care Services” product that UNH controls, Optum Rx expanded its service portfolio to include not only traditional retail, specialty and infusion pharmacy benefits but also a suite of clinical programs, digital tools, and utilization‑management solutions that tie medical and pharmaceutical care together through advanced analytics.  This strategic positioning enables Optum Rx to coordinate pharmacy spending—managing $112 billion of drug spend in 2021, including $45 billion in specialty drugs—across UnitedHealthcare’s broader network of 1.5 million physicians and 7,000 facilities, thereby reinforcing UnitedHealth Group’s mission to deliver higher‑performing, value‑oriented, end‑to‑end health‑care solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Controls]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Pharmacy Care Services (PRODUCT)",
        "Pharmacy Care Services (PRODUCT) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9133,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2941,
        "completion_tokens": 227,
        "total_tokens": 3169
      }
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "Between 2023 and 2024, BlackRock's Equity Securities at FVTNI—particularly those held for deferred cash compensation plans—showed a significant increase in valuation and composition. In 2023, investments economically hedging deferred cash compensation plans totaled $241 million within equity method investments, as disclosed in the 2023 10-K (Chunk 1). By 2024, the carrying value of investments measured at NAV specifically for \"Investments related to deferred cash compensation plans\" reached $173 million (Chunk 2), indicating growth in this category. Additionally, the total equity securities at FVTNI rose to $1,950 million (primarily mutual funds) and $2,783 million when including equity method investments (Chunk 2), reflecting expanded holdings tied to compensation plans. The increase underscores a strategic expansion in deferred compensation-linked investments, with $173 million explicitly attributed to these plans in 2024, up from $241 million in total hedging investments across all equity method holdings in 2023. This shift highlights both quantitative growth and structural emphasis on deferred compensation-linked assets within BlackRock's FVTNI portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BLK (ORG) -> Equity Securities at FVTNI (FIN_INST)",
        "Equity Securities at FVTNI (FIN_INST) -> BLK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BLK_10k_2023.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BLK_10k_2024.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12807,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3854,
        "completion_tokens": 294,
        "total_tokens": 4148
      }
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "Between fiscal 2022 and 2024, Accenture's aggregate available authorization under its open‑market share purchase program declined from **$3,129,296** (as of August 31 2022) to **$2,694,281** (as of August 31 2024). This reduction reflects a deliberate scaling back of the company’s share‑repurchase authority, indicating a shift in capital allocation priorities toward investments in growth initiatives and debt management rather than aggressive equity buy‑backs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Share Purchase Program (FIN_INST)",
        "Share Purchase Program (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8442,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2764,
        "completion_tokens": 115,
        "total_tokens": 2880
      }
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure of Accenture Canada Holdings Inc. Exchangeable Shares evolved significantly, particularly regarding shareholder rights and repurchase mechanisms. In 2022, as noted in Chunk 1, the company disclosed that share repurchases could include redemptions of Accenture Canada Holdings Inc. exchangeable shares under its open-market program, with activity subject to market conditions and board discretion, but did not specify redemption pricing or structural limitations. By 2024, as detailed in Chunk 2, Accenture plc explicitly outlined that Class X ordinary shares—issued to original holders of these exchangeable shares—could be redeemed at par value, but only if such redemption did not reduce a holder’s Class X shares below the number of exchangeable shares they owned, and redemption required company consent due to transfer restrictions. Furthermore, Chunk 2 clarified that the open-market share purchase program now explicitly included redemptions of Accenture Canada Holdings Inc. exchangeable shares held by leadership and permitted transferees, with $2.69 billion in authorization as of August 2024, indicating a formalized and expanded commitment to repurchasing these shares. This reflects a maturation in disclosure, moving from general statements about potential repurchases in 2022 to a detailed, structured framework governing redemption rights, transferability, and capital allocation by 2024, while maintaining alignment with the KG pattern of disclosure between the Exchangeable Shares (FIN_INST) and the issuing organization (ACN).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Accenture Canada Holdings Inc. Exchangeable Shares (FIN_INST)",
        "Accenture Canada Holdings Inc. Exchangeable Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7446,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2529,
        "completion_tokens": 399,
        "total_tokens": 2928
      }
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The global revenue from Electrophysiology Devices increased from $2,195 million in 2023 to $2,467 million in 2024, reflecting a 12.3 % rise before foreign‑exchange effects and a 14.4 % increase when adjusted for exchange‑rate fluctuations. This growth is captured in the KG relationship where **ABT (ORG) → Electrophysiology Devices (PRODUCT)** and **Electrophysiology Devices (PRODUCT) → ABT (ORG)**, linking the product’s revenue performance directly to its producing organization across both fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Electrophysiology Devices (PRODUCT)",
        "Electrophysiology Devices (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7231,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2460,
        "completion_tokens": 127,
        "total_tokens": 2587
      }
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Accenture's financial relationship with Duck Creek Technologies evolved significantly between fiscal 2022 and 2024, with the investment transitioning from an equity method holding to a source of notable financial impact. In fiscal 2022, Accenture held a 16% stake in Duck Creek Technologies, recorded under the equity method with a carrying amount of $138,902 and estimated fair value of $223,166, reflecting its influence through board representation and business relationships. By fiscal 2024, the investment gained strategic significance, culminating in a $253 million gain recognized in fiscal 2023 (and referenced again in fiscal 2024 results), which contributed to adjusted earnings per share and operating performance metrics. This investment, initially valued at cost with impairment monitoring under the fair value measurement alternative for securities without readily determinable fair value, now plays a measurable role in Accenture's financial results, underscoring its evolving strategic and financial importance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Duck Creek Technologies (COMP)",
        "Duck Creek Technologies (COMP) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5880,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2122,
        "completion_tokens": 256,
        "total_tokens": 2379
      }
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Union Pacific's executive compensation strategy shifted significantly between 2022 and 2023, with retention awards declining from 1,218,397 shares under the 2013 Plan (as of 2021) to 389,207 retention shares outstanding under the 2021 Plan, while retention units increased to 366,046 (excluding issued shares). This reduction in retention share grants—from 1.2 million to 389,000 shares—combined with the elimination of retention grants for new directors in 2018 and the transition to the 2021 Plan's smaller share reserve (23 million vs. 78 million under the 2013 Plan) indicates a strategic pivot toward tighter control of equity compensation costs and a greater emphasis on cash-based incentives or simplified equity structures for top executives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Retention Shares (FIN_INST)",
        "Retention Shares (FIN_INST) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7158,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2438,
        "completion_tokens": 187,
        "total_tokens": 2625
      }
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "MetLife's application of GAAP guidance for adjusted earnings has evolved between 2023 and 2024 by formally incorporating LDTI framework requirements into its adjusted earnings calculation, explicitly expanding exclusions related to market volatility and asymmetrical accounting adjustments. The 2024 disclosure confirms that adjusted earnings now systematically excludes market volatility impacts (including MRB remeasurement gains/losses, net investment and derivative gains/losses, and discount rate changes on annuitization guarantees) and asymmetrical accounting adjustments (such as basis adjustments for de-designated fair value hedges, inflation-indexed benefit adjustments, in-force reinsurance asymmetries, and non-economic losses at contract inception), building directly on the 2023 foundation where these exclusions were established but not yet fully operationalized under LDTI. This evolution reflects a deliberate refinement in how the company isolates core profitability by removing complex, non-economic accounting effects that could distort performance trends, with both years consistently defining adjusted earnings as adjusted revenues less adjusted expenses, net of income tax, while progressively tightening the scope of exclusions to enhance comparability across periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "MET (ORG) -> GAAP Guidance (REGULATORY_REQUIREMENT)",
        "GAAP Guidance (REGULATORY_REQUIREMENT) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_170",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_150",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9135,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2946,
        "completion_tokens": 323,
        "total_tokens": 3269
      }
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture's approach to compressed transformations has evolved from emphasizing broad technology adoption (including blockchain, robotics, 5G, and edge computing) to strategically prioritizing generative AI as a core accelerator, while expanding the scope of transformation services to include deeper integration of AI-driven capabilities across operations and Industry X initiatives. This evolution is reflected in the 2024 filing's explicit focus on \"generative AI\" as a key innovation driver (Chunk 2) and its expanded application in reimagining product design, engineering, and manufacturing processes through technologies like AI, digital twins, and advanced robotics—building directly on the 2022 foundation of Industry X's digital transformation of capital projects and product lifecycle management (Chunk 1). Crucially, the 2024 iteration also broadens operational reinvention to include human resources and emphasizes SynOps as a cloud-enabled platform leveraging generative AI and a wider ecosystem of partners (including Databricks, Snowflake, and NVIDIA), demonstrating a matured, AI-centric strategy that extends beyond 2022's more generalized technology investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Achieves]-> CONCEPT <-[Announces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Compressed Transformations (CONCEPT)",
        "Compressed Transformations (CONCEPT) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10579,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3298,
        "completion_tokens": 299,
        "total_tokens": 3598
      }
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Abbott's use of interest rate hedge contracts to manage exposure to changes in the fair value of fixed-rate debt remained consistent in scale and purpose between 2023 and 2024, with notional values totaling approximately $2.2 billion at both December 31, 2023 (as noted in Chunk 1) and December 31, 2024 (as confirmed in Chunk 2). These contracts, which convert fixed-rate debt obligations to variable rates, were designated as fair value hedges and recorded at fair value, with adjustments offsetting changes in the carrying amount of the underlying fixed-rate debt. The company continued to rely on this mechanism to mitigate interest rate risk, as evidenced by the unchanged $2.2 billion notional value figure across both years, while also maintaining its broader portfolio of foreign currency hedges to manage other exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Interest Rate Hedge Contracts (FIN_INST)",
        "Interest Rate Hedge Contracts (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8740,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2830,
        "completion_tokens": 207,
        "total_tokens": 3037
      }
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "MetLife's Adjusted Earnings definition was updated in 2024 to align with LDTI implementation, which simplified measurement models for DAC/VOBA and reclassified embedded derivatives as MRBs, removing amortization adjustments for these intangibles and modifying accounting for guarantee liabilities. This evolution reflects compliance with GAAP segment reporting requirements while refining performance measurement to exclude market volatility impacts and asymmetrical accounting adjustments. The 2024 framework explicitly incorporates segment-specific exclusions (e.g., MRB remeasurement gains, discount rate changes on annuitization guarantees) and maintains consistency with GAAP guidance as the basis for segment performance evaluation, directly linking regulatory compliance (via ORG-Subject_To-GAAP Guidance) to operational reporting practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "MET (ORG) -> GAAP Guidance (REGULATORY_REQUIREMENT)",
        "GAAP Guidance (REGULATORY_REQUIREMENT) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_119",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_150",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7318,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2483,
        "completion_tokens": 212,
        "total_tokens": 2695
      }
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From 2022 to 2024, Accenture's share purchase program evolved with a $3,129,296 authorization for open-market Class A share purchases and related redemptions, primarily used to fund employee equity plans and settle tax obligations from share withholding, while maintaining separate authorization for other programs; the 2024 filings confirm continued use of treasury shares for employee benefits without impacting the core authorization, reflecting a sustained but structurally consistent approach to share acquisition methods across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Announces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Share Purchase Program (FIN_INST)",
        "Share Purchase Program (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5186,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1944,
        "completion_tokens": 136,
        "total_tokens": 2081
      }
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "MetLife's valuation methodology for Unit-linked Securities remained consistent in its core approach from 2023 to 2024, continuing to rely on amortized cost for fixed maturity securities and original cost for equity securities, while maintaining the same fair value sensitivity framework for embedded derivatives within these instruments. The 2024 disclosure explicitly confirms that all Level 3 securities, including Unit-linked and FVO securities, use identical valuation techniques and significant unobservable inputs as previously described, with sensitivity analyses directly tied to key variables like mortality rates, lapse rates, utilization rates, withdrawal rates, and long-term equity volatilities—factors that collectively drive fair value fluctuations. Notably, while the cost basis methodology (amortized/original cost) showed no structural change, the 2024 text emphasizes that sensitivity to these unobservable inputs (e.g., mortality improvements decreasing MRB fair value for GMDB+living benefit contracts) remains a critical determinant of valuation outcomes, directly linking the evolution to dynamic actuarial assumptions rather than methodological shifts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> Unit-linked Securities (FIN_INST)",
        "Unit-linked Securities (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_320",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5318,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1976,
        "completion_tokens": 294,
        "total_tokens": 2270
      }
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "The structure of market-based RSUs remained consistent between fiscal years 2022 and 2023, continuing to be granted under the Amended 2012 Plan with a four-year vesting schedule subject to market conditions, though the 2023 filing explicitly notes that in fiscal year 2023, market-based RSUs were granted vesting over five years subject to stock price performance milestones, indicating a structural evolution in vesting terms. The vesting timeline shifted from a standard four-year schedule in prior years (including 2022) to a five-year schedule for certain grants in 2023, reflecting an evolution in design while maintaining the core market-condition-based mechanics. Both fiscal years utilized the same underlying equity incentive framework under the 2012 Plan, as evidenced by the consistent reference to market-based RSUs with TSR-based vesting subject to service and market conditions across both periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Vests]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Market-Based RSUs (FIN_INST)",
        "Market-Based RSUs (FIN_INST) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7894,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2599,
        "completion_tokens": 228,
        "total_tokens": 2827
      }
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "The phase-in treatment of CECL's ongoing impact on regulatory capital evolved from a full five-year delay through 2021 to a scheduled 25% annual phase-in of both the day 1 adoption impact and the cumulative day 2 ongoing impact from 2022 through 2024, after which the full estimated impact will be reflected in regulatory capital. During the phase‑in period, the applicable regulatory capital treatment allowed banks to add back the after‑tax day 1 CECL adoption impact plus 25 % of the increase in the allowance, and thereafter to phase in the remaining impact at 25 % per year, with the process completing by the end of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "COF (ORG) -> CECL Transition Election (ACCOUNTING_POLICY)",
        "CECL Transition Election (ACCOUNTING_POLICY) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7608,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2565,
        "completion_tokens": 156,
        "total_tokens": 2721
      }
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom's relationship with Wilmington Trust, National Association evolved from issuing senior notes under indentures dated January 19, 2021 (4.32, 4.33, 4.34, 4.35, 4.36, 4.37), to entering a new indenture on April 18, 2022 (4.46), and later executing a supplemental indenture on July 12, 2024 (4.49) and October 2, 2024 (4.54), which collectively reflect the ongoing use of Wilmington Trust as trustee for Broadcom's debt instruments, with the 2022 and 2024 indentures governing the terms and issuance of senior notes such as the 4.926% due 2037 and 5.050%–4.800% series due through 2034, all under the framework of agreements filed in 8-K reports and tied to Wilmington Trust’s role as trustee as shown in the KG triplet ORG → COMP ← INDENTURE.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Enters_Agreement_With]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Wilmington Trust, National Association (COMP)",
        "Wilmington Trust, National Association (COMP) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_134",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14542,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4294,
        "completion_tokens": 192,
        "total_tokens": 4487
      }
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One's regulatory capital add-back under the CECL Transition Rule decreased from $2.4 billion in 2023 to $0.9 billion in 2024, reflecting the phase-in progression where 75% ($1.8 billion) was added back as of January 1, 2024, leaving 25% ($0.6 billion) remaining to be phased in through 2025. This evolution follows the rule's structured schedule: the initial $2.4 billion add-back was fully recognized by the end of 2021, with subsequent phases adding back 25% annually of the remaining estimated impact through December 31, 2024, resulting in a $0.9 billion balance as of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Complies_With]- ORG",
      "triplets_used": [
        "COF (ORG) -> CECL Transition Rule (REGULATORY_REQUIREMENT)",
        "CECL Transition Rule (REGULATORY_REQUIREMENT) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5290,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1979,
        "completion_tokens": 146,
        "total_tokens": 2126
      }
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "The treatment of VMware stock options for non-employee directors was accelerated and converted into the right to receive cash and shares of Broadcom common stock in equal parts upon the May 26, 2022 merger agreement, as explicitly stated in both Chunk 1 and Chunk 2. This conversion mechanism was part of the broader acquisition strategy where VMware's outstanding awards (including those held by non-employee directors) were assumed and converted into Broadcom equity or cash, with the VMware Merger expected to close in fiscal year 2023 (Chunk 1), thereby finalizing the transition of these director compensation terms following the Broadcom acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Converts]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> VMware Stock Options (FIN_INST)",
        "VMware Stock Options (FIN_INST) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5283,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1957,
        "completion_tokens": 164,
        "total_tokens": 2121
      }
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures across both filings, Vraylar's therapeutic positioning has significantly expanded from 2022 to 2024. Initially approved in October 2021 as an adjunctive treatment for major depressive disorder (MDD) following positive Phase 3 trials (Study 3111-301-001 meeting primary endpoints, Study 3111-302-001 showing numerical but non-significant improvement), Vraylar received expanded FDA approvals by 2024 for multiple additional neuroscience indications, including acute and maintenance treatment of schizophrenia, acute treatment of manic/mixed episodes in bipolar disorder, and acute treatment of depressive episodes in bipolar I disorder, as detailed in Chunk 2. This evolution reflects a strategic broadening of its clinical utility beyond its initial MDD adjunctive role to become a core treatment for several serious psychiatric conditions, with AbbVie consistently emphasizing its established safety profile and differentiated dopamine D3-preferring mechanism across all approved uses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Vraylar (PRODUCT)",
        "Vraylar (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7572,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2514,
        "completion_tokens": 254,
        "total_tokens": 2768
      }
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "GE's accounting policy for long-term services agreements has evolved from a straight-line revenue recognition approach in 2022 to a percentage of completion method by 2024, specifically within its CES segment for contracts spanning 5-25 years. This shift requires estimating customer utilization rates to determine revenue timing and amounts, with significant adjustments made for changes in utilization forecasts, cost estimates, and contract modifications that impact profitability. The company now assesses expected billings adjustments and credit risk more rigorously, recognizing revenue cumulatively as costs are incurred relative to total expected costs, while revisions to estimates affect earnings through cumulative catch-up adjustments. Notably, the 2024 policy explicitly ties revenue recognition to asset utilization patterns and incorporates forward-looking market data, with contract billing estimates directly influencing the $6.6 billion net liability balance representing 4.1% of total contract billings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "GE (ORG) -> Long-Term Services Agreements (ACCOUNTING_POLICY)",
        "Long-Term Services Agreements (ACCOUNTING_POLICY) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13144,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3943,
        "completion_tokens": 255,
        "total_tokens": 4198
      }
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "IBM's disclosure of the 1.250% Notes due 2027 evolved from being introduced as a new debt instrument in its 2019 Form 8-K filing (where it was listed alongside other notes including the 1.250% Notes due 2027 as part of a broader issuance) to being explicitly identified in its 2023 10-K filing under \"Title of each class\" as \"1.250% Notes due 2027\" with the trading symbol \"IBM 27B\" registered on the New York Stock Exchange, reflecting its ongoing presence and formal registration in IBM's capital structure. This progression is confirmed by the KG triplet relationship where IBM discloses the 1.250% Notes due 2027 (FIN_INST) and the instrument itself references IBM as its issuer, with the 2023 10-K specifically documenting its registration details and trading symbol, demonstrating the transition from a newly issued instrument to a formally registered, actively traded debt security.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 1.250% Notes due 2027 (FIN_INST)",
        "1.250% Notes due 2027 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8934,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2861,
        "completion_tokens": 222,
        "total_tokens": 3084
      }
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "Between 2022 and 2024, AbbVie's performance-vested RSUs evolved from a structure where vesting was tied to one-third increments over a three-year performance period based on return on invested capital (ROIC) relative to a peer group (as described in 2022 and 2024 filings), maintaining this same vesting mechanism but with updated performance metrics and peer group definitions in 2024; the 2022 chunk confirms the use of ROIC-based performance metrics for 2020 and 2021 awards with potential one-third vesting increments, while the 2024 chunk explicitly states that performance-vested RSUs \"may be earned based on AbbVie's return on invested capital (ROIC) performance relative to a defined peer group,\" indicating continuity of the performance metric but with updated peer group specifications in 2024, and both chunks confirm the one-third vesting increments during the three-year performance period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Vests]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Performance-Vested RSUs (FIN_INST)",
        "Performance-Vested RSUs (FIN_INST) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2022.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2790,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 225,
        "total_tokens": 1572
      }
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "From 2022 to 2024, GE's investment relationship with AerCap evolved from an initial unrealized loss of $865 million in 2022 to a realized and unrealized gain of $38 million by 2024, reflecting a significant improvement in financial performance tied to the investment. This progression is documented in the investment gains/losses data across the years, where the 2022 figure shows a negative $865, the 2023 shows $129, and the 2024 shows $38, indicating a turnaround in value. The KG triplet relationship between GE and AerCap as both investor and investee underscores the direct financial linkage, which is further contextualized by the broader portfolio of investments including Baker Hughes and GEHealthCare, where the realized and unrealized gains and losses on these equity positions collectively contributed to total other income (loss) of $2,264 in 2024, $6,718 in 2023, and $811 in 2022, highlighting the material impact of these investments on GE's financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Disposes]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> AerCap (COMP)",
        "AerCap (COMP) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7976,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2625,
        "completion_tokens": 244,
        "total_tokens": 2869
      }
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "IBM's treatment of the 0.300% Notes due 2026 evolved from being disclosed as an incorporated exhibit in multiple 2016 8-K filings (Chunk 1) to being explicitly listed as a registered financial instrument with a dedicated trading symbol (IBM 26B) on the NYSE in its 2023 10-K (Chunk 2), reflecting a shift from passive incorporation to active prominence in financial instrument visibility. This progression is confirmed by the KG pattern ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG, where IBM's 2022 filing contextually establishes the 0.300% Notes due 2026 as a disclosed instrument (via 2016 8-K Exhibit 4), while the 2023 filing elevates its status by registering it under a specific trading symbol (IBM 26B) alongside other debt securities, thereby increasing its market visibility and formal recognition in IBM's capital structure disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.300% Notes due 2026 (FIN_INST)",
        "0.300% Notes due 2026 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8934,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2883,
        "completion_tokens": 212,
        "total_tokens": 3096
      }
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "GE's approach to the RISE Program has evolved from initial technology development and partnership building to increased investment focus and strategic integration between 2022 and 2024. In 2021, GE Aviation and Safran announced RISE as a targeted technology development program aiming for over 20% lower fuel consumption and CO2 emissions, with the Catalyst turboprop engine completing its first flight as a foundational innovation. By 2024, GE has significantly expanded its investment in RISE, leveraging external funding from customers and partners while embedding the program within broader R&D cycles to advance sustainable propulsion technologies like adaptive cycle engines, demonstrating a strategic shift from conceptual development to active investment and application across engine platforms. This progression reflects a deepening commitment to sustainable aviation, with RISE transitioning from a collaborative announcement to a core investment priority integrated into GE's engineering roadmap and external partnerships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "GE (ORG) -> RISE Program (PRODUCT)",
        "RISE Program (PRODUCT) -> GE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GE_10k_2022.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GE_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5482,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2003,
        "completion_tokens": 258,
        "total_tokens": 2261
      }
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, American Express maintained a consistent emphasis on asset securitizations as a core component of its funding strategy, as evidenced by its continued reliance on the Lending Trust and Charge Trust structures to securitize Card Member loans and receivables—where these securitized assets remain reported as assets and the issued securities as liabilities on the balance sheet, per the 2022 disclosure. While the 2023 filing underscores a broader funding strategy focused on diversified sources including deposits, unsecured debt, and securitizations to support global operations and regulatory liquidity needs, it does not indicate a strategic shift away from securitizations; rather, it reinforces their role within a balanced mix that also includes direct retail deposits and unsecured debt, demonstrating that asset securitizations remain a stable and integral pillar of American Express’s funding approach, even as the company prioritizes scale and cost efficiency in its deposit program and overall debt maturity profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Asset Securitizations (FIN_INST)",
        "Asset Securitizations (FIN_INST) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7153,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2438,
        "completion_tokens": 261,
        "total_tokens": 2699
      }
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "Emerson's strategic relationship with AspenTech evolved from a 55% equity investment in 2022 to full operational integration following the Heritage AspenTech acquisition, which closed with approximately $6 billion in cash consideration and created \"New AspenTech\" operating under the previous name \"Aspen Technology, Inc.\" (AZPN) on NASDAQ, with Emerson retaining majority ownership and operational control. This integration generated significant financial returns through AspenTech's contribution to key performance metrics, including $656 million in sales and $12 million in earnings (loss) in 2022 (rising to $319 million in sales and $(7) million in earnings loss in 2021), while also driving margin expansion through the Test & Measurement acquisition that contributed $869 million in cost of sales increases and $231 million in acquisition-related inventory step-up amortization that impacted gross margins by 1.3 percentage points. The partnership's financial impact is further evidenced by Emerson's recognition of $453 million in gains from subordinated interest distributions in 2022 (including $438 million in Q1 2022 and $15 in Q1 2023), alongside $161 million in additional 2023 distributions ($122 million after-tax), demonstrating ongoing financial benefits from the relationship that were later complemented by the $1.5 billion sale of Copeland's non-controlling interest in August 2024, which generated $539 million in discontinued operations gains.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8053,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2649,
        "completion_tokens": 366,
        "total_tokens": 3016
      }
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved through its acquisition of Heritage AspenTech, which established a noncontrolling interest accounting framework. Emerson recorded a $5.9 billion noncontrolling interest for the 45% stake held by former Heritage AspenTech stockholders, with $550 million reducing additional paid-in-capital due to the noncontrolling interest in the Emerson Industrial Software Business. The acquisition, completed on May 16, 2022, involved Emerson contributing two industrial software businesses and $6.0 billion in cash to form \"New AspenTech,\" with Emerson retaining 55% ownership. By 2023, AspenTech's financial impacts were reflected in Emerson's cost of sales and SG&A expenses, where the Heritage AspenTech acquisition contributed $231 million in acquisition-related inventory step-up amortization (reducing gross margins by 1.3 percentage points) and $125 million in stock compensation expenses (partially offsetting SG&A increases). This acquisition-related accounting treatment directly influenced Emerson's equity structure and expense recognition, while the 2023 financial results continued to reflect the legacy of the acquisition through ongoing amortization and integration effects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7387,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2491,
        "completion_tokens": 314,
        "total_tokens": 2805
      }
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved from being defined by reference to an incorporated 1997 Form 8-K filing in its 2022 SEC disclosure (Chunk 1), to being explicitly listed as a registered debt instrument with its specific identifier \"IBM 27\" on the New York Stock Exchange in the 2023 filing (Chunk 2), reflecting a shift from merely referencing historical documentation to directly naming and registering the security under its current designation. This progression is confirmed by the KG relationship where IBM discloses the 6.22% Debentures due 2027 (FIN_INST), which in turn is linked to IBM as its issuer, with the 2023 filing providing concrete evidence of its active registration and trading symbol designation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 6.22% Debentures due 2027 (FIN_INST)",
        "6.22% Debentures due 2027 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6112,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2162,
        "completion_tokens": 188,
        "total_tokens": 2351
      }
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers has increased from 2023 to 2024 as evidenced by the expanded scope of value-based contracts in both Optum and UnitedHealthcare divisions, particularly through Medicare Advantage risk adjustment methodologies and provider payment disputes. This evolution directly impacts cost estimation by requiring more complex projections of medical costs and risk adjustment premiums based on CMS methodologies and provider data submissions, while simultaneously expanding service delivery responsibilities to include managing financial solvency risks of contracted providers and assuming liability for unpaid claims when provider organizations face financial difficulties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Impacted_By]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Risk-Based Arrangements (ACCOUNTING_POLICY)",
        "Risk-Based Arrangements (ACCOUNTING_POLICY) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11690,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3593,
        "completion_tokens": 191,
        "total_tokens": 3785
      }
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved from a strategic investment to full ownership following its $13.1 billion acquisition of AspenTech (including $6.0 billion in cash to Heritage AspenTech shareholders), which established Emerson as the majority owner (55% of outstanding shares) and integrated AspenTech into its operations under the Heritage AspenTech name. This transformation is evidenced by the 2022 financial data showing AspenTech contributing $131 million in revenue (with $319 million in 2022 total revenue attributed to AspenTech across segments), which was subsequently absorbed into Emerson's consolidated results after the acquisition closed, as reflected in the 2023 financial disclosures detailing integration impacts like the Test & Measurement acquisition and Heritage AspenTech's influence on gross margin (0.6 percentage point benefit) and SG&A expenses (including $50 attributed to AspenTech stock plans). The strategic involvement deepened significantly through the acquisition, shifting from a minority investment position to full operational and financial control, with the 2023 financial statements now incorporating AspenTech's performance as part of Emerson's broader portfolio, including its contribution to revenue streams and margin dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6033,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2142,
        "completion_tokens": 328,
        "total_tokens": 2470
      }
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "Adobe Target's role within Adobe's customer journey solutions has evolved significantly from fiscal 2022 to fiscal 2023, transitioning from a standalone personalization tool to a core component of the unified Adobe Experience Platform ecosystem. This evolution, highlighted by its integration with Adobe Journey Optimizer and expanded AI-driven capabilities for omnichannel personalization (as detailed in Chunk 2), indicates Adobe's strategic shift toward embedding AI-powered personalization deeply into end-to-end customer journey orchestration, moving beyond isolated use cases to enable cohesive, data-driven experiences across all touchpoints as part of its broader Digital Experience segment strategy (consistent with Chunk 1's description of Experience Cloud's role in managing customer journeys and Chunk 2's emphasis on Journey Optimizer's real-time personalization capabilities).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Target (PRODUCT)",
        "Adobe Target (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8378,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2745,
        "completion_tokens": 222,
        "total_tokens": 2968
      }
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson's relationship with AspenTech evolved from a strategic investment to full acquisition integration between 2022 and 2023, with financial stakes transitioning from partial ownership to complete control. While Chunk 1 shows Emerson's prior equity stake in AspenTech (reflected in balance sheet figures under \"Automation Solutions\" with $7,289 million acquired during 2021-2022), Chunk 2 details the post-acquisition integration where Emerson converted Heritage AspenTech's stock awards—including unexercised options and unvested restricted stock units—into AspenTech's equity awards, as mandated by ASC 805 accounting rules. This acquisition, completed in Q3 2022, required Emerson to allocate purchase price portions between pre- and post-combination service periods, with the latter portion recognized as stock-based compensation expense in consolidated financials over remaining service terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5390,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1982,
        "completion_tokens": 225,
        "total_tokens": 2207
      }
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform's role within Adobe's customer journey solutions evolved from being positioned as a foundational infrastructure for connecting Adobe Experience Cloud applications and enabling AI-powered analytics (Chunk 1) to becoming the central orchestration engine for cross-channel campaign management through native integration with AI-driven tools like Journey Optimizer and Adobe Target (Chunk 2). The 2023 documentation explicitly highlights Journey Optimizer as a scalable application built *on* Adobe Experience Platform that allows brands to orchestrate personalized, connected customer journeys across any channel using real-time profiles and AI-powered automation, while also enabling detailed performance tracking that feeds back into Adobe Experience Platform for full-funnel analysis—demonstrating a strategic shift toward deeper AI integration and unified cross-channel campaign execution as the core evolution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Experience Platform (PRODUCT)",
        "Adobe Experience Platform (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10144,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3194,
        "completion_tokens": 239,
        "total_tokens": 3433
      }
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "UnitedHealth Group's care delivery evolution from 2023 to 2024 has been a strategic acceleration of value-based payment models to counter Medicare Advantage funding pressures, as evidenced by its explicit transition from fee-for-service to fully accountable value-based care in its 2023 filing (Chunk 1), which requires system enhancements, integrated care coordination technology, and enhanced clinical engagement to improve outcomes and reduce system-wide costs. This shift directly responds to 2024 funding pressures highlighted in Chunk 2, where CMS benchmark reductions and risk adjustment model changes created \"continued pressure\" in Medicare Advantage, forcing UnitedHealth to implement cost management strategies including network adjustments, benefit redesign, and premium increases while simultaneously advancing its accountable care infrastructure to meet CMS's quality star requirements and payment mechanisms that tie reimbursement to care coordination and outcomes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Impacted_By]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Care Delivery Models (PRODUCT)",
        "Care Delivery Models (PRODUCT) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11367,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3478,
        "completion_tokens": 245,
        "total_tokens": 3723
      }
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "Between 2022 and 2023, TMO's debt composition evolved with the 1.950% Notes due 2029 maintaining its presence in the 2022 schedule (Chunk 1) and continuing unchanged in the 2023 schedule (Chunk 2), indicating no modification to this specific instrument during this period. The 2023 filing additionally introduced new 3.200% Notes due 2034 (Chunk 2), reflecting a strategic expansion of TMO's debt profile with higher-yielding instruments while preserving the existing 1.950% Notes due 2029 as part of its long-term financing structure. This demonstrates TMO's approach to diversifying debt maturities and interest rates while retaining key legacy instruments like the 1.950% Notes due 2029.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "TMO (ORG) -> 1.950% Notes due 2029 (FIN_INST)",
        "1.950% Notes due 2029 (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3762,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1576,
        "completion_tokens": 172,
        "total_tokens": 1749
      }
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, TMO's debt composition showed notable evolution in its long-dated instruments, particularly with the sustained presence and reclassification of key note categories. The 0.500% Notes due 2028 (TMO 28A) remained a consistent component in both filings, maintaining its $1,000 principal value and New York Stock Exchange listing under TMO 28A and TMO 28 identifiers, reflecting no structural change in this specific tranche. Concurrently, the company introduced new debt instruments, most notably the 3.200% Notes due 2026 (TMO 26B) in 2023, which replaced the previously existing 2.000% Notes due 2025 (TMO 25) and 1.400% Notes due 2026 (TMO 26A) from the prior year's structure, indicating a strategic shift toward higher-yielding, longer-dated debt instruments to manage future capital requirements. This evolution is further underscored by the KG triplet relationship where TMO introduces FIN_INST entities like the 0.500% Notes due 2028, establishing a direct link between the issuer and its debt instruments across both reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "TMO (ORG) -> 0.500% Notes due 2028 (FIN_INST)",
        "0.500% Notes due 2028 (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3762,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1587,
        "completion_tokens": 265,
        "total_tokens": 1853
      }
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The excess of fair value over carrying value for DHR's reporting units decreased from a range of approximately 115% to 435% in the 2023 annual goodwill impairment analysis to a range of approximately 70% to 450% in the 2024 analysis, reflecting a modest contraction in the minimum and maximum excess percentages across both years. This change indicates that while the Company's reporting units continued to generate fair values exceeding carrying values in both years, the margin of excess narrowed slightly in 2024 compared to 2023, with the lowest excess percentage declining from 115% to 70% and the highest increasing marginally from 435% to 450%. Both analyses confirmed no impairment charges were required, as fair values consistently exceeded carrying values across all reporting units.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Conducts]-> ACCOUNTING_POLICY <-[Performs]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Annual Goodwill Impairment Analysis (ACCOUNTING_POLICY)",
        "Annual Goodwill Impairment Analysis (ACCOUNTING_POLICY) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12298,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3729,
        "completion_tokens": 198,
        "total_tokens": 3927
      }
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "From 2022 to 2023, the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan remained consistent in its mechanics: both types of events increase the available share pool by a factor of two times the number of RSUs canceled or shares withheld, as explicitly stated in Note 9 of the 2022 filing and reiterated in Note 11 of the 2023 filing. This policy, tied to the 2022 Plan’s structure and its predecessor the 2014 Plan (which was terminated for new grants in Q3 2022), ensures that cancellations and withholdings directly replenish the pool of shares available for future issuance, maintaining the same mathematical relationship across both years without alteration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> 2022 Employee Stock Plan (ACCOUNTING_POLICY)",
        "2022 Employee Stock Plan (ACCOUNTING_POLICY) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3458,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 174,
        "total_tokens": 1695
      }
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Danaher's strategic relationship with Aldevron has deepened significantly between 2023 and 2024, with Aldevron now fully integrated into Danaher's Life Sciences segment as a core business acquired in 2021 and expanded through the 2023 acquisition of Abcam. The financial stake is evidenced by the $9,561 million net cash consideration paid for Aldevron's net assets (as reported in DHR_10k_2023.pdf), which contributed to the Life Sciences segment's growth and strategic positioning. This integration is further solidified by Aldevron's role in providing critical bioprocessing and life sciences technologies—such as cell culture media, filtration solutions, and assay development tools—that directly support Danaher's Biotechnology segment, as detailed in DHR_10k_2024.pdf's segment description, where Aldevron's products are marketed under key brands like CYTIVA and PALL to pharmaceutical and biopharmaceutical customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Aldevron (COMP)",
        "Aldevron (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7881,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2609,
        "completion_tokens": 231,
        "total_tokens": 2840
      }
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Microsoft's strategic positioning of Microsoft 365 has evolved from a productivity suite to an AI-first platform integrating deeply with its commercial business metrics, as evidenced by its role in the \"Productivity and Business Processes\" segment that generated $75.3 billion in revenue for fiscal year 2023 (Chunk 2). The company explicitly positions Microsoft 365 as an \"AI first platform\" that unifies Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data in Microsoft Graph to streamline workflows across roles (Chunk 1). This integration is directly tied to commercial performance, as Microsoft 365's consumer subscription base (including Basic subscribers) and cloud revenue metrics now serve as key leading indicators of business health and future growth (Chunk 2). The evolution is further accelerated by AI-specific investments like Azure Maia and Cobalt hardware, enabling the company to monetize AI capabilities through both enterprise subscriptions (Copilot Pro) and role-specific extensions (Copilot for Sales, Service, Finance), thereby transforming Microsoft 365 into a central engine for commercial revenue generation and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Microsoft 365 (PRODUCT)",
        "Microsoft 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6453,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2265,
        "completion_tokens": 308,
        "total_tokens": 2573
      }
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Microsoft's positioning of Copilot Pro has evolved from a consumer-focused AI subscription to a core component of the Microsoft 365 ecosystem, with its role expanding significantly between 2023 and 2024. In both years, Copilot Pro was explicitly positioned as a service offering \"faster and more powerful AI assistance in Microsoft 365 apps and on the web\" (Chunk 1, Chunk 2), directly integrated into the AI-first Microsoft 365 platform that unifies Office, Windows, and Enterprise Mobility + Security. By 2024, its strategic emphasis intensified as part of Microsoft's broader push to embed AI across all productivity workflows, with Copilot Pro serving as the consumer-facing gateway to the more advanced Copilot capabilities within Microsoft 365 (e.g., Copilot for Sales, Service, and Finance), while LinkedIn leveraged similar AI to transform professional workflows (Chunk 1, Chunk 2). This evolution underscores Copilot Pro's role as the critical bridge between Microsoft's enterprise AI ambitions and individual user access to personalized, AI-enhanced productivity tools.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Copilot Pro (PRODUCT)",
        "Copilot Pro (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8702,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2818,
        "completion_tokens": 269,
        "total_tokens": 3088
      }
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan has maintained its structural framework through 2023‑2024, with the Company still authorizing new equity awards under the same plan; however, the pool of shares available for future issuance has been reduced to approximately 47 million shares as of December 31 2024, reflecting the shares already granted and outstanding under the plan. This remaining availability is distinct from the cash‑conversion events of the 4.75% MCPS Series A and 5.00% MCPS Series B preferred stocks, which converted into common shares in 2022 and early 2023 and are unrelated to the plan’s equity reserve. Consequently, while the plan’s governing terms and award types (stock options, RSUs, PSUs) remain unchanged, the number of shares that can still be issued under it has declined from the roughly 135 million shares ever authorized to the 47 million shares left for issuance at the end of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> 2007 Omnibus Incentive Plan (ACCOUNTING_POLICY)",
        "2007 Omnibus Incentive Plan (ACCOUNTING_POLICY) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2024.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5488,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2028,
        "completion_tokens": 226,
        "total_tokens": 2254
      }
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Microsoft increased the estimated useful lives of its server and network equipment from four to six years, effective in fiscal year 2023, as disclosed in both 2023 and 2024 10-K filings. This change, driven by software investments that improved operational efficiency and technological advances, reduced depreciation expenses and altered financial reporting for infrastructure costs. The policy shift reflects Microsoft's strategic adaptation to evolving cloud and AI infrastructure demands, directly impacting its accounting treatment of capital expenditures and long-term asset valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Useful Lives of Server Equipment (ACCOUNTING_POLICY)",
        "Useful Lives of Server Equipment (ACCOUNTING_POLICY) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8161,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2703,
        "completion_tokens": 147,
        "total_tokens": 2851
      }
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "From 2022 to 2023, MDT's exposure to auction rate securities decreased from $33 million in fair value (classified as Level 3 investments within Other Assets) to $33 million fair value but reclassified to Level 2 investments within Investments, with the same $3 million unrealized loss; this evolution reflects a shift in classification from Other Assets to Investments while maintaining the same fair value position, as evidenced by the $33 million fair value reported in both years with corresponding unrealized loss of $3.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MDT (ORG) -> Auction rate securities (FIN_INST)",
        "Auction rate securities (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4537,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1774,
        "completion_tokens": 131,
        "total_tokens": 1905
      }
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "The net gains (losses) on Cisco's available-for-sale debt investments decreased from $(21) million in fiscal 2023 to $(67) million in fiscal 2024, a $(46) million variance, indicating reduced investment performance in this category. This decline aligns with the valuation decreases observed in the securities portfolio, where fair values dropped from $15,592 million (2023) to $9,865 million (2024) under specific interest rate scenarios, reflecting broader market impacts on the company's debt investment strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Available-for-sale debt investments (FIN_INST)",
        "Available-for-sale debt investments (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4960,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1903,
        "completion_tokens": 128,
        "total_tokens": 2032
      }
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Cisco's operational structure in the APJC region remained anchored in its three-segment geographic organization (Americas, EMEA, APJC) across both fiscal 2023 and 2024, with APJC continuing to represent a distinct business unit focused on networking, security, collaboration, and observability solutions. While the core operational framework persisted, financial investment in the region evolved through strategic shifts toward AI integration and subscription-based consumption models, as evidenced by Cisco's emphasis on \"harnessing the power of AI and data\" and flexible consumption models in its 2023 strategy, which laid groundwork for 2024's focus on monetizing these innovations. This evolution directly impacts Cisco's revenue model in APJC by transitioning from traditional product sales toward recurring revenue streams via subscriptions and services, aligning with customer priorities of resilient infrastructure, cybersecurity, and AI adoption—thereby driving higher-margin, predictable revenue growth in the region despite macroeconomic headwinds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> APJC (GPE)",
        "APJC (GPE) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10561,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3285,
        "completion_tokens": 264,
        "total_tokens": 3549
      }
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Apple's approach to App Store commissions and regulatory compliance has evolved significantly between 2022 and 2024 in direct response to legal and market pressures. In 2022, the Company acknowledged that changes to its App Store model—such as those driven by the EU Digital Markets Act (DMA) and litigation—could materially impact its commission structure, potentially reducing revenue from digital sales and requiring shifts in how apps are distributed and monetized (Chunk 1). By 2024, Apple detailed concrete compliance measures, including alternative fee structures, new distribution channels, and modified payment systems in the EU to align with the DMA, while also adjusting communication policies in the U.S. regarding alternative purchasing mechanisms (Chunk 2). These changes reflect a strategic adaptation to regulatory scrutiny and competitive pressures, where failure to comply could reduce App Store sales volume and commission rates, directly affecting the Company’s financial condition (Chunk 1 & 2). The consistent emphasis across both years underscores that regulatory compliance is not just a legal obligation but a core business imperative tied to sustaining revenue from its platform ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AAPL (ORG) -> App Store (PRODUCT)",
        "App Store (PRODUCT) -> AAPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AAPL_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AAPL_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11812,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3589,
        "completion_tokens": 303,
        "total_tokens": 3893
      }
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "The allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan shifted significantly from 2022 to 2024, with fixed income securities decreasing from 80% in 2022 to 61% in 2024 while equity securities increased from 20% to 39%, reflecting a strategic rebalancing toward equities. This evolution is documented in the 2022 financial disclosures (Chunk 1) showing 80% fixed income ($238) and 20% equity ($137) allocations, and confirmed in the 2024 data (Chunk 2) where fixed income dropped to 61% and equity rose to 39%, aligning with the disclosed shift in asset class priorities across all provided chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> U.S. Retiree Health Care Plan (FIN_INST)",
        "U.S. Retiree Health Care Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3227,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 154,
        "total_tokens": 1610
      }
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "Texas Instruments' strategic emphasis on Embedded Processing Products has evolved from 2022 to 2024 as a core pillar of its business model, explicitly positioned to leverage its four sustainable competitive advantages—particularly the broad portfolio of analog and embedded processing products (Chunk 1). This focus directly supports its segment reporting structure, where Embedded Processing is now a distinct reportable segment alongside Analog, reflecting how the company allocates resources and measures performance based on revenue growth, gross margin, and operating profit (Chunk 2). Critically, the KG triplet relationship **TXN → Embedded Processing Products** and **Embedded Processing Products → TXN** underscores that this segment is not just a product line but a strategic differentiator, driving competitive advantages through diversified customer access and specialized digital \"brains\" for electronic systems, thereby reinforcing TI’s unique position in generating long-term free cash flow per share growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Embedded Processing Products (PRODUCT)",
        "Embedded Processing Products (PRODUCT) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7144,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2446,
        "completion_tokens": 255,
        "total_tokens": 2702
      }
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "TMO issued its 2.00% 10-Year Senior Notes due 2031 in both 2022 and 2024, with the 2022 issuance recorded at $1,200 million (carrying value) reflecting a 2.23% effective interest rate, and the 2024 issuance showing a near-identical $1,200 million carrying value at a 2.23% effective rate, indicating consistent valuation and issuance scale for this specific tranche across both years. The 2022 data (Chunk 1) confirms the notes were originally issued with a 2.23% effective rate and $1,200 million par value due 2031, while the 2024 data (Chunk 2) shows the same $1,200 million carrying value with a 2.23% effective rate, demonstrating no material change in the instrument's terms or valuation between 2022 and 2024. This consistency aligns with the KG pattern where TMO maintains a direct issuance relationship with the 2.00% 10-Year Senior Notes (FIN_INST), as evidenced by the identical $1,200 million carrying value and 2.23% effective rate reported in both 2022 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG",
      "triplets_used": [
        "TMO (ORG) -> 2.00% 10-Year Senior Notes (FIN_INST)",
        "2.00% 10-Year Senior Notes (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9649,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3042,
        "completion_tokens": 246,
        "total_tokens": 3288
      }
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "The financial performance of REMICADE has declined significantly between 2022 and 2024, with sales dropping from $1,839 million to $1,605 million—a 12.8% decrease—driven by an 11.4% operational decline and minor currency impact. This downward trend in REMICADE sales, alongside the broader Immunology segment's 1.2% total decrease ($17,828M to $18,052M), indicates that while REMICADE remains a key product within Johnson & Johnson's Pharmaceutical segment, its weakening performance reflects growing competitive or market pressures in immunology therapeutics. Despite this, REMICADE continues to contribute meaningfully to the segment's revenue, as evidenced by its presence in the 2024 financial tables and its historical role in the segment's portfolio, though its relative importance appears to be diminishing within JNJ's overall pharmaceutical strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> REMICADE (PRODUCT)",
        "REMICADE (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10194,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3185,
        "completion_tokens": 214,
        "total_tokens": 3400
      }
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "The sales performance of REMICADE declined from $3,190 million in 2021 to $1,605 million in 2024, reflecting a significant downward trend over the period, which indicates a weakening market position within JNJ's Immunology portfolio despite its historical prominence. This decline contrasts with the growth observed in newer immunology products like TREMFYA ($3,670 million in 2024) and SIMPONI/SIMPONIARIA ($2,190 million in 2024), suggesting a strategic shift toward newer assets as REMICADE's contribution to Total Immunology sales diminished from 18.9% in 2021 (3,190/16,750) to 9.0% in 2024 (1,605/17,828), highlighting its diminishing role in JNJ's current Immunology revenue mix.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> REMICADE (PRODUCT)",
        "REMICADE (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7980,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2629,
        "completion_tokens": 171,
        "total_tokens": 2800
      }
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "The sales of REMICADE declined by 12.8% from $1,839 million in 2023 to $1,605 million in 2024, reflecting ongoing biosimilar competition that has persisted since at least 2021, as noted in Chunk 1 where biosimilars were identified as a key factor reducing REMICADE sales and were expected to drive further declines. This downward trend continued into 2024, with the 2024 figure ($1,605M) remaining significantly below the 2021 level implied by the earlier context, though absolute 2021 sales are not directly stated in Chunk 2. The decline was partially offset by growth in other immunology products like SIMPONI/SIMPONIARIA ($2,190M in 2024) and TREMFYA ($3,670M in 2024), which grew 16.6% year-over-year, contributing to the broader immunology segment's performance. The expiration of STELARA's U.S. patent in September 2023 (Chunk 1) likely impacted its sales, but REMICADE's decline was driven specifically by biosimilar competition rather than patent expiration, as REMICADE's patent life was not cited as a factor in the provided data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> REMICADE (PRODUCT)",
        "REMICADE (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7429,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2481,
        "completion_tokens": 260,
        "total_tokens": 2742
      }
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Between 2022 and 2024, STELARA's commercial performance declined significantly, with sales dropping 4.6% from $10,858 million in 2023 to $10,361 million in 2024 (Chunk 2), reflecting reduced market penetration despite maintaining pediatric psoriatic arthritis approval (Chunk 1). This decline occurred within JNJ's broader immunology portfolio, which saw total immunology sales decrease 1.2% to $17,828 million in 2024 (Chunk 2), indicating competitive pressures affecting STELARA's position even as JNJ continued to leverage its established relationship with the product (KG: JNJ Introduces STELARA).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> STELARA (PRODUCT)",
        "STELARA (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11031,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3378,
        "completion_tokens": 150,
        "total_tokens": 3528
      }
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "Based on the provided financial data across both chunks, the total net revenue from Restasis in the United States experienced a significant decline. In 2023, Restasis generated $382 million in the U.S. (Chunk 1), which decreased to $172 million in 2024 (Chunk 2), representing a 55.2% decrease from 2023 to 2024. This follows a prior 38.5% decrease observed between 2022 and 2023 (as shown in the 2023 data within Chunk 1). The overall trend indicates a sustained downward trajectory in U.S. sales of Restasis, with both years showing double-digit percentage declines, totaling a cumulative reduction of over 55% from 2023 levels. This contraction is consistent with the broader revenue shifts noted across other eye care products and aligns with the disclosed percentage changes in the financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "ABBV (ORG) -> Restasis (PRODUCT)",
        "Restasis (PRODUCT) -> ABBV (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABBV_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABBV_10k_2024.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14548,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4269,
        "completion_tokens": 202,
        "total_tokens": 4471
      }
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "The strategic role of Master Lease Agreements has intensified between 2022 and 2023 as AMT expanded its international footprint from approximately 177,000 to 182,000 communications sites, directly supporting growth in emerging markets where network densification and technology transitions (e.g., 2G-to-4G in India, 4G/5G adoption in Latin America) drive new tenant demand. These agreements have evolved from simple revenue generators into comprehensive strategic tools that reduce tenant churn, accelerate colocation cycles, and enable rapid deployment of equipment—critical for capturing opportunities in markets with evolving wireless infrastructure, such as Bangladesh, Nigeria, and South Africa, where carriers are aggressively investing in data networks despite nascent smartphone penetration. This evolution is underscored by AMT’s 2023 acquisition of 3,355 new sites globally, which generated incremental tenant and pass-through revenue while reinforcing the master lease framework as a cornerstone of its international growth strategy and long-term partnerships with multinational carriers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Master Lease Agreements (ACCOUNTING_POLICY)",
        "Master Lease Agreements (ACCOUNTING_POLICY) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9172,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2945,
        "completion_tokens": 274,
        "total_tokens": 3220
      }
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "The role of Google Marketing Platform in advertising revenue generation has expanded significantly between 2023 and 2024, particularly as a dedicated channel for monetizing inventory across Google Network properties through programmatic and automated advertising solutions. In 2023, advertising revenues from Google Network properties—including those generated via Google Marketing Platform—were recognized on a gross basis when we acted as the principal, with revenues recorded at the full amount billed to customers before sharing with partners; this recognition model persisted into 2024, where Google Marketing Platform remained a key channel for delivering ads on Google Network properties, enabling the company to maintain control over advertising inventory and pricing while generating revenue from both performance and brand advertising through this platform.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Marketing Platform (PRODUCT)",
        "Google Marketing Platform (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8532,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2797,
        "completion_tokens": 216,
        "total_tokens": 3014
      }
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "Based on the financial data across both chunks, Federal Funds Purchased & Securities Loaned increased from **$14,804 million (2023)** to **$570,236 million (2024)** in volume, while its fair value measurement decreased from **$16,466 million (2023)** to **$192,859 million (2024)**. This dramatic shift indicates Bank of America significantly expanded its short-term funding reliance on wholesale money markets—particularly through Federal Funds Purchased—to support liquidity needs or asset-liability management, though the declining fair value relative to volume suggests heightened market sensitivity or potential valuation discounts in a rising rate environment. The parallel movement in related line items (e.g., Short-term borrowings rising to $6,245 million and Derivative liabilities increasing) further confirms a strategic pivot toward external funding sources rather than core deposit growth for short-term financing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Fed Funds Purchased & Sec Loaned (FIN_INST)",
        "Fed Funds Purchased & Sec Loaned (FIN_INST) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_155",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 24383,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6747,
        "completion_tokens": 232,
        "total_tokens": 6979
      }
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "PepsiCo's 2022 disclosure explicitly identifies the sensitivity of pension and retiree medical plan assets and liabilities to market fluctuations in the \"Our Critical Accounting Policies and Estimates\" section, while its 2024 filing expands this exposure to include impacts on indefinite-lived intangible assets and reiterates the market risk connection through hedging strategies and commodity/foreign exchange volatility. Both years link market fluctuations to financial instruments via derivatives (noted in Note 9), with 2024 further quantifying commodity derivative notional values ($1.4B in 2024 vs. $1.7B in 2023) and their potential $140M impact from price shifts, demonstrating an evolved but consistent focus on market sensitivity across pension-related liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Pension and Retiree Medical Plan Liabilities (FIN_INST)",
        "Pension and Retiree Medical Plan Liabilities (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7352,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2492,
        "completion_tokens": 194,
        "total_tokens": 2686
      }
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Adobe Scan has evolved from a standalone mobile scanning tool into a tightly integrated component of Adobe's broader Document Cloud ecosystem, now positioned alongside Acrobat and Acrobat Sign as part of Adobe Document Cloud's unified platform for document management. The 2024 update emphasizes its role within Adobe's AI-driven workflow, particularly through integration with Adobe Document Cloud's services that enable instant sharing, conversion of scanned documents into editable/searchable PDFs via Adobe Sensei, and seamless connectivity across Adobe's Creative Cloud and Experience Cloud platforms. This evolution reflects Adobe's strategy to position scanning not as a discrete feature but as a foundational capability within its comprehensive document management and digital experience ecosystem, supporting end-to-end workflows from document capture to collaboration and e-signature.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Scan (PRODUCT)",
        "Adobe Scan (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10047,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3149,
        "completion_tokens": 223,
        "total_tokens": 3373
      }
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini's integration across Google's products has evolved from its initial 2023 launch as a natively multimodal model to a foundational component powering AI features across all seven of Google's two-billion-user products (Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube) by 2024, with significant advancements in multimodal capabilities demonstrated by Gemini 2.0's enhanced understanding and combination of text, code, audio, images, and video. The model's progression is further evidenced by its application in specialized research prototypes like Project Astra (exploring universal AI assistants) and Project Mariner (an early Chrome extension prototype for action-taking), while also driving innovations in Google Cloud through Vertex AI and Gemini for Google Cloud, which provide pre-packaged AI agents for developers and cybersecurity teams, and enabling features such as AI Overviews, NotebookLM, and Gemini's image generation and coding support in Workspace and YouTube.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Gemini (PRODUCT)",
        "Gemini (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11081,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3411,
        "completion_tokens": 248,
        "total_tokens": 3659
      }
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Linde's relationship with helium has evolved significantly between 2022 and 2024, with helium now operating as a critical raw material under the KG pattern where \"Helium (RAW_MATERIAL) -> LIN (ORG)\" indicates its direct impact on Linde's operations. While sales for Linde's \"Other\" segment—which includes global helium wholesale—decreased $32 million (2%) in 2024 versus 2023 due to lower helium volumes, operating profit in this segment increased $19 million (44%) driven by insurance recovery for LAMT partially offset by higher helium-related costs, demonstrating a complex evolution where helium's negative impact on volumes is partially mitigated by cost recovery mechanisms. This dynamic is further contextualized by the KG triplet \"ORG -[Supplies]-> RAW_MATERIAL <-[Negatively_Impacts]- ORG\" showing how helium as a raw material negatively affects Linde's business, yet the 2024 results reveal operational resilience through insurance gains despite ongoing helium cost pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> RAW_MATERIAL <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Helium (RAW_MATERIAL)",
        "Helium (RAW_MATERIAL) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2022.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1310,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 962,
        "completion_tokens": 246,
        "total_tokens": 1208
      }
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights declined from $1,538 million in 2022 to $1,102 million in 2024, a reduction of $436 million over the two‑year period. This decrease reflects the combined effect of higher accumulated amortization and lower gross balances reported in the 2024 filing, as shown in the comparative tables for 2022, 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Acquired Franchise Rights (FIN_INST)",
        "Acquired Franchise Rights (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3124,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 88,
        "total_tokens": 1504
      }
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil increased from 2023 to 2024, with \"as sold\" natural gas volumes rising from 7,148 million to 7,569 million cubic feet per day, reflecting higher production at Tengizchevroil (as indicated by the KG triplet CVX -[Depends_On]-> Tengizchevroil and Tengizchevroil -[Depends_On]-> CVX). The company's contractual obligations under delivery commitments, which include fixed quantities for natural gas sales, were maintained through 2026, with 2024 volumes showing growth compared to 2023, consistent with the operational data provided in both chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2446,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 159,
        "total_tokens": 1399
      }
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "The role of Google Network partners in Google's advertising revenue model has evolved significantly between 2023 and 2024, as reflected in the shift from describing payments to these partners as part of \"payments to Google Network partners primarily for ads displayed on their properties\" (2023) to explicitly integrating them into the \"Cost of Revenues\" structure where TAC includes \"amounts paid to Google Network partners primarily for ads displayed on their properties\" (2024). This evolution indicates a more formalized and financially significant relationship, where payments to Network partners are now a standardized, measurable component of revenue cost structure rather than an ancillary distribution channel—directly tying partner compensation to ad performance on their properties and embedding it within Google's core advertising monetization framework. The KG triplet connections (GOOGL → Google Network Partners ← Supplies) and the consistent reference to \"ads displayed on their properties\" across both years confirm this structural integration, showing that Network partners are no longer peripheral but central to the revenue model's operational mechanics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Network Partners (COMP)",
        "Google Network Partners (COMP) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7767,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2589,
        "completion_tokens": 293,
        "total_tokens": 2882
      }
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, the impact of public policies on Bank of America’s climate-related regulatory requirements has intensified through greater jurisdictional divergence and heightened compliance risks. Both the 2023 and 2024 10-K filings highlight that an increasing global regulatory focus—including state, federal, and non-U.S. jurisdictions—has introduced new or heightened climate-related requirements, creating divergent rules across regions and amplifying legal, compliance, and reputational exposure. This evolving landscape directly affects BAC’s ability to meet its GHG emissions targets by 2030 and net-zero by 2050, with climate-related data challenges, transition risks, and stakeholder scrutiny further elevating compliance costs and operational uncertainty.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Public Policies (REGULATORY_REQUIREMENT)",
        "Public Policies (REGULATORY_REQUIREMENT) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15557,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4551,
        "completion_tokens": 192,
        "total_tokens": 4744
      }
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "General Motors' strategic emphasis on full-size pickup trucks has intensified from 2022 to 2024, with the 2024 10-K explicitly highlighting these trucks as a \"successful line\" (Chunk 1) and citing them as a primary driver of revenue growth through \"increased sales of full-size pickup trucks\" alongside mid-size pickups and SUVs (Chunk 2). This focus is quantitatively validated by 2024 performance metrics: GMNA's net sales rose significantly due to \"increased sales of full-size pickup trucks\" contributing to higher wholesale volumes and favorable pricing/mix, while EBIT-adjusted profitability was notably bolstered by this segment's strong volume and mix, with trucks contributing approximately 160% of portfolio profit margins (Chunk 2). The 2024 data thus demonstrates a clear strategic shift toward stronger market positioning for full-size pickups, evidenced by their disproportionate impact on revenue growth, volume-driven profitability, and favorable pricing dynamics relative to other vehicle categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GM (ORG) -> Full-Size Pickup Trucks (PRODUCT)",
        "Full-Size Pickup Trucks (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8526,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2790,
        "completion_tokens": 254,
        "total_tokens": 3045
      }
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "From 2022 to 2024, the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts increased significantly, rising from $21 million (Alabama Power) and $293 million (Georgia Power) in 2022 to $20 million (Alabama) and $349 million (Georgia) in 2023, reflecting a strategic shift toward safer, more liquid assets amid regulatory and funding pressures. This evolution underscores the company’s conservative investment approach to de-risk the nuclear trust portfolios, aligning with liability-driven investment (LDI) principles to ensure stable cash flows for decommissioning obligations. The consistent growth across both entities, as captured in Chunk 1 (2022) and Chunk 2 (2023), confirms a deliberate reallocation from riskier assets like corporate bonds and private equity toward U.S. Treasuries, driven by market volatility and regulatory requirements. This trend is further reinforced by the KG triplet relationship where U.S. Treasury and government agency securities (FIN_INST) are held by SO (ORG), with the shift directly tied to evolving liability management strategies in the decommissioning trusts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> U.S. Treasury and government agency securities (FIN_INST)",
        "U.S. Treasury and government agency securities (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2022.pdf",
          "page_id": "page_311",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_277",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21580,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6064,
        "completion_tokens": 288,
        "total_tokens": 6352
      }
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "PepsiCo's relationship with independent bottlers has deepened strategic dependency while evolving financial incentives, as evidenced by contractual bottler funding negotiations tied to annual targets and market concentration risks. The 2024 10-K reveals that bottler funding—covering advertising, new product support, and equipment placement—is now negotiated annually with each bottler to drive consumer promotions, retail distribution, and vending infrastructure, directly linking financial support to market expansion amid industry consolidation (e.g., Walmart's 14% revenue contribution). This dependency is underscored by the company's reliance on bottlers for finished goods distribution to major clients like Walmart, making the relationship both financially incentivized and operationally critical for sustaining brand growth and market share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Independent Bottlers (COMP)",
        "Independent Bottlers (COMP) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8764,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2826,
        "completion_tokens": 212,
        "total_tokens": 3039
      }
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly's role in Adobe's product innovation strategy has evolved from a newly introduced generative AI product in 2023 to a central component of the company's AI-driven innovation agenda by 2024, as evidenced by its explicit inclusion in the trademark portfolio (ADBE → Adobe Firefly) and its strategic positioning within risk disclosures about AI innovation and regulatory challenges (Adobe Firefly → ADBE). The 2023 10-K highlighted Firefly as part of Adobe's expanding AI portfolio amid industry disruption, while the 2024 10-K elevated it to a critical focus area for AI integration, emphasizing its role in product development, monetization risks, and compliance with evolving AI regulations like the EU AI Act, which directly impacts Adobe's ability to deploy and sustain Firefly-based offerings without costly modifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Firefly (PRODUCT)",
        "Adobe Firefly (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7180,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2438,
        "completion_tokens": 209,
        "total_tokens": 2648
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "Between 2022 and 2023, contractual rent escalations remained a key driver of property revenue growth, but their impact was partially offset by elevated churn—approximately 3% of tenant billings in 2023, primarily from U.S. and Canada—driven by lease cancellations, notably T-Mobile’s non-renewals under the September 2020 MLA. While escalations continue to contribute to revenue growth through rent increases on existing leases (net of churn), the rise in churn has introduced volatility, potentially reducing the net contribution of escalations compared to prior periods. This shift underscores a growing interplay between escalation-driven growth and churn-related revenue losses, particularly in key segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Contractual Rent Escalations (ACCOUNTING_POLICY)",
        "Contractual Rent Escalations (ACCOUNTING_POLICY) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11425,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3517,
        "completion_tokens": 178,
        "total_tokens": 3695
      }
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's capital expenditure commitment to Tengizchevroil increased from $1.5 billion in 2023 (half of its $3 billion 2024 affiliate capex) to a planned $3 billion in 2024, reflecting a continued focus on the FGP/WPMP project in Kazakhstan, while production volumes from Tengizchevroil are included in Chevron's reported sales and are subject to the company's ability to adjust future outlays based on market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Tengizchevroil (COMP)",
        "Tengizchevroil (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3322,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 105,
        "total_tokens": 1572
      }
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "The specificity of UPS's bond matching approach for determining discount rates in its U.S. pension and postretirement plans has remained consistent between 2023 and 2024, with both years explicitly describing the use of a bond matching approach to select specific bonds that satisfy projected benefit payments, reflecting the process they would employ to settle obligations. While the 2023 and 2024 disclosures (in Chunks 1 and 2) do not indicate any change in methodology, they both emphasize that the approach is applied to U.S. plans and updated annually based on measurement-date conditions, with no mention of increased or decreased specificity—only the consistent application of this method across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Guides_On]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Bond Matching Approach (ACCOUNTING_POLICY)",
        "Bond Matching Approach (ACCOUNTING_POLICY) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2088,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 178,
        "total_tokens": 1353
      }
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "From 2022 to 2024, Linde's relationship with helium evolved through a strategic shift in its business focus, particularly within its \"Other\" segment, which includes global helium wholesale. As noted in the KG pattern (ORG -[Supplies]-> RAW_MATERIAL <-[Negatively_Impacts]- ORG), helium functions as a raw material whose supply dynamics directly impact Linde's operational performance. This is reflected in Chunk 2, where helium-related volume declines contributed to a 2% underlying sales decrease in the \"Other\" segment in 2024, despite stable currency effects. However, the financial impact was not uniformly negative: while lower helium volumes pressured sales, Chunk 2 reports that operating profit in \"Other\" increased by $19 million (44%) due to insurance recoveries for LAMT partially offsetting higher helium-related costs. This indicates that Linde adapted to evolving helium supply conditions through cost management and risk mitigation, ultimately improving profitability even as sales faced pressure from volume reductions tied to helium supply constraints. The 2022 context (Chunk 1) provides the baseline for this evolution, showing helium's role in Linde's industrial gases operations prior to these strategic adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> RAW_MATERIAL <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Helium (RAW_MATERIAL)",
        "Helium (RAW_MATERIAL) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1300,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 969,
        "completion_tokens": 309,
        "total_tokens": 1279
      }
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Based on the provided 10-K filings and KG relationships, Bank of America's unfunded capital contributions for renewable energy investments **decreased** from $6.2 billion (2023) to $4.6 billion (2024), a reduction of $1.6 billion. This decline correlates with a **decrease in recognized tax credits** from $4.0 billion (2023) to $3.9 billion (2024), reflecting the direct relationship between unfunded commitments and tax credit recognition as disclosed in both chunks. The reduction in both metrics aligns with the Corporation's contingent funding structure for renewable energy VIEs, where lower unfunded contributions correspond to slightly reduced tax credit benefits in the subsequent period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "BAC (ORG) -> Unfunded Capital Contributions (FIN_INST)",
        "Unfunded Capital Contributions (FIN_INST) -> BAC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BAC_10k_2023.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BAC_10k_2024.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4329,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1743,
        "completion_tokens": 174,
        "total_tokens": 1917
      }
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "From 2022 to 2024, General Motors' approach to fleet sales involving commercial fleet customers has evolved in terms of sales channels and profitability considerations as follows:  \n- **Sales Channels**: Fleet sales continue to be executed through GM's dealer network and, in some cases, directly with fleet customers (e.g., commercial fleets, governments), as noted in both 2022 and 2024 disclosures (Chunk 1 and Chunk 2).  \n- **Profitability Focus**: GM explicitly prioritizes profitability by treating fleet sales—particularly to daily rental companies—as less profitable than retail sales, with ongoing efforts to optimize fleet mix and channel efficiency (Chunk 1 and Chunk 2).  \n- **Strategic Context**: This evolution aligns with GM's broader segment reporting strategy (GMNA/GMI), where fleet sales are managed as part of consolidated operations to support fixed cost efficiency and resource allocation, reflecting a deliberate shift toward higher-margin retail channels while maintaining fleet sales as a strategic, albeit lower-margin, component of total volume (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Sells_To]- ORG",
      "triplets_used": [
        "GM (ORG) -> Commercial Fleet Customers (COMP)",
        "Commercial Fleet Customers (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4439,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1757,
        "completion_tokens": 270,
        "total_tokens": 2027
      }
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "PepsiCo's relationship with Sabra evolved significantly between 2022 and 2024, transitioning from a 39% noncontrolling interest in a joint venture (retaining distribution rights in the U.S. for small-format and foodservice customers) to full ownership following the sale of Tropicana and other juice brands to PAI Partners. This strategic shift culminated in a pre-tax gain of $122 million ($92 million after-tax) in 2024 from remeasuring PepsiCo's previously held 50% equity stake in Sabra at fair value, as disclosed in Note 13 of the financial statements. The financial implications included a direct positive impact on PepsiCo's earnings through this gain, while also reflecting the broader divestiture of juice assets and the reallocation of resources toward core beverage and snack segments, as evidenced by the $2,888 million after-tax proceeds from the Juice Transaction affecting PBNA and Europe divisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Sabra (PRODUCT)",
        "Sabra (PRODUCT) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7386,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2474,
        "completion_tokens": 228,
        "total_tokens": 2703
      }
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Adobe Scan has evolved from a standalone document scanning tool to a core component of Adobe's Document Cloud suite, now deeply integrated with Creative Cloud applications and enhanced by Firefly AI capabilities. While the 2023 10-K listing confirms Adobe Scan as a registered trademark under Adobe Inc., the 2024 10-K reveals its expanded positioning: it now operates within Adobe's broader Document Cloud ecosystem (which includes Acrobat, Acrobat Sign, and Document Cloud services) and benefits from Firefly-powered generative AI features that enhance its functionality across Adobe's product ecosystem. This evolution reflects Adobe's strategy to position Document Cloud—including Adobe Scan—as a unified platform for digital document workflows, tightly integrated with Creative Cloud tools like Photoshop and Illustrator, while leveraging Firefly's commercial-safe generative AI to extend its value within Adobe's interconnected product landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ADBE (ORG) -> Adobe Scan (PRODUCT)",
        "Adobe Scan (PRODUCT) -> ADBE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ADBE_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ADBE_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5997,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2132,
        "completion_tokens": 238,
        "total_tokens": 2370
      }
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "From 2022 to 2024, GM's financial exposure and indemnification obligations to Stellantis have remained limited and largely contingent, with no material liabilities recognized. While GM continues to indemnify Stellantis for certain post-sale liabilities—including emissions-related claims, product recalls (such as Takata inflators in legacy Opel vehicles), and potential regulatory fines from EU/UK competition investigations—the company explicitly states it cannot estimate any reasonably possible material loss from these obligations, and any future indemnification claims are considered remote. This indemnification framework, rooted in the 2017 sale agreement, persists without measurable financial impact on GM’s balance sheet, as evidenced by the immaterial accruals and lack of quantified exposure in its 2024 disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Guarantees]- ORG",
      "triplets_used": [
        "GM (ORG) -> Stellantis (COMP)",
        "Stellantis (COMP) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6572,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2281,
        "completion_tokens": 207,
        "total_tokens": 2488
      }
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "PepsiCo's operational dependency on co-packers has deepened through expanded distribution infrastructure while maintaining strategic oversight, as evidenced by both 2022 and 2024 disclosures confirming their continued use of co-packers' owned/leased facilities within their \"highly distributed network\" for plants and warehouses, though the 2024 filing specifically notes legal challenges related to plastic pollution that may indirectly impact co-packing operations. While the knowledge graph shows mutual dependency (PEP ↔ Co-Packers), the 2024 annual report reveals increased regulatory scrutiny through the New York Attorney General's plastic pollution lawsuit—later dismissed at the trial level but appealed—demonstrating how external legal pressures now intersect with PepsiCo's co-packing relationships, potentially influencing future strategic involvement despite unchanged operational reliance on these partners for distribution capacity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PEP (ORG) -> Co-Packers (COMP)",
        "Co-Packers (COMP) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2022.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2971,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 236,
        "total_tokens": 1612
      }
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "SPG's financial relationship with ABG evolved significantly between 2023 and 2024 through strategic investments and gains recognition. In 2023, SPG recognized $145.8 million in non-cash pre-tax gains from SPARC Group's equity issuance diluting its ABG stake to 33.3%, alongside $59.1 million in gains from ABG's capital transactions causing further dilution, plus $157.1 million from partial ABG interest sales - all stemming from the KG pattern ORG-Has_Stake_In-COMP with mutual disclosures. By 2024, SPG recorded an $18.8 million pre-tax gain from selling a portion of its ABG interest in December 2021 (followed by a $100 million reinvestment), while simultaneously entering a strategic partnership where SPARC Group became ABG's core U.S. licensee for Reebok operations, demonstrating how the ORG-Has_Stake_In-COMP relationship directly drove both financial gains and strategic business evolution across both chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> ABG (COMP)",
        "ABG (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2288,
        "completion_tokens": 230,
        "total_tokens": 2518
      }
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "Lockheed Martin's involvement in Sikorsky helicopter programs has expanded significantly from 2022 to 2024, with production volume increasing across multiple platforms including the CH-53K King Stallion heavy-lift helicopter and other Sikorsky models, as evidenced by the $560 million higher product costs at RMS attributed to higher production volume on various Sikorsky helicopter programs in 2021 (Chunk 1) and the explicit inclusion of Sikorsky helicopter programs as core to RMS' portfolio in 2024 (Chunk 2). The program scope has broadened to encompass not only legacy platforms like Black Hawk and Seahawk but also advanced capabilities such as the CH-53K and hypersonics integration, while RMS continues to support classified government contracts and global logistics services, reflecting a strategic evolution from 2022's focus on volume growth to 2024's expanded technological and operational footprint.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Sikorsky Helicopter Programs (PRODUCT)",
        "Sikorsky Helicopter Programs (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10316,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3224,
        "completion_tokens": 228,
        "total_tokens": 3452
      }
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "Walmart's ownership stake and financial investment in Alert Innovation evolved significantly between fiscal 2023 and 2024: the company acquired Alert Innovation for $0.4 billion in fiscal 2023, increasing its ownership to 100% (as noted in Chunk 1), and subsequently sold and deconsolidated the entity in fiscal 2025 (Chunk 2); however, during fiscal 2024, Walmart's investment was partially offset by a $3.5 billion outflow for Flipkart and PhonePe transactions (Chunk 1), while Chunk 2 confirms the 2023 acquisition was completed to achieve full ownership, though the entity was later divested.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Acquires]- ORG",
      "triplets_used": [
        "WMT (ORG) -> Alert Innovation (COMP)",
        "Alert Innovation (COMP) -> WMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WMT_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WMT_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4905,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1854,
        "completion_tokens": 149,
        "total_tokens": 2003
      }
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG significantly reduced its reliance on the Supplemental Facility through targeted repayments funded by debt capital markets activity. In 2023, SPG drew $180 million under the Credit Facility and later used proceeds from €750 million of exchangeable bonds (settled November 17, 2023) to fully repay the €750 million ($815.4 million USD equivalent) outstanding under the Supplemental Facility, effectively retiring that specific borrowing channel. This was preceded by strategic debt refinancing, including issuing $1.3 billion in new senior notes in March 2023 ($650M at 5.50% and $650M at 5.85%) and redeeming $500 million floating rate notes, followed by redeeming $600 million 2.75% notes in June 2023 and $600 million 3.75% notes in February 2024. The culmination of this strategy occurred in September 2024 when SPG redeemed its $1.0 billion 2.00% notes at par and issued $1.0 billion of new 4.75% notes due 2034, further strengthening its balance sheet and reducing Supplemental Facility usage. By December 31, 2024, borrowings under the Commercial Paper program (which relies on Credit Facility support) stood at zero, reflecting a disciplined approach to managing liquidity and capital structure while maintaining investment-grade credit ratings through proactive debt maturity management and facility optimization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Supplemental Facility (FIN_INST)",
        "Supplemental Facility (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9271,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2962,
        "completion_tokens": 337,
        "total_tokens": 3299
      }
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Linde's treatment of helium in its industrial gases business has evolved from being a secondary atmospheric byproduct to a strategically positioned primary product with dedicated supply chain development, particularly evident in its 2024 focus on securing long-term merchant helium contracts and expanding pipeline infrastructure to support growing demand in semiconductor and cryogenic applications, while maintaining its status as a critical raw material under the KG relationship pattern where Helium (RAW_MATERIAL) depends on LIN (ORG) for production and distribution through merchant and packaged gas channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> RAW_MATERIAL <-[Depends_On]- ORG",
      "triplets_used": [
        "LIN (ORG) -> Helium (RAW_MATERIAL)",
        "Helium (RAW_MATERIAL) -> LIN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LIN_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LIN_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1990,
        "completion_tokens": 153,
        "total_tokens": 2144
      }
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retiree Health Care Plan's allocation in fixed income securities decreased from $10 million to $4 million, while equity securities dropped from $137 million to $54 million. This shift reflects a reduction in both fixed‑income and equity holdings within the plan’s portfolio over the one‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> U.S. Retiree Health Care Plan (FIN_INST)",
        "U.S. Retiree Health Care Plan (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4202,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1700,
        "completion_tokens": 82,
        "total_tokens": 1783
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Based on the comprehensive analysis of all provided data across Chunk 1 and Chunk 2, including the KG triplets and financial disclosures:\n\nTrodelvy's revenue demonstrated significant growth from $380 million in 2021 to $49 million in 2022 (reflecting early commercial traction), with 2023 showing further expansion as it achieved key regulatory milestones including FDA and EC approvals for HR+/HER2- metastatic breast cancer monotherapy. This strategic positioning was solidified through the exclusive license agreement with Compugen for novel anti-IL18 antibodies and the collaboration with Tentarix Biotherapeutics, while its integration into Gilead's broader oncology portfolio was underscored by the acquisition of XinThera and Tmunity, enhancing its pipeline with PARP1 inhibitors and armored CAR-T technology. The product's revenue contribution was further amplified by its inclusion in total revenues ($27.3 billion in 2022, $24.7 billion in 2023), supported by regulatory approvals in key markets like China (via Fosun Kite joint venture) and Japan (Yescarta transfer), establishing Trodelvy as a critical growth driver within Gilead's diversified therapeutic landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 36068,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 9656,
        "completion_tokens": 294,
        "total_tokens": 9950
      }
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron's downstream-related earnings and investment relationship with GS Caltex evolved significantly from 2022 to 2024, demonstrating its strategic importance. In 2022, GS Caltex contributed to improved downstream earnings noted in CVX's 2021 MD&A (though referenced as 2021 data for context), and by 2024, Chevron maintained a 50% stake in GS Caltex, with $13,850 million in sales and $6,547 million in crude oil/product purchases from the joint venture (Chunk 2). This consistent partnership, highlighted alongside other major equity affiliates like Tengizchevroil and Angola LNG in Chevron's 2024 disclosures (Chunk 2), underscores GS Caltex as a key strategic asset where Chevron's investment is deeply integrated into its global downstream operations and financial performance. The joint venture's role in generating substantial affiliated revenue streams and the inclusion of its financial data in Chevron's consolidated reports (e.g., $1,258 million receivables from affiliates) confirm its critical contribution to Chevron's downstream strategy and long-term value creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> GS Caltex (COMP)",
        "GS Caltex (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2024.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3547,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 271,
        "total_tokens": 1801
      }
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program’s financial and production trajectory was defined by risk retirements, volume growth, and strategic portfolio shifts. In 2021, Sikorsky’s CH-53K contributed to a $140 million operating‑profit lift driven by higher risk retirements and increased production volume, while the 2024 LMT filing notes a $1.2 billion profit‑booking adjustment tied to a classified program that offset the gains from production ramp‑up on CH-53K and other tactical missile systems. Consequently, although overall MFC operating profit fell 73 % in 2024 due to those adjustments, the CH-53K remained a key growth driver, reflected in a rising backlog and continued volume expansion across rotary and mission systems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "LMT (ORG) -> CH-53K (PRODUCT)",
        "CH-53K (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3289,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 182,
        "total_tokens": 1640
      }
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "PayPal's approach to seller protection programs shifted from a focus on mitigating transaction loss risk (evidenced by its historical risk exposure tied to accounting policies for buyer/seller protection programs and the $0.09–0.15% transaction loss rate range noted in 2021) to a strategic emphasis on program consistency and trust-building, as highlighted in its 2023 10-K where it describes these programs as \"generally consistent with or broader than protections provided by other participants in the payments industry\" to reinforce merchant and consumer confidence. This evolution reflects a deliberate move to strengthen its competitive differentiation—positioning seller protection as a core trust signal amid intensifying competition from banks, fintechs, and emerging payment methods—while maintaining risk management through data-driven safeguards across its two-sided network, ensuring protection programs remain resilient against fraud and regulatory changes without altering their foundational role in its value proposition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Risk]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Seller Protection Programs (ACCOUNTING_POLICY)",
        "Seller Protection Programs (ACCOUNTING_POLICY) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10284,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3220,
        "completion_tokens": 259,
        "total_tokens": 3480
      }
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Starbucks' approach to its ready-to-drink beverages has evolved between 2023 and 2024 through refined revenue recognition practices and supplier management. The company recognizes revenue from ready-to-drink beverage sales to Nestlé and other third parties upon shipment, consistent with its standard product sales recognition policy, while also recognizing royalty revenues from Nestlé based on reported sales of these products. Regarding supplier dependency, Starbucks maintains long-term supply contracts with specialty suppliers for ready-to-drink beverages and other products, and explicitly states that the risk of non-delivery from established suppliers—including those for dairy and packaged goods—is remote, indicating stable supplier relationships that support continued production without significant disruption. This supplier stability aligns with the company's operational resilience strategy as reflected in its 2024 disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Ready to Drink Beverages (PRODUCT)",
        "Ready to Drink Beverages (PRODUCT) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10814,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3347,
        "completion_tokens": 235,
        "total_tokens": 3583
      }
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's geographic reach expanded significantly with regulatory approvals extending to new markets. The FDA approved Trodelvy for metastatic HR+/HER2- breast cancer in 2023, while the EC approved it as monotherapy for similar breast cancer patients in the EU. Additionally, China's NMPA approved axicabtagene ciloleucel (Yikaida), a separate GILD-developed CAR-T therapy (not Trodelvy), through the Fosun Kite joint venture, reflecting GILD's expanded global footprint in oncology. This growth occurred alongside GILD's strategic acquisitions of XinThera and Tmunity to bolster its pipeline, though Trodelvy itself remained a key product under GILD's portfolio with established U.S. sales of $370M in 2021 (rising to $49M in 2022 per Chunk 1, though 2023 figures are not explicitly stated).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Trodelvy (PRODUCT)",
        "Trodelvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8402,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2720,
        "completion_tokens": 204,
        "total_tokens": 2924
      }
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Simon Property Group's ownership stake in ABG declined from approximately 12.3% to 9.6% between 2022 and 2023, triggering non-cash pre-tax gains of $36.4 million (Q2 2023), $12.4 million (Q3 2023), and $159.0 million (Q4 2022), while its 45% noncontrolling interest in Rue Gilt Groupe as of December 31, 2023, reflects ongoing strategic adjustments to its ABG position. The company recorded $18.8 million in pre-tax gains from a 2021 partial ABG sale and subsequently acquired additional ABG interests for $100 million in cash, though its stake continued to dilute through subsequent capital transactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> ABG (COMP)",
        "ABG (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7303,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2449,
        "completion_tokens": 151,
        "total_tokens": 2600
      }
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "The 2012 Equity Incentive Plan has been amended through the Third Amendment (effective February 2, 2023, disclosed in both 2023 and 2024 10-K filings as Exhibit 10.2(B)+) and further amended by the Fourth Amendment (effective August 1, 2024, disclosed in the 2024 10-Q filing as Exhibit 10.2(C)+), with all amendments and their associated forms of award agreements detailed in the respective exhibits across both filings. The plan’s forms of award agreements have been progressively updated through multiple iterations (including Additional Forms disclosed in exhibits 10.2(D)+ through 10.2(K)+ across 2023 and 2024 filings), reflecting iterative refinements to award structures as required by regulatory updates and governance practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "META (ORG) -> 2012 Equity Incentive Plan (ACCOUNTING_POLICY)",
        "2012 Equity Incentive Plan (ACCOUNTING_POLICY) -> META (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "META_10k_2023.pdf",
          "page_id": "page_128",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "META_10k_2024.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11828,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3609,
        "completion_tokens": 184,
        "total_tokens": 3793
      }
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "The treatment and valuation of capitalized software licenses evolved from $152 million amortized over their license terms in 2022 to $223 million in 2023, reflecting an increase in capitalized software assets and a corresponding rise in amortization expense. This growth indicates the company’s heightened investment in software licensing, as it continues to acquire and capitalize new software licenses that are subsequently amortized on a straight‑line basis over their useful lives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amortizes]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Capitalized Software Licenses (FIN_INST)",
        "Capitalized Software Licenses (FIN_INST) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10243,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3212,
        "completion_tokens": 121,
        "total_tokens": 3333
      }
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "PayPal's strategic approach to funding credit products evolved significantly between 2022 and 2023, as evidenced by the Luxembourg CSSF's expanded designation authority for European customer balances. In 2022, up to 35% of European customer balances in its Luxembourg subsidiary could be designated for credit activities, with $2.7 billion approved by end-2021 representing 27% of balances; by 2023, this limit was increased to 50%, with $3.0 billion approved for 2023 (39% of balances) and $3.8 billion for 2022 (37% of balances), reflecting a deliberate scaling of internal funding capacity. This expansion, coupled with the $5.5 billion sale of consumer installment receivables under a multi-year agreement with a global investment firm in 2023, demonstrates PayPal's proactive strategy to diversify and scale credit funding sources beyond external capital, leveraging both regulatory-approved balance designations and asset sales to support growth while maintaining flexibility for future designation increases based on utilization and funding needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Designates]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Credit Activities (FIN_INST)",
        "Credit Activities (FIN_INST) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9220,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2955,
        "completion_tokens": 263,
        "total_tokens": 3219
      }
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks' investment in Valor Siren Ventures I L.P. remains part of a broader portfolio of private equity holdings, with the total carrying value of these strategic investments—including Valor Siren Ventures I L.P. and II L.P.—reaching $211.9 million as of September 29, 2024 (per both Chunk 1 and Chunk 2 disclosures). While the specific carrying value attributable solely to Valor Siren Ventures I L.P. is not isolated, the company reports that its share of income and losses from these private equity interests is recorded in \"interest income and other, net\" on the consolidated statements of earnings, though this impact was not material during the fiscal periods presented. This investment structure, disclosed across both fiscal years 2023 and 2024 filings, reflects Starbucks' ongoing strategy of partnering with specialized funds to advance technologies and products aligned with its food and retail ecosystem, without materially affecting consolidated financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Valor Siren Ventures I L.P. (COMP)",
        "Valor Siren Ventures I L.P. (COMP) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4948,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1902,
        "completion_tokens": 245,
        "total_tokens": 2147
      }
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, Analog Products' strategic positioning at Texas Instruments (TI) was reinforced through its role as a core product line within TI's analog and embedded processing portfolio, directly contributing to enhanced competitive advantages and financial performance. The 2023 10-K explicitly identifies Analog Products as one of four sustainable competitive advantages—specifically highlighting its \"broad portfolio\" (advantage 2b) and \"reach of market channels\" (advantage 2c)—which collectively drive higher revenue growth, improved gross margins (67.5% in 2021), and stronger cash flow generation ($6.29 billion free cash flow in 2021). This strategic emphasis on industrial and automotive end markets, where Analog Products saw 27% revenue growth to $18.34 billion in 2021 (driven by Analog segment performance), solidified TI's unique market position and enabled sustained investment in manufacturing capacity and R&D to further leverage these advantages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "TXN (ORG) -> Analog Products (PRODUCT)",
        "Analog Products (PRODUCT) -> TXN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TXN_10k_2022.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TXN_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7614,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2540,
        "completion_tokens": 243,
        "total_tokens": 2784
      }
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron's capital allocation strategy in the Lower 48 region shifted significantly from 2022 to 2023, with depreciation, depletion, and amortization (DDA) expenses rising to $5,729 million in 2023 from $4,854 million in 2022, reflecting increased investment in upstream operations and infrastructure within this key U.S. onshore basin. This strategic focus aligns with Chevron's operational emphasis on the Lower 48, as confirmed by its consolidated financial reporting and the KG triplet relationship where \"COP\" (Chevron) operates in \"Lower 48\" (GPE), with the region explicitly disclosed in its accounting policies and segment reporting. The DDA increase in the Lower 48—outpacing other regions like Canada and Europe—demonstrates a deliberate capital allocation priority to sustain and expand its core U.S. unconventional production, while the corresponding rise in impairments and DDA across all segments ($8,284 million in 2023 vs. $7,492 million in 2022) underscores the company's capital discipline amid market volatility, prioritizing high-return projects in the Lower 48 to drive long-term value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5875,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2105,
        "completion_tokens": 276,
        "total_tokens": 2382
      }
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Verizon's approach to FWA Broadband has evolved significantly between 2023 and 2024, transitioning from a niche offering to a strategically integrated component of its core product portfolio. In 2023, FWA was positioned as a key alternative broadband solution leveraging 5G and LTE networks to serve both Consumer and Business segments, particularly targeting underserved areas where traditional wired infrastructure was lacking, with approximately 3.1 million FWA connections reported as of December 31, 2023. By 2024, this positioning was reinforced as a core growth driver within the Consumer segment's product mix, explicitly framed as a critical alternative to traditional landline internet access alongside fiber and copper-based solutions, with FWA now seamlessly integrated into the company's broader wireless and wireline service offerings across its extensive network. This evolution reflects a strategic shift toward targeting a wider customer base, including both residential consumers seeking flexible connectivity options and business clients requiring scalable IoT and enterprise connectivity solutions, as evidenced by its expanded role in supporting wholesale network access for MVNOs and its inclusion in the Business Group's service portfolio alongside data, video, and managed network services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "VZ (ORG) -> FWA Broadband (PRODUCT)",
        "FWA Broadband (PRODUCT) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8258,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2708,
        "completion_tokens": 328,
        "total_tokens": 3037
      }
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech has evolved from a strategic partnership to majority ownership, culminating in the 2024 acquisition of a 55% stake in New AspenTech through the Heritage AspenTech acquisition, which created a new publicly traded entity under the AspenTech name. This evolution directly impacted Emerson's financial structure and margins, as evidenced by the 2024 gross margin increase to 50.8% (up 1.8 percentage points from 2023), driven by the Test & Measurement acquisition and AspenTech integration, while the sale of its Copeland equity stake generated a $539 pretax gain ($435 after-tax) that was recognized in discontinued operations, reflecting the financial impact of this strategic shift.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9781,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3082,
        "completion_tokens": 179,
        "total_tokens": 3262
      }
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "The financial relationship between NEE and FPL Group Capital Inc evolved from 2022 to 2023 through continued structural involvement in debt financing and capital obligations, as evidenced by multiple indentures and covenants tied to subordinated securities. While Chunk 1 reveals a foundational Guarantee Agreement from 1998 (Exhibit *10(uu)) establishing FPL Group Capital Inc’s role in guaranteeing FPL’s securities, Chunk 2 details a series of evolving debt instruments—including the 2022 Purchase Contract Agreement (Exhibit *4(fff))—that underscore ongoing capital market engagement, with FPL Group Capital Inc acting as a key issuer of junior subordinated debentures and FPL serving as guarantor in these arrangements. This progression reflects a sustained, multi-decade financial interdependence where FPL Group Capital Inc has consistently facilitated NEE’s (and by extension FPL’s) long-term capital structure needs through layered debt obligations and covenant frameworks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> FPL Group Capital Inc (COMP)",
        "FPL Group Capital Inc (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14676,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4317,
        "completion_tokens": 245,
        "total_tokens": 4562
      }
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "Between 2022 and 2024, InterStim II evolved from one of Medtronic's core Pelvic Health neurostimulators alongside InterStim Micro and InterStim X, maintaining its established market acceptance for treating overactive bladder, urinary retention, and chronic fecal incontinence within the Specialty Therapies division. This positioning was reinforced by the 2024 FDA approval of the Inceptiv closed-loop SCS therapy (which shares the same Pelvic Health therapeutic space) and continued global adoption of InterStim II as a recharge-free solution, directly building on its prior success highlighted in 2022 filings where it was noted alongside other key Pelvic Health therapies like the Solitaire X device. While InterStim II competed with other neurostimulators such as the Intellis SCS platform for DPN and chronic pain indications, its distinct recharge-free design and integration into Medtronic's broader AiBLE spinal ecosystem (emphasized in 2024 Neuroscience net sales growth) solidified its market acceptance as a key driver of Specialty Therapies' 3% net sales increase, demonstrating sustained growth relative to both earlier InterStim iterations and adjacent Pelvic Health therapies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MDT (ORG) -> InterStim II (PRODUCT)",
        "InterStim II (PRODUCT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8060,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2660,
        "completion_tokens": 297,
        "total_tokens": 2957
      }
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Simon Property Group's utilization and management of the Supplemental Facility evolved significantly between 2022 and 2024, reflecting strategic shifts in borrowing capacity, interest rate hedging, and targeted repayments. Initially endowed with a $3.5 billion capacity expandable to $4.5 billion and maturing in 2026 (extendable to 2027), the facility was actively deployed and optimized. A pivotal development occurred in November 2023 when the Operating Partnership issued €750 million of exchangeable bonds (equivalent to $808 million USD), explicitly using proceeds to repay €750 million ($815.4 million) of debt under the Supplemental Facility—demonstrating a direct reduction in reliance on this specific borrowing source. Concurrently, the facility's interest rate was hedged via swaps converting €750 million of borrowings to a fixed 3.81% all-in rate, though these swaps were terminated upon repayment. Complementing this, Simon issued $1.3 billion in fixed-rate senior unsecured notes in 2023 and 2024 (including $650 million at 5.50% and 5.85% maturing in 2033/2053, and $500 million at 6.25% and 6.65% maturing in 2034/2054), strategically redeeming older floating-rate notes and reducing variable-rate exposure. This multi-pronged approach—issuing fixed-rate debt, executing interest rate swaps, and making targeted repayments—resulted in the full retirement of $1.0 billion in 2.00% notes (September 2024) and $900 million in 3.38% notes (October 2024), underscoring a deliberate transition toward fixed-rate financing and active management of the Supplemental Facility's utilization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Supplemental Facility (FIN_INST)",
        "Supplemental Facility (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11420,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3510,
        "completion_tokens": 399,
        "total_tokens": 3910
      }
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "Verizon's approach to device payment plans has evolved from 2023 to 2024 by maintaining its core installment structure while enhancing promotional incentives tied to service retention. In 2023, the company continued offering device payment plans for both Consumer and Business customers, allowing non-interest-bearing 36-month installments concurrent with month-to-month service contracts, with promotions featuring trade-in rights that required customers to pay a specified portion of their plan and maintain service to qualify for upgrades (VZ_10k_2023.pdf, page_5; VZ_10k_2024.pdf, page_60). By 2024, Verizon refined this structure by explicitly accounting for promotional billing credits as part of the transaction price allocated across performance obligations and recognized as revenue when earned, while still treating the financing component as non-significant for accounting purposes (VZ_10k_2024.pdf, page_60). The company also preserved its strategic focus on subsidized plans for Business customers and leveraged device payment plans as a key channel for equipment acquisition, integrating them within its broader wireless equipment and service revenue model that emphasizes standalone pricing estimates for devices and service (VZ_10k_2023.pdf, page_5; VZ_10k_2024.pdf, page_60). This evolution reflects a consistent emphasis on customer financing flexibility and incentive-driven engagement, with promotional terms increasingly structured to tie revenue recognition to ongoing service continuity rather than upfront device subsidies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "VZ (ORG) -> Device Payment Plans (PRODUCT)",
        "Device Payment Plans (PRODUCT) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11589,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3537,
        "completion_tokens": 386,
        "total_tokens": 3923
      }
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "The Coca-Cola Company's legal relationship with Aqua-Chem has remained unchanged between 2023 and 2024, with the Company maintaining its position that it holds **no liability** for Aqua-Chem's asbestos-related claims, as explicitly stated in the 2023 and 2024 filings regarding the Georgia Case and the 2004 insurance coverage litigation. This stance is reinforced by the 1981 stock sale agreement and 1983 settlement agreement, which defined the parties' rights and obligations concerning past and future claims, including the $400 million in insurance coverage purchased during Coca-Cola's ownership (1970–1981) that specifically covers asbestos-related liabilities. The Company continues to assert that its former subsidiary, now Cleaver-Brooks, Inc., bears responsibility for the approximately 15,000 active asbestos claims pending against it, with no indication of a shift in this position in the latest disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sold]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Aqua-Chem (COMP)",
        "Aqua-Chem (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8906,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2865,
        "completion_tokens": 230,
        "total_tokens": 3096
      }
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's 2024 long-term income tax payable of $1.6 billion, reduced by non-US tax credits, reflects a significant decrease from $4.3 billion in 2021 (per Chunk 1), indicating that utilization of non-US tax credits has lowered its long-term tax liabilities over time. This trend, supported by the consistent KG pattern where Non-US Tax Credits positively impact Intel's accounting policy (Chunk 1 and KG triplets), demonstrates a strategic reduction in tax burdens through international tax planning, as evidenced by the declining long-term payable despite evolving uncertain tax position disclosures (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Positively_Impacts]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Non-US Tax Credits (ACCOUNTING_POLICY)",
        "Non-US Tax Credits (ACCOUNTING_POLICY) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_92",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1177,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 953,
        "completion_tokens": 152,
        "total_tokens": 1106
      }
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "The treatment and risk exposure of pension risk transfers have evolved significantly between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence. In 2022, pension risk transfers were primarily discussed within the Retirement and Income Solutions segment, which includes capital market products, pension risk transfers, and structured settlements, with exposure to interest rate scenarios affecting reinvestment yields and gross margin compression in retained asset accounts (Chunk 1). By 2024, regulatory changes—particularly those related to pension plan funding rules—have been identified as potentially limiting corporate plan sponsors' ability to terminate plans or transfer pension obligations, thereby affecting the mix of pension risk transfers and increasing reliance on non-guaranteed funding products (Chunk 1 and Chunk 2). Additionally, heightened regulatory scrutiny under evolving solvency standards and pension-related regulations may increase capital requirements and compliance costs, further shaping the risk profile and structural treatment of these transfers (Chunk 2). Interest rate sensitivity remains central, as pension risk transfers are influenced by reinvestment strategies and hedging through derivatives, but their growth and design are now increasingly constrained by regulatory environments that may delay or deter plan terminations, altering both risk exposure and market dynamics over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "MET (ORG) -> Pension Risk Transfers (PRODUCT)",
        "Pension Risk Transfers (PRODUCT) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7519,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2528,
        "completion_tokens": 369,
        "total_tokens": 2897
      }
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Medtronic's positioning and product strategy around the InterStim Micro neurostimulator has evolved from a rechargeable platform to a recharge-free solution, as evidenced by its continued acceptance and growth within the Specialty Therapies division highlighted in both 2022 and 2024 SEC filings. The 2022 filing notes the InterStim Micro's role alongside InterStim II and X in treating overactive bladder, urinary retention, and bowel incontinence, while the 2024 update specifically cites the InterStim Micro as a \"recharge-free neurostimulator\" alongside InterStim II and X within Pelvic Health therapies, underscoring its strategic shift toward longer-term, patient-friendly implantation without recharging requirements. This evolution is further reinforced by its integration into Medtronic's broader neuromodulation growth strategy, which includes FDA approvals for next-generation devices like the Inceptiv closed-loop SCS in April 2024 and continued global adoption of the InterStim Micro as part of a diversified portfolio addressing chronic pain, DPN, and pelvic health conditions across key markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MDT (ORG) -> InterStim Micro (PRODUCT)",
        "InterStim Micro (PRODUCT) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8060,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2645,
        "completion_tokens": 277,
        "total_tokens": 2923
      }
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Simon Property Group's use of the Supplemental Facility evolved significantly between 2022 and 2024, with the facility's borrowing capacity expanding from $3.5 billion to $4.5 billion and its maturity extending from January 31, 2026 to January 31, 2027. By December 31, 2024, the weighted average outstanding balance under the Supplemental Facility had decreased to $31.1 million, down from $519.9 million in 2021, reflecting active repayment actions including the November 14, 2023 repayment of €750 million ($815.4 million) of borrowings using proceeds from €750 million senior unsecured bonds issued by the Operating Partnership. This repayment, coupled with strategic debt refinancing through $1.0 billion of 4.75% notes maturing in 2034 and other note redemptions, demonstrates a deliberate reduction in reliance on the Supplemental Facility to optimize the capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Extends]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Supplemental Facility (FIN_INST)",
        "Supplemental Facility (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_124",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10653,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3306,
        "completion_tokens": 220,
        "total_tokens": 3527
      }
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "COP's investment activity in the Lower 48 region expanded significantly from 2022 to 2023, as evidenced by the 18% year-over-year increase in depreciation, depletion, amortization, and impairments expenses specifically allocated to this region ($4,854 million in 2022 to $5,729 million in 2023), while Alaska's corresponding expenses declined slightly ($941 million to $1,061 million), reflecting a strategic shift toward Lower 48 operations; this trend aligns with the operational focus documented in Chunk 1 where Lower 48 represented 87% of U.S. productive acreage in 2021 and maintained substantial equity affiliate investments ($30 million in 2023), demonstrating sustained capital commitment to the region across both exploration and development activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_172",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5002,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1886,
        "completion_tokens": 190,
        "total_tokens": 2077
      }
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "Verizon's corporate networking solutions have evolved from 2023 to 2024 by shifting emphasis from standalone wireless services toward integrated enterprise connectivity, as evidenced by the Business Group's expanded description in the 2024 10-K that explicitly includes \"corporate networking solutions\" alongside wireless and wireline services while maintaining the same ORG-PRODUCT relationship (VZ → Corporate Networking Solutions → VZ) across both filings. The 2023 filing details this evolution through specific offerings like private networking services, private cloud connectivity, and SD-WAN under Network Services, while the 2024 filing reinforces the strategic focus by placing these solutions within the Business Group's core portfolio and highlighting their role in enabling enterprise digital transformation through services designed to \"optimize business operations, mitigate risks, and capitalize on data.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "VZ (ORG) -> Corporate Networking Solutions (PRODUCT)",
        "Corporate Networking Solutions (PRODUCT) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8258,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2710,
        "completion_tokens": 230,
        "total_tokens": 2940
      }
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "MetLife's valuation approach for FVO securities evolved from 2022 to 2024 with increased sensitivity to U.S. dollar fluctuations, as evidenced by the 2021 data showing a $11,832 million negative fair value impact from a 10% U.S. dollar appreciation across all asset categories, including FVO securities ($54 million impact), and the 2024 disclosure confirming that changes in estimated fair value are \"based on long U.S. dollar net asset positions and will be inversely impacted for short U.S. dollar net asset positions\" – meaning MetLife's valuation approach now explicitly ties FVO securities' fair value movements to U.S. dollar strength, with appreciation directly reducing the estimated fair value of these securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Subject_To]- ORG",
      "triplets_used": [
        "MET (ORG) -> FVO Securities (FIN_INST)",
        "FVO Securities (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_151",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2024.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13158,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3935,
        "completion_tokens": 181,
        "total_tokens": 4116
      }
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy's engagement in power marketing activities expanded significantly from 2022 to 2023, particularly through NEER's enhanced energy trading operations that generated $3,558 million in net income (up from $285 million in 2022), driven by optimized power and fuel marketing strategies and trading activities that leveraged generation assets and market conditions. This growth is directly connected to the Power Marketing product entity in the knowledge graph, which shows mutual engagement between NEE and Power Marketing as both the operator and beneficiary of these trading services, while the 2023 financial performance reflects the operational scale and profitability of these activities compared to prior periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Engages]-> PRODUCT <-[Operates_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Power Marketing (PRODUCT)",
        "Power Marketing (PRODUCT) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7298,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2470,
        "completion_tokens": 182,
        "total_tokens": 2652
      }
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "The Coca-Cola Company's financial relationship with Coca-Cola FEMSA has evolved through its equity stake ownership, directly impacting equity income reporting. As disclosed in the 2024 10-K (Note 6), the Company holds a 28% ownership interest in Coca-Cola FEMSA, which is accounted for using the equity method, with its proportionate share of FEMSA's net income recorded as \"equity income (loss) - net\" in the consolidated statement of income. This relationship is critical to the Company's financial results, as evidenced by the $7,791 million aggregate difference between the carrying values of its equity method investments and their proportionate share of underlying net assets, a non-amortized adjustment highlighted in the 2024 filing. The 2023 10-K further contextualizes this dynamic by noting that changes in bottler credit ratings—such as those affecting Coca-Cola FEMSA—could reduce the Company's equity income due to potential increases in interest expense for those entities, underscoring the direct financial linkage between stake ownership and equity income volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Coca-Cola FEMSA (COMP)",
        "Coca-Cola FEMSA (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7599,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2543,
        "completion_tokens": 271,
        "total_tokens": 2814
      }
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Between 2022 and 2023, ConocoPhillips significantly increased its operational focus on the Lower 48 region, as evidenced by a substantial rise in production volumes from 585 thousand barrels daily (2022) to 1,340 thousand barrels daily (2023) in the Lower 48, while depreciation expenses for this region nearly doubled from $4,854 million to $5,729 million. This strategic shift reflects a clear evolution from 2022's lower production base toward intensified investment and operational prioritization of the Lower 48, as demonstrated by both surging production metrics and rising depreciation costs across all relevant chunks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_169",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8436,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2742,
        "completion_tokens": 156,
        "total_tokens": 2899
      }
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Verizon's 4G LTE network remains a foundational component of its network infrastructure, directly supporting both its Consumer and Business segments as highlighted in the 2023 and 2024 10-K filings. While the company is prioritizing 5G monetization and expansion in 2024—leveraging its C-Band spectrum and millimeter wave holdings—the 4G LTE network continues to serve as a critical platform for delivering FWA broadband services, underpinning growth initiatives across both segments through reliable connectivity and network quality. The network's role has evolved from being a standalone service to a strategic enabler of integrated solutions, with its infrastructure directly supporting Verizon's focus on retaining high-value customers and driving financial performance through enhanced network monetization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "VZ (ORG) -> 4G LTE Network (PRODUCT)",
        "4G LTE Network (PRODUCT) -> VZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "VZ_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "VZ_10k_2024.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5108,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1920,
        "completion_tokens": 203,
        "total_tokens": 2123
      }
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "Emerson's financial relationship with AspenTech underwent a transformative evolution from 2022 to 2024, marked by a strategic shift from a 328 stake in 2022 to 55% ownership by 2024 following the Heritage AspenTech acquisition, which created \"New AspenTech\" and positioned Emerson as a majority owner with significant influence over the company's operations and financial trajectory. This relationship directly impacted key financial metrics, as evidenced by the 2022 backlog of $8,053 (including $1,042 from AspenTech) growing to a pivotal role in Emerson's $8,607 cost of sales and $8,885 gross profit in 2024, where AspenTech's integration contributed to a 50.8% gross margin—up 1.8 points—driven by the Test & Measurement acquisition and favorable pricing, while also generating $560 in intangibles amortization that affected other deductions. The 2024 divestiture of Emerson's 40% stake in Copeland for $1.5 billion cash and $1.9 billion note receivable, alongside the $539 gain on equity sale, underscored the complex financial interplay of Emerson's AspenTech ties, which were further reflected in the $1,434 other deductions (up $928 from 2023) driven by AspenTech-related acquisition costs and amortization. Crucially, the KG triplets (EMR → AspenTech and AspenTech → EMR) and all chunks confirm that Emerson's ownership stake, acquisition integration, and subsequent divestiture directly shaped backlog growth, gross margin expansion, and financial results across 2022–2024, with the 2022 Heritage AspenTech acquisition serving as the catalyst for the 55% ownership structure that defined the relationship through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2022.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5368,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1992,
        "completion_tokens": 407,
        "total_tokens": 2400
      }
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "NEE's financial commitment to the Mountain Valley Pipeline has increased significantly between 2022 and 2023, with $400 million in firm commitments allocated for 2024-2028 in 2023 versus $5,160 million in total commitments extending through 2028 and beyond in 2022, reflecting a strategic shift toward near-term pipeline infrastructure investments. This evolution demonstrates NEE's active role in advancing the joint venture project through NEER's 32.8% equity stake, where contractual transportation agreements with Mountain Valley Pipeline represent a key component of its long-term energy infrastructure strategy, particularly as evidenced by the $70 million annual commitment tied to the pipeline's construction phase. The growing financial commitments across both years, while substantial, are embedded within broader investment frameworks that include technology investments through 2031 and joint obligations with NEECH, underscoring NEE's systematic approach to expanding its midstream energy portfolio through targeted pipeline infrastructure development.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Mountain Valley Pipeline (COMP)",
        "Mountain Valley Pipeline (COMP) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6196,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2190,
        "completion_tokens": 266,
        "total_tokens": 2456
      }
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "Coca-Cola's relationship with Costa Limited has evolved from a strategic partnership to full operational integration within the Global Ventures segment, as evidenced by Costa Limited's inclusion in the Company's Global Ventures operating segment and its direct contribution to sales through Costa-operated retail stores. The 2024 filing confirms this integration by explicitly linking Costa Limited's business (including its innocent and doğadan brands) to the Global Ventures segment, while also revealing that the Company now sells finished beverages directly to consumers through Costa's retail stores, a key channel for Global Ventures revenue. This strategic positioning is further reinforced by the Company's broader beverage portfolio expansion, including Costa-branded products in its marketing and distribution network, cementing Costa Limited's role as a core component of Coca-Cola's global growth strategy beyond traditional bottling partnerships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Costa Limited (COMP)",
        "Costa Limited (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10790,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3339,
        "completion_tokens": 239,
        "total_tokens": 3579
      }
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel's investment in financial institution instruments has evolved significantly between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments. In 2022, the fair value of these hedged investments was $17.1 billion, which declined to $13.5 billion by 2024, reflecting net losses of $748 million in 2022, net gains of $534 million in 2023, and net losses of $464 million in 2024, indicating a shift in market conditions and hedging outcomes. This trend is directly tied to Intel's strategy of designating certain marketable debt investments as trading assets when a market risk is economically hedged at inception, as noted in Chunk 1, where such investments are reported at fair value with gains and losses offsetting related derivative instruments and balance sheet remeasurements. The decline in fair value from 2023 to 2024 ($17.1 billion to $13.5 billion) underscores the volatility in Intel's financial instrument portfolio, driven by interest rate shifts, currency fluctuations, and credit market dynamics, which are explicitly managed through hedging strategies referenced in both Chunk 1 and Chunk 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Financial Institution Instruments (FIN_INST)",
        "Financial Institution Instruments (FIN_INST) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8654,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2819,
        "completion_tokens": 290,
        "total_tokens": 3109
      }
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "From 2023 to 2024, AMT's financial focus evolved to emphasize **recurring revenue generation** from its communications sites, which accounted for 99% of total 2023 revenues and remains central to its cash flow strategy, as highlighted in Chunk 1's discussion of multiyear tenant leases and operational efficiency. This recurring revenue model directly supports the company's liquidity, as noted in Chunk 2's \"Factors Affecting Sources of Liquidity\" section, which states that maintaining this revenue stream is critical to converting it into operating profit and sustaining future cash flows. Concurrently, AMT's asset retirement liabilities increased significantly, with the estimated undiscounted future cash outlay for removing assets and remediating leased sites rising to **$4.5 billion as of December 31, 2024** (Chunk 2), reflecting a strategic expansion in infrastructure obligations tied to its communications site portfolio. The KG triplets confirm the core relationship between AMT and Communications Sites (ORG-Supplies-PRODUCT), where the evolution of recurring revenue and asset retirement liabilities is intrinsically linked to the operational and financial management of these sites across all segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Communications Sites (PRODUCT)",
        "Communications Sites (PRODUCT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6214,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2198,
        "completion_tokens": 304,
        "total_tokens": 2503
      }
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "XOM's strategic positioning in Guyana has evolved significantly between 2023 and 2024 through enhanced legal frameworks and growth focus. In 2023, the Guyana Petroleum Activities Act 2023 established a formal licensing regime enabling 20-year production periods with 10-year renewal options, creating a stable regulatory foundation for XOM's operations. By 2024, XOM strategically positioned Guyana as a core \"Advantaged Asset\" within its growth portfolio, explicitly highlighting it alongside Permian and LNG as a driver of advantaged volume growth, reflecting a deliberate shift toward emphasizing Guyana's high-value potential within its integrated business model. This progression demonstrates XOM's transition from establishing the legal framework to actively leveraging Guyana as a strategic growth engine within its broader earnings drivers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Guyana (GPE)",
        "Guyana (GPE) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6531,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2265,
        "completion_tokens": 212,
        "total_tokens": 2477
      }
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar's strategic positioning and operational responsibilities in the diesel-electric locomotives business have evolved significantly between 2023 and 2024, with the company maintaining a consistent role as the primary designer, manufacturer, and remanufacturer of these locomotives through its integrated business structure. As documented in both the 2023 and 2024 SEC filings, the Machinery, Energy & Transportation (ME&T) segment—specifically responsible for diesel-electric locomotives and components—retains operational oversight for remanufacturing reciprocating engines and components, while also providing product support for rail-related services, including leasing and maintenance. This aligns with the KG triplet relationship where CAT (ORG) is directly connected to Diesel-Electric Locomotives (PRODUCT) as both the producer and owner, with no indication of strategic shifts in this core business line, even as the company expands its focus on electrified powertrains and zero-emission solutions within the broader ME&T segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Diesel-Electric Locomotives (PRODUCT)",
        "Diesel-Electric Locomotives (PRODUCT) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10760,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3343,
        "completion_tokens": 261,
        "total_tokens": 3605
      }
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "From 2022 to 2024, the company's reliance on securitized debt obligations as a funding source increased significantly, with the carrying value rising from $14,264 million to $14,335 million (a $71 million increase) and estimated fair value growing from $14,335 million to $14,335 million (indicating stable market valuation despite growth in underlying loan portfolios). This trend, coupled with the consistent disclosure of securitized debt obligations as a distinct funding category across both 2022 and 2024 filings, demonstrates a strategic continuation of securitization as a core funding channel—particularly notable given the company's emphasis on deposits as its \"primary source of funding\" and the use of securitized debt to support loan portfolio growth (e.g., $277.3 billion in loans held for investment as of 2021). The persistent use of securitized debt obligations, alongside other funding mechanisms like senior notes and FHLB advances, reflects a diversified but intentionally structured funding strategy that balances stability with targeted leverage to support portfolio expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Raises]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5054,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1910,
        "completion_tokens": 274,
        "total_tokens": 2185
      }
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "McDonald's treatment of developmental licensees has shifted toward more transparent financial reporting and structured relationship management between 2023 and 2024, as evidenced by both chunks. In its 2023 10-K, McDonald's explicitly detailed how developmental licensees pay royalties based on a percent of sales and initial fees, while also disclosing the disaggregation of franchise revenue into lease (rental income), royalty (non-lease), and initial fee (non-lease) components to reflect the nature and timing of cash flows—highlighting how these arrangements are systematically allocated and presented (Chunk 1). This structured approach continued into 2024, where the company maintained its focus on evaluating business relationships with developmental licensees as part of its consolidation assessments, confirming that such entities (including those under license agreements) do not require consolidation due to scope exceptions under variable interest entity guidance, thereby reinforcing a relationship management model centered on contractual clarity and financial transparency without absorbing these entities into the consolidated financial statements (Chunk 2). The consistent emphasis on revenue disaggregation and non-consolidation underscores a strategic evolution toward clearer financial reporting of developmental licensing arrangements while preserving the arm's-length, fee-based relationship dynamics between McDonald's and its developmental licensees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Developmental Licensees (COMP)",
        "Developmental Licensees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4376,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1735,
        "completion_tokens": 369,
        "total_tokens": 2104
      }
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Southern Company's Equity and Incentive Compensation Plan (EICP) maintained its core structure through 2023-2024, with **26.9 million shares reserved and available for awards under the plan as of December 31, 2023** (Chunk 1), while the 2024 filing confirms ongoing governance through the **2021 EICP** (effective May 26, 2021) and references to executive award disclosures under its terms (Chunk 2). The plan's share availability remained consistent with prior-year reserves, and executive compensation disclosures continued to be governed by the same EICP framework, including specific award forms referenced in 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Equity and Incentive Compensation Plan (ACCOUNTING_POLICY)",
        "Equity and Incentive Compensation Plan (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_232",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_316",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 19606,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5566,
        "completion_tokens": 156,
        "total_tokens": 5723
      }
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Based on the provided financial data across both chunks, Inlyta's revenue demonstrated consistent growth between 2022 and 2023, with worldwide revenue increasing from $1,003 million to $1,036 million (a 3% operational increase), and U.S. revenue rising from $618 million to $642 million (a 4% increase). This growth was primarily driven by the adoption of Inlyta in combination with immune checkpoint inhibitors for first-line treatment of advanced renal cell carcinoma (RCC), particularly in the U.S. market, though this was partially offset by lower volumes and net price pressures in certain European markets. The growth trajectory remained positive but showed early signs of moderation, as evidenced by the commentary noting that international growth \"primarily reflects continued growth in emerging markets\" while U.S. growth was attributed to specific therapeutic adoption dynamics. The revenue performance aligns with the KG relationship where Inlyta (PRODUCT) is produced by and discloses information to PFE (ORG), with operational metrics confirming the upward trend despite market-specific headwinds.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Inlyta (PRODUCT)",
        "Inlyta (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 25424,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6985,
        "completion_tokens": 277,
        "total_tokens": 7262
      }
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's financial relationship with franchisees has deepened through expanded cost-sharing for technology platforms and refined revenue recognition practices, reflecting greater operational interdependence. The Company now generates revenue from franchisees via royalties based on a percent of sales (including minimum rent payments), initial fees, and critical **technology platform fees**—disclosed in Chunk 1 as \"revenues primarily comprised of fees paid by franchisees to recover a portion of costs incurred by the Company for various technology platforms\"—which are recognized gross under Chunk 2's revenue recognition rules. This model, underpinned by the ORG-Partners_With-COMP and COMP-Depends_On-ORG KG pattern, ensures McDonald's revenue stability (as noted in Chunk 1's \"stable and predictable revenue\" tied to franchisee sales) while increasing franchisee reliance on the brand's centralized systems, particularly as new accounting standards (like ASU 2024-03) mandate enhanced expense disclosures for these platform costs. Consequently, the financial structure has shifted toward tighter integration, with franchisees bearing operational costs for tech adoption while McDonald's captures scalable revenue from these arrangements, reinforcing mutual dependency without direct capital investment in franchisee operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12526,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3780,
        "completion_tokens": 338,
        "total_tokens": 4119
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "The fair value of energy-related derivatives held by Southern Company's subsidiaries increased from $84 million at December 31 2022 to $1176 million at December 31 2023, reflecting a substantial rise in the valuation of these instruments across all reporting segments. This growth indicates that the company’s exposure to energy market fluctuations intensified during the period, as the fair‑value gains and losses on these derivatives are directly tied to changes in underlying commodity prices and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Energy-related derivatives (FIN_INST)",
        "Energy-related derivatives (FIN_INST) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_285",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_277",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21182,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5950,
        "completion_tokens": 129,
        "total_tokens": 6080
      }
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The Procter & Gamble 2019 Stock and Incentive Compensation Plan (2019 Plan) was adopted by shareholders on October 8, 2019 and, as disclosed in the 2022 Form 10‑K (Exhibit 10‑28), it serves as the primary accounting‑policy framework for the company’s equity‑based compensation, with its terms incorporated by reference to the 2021 10‑K filing. In the 2024 Form 10‑K, the 2019 Plan is listed alongside legacy plans (e.g., 1992, 2001, 2003, 2009, 2014) as one of the equity‑compensation arrangements that may issue shares upon exercise of options, warrants or rights, confirming its continued materiality and ongoing relevance to shareholder‑approved compensation structures through at least 2024. Thus, from 2022 to 2024 the 2019 Plan’s treatment evolved from being highlighted as a newly adopted, shareholder‑approved plan in 2019 to being regularly referenced in periodic disclosures as an active component of the company’s broader equity‑compensation portfolio, maintaining its significance in governing the terms and conditions of equity awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PG (ORG) -> 2019 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY)",
        "2019 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2863,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 262,
        "total_tokens": 1644
      }
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company's approach to managing the risk of large losses in its pension plan assets has evolved from 2023 to 2024 by maintaining its core risk management strategy while emphasizing formal rebalancing and external oversight more explicitly in 2024. Both years confirm the company minimizes large loss risk primarily through diversification, as stated in Chunk 1 and reiterated in Chunk 2, but Chunk 2 adds that the Southern Company system employs a formal rebalancing program to manage actual asset class exposures relative to target allocations, a detail not highlighted in the 2023 version. Additionally, Chunk 2 specifies that external investment managers and service providers are subject to written guidelines for prudent practices, reinforcing an added layer of structured oversight compared to the 2023 disclosure which only generally noted external managers as part of risk management without this specific governance mechanism. This evolution reflects a shift toward more systematic, documented controls to ensure consistent risk mitigation across plan assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "SO (ORG) -> Risk of Large Losses (RISK_FACTOR)",
        "Risk of Large Losses (RISK_FACTOR) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_263",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_255",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3673,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 269,
        "total_tokens": 1842
      }
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "NVIDIA's role in the CUDA platform has evolved from being solely a developer of the CUDA parallel programming model and its associated libraries, SDKs, and AI acceleration tools (as highlighted in Chunk 2's description of CUDA-X and software integration) to becoming a full-stack computing platform provider that now includes DPUs (introduced in fiscal 2022) and CPUs (planned for fiscal 2024), while also expanding CUDA's application beyond GPUs into data center infrastructure through services like NVIDIA DGX Cloud and AI Enterprise licensing (Chunk 2). This strategic shift—evidenced by the company's emphasis on \"optimizing across the entire computing, networking and storage stack\" and forming partnerships with cloud providers to host DGX Cloud—signals a deliberate move to own the end-to-end AI infrastructure stack, moving beyond just GPU hardware to control software, services, and cloud-based delivery, thereby positioning NVIDIA as the central enabler of AI computing platforms rather than just a component supplier (Chunk 2). The KG triplets (NVDA → CUDA Platform ← Develops → NVDA and CUDA Platform → NVDA) confirm this bidirectional relationship, showing that while NVIDIA develops CUDA, the platform's evolution now directly enables NVIDIA's broader strategic focus on integrated AI infrastructure solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Develops]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> CUDA Platform (PRODUCT)",
        "CUDA Platform (PRODUCT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2022.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5502,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2017,
        "completion_tokens": 331,
        "total_tokens": 2348
      }
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Pfizer's financial relationship with Viatris evolved significantly between 2022 and 2023 through the termination of their supply agreements and settlement of outstanding balances. According to the 2022 10-K, Pfizer recognized $780 million in revenue from manufacturing legacy Upjohn products for Viatris under supply agreements, with $33 million due to Viatris as of December 31, 2023 (down from $94 million in 2022), indicating the winding down of transitional billing arrangements under the interim TSAs and MSAs. The 2023 10-K confirms these agreements were largely completed by December 31, 2023, with no material amounts recorded in 2023, and the $277 million payment to Viatris in 2021 (reported in financing activities) was a key settlement from the separation agreement, finalizing the financial relationship between the entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Viatris (COMP)",
        "Viatris (COMP) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11756,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3569,
        "completion_tokens": 209,
        "total_tokens": 3778
      }
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "The treatment and disclosure of communications sites in relation to debt obligations has evolved from a strict structural subordination model in 2023 to a more transparent, yet still restricted, cash flow management approach in 2024. In 2023, the Company disclosed that securitized debt was solely secured by communications sites and their cash flows, with no availability for other obligations (Chunk 1), but by 2024, the Company explicitly tied debt maturities to site security and required compliance with covenants that could trigger site-related obligations (Chunk 2). This evolution reflects a shift from merely describing the legal structure of site-backed debt to actively managing and disclosing the financial implications of site-related cash flows and covenants, as evidenced by the 2024 disclosure of asset retirement obligations ($4.5 billion) and the expectation of $3.2 billion in 2025 distributions contingent on maintaining site-related revenue streams (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Secures]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Communications Sites (PRODUCT)",
        "Communications Sites (PRODUCT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8984,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2877,
        "completion_tokens": 245,
        "total_tokens": 3122
      }
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements has evolved from recognizing revenue as a **license of functional intellectual property** (2022) to recognizing it as **monthly subscription fees** under multiyear agreements with multichannel video providers (2023), reflecting a shift toward recurring revenue models. While 2022 emphasized revenue recognition tied to programming availability and payment terms within 60 days, 2023 explicitly highlights that these fees—including those from retransmission consent agreements—are now structured as **monthly subscription fees** based on subscriber counts, directly linking to Peacock's streaming revenue and reinforcing a distribution model centered on subscriber-based monetization rather than one-time licensing fees. This evolution aligns with the KG triplet relationship where Retransmission Consent Agreements (ACCOUNTING_POLICY) are now operationalized as part of CMCSA's broader distribution revenue stream, with revenue recognized monthly as programming is delivered to subscribers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Retransmission Consent Agreements (ACCOUNTING_POLICY)",
        "Retransmission Consent Agreements (ACCOUNTING_POLICY) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7830,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2615,
        "completion_tokens": 261,
        "total_tokens": 2876
      }
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "Caterpillar's involvement in diesel-electric locomotives has evolved from a direct manufacturing role to a strategic partnership within the Energy & Transportation segment, where it now focuses on remanufacturing and product support while relying on specialized partners for production, as evidenced by the KG pattern showing mutual stake between CAT and diesel-electric locomotives (CAT -> Diesel-Electric Locomotives <- Produces CAT) and the 2024 disclosure confirming diesel-electric locomotives as a key rail-related product in its portfolio alongside remanufacturing services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Diesel-Electric Locomotives (PRODUCT)",
        "Diesel-Electric Locomotives (PRODUCT) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3232,
        "completion_tokens": 145,
        "total_tokens": 3377
      }
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "McDonald's relationship with its franchisees has evolved through updated revenue recognition practices and cost-sharing arrangements that reflect both contractual obligations and operational collaboration. Under the franchise model described in the 2023 and 2024 10-K filings, revenue from conventional franchised restaurants now includes minimum rent payments recognized straight-line over the franchise term, along with variable rent based on a percentage of sales—both of which are tied to franchisee performance and require careful estimation of collectibility and allocation of costs (Chunk 1, Chunk 2). The company recognizes initial fees and ongoing royalties as performance obligations are satisfied over the typical 20-year franchise term, ensuring alignment with long-term partnership goals (Chunk 2). Additionally, McDonald's shares in the cost of certain restaurant improvements by funding projects upfront and later allocating expenses between property and equipment and receivables based on responsibility, a practice that strengthens financial integration while maintaining distinct accounting for franchisee-specific investments (Chunk 1, Chunk 2). These arrangements underscore a shift toward more nuanced, performance-based financial interdependence between McDonald's and its franchisees, particularly as new accounting standards like ASU 2023-07 and ASU 2024-03 enhance transparency in segment reporting and expense disclosures (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7000,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2382,
        "completion_tokens": 364,
        "total_tokens": 2746
      }
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Southern Company's executive equity compensation framework remains anchored in its **Equity and Incentive Compensation Plan (EICP)**, as explicitly referenced in both 2023 and 2024 disclosures (Chunks 1 and 2). The 2023 filing confirms PSU and RSU grants to executives under this plan (Chunk 1), while the 2024 filing details specific award terms—including the **2021 EICP** (effective May 26, 2021) and **ninth amendment to the Employee Savings Plan** (effective December 16, 2024)—that govern compensation structure and deferred compensation agreements (Chunks 2). Critically, the KG pattern (*SO → EICP ← Discloses SO*) demonstrates consistent regulatory disclosure of the EICP as the governing document, with the 2024 amendment extending its terms to 2024 while maintaining the core equity compensation structure established in 2021. This evolution reflects a deliberate update to plan terms—evidenced by the 2024 amendment—without altering the foundational EICP framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SO (ORG) -> Equity and Incentive Compensation Plan (ACCOUNTING_POLICY)",
        "Equity and Incentive Compensation Plan (ACCOUNTING_POLICY) -> SO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SO_10k_2023.pdf",
          "page_id": "page_276",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SO_10k_2024.pdf",
          "page_id": "page_316",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18792,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5355,
        "completion_tokens": 244,
        "total_tokens": 5599
      }
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble's strategic reliance on membership club stores has evolved from being a key customer channel highlighted in its 2022 10-K (where membership club stores were explicitly listed among top customers accounting for ~15% of sales and part of a diversified retail mix including mass merchandisers, e-commerce, and grocery) to being positioned as a critical component of its broader retail strategy in the 2024 filing, where it is specifically emphasized in the \"Key Customers\" narrative as a channel requiring careful management of trade terms, concentration risks, and shelf space allocation to maintain profitability. This shift indicates a deliberate focus on optimizing high-value retail partnerships—particularly membership clubs—within a competitive landscape where evolving channels like e-commerce and discounters demand adaptive trade practices, while also reflecting P&G's broader strategy to leverage concentrated, high-impact relationships (e.g., with Walmart) to drive growth and margin resilience amid cost pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PG (ORG) -> Membership Club Stores (COMP)",
        "Membership Club Stores (COMP) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12998,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3895,
        "completion_tokens": 260,
        "total_tokens": 4155
      }
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "Between 2023 and 2024, AMT's financial exposure to the Nigeria Letters of Credit shifted from a disclosed $3.4 million liability in 2023 (shown in the 2023 10‑K under variable‑rate debt) to a $3.4 million carrying value reported in 2024 with a carrying amount of $‑ (i.e., no net liability) and a USD carrying value of $‑, indicating that the instrument was either settled, derecognized, or re‑classified during the year. This evolution suggests that AMT’s direct financial obligation tied to the Nigeria Letters of Credit was effectively removed or offset by the 2024 reporting, reflecting a reduction in its contingent liability and a corresponding decrease in future payment risk associated with that instrument.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Nigeria Letters of Credit (FIN_INST)",
        "Nigeria Letters of Credit (FIN_INST) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2111,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 178,
        "total_tokens": 1355
      }
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, GD's Retirement Annuity Contracts shifted from being classified as Level 3 assets with disclosed unrealized gains/losses and purchases/sales activity (as shown in 2022 data where they totaled $35 with $3 in unrealized gains and $2 in purchases) to being explicitly categorized as Level 3 investments requiring fair value disclosure under a market approach using observable inputs, while also being explicitly grouped with insurance deposits contracts as \"i n su ran ce deposi t contracts,retti rem ent annui ty contracts\" in the 2024 hierarchy. This evolution indicates GD is increasingly emphasizing transparent fair value reporting through observable market inputs for these contracts, moving from basic Level 3 classification to detailed methodology disclosure that aligns with their broader plan asset valuation framework, which now explicitly separates Level 1 (actively traded funds), Level 2 (observable inputs), and Level 3 (including these contracts) assets for comprehensive reconciliation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Consists_Of]- ORG",
      "triplets_used": [
        "GD (ORG) -> Retirement Annuity Contracts (FIN_INST)",
        "Retirement Annuity Contracts (FIN_INST) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4121,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1686,
        "completion_tokens": 255,
        "total_tokens": 1942
      }
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "Between 2022 and 2024, the composition of restricted cash for securitization investors remained unchanged at $441 million in carrying value, with consistent fair value classification across all years. The 2024 disclosure explicitly confirms this balance is categorized as Level 1 in the fair value hierarchy (estimated fair value = $441 million, with $441 million classified under Level 1), indicating no change in valuation methodology or hierarchy level during this period. This stability aligns with the core securitization structure described in 2022 documentation where restricted cash represented the primary source of funds for VIE obligations, and the 2024 fair value hierarchy breakdown maintains the same Level 1 classification without any Level 2 or Level 3 components for this specific line item.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reports]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Restricted Cash for Securitization Investors (FIN_INST)",
        "Restricted Cash for Securitization Investors (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_179",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2024.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6372,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2251,
        "completion_tokens": 202,
        "total_tokens": 2453
      }
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's financial recognition and asset management relationship with its franchisees has evolved through strategic asset sales and enhanced financial disclosures. The Company continues to acquire restaurants from franchisees—often using discounted cash flow valuations (Level 3 inputs)—and has adopted new accounting standards (ASU 2023-07) requiring expanded segment reporting that impacts how franchisee-related revenues and asset disposals are disclosed. Additionally, while goodwill from such acquisitions is subject to write-offs if sold within 24 months, the 2023 activity and 2024 pronouncements reflect a structured approach to recognizing revenue from franchisee-operated locations, including rent, royalties, and technology fees, while managing asset lives and depreciation in alignment with evolving regulatory requirements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8046,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2641,
        "completion_tokens": 215,
        "total_tokens": 2857
      }
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "The 2019 Stock and Incentive Compensation Plan (2019 Plan) was adopted by shareholders at the October 8, 2019 annual meeting (10‑27) and its additional terms were later disclosed in the 2021 Annual Report (10‑28), showing its evolution and integration with earlier plans. It co‑exists with the 2009, 2014 and other legacy plans (e.g., 1992, 2001, 2003 Directors’ Plan) as listed in Item 12 of the 2024 filing (Chunk 2), illustrating that the 2019 Plan is part of a broader suite of equity compensation plans that collectively cover options, warrants and rights issued to employees and directors. This relationship underscores its role within Procter & Gamble’s overall equity compensation framework and its interplay with other shareholder‑approved plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PG (ORG) -> 2019 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY)",
        "2019 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16526,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4812,
        "completion_tokens": 188,
        "total_tokens": 5001
      }
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations has remained consistent between 2022 and 2023, with the brand operating in nine distinct international outlet properties across Japan through SPG's 40% ownership stake in each location. This international footprint includes key locations such as Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, Rinku Premium Outlets, Sano Premium Outlets, and Toki Premium Outlets, where Ferragamo maintains a presence alongside other luxury tenants like Coach, Prada, and Nike. The company's operational structure remains anchored in its disclosed partnership with SPG, as evidenced by the recurring KG triplets showing mutual \"Operates_In\" and \"Discloses\" relationships between SPG and Salvatore Ferragamo across both 2022 and 2023 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Salvatore Ferragamo (COMP)",
        "Salvatore Ferragamo (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16364,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4721,
        "completion_tokens": 204,
        "total_tokens": 4926
      }
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region has grown significantly from 2023 to 2024, with consolidated operations in this region increasing from 7,439 (net undeveloped) and 1,100 (equity affiliates) in 2023 to 5,870 (net undeveloped) and 5,870 (equity affiliates) in 2024, while natural gas production in this region rose from 296 billion cubic feet (end of 2023) to 468 billion cubic feet (end of 2024), reflecting a strategic expansion of its operational focus in this high-growth region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_155",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11307,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3470,
        "completion_tokens": 128,
        "total_tokens": 3599
      }
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "Comcast's approach to wireless gateways has evolved from a product-focused offering in 2022 to a strategically prioritized investment area by 2024, reflecting a shift in emphasis toward integrated connectivity solutions. In 2022, wireless gateways were presented as part of the Broadband segment's service bundle, combining modem and Wi-Fi router functionality with features like xFi Pods and whole-home management via the xFi application, targeting enhanced coverage and personalized network management for residential customers. By 2024, the company explicitly elevated wireless gateways as a core component of its capital expenditure strategy, directing investments toward \"upgrading our network to deliver multigigabit symmetrical speeds\" and \"continued deployment of wireless gateways\" within the Connectivity & Platforms business, signaling a strategic pivot to prioritize scalable infrastructure that integrates wireless gateway deployment with broader network evolution. This investment focus aligns with the 2024 capital allocation strategy, which earmarks funds for network upgrades and wireless gateway expansion alongside other initiatives like Universal theme park investments, while also supporting related financial activities such as debt refinancing to fund these network enhancements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Wireless Gateways (PRODUCT)",
        "Wireless Gateways (PRODUCT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10659,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3298,
        "completion_tokens": 325,
        "total_tokens": 3624
      }
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "The G600's market presence and production evolution between 2022 and 2024 reflect a strategic transition within Gulfstream's product lineup, marked by cumulative deliveries surpassing 300 units by end-2024 (up from nearly 150 by end-2021) and its role as a foundational model for newer aircraft. While the G600 itself was introduced in 2019 as a clean-sheet replacement for the G550, its production and market relevance were directly tied to the development of subsequent models like the G700 (expected 2022 service) and G800 (replacing the G650ER in 2023), with the G600's design enabling shared technology and commonality across Gulfstream's large-cabin portfolio, including the G400 (2025 service) and G800, which expanded Gulfstream's market reach into previously unserved segments. This evolution underscores the G600's role as a critical predecessor in a product lineage that drove cumulative deliveries to over 300 units by 2024, while its technological advancements in fuel efficiency, range, and cabin volume directly supported the company's broader strategy of introducing first-to-market capabilities that reinforced its dominance in the ultra-large-cabin business jet market, as evidenced by its contribution to holding over 270 city-pair speed records led by the G650ER family.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "GD (ORG) -> G600 (PRODUCT)",
        "G600 (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8583,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2785,
        "completion_tokens": 322,
        "total_tokens": 3107
      }
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "AIG's financial relationship with Corebridge has evolved significantly between 2023 and 2024 through both equity disposition and income recognition mechanisms. As of December 31, 2023, AIG held 52.2% ownership in Corebridge following its initial public offering in September 2022, with intentions to gradually reduce this stake over time while maintaining significant equity exposure. The separation of AIG's Life & Retirement business has created ongoing equity market exposure to Corebridge until full divestiture, making Corebridge's stock price movements directly impact AIG's financial results. \n\nUnder the equity method accounting reflected in AIG's 2024 10-K (page 109), AIG recognizes income from Corebridge through dividends received plus changes in the equity's market value, with pre-tax income from Corebridge reported for the period June 10, 2024 to December 31, 2024. This relationship is further reinforced by the KG pattern showing mutual stake-holding between AIG and Corebridge that impacts both entities, while the 2023 10-K details how continued ownership concentration and market fluctuations in Corebridge stock could materially affect AIG's financial condition and results of operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6457,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2246,
        "completion_tokens": 302,
        "total_tokens": 2548
      }
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Tesla's Solar Roof production strategy evolved significantly between 2022 and 2024 by shifting from standalone solar roof production to integrated manufacturing at Gigafactory New York, where it now produces Solar Roof alongside energy storage components and Supercharger systems as part of a vertically integrated approach. This strategy relies on Gigafactory New York as its primary manufacturing hub, which depends on Tesla's broader manufacturing network including Gigafactory Nevada for battery supply and Gigafactory Shanghai for localized procurement and cost efficiency, while facing operational challenges from supply chain dependencies on single-source suppliers for critical components like battery cells and electronics, as highlighted by the 2024 disclosure of risks related to supplier delays, raw material inflation, and production ramp complications at new facilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10382,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3233,
        "completion_tokens": 221,
        "total_tokens": 3454
      }
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm’s strategic focus on on-device AI has deepened through both organic investment and expanded business integration, as reflected in its financial disclosures and risk factors. The company continues to scale its foundational technologies—including on-device AI—into new product areas like automotive and IoT, leveraging its expertise to drive growth beyond mobile handsets (Chunk 1, Chunk 2). This evolution is underscored by its $560 million in prior-year product revenues from Huawei, which were abruptly cut off in May 2024 due to U.S. export restrictions, highlighting the geopolitical risks to its supply chain and customer relationships (Chunk 2). Concurrently, Qualcomm’s investment approach emphasizes sustained R&D in AI and next-generation wireless technologies, aligning with its broader strategy to embed intelligent computing across industries while navigating regulatory and competitive challenges (Chunk 1, Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> On-Device AI (PRODUCT)",
        "On-Device AI (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13850,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4105,
        "completion_tokens": 239,
        "total_tokens": 4344
      }
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "Between 2022 and 2023, Dolce & Gabbana's presence in SPG-operated properties remained consistent across both Japan and U.S. premium outlet locations, with explicit mentions in Japan's Gotemba, Kobe-Sanda, and Rinku outlets (Chunk 1), and in the Las Vegas North Premium outlet (Chunk 2), confirming sustained inclusion in high-end tenant mixes. This persistence across geographically distinct premium properties—particularly in Japan's largest outlet (Gotemba, 659,500 GLA) and the U.S.'s largest single U.S. outlet (Las Vegas, 675,814 GLA)—demonstrates SPG's deliberate brand positioning strategy to anchor luxury fashion credibility in its premium outlet portfolio through selective, high-visibility designer partnerships, reinforcing premium perception without relying on brand exclusivity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> COMP <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Dolce & Gabbana (COMP)",
        "Dolce & Gabbana (COMP) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16364,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4737,
        "completion_tokens": 198,
        "total_tokens": 4935
      }
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "COP's investment in exploration activities in the Asia Pacific/Middle East region increased from $462 million in 2023 to $462 million in 2024 (the same absolute amount, though the proportion of total exploration spend rose as overall exploration declined), reflecting a continued strategic focus on that region; this is supported by the KG relationship ORG‑[Operates_In]-> GPE where COP operates in the Asia Pacific/Middle East and discloses its activities there, indicating the company's ongoing emphasis on growth and resource development in that geographic area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_156",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 21358,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5990,
        "completion_tokens": 141,
        "total_tokens": 6131
      }
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "From 2022 to 2024, Comcast's financial stake and debt involvement in Universal Beijing Resort evolved as follows: Comcast maintains a 30% ownership interest in Universal Beijing Resort (as stated in Chunk 2), while the resort itself has significantly increased its debt burden from $3.5 billion outstanding as of December 31, 2023 to $3.4 billion as of December 31, 2024 (Chunk 2), though the provided text does not specify Comcast's direct debt guarantees or financing commitments beyond its equity stake. The resort's debt financing, secured by its assets and equity interests of investors, includes a term loan of $3.0 billion outstanding as of December 31, 2024 (Chunk 2), reflecting ongoing capital investment in the venture. This debt structure, combined with Comcast's 30% equity stake and consolidation of the resort as a variable interest entity (VIEs) in its financial statements (Chunk 2), underscores the material financial risk and obligation Comcast holds despite not having direct debt guarantees, with the resort's liabilities and assets being fully consolidated in Comcast's balance sheet (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Universal Beijing Resort (COMP)",
        "Universal Beijing Resort (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_86",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6665,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2296,
        "completion_tokens": 279,
        "total_tokens": 2575
      }
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "Duke Energy's net derivatives balance decreased significantly from $22 million at the end of 2022 to $13 million at the end of 2023, reflecting purchases of $42 million and settlements of $(68) million in 2023 (Chunk 2), while the prior year saw a balance of $29 million after $74 million of purchases and $(32) million of settlements (Chunk 2). This evolution indicates the company actively manages its derivative positions, using purchases and settlements to adjust exposure, and the net balance decline suggests a deliberate reduction in outstanding derivative contracts over the period (Chunks 1 & 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Derivatives (net) (FIN_INST)",
        "Derivatives (net) (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_199",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_192",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3856,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1616,
        "completion_tokens": 151,
        "total_tokens": 1767
      }
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG's treatment and disclosure of LTIP Units evolved in three key financial dimensions:  \n\n1. **Dilutive Effect**: Chunk 1 confirms LTIP Units were classified as \"potentially dilutive securities\" in 2021 (and by extension, 2022/2023), though no material dilutive impact was observed in prior years. Chunk 2 explicitly identifies LTIP Units as \"participating securities\" under the two-class earnings-per-share method (implying ongoing dilution risk), with awarded units entitled to 10% of quarterly distributions—directly linking their economic value to SPG’s cash flow and equity structure.  \n\n2. **Valuation Modeling**: Chunk 2 reveals LTIP Units are valued using Monte Carlo models for market-based awards (with fixed expense recognition regardless of performance), and are issued by the Operating Partnership as \"limited partnership interests.\" This contrasts with Chunk 1’s 2021 focus on exchangeability into common stock, indicating a shift toward formalized partnership-based valuation.  \n\n3. **Disclosure Context**: The KG triplet relationship (SPG → Introduces → LTIP Units → Discloses → SPG) is operationalized through Chunk 2’s detailed equity activity disclosures, which specify LTIP Units’ governance (via the 2019 Plan), distribution mechanics, and integration with director compensation—demonstrating how SPG’s 2023 filing expanded quantitative and structural disclosures around LTIP Units’ role in equity compensation and financial reporting.  \n\nCritically, while Chunk 1’s 2021 language established LTIP Units as dilutive instruments, Chunk 2’s 2023 details confirm their active use in long-term incentive programs with measurable financial impact (via distributions and Monte Carlo valuation), reflecting a maturation in how SPG quantifies and communicates their economic and dilutive effects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> LTIP Units (FIN_INST)",
        "LTIP Units (FIN_INST) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_127",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5718,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2064,
        "completion_tokens": 457,
        "total_tokens": 2521
      }
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Comcast's financial commitment to Atairos Group, Inc. has significantly evolved between 2022 and 2024, with both capital funding and management fee commitments being formally adjusted and reaffirmed. In November 2020, Comcast amended its agreement with Atairos to reduce its aggregate capital commitment from up to $5 billion to up to $4.5 billion, while simultaneously establishing a separate commitment to fund $40 million annually for management fees, subject to adjustments. This commitment remains active through 2024, as evidenced by the $297 million in distributions from equity method investments reported in 2024 (Chunk 2), which reflects ongoing financial engagement. The KG triplets confirm the mutual control and investment relationship between CMCSA and Atairos Group, Inc., with Comcast maintaining its role as the sole third-party investor and absorbing approximately 99% of losses while receiving about 86% of residual returns (Chunk 2). Thus, Comcast's involvement has shifted from a broader capital commitment to a more structured, predictable funding framework including both reduced capital exposure and sustained management fee support through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Controls]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Atairos Group, Inc. (COMP)",
        "Atairos Group, Inc. (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5972,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2138,
        "completion_tokens": 292,
        "total_tokens": 2430
      }
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 312 billion cubic feet at the end of 2023 to 296 billion cubic feet at the end of 2024, reflecting a modest decline of 16 billion cubic feet despite revisions and extensions that added 9 billion cubic feet and 4 billion cubic feet respectively. This reduction, occurring alongside a broader rise in total consolidated natural‑gas reserves from 13,718 billion cubic feet in 2023 to 15,641 billion cubic feet in 2024, indicates that the company is shifting its operational focus away from the Asia Pacific/Middle East basin toward higher‑growth areas such as Canada and the U.S., while still maintaining a presence in the region through equity affiliates and ongoing exploration activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_137",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13572,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4041,
        "completion_tokens": 192,
        "total_tokens": 4234
      }
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "Comcast's 2022 wireless gateway procurement strategy was driven by its reliance on a limited number of suppliers for customer premise equipment, including wireless gateways and set-top boxes, which it purchased to support residential and business services, while its 2024 network deployment strategy explicitly prioritizes continued investment in wireless gateway deployment as part of scalable infrastructure upgrades to enable multigigabit symmetrical speeds, aligning with its broader capital expenditure focus on Connectivity & Platforms initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Purchases]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Wireless Gateways (PRODUCT)",
        "Wireless Gateways (PRODUCT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10841,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3340,
        "completion_tokens": 138,
        "total_tokens": 3479
      }
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Tesla's Solar Roof strategy shifted from early 2021 deployment focus (highlighted in 2022 10-K's 40% energy revenue growth driven by Solar Roof alongside Powerwall and solar jobs) to becoming a critical but production-constrained component of its broader energy business by 2024, where its development and ramp faced significant supply chain challenges detailed in the 2024 10-K's warnings about supplier dependencies, manufacturing bottlenecks, and production delays affecting new product launches like Solar Roof. The 2024 filing explicitly identifies Solar Roof as subject to the same \"delays in launching and/or ramping production\" and \"supplier failure to deliver components\" risks that now define Tesla's entire energy product strategy, underscoring its strategic importance while revealing that production challenges—particularly around component availability and manufacturing scale—have become central to its evolution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6540,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2271,
        "completion_tokens": 232,
        "total_tokens": 2503
      }
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments declined from $53 million in 2021 (as reported in the 2022 10‑K) to $14 million in 2022 (as reported in the 2023 10‑K), reflecting a $39 million reduction year‑over‑year. This decrease signals a strategic shift away from these relatively small, non‑core investment holdings toward more core equity and debt securities, as evidenced by the overall drop in total fair‑value assets from $9.35 billion to $7.07 billion. Consequently, the company appears to be reallocating capital toward its primary business investments and reducing exposure to the “Net pending transactions and other investments” category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Net Pending Transactions and Other Investments (FIN_INST)",
        "Net Pending Transactions and Other Investments (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_226",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4769,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1857,
        "completion_tokens": 169,
        "total_tokens": 2027
      }
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "The company's liability-driven investment framework has remained consistent between 2023 and 2024, continuing to align pension assets with liabilities through a fixed equity/fix income allocation (20%/80% for pension plans and 55%/45% for postretirement plans) to balance liability hedging and asset growth. While defined contribution plan expenses increased slightly to $112 million in 2024 (up from $109 million in 2023), the framework's structure and asset composition disclosure remained unchanged, with the 2024 annual report specifically detailing the actual plan asset allocation at December 31, 2024 as broadly characterized by the same target allocations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Liability-Driven Investment Framework (ACCOUNTING_POLICY)",
        "Liability-Driven Investment Framework (ACCOUNTING_POLICY) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3576,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 166,
        "total_tokens": 1731
      }
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Qualcomm's strategic focus on On-Device AI has intensified through explicit investments in foundational technologies and expanded applications beyond mobile handsets, as highlighted in both fiscal 2023 and 2024 disclosures. The company emphasized that advancements in \"high-performance, low-power computing and on-device artificial intelligence\" will continue to drive adoption of AI-enabled technologies across smartphones, automotive, and IoT, while simultaneously increasing R&D and licensing investments to sustain leadership in 5G and next-generation wireless standards. Critically, fiscal 2024 disclosures revealed concrete actions including entering license agreements with key OEMs (such as Shenzhen Transsion) and pursuing legal enforcement of intellectual property rights to protect its AI and 5G technology portfolio, even as it faces competitive and regulatory pressures from vertical integration by customers like Huawei. This strategic evolution reflects a dual commitment: deepening On-Device AI capabilities while broadening its application into new growth areas, supported by sustained investment in both core semiconductor innovation and cross-industry technology licensing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> On-Device AI (PRODUCT)",
        "On-Device AI (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2023.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11175,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3443,
        "completion_tokens": 298,
        "total_tokens": 3741
      }
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members has been consistently disclosed as a foundational governance document in both the 2022 and 2023 10-K filings, with identical Exhibit 9.1 and 9.2 references to the \"Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated as of March 1, 2004\" across both years. This unchanged disclosure, maintained through the KG pattern of ORG-SPG entering into ACCOUNTING_POLICY (Voting Trust Agreement) which discloses itself, indicates a stable and unaltered governance structure where the voting rights of the Simon family members remain under the original 2004 agreement without any reported modifications or new classifications between the filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "SPG (ORG) -> Voting Trust Agreement (ACCOUNTING_POLICY)",
        "Voting Trust Agreement (ACCOUNTING_POLICY) -> SPG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SPG_10k_2022.pdf",
          "page_id": "page_144",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SPG_10k_2023.pdf",
          "page_id": "page_140",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 20268,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5743,
        "completion_tokens": 190,
        "total_tokens": 5933
      }
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region declined slightly from 312 billion cubic feet at the end of 2023 to 296 billion cubic feet by the end of 2024, while total consolidated and equity‑affiliated reserves grew from 8,443 billion cubic feet (2023) to 9,771 billion cubic feet (2024). This modest reduction in the Asia Pacific/Middle East share—from roughly 3.7 % of consolidated reserves (312 ÷ 8,443) to about 3.0 % (296 ÷ 9,771)—reflects a strategic shift as COP's global reserve portfolio expanded more rapidly in other regions (notably the Lower 48 and Canada), suggesting that the Asia Pacific/Middle East is becoming a comparatively smaller component of its overall resource base despite ongoing development and discovery activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2023.pdf",
          "page_id": "page_154",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12359,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3744,
        "completion_tokens": 191,
        "total_tokens": 3936
      }
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly through debt structuring and equity method income recognition. In 2023, AIG reported $11,874 million in total debt issued or guaranteed, which included $9,368 million of Corebridge debt structured as CRBGLH notes ($200M), CRBGLH junior subordinated debt ($227M), Corebridge senior unsecured notes ($7,702M), and DDTL facility ($250M), with notable repayments of $1,250M reducing DDTL balances (Chunk 1). By 2024, AIG recognized equity method income from Corebridge amounting to $225 million in cash dividends plus changes in stock price value during the period June 10–December 31, 2024 (Chunk 2), reflecting a strategic shift toward equity investment returns rather than direct debt obligations. This transition is further evidenced by the $2,591 million in debt of consolidated investment entities (including Corebridge) that remained outstanding but was explicitly not guaranteed by AIG (Chunk 1), indicating a deliberate separation of financial risk while maintaining economic interdependence through equity stakes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Impacts]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Corebridge (COMP)",
        "Corebridge (COMP) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_112",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6399,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2231,
        "completion_tokens": 277,
        "total_tokens": 2508
      }
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "From 2022 to 2024, NextEra Energy’s Special Use Funds allocation shifted significantly toward equity exposure, with fixed income declining from $2,505 million (2022) to $2,614 million in equity securities (2024) while total fund assets grew to $6,164 million (2024), reflecting a strategic pivot toward growth-oriented assets. This evolution—evidenced by the tripling of Level 3 equity holdings ($229M to $229M) and increased corporate bond exposure ($685M to $685M)—suggests a deliberate reduction in fixed income reliance and a calculated expansion of equity risk to capture market opportunities, balancing growth ambitions with liquidity management through structured investments in U.S. municipal bonds and asset-backed securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Special Use Funds (FIN_INST)",
        "Special Use Funds (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6247,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2225,
        "completion_tokens": 183,
        "total_tokens": 2409
      }
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The risk associated with site infrastructure sharing has evolved from primarily customer consolidation concerns in 2022 to include intensified 5G-driven infrastructure sharing pressures by 2024, as evidenced by both chunks explicitly linking advanced network technology like 5G to \"extensive sharing of site infrastructure\" that \"may cause new lease activity to slow if carriers utilize shared equipment rather than deploy new equipment\" or \"result in the decommissioning of equipment on certain existing sites because portions of the customers' networks may become redundant.\" While 2022's risk factors focused on consolidation reducing demand and potential lease terminations, the 2024 filing specifically identifies 5G-related sharing arrangements as a direct threat to new lease growth, with the knowledge graph pattern showing mutual negative impact between AMT and Site Infrastructure Sharing as a risk factor that has intensified with next-generation technology adoption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Site Infrastructure Sharing (RISK_FACTOR)",
        "Site Infrastructure Sharing (RISK_FACTOR) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10876,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3381,
        "completion_tokens": 244,
        "total_tokens": 3626
      }
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron's financial relationship with Angola LNG Limited has evolved through a consistent 36.4% equity investment structure between 2022 and 2023, with no change in ownership stake as evidenced by the identical percentage disclosed in both CVX_10k_2022.pdf (page 78) and CVX_10k_2023.pdf (page 82). The company continues to account for this investment using the equity method, as demonstrated by the ongoing reporting of significant differences between its carrying value ($100 higher in 2021, with no updated carrying value specified in 2023 but implied to persist) and underlying equity in Angola LNG Limited's net assets, alongside a $4,500 loan to fund development that remains part of the investment balance. This stable equity method accounting is further reinforced by the consistent 36.4% interest disclosure across both annual reports and the inclusion of Angola LNG Limited's operational activities in Chevron's consolidated financial statements, where related party transactions such as sales ($13,623 in 2023) and accounts receivable ($1,480 at 2023) reflect the integrated financial relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CVX (ORG) -> Angola LNG Limited (COMP)",
        "Angola LNG Limited (COMP) -> CVX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVX_10k_2022.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVX_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5049,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1904,
        "completion_tokens": 277,
        "total_tokens": 2182
      }
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 remained a cornerstone of Gulfstream's large-cabin product lineup, with its performance metrics and production status reflecting incremental advancements and sustained manufacturing momentum. According to the 2022 10-K (Chunk 1), the G600 was introduced in 2019 as a clean-sheet replacement for the G550, offering industry-leading range, speed, and cabin technologies, while the 2023 filing (Chunk 2) confirms that by year-end 2023, cumulative deliveries of the G500 and G600 exceeded 250 aircraft, underscoring robust production and market adoption. Furthermore, the G600 was highlighted for its enhanced performance—being faster, more fuel-efficient, with greater cabin volume, reduced emissions, and improved flight controls compared to its predecessors—while also contributing to Gulfstream's portfolio of over 355 city-pair speed records, led by the G650ER (Chunk 2), thereby reinforcing its role in advancing the company’s technological and commercial objectives across its product ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> G600 (PRODUCT)",
        "G600 (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5792,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2081,
        "completion_tokens": 256,
        "total_tokens": 2338
      }
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's financial relationship with its franchisees has evolved from a purely passive revenue collection model toward a more collaborative, capital-investment-driven partnership. While franchisees continue to pay rent, royalties, and initial fees—providing McDonald's with stable, predictable cash flow tied to sales—there has been a strategic shift toward co-investment, where the Company actively partners with franchisees to fund restaurant modernization and operational improvements, directly tying financial involvement to brand value enhancement and long-term system growth. This evolution reflects a deliberate move to deepen strategic collaboration, ensuring franchisees are active investors in their businesses rather than passive operators, thereby aligning financial incentives with sustained brand vitality and operational excellence across the system.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6613,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2285,
        "completion_tokens": 222,
        "total_tokens": 2507
      }
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, smokeable products' net revenues declined slightly from $22,476 million to $21,756 million, while operating income remained nearly flat at $10,688 million in 2022 versus $10,670 million in 2023, reflecting stable profitability despite modest revenue reduction. This performance is contextualized by the KG relationship where MO (the organization) holds stake in smokeable products, and these products disclose financial metrics under MO's reporting, as evidenced by the consistent $99 million goodwill and $3,017 million other intangible assets for smokeable products in 2021-2020 (Chunk 1), which aligns with the core business segment driving these financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Smokeable products (PRODUCT)",
        "Smokeable products (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3154,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 171,
        "total_tokens": 1596
      }
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within BMY's strategy evolved from a collaborative oncology product developed jointly with Ono under a shared-risk framework—where profits, losses, and development costs for combination therapies were split equally, and supply responsibilities were divided by formulation—to a broader commercialized asset with expanded therapeutic approvals, including FDA clearances in 2024 for first-line urothelial carcinoma (in combination with chemotherapy) and continued global uptake in melanoma, NSCLC, and now hematologic indications like Reblozyl in MDS, reflecting both regulatory progression and BMY's deepening integration of Opdivo into its diversified, multi-class pipeline while maintaining its foundational partnership structure with Ono for co-development and market commercialization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4537,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1779,
        "completion_tokens": 205,
        "total_tokens": 1984
      }
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "From 2022 to 2024, AMT's disclosure regarding interest rate benchmarks for debt instruments evolved from referencing **LIBOR and EURIBOR** as applicable base rates for borrowings under its 2021 credit facilities (including the 2021 Multicurrency Credit Facility and 2021 Credit Facility), with interest rates set above these benchmarks based on debt ratings, to adopting **SOFR** as the benchmark for new draws under subsidiary debt instruments in Nigeria, while maintaining similar covenantal language about financial and operating restrictions in loan agreements. The core regulatory compliance framework—where operating covenants govern AMT's adherence to debt covenants—remains consistent across both filings, but the specific benchmark rates shifted from LIBOR/EURIBOR to SOFR for newer instruments, reflecting broader market transitions in benchmark rate usage.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Operating Covenants (REGULATORY_REQUIREMENT)",
        "Operating Covenants (REGULATORY_REQUIREMENT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3643,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 216,
        "total_tokens": 1785
      }
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's has refined its real estate and co-investment strategy by maintaining ownership of land and buildings for conventional franchises while requiring franchisees to co-invest in equipment and fit-outs, a model that leverages its global brand and operational expertise to drive performance; this approach is reinforced by the company's reliance on franchisees as independent operators who benefit from the brand's strength, with disputes over franchise relationships—such as those involving quality, pricing, or termination—highlighting the importance of the contractual framework governing their partnership, as noted in the 2022 10-K's discussion of franchising and the 2024 10-K's emphasis on franchising as paramount to delivering customer experiences and profitability; additionally, the 2024 filing underscores that the optimal ownership structure for restaurants depends on local factors like property ownership laws, and that company-owned operations provide critical training and innovation testing to refine standards, marketing, and pricing strategies that ultimately benefit both the company and its franchisees across its 95% franchised global system.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12260,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3695,
        "completion_tokens": 298,
        "total_tokens": 3994
      }
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "Between 2022 and 2023, the 2015 Stock Compensation Plan for Non-Employee Directors was formally amended and restated effective October 26 2022 (as disclosed in the 2022 10‑Q incorporated by reference in the 2023 filing) and continued to be referenced in the 2023 proxy materials, indicating that the plan remained the vehicle for director equity awards but with updated documentation and new grant‑year agreements (e.g., 2023 RSU and PSU agreements). This evolution shows that Altria maintains a structured, long‑term approach to director compensation—periodically revising and restating the plan to reflect governance best practices and evolving equity‑based award formats while preserving the core objective of aligning director interests with shareholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "MO (ORG) -> 2015 Stock Compensation Plan for Non-Employee Directors (ACCOUNTING_POLICY)",
        "2015 Stock Compensation Plan for Non-Employee Directors (ACCOUNTING_POLICY) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8437,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2792,
        "completion_tokens": 189,
        "total_tokens": 2982
      }
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "From 2022 to 2024, the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity has intensified competitive pressures, leading to slower new lease growth. As documented in both 2022 and 2024 filings, extensive sharing of site infrastructure through roaming, resale, or RAN sharing—driven by advances like 5G—allows carriers to avoid leasing AMT's sites without compensation, which can cause new lease activity to decelerate or result in site decommissioning. This trend is part of broader industry consolidation and competitive dynamics that AMT identifies as materially reducing demand for its communications infrastructure, directly threatening its lease growth and revenue sustainability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Roaming Arrangements (RISK_FACTOR)",
        "Roaming Arrangements (RISK_FACTOR) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10876,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3383,
        "completion_tokens": 183,
        "total_tokens": 3566
      }
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "McDonald's relationship with its franchisees has evolved significantly between 2022 and 2024 through increased strategic co-investment and heightened operational expectations, reflecting a shift toward collaborative modernization rather than passive oversight. While the company maintains its heavily franchised model requiring franchisees to meet rigorous standards and contribute through rent and royalties (Chunk 2), it now actively partners with them to fund restaurant upgrades and operational improvements that align with evolving consumer preferences and digital transformation goals (Chunk 2). This collaborative approach is embedded within the Accelerating the Arches strategy, which explicitly depends on franchisees' ability to execute capital investments and operational efficiencies while preserving brand value through consistent quality and community engagement (Chunk 1). Critically, the company's success in driving Systemwide sales growth and brand resilience now hinges on franchisees' capacity to adapt to post-pandemic shifts in labor dynamics, supply chains, and consumer behavior—making their active partnership central to McDonald's financial strategy and long-term value creation (Chunk 1 & Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12450,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3747,
        "completion_tokens": 306,
        "total_tokens": 4053
      }
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "NextEra Energy's investment strategy in equity securities within its Special Use Funds evolved significantly from 2022 to 2024, as reflected in the disclosed asset allocations across its funds. In 2022, the Special Use Funds held $2,614 million in NEE equity securities (Level 1), $663 million in U.S. Government and municipal bonds (Level 1), and $5 million in corporate debt securities (Level 1), with additional exposure in corporate and asset-backed securities at higher levels. By 2024, the fund's equity securities allocation surged to $2,614 million (Level 1) plus $3,321 million (Level 2) and $229 million (Level 3) for NEE, totaling $6,164 million, while FPL's equity securities grew from $1,028 million (Level 1) in 2022 to $1,028 million (Level 1) plus $2,987 million (Level 2) and $204 million (Level 3) in 2024, totaling $4,219 million. This expansion across multiple levels indicates a strategic shift toward more complex, higher-yielding investments, particularly in corporate debt securities (e.g., $680 million Level 2 for NEE in 2024 vs. $5 million Level 1 in 2022) and asset-backed securities (e.g., $873 million Level 2 for NEE in 2024), reflecting a deliberate evolution from primarily Level 1 equity holdings to a diversified, multi-tiered portfolio to optimize returns within the Special Use Funds structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Special Use Funds (FIN_INST)",
        "Special Use Funds (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_63",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12733,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3814,
        "completion_tokens": 332,
        "total_tokens": 4147
      }
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "The financial performance of smokeable products showed a decline in net revenues from $22,476 million in 2022 to $21,756 million in 2023, while operating income remained relatively stable at $10,688 million in 2022 versus $10,670 million in 2023, reflecting minimal change in profitability despite the revenue dip. This trend aligns with the knowledge graph relationship where Smokeable products (PRODUCT) are disclosed by MO (ORG) and show a decreasing pattern in financial metrics across the two years, as evidenced by the consistent operating income figures and the product's role in MO's financial disclosures across both 2022 and 2023 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Smokeable products (PRODUCT)",
        "Smokeable products (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_67",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4795,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1834,
        "completion_tokens": 162,
        "total_tokens": 1996
      }
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between 2022 and 2023, the utilization of Accenture plc Class A Ordinary Shares evolved through distinct share purchase programs with specific intended uses. In 2022, the company maintained a publicly announced open-market share purchase program with an aggregate authorization of $3,129,296 for acquiring Class A shares and related redemptions of Class A shares and exchangeable shares held by leadership, primarily for employee benefits and equity awards (Chunk 1). By fiscal 2024 (2023), this usage shifted: Class A shares acquired via share withholding for payroll tax obligations under employee equity plans were explicitly separated from the open-market program's authorization, ensuring these purchases did not impact the remaining $3,129,296 authorization for the public program (Chunk 2). Thus, while both years involved Class A share transactions, the 2023 utilization focused on tax-driven acquisitions under employee plans without consuming the open-market program's budget, whereas 2022 included active authorization for both open-market purchases and leadership redemptions under the same $3,129,296 allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2022.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5135,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1930,
        "completion_tokens": 281,
        "total_tokens": 2211
      }
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants remained tied to its senior debt instruments but shifted from LIBOR-based benchmarks to SOFR-based rates for its Nigeria letter of credit facility, reflecting broader market transitions. The 2021 credit agreements originally required compliance with covenants across multiple facilities (including LIBOR-based USD and EUR borrowings), while newer debt issuances like the 0.450%–1.250% EUR senior notes (offered in May 2021) and subsequent offerings funded specific acquisitions, maintained covenants tied to reporting and financial restrictions, but the underlying benchmark rate evolved to SOFR for draws under the 2021 Multicurrency Credit Facility. This transition preserved structural covenants—such as limitations on additional debt and asset sales—while adapting interest rate benchmarks to SOFR, ensuring continuity in compliance obligations despite changes in debt composition and maturity profiles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "triplets_used": [
        "AMT (ORG) -> Operating Covenants (REGULATORY_REQUIREMENT)",
        "Operating Covenants (REGULATORY_REQUIREMENT) -> AMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMT_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMT_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4862,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1878,
        "completion_tokens": 239,
        "total_tokens": 2117
      }
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Based on the provided SEC filings and knowledge graph relationships, Disney+ Hotstar's subscriber base grew from approximately 36 million paid subscribers (as of September 28, 2024, per Chunk 1) to 123 million paid subscribers (as of September 28, 2024, per Chunk 1), reflecting a significant expansion driven by strategic consolidation. The merger of Star+ into Disney+ across Latin America at the end of June 2024 (documented in both Chunk 1 and Chunk 2) unified the company's streaming offering in the region, eliminating standalone competition and strengthening Disney's international strategy by creating a single, cohesive platform that leverages combined content libraries and subscriber bases to accelerate market penetration and revenue growth in key emerging markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Disney+ Hotstar (PRODUCT)",
        "Disney+ Hotstar (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9242,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2963,
        "completion_tokens": 194,
        "total_tokens": 3157
      }
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The number of employees covered under collective labor agreements decreased from approximately 3,000 in 2022 (as stated in the 2022 filing for 2022 agreements) to approximately 2,100 in 2023 (as stated in the 2023 filing for 2024 agreements), reflecting a reduction of about 900 employees covered under renegotiated agreements. This decline indicates a strategic shift toward negotiating fewer, potentially broader agreements covering fewer employees, while maintaining the historical success of reaching settlements without operational disruption or material financial impact, as emphasized in both chunks regarding the non-material effect of these negotiations on results of operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Negotiates]- ORG",
      "triplets_used": [
        "GD (ORG) -> Collective Agreements (ACCOUNTING_POLICY)",
        "Collective Agreements (ACCOUNTING_POLICY) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8178,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2697,
        "completion_tokens": 172,
        "total_tokens": 2869
      }
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "NextEra Energy's investment in U.S. Government and municipal bonds increased from $137 million at the end of 2021 (as reported in the 2022 10‑K) to $722 million at the end of 2024 (as reported in the 2024 10‑K), reflecting a $585 million growth over the three‑year period. This evolution is captured by the disclosed holdings of U.S. Government and municipal bonds within NEE’s Level 1 and Level 2 fair‑value classifications across both years, illustrating the company’s expanding exposure to these fixed‑income securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "NEE (ORG) -> U.S. Government and Municipal Bonds (FIN_INST)",
        "U.S. Government and Municipal Bonds (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2022.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7826,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2606,
        "completion_tokens": 130,
        "total_tokens": 2737
      }
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Based on the KG pattern (ORG -[Supplies]-> PRODUCT) and the provided data, Opdivo's role in Bristol-Myers Squibb's portfolio has evolved from a mature product reliant on flexible manufacturing (including internal and third-party capacity for supply continuity) to a newly approved first-line therapy for metastatic urothelial carcinoma (FDA March 2024), while its manufacturing strategy remains anchored in both internal capability and external partnerships to ensure supply resilience, as evidenced by the company's ongoing investments in complex biologics manufacturing infrastructure and regulatory approvals across its portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Opdivo (PRODUCT)",
        "Opdivo (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2022.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9676,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3058,
        "completion_tokens": 158,
        "total_tokens": 3216
      }
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Disney's relationship with National Geographic magazine has evolved from a distinct publishing unit within its Entertainment segment to an integrated content licensing component of its Direct-to-Consumer and Content Sales/Licensing operations. As noted in the 2023 10-K, National Geographic magazine and its online business were owned 73% by Disney and reported under Content Sales/Licensing revenue streams, while the 2024 filing confirms this business is now specifically referenced as part of Disney's publishing activities within Content Sales/Licensing and Other, directly tied to its DTC services like Disney+ which features National Geographic branded programming tiles globally. This strategic positioning reflects Disney's consolidation of National Geographic content under its broader DTC and licensing framework rather than as a standalone publishing entity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "DIS (ORG) -> National Geographic Magazine (PRODUCT)",
        "National Geographic Magazine (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_78",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2813,
        "completion_tokens": 217,
        "total_tokens": 3030
      }
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "PayPal's transaction management databases have expanded their global payment processing capabilities between 2023 and 2024, specifically increasing currency support from approximately 150 currencies in 2023 to approximately 140 currencies in 2024 for sending payments, while also expanding bank withdrawal options from 56 to 57 currencies and maintaining balance holdings in 24 currencies. This evolution reflects the company's strategic focus on \"expanding our global capabilities\" and \"offering consumers simple, secure, and flexible ways to manage and move money across different markets\" as outlined in its 2023 strategy documentation, with the 2024 update demonstrating concrete implementation of these capabilities through measurable increases in supported currencies and transaction functions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PYPL (ORG) -> Transaction Management Databases (PRODUCT)",
        "Transaction Management Databases (PRODUCT) -> PYPL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PYPL_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PYPL_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9653,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3069,
        "completion_tokens": 200,
        "total_tokens": 3269
      }
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The interest rate on NEE's Series K Debentures was reset to 6.051% per year in March 2023 following their August 2022 remarketing of $2.5 billion principal amount, and this rate applies to interest payments due on March 1 and September 1 of each year commencing September 1, 2023, while the debt matures on March 1, 2025. This refinancing activity, part of NEE's broader strategy to manage debt maturities and optimize capital structure through equity-linked instruments like the February 2020 equity units, reflects a deliberate approach to securing long-term financing at targeted rates, as evidenced by the sequential remarketing of Series J (August 2022), Series K (March 2023), and Series L (August 2023) debentures with reset rates of 4.255%, 6.051%, and 5.749% respectively, all guaranteed by NEE and tied to its subsidiaries' debt obligations within the NEER segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Series K Debentures (FIN_INST)",
        "Series K Debentures (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13077,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3911,
        "completion_tokens": 218,
        "total_tokens": 4130
      }
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil's application of the Unit-of-Production Depreciation method remained consistent between 2022 and 2023, continuing to base depreciation rates on proved reserves estimates subject to variability from reserve revisions and SEC price averages. The 2023 filing explicitly states that when proved reserves are substantially de-booked or when depreciation allocation becomes inequitable, the company adjusts to use reserves determined at the most recent SEC price—reflecting updated reserve volumes and price assumptions—while maintaining the core methodology. This evolution directly responds to reserve revisions driven by technical evaluations, price changes, and development strategy shifts, ensuring depreciation aligns with current reserve estimates and economic conditions across both reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Unit-of-Production Depreciation (ACCOUNTING_POLICY)",
        "Unit-of-Production Depreciation (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_77",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11775,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3607,
        "completion_tokens": 203,
        "total_tokens": 3810
      }
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Netflix's strategic emphasis on original programming has shifted decisively toward greater internal studio scaling between 2023 and 2024, as evidenced by its 2024 10-K disclosures which explicitly detail aggressive expansion of its own production capabilities through acquisitions like Scanline and Animal Logic to reduce reliance on third-party partners (Chunk 1 & 2). While both filings confirm Netflix continues contracting with third parties for development, production, and distribution of original content (Chunk 1 & 2), the 2024 filing underscores a strategic pivot toward building in-house expertise across creative, marketing, legal, and finance disciplines to manage this scaling, directly linking studio growth to its ability to mitigate risks and maintain market competitiveness amid evolving industry dynamics (Chunk 2). This evolution is further contextualized by the persistent industry-wide risks of content acquisition costs, regulatory pressures, and competitive threats from rivals scaling their own streaming offerings and AI-driven content strategies—risks that Netflix acknowledges as critical to its operational resilience and brand reputation (Chunk 1 & 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Original Programming (PRODUCT)",
        "Original Programming (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13709,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4078,
        "completion_tokens": 295,
        "total_tokens": 4374
      }
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Between 2022 and 2023, Mastercard's strategic positioning of Cyber and Intelligence Solutions evolved from being categorized under \"Other revenues\" in its 2022 10-K (Chunk 1) to being explicitly highlighted as a core component of its value-added services within the payments ecosystem in the 2023 10-K (Chunk 2). This shift reflects a deliberate strategic emphasis on security and intelligence as foundational to its multi-rail network and franchise model, where cyber and intelligence solutions are described as enabling \"secure, simple, smart, and accessible\" transactions through proprietary insights and fraud prevention capabilities (Chunk 2). The 2022 filing details these solutions as fee-based products for fraud prevention and transaction safety, while the 2023 overview elevates them as integral to Mastercard's proprietary data use and network interoperability, directly supporting its broader mission of securing the global payments ecosystem without issuing cards or controlling issuer revenue (Chunk 2). This progression underscores a strategic deepening of Cyber and Intelligence Solutions from a tactical revenue stream into a central, interdependent pillar of Mastercard's value proposition across its payment flows and network capabilities (Chunk 1 & Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Cyber and Intelligence Solutions (PRODUCT)",
        "Cyber and Intelligence Solutions (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_80",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8005,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2635,
        "completion_tokens": 319,
        "total_tokens": 2955
      }
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "Tesla's energy storage product evolution from 2023 to 2024 reflects a strategic shift marked by intensified production challenges and heightened dependencies, as revealed across both documents. While Chunk 1 details the foundational design philosophy—leveraging vehicle-derived modular battery systems, software-controlled dispatch capabilities, and integration with Solar Roof—the 2024 filing (Chunk 2) explicitly identifies energy storage products (including Megapack and Solar Roof) as subject to the same \"bottlenecks and unexpected challenges\" as vehicle production ramps, with explicit references to \"delays in launching and/or ramping production of our energy storage products\" and supply chain vulnerabilities affecting component availability. This confirms that Tesla's energy storage ambitions are now critically dependent on overcoming manufacturing scaling issues and supplier reliability, directly tying its energy storage evolution to the same operational pressures driving its automotive expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Energy Storage Products (PRODUCT)",
        "Energy Storage Products (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9861,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3107,
        "completion_tokens": 253,
        "total_tokens": 3360
      }
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "From 2023 to 2024, NextEra Energy Capital Holdings expanded its floating rate debenture program with a more targeted maturity profile and increased principal issuance. In January 2023, the company issued floating rate debentures maturing in 2028, 2030, 2033, and 2053, and by January 31, 2024, it issued $600 million of floating rate debentures due 2026 alongside additional floating rate series maturing in 2029, 2034 and 2054 (as shown in the officer’s certificates *4(oo), *4(jj), *4(rr) and the January 31, 2024 filing). This evolution reflects a shift toward shorter‑term floating rate debt—particularly the 2026 maturity—while maintaining a broader range of longer‑dated issues to support the company’s funding strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Floating Rate Debentures (FIN_INST)",
        "Floating Rate Debentures (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6566,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2291,
        "completion_tokens": 181,
        "total_tokens": 2473
      }
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel has evolved its industry supply chain responsibility initiatives by deepening collaboration and expanding supplier engagement scope. In 2023, Intel announced its goal to achieve net-zero Scope 3 emissions by 2050 and linked executive compensation to emissions reductions, while advancing industry-wide standards through initiatives like the Responsible Minerals Partnership and training programs (Chunk 1). Building on this, the 2024 disclosure confirms continued leadership in industry collaboration, including advancing responsible minerals sourcing and climate transparency, while significantly expanding supplier engagement—both direct and indirect—to drive sustainability acumen, emissions reductions, and diversity targets (Chunk 2). This progression reflects a strategic shift from foundational programs to integrated, measurable commitments across the value chain, with 2024 efforts emphasizing scaling supplier partnerships to meet RISE goals and industry benchmarks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> CONCEPT <-[Partners_With]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Industry Initiatives (CONCEPT)",
        "Industry Initiatives (CONCEPT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12196,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3699,
        "completion_tokens": 250,
        "total_tokens": 3949
      }
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "The characterization of assumptions underlying the standardized measure of discounted future cash flows remained materially consistent between XOM's 2022 and 2023 disclosures, with both periods continuing to apply first-day-of-the-month average prices as a prescribed accounting assumption that inherently creates variability in cash flow estimates due to discrete pricing points. While the 2022 disclosure explicitly states the Corporation believes this measure \"does not provide a reliable estimate\" of expected cash flows or reserve value, the 2023 version retains this critical framing but adds no substantive evolution in its treatment—both iterations continue to rely on the same first-day-of-the-month average price methodology that the company views as fundamentally disconnected from realistic cash flow expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Prepared_On_Basis_Of]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "XOM (ORG) -> Prescribed Assumptions (ACCOUNTING_POLICY)",
        "Prescribed Assumptions (ACCOUNTING_POLICY) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_133",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2120,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 206,
        "total_tokens": 1416
      }
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, MA expanded its digital identity solutions by deepening integration with open banking capabilities, enabling seamless and secure payment experiences across individuals, devices, and accounts through privacy-by-design and consent-centric approaches. In 2023, the company leveraged these capabilities to connect with over 95% of U.S. deposit accounts and approximately 3,000 banks across Europe, while continuing to enhance fraud prevention and transaction approval rates using Ekata’s acquired identity verification technology and advanced behavioral biometrics. This evolution reflects a strategic expansion of MA’s open banking platform to drive financial inclusion and improve payment security at scale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Digital Identity Solutions (PRODUCT)",
        "Digital Identity Solutions (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6668,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2317,
        "completion_tokens": 182,
        "total_tokens": 2499
      }
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Tesla's Solar Roof evolution between 2023 and 2024 reflects a strategic shift toward production scaling amid persistent challenges, with critical dependencies on manufacturing infrastructure and supply chain resilience. While 2023 documentation (Chunk 1) highlights iterative design refinements—leveraging vehicle engineering expertise for durability and integration with Powerwall—and emphasizes modular energy storage approaches, 2024 disclosures (Chunk 2) explicitly identify Solar Roof as a \"future product\" facing ramp delays due to manufacturing complexities, supplier dependencies, and site-specific construction hurdles across global facilities like Texas and Germany. Both chunks confirm that Solar Roof production remains constrained by Tesla's broader manufacturing ambitions, where delays in vehicle production at new factories (e.g., Mexico) or supplier disruptions could directly impact Solar Roof's cost-effectiveness and market deployment, underscoring its role as a high-stakes, dependency-driven extension of Tesla's energy strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9861,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3101,
        "completion_tokens": 262,
        "total_tokens": 3364
      }
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "Based on the provided 10-K filings and KG relationships, NextEra Energy, Inc.'s use of Pledge Agreements has evolved with new agreements dated **September 1, 2022** (in 2022 filing), **June 1, 2024** (in 2024 Q2 filing), and **October 1, 2024** (in 2024 filing), all involving **The Bank of New York Mellon** and **Deutsche Bank Trust Company Americas** as Collateral Agent. The 2023 filing (Chunk 1) references the September 1, 2022 agreement, while the 2024 filing (Chunk 2) explicitly documents subsequent Pledge Agreements on **June 1, 2024**, and **October 1, 2024**, confirming the continuation and expansion of this structure with updated dates and identical counterparties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Pledge Agreement (FIN_INST)",
        "Pledge Agreement (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 26829,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 7345,
        "completion_tokens": 170,
        "total_tokens": 7515
      }
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "Intel's strategic positioning in Edge AI has evolved from 2023 to 2024 by deepening its software-centric approach and expanding ecosystem partnerships to accelerate intelligent edge adoption. In 2023, Intel emphasized its open-edge software platform to enable developers in building and managing distributed edge infrastructure across verticals like healthcare and manufacturing, while 2024 highlights expanded collaboration with over 500 network builders and telecom partners to deploy software-defined 5G RAN and cloud-native edge solutions (e.g., FlexRAN™ and IPU platforms), reinforcing its shift from hardware-centric to integrated software-hardware ecosystems that streamline edge AI deployment and reduce operational complexity for customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enables]-> CONCEPT <-[Positively_Impacts]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Edge AI (CONCEPT)",
        "Edge AI (CONCEPT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11487,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3509,
        "completion_tokens": 187,
        "total_tokens": 3696
      }
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "Between 2023 and 2024, CVS's long-term debt composition evolved significantly, particularly for the 1.75% senior notes due August 2030, which remained consistently at $1,250 million across both years, indicating no change in this specific tranche. While total long-term debt decreased slightly from $35,771 million (2023) to $35,215 million (2024) due to maturities of older notes like the $1,000 million 5% senior notes due January 2029 and reduced balances in earlier-dated notes such as the $1,000 million 4.125% notes due April 2040 (down from $1,000 to $602 million), the company maintained its strategic focus on long-term financing by retaining the 1.75% notes at their original $1,250 million value and adding new long-term instruments like the $1,000 million 5.4% senior notes due June 2029. This reflects a deliberate capital structure management, preserving low-cost debt (1.75% coupon) while adapting to market conditions through selective refinancing and maturity management across its diverse senior note portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CVS (ORG) -> 1.75% Senior Notes (FIN_INST)",
        "1.75% Senior Notes (FIN_INST) -> CVS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CVS_10k_2023.pdf",
          "page_id": "page_168",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CVS_10k_2024.pdf",
          "page_id": "page_161",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5996,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2147,
        "completion_tokens": 257,
        "total_tokens": 2404
      }
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Netflix's ad-supported subscription plan has evolved from a strategic test to a core component of its pricing strategy between 2023 and 2024, directly supporting membership growth objectives amid intensifying competition and macroeconomic pressures. The company explicitly leveraged this plan to attract price-sensitive subscribers while maintaining its broader goal of expanding global penetration, as evidenced by its 2023 introduction of the lower-priced tier and continued emphasis on \"winning moments of truth\" through diverse pricing options in the 2024 filing. This evolution is critically tied to Netflix's need to counteract slowing growth in mature markets and compete with rivals, as highlighted by its 2023 risk disclosures about pricing adjustments potentially adverse to member retention and its 2024 focus on \"membership growth, including impact of content and pricing changes\" as a key forward-looking metric.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Ad-Supported Subscription Plan (PRODUCT)",
        "Ad-Supported Subscription Plan (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11189,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3446,
        "completion_tokens": 231,
        "total_tokens": 3677
      }
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Tesla's approach to the Tesla Semi has evolved significantly between 2023 and 2024, transitioning from early production and deliveries launched in 2022 to pilot production status at its Nevada facility as documented in the 2024 10-K, while maintaining its strategic positioning within the commercial electric vehicle market through continued development of proprietary Full Self-Driving technology and battery innovations originally tied to its broader vehicle platform. The Semi remains actively positioned alongside other key products like Cybertruck (now in active production in Texas) and is integrated into Tesla's vertically integrated business model that emphasizes performance, cost reduction, and energy storage synergies through its battery cell advancements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Tesla Semi (PRODUCT)",
        "Tesla Semi (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_36",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4674,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1798,
        "completion_tokens": 192,
        "total_tokens": 1990
      }
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024—evidenced by new agreements with Mark Lemasney (2023) and Nicole J. Daggs (2024), alongside the addition of a 2024 agreement for Brian Bolster (effective May 6, 2024)—demonstrates a deliberate strategy to institutionalize leadership continuity through long-term retention commitments, ensuring stability in executive talent as the company advances its strategic priorities. This pattern, reinforced by the recurring use of the \"Executive Retention Employment Agreement\" accounting policy across multiple filings (e.g., 2023 10-K and 2024 10-K), underscores NextEra Energy's systematic focus on securing key leadership through tailored contractual frameworks, directly aligning executive incentives with sustained organizational execution and strategic momentum.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Executive Retention Employment Agreement (ACCOUNTING_POLICY)",
        "Executive Retention Employment Agreement (ACCOUNTING_POLICY) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_123",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_125",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14643,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4335,
        "completion_tokens": 213,
        "total_tokens": 4549
      }
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "Intel's xPU strategy has evolved from a broad, risk‑laden R&D and manufacturing push in 2023—where it incurred $16 billion in R&D spend and emphasized five new process nodes, unified oneAPI tools, and aggressive packaging designs—to a more focused 2024 approach that centers on product competitiveness within its xPU portfolio (including GPUs, IPUs, FPGAs and other accelerators) while leveraging open‑platform initiatives and selective third‑party foundry capacity to meet AI‑driven compute demand. This shift reflects a strategic prioritization of xPU product development and ecosystem expansion (e.g., advisory groups for x86 compatibility) amid ongoing capital‑intensive investments and the need to mitigate delays and cost pressures inherent in advanced packaging and new process technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "INTC (ORG) -> xPU Products (PRODUCT)",
        "xPU Products (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12340,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3719,
        "completion_tokens": 199,
        "total_tokens": 3918
      }
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Netflix's advertising technology evolution between 2023 and 2024 reflects a deliberate organizational and infrastructural shift, as evidenced by its 2024 10-K disclosures. The company explicitly prioritized developing its \"advertising sales and advertising technology organization team\" and \"technology and related infrastructure to support advertising\" (Chunk 2), directly building on its foundational work in ad tech identified in 2023. This expansion is underscored by its strategic focus on securing exclusive content rights to drive advertiser value, while simultaneously navigating complex risks like content licensing volatility and CMO negotiations that could impact both its content mix and advertising capabilities (Chunks 1 and 2). Crucially, the 2024 filing confirms this infrastructure investment is now central to its growth strategy, with explicit emphasis on \"drive[ing] value to advertisers\" through technological advancement, even as it manages regulatory, legal, and competitive pressures inherent in scaling ad-supported services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Develops]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Advertising Technology (PRODUCT)",
        "Advertising Technology (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11602,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3545,
        "completion_tokens": 262,
        "total_tokens": 3807
      }
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Tesla's approach to free Supercharging programs has evolved from a revenue-neutral offering to a structured revenue recognition component tied to vehicle sales and financing arrangements, as evidenced by its inclusion in \"Automotive and Services and Other Segment\" revenue streams in both 2023 and 2024 filings. The company now recognizes revenue from free Supercharging as part of upfront payments for vehicle access to FSD features and ongoing maintenance, with deferred revenue accounting reflecting its integration into post-sale service and financing structures—particularly notable in 2024's disclosure of $1.45 billion in maximum exposure for lease residual value guarantees that indirectly supports Supercharging program economics through program design and risk allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Free Supercharging Programs (PRODUCT)",
        "Free Supercharging Programs (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3733,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1577,
        "completion_tokens": 195,
        "total_tokens": 1772
      }
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "NextEra Energy's approach to issuing Series O Junior Subordinated Debentures has evolved from the previously issued Series N (due March 1, 2079) and Series M (due December 1, 2077) instruments, with the Series O now featuring a shorter maturity of November 1, 2029, while maintaining a floating rate structure as indicated by its designation in the latest 2024 filings. This shift toward shorter-dated, floating rate debt—evident in the Series O's November 2024 issuance alongside newer fixed-rate debentures like the 4.85% Series due April 30, 2031 and 5.55% Series due March 15, 2054—suggests a strategic pivot toward more flexible, interest rate-sensitive financing to manage rising rates and reduce long-term refinancing risks, contrasting with the ultra-long-dated, fixed-rate subordinated debt structures (e.g., Series N/M) that dominated their capital strategy through 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Creates]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "NEE (ORG) -> Series O Debentures (FIN_INST)",
        "Series O Debentures (FIN_INST) -> NEE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NEE_10k_2023.pdf",
          "page_id": "page_120",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NEE_10k_2024.pdf",
          "page_id": "page_121",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14207,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4214,
        "completion_tokens": 220,
        "total_tokens": 4434
      }
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "ExxonMobil's consideration of OPEC investment activities has remained a consistent element in its impairment assessment framework from 2022 to 2023, as evidenced by its inclusion in both years' disclosures regarding long-term oil supply dynamics. The corporation explicitly identifies OPEC investment activities and production policies as factors influencing world oil supplies within its broader analysis of commodity price drivers, which directly informs its impairment testing for long-lived upstream assets. This assessment relies on long-term price and margin projections from its Corporate Plan, where OPEC's role in offsetting declining field production through strategic investments is recognized as a key supply-side variable affecting future cash flow estimates used in recoverability evaluations. Consequently, changes in OPEC's investment activities or production policies are treated as potential indicators of impairment only when they signal significant shifts in the long-term oil supply balance that would materially alter the Corporation's price and margin assumptions underpinning its asset valuation models.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Considers]-> MACRO_CONDITION <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> OPEC Investment Activities (MACRO_CONDITION)",
        "OPEC Investment Activities (MACRO_CONDITION) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2023.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13118,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3937,
        "completion_tokens": 281,
        "total_tokens": 4219
      }
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "Netflix's ad-supported subscription plan has evolved from a nascent offering in 2023 to a strategically emphasized revenue stream in 2024, as evidenced by its explicit inclusion in forward-looking statements and business priorities within the 2024 10-K filing. While the 2023 filing (Chunk 1) acknowledges the inherent difficulty in predicting consumer adoption of pricing strategies like the ad-supported plan and highlights its status as a \"new revenue stream\" with \"lack of operating history,\" the 2024 filing (Chunk 2) elevates its strategic importance by detailing it as a core component of Netflix's pricing portfolio (\"a range of pricing plans, including our ad-supported subscription plan\") and linking it directly to membership growth drivers (\"impact of content and pricing changes on membership growth\") and overall business objectives (\"grow our business globally within the parameters of our operating margin target\"). This progression reflects a shift from cautious experimentation to deliberate integration into the company's growth strategy, with the 2024 filing placing greater emphasis on its role in attracting and retaining members through flexible pricing options within an intensely competitive market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Ad-Supported Subscription Plan (PRODUCT)",
        "Ad-Supported Subscription Plan (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11732,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3581,
        "completion_tokens": 306,
        "total_tokens": 3887
      }
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon's shipping offers have evolved significantly between 2022 and 2024, with a strategic shift toward improving fulfillment efficiency while managing cost drivers. In 2022, shipping costs were identified as a major component of cost of sales—rising to $76.7 billion in 2021 due to expanded fulfillment networks, higher carrier rates, wage increases, and supply chain constraints, with Amazon emphasizing that offering low shipping prices is fundamental to its customer value proposition. By 2024, fulfillment costs as a percentage of net sales continued to be influenced by network investments and operational scale, but efficiency gains partially offset growth, as noted in Chunk 2’s discussion of fulfillment network improvements and foreign exchange impacts ($223M reduction). Chunk 2 also highlights that shipping offers—though not directly in sales and marketing expenses—are viewed as key marketing tools, reinforcing their strategic role in customer acquisition and retention. Together, the chunks reveal that while shipping cost pressures persist due to volume, service level increases, and network expansion, Amazon is actively mitigating these through operational efficiencies, network optimization, and leveraging scale, reflecting a dual focus on cost control and enhanced fulfillment capabilities to sustain its competitive shipping strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Shipping Offers (PRODUCT)",
        "Shipping Offers (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7897,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2616,
        "completion_tokens": 339,
        "total_tokens": 2955
      }
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Duke Energy's utilization of the Master Retirement Trust evolved between 2023 and 2024 through both structural disclosure and asset allocation changes, as evidenced by the KG pattern ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG connecting DUK to the Master Retirement Trust. In 2023, the Trust's assets were composed of VEBA trusts and 401(h) accounts, with Duke Energy's investment objective focused on achieving sufficient returns while maintaining prudent risk to secure plan benefits (Chunk 1). By 2024, the Trust's allocation was explicitly detailed across subsidiaries, with Duke Energy Carolinas, Progress Energy, Florida, Ohio, Indiana, and Piedmont receiving approximately 27%, 33%, 15%, 18%, 5%, and 3% allocations respectively as of December 31, 2023 (Chunk 2). Additionally, the 2024 filing disclosed that certain investments measured at fair value using net asset value per share were excluded from the fair value hierarchy, reflecting a refinement in disclosure practices regarding asset valuation transparency (Chunk 2). This evolution demonstrates both expanded subsidiary-level allocation reporting and enhanced transparency in fair value disclosures, while maintaining the Trust's core role as a centralized retirement vehicle for Duke Energy's post-retirement obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Master Retirement Trust (FIN_INST)",
        "Master Retirement Trust (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_218",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_228",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1041,
        "completion_tokens": 323,
        "total_tokens": 1365
      }
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "Between 2022 and 2024, Google's financial relationship with Google Network Partners evolved significantly in cost structure and payment obligations, as revealed by the interconnected disclosures across all provided chunks. The cost of revenues component explicitly tied to Google Network Partners—primarily TAC payments for ads on their properties—remained materially higher as a percentage of ad revenue from those networks compared to Google Search properties, driven by the structural obligation to share advertising revenue with network partners (Chunk 1). This revenue-sharing model directly increased cash outflows, as evidenced by the 2024 cash flow statement showing \"payments to distribution and Google Network partners\" as a primary operating cash usage, alongside other operational expenses (Chunk 2). Concurrently, the growing scale of Google Network properties—contributing to increased advertising revenue across Google Search, Network, and YouTube properties—amplified both the absolute dollar payments to partners and their strategic importance to Google's overall revenue model, necessitating larger cash outflows to sustain network participation while maintaining profitability (Chunk 2). Thus, the evolution reflects a sustained, revenue-dependent cost structure where payments to Google Network Partners are not discretionary but intrinsically linked to ad revenue generation on their platforms, requiring ongoing cash allocation that directly impacts operating cash flow dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Supplies]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Network Partners (COMP)",
        "Google Network Partners (COMP) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5874,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2112,
        "completion_tokens": 375,
        "total_tokens": 2487
      }
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, UPS's fair value changes and settlements related to offsetting swap positions evolved significantly, with the financial impact reflected in its consolidated income statements. In 2022, settlements and fair value adjustments for non-designated interest rate swaps, foreign currency forwards, and investment market price forwards totaled $14 million, while in 2023, these amounts increased substantially to $36 million—a 157% rise—indicating heightened market-related volatility or strategic repositioning of derivative instruments. This shift aligns with UPS's practice of periodically terminating original swap positions and entering offsetting contracts, which triggers de-designation of prior hedge relationships and necessitates fresh fair value accounting under non-hedge treatment. The consistent pattern across both years, as disclosed in the 10-K filings, underscores that settlements and fair value gains/losses from these offsetting derivatives directly flow through the consolidated income statement, impacting reported earnings each period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "UPS (ORG) -> Offsetting Swap Positions (FIN_INST)",
        "Offsetting Swap Positions (FIN_INST) -> UPS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UPS_10k_2022.pdf",
          "page_id": "page_159",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UPS_10k_2023.pdf",
          "page_id": "page_132",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2427,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 268,
        "total_tokens": 1529
      }
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures signals a strategic shift toward greater reliance on nonqualified deferred compensation to align director incentives with long-term shareholder interests, as evidenced by its expanded disclosure in Item 12 of the 2024 10-K compared to prior years. This is further reinforced by the 2024 filing's explicit linkage of the Directors' Savings Plan to the Executive Savings Plan and the 2023 Long-Term Incentive Plan (Chunk 2), while the 2023 10-K (Chunk 1, Item 10.12) confirms the plan's amendment became effective December 16, 2021, indicating a deliberate evolution in compensation structure to enhance retention and performance-based rewards for directors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amends]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Directors' Savings Plan (ACCOUNTING_POLICY)",
        "Directors' Savings Plan (ACCOUNTING_POLICY) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_245",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_239",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 23080,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6424,
        "completion_tokens": 186,
        "total_tokens": 6610
      }
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "American Express has evolved its value propositions from a focus on premium consumer and commercial payment solutions toward a broader digital ecosystem strategy that directly addresses competitive pressures and shifting customer behaviors, as evidenced by its 2022 emphasis on differentiating from Visa and Mastercard through enhanced rewards, merchant acceptance, and innovation in mobile payments (Chunk 1), while its 2024 strategy explicitly prioritizes expanding leadership among Millennial and Gen-Z consumers through new benefits, rewards programs, and digital product innovation to counter competitive threats and changing spending patterns (Chunk 2). This evolution reflects a strategic response to competitive intensity—particularly from rivals with greater resources and digital capabilities—and a proactive adaptation to customer demands for personalized, seamless experiences, as highlighted by its focus on \"new product innovation,\" \"digital channels,\" and \"building a multiproduct digital ecosystem\" to retain Card Members amid rising alternative payment mechanisms and fragmented spending (Chunk 1 and Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Value Propositions (RISK_FACTOR)",
        "Value Propositions (RISK_FACTOR) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12464,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3767,
        "completion_tokens": 281,
        "total_tokens": 4049
      }
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Exxon Mobil's long-term debt financing approach has evolved from a diversified short-to-mid term note structure in 2022 (including 0.142% Notes due 2024 and 0.524% Notes due 2028) to a more concentrated focus on long-dated instruments by 2024, as evidenced by the continued prominence of its 1.408% Notes due 2039 (traded under XOM39A on the NYSE) which represented a key component of its extended maturity profile. This shift is underscored by the 2024 10-K filing confirming the registration of these 2039-dated notes alongside other long-term securities, reflecting a strategic emphasis on securing low-cost, long-term capital through instruments like the 1.408% Notes due 2039 to support its capital allocation priorities amid evolving energy transition considerations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "XOM (ORG) -> 1.408% Notes due 2039 (FIN_INST)",
        "1.408% Notes due 2039 (FIN_INST) -> XOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "XOM_10k_2022.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "XOM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5212,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1944,
        "completion_tokens": 193,
        "total_tokens": 2137
      }
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "American Express has maintained a consistent strategic emphasis on evolving its corporate card solutions through enhanced product differentiation, particularly in the commercial payments space, as evidenced by its 2021-2024 strategic imperatives in both 2022 and 2024 filings where it explicitly states it \"evolves our card value propositions, further differentiating our corporate card and accounts payable expense management solutions\" (Chunk 1) and \"further differentiating our corporate card and accounts payable expense management solutions\" (Chunk 2). This demonstrates a sustained focus on innovation in corporate card offerings, including financing, banking, and payment solutions for business customers, while strengthening its global integrated network to provide expanded merchant services and fraud protection (Chunks 1 and 2). The company's approach reflects a continuous refinement of its corporate card value proposition rather than a fundamental shift, aligning with its broader strategic imperative to \"build on our strong position in commercial payments\" through product innovation and network expansion (Chunks 1 and 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enhances]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Corporate Card (PRODUCT)",
        "Corporate Card (PRODUCT) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3916,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 284,
        "total_tokens": 1904
      }
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Amazon's financial relationship with AWS Services has shifted from a strategic cost center to a dominant cash flow engine between 2022 and 2024, reflecting both operational maturity and strategic prioritization. While AWS remains embedded within Amazon's broader risk profile—highlighted by competitive pressures in cloud services (Chunk 1)—its financial contribution has become increasingly central, as evidenced by the company's $115.9 billion in operating cash flow for 2024 (Chunk 2), driven significantly by AWS's profitability and scalable infrastructure investments. This evolution underscores AWS's transition from a supporting service to a cornerstone of Amazon's financial resilience and strategic growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT <-[Pays_For]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> AWS Services (PRODUCT)",
        "AWS Services (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7152,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2427,
        "completion_tokens": 178,
        "total_tokens": 2606
      }
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "The scope of trend analyses used to evaluate historical consistency of regulatory asset balances remained focused on assessing the reasonableness of management’s judgments regarding recoverability through comparisons with independently developed expectations and analysis of changes tied to commission-approved amortization and recently approved regulatory orders, as explicitly detailed in both 2023 and 2024 audit reports. While the 2023 analysis (Chunk 1) emphasized evaluating historical consistency specifically through trend analyses to test recoverability of regulatory assets, the 2024 analysis (Chunk 2) expanded this approach to include additional procedures assessing the ongoing regulatory recoverability of coal ash-related asset retirement obligations, though the core methodology for evaluating historical consistency via trend analyses was retained without fundamental scope change.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Trend Analyses (ACCOUNTING_POLICY)",
        "Trend Analyses (ACCOUNTING_POLICY) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2023.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2937,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 224,
        "total_tokens": 1603
      }
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Costco's strategy regarding private-label penetration evolved from a deliberate, long-term approach to a more responsive, pressure-driven tactic between 2022 and 2023. In 2022, as noted in Chunk 1, the company explicitly framed increasing private-label penetration as part of its core strategy to \"make available to our members the right merchandise at the right prices\" and to adapt to inflation-driven cost pressures through \"adjustments to our pricing and merchandise mix,\" including private-label expansion, while maintaining its \"pricing authority\" perception. By 2023, as reflected in Chunk 2, the same strategy was reiterated but with heightened emphasis on its urgency amid \"cost increases\" and \"inflation or deflation,\" directly linking private-label growth to mitigating margin pressure from cost inflation—specifically noting that adjusting merchandise mix (including private-label penetration) was a key method to \"reduce the impact of cost increases\" on profitability, even as it risked near-term margin compression. This evolution shows a shift from strategic positioning to operational necessity, driven by escalating cost pressures that forced more aggressive private-label adoption to sustain competitive pricing without eroding margins further.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Increases]- ORG",
      "triplets_used": [
        "COST (ORG) -> Private Label Items (PRODUCT)",
        "Private Label Items (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9940,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3123,
        "completion_tokens": 315,
        "total_tokens": 3438
      }
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Based on the financial disclosures in both 2023 and 2024 Form 10-K filings, Pfizer's outlook for Paxlovid has shifted significantly due to evolving government inventory management and contractual commitments. While the 2023 filing noted only Emergency Use Authorization (EUA) for Paxlovid in pediatric patients without specific revenue projections, the 2024 filing reveals approximately $1 billion in remaining performance obligations for Paxlovid supply through 2028, reflecting contracted deliveries to customers despite a notable reduction in U.S. government purchases—evidenced by the $771 million favorable adjustment from returned EUA courses in early 2024. This transition from pandemic-driven demand to sustained contractual obligations underscores a strategic shift toward commercialization, with remaining obligations tied to foreign exchange rates and subject to renegotiation of delivery timelines between 2025 and 2028.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7769,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2569,
        "completion_tokens": 233,
        "total_tokens": 2802
      }
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "American Express has extended its Reasonable and Supportable (R&S) Period for estimating credit loss reserves from a shorter historical horizon to a longer, forward-looking period that incorporates current and projected economic conditions, reflecting a more sophisticated, data‑driven approach to risk assessment. This evolution—evidenced by its explicit disclosure in the 2022 10‑K and reinforced by the 2024 audit discussion of the R&S assumptions—demonstrates a proactive financial risk management strategy that relies on quantitative models, qualitative adjustments, and continuous validation of underlying assumptions to capture expected credit losses with greater precision.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "triplets_used": [
        "AXP (ORG) -> R&S Period (ACCOUNTING_POLICY)",
        "R&S Period (ACCOUNTING_POLICY) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_95",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9162,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2957,
        "completion_tokens": 170,
        "total_tokens": 3127
      }
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon's debt financing strategy has evolved to include increasingly lower-cost instruments, exemplified by the 0.800% Note due 2025 introduced in 2020 (Chunk 1, Chunk 2) as part of its broader debt management approach. This evolution is further evidenced by subsequent debt issuances like the 0.250% Note due 2023 (May 2021, Chunk 2) and the 4.600% Note due 2025 (December 2022, Chunk 2), reflecting a strategic shift toward shorter-term, lower-rate debt while maintaining diverse maturity profiles across its capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> 0.800% Note due 2025 (FIN_INST)",
        "0.800% Note due 2025 (FIN_INST) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12188,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3681,
        "completion_tokens": 132,
        "total_tokens": 3813
      }
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The treatment and disclosure of the Twenty-third Supplemental Indenture have evolved from its initial incorporation in the 2022 filing (Chunk 1), where it was referenced as a historical instrument tied to Duke Energy Progress (DUK) through a series of supplemental indentures dating back to 1978 (e.g., \"Twenty-third Supplemental Indenture dated June 1, 1978, File No. 2-61611\"), to its re-emergence in the 2024 filing (Chunk 2), where it appears as part of a lineage of supplemental indentures issued by Duke Energy Indiana, LLC (formerly PSI Energy, Inc.)—specifically, the \"Twenty-third Supplemental Indenture, dated as of January 1, 1977\" (Chunk 2, 4.14.2)—demonstrating a continuity in legal structure and regulatory disclosure across decades, while its presence in recent 2023–2024 Current Reports on Form 8-K (e.g., \"Forty-eighth Supplemental Indenture, dated as of March 22, 2023\" and \"Forty-ninth Supplemental Indenture, dated as of March 14, 2024\") confirms its ongoing relevance as an active, evolving instrument in Duke Energy’s debt financing framework, underscored by the KG pattern ORG → FIN_INST ← ORG, which reflects the bidirectional relationship between Duke Energy entities and the indenture as a disclosed financial instrument, thereby affirming its persistent legal and regulatory significance in the company’s capital markets activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Twenty-third Supplemental Indenture (FIN_INST)",
        "Twenty-third Supplemental Indenture (FIN_INST) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_249",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_252",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16353,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4746,
        "completion_tokens": 340,
        "total_tokens": 5086
      }
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "The repurchase activity for Class C Capital Stock increased significantly from $1.294 billion in 2022 to $2.159 billion in 2023 and $2.324 billion in 2024, reflecting a $59.3 billion total repurchase of Class A and Class C shares in 2022, $62.2 billion in 2023 and $62.0 billion in 2024, with $44.7 billion remaining available for future repurchases as of December 31 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Repurchases]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Class C Capital Stock (FIN_INST)",
        "Class C Capital Stock (FIN_INST) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2024.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10399,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3241,
        "completion_tokens": 93,
        "total_tokens": 3334
      }
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "The American Express Company Salary/Bonus Deferral Plan was initially introduced in the 1988 filing (Chunk 1, 10.16) and has undergone multiple amendments, including a 1994 amendment referenced in both 1994 and 1997 filings (Chunk 1, 10.17; 10.19). The most recent update documented in the 2024 filing (Chunk 2, 10.14) references an amendment originally filed in 1994, while the 2022 filing (Chunk 1, 10.24) details a 2013 amendment to the related Retirement Restoration Plan, indicating ongoing regulatory updates to compensation structures. This demonstrates a continuous pattern of amendments to executive compensation plans, with the 2024 filing incorporating historical changes while maintaining documentation continuity across SEC filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "AXP (ORG) -> Salary/Bonus Deferral Plan (ACCOUNTING_POLICY)",
        "Salary/Bonus Deferral Plan (ACCOUNTING_POLICY) -> AXP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AXP_10k_2022.pdf",
          "page_id": "page_165",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AXP_10k_2024.pdf",
          "page_id": "page_171",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10577,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3295,
        "completion_tokens": 186,
        "total_tokens": 3481
      }
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks' interest rate swap exposure shifted from a $34.0 million liability classified in \"Other long-term liabilities\" on its 2022 balance sheet (Oct 2, 2022) to a $19.2 million liability in \"Other long-term liabilities\" as of September 29, 2024, reflecting both a reduction in magnitude and continued classification in long-term liabilities despite the change in reporting periods. This evolution shows a strategic de-risking of swap positions over the two-year period, with the liability decreasing by nearly 44% while maintaining its balance sheet classification in long-term obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Interest rate swap (FIN_INST)",
        "Interest rate swap (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5598,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2044,
        "completion_tokens": 148,
        "total_tokens": 2193
      }
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "The Directors' Savings Plan has evolved from its original Amended and Restated version dated January 1, 2014 (introduced in 2013) to include a December 16, 2021 amendment (referenced as *10.12*), reflecting Duke Energy’s ongoing refinement of director compensation governance and deferral mechanisms. This progression—documented in the 2022 filing and reiterated in the 2024 proxy discussion—demonstrates a structured approach to aligning director remuneration with long‑term shareholder interests through unfunded, performance‑linked savings accounts that allow flexible deferral of compensation and crediting of phantom stock earnings. Consequently, Duke Energy’s governance strategy emphasizes transparent, controllable deferral options for outside directors while maintaining rigorous oversight of related compensation plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "DUK (ORG) -> Directors' Savings Plan (ACCOUNTING_POLICY)",
        "Directors' Savings Plan (ACCOUNTING_POLICY) -> DUK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DUK_10k_2022.pdf",
          "page_id": "page_258",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DUK_10k_2024.pdf",
          "page_id": "page_239",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14440,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4270,
        "completion_tokens": 207,
        "total_tokens": 4478
      }
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023, Costco's Kirkland Signature brand continued its strategic positioning as a high-quality private-label offering that drives margin expansion and differentiation, with explicit emphasis on increasing its sales penetration and leveraging its \"generally lower\" pricing advantage over national brands to enhance profitability—consistent with the 2022 disclosure that the company \"expect[s] to continue to increase the sales penetration of our private-label items\" (Chunk 1). This positioning remained unchanged in 2023, as evidenced by the 2023 filing's focus on Kirkland Signature's role in the broader competitive landscape and brand strategy, though specific 2023 metrics on Kirkland's market share or margin contribution were not detailed in the provided excerpts (Chunk 1). Critically, the risk profile of the brand was reinforced through its integration into Costco's core business exposure, as the 2023 document explicitly links Kirkland Signature's performance to broader operational risks—including supply chain disruptions from natural disasters, currency fluctuations affecting merchandise costs, and pandemic-related uncertainties—all of which could materially impact the brand's profitability and market positioning (Chunk 2). Thus, while Kirkland Signature's value proposition remained stable, its associated risks evolved to include heightened sensitivity to macroeconomic and operational volatility, reflecting the company's expanded international footprint and complex supply chain dependencies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "COST (ORG) -> Kirkland Signature (PRODUCT)",
        "Kirkland Signature (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8052,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2645,
        "completion_tokens": 382,
        "total_tokens": 3028
      }
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 326 billion cubic feet at the end of 2022 to 296 billion cubic feet at the end of 2024, reflecting a net decline of 30 billion cubic feet over the two‑year period.  The primary sources of additions were extensions and discoveries (121 billion cubic feet in 2023 and 87 billion cubic feet in 2024) and purchases (1,177 billion cubic feet in 2023 and 47 billion cubic feet in 2024), while revisions contributed modest upward adjustments of 356 billion cubic feet in 2023 and 356 billion cubic feet in 2024.  These changes are captured in the KG relationship COP → Asia Pacific/Middle East ← Discloses, linking the operator to the region and its disclosed reserve data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_167",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18705,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5320,
        "completion_tokens": 186,
        "total_tokens": 5507
      }
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F evolved from significant ownership toward targeted modernization, as evidenced by its 2022 10-K filing showing 114 owned 767F aircraft (Chunk 1) and its 2024 disclosure confirming active modernization programs specifically involving the purchase of Boeing 767-300 Freighters (B767F) to replace older aircraft and achieve long-term fuel efficiency gains (Chunk 2). While the 2022 data reveals FedEx owned 114 767F aircraft with no leased units, the 2024 context indicates this fleet is being modernized—not replaced wholesale—through strategic acquisitions of newer 767-300F models that offer superior fuel efficiency, directly supporting FedEx's need to upgrade its cargo fleet while navigating constrained purchase agreement flexibility (Chunk 2). This evolution reflects a shift from mere ownership of existing 767F assets to a deliberate, capital-intensive modernization strategy where new 767-300F purchases are deemed necessary to replace older aircraft types and realize significant operational savings, despite limitations on delaying these expenditures without incurring substantial modification costs to existing agreements (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Boeing 767F (PRODUCT)",
        "Boeing 767F (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_116",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2562,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 304,
        "total_tokens": 1582
      }
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks' roasted coffee inventory value increased significantly from $310.3 million to $340.1 million, reflecting growth in product holdings. This expansion coincides with major infrastructure investments, including new roasting facilities at the 1.957 million sq. ft. York, PA location and 1.08 million sq. ft. Minden, NV site, which support both production capacity and distribution networks. The company's vertically integrated model, where roasted coffee is both produced by and supplied to Starbucks, is reinforced by its global footprint spanning 8 strategic locations dedicated to roasting, warehousing, and distribution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Roasted Coffee (PRODUCT)",
        "Roasted Coffee (PRODUCT) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1708,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1059,
        "completion_tokens": 162,
        "total_tokens": 1221
      }
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "PepsiCo's utilization of the 2.750% Senior Notes due 2025 has expanded significantly between 2023 and 2024, as evidenced by its inclusion in multiple new financing transactions across both filings. In the 2023 filing (Chunk 1), the instrument was referenced as part of the 2018 indenture amendments for general corporate purposes, while the 2024 filing (Chunk 2) explicitly incorporates the 2.750% Senior Notes due 2025 within a broader set of authorizations for new debt issuances, including its appearance in both the Board resolutions (page 130) and the February 12, 2024 Indenture filing (page 130), demonstrating its ongoing role in PepsiCo's capital structure management through at least 2051.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 2.750% Senior Notes due 2025 (FIN_INST)",
        "2.750% Senior Notes due 2025 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6273,
        "completion_tokens": 174,
        "total_tokens": 6448
      }
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "From 2022 to 2024, FedEx's planned utilization of the B777F aircraft increased from 2 units in 2023 to 4 units in 2024 (as shown in Chunk 1's 2023 and 2024 rows for B777F), reflecting a strategic shift toward greater reliance on this long-haul freighter for international capacity needs. This trend is reinforced by Chunk 2's projection of 2 B777F units in 2025 and 2026, indicating the B777F's continued role as a core asset in FedEx's fleet strategy for global freight operations, particularly as other aircraft types like the B767F are phased out.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> B777F (PRODUCT)",
        "B777F (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1669,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1049,
        "completion_tokens": 137,
        "total_tokens": 1186
      }
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "Starbucks' foreign currency - other derivative liabilities decreased from $7.4 billion in 2021 to $0.3 billion in 2022, reflecting a reduction in accrued foreign‑currency exposure, and the 2024 data shows a net gain of $11.5 million (down from $55.3 million in 2022) recorded in AOCI, indicating that while the company still holds foreign‑currency derivatives, the magnitude of unrealized gains has sharply declined, suggesting reduced sensitivity to foreign‑currency fluctuations but still some residual exposure reflected in the remaining $9.5 million expected to be reclassified from AOCI over the next 12 months.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5265,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1981,
        "completion_tokens": 154,
        "total_tokens": 2135
      }
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "PepsiCo's engagement with the 2.625% Senior Notes due 2026 has evolved through multiple debt instrument disclosures across both 2023 and 2024 filings, with the instrument consistently referenced as a key long-term financing tool under its broader debt framework. In the 2023 filing (Chunk 1), the notes were explicitly tied to Board resolutions authorizing their terms within a comprehensive list of senior debt instruments (including 2013-era supplements), while the 2024 filing (Chunk 2) expands this disclosure to show the notes' continued presence amid a significantly broader 2024 issuance of new senior notes across multiple maturities and structures, including updated references to the 2024 Indenture with U.S. Bank Trust Company. This progression demonstrates how PepsiCo systematically integrates its legacy debt instruments like the 2.625% Senior Notes due 2026 into an increasingly expansive debt disclosure strategy, maintaining their relevance while adding new instruments to its capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 2.625% Senior Notes due 2026 (FIN_INST)",
        "2.625% Senior Notes due 2026 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6273,
        "completion_tokens": 253,
        "total_tokens": 6526
      }
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco's reliance on overcoming technical hurdles has intensified from 2022 to 2024 as its strategic investments in key growth areas like End-to-End Security and cloud infrastructure directly depend on resolving these challenges to meet product development timelines, with delayed or failed execution risking market share loss, revenue decline, and competitive disadvantages in rapidly evolving markets like AI and security. The 2022 filing explicitly warned that technical hurdles could cause competitors to launch solutions first, while the 2024 update emphasizes that scaling infrastructure and developing new technologies—critical for subscription services and product innovation—require sustained investment, where failure to overcome these hurdles would impair growth, increase costs, and undermine the company's strategic vision.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Depends_On]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Technical Hurdles (RISK_FACTOR)",
        "Technical Hurdles (RISK_FACTOR) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12430,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3757,
        "completion_tokens": 208,
        "total_tokens": 3966
      }
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Between 2022 and 2023, Google Ad Manager's role in driving Google Network revenues **shifted from being a key growth contributor to a more structurally embedded revenue driver**, as evidenced by its explicit inclusion in the core description of Google Network's revenue streams in 2023 (Chunk 2) and its continued prominence in performance narratives. While Chunk 1 (2022) highlights Google Ad Manager as one of several drivers (\"strength in AdMob, Google Ad Manager, and AdSense\") for Google Network revenue growth in 2021, Chunk 2 (2023) elevates its strategic positioning by detailing its role within the broader \"Google Network properties\" ecosystem where it directly generates revenue through ad delivery on network properties, including its function in both performance and brand advertising (Chunk 2). This evolution reflects a deeper integration of Google Ad Manager into Alphabet's core monetization strategy, moving from a supporting player in 2021 growth to a foundational component of Google Network's revenue architecture by 2023, as confirmed by its specific mention in the revenue recognition framework and the $8.6 billion growth context (Chunk 1) now contextualized within a matured 2023 operational landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Ad Manager (PRODUCT)",
        "Google Ad Manager (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5579,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2044,
        "completion_tokens": 306,
        "total_tokens": 2351
      }
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks' foreign currency derivative liabilities decreased from $7.4 billion in 2021 to $4.7 billion in 2022, then further declined to $4.7 billion (reported as $4.7 billion in accrued liabilities) by the end of 2024, reflecting a $2.7 billion reduction between 2021 and 2024 and a $2.3 billion decline from 2022 to 2024. This change is tracked across both designated and non‑designated foreign‑currency derivatives, with the 2024 figures showing $4.7 billion in accrued liabilities and $2.5 billion in other long‑term liabilities for foreign‑currency contracts, underscoring the magnitude of the liability reduction over the three‑year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "SBUX (ORG) -> Foreign currency - other (FIN_INST)",
        "Foreign currency - other (FIN_INST) -> SBUX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SBUX_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SBUX_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5598,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2040,
        "completion_tokens": 161,
        "total_tokens": 2201
      }
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo's 4.600% Senior Notes due 2045 were initially authorized in 2018 through the Third Supplemental Indenture referenced in both 2023 and 2024 filings (Chunks 1 and 2), but their strategic prominence evolved as evidenced by their inclusion among a significantly expanded set of debt instruments in the 2024 authorization (Chunk 2), reflecting PepsiCo's ongoing refinement of its long-term debt structure to manage maturity profiles and funding diversification across multiple tenors. This progression demonstrates a deliberate strategy to optimize the company's capital structure through sustained access to varied debt markets while maintaining a strong credit profile, as further reinforced by the continuous incorporation of new indentures and supplemental agreements governing these securities across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 4.600% Senior Notes due 2045 (FIN_INST)",
        "4.600% Senior Notes due 2045 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6274,
        "completion_tokens": 205,
        "total_tokens": 6479
      }
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region has evolved from 764 billion cubic feet of developed and undeveloped gas at the end of 2021 to 296 billion cubic feet of developed and 468 billion cubic feet of undeveloped gas by the end of 2024, reflecting a strategic shift toward expanding undeveloped resources and increasing equity‑affiliated production in that region. This growth—driven by extensions and discoveries, modest purchases, and a focus on equity affiliates—indicates that COP is prioritizing long‑term resource development and portfolio diversification in Asia Pacific/Middle East to strengthen its natural‑gas footprint and support future cash‑flow stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Asia Pacific/Middle East (GPE)",
        "Asia Pacific/Middle East (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_173",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_145",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11307,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3471,
        "completion_tokens": 173,
        "total_tokens": 3644
      }
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Google's non-advertising revenue strategy evolved from being positioned alongside hardware and YouTube non-advertising as a distinct growth vector to being explicitly categorized as a core pillar of Google Services revenue beyond advertising. In 2022, the filing highlighted Google Play's revenue generation from app and in-app purchases/digital content sales as part of broader non-advertising initiatives (\"revenues from Google Play, hardware, and YouTube non-advertising\"), while 2023 refined this by elevating it to a standalone category within Google Services' non-advertising revenue streams (\"consumer subscriptions... including YouTube services... and platforms, which primarily include revenues from Google Play\"). This structural emphasis underscores Google Play's increasing strategic importance as a direct revenue driver from its ecosystem, moving from a supporting element to a clearly defined, scalable source of non-advertising income alongside subscriptions and hardware.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Generates_Revenue]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GOOGL (ORG) -> Google Play (PRODUCT)",
        "Google Play (PRODUCT) -> GOOGL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GOOGL_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GOOGL_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9892,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3113,
        "completion_tokens": 257,
        "total_tokens": 3370
      }
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "The projected utilization of the Cessna SkyCourier 408 fluctuates across the provided data but shows a net increase from 11 units in 2023 (Chunk 1) to 17 units in 2025 (Chunk 2), indicating FedEx's growing reliance on this aircraft for future capacity needs. This upward trend, particularly the 55% rise from 2023 to 2025 projections, demonstrates strategic scaling of the SkyCourier model to meet evolving logistics demands, though long-term utilization (2026 onward) requires integration of all chunk data to fully assess sustained dependency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Cessna SkyCourier 408 (PRODUCT)",
        "Cessna SkyCourier 408 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1669,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1063,
        "completion_tokens": 136,
        "total_tokens": 1199
      }
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "Between 2022 and 2023, AIG maintained its use of expected loss ratio methods for excess casualty lines but refined segmentation and analysis approaches. In 2022, the company segmented non-automobile claims into categories like construction defects and mass torts—particularly noting mass torts' extended development across multiple accident years—and further analyzed standard claims by attachment point bands, using expected loss ratios for losses above $10 million derived from lower-layer estimates. By 2023, this methodology expanded to U.S. Workers' Compensation, where AIG applied expected loss ratio methods alongside development and frequency/severity techniques, while segmenting guaranteed cost and excess-of-deductible business by state, industry, and deductible size, reflecting evolving risk-sharing structures and slower reporting patterns. The 2023 supplemental loss development disclosures also highlighted ongoing adjustments for market conditions, including inflation and post-pandemic claims frequency shifts, underscoring the continued reliance on expected loss ratios for recent accident years where loss credibility remains low.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_263",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2023.pdf",
          "page_id": "page_202",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5294,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1977,
        "completion_tokens": 287,
        "total_tokens": 2264
      }
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal years 2022 and 2024, Nike maintained the classification of unallocated products within its new consumer construct of Men's, Women's, Kids' and Jordan Brand, where products not allocated to these categories—including certain adjustments not assigned to consumer-designated products—were grouped under \"Others\" as documented in both 2022 and 2024 filings. This categorization remained consistent with the Consumer Direct Acceleration strategy implemented in fiscal 2022, which reorganized the company around this consumer-centric structure and preserved the reporting treatment of unallocated products without impacting consolidated results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Unallocated Products (PRODUCT)",
        "Unallocated Products (PRODUCT) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2534,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 163,
        "total_tokens": 1445
      }
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "PepsiCo's engagement with the 3.500% Senior Notes due 2025 reflects a strategic evolution in its debt management, marked by consistent reauthorizations and expansions across multiple financing filings. In the 2023 filing (Chunk 1), the notes were included among key senior debt instruments authorized through Board resolutions, with references to prior indentures dating back to 1993, underscoring long-term structural support (Chunks 1, 4.64–4.66). By 2024, the reauthorization of these notes within a broader suite of new issuances—including floating rate and multi-year senior notes—demonstrated ongoing access to diverse capital markets and reinforced confidence in PepsiCo’s creditworthiness (Chunk 2, 4.64–4.65). The inclusion of the 3.500% Senior Notes due 2025 in both filings, alongside newer tranches and extended maturities, indicates a deliberate strategy to manage debt maturity profiles, maintain liquidity, and leverage low-cost financing amid evolving market conditions (Chunks 1, 2, KG: PEP ↔ 3.500% Senior Notes due 2025). This progression highlights PepsiCo’s proactive approach to optimizing its capital structure through iterative engagement with debt covenants and investor frameworks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "PEP (ORG) -> 3.500% Senior Notes due 2025 (FIN_INST)",
        "3.500% Senior Notes due 2025 (FIN_INST) -> PEP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PEP_10k_2023.pdf",
          "page_id": "page_129",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PEP_10k_2024.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 22508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 6275,
        "completion_tokens": 301,
        "total_tokens": 6577
      }
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "COP's financial disclosures for the Lower 48 region show a significant shift in capital expenditures and cash flow expectations between 2022 and 2024. In 2022, capital expenditures for Lower 48 were $3,129 million, but by 2024, these expenditures were revised downward to $1,881 million, reflecting a strategic reduction in investment. Concurrently, the company revised its future cash inflow projections upward, with \"Certain amounts in Lower 48 have been revised to reflect additional Future cash inflows,\" indicating enhanced expected cash generation from this region. This evolution demonstrates a strategic pivot toward optimizing capital allocation while increasing confidence in long-term cash flow potential from the Lower 48 assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> GPE <-[Discloses]- ORG",
      "triplets_used": [
        "COP (ORG) -> Lower 48 (GPE)",
        "Lower 48 (GPE) -> COP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COP_10k_2022.pdf",
          "page_id": "page_149",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COP_10k_2024.pdf",
          "page_id": "page_158",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6745,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2323,
        "completion_tokens": 185,
        "total_tokens": 2508
      }
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast's financial commitments to Atairos Group evolved through amendments to their governance and capital structure, as evidenced by the Fourth Amended and Restated Shareholders Agreement (10.27) and its First Amendment (10.28) in 2023, which formalized updated terms for capital calls and involvement. Comcast maintains a strategic partnership with Atairos Group, Inc. (KG: CMCSA Partners_With Atairos Group, Inc.), where it holds a significant economic interest without voting rights, obligating it to absorb ~99% of losses and receive ~86% of residual returns (Chunk 2), while also participating in capital commitments up to $4.5 billion aggregate, with annual calls capped at $400 million plus offsets (Chunk 2). This arrangement underscores a governance model where Atairos is controlled by management companies led by Comcast's former CFO, with Comcast acting as the sole third-party investor (Chunk 2), reflecting a strategic but non-controlling financial relationship governed by shared economic alignment rather than operational control.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Atairos Group, Inc. (COMP)",
        "Atairos Group, Inc. (COMP) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10808,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3348,
        "completion_tokens": 267,
        "total_tokens": 3616
      }
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx's projected utilization of the Cessna SkyCourier 408 increased from 11 units in 2023 (per 2022 filing) to 17 units in 2025 (per 2023 filing), reflecting a 54.5% rise in near-term demand. This strategic shift—from 12 units projected through 2026 in 2022 to 17 units through 2025 in 2023—indicates a deliberate prioritization of the SkyCourier for regional express growth, contrasting with its reduced reliance on older platforms like the ATR 72-600F (declining from 11 to 7 units in 2025) and B767F (stable at 11 units), while the SkyCourier's role as a dedicated regional asset supersedes other aircraft in the near-term fleet strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Cessna SkyCourier 408 (PRODUCT)",
        "Cessna SkyCourier 408 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1668,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1067,
        "completion_tokens": 160,
        "total_tokens": 1228
      }
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "Nike's Air Max product line has evolved from 2022 to 2024 with a strategic shift toward greater technological innovation and integrated revenue transparency, as evidenced by its 2024 Form 10-K disclosures. While the 2022 10-K (Chunk 1) details revenue disaggregation by reportable segment and product line—including Air Max as a key product—2024’s filing (Chunk 2) emphasizes that innovation in design and manufacturing, particularly through technologies like Air Max, Zoom X, and Flyknit, is central to product development and consumer engagement, with no single customer accounting for 10% or more of consolidated revenue, reflecting a diversified revenue base. This progression underscores Nike’s heightened focus on embedding cutting-edge R&D (highlighted by its use of biomechanics, chemistry, and digital technologies across design committees and athlete testing) into the Air Max line, while simultaneously ensuring revenue transparency through granular disclosures of manufacturing footprints—such as 169 Tier 2 suppliers and 96 footwear factories across 11 countries—directly supporting its innovation-driven growth strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Air Max (PRODUCT)",
        "Air Max (PRODUCT) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3993,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1633,
        "completion_tokens": 283,
        "total_tokens": 1917
      }
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "Comcast's capital expenditure strategy for Epic Universe evolved from a focused investment in 2023 to a sustained, multi-year commitment in 2024, with $1.5 billion allocated specifically to the Universal Orlando Epic Universe expansion—explicitly cited as driving capital spending in the parks segment—and continued thematic development prioritized through 2025, as evidenced by the 2024 10-K's statement that \"capital expenditures for subsequent years will depend on... the timing of new attractions at our theme parks\" including Epic Universe, while 2023's $8.2 billion total capex included dedicated funding for the Orlando park's development, and 2024's strategy explicitly extends this investment into future years with no indication of reduction, aligning with the company's broader theme park capital focus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "CMCSA (ORG) -> Epic Universe (PRODUCT)",
        "Epic Universe (PRODUCT) -> CMCSA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CMCSA_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CMCSA_10k_2024.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6798,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2346,
        "completion_tokens": 203,
        "total_tokens": 2550
      }
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Between 2022 and 2023, FedEx's utilization of the ATR 72-600F aircraft declined significantly, as reflected in its fleet projections across both planning periods. In 2022 (referenced in Chunk 1's 2023 column as the prior year), FedEx operated 11 ATR 72-600F aircraft, but this decreased to 6 in 2023 under the 2023 plan (Chunk 1) and further to 3 in 2023 under the 2025 plan (Chunk 2), indicating a strategic reduction in reliance on this regional freighter. This reduction is contextualized by the concurrent increase in larger aircraft like the B767F and B777F, with total fleet projections for 2023 showing 11 ATR 72-600Fs (Chunk 1) versus 7 in 2025 (Chunk 2), while the total fleet size remained relatively stable at 38 (Chunk 1) and 37 (Chunk 2), reflecting a shift toward larger capacity aircraft rather than expansion of the ATR 72-600F fleet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> ATR 72-600F (PRODUCT)",
        "ATR 72-600F (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1668,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1051,
        "completion_tokens": 212,
        "total_tokens": 1264
      }
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Nike's approach to estimating product return reserves evolved significantly between fiscal 2022 and 2024, reflecting a more structured and standardized methodology for revenue recognition. In fiscal 2022, the company reported sales-related reserves of $1,015 million (including returns, discounts, and claims), with an estimated cost of inventory for expected returns of $194 million, both recorded in accrued liabilities and prepaid expenses respectively. By fiscal 2024, the accounting policy explicitly formalized the estimation of variable consideration—such as anticipated returns, discounts, and claims—by recording a most likely amount against revenue with a corresponding accrual, while also disclosing the estimated cost of inventory for returns in prepaid assets. This evolution indicates a more refined and consistent application of revenue recognition principles, particularly in quantifying and reserving for returns across its diverse brand portfolio, including Nike, Jordan, and Converse, as disclosed in the segment reporting and accounting policy updates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Athletic Footwear (PRODUCT)",
        "Athletic Footwear (PRODUCT) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_66",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8136,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2681,
        "completion_tokens": 268,
        "total_tokens": 2949
      }
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "The planned fleet composition for the Cessna SkyCourier 408 shifts from 12 units in 2025 (per the 2022 10-K) to 17 units in 2025 (per the 2023 10-K), reflecting an upward revision of 5 aircraft for 2025 and beyond, while the 2026–2027 outlook remains unchanged at 14 units in both documents. This increase in the 2025 delivery target indicates the company's strategic pivot toward greater reliance on the SkyCourier model to support its regional cargo expansion, as evidenced by its elevated placement in the fleet planning hierarchy (e.g., 17 SkyCouriers versus 11 ATR 72-600Fs and 11 B767Fs in 2025 under the 2023 plan). The consistent emphasis on the SkyCourier across both filings, despite minor adjustments to other aircraft types, underscores its central role in FedEx's long-term fleet strategy for the 2025–2027 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Cessna SkyCourier 408 (PRODUCT)",
        "Cessna SkyCourier 408 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1669,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1073,
        "completion_tokens": 206,
        "total_tokens": 1280
      }
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard's real-time account-based payments infrastructure has expanded from 13 markets as of December 31 2023 to include implementation in additional jurisdictions by 2024, scaling its globally integrated, peer‑to‑peer network that provides 24‑hour availability and intelligent, real‑time routing with value‑added services such as fraud scoring and tokenization.  The platform’s security framework, built on a multi‑layered approach and reinforced through third‑party assessments, industry benchmarking, and collaborative standards (e.g., EMV), now underpins its cross‑border and domestic transaction switching—handling over 65 % of Mastercard and Maestro transactions—while ensuring settlement integrity and protecting the ecosystem from cyber and physical threats.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Provides]- ORG",
      "triplets_used": [
        "MA (ORG) -> Real-Time Account-Based Payments (PRODUCT)",
        "Real-Time Account-Based Payments (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11676,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3569,
        "completion_tokens": 192,
        "total_tokens": 3761
      }
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Nike's use of foreign exchange forwards and options evolved from a 2022 net gain of $30 million reclassified from accumulated other comprehensive income into earnings—driven by $82 million of losses on cash‑flow hedges partially offset by gains elsewhere—to a 2024 derivative liability of $151 million, reflecting a shift toward larger accrued and deferred‑tax liabilities that signals an expanded hedging program and tighter management of foreign‑exchange risk. This progression illustrates a strategic deepening of Nike’s hedging strategy, where the increasing liability balances both the growing notional exposure and the reclassification of prior hedging gains/losses into income, thereby directly impacting financial liabilities and the company’s approach to mitigating currency volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Foreign Exchange Forwards and Options (FIN_INST)",
        "Foreign Exchange Forwards and Options (FIN_INST) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10805,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3355,
        "completion_tokens": 198,
        "total_tokens": 3554
      }
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "Between 2022 and 2023, the product category classification of Puffs within the Baby, Feminine & Family Care segment underwent a structural shift, reflecting evolving strategic focus. In 2022, Puffs was categorized under **Baby Care** within this segment, alongside other baby-specific products like diapers and wipes, as evidenced by its inclusion in the \"Baby Care (Baby Wipes, Taped Diapers and Pants)\" sub-category (Chunk 1). By 2023, however, Puffs was reclassified under **Feminine Care** within the same broader segment, specifically nested under \"Feminine Care (Adult Incontinence, Menstrual Care)\" alongside Always and Tampax Bounty, indicating a strategic pivot toward positioning Puffs as a menstrual care product rather than a baby care item (Chunk 2). This reclassification is further underscored by its consistent mention as a major brand in the Baby, Feminine & Family Care segment across both years (Chunk 1: \"Puffs\" listed under Baby, Feminine & Family Care; Chunk 2: \"Puffs\" retained as a key brand in the same segment), while its placement shifted from the Baby Care sub-category to the Feminine Care sub-category, reflecting a deliberate evolution in market segmentation and product categorization strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Puffs (PRODUCT)",
        "Puffs (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5039,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1885,
        "completion_tokens": 306,
        "total_tokens": 2192
      }
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax's categorization within P&G's portfolio shifted from being grouped under **Baby, Feminine & Family Care** (25% of net sales, 23% of earnings in 2022) to being explicitly categorized under **Feminine Care** within the broader **Baby, Feminine & Family Care** segment (24% of net sales, 25% of earnings in 2023), reflecting a strategic emphasis on menstrual health products like Tampax alongside Always and Always Discreet. This repositioning aligns with its inclusion in the **Feminine Care** sub-category (highlighting menstrual care products) and its continued association with P&G through the KG triplet relationship **PG → Tampax → PG**, underscoring its stable yet refined role in P&G's portfolio as a key brand within the Feminine Care sub-segment of Baby, Feminine & Family Care.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Tampax (PRODUCT)",
        "Tampax (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5039,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1895,
        "completion_tokens": 203,
        "total_tokens": 2099
      }
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Oracle's strategy for Engineered Systems shifted toward cloud infrastructure expansion and R&D investment between fiscal 2022 and 2023, with hardware revenue representing 6% of total sales in both years (per Chunk 2), while fiscal 2023 saw increased R&D spending to enhance hardware products and services (Chunk 2). The company emphasized that hardware operating margins remain lower than cloud/license businesses due to incremental production and support costs (Chunk 1), and while hardware revenue recognition timing depends on customer support contract renewals and product lifecycle dynamics (Chunk 1), fiscal 2023 expectations included continued investments to improve existing offerings and develop new hardware solutions (Chunk 2). This strategic focus reflects a deliberate positioning of Engineered Systems as a complementary pillar to cloud growth, with R&D commitments directly tied to maintaining competitiveness in hardware support and infrastructure markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Engineered Systems (PRODUCT)",
        "Oracle Engineered Systems (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7444,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2514,
        "completion_tokens": 243,
        "total_tokens": 2757
      }
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Honeywell's investment in private funds for its Non-U.S. pension plans decreased from $115 million in 2022 to $8 million in 2023, with the 2023 allocation classified as Level 3 fair‑value (74 % of the $115 million) and the remainder ($41 million) classified as Level 2; the 2022 data show $1,105 million of private‑fund investments measured at NAV, reflecting a shift toward lower‑level fair‑value classifications across the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "HON (ORG) -> Private funds (FIN_INST)",
        "Private funds (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_110",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7528,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2530,
        "completion_tokens": 108,
        "total_tokens": 2639
      }
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "The 2014 USD Notes, originally issued by MA as a long‑term financing instrument, saw $1 billion of principal mature and be paid in April 2024, while the company continued to refinance and extend its debt profile through the 2024 USD Notes issuance (total $4 billion of new notes due 2028, 2032 and 2035).  In 2024 MA also issued $1 billion of new 2034 notes and, alongside the 2014 USD Notes, used the proceeds to fund general corporate purposes, maintaining a total outstanding debt of $18.2 billion at year‑end 2024 with the next maturity scheduled for March 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "MA (ORG) -> 2014 USD Notes (FIN_INST)",
        "2014 USD Notes (FIN_INST) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2023.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4553,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1774,
        "completion_tokens": 141,
        "total_tokens": 1916
      }
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "The treatment and documentation of Lowe's Officer Indemnification Agreements have evolved through continuous refinement and formalization of executive risk management protocols between 2022 and 2024, as evidenced by the progression from the foundational 2019 agreement (disclosed in both 2022 and 2024 filings as Exhibit 10.23/10.23) to the introduction of updated governance documents like the 2022 Severance Plan for Senior Officers (Exhibit 10.28, filed November 27, 2024) and the 2023 performance-based award agreements (Exhibits 10.29-10.31). This evolution reflects a deliberate strengthening of executive protection frameworks, with the 2024 filing maintaining the same Exhibit 10.23 designation for the Officer Indemnification Agreement while incorporating newer instruments that demonstrate enhanced continuity in governance—particularly through the retention of consistent disclosure patterns and the integration of updated compensation structures that align with evolving regulatory expectations and board oversight priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Officer Indemnification Agreement (ACCOUNTING_POLICY)",
        "Officer Indemnification Agreement (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_79",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10034,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3178,
        "completion_tokens": 259,
        "total_tokens": 3437
      }
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "Based on the provided 10-K filings and knowledge graph relationships, Always Discreet maintained its strategic positioning in the adult incontinence category within P&G's Baby, Feminine & Family Care segment. In both the 2022 and 2023 filings, the product was noted as part of the feminine care category with over 20% global market share behind P&G's Always and Tampax brands, and specifically held over 10% market share in key markets where it competes (Chunk 1). The 2023 filing (Chunk 2) confirms this category positioning remains consistent, listing Always Discreet under \"Feminine Care (Adult Incontinence)\" alongside Always and Tampax, indicating no significant change in market share or category strategy between the filings. The knowledge graph relationship (Always Discreet PRODUCT -> PG ORG) further reinforces P&G's direct ownership and market focus on this product line across both reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "PG (ORG) -> Always Discreet (PRODUCT)",
        "Always Discreet (PRODUCT) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2022.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6216,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2193,
        "completion_tokens": 228,
        "total_tokens": 2421
      }
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Oracle's strategic positioning of Engineered Systems has evolved from being primarily a hardware-centric offering to a core enabler of its cloud transformation narrative, as evidenced by the 2023 10-K's explicit framing of hardware (including Engineered Systems) as foundational to cloud infrastructure with integrated software and support services that drive recurring revenue through ratable hardware support contracts [Chunk 2]. This evolution is underscored by the 2022 10-K's detailed description of Engineered Systems as \"pre-integrated products\" combining database, storage, OS, and management software with hardware to deliver superior performance and operational efficiency—specifically highlighting Exadata's cost advantages in cloud and on-premise data centers as a key differentiator [Chunk 1]. Critically, the 2023 10-K reveals that hardware (including Engineered Systems) now represents 6% of total revenue and is positioned as a strategic growth area with investments in R&D to improve products and develop new offerings, directly supporting Oracle's cloud transformation by providing the hardware backbone for OCI and hybrid cloud deployments [Chunk 2]. This shift is further reinforced by the KG relationship where Oracle Engineered Systems (PRODUCT) is produced by ORCL (ORG) and simultaneously introduces ORCL (ORG) into the hardware ecosystem, demonstrating how the product's evolution is intrinsically tied to Oracle's broader cloud strategy [KG Triplets]. Consequently, Engineered Systems have transitioned from a standalone hardware business to a critical component of Oracle's cloud infrastructure narrative, enabling recurring revenue through support contracts while driving the integration of hardware, software, and cloud services to accelerate customer adoption of OCI.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Engineered Systems (PRODUCT)",
        "Oracle Engineered Systems (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9849,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3121,
        "completion_tokens": 449,
        "total_tokens": 3570
      }
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "The disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan remained consistent between the 2022 and 2023 10-K filings, with both explicitly identifying the 2020 Stock Plan as the successor to the 2011 Stock Plan in their respective \"Stock Option Plan\" sections. Neither filing introduced new changes to this succession relationship, as evidenced by the identical language in Chunk 1 (2022) and Chunk 2 (2023) confirming the 2020 Plan superseded the 2011 Plan and authorized 17.5 million new shares while utilizing shares previously reserved under the 2011 Plan. This consistency reflects stable accounting policy disclosure across both filings, with no evolution in the described relationship between the plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> 2020 Stock Plan (ACCOUNTING_POLICY)",
        "2020 Stock Plan (ACCOUNTING_POLICY) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_61",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1960,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 184,
        "total_tokens": 1317
      }
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell's allocation to private funds increased from $1,244 million in 2022 to $1,265 million in 2023, reflecting a strategic shift toward illiquid assets despite an overall reduction in total investment assets from $20,560 million to $16,594 million. This indicates prioritization of long-term, potentially higher-return investments over public market positions, aligning with capital deployment toward alternative strategies while maintaining exposure through commingled funds ($112 million in 2023) and real estate funds ($8 million). The growth in private fund allocations ($21 million increase) suggests deliberate expansion of exposure to private equity and real estate partnerships, likely to enhance portfolio diversification and capture private market premiums amid evolving capital deployment priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "HON (ORG) -> Private funds (FIN_INST)",
        "Private funds (FIN_INST) -> HON (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HON_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HON_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7192,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2439,
        "completion_tokens": 204,
        "total_tokens": 2643
      }
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B-2 Common Stock remained outstanding but was subject to dilution through the U.S. litigation escrow account under the retrospective responsibility plan, as disclosed in V's 2023 10-K (Note 5). This plan adjusted the conversion rates of both Class B-1 and Class B-2 Common Stock into Class A Common Stock upon funding the escrow account, directly linking their outstanding status to the Company's funding actions. By 2024, no new shares of Class B-2 Common Stock were issued prior to the Class B-1 exchange offer, though the existing Class B-2 shares continued to be subject to conversion adjustments affecting their as-converted value relative to Class A Common Stock.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class B-2 Common Stock (FIN_INST)",
        "Class B-2 Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1861,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 174,
        "total_tokens": 1285
      }
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The Target Circle program's financial obligations decreased significantly between 2022 and 2024, with deferred revenue declining from $89 million (as of January 30, 2022) to $117 million (as of February 3, 2024) – a substantial increase in the 2024 measurement period that contradicts typical expectations of program scaling down. This shift indicates a strategic evolution of the program, evidenced by its expanded scope (including new Target Circle Cards and integration with Target Plus third-party marketplace) and altered revenue recognition patterns, as reflected in the updated liability disclosures across both reporting periods. The program's transformation is further underscored by its reclassification within financial statements, where it now appears under \"Other\" revenues alongside new digital marketplace and membership revenue streams, demonstrating a fundamental reorientation of its business model and financial impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Target Circle Program (PRODUCT)",
        "Target Circle Program (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3499,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 234,
        "total_tokens": 1751
      }
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes increased from $1,111 million at December 31, 2022, to $996 million at December 31, 2023, reflecting a $15 million decline in fair value despite stable principal amounts ($1,000 million each period). This decrease, documented in both Chunk 1 (2022 data) and Chunk 2 (2023 data), indicates market-driven valuation adjustments likely influenced by rising interest rates or shifting investor sentiment toward debt instruments during 2023, though the relatively modest change ($15M out of $1,111M) suggests stable market conditions for this specific tranche. The consistent principal amounts across both years confirm the change reflects pure fair value movement rather than new issuance or redemption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> 4.375% Senior Notes (FIN_INST)",
        "4.375% Senior Notes (FIN_INST) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2023.pdf",
          "page_id": "page_56",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6978,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2394,
        "completion_tokens": 186,
        "total_tokens": 2581
      }
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, the equity structure related to Class C Common Stock evolved through targeted issuances and reclassifications disclosed in Visa's 10-K filings. In May 2024, Visa issued approximately 48 million shares of Class C Common Stock as part of its exchange offer for Class B-1 common stock, directly linking Class C Common Stock to V through the KG pattern ORG -[Issues]-> FIN_INST <-[Discloses]- ORG. This followed the July 2024 release of $2.7 billion in value from Series B and C preferred stock, which included the issuance of 99,264 shares of Series A preferred stock, further tying equity classification to Visa's corporate actions. Additionally, the September 2024 10-K reveals Class C Common Stock had only 10 shares issued and outstanding as of September 30, 2024, reflecting minimal but deliberate classification within the broader equity structure, while Class B-1 and B-2 common stock issuances (125 million and 245 million shares respectively) demonstrate ongoing reorganization of share classes. The equity section of the 2024 10-K also shows Class C Common Stock's par value ($0.0001) and minimal share count remaining unchanged from 2023, confirming its static classification despite other equity movements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class C Common Stock (FIN_INST)",
        "Class C Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_58",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17677,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5059,
        "completion_tokens": 309,
        "total_tokens": 5368
      }
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "From 2022 to 2024, Lowe's business classification and service offerings related to Rough Plumbing evolved significantly, as reflected in the provided materials. In the 2022 10-K (Chunk 1), Rough Plumbing was explicitly listed as a product category within the Building Products division of Lowe's, indicating its role as a core merchandise offering. By 2024, Lowe's expanded its focus on Rough Plumbing beyond mere product sales to include integrated service offerings, as detailed in Chunk 2 where it is specifically cited among the product categories (alongside Kitchen & Bath, Flooring, Millwork, and Electrical) that account for the majority of \"installed sales\" – a service model combining product sales with professional installation. This shift is further reinforced by Lowe's introduction of extended protection plans and repair services for Rough Plumbing within its broader \"Lowe's Protection Plans and Repair Services\" section (Chunk 2), demonstrating a strategic move to enhance customer value through post-purchase support. Additionally, the 2024 10-K emphasizes Lowe's operational simplification in installed sales, including a central selling team that handles project administration and digital checkout for installation services, directly supporting the evolution of Rough Plumbing from a standalone product category to a key component of Lowe's integrated, service-driven business model. This progression reflects Lowe's strategic shift to position Rough Plumbing not just as a merchandise line, but as a critical element of its value-added services, directly contributing to its installed sales strategy and customer experience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Operates_In]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Rough Plumbing (PRODUCT)",
        "Rough Plumbing (PRODUCT) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5371,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1978,
        "completion_tokens": 411,
        "total_tokens": 2390
      }
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B-2 common stock transitioned from having no outstanding shares (prior to the Class B-1 exchange offer) to 77 million shares outstanding by September 30, 2024, as disclosed in V’s 2024 10-K (Chunk 1) and confirmed by the 2024 filing’s reference to the Class B-1 stock exchange offer (Chunk 2). This evolution indicates that Class B-2 stock was newly introduced as part of a strategic capital structure adjustment—specifically, it emerged through the Class B-1 stockholders’ exchange offer, positioning it as a distinct equity class that enhances V’s capital flexibility and reflects a deliberate restructuring of ownership tiers within the company’s equity framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class B-2 Common Stock (FIN_INST)",
        "Class B-2 Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_91",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1512,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1025,
        "completion_tokens": 174,
        "total_tokens": 1199
      }
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The Target Circle program's financial liability—reflected as deferred revenue in Accrued and Other Current Liabilities—declined significantly from $117 million in 2024 to $19 million in 2025, indicating a contraction in the program’s scale or a shift in how rewards are being recognized. This reduction suggests that Target is either scaling back the program’s scope or moving away from the traditional reward‑based model, as the liability associated with unredeemed rewards has dropped sharply between the 2022 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Target Circle Program (PRODUCT)",
        "Target Circle Program (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4977,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1888,
        "completion_tokens": 132,
        "total_tokens": 2021
      }
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVDA's exposure to pollution limits has intensified between 2023 and 2024, with regulatory impacts increasingly threatening its data center expansion strategy. The company explicitly identifies pollution limits, carbon taxes, and energy regulations as drivers of \"greater direct costs\" including \"changes to manufacturing processes,\" \"increased capital expenditures to improve facilities,\" and \"higher compliance and energy costs to reduce emissions\" (Chunk 1), while simultaneously warning that \"regulations that limit energy or water availability could impair the ability of our customers to expand their data center capacity and consume our products and services\" (Chunk 1). This regulatory pressure directly undermines NVDA's growth ambitions, as evidenced by its 2024 disclosure that \"water and energy availability... is critical\" and that \"extreme heat... may lead to power safety shut-offs... impairing the ability of our employees to work effectively\" (Chunk 2), with the company now monitoring these climate-related regulatory risks as a core operational threat across both fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "triplets_used": [
        "NVDA (ORG) -> Pollution Limits (REGULATORY_REQUIREMENT)",
        "Pollution Limits (REGULATORY_REQUIREMENT) -> NVDA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NVDA_10k_2023.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NVDA_10k_2024.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13304,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3984,
        "completion_tokens": 274,
        "total_tokens": 4258
      }
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "The composition and valuation of the company's Guaranteed Senior Notes underwent specific changes between 2023 and 2024, with measurable impacts on issuance, repayment, and fair value inputs. In November 2023, the Japanese subsidiary issued approximately $500 of Guaranteed Senior Notes at fixed rates (1.400%-2.120%), valued using Level 3 inputs, which were later partially repaid ($77 in July 2024). Concurrently, the parent company retired $1,000 of its 2.750% Senior Notes on May 18, 2024, using cash equivalents. By year-end 2024, the estimated fair value of all long-term debt (including Guaranteed Senior Notes) was $5,412, down from $5,738 in 2023, reflecting both the repayment of $77 in Japan and the $1,000 retirement of U.S. Senior Notes, while the carrying value of long-term debt was updated to reflect these adjustments. The fair value inputs remained consistent in methodology—Level 2 for parent-issued Senior Notes and Level 3 for the Japanese subsidiary's Guaranteed Senior Notes—though the overall portfolio valuation declined due to targeted repayments and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "COST (ORG) -> Guaranteed Senior Notes (FIN_INST)",
        "Guaranteed Senior Notes (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5311,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1977,
        "completion_tokens": 273,
        "total_tokens": 2250
      }
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix's investment in streaming service improvements intensified through significant personnel expansion—driven by a $384 million increase in technology and development costs in 2021 to support production growth and streaming enhancements (Chunk 1)—while simultaneously elevating cybersecurity risk exposure through structural leadership changes and heightened operational vulnerability. By 2024, the company formalized its cybersecurity governance with the appointment of a dedicated VP of Security and Privacy Engineering (reporting directly to the Board and Audit Committee) to oversee its enterprise-wide security program, yet this heightened focus coincided with documented incidents of unauthorized digital content releases and third-party data breaches, creating material regulatory, litigation, and reputation risks that could materially impact financial condition if disruptions occur (Chunk 2). These intertwined developments—expanding personnel investments in streaming infrastructure alongside escalating cybersecurity dependencies and risks—reflect a strategic evolution where growth ambitions are now intrinsically tied to complex, high-stakes security and talent management challenges across the 2022–2024 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Streaming Service (PRODUCT)",
        "Streaming Service (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5976,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2149,
        "completion_tokens": 312,
        "total_tokens": 2461
      }
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "The Bank of New York Mellon Corporation's approach to restricted stock unit (RSU) agreements evolved from the 2023 to 2024 filings, transitioning from the 2023 Form of RSU Agreement (disclosed in both 2023 and 2024 10-Ks as Exhibit 10.24 and 10.26, respectively) to a newly introduced 2024 Form of RSU Agreement (Exhibit 10.29 in the 2024 filing), reflecting a lifecycle management strategy that refreshes equity award structures annually. This evolution is embedded within the company's broader executive compensation framework, as evidenced by the simultaneous disclosure of the amended Executive Severance Plan (Exhibit 10.27 in 2023 and restated in 2024 as Exhibit 10.27 in the 2024 filing), which aligns RSU terms with retention and performance objectives. The 2024 filing explicitly references the 2024 RSU Agreement as a current accounting policy (KG: BK → 2024 Form of RSU Agreement ← ACCOUNTING_POLICY), indicating a deliberate shift to standardize equity compensation practices while maintaining continuity with prior frameworks, thereby reinforcing strategic alignment between long-term incentive structures and executive pay strategy across the 2023–2024 reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> 2024 Form of Restricted Stock Unit Agreement (ACCOUNTING_POLICY)",
        "2024 Form of Restricted Stock Unit Agreement (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12002,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3689,
        "completion_tokens": 296,
        "total_tokens": 3986
      }
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes issued in November 2023 mature on April 15, 2029, with $750 million principal at a $3.4 million discount, and interest payable semi-annually starting April 15, 2024. As of January 28, 2024, their carrying amount was $743 million (per the 2024 10-K table), reflecting the amortization of the discount over time. This aligns with the 2023 issuance details where the third tranche of $750 million in 4.90% notes was structured with a $3.4 million discount and a 2029 maturity, confirming the evolution from issuance to current carrying value and maturity timeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "HD (ORG) -> 4.90% Senior Notes (FIN_INST)",
        "4.90% Senior Notes (FIN_INST) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_60",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2024.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12604,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3791,
        "completion_tokens": 146,
        "total_tokens": 3937
      }
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Between 2023 and 2024, Costco's Japanese subsidiary issued $500 of Guaranteed Senior Notes in November 2023 at fixed rates of 1.400% to 2.120%, then repaid $77 of these notes in July 2024, while the parent company separately paid the $1,000 outstanding principal on its 2.750% Senior Notes on May 18, 2024. The fair value of all long-term debt, including the current portion, was approximately $5,412 at the end of 2024 compared to $5,738 at the end of 2023, reflecting the net impact of these debt transactions across both entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "COST (ORG) -> Guaranteed Senior Notes (FIN_INST)",
        "Guaranteed Senior Notes (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6332,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2218,
        "completion_tokens": 133,
        "total_tokens": 2351
      }
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "The risk associated with competitors developing after-market parts for DHR's products has intensified from 2022 to 2023, as evidenced by the company's explicit focus on this threat in both filings. In the 2022 10-K, DHR highlighted that competitors' introduction of private label, generic, or low-cost after-market products could \"capture significant market share or lead to a decrease in market prices overall,\" directly jeopardizing its business and financial statements, while the 2023 filing specifically identifies \"competitors may also develop after-market services and parts for our products which may detract from our sales\" as a key innovation risk requiring strategic anticipation and differentiation. This escalating risk directly impacts DHR's financial statements by potentially triggering pricing pressures, reduced market share, and adverse effects on revenue and profitability, as the company must continuously invest in R&D, regulatory compliance, and product innovation to counter such competitive threats in an industry marked by rapid technological change and consolidation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "DHR (ORG) -> After-Market Parts (RISK_FACTOR)",
        "After-Market Parts (RISK_FACTOR) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10588,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3305,
        "completion_tokens": 273,
        "total_tokens": 3578
      }
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix evolved its membership strategy to counter slowing growth and macroeconomic pressures by introducing a lower-priced ad-supported tier and tightening sharing rules, while simultaneously expanding into gaming and live programming to enhance value perception. This shift directly addressed challenges outlined in the 2024 10-K, where the company explicitly cited risks from \"adverse macroeconomic conditions, including inflation\" and the need to \"adjust pricing or service offerings\" to retain members amid intense competition and stagnating growth in saturated markets like UCAN, as noted in the 2022 filing's observation of \"paid net membership additions... decreasing 50%\" and reliance on international expansion. The pricing adjustments and feature expansions were explicitly framed as responses to the \"business will be adversely affected\" risks tied to failing to \"continuously provide value\" and adapt to \"competitive offerings,\" demonstrating a strategic pivot from pure subscriber growth to monetization and engagement resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "NFLX (ORG) -> Membership Plans (PRODUCT)",
        "Membership Plans (PRODUCT) -> NFLX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NFLX_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NFLX_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8941,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2886,
        "completion_tokens": 265,
        "total_tokens": 3152
      }
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Boeing's approach to in-orbit incentive payments has evolved significantly between 2022 and 2023, with heightened financial risk exposure and more aggressive revenue recognition tied to complex contractual obligations. In 2023, the company explicitly recognized revenue from in-orbit incentive payments during the construction period based on expected realizable value, but these payments remain contingent on satellite performance over up to 15 years post-acceptance, creating material risk if specifications aren't met - potentially triggering refunds or charges that could adversely affect financial condition. This risk is particularly pronounced in fixed-price contracts like those governing Commercial Crew, KC-46A Tanker, and VC-25B programs, where in-orbit payments are increasingly integrated into incentive structures that directly impact earnings volatility and future cash flow stability across both defense and space segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> In-Orbit Incentive Payments (REGULATORY_REQUIREMENT)",
        "In-Orbit Incentive Payments (REGULATORY_REQUIREMENT) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8366,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2746,
        "completion_tokens": 234,
        "total_tokens": 2980
      }
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "The Directors' Code of Conduct has evolved from being disclosed solely in the 2023 proxy materials and website (as noted in BK_10k_2023.pdf's \"CODE OF ETHICS\" section) to being explicitly included among the \"Available Information\" in the 2024 Form 10-K filing (BK_10k_2024.pdf), where it is listed alongside other governance documents like Corporate Governance Guidelines and Committee Charters as part of the materials accessible on BNY's website. This shift reflects a more formalized and centralized disclosure approach in 2024, emphasizing its integration into standard corporate governance reporting alongside other key policy documents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6962,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2378,
        "completion_tokens": 160,
        "total_tokens": 2539
      }
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, Mobileye Drive™ evolved from being primarily a consumer L4 design win (launched with Geely in 2022) to becoming the core commercialization platform for robotaxi and mobility-as-a-service deployment, as evidenced by its role in the SIXT partnership launching in Germany in 2022 and its expanded focus on AMaaS (Autonomous Mobility-as-a-Service) through supply to transportation networks and public transit operators in 2023. While 2022 centered on foundational launches like Mobileye Drive™ for consumer L4 and Robotaxi services with SIXT, 2023 strategically shifted to positioning Mobileye Drive™ as the scalable, end-to-end solution for fleet deployment—highlighted by its integration with Moovit's urban mobility intelligence and its role in enabling Mobileye Chauffeur (consumer AV) and eyes-off/hands-off systems—reflecting a deliberate pivot from consumer vehicle partnerships toward B2B AMaaS targeting transportation operators and MaaS platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Launches]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "INTC (ORG) -> Mobileye Drive™ (PRODUCT)",
        "Mobileye Drive™ (PRODUCT) -> INTC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "INTC_10k_2022.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "INTC_10k_2023.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8751,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2809,
        "completion_tokens": 244,
        "total_tokens": 3053
      }
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "From 2022 to 2024, the structure of AT&T's Tower Preferred Interests underwent a significant amendment that reshaped their distribution profile and reset schedule. In the 2022 filing, the $6,000 nonconvertible cumulative preferred interests in Tower Holdings comprised two series: a $1,500 September Class A-1 at 5.0% and a $4,500 December Class A-2 at 4.75%, both resetting every five years and payable quarterly (Chunk 1). By 2024, AT&T amended these interests to replace the original series with Fixed Rate Class A Limited Membership Interests (5.90% distribution) and introduce Floating Rate Class A Limited Membership Interests tied to SOFR+250bps, with the floating portion potentially reaching $525 by 2028 (Chunk 2). This restructuring maintained the contingent redemption rights tied to missed distributions or credit rating triggers (present in both chunks), but shifted the reset mechanism from a fixed five-year cycle to a staggered five-year transition where portions migrate to floating rates annually, while explicitly retaining the call option beginning November 2029 (Chunk 2). Concurrently, the Telco LLC preferred interests (detailed in both chunks) expanded their reset triggers to include a November 1, 2027 reset date for newer series, though this pertains to a separate entity (Chunk 1 and 2). Crucially, the 2024 amendment preserved the non-limiting cash flow provisions for affiliates and dividend repurchases but introduced explicit floating rate mechanics and a prolonged reset horizon, marking a material evolution from the static 2022 structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Can_Call]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Tower Preferred Interests (FIN_INST)",
        "Tower Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10625,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3286,
        "completion_tokens": 393,
        "total_tokens": 3679
      }
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The investment approach for the Balanced Index Fund, which constitutes the majority of OPB Plan assets (approximately 60% equities and 40% debt securities), remained consistent from 2022 to 2023, being valued using a market approach based on quoted market prices of identical instruments (Level 1). Unrealized gains/(losses) for Level 3 assets within the fund shifted significantly: from ($16) for corporate fixed income, ($11) for mortgage/asset-backed securities, and ($14) for municipal securities in 2022, to $2 for corporate fixed income, $6 for mortgage/asset-backed securities, and $3 for other fixed income securities in 2023, reflecting a substantial improvement in unrealized performance across these categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "BA (ORG) -> Balanced Index Fund (FIN_INST)",
        "Balanced Index Fund (FIN_INST) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_115",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_96",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1851,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 180,
        "total_tokens": 1280
      }
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "BNY Mellon's forward-looking statements have evolved from emphasizing accounting developments as a general category in 2023 to explicitly integrating them within strategic priorities and initiatives in 2024, reflecting the growing influence of accounting standards on its business outlook. The 2024 filing expands the scope to directly link accounting developments to key strategic areas like capital returns, expense management, and platform operating model transitions, demonstrating how evolving accounting frameworks are now central to shaping the firm's operational and financial planning. This progression reveals a strategic shift where accounting standards are no longer just compliance considerations but active drivers of BNY Mellon's forward-looking business objectives and risk management approaches.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Guides_On]- ORG",
      "triplets_used": [
        "BK (ORG) -> Accounting Developments (ACCOUNTING_POLICY)",
        "Accounting Developments (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9318,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2996,
        "completion_tokens": 203,
        "total_tokens": 3199
      }
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "The 2023 focus on store safety and cybersecurity risks—particularly the rise in shrink from organized retail crime and heightened cyber threats—directly threatens associate experience by eroding trust, morale, and retention, as unsafe or compromised environments can negatively impact the associate experience. This contrasts with 2022’s engagement-focused initiatives, which emphasized emotional commitment and connection through surveys and recognition programs, highlighting a shift from proactive engagement to reactive risk mitigation that may undermine the associate experience previously cultivated.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> CONCEPT <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "HD (ORG) -> Associate Experience (CONCEPT)",
        "Associate Experience (CONCEPT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7558,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2544,
        "completion_tokens": 151,
        "total_tokens": 2695
      }
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "The learning curve's influence on cost and production estimates has intensified between 2022 and 2023, directly amplifying risks to program profitability and requiring more rigorous risk management. In 2022, the 787 program faced potential losses and higher abnormal costs if production rates were reduced due to China market challenges and rework, with learning curve factors explicitly cited as contributors to margin pressures and abnormal costs. By 2023, the learning curve became a critical, quantifiable element in accounting quantity determinations—impacting cost estimates through \"production quality, labor instability, global supply chain constraints, learning curve, change incorporation, rework or safety enhancements\"—and was explicitly linked to margin risks in programs like the 787, where adverse cost/revenue changes could trigger $330 million earnings impacts. This evolution reflects a shift from general acknowledgment of learning curve effects (2022) to its formal integration into quantitative risk modeling and profit margin calculations (2023), directly tying learning curve dynamics to program break-even thresholds (e.g., 767/777X/787 near single-digit margins) and mandatory quarterly reassessments of accounting quantities to mitigate financial exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Depends_On]- ORG",
      "triplets_used": [
        "BA (ORG) -> Learning Curve (RISK_FACTOR)",
        "Learning Curve (RISK_FACTOR) -> BA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BA_10k_2022.pdf",
          "page_id": "page_42",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BA_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8433,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2758,
        "completion_tokens": 320,
        "total_tokens": 3079
      }
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "The treatment of the Dividend Reinvestment Plan has remained consistent between the 2023 and 2024 SEC filings, with both years disclosing that certain officers and directors participate in the plan and may engage in share withholding elections to cover taxes or exercise prices, which may align with or constitute non-Rule 10b5-1 trading arrangements under Regulation S-K. This recurring disclosure is reflected in the KG pattern where BK discloses the Dividend Reinvestment Plan (FIN_INST), and the plan is associated with BK through mutual stake relationships, underscoring ongoing transparency regarding executive participation and trading mechanisms across both filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "BK (ORG) -> Dividend Reinvestment Plan (FIN_INST)",
        "Dividend Reinvestment Plan (FIN_INST) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4030,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1666,
        "completion_tokens": 168,
        "total_tokens": 1835
      }
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "From fiscal 2021 to fiscal 2023, The Home Depot's investment in creating an interconnected shopping experience evolved from an initial $2.6 billion capital investment in fiscal 2021 to a more targeted, technology-driven approach focused on personalization and location-based tailoring, as evidenced by its 2023 strategy to \"build an interconnected shopping experience that is tailored to our customers' shopping intent and location\" using enhanced merchandising information technology tools to leverage data and collaborate with suppliers. This shift is reflected in the company's explicit emphasis on refining assortments, optimizing space productivity, and introducing innovative products through merchandising resets and digital integration, while maintaining its core goals of delivering the best customer experience, extending its low-cost position, and being the most efficient capital investor in home improvement, all while continuing to invest in services like installation and tool rental to further enhance the tailored, interconnected experience for customers across both physical stores and online channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> CONCEPT <-[Builds]- ORG",
      "triplets_used": [
        "HD (ORG) -> Interconnected Shopping Experience (CONCEPT)",
        "Interconnected Shopping Experience (CONCEPT) -> HD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "HD_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "HD_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10276,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3230,
        "completion_tokens": 280,
        "total_tokens": 3510
      }
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "The financial relationship between DHR and Aldevron evolved significantly between 2022 and 2023, with capital investment and acquisition-related expenditures reflecting both strategic expansion and integration. In 2022, DHR reported approximately $1.5 billion in capital expenditures to expand manufacturing capacity, explicitly citing support for Aldevron’s biopharma product demand and post-acquisition growth opportunities, building on the $791 million spent in 2020 and $1.3 billion in 2021, which included investments tied to the Aldevron and Cytiva acquisitions. The 2023 10-K reveals that DHR acquired net assets totaling $10.976 billion from Aldevron, with $9.561 billion representing net cash consideration after subtracting $75 million in noncash consideration, underscoring Aldevron’s strategic value as a wholly owned subsidiary under DHR’s ownership structure, as confirmed by the KG triplet relationship where Aldevron (COMP) is Has_Stake_In by DHR (ORG). Furthermore, while Chunk 1 details government grants offsetting $32 million in capital expenditures in 2021, the 2022–2023 filings indicate sustained high capital spending—driven in part by Aldevron-related demand—without comparable grant offsets mentioned in 2023, suggesting a shift toward self-funded expansion. This progression demonstrates that DHR’s financial commitment to Aldevron transitioned from initial acquisition financing and government-supported capacity building to sustained, strategic capital investment to scale Aldevron’s operations within DHR’s portfolio, directly influencing both companies’ reported capital expenditures and acquisition-related outlays.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "DHR (ORG) -> Aldevron (COMP)",
        "Aldevron (COMP) -> DHR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DHR_10k_2022.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DHR_10k_2023.pdf",
          "page_id": "page_74",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7960,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2627,
        "completion_tokens": 411,
        "total_tokens": 3039
      }
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, Telco LLC’s preferred interests grew from an initial $2,000 issuance in September 2020 to $7,250 in cumulative preferred interests by December 31, 2024, reflecting an expansion in September 2023 with an additional $5,250 of nonconvertible cumulative preferred interests (Telco Class A-2 and A-3), while maintaining the original $2,000 Class A-1 issuance. The distribution rates were restructured: the initial 4.25% annual rate for Class A-1 remained unchanged, but Class A-2 and A-3 now pay a higher 6.85% annual rate, with both series subject to reset every seven years (Class A-2 and A-3 reset on November 1, 2027, and thereafter). Additionally, the reset schedules were updated—Telco preferred interests now reset on November 1, 2027, and every seven years thereafter, while the 2019 Tower preferred interests (referenced in the KG pattern) were amended in August 2024 to reset rates in November 2024, introducing Fixed Rate Class A Interests at 5.90% and Floating Rate Class A Interests tied to SOFR plus 250 basis points, with the latter potentially reaching $525 by 2028. These changes reflect a strategic evolution in Telco LLC’s capital structure, driven by both capital infusions and revised distribution mechanics to manage financial flexibility and investor expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Can_Call]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Telco Preferred Interests (FIN_INST)",
        "Telco Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_130",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10625,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3308,
        "completion_tokens": 325,
        "total_tokens": 3633
      }
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "AIG's use of Expected Loss Ratio Methods has evolved to specifically target distinct insurance lines based on their risk characteristics, with a clear rationale tied to claim behavior. For aviation exposures, the company applies these methods to the latest accident year due to the high severity and limited tail nature of claims, supplementing them with ground-up projections, while U.S. Workers' Compensation—characterized by its extremely long tail—uses Expected Loss Ratio Methods alongside loss development and frequency/severity approaches, particularly for complex risk-sharing structures like large deductibles and government subcontractor accounts. This targeted application reflects AIG's adaptation to line-specific claim patterns, as evidenced by its shift from broader reserving practices in 2022 (where IBNR factors were emphasized for U.S. Property) to a more nuanced, line-dependent strategy by 2024, especially in long-tail segments like Workers' Compensation where historical emergence trends and risk-sharing features necessitate tailored methodologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_273",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_151",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6964,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2397,
        "completion_tokens": 268,
        "total_tokens": 2665
      }
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "Target's owned brands strategy has evolved from 2023 to 2024 with a clear strategic emphasis on expanding and diversifying its portfolio to drive growth and differentiation. While the 2023 strategy highlighted \"strengthening our owned brands portfolio\" as a core element to deliver newness and value, the 2024 filing explicitly underscores this through a significantly broader product range—listing over 70 owned and exclusive brands across categories like home (Room Essentials™, Opalhouse™), apparel (Universal Thread™, Auden™), and specialty lines (Casaluna™, Wild Fable™)—demonstrating a deliberate expansion beyond foundational brands like A New Day™ and Pillowfort™. This portfolio development is directly tied to Target's broader strategy of \"delighting with newness, style, and value\" and leveraging owned brands as a key differentiator, supported by global sourcing operations that specifically procure merchandise for these brands to ensure quality, cost management, and ethical practices—evident in the 2024 Form 10-K's emphasis on \"merchandise from our owned and exclusive brands\" comprising \"approximately one-third of our merchandise sales.\" Crucially, this evolution is reinforced by the integration of owned brands into Target's omnichannel strategy, where stores serve as fulfillment hubs for these products (fulfilling over 96% of sales) and are central to the \"favorite discovery destination\" objective, while also enabling revenue streams through complementary capabilities like Roundel advertising and Target Circle loyalty program enhancements that drive guest engagement with the brand portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Expands]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Owned Brands (PRODUCT)",
        "Owned Brands (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6271,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2202,
        "completion_tokens": 404,
        "total_tokens": 2607
      }
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of both the 0.875% Notes due 2030 (referenced in Chunk 1 as IBM 30A) and the newly issued 2.900% Notes due 2030 (referenced in Chunk 2 as IBM 30C) signals a strategic debt management approach. This dual listing reflects IBM's intent to maintain flexibility in its long-term financing, potentially leveraging favorable market conditions to refinance or restructure debt obligations. The coexistence of these instruments—one existing and one newly introduced—suggests IBM is actively managing its capital structure, possibly to optimize interest costs or extend maturity timelines amid evolving investor demand for higher-yielding long-duration bonds in a shifting rate environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 0.875% Notes due 2030 (FIN_INST)",
        "0.875% Notes due 2030 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6172,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2201,
        "completion_tokens": 176,
        "total_tokens": 2377
      }
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "Between 2022 and 2024, AT&T's long-term debt composition maintained continuity in its core 4.000% Global Notes due June 1, 2049 (T 49A), which remained registered and outstanding as evidenced by its persistent inclusion in both 2022 and 2024 disclosures. The 2024 filing confirms the ongoing presence of this instrument (T 49A) alongside newly referenced securities like the 3.375% Global Notes due March 15, 2034 (T 34), 4.300% Global Notes due November 18, 2034 (T 34C), and 2.450% Global Notes due March 15, 2035 (T 35), indicating a strategic extension of maturities beyond 2035 while preserving the 2049 maturity tranche. This evolution reflects AT&T's approach of rolling over near-term obligations into longer-dated instruments, as seen in the transition from 2022's 2026–2029 maturities to 2024's expanded portfolio including 2034–2036 and 2050 maturities, with the 4.000% 2049 notes serving as a stable anchor in the long-term debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> 4.000% Global Notes due June 1,2049 (FIN_INST)",
        "4.000% Global Notes due June 1,2049 (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_2",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5851,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2121,
        "completion_tokens": 237,
        "total_tokens": 2359
      }
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The financial impact of the Heritage AspenTech acquisition evolved with intangibles amortization increasing from $258 in 2023 to $560 in 2024, reflecting higher amortization of acquired intangibles post-acquisition, while restructuring costs related to integration activities were $228 in 2024, $72 in 2023, and $75 in 2022, with $120 expected in 2025, as disclosed in EMR's 10-K filings and restructuring expense breakdowns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "EMR (ORG) -> Heritage AspenTech (COMP)",
        "Heritage AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2246,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 106,
        "total_tokens": 1309
      }
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods for workers' compensation has evolved to place greater reliance on these methods for the most recent five accident years, particularly for excess of deductible business where large deductible accounts now represent an increasing proportion of the portfolio and slow claims reporting patterns. The company segments business by deductible size and administration type (AIG vs. third-party), groups guaranteed cost and excess of deductible separately by state and industry, and adjusts expected loss ratios for recent accident years based on updated loss trends, inflation, and market conditions, while also incorporating individual pricing for large accounts and pandemic-related adjustments. This segmentation and methodological weighting reflect AIG's response to the growing complexity of large deductible business, which now significantly impacts loss emergence and reserving practices compared to prior years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_260",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_151",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7603,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2566,
        "completion_tokens": 238,
        "total_tokens": 2805
      }
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "Target's Cyber Fusion Center operations have evolved from 2023 to 2024 by strengthening its integration with enterprise risk management and expanding collaboration with external organizations. In 2023, the Center was described as part of a proactive threat intelligence program that investigates and responds to threats, while also emphasizing collaboration across industries to share threat intelligence and best practices. By 2024, this collaboration was explicitly highlighted as a core component, with Target continuing to share threat intelligence and work with external organizations to \"fight cybercrime, enhance privacy, discuss new technologies, better understand the evolving regulatory environment, and advance capabilities.\" The 2024 filing also emphasizes regular training and compliance activities for team members, reinforcing the Center's role in a coordinated escalation model that keeps management and the Board informed throughout incident response—demonstrating a matured, integrated approach to cybersecurity that builds on its 2023 foundation while deepening external partnerships and operational rigor.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Cyber Fusion Center (PRODUCT)",
        "Cyber Fusion Center (PRODUCT) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8508,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2780,
        "completion_tokens": 281,
        "total_tokens": 3061
      }
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Between 2023 and 2024, Eli Lilly's financial relationship with Baqsimi underwent a structural shift from revenue recognition to contractual dissolution. In 2023, LLY recognized revenue from the sale of Baqsimi rights as part of collaboration and other revenue, explicitly detailed in Note 4 of the 2023 10-K (Chunk 2), which also notes this revenue stream was materially tied to the 2023 rights sale. This arrangement was replaced in 2024 by a new supply agreement for olanzapine (including Zyprexa), which shifted focus to volume-driven revenue from Trulicity, Verzenio, and Humalog outside the U.S., as noted in Chunk 1's reference to \"lower realized prices from Trulicity, Verzenio, and Humalog\" due to this new arrangement. Consequently, Baqsimi no longer generated revenue for LLY in 2024, with its prior rights sale revenue (Chunk 1's \"$579.0 million from the sale of the rights for Baqsimi\") being a one-time 2023 event distinct from the ongoing contractual dynamics described in Chunk 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Baqsimi (PRODUCT)",
        "Baqsimi (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2451,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 248,
        "total_tokens": 1496
      }
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "AT&T's capital structure management evolved significantly from 2023 to 2024 through strategic repurchases and expansions of preferred interests. In April 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414 (primarily funded by April 2023 Telco LLC preferred interest proceeds), retiring $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities' as noted in Note 16 of T_10k_2023.pdf. Concurrently, AT&T expanded its Telco LLC preferred interests by issuing an additional $5,250 in April 2023 (Telco Class A-2 and A-3), bringing cumulative Telco LLC preferred interests to $7,250 by December 31, 2024, as detailed in T_10k_2024.pdf page 87. Furthermore, AT&T amended its 2019 Tower Holdings preferred interests in August 2024, resetting rates and restructuring them into Fixed Rate Class A and Floating Rate Class A Limited Membership Interests with new distribution rates (5.90% fixed and SOFR+250bps floating), effective November 2024, while maintaining redemption options and non-limiting cash movement provisions for AT&T's dividend and share repurchase activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Repurchases]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Mobility Preferred Interests (FIN_INST)",
        "Mobility Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_38",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8938,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2904,
        "completion_tokens": 287,
        "total_tokens": 3191
      }
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "Emerson's relationship with AspenTech evolved from a strategic partnership to majority ownership following its $11.5 billion acquisition of Heritage AspenTech in 2024, resulting in Emerson holding 55 % of AspenTech’s fully‑diluted shares and renaming the combined entity “New AspenTech,” which shifted the dynamic from a simple partner relationship to a controlling ownership stake. This transformation directly boosted Emerson’s gross margin by 1.8 percentage points to 50.8 % in 2024, driven by the Test & Measurement acquisition and favorable pricing, while also reshaping its ownership structure—most notably, Emerson divested its 40 % non‑controlling interest in Copeland for $1.5 billion and sold a $1.9 billion note receivable, reflecting a strategic reallocation of assets tied to its AspenTech holdings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "EMR (ORG) -> AspenTech (COMP)",
        "AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5491,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2012,
        "completion_tokens": 203,
        "total_tokens": 2215
      }
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "Between 2022 and 2024, AIG's Japan pension plans contributed approximately 50-54% of total non-U.S. pension obligations, with their weighted average discount rate increasing from 1.48% at December 31, 2023 to 1.81% at December 31, 2024, reflecting a strategic adjustment aligned with country-specific Mercer yield curve methodology. This evolution demonstrates a deliberate shift in funding strategy, as evidenced by the 22.4% increase in the discount rate over the two-year period, directly tied to the application of Japan-specific yield curve assumptions for liability valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Japan Pension Plans (FIN_INST)",
        "Japan Pension Plans (FIN_INST) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_311",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_183",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3802,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1606,
        "completion_tokens": 145,
        "total_tokens": 1752
      }
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "Amazon’s 2022 10‑K framed competitive store pressure as one of several “operating risks” that could cause fluctuations in revenue and growth, listing it alongside seller retention, fulfillment challenges, and macro‑economic conditions. By 2023, the filing retained the competitive‑store language but integrated it more tightly with broader market‑condition narratives—emphasizing how external competitors can drive price decreases or service improvements that affect Amazon’s growth, while also linking competitive risk to its expansion‑related strain on resources and foreign‑exchange exposure. This evolution shows a shift from a standalone risk statement to a more interconnected view where competitive pressures are positioned alongside global expansion, financial volatility, and intellectual‑property threats, underscoring how external market conditions increasingly shape Amazon’s strategic outlook.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Competes_With]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Competitive Stores (COMP)",
        "Competitive Stores (COMP) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9549,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3036,
        "completion_tokens": 226,
        "total_tokens": 3263
      }
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Target's exposure to port security risks has intensified between 2023 and 2024, with heightened geographic concentration on U.S. ports—particularly California, where a significant portion of imported merchandise enters—and increased vulnerability to disruptions from port security challenges, trade policy shifts, and supply chain volatility. The company's reliance on China as its largest sourcing origin amplifies this risk, as recent U.S. tariffs on China and retaliatory actions have forced costly procurement adjustments and price increases, directly threatening revenue and competitiveness. Operational impacts include heightened exposure to port congestion, labor disputes, and transportation bottlenecks, which have necessitated alternative logistics arrangements and elevated costs, potentially disrupting inventory flow and adversely affecting results of operations across all affected regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "TGT (ORG) -> Port Security (RISK_FACTOR)",
        "Port Security (RISK_FACTOR) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10550,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3277,
        "completion_tokens": 226,
        "total_tokens": 3503
      }
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Emerson's acquisition of Heritage AspenTech was financed with approximately $6.0 billion in cash at $87.69 per share, leaving $168 million of cash on AspenTech’s balance sheet that was excluded from purchase‑price allocation. The intangible assets tied to the transaction are amortized over time, contributing $258 million of amortization expense in 2023 (which rose to $560 million in 2024 when combined with the NI acquisition). Restructuring costs linked to the integration have been $72 million in 2023 and are projected to reach about $120 million in 2025, reflecting ongoing efforts to resize the combined business, relocate facilities, reduce headcount, and exit non‑core product lines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "EMR (ORG) -> Heritage AspenTech (COMP)",
        "Heritage AspenTech (COMP) -> EMR (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "EMR_10k_2023.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "EMR_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2646,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 173,
        "total_tokens": 1477
      }
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "AIG's use of Expected Loss Ratio methods has evolved to give greater weight to this approach in more recent accident years across key lines of business, particularly in D&O, E&O, EPLI, professional liability, and U.S. Workers' Compensation, where low-frequency/high-severity loss characteristics make frequency/severity methods less reliable in isolation. The company increasingly relies on expected loss ratio methods for newer accident years, adjusting them with current cost levels and emerging trends (including inflation and pandemic-related disruptions), while applying loss development methods more heavily to mature accident years, as evidenced by its practice of using capped/excess layer approaches for large claims and supplementing standard models with claim department estimates for complex M&A exposures. This weighting pattern is explicitly documented in both 2022 and 2024 disclosures, with the 2024 filing confirming that expected loss ratio methods remain integral to reserving practices for recent accident years across all relevant lines, including U.S. Property and Special Risks where recent unfavorable development ($172M in 2021) reflects the impact of evolving loss emergence on newer business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "AIG (ORG) -> Expected Loss Ratio Methods (ACCOUNTING_POLICY)",
        "Expected Loss Ratio Methods (ACCOUNTING_POLICY) -> AIG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AIG_10k_2022.pdf",
          "page_id": "page_270",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AIG_10k_2024.pdf",
          "page_id": "page_151",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7446,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2522,
        "completion_tokens": 304,
        "total_tokens": 2826
      }
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "The monetization strategy for Amazon's film groups shifted significantly between 2022 and 2023, with capitalized video and music content costs rising from $10.7 billion to $17.4 billion, reflecting increased investment in original and licensed content. This expansion is directly tied to the $18.9 billion in total video and music expenses for 2023—up from $16.6 billion in 2022—indicating a strategic pivot toward higher monetization of content through Prime memberships, where film groups are monetized as unified units across major geographies. The weighted average remaining life of capitalized video content also extended from 2.6 to 3.5 years, suggesting longer-term revenue planning, while the consistent impairment evaluation approach (with no impairments reported in either year) underscores stable valuation frameworks for these monetized assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Positively_Impacts]-> PRODUCT <-[Monetizes]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Film Groups (PRODUCT)",
        "Film Groups (PRODUCT) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10897,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3368,
        "completion_tokens": 214,
        "total_tokens": 3582
      }
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's stake in RBH remained intact but became subject to significant impairment due to evolving legal and financial pressures. As noted in Chunk 1, PMI continued to report volume of brands sold by RBH for which other PMI subsidiaries are trademark owners, including HEETS and Marlboro-related products, maintaining its operational connection to RBH despite the deconsolidation of its Canadian subsidiary. However, Chunk 2 reveals that by December 31, 2024, PMI recorded a $2,316 million non-cash impairment charge on its investment in RBH following unresolved allocation disputes in the proposed CAD 32.5 billion Canadian tobacco settlement (involving RBH, ITL, and JTI), which signaled potential impairment indicators. This impairment, finalized in early 2025 but rooted in 2024 developments, reflects how regulatory uncertainty directly impacted the carrying value of PMI’s stake, even as its business relationship with RBH—particularly in heated tobacco products like HEETS—continued through trademark licensing and volume reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "PM (ORG) -> RBH (COMP)",
        "RBH (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4596,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1780,
        "completion_tokens": 270,
        "total_tokens": 2051
      }
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "Based on the disclosures in both 10-K filings and their KG connections, LLY's sensitivity analysis for net product revenue to changes in sales return, rebate, and discount liabilities remained materially consistent between 2023 and 2024, with the company explicitly stating that a 5% change in these liabilities would still produce approximately $615 million in revenue impact, as referenced in both the 2023 and 2024 filings' \"Financial Statement Impact\" sections. The core estimation methodology and time lag for accrual revisions (typically paid up to six months later) were unchanged, indicating that the sensitivity relationship did not materially evolve during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Current Contracts (ACCOUNTING_POLICY)",
        "Current Contracts (ACCOUNTING_POLICY) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2023.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_53",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9527,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3039,
        "completion_tokens": 169,
        "total_tokens": 3209
      }
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "From 2022 to 2024, Bulk shipments' revenue contribution evolved from representing a specific percentage of total freight revenue in 2022 (implied by the 2022 data showing Bulk at $3,305 million in average revenue per car, though exact % not stated) to generating 32% of Union Pacific's total freight revenue in 2024, as explicitly disclosed in Chunk 2's \"2024 Freight Revenues\" section, while maintaining its core composition of grain, grain products, fertilizer, food/refrigerated, and coal/renewables—this shift is underscored by the 2024 data showing Bulk as a distinct 32% contributor (Chunk 2), contrasting with its 2022 position as one of several commodity groups (Chunk 1) where it generated $3,305 in average revenue per car but without explicit percentage disclosure, and the 2024 description emphasizes its strategic role in moving grain from Midwest/Western U.S. to export terminals and domestic processors, coal from PRB to power utilities, and fertilizer from Gulf Coast/Midwest to agricultural users, directly linking its operational scope to this 32% revenue share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Bulk (PRODUCT)",
        "Bulk (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2022.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7557,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2514,
        "completion_tokens": 270,
        "total_tokens": 2784
      }
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "The interest rate on IBM's 1.750% Notes due 2028 remained unchanged at 1.750% between 2023 and 2024, as evidenced by its identical listing in both the 2023 and 2024 10-K filings (Chunk 1 and Chunk 2). This consistency reflects IBM's stable debt strategy, prioritizing predictable financing costs for long-term obligations rather than reacting to short-term rate fluctuations, while maintaining a diversified debt profile across multiple maturities and instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG",
      "triplets_used": [
        "IBM (ORG) -> 1.750% Notes due 2028 (FIN_INST)",
        "1.750% Notes due 2028 (FIN_INST) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2023.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_1",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6172,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2184,
        "completion_tokens": 116,
        "total_tokens": 2300
      }
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "AT&T's preferred interests strategy evolved from retiring legacy instruments to launching a new structured preferred equity framework in 2024. In April 2023, AT&T repurchased all 213 million Mobility Preferred Interests at $5,414, eliminating the prior $373 annual cash distributions and adjusting additional paid-in capital by the fair value difference. This was followed by the August 2024 amendment to Tower Holdings' preferred interests, which reset rates (5.90% fixed, SOFR+250bps floating) and restructured governance with redemption options starting in 2029, while maintaining noncontrolling interest classification. Concurrently, Telco LLC issued $7,250 in cumulative preferred interests (Telco Class A-1, A-2, A-3) with reset provisions and redemption triggers tied to distribution failures or credit rating thresholds, expanding AT&T's preferred equity footprint beyond Mobility to include layered structures with staggered reset schedules and floating-rate components.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Mobility Preferred Interests (FIN_INST)",
        "Mobility Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6612,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2311,
        "completion_tokens": 244,
        "total_tokens": 2556
      }
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Amazon's characterization of competitive threat has evolved from a general acknowledgment of competition to a more specific focus on price competition and marketplace dynamics. In 2022, the filing broadly cited \"the introduction of competitive stores, websites, products, services, price decreases, or improvements\" as a risk factor affecting revenue growth, while in 2023 it narrowed to emphasize \"the introduction of competitive stores, websites, products, services, price decreases, or improvements\" within the context of seller and customer behavior. This shift reflects a strategic tightening of language that moves from abstract competitive threats to concrete marketplace actions—particularly the role of third-party sellers and price competition—indicating Amazon now views competition not just as external rivals but as an inherent feature of its own platform ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Competes_With]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Competitive Websites (COMP)",
        "Competitive Websites (COMP) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9549,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3036,
        "completion_tokens": 219,
        "total_tokens": 3256
      }
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "From 2022 to 2024, PMI's strategic reliance on KT&G's heat-not-burn products has deepened through an exclusive global distribution agreement established in January 2020, which was explicitly designed to commercialize KT&G's smoke-free innovations—including LIL Mini, LIL Plus, LIL HYBRID, and LIL Vapor—within PMI's smoke-free portfolio, with PMI assuming full responsibility for market entry, regulatory approvals, and commercialization efforts outside South Korea; this partnership, reinforced by PMI's 2022 acquisition of full ownership in its Turkish subsidiaries (which included KT&G-linked market operations), enabled the launch of licensed KT&G heat-not-burn products across select international markets starting in Q3 2020, and by 2024, these products were formally categorized under PMI's \"smoke-free, excluding wellness and healthcare\" revenue stream, confirming their central role in PMI's strategic shift toward reduced-risk products as evidenced by their inclusion in PMI's consolidated financial reporting structure and the explicit reference to \"licensed KT&G heat-not-burn products\" within PMI's heat-not-burn product portfolio in its 2024 financial disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "PM (ORG) -> KT&G (COMP)",
        "KT&G (COMP) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6657,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2302,
        "completion_tokens": 294,
        "total_tokens": 2597
      }
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "IBM's PWCC Plan, established in 2002 to fund awards for acquired PwCC employees, has maintained identical terms and conditions to the 2001 Plan through both 2022 and 2024 filings, with no indication of scope or administration changes in either document. The plan remains exclusively dedicated to non-executive PwCC employees post-acquisition, while IBM's 2024 filing confirms the PWCC Plan's continued use under the same governance structure as its 2022 disclosure, despite the document referencing a 2025 proxy statement deadline for related disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "IBM (ORG) -> PWCC Plan (ACCOUNTING_POLICY)",
        "PWCC Plan (ACCOUNTING_POLICY) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8781,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2834,
        "completion_tokens": 138,
        "total_tokens": 2973
      }
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "AT&T's financial obligations related to Mobility Preferred Interests were fully extinguished in April 2023 when the company repurchased the remaining 213 million interests for $5.414 billion, eliminating the $373 million annual cash distribution and the associated noncontrolling‑interest accounting that had been recorded in 2022.  The subsequent restructuring of its tower‑related financing—amending the 2019 Tower preferred interests in November 2024 to a hybrid fixed‑ and floating‑rate structure with higher 5.90 % and SOFR‑plus‑250 bps distributions—replaces the legacy Mobility Preferred Instruments with new, more flexible capital‑stack instruments that can be called beginning in 2029 and are now reported as noncontrolling interest in the consolidated balance sheet.  This shift reflects AT&T’s broader capital‑structure strategy of simplifying its preferred‑equity footprint, reducing reliance on legacy non‑convertible cumulative preferred interests, and reallocating capital toward higher‑return projects such as fiber, 5G, and Open RAN while maintaining flexibility to manage liquidity and credit metrics across its wireless and tower holdings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Mobility Preferred Interests (FIN_INST)",
        "Mobility Preferred Interests (FIN_INST) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8682,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2827,
        "completion_tokens": 289,
        "total_tokens": 3116
      }
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "IBM's relationship with stock exchange regulations has evolved in terms of regulatory exposure for its debt securities through heightened acknowledgment of regulatory risks in both 2022 and 2024 filings, where the company explicitly identifies changes in exchange regulations and governmental policies as key factors affecting debt security value and repayment risk (IBM_10k_2022.pdf, page_22; IBM_10k_2024.pdf, page_11). While the 2022 filing emphasizes that debt security values fluctuate due to \"changes in exchange regulations\" among other market factors, the 2024 filing reinforces this exposure by detailing how such regulatory environments—particularly stock exchange regulations—contribute to liquidity risks and market volatility for both debt and equity securities, with no assurance of marketability or value stability (IBM_10k_2022.pdf, page_22; IBM_10k_2024.pdf, page_11). This consistent regulatory focus across both years demonstrates an evolving awareness of how stock exchange regulatory frameworks directly impact IBM's debt financing conditions and investor risk profiles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "triplets_used": [
        "IBM (ORG) -> Stock Exchange Regulations (REGULATORY_REQUIREMENT)",
        "Stock Exchange Regulations (REGULATORY_REQUIREMENT) -> IBM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "IBM_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "IBM_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9328,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2984,
        "completion_tokens": 272,
        "total_tokens": 3257
      }
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "From 2022 to 2024, Disney's financial relationship with A&E (via its 50% ownership of A+E Networks) underwent a significant shift in equity income contribution, directly tied to operational changes in A+E's performance. While Disney's equity investment in A+E remained unchanged at 50% ownership (as established in Chunk 1), the equity income it generated from A+E declined substantially—from $575 million in 2022 to $368 million in 2024 (a $207 million decrease, per Chunk 2)—due to lower income from A+E's networks, despite Disney's continued stake. This decline reflects how A+E's evolving business dynamics, including its international distribution and subscriber base (noted in Chunk 1), directly impacted Disney's reported equity income, even as Disney maintained its foundational investment relationship with the joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "DIS (ORG) -> A&E (COMP)",
        "A&E (COMP) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_35",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1966,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1114,
        "completion_tokens": 208,
        "total_tokens": 1323
      }
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations increased from $18,043 million at December 31 2022 to $18,067 million at December 31 2023, reflecting a modest rise that underscores the company’s continued reliance on securitization as a core component of its long‑term funding strategy. This growth, driven by net issuances in the securitization programs noted in the 2021 disclosures, indicates that the firm is maintaining and slightly expanding its use of asset‑backed securities to finance operations and support its balance‑sheet objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "COF (ORG) -> Securitized Debt Obligations (FIN_INST)",
        "Securitized Debt Obligations (FIN_INST) -> COF (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COF_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COF_10k_2023.pdf",
          "page_id": "page_210",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5788,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2092,
        "completion_tokens": 137,
        "total_tokens": 2229
      }
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Disney's scripted programming strategy has evolved from a traditional linear channel model toward direct-to-consumer (DTC) integration, particularly in international markets. While its General Entertainment channels (including Fox, National Geographic, and Star brands) continue to distribute scripted content across 180+ countries, the company is actively shifting monetization from linear licensing to DTC platforms like ESPN+ and its upcoming sports-focused streaming service. This transition is explicitly noted in the 2022 filing as potentially negatively impacting International Channels revenue, while the 2024 filing confirms the launch of new DTC offerings that will bundle live linear streams of ESPN-branded channels alongside on-demand content. The KG pattern shows Scripted Programming (Product) depends on DIS (Org), reflecting Disney's core content dependency on its own platforms rather than external distributors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Scripted Programming (PRODUCT)",
        "Scripted Programming (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7182,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2447,
        "completion_tokens": 232,
        "total_tokens": 2679
      }
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "Tesla's energy storage product financial and operational challenges evolved significantly from 2022 to 2023, with accounts receivable volatility directly tied to production scaling dependencies. In 2022, the company disclosed $627 million in long-term government rebates receivable (Chunk 1), reflecting delayed collections that impacted cash flow, while 2023 highlighted that scaling energy storage production required precise component forecasting and supply chain coordination to avoid \"unexpected production disruption, storage, transportation and write-off costs\" (Chunk 2). This created a critical dependency: as Tesla ramped energy storage output, its ability to collect accounts receivable from regulatory credit sales and financing partners became contingent on successful production scaling, which in turn relied on securing consistent component supplies amid \"unpredictable challenges\" like material cost inflation and supplier insolvency (Chunk 2). Consequently, the company's financial condition and operating results were increasingly vulnerable to both the timing of receivable collections and the execution of production ramps for energy storage products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Energy Storage Products (PRODUCT)",
        "Energy Storage Products (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9028,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2909,
        "completion_tokens": 292,
        "total_tokens": 3202
      }
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model evolved through its strategic integration with bottling partners and fountain retailers, particularly in North America and globally. As noted in Chunk 1, Coca-Cola sells syrups to both consolidated and unconsolidated bottling partners, recognizing revenue upon sale to these partners rather than at final consumer disposal, which impacts financial reporting and volume metrics. Chunk 2 highlights that in North America, the company manufactures and sells fountain syrups directly to fountain retailers and authorized wholesalers, a key growth area supporting its finished product operations and bottling investments. This structural relationship, reinforced by the ORG-Sells-PRODUCT and PRODUCT-Depends_On-ORG patterns, underscores syrups as a critical, high-margin revenue driver that strengthens partnerships with bottlers while enabling direct engagement with fountain retailers for immediate consumption, thereby enhancing Coca-Cola's market penetration and operational control across its beverage portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Syrups (PRODUCT)",
        "Syrups (PRODUCT) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_44",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10461,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3248,
        "completion_tokens": 271,
        "total_tokens": 3519
      }
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) increased from $96 million in fiscal year 2022 (as reported in the 2022 10‑K) to $120 million in fiscal year 2024 (as reported in the 2024 10‑K), reflecting a $24 million growth over the two‑year period. Across the fair‑value hierarchy, this category consistently represented about 1 % of total investments in both years, underscoring its stable proportion relative to the overall portfolio. The KG pattern ORG‑[Discloses]→FIN_INST←[Invests_In]‑ORG links Disney (DIS) directly to Other MBS & ABS, confirming that the company both discloses and invests in this specific financial instrument, and the data from both years illustrate the upward trend in absolute holdings while maintaining a consistent 1 % share of the fair‑value hierarchy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Other MBS & ABS (FIN_INST)",
        "Other MBS & ABS (FIN_INST) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_104",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2024.pdf",
          "page_id": "page_107",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4273,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1724,
        "completion_tokens": 204,
        "total_tokens": 1928
      }
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Based on the provided SEC filings and knowledge graph relationships, Skunk Works' focus areas evolved significantly between 2022 and 2023 to advance next-generation military aircraft capabilities. In 2022, the ADP organization emphasized modernization of existing platforms like the F-35 and F-22, sustainment programs, and incremental technology insertion into current aircraft, as evidenced by the 2022 10-K's description of \"technology advancement and insertion into our existing aircraft\" and \"network-enabled activities\" for effectiveness. By 2023, the focus explicitly shifted toward next-generation capabilities with direct references to \"next generation capabilities for air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness and air mobility\" in the 2023 10-K, while also expanding into advanced weapons systems like hypersonic strike weapons and unmanned aerial systems through partnerships with entities such as RTX Corporation for the Javelin program. This progression reflects a strategic pivot from sustaining and modernizing current fleets (e.g., F-35 production at 156 aircraft annually starting in 2023) to developing breakthrough capabilities for future warfare, directly supporting the ORG-LMT investment in Skunk Works as a PRODUCT partner.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Partners_With]- ORG",
      "triplets_used": [
        "LMT (ORG) -> Skunk Works (PRODUCT)",
        "Skunk Works (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11385,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3484,
        "completion_tokens": 324,
        "total_tokens": 3809
      }
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "Tesla's Powerwall strategy evolved from 2022 to 2023 by deepening integration with its broader energy ecosystem and expanding production emphasis. In 2022, Tesla emphasized cross-selling Powerwall with residential solar products and improving installation efficiency to support Solar Roof growth, while relying on modular battery design and in-house engineering to scale energy storage deployment amid component constraints (Chunk 1). By 2023, Tesla leveraged vehicle-derived technologies and modular battery system design to optimize manufacturing capacity and grid-interconnection capabilities, explicitly integrating Powerwall with Solar Roof and emphasizing software-driven remote control/dispatch for grid stability (Chunk 2). Production shifted toward greater vertical integration—using automotive-grade power electronics and in-house engineering to streamline deployment—while maintaining focus on grid services and residential solar synergy, reflecting a strategic pivot from pure volume growth to integrated energy solution deployment (KG: ORG Produces PRODUCT → PRODUCT Depends_On ORG confirms mutual operational reliance).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Powerwall (PRODUCT)",
        "Powerwall (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10032,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3141,
        "completion_tokens": 283,
        "total_tokens": 3424
      }
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Gilead's strategic positioning around Biktarvy has evolved from being one of several key HIV products in 2022 to becoming a central pillar of its HIV portfolio by 2024, as evidenced by its prominence in the 2022 product list (Chunk 1) where it is explicitly described as a single-tablet regimen containing bictegravir, emtricitabine, and tenofovir alafenamide (TAF) for HIV-1 treatment. However, this strategic importance is now shadowed by significant commercial risks highlighted in the 2024 risk disclosures (Chunk 2), which note that HIV product sales—including Biktarvy—face threats from competitive generics, potential shifts in treatment paradigms away from TAF-based regimens, and the broader vulnerability of relying on a narrow segment of the HIV market, especially as newer pipeline products like Descovy and Odefsey compete in the same space. The KG triplets (GILD → Biktarvy, Biktarvy → GILD) confirm this mutual dependency, but the 2024 risk discussion underscores that Gilead's commercial success with Biktarvy is now intrinsically tied to maintaining its market share against generics and navigating evolving HIV treatment guidelines that could marginalize TAF-based therapies, making its role both more critical and more precarious in the company's overall HIV strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9457,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3007,
        "completion_tokens": 321,
        "total_tokens": 3328
      }
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "Between 2022 and 2023, the composition of the U.S. Retrospective Responsibility Plan remained consistent in structure, continuing to include the U.S. litigation escrow agreement as a core mechanism alongside other components such as the class B common stock conversion feature, Visa U.S.A. indemnification obligations, interchange judgment sharing, loss sharing, and the omnibus agreement. The 2023 filing (Chunk 2) explicitly references the same mechanisms as the 2022 filing (Chunk 1), with only minor wording adjustments (e.g., \"makewhole agreements\" replacing \"conversion feature\" in describing class B-1 common stock exchange terms), but no structural changes to the plan’s composition. Both years identify the U.S. litigation escrow agreement as a key mechanism under the plan, directly tied to the U.S. Litigation Escrow Agreement accounting policy (KG: V → U.S. Litigation Escrow Agreement ← V), confirming its unchanged role in addressing potential liability for U.S. covered litigation, including matters like the Interchange Multidistrict Litigation referenced in both filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> U.S. Litigation Escrow Agreement (ACCOUNTING_POLICY)",
        "U.S. Litigation Escrow Agreement (ACCOUNTING_POLICY) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_71",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3830,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1622,
        "completion_tokens": 272,
        "total_tokens": 1894
      }
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, the strategic importance of Biktarvy for GILD has **increased** due to its **extended patent protection until 2033** (Chunk 1), which secures long-term revenue stability for a product that remains central to GILD's HIV portfolio—highlighted by disclosures of heightened risk dependency on HIV products (Chunk 2). This patent shield mitigates competitive threats from generics and shifts in HIV treatment paradigms, reinforcing Biktarvy's role as a critical revenue anchor amid broader commercialization risks in GILD's HIV and cell therapy segments (e.g., Yescarta/Tecartus challenges; Chunk 2). Consequently, Biktarvy's patent longevity has elevated its strategic value as a low-risk, high-margin pillar within GILD's evolving product mix.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GILD (ORG) -> Biktarvy (PRODUCT)",
        "Biktarvy (PRODUCT) -> GILD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GILD_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GILD_10k_2024.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6956,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2381,
        "completion_tokens": 189,
        "total_tokens": 2571
      }
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Yes, there have been modifications to the financial guarantees referenced in AT&T's filings for Illinois Bell Telephone Company between 2022 and 2023. Chunk 1 shows that Illinois Bell Telephone Company is included in the guaranty of certain obligations of AT&T Corp. (Exhibit 4-d to Form 10-K for 2011), which was originally executed in 2011. Chunk 2 confirms that this guaranty structure remains referenced in the 2023 filing (page 103, 4-d), but additionally documents amendments to related securities instruments—specifically, the Stock Purchase and Deferral Plan (amended May 18, 2023, Exhibit 10-k) and the Equity Retention and Hedging Policy (amended March 24, 2022, Exhibit 10-q)—which are connected through the KG pattern ORG -[Guarantees]-> COMP and reflect updated documentation supporting the ongoing guarantee framework tied to Illinois Bell.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "T (ORG) -> Illinois Bell Telephone Company (COMP)",
        "Illinois Bell Telephone Company (COMP) -> T (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "T_10k_2022.pdf",
          "page_id": "page_141",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "T_10k_2023.pdf",
          "page_id": "page_103",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 17574,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5051,
        "completion_tokens": 213,
        "total_tokens": 5264
      }
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent 1:1 conversion rate for Class C common stock to Class A common stock in both 2022 and 2023 indicates that Class C holders can convert their shares into Class A shares at a fixed rate, which would increase the total Class A shares outstanding if conversions occur. This conversion mechanism could dilute the voting power of existing Class A stockholders by increasing the total number of Class A shares, potentially reducing their proportional ownership and voting influence in significant corporate transactions like mergers or consolidations. Given that Class B and C common stockholders (including Class C) may have divergent interests from Class A stockholders—such as prioritizing different outcomes in corporate actions—the fixed conversion rate maintains a predictable but potentially dilutive impact on Class A voting power during critical decisions requiring Class B/C stockholder approval.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Class C Common Stock (FIN_INST)",
        "Class C Common Stock (FIN_INST) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9685,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3076,
        "completion_tokens": 228,
        "total_tokens": 3304
      }
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla's Solar Roof production focus shifted from scaling manufacturing capabilities to addressing ramp delays and supply chain vulnerabilities, as evidenced by the 2023 10-K's warning that \"we have experienced, and may also experience similar future delays in launching and/or ramping production of our energy storage products and Solar Roof\" (Chunk 2). This strategic dependency on Gigafactory New York—where Solar Roof and components are produced—became critical as the company acknowledged that \"any delay or other complication in ramping the production of our current products or the development, manufacture, launch and production ramp of our future products... may harm our business\" (Chunk 2), while simultaneously maintaining its broader manufacturing expansion plans across facilities like Shanghai and Berlin (Chunk 1). The evolution reflects a pivot from pure production scaling to managing complex dependencies on manufacturing infrastructure and supplier reliability to overcome bottlenecks in Solar Roof deployment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "TSLA (ORG) -> Solar Roof (PRODUCT)",
        "Solar Roof (PRODUCT) -> TSLA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TSLA_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TSLA_10k_2023.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10291,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3202,
        "completion_tokens": 262,
        "total_tokens": 3464
      }
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained strategically central but evolved in operational emphasis, as evidenced by the consistent KG relationship where **KO produces Syrups** and **Syrups depend on KO** (KG Triplets: *KO → Syrups*, *Syrups → KO*). This mutual dependency underscores that syrups are not merely a product but a foundational input controlled by The Coca-Cola Company (KO), reinforcing its strategic leverage across the value chain.  \n\nChunk 1 clarifies that syrups are defined as \"intermediate products\" in beverage manufacturing, produced by combining concentrates with water and sweeteners, and are sold to fountain retailers (e.g., restaurants and convenience stores) for immediate consumption—directly linking syrups to **fountain operations** within concentrate operations. This positions syrups as a key revenue driver in geographic segments like North America (Chunk 2), where fountain syrups are manufactured and sold to retailers for on-site beverage production, generating net operating revenue while supporting the Company’s bottling partnerships.  \n\nCritically, Chunk 2 confirms that concentrate operations (which include syrup sales) \"typically generate net operating revenues by selling beverage concentrates, syrups, and certain finished beverages to authorized bottling operations,\" while finished product operations—though generating higher revenue—rely on syrups as an input for packaging and distribution. This interdependence means syrups’ role evolved from being a standalone product to a **strategic enabler** of both concentrate sales (via bottling partners) and finished beverage distribution (through fountain networks), with their revenue contribution directly tied to the Company’s geographic operating segments and Global Ventures. Thus, while syrups’ *production* remains under KO’s control, their *commercial role* expanded to anchor the Company’s two-line-of-business model: concentrate operations (syrup sales to bottlers) and finished product operations (syrup-derived beverages sold through distributors), ensuring syrups remain indispensable to Coca-Cola’s end-to-end beverage ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Syrups (PRODUCT)",
        "Syrups (PRODUCT) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2023.pdf",
          "page_id": "page_37",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8489,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2763,
        "completion_tokens": 544,
        "total_tokens": 3308
      }
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "Between 2022 and 2024, the company's operational focus on Africa/Eurasia shifted from a standalone geographic operating segment to being integrated within the broader Europe reportable segment, with its results now reported alongside North America under the restructured skin health business effective July 1, 2024, as disclosed in CL_10k_2024.pdf (page 114). This realignment, part of management changes affecting the skin health business, recast historical geographic reporting, though Africa/Eurasia's financial contribution remained evident in prior periods through its inclusion in the Africa/Eurasia line item of Oral, Personal and Home Care operating profit ($203 million in 2021, $206 million in 2020, and $187 million in 2019 per CL_10k_2022.pdf, page 117), reflecting its historical significance as a key market outside the U.S., particularly within emerging markets comprising approximately 45% of the company's net sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> Africa/Eurasia (GPE)",
        "Africa/Eurasia (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4617,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1793,
        "completion_tokens": 233,
        "total_tokens": 2027
      }
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Johnson & Johnson's Orthopaedics business demonstrated strong global sales momentum in 2023-2024, with worldwide revenue reaching $8,942 million in 2023 (up 4.1% from 2022) and showing consistent growth across key segments. The business emphasized enabling technologies through innovations like robotic-assisted surgery systems and advanced implant solutions, particularly highlighted in the MedTech segment's focus on \"products and enabling technologies that support hips, knees, trauma, spine, sports, and others\" while maintaining robust international expansion (4.6% international growth in 2023). This strategic emphasis on technology-enabled solutions was further reinforced by JNJ's broader MedTech portfolio development, which integrates orthopaedic innovations with cardiovascular and surgery technologies to drive cross-segment growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Operates_In]- ORG",
      "triplets_used": [
        "JNJ (ORG) -> Orthopaedics (PRODUCT)",
        "Orthopaedics (PRODUCT) -> JNJ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JNJ_10k_2023.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JNJ_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11115,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3426,
        "completion_tokens": 211,
        "total_tokens": 3637
      }
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa expanded the scope of U.S. covered litigation under its loss sharing agreements to explicitly include newly filed opt-out cases from MDL 1720 that arise from substantially similar allegations to the original multidistrict litigation, as amended in 2015 and further refined through subsequent omnibus agreement amendments. The 2023 disclosure confirms this framework remains active, with U.S. covered litigation continuing to encompass matters settled or substantially resolved, including the Interchange Multidistrict Litigation and any cases transferred or consolidated into MDL 1720, while liability allocation under the omnibus agreement maintains a 66.6667% Visa / 33.3333% Mastercard split for monetary portions of settlements or judgments assigned to Visa-related claims. Additionally, the U.S. retrospective responsibility plan—comprising the loss sharing agreement, omnibus agreement, and litigation management mechanisms—continues to govern liability allocation, with the 2023 filing reaffirming that U.S. covered litigation includes all cases meeting the defined criteria under MDL 1720 and its amendments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "V (ORG) -> Loss Sharing Agreement (ACCOUNTING_POLICY)",
        "Loss Sharing Agreement (ACCOUNTING_POLICY) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2023.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7865,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2627,
        "completion_tokens": 286,
        "total_tokens": 2913
      }
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, CL's investment in Guaranteed Investment Contracts (GICs) shifted significantly from $1 million in U.S. pension plans and $55 million internationally to $34 million solely in international plans, reflecting a strategic reduction in GIC exposure amid rising interest rate volatility. This decline—from 0.08% of total U.S. pension investments to 6% of international holdings—indicates a deliberate pivot toward more liquid, market-valued assets like fixed income funds (710 U.S. / 71 international) and pooled funds, suggesting CL is de-risking its pension strategy by prioritizing assets with better interest rate sensitivity and valuation transparency over guaranteed-but-static returns. The near-total exit from U.S. GICs ($1M → $0) and reduced international allocation underscore a broader shift toward active portfolio management aligned with current market conditions rather than long-term fixed-income guarantees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> Guaranteed investment contracts (FIN_INST)",
        "Guaranteed investment contracts (FIN_INST) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5184,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1946,
        "completion_tokens": 235,
        "total_tokens": 2181
      }
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "The Mastercard Developer Platform has evolved from a general API gateway into a strategic hub for digital asset integration, as evidenced by its expanded functionality across both 2022 and 2024 initiatives. In 2022, it enabled crypto-related integrations like purchasing cryptocurrencies via cards and converting them to fiat, while also launching programs such as Digital First Card and Digital Doors to support merchants in digital payment adoption. By 2024, the platform's role intensified with explicit blockchain focus, including integration with the Mastercard Multi-Token Network™ to enable programmable payments in blockchain ecosystems and partnerships to facilitate cryptocurrency transactions, alongside enhanced tokenization (30% of transactions) and expanded contactless capabilities like SmartPOS/SoftPOS. Critically, the platform's core evolution centers on simplifying integration of digital assets through its single-access-point model for APIs, directly supporting new business models in decentralized systems while maintaining security via tokenization and authentication innovations like Payment Passkey Service.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "MA (ORG) -> Mastercard Developer Platform (PRODUCT)",
        "Mastercard Developer Platform (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9205,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2961,
        "completion_tokens": 283,
        "total_tokens": 3244
      }
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "The company's investment in U.S. common stocks within its pension plans declined significantly from $1,834 million in 2022 to $1,360 million in 2024, reflecting a strategic shift toward a more diversified asset mix—evidenced by the rise in international common stocks (from $2 million to $20 million) and increased allocations to pooled funds, fixed‑income securities, and other fund categories—indicating a deliberate rebalancing to reduce concentration in U.S. equities and enhance broader risk‑adjusted returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> U.S. common stocks (FIN_INST)",
        "U.S. common stocks (FIN_INST) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2024.pdf",
          "page_id": "page_100",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5183,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1940,
        "completion_tokens": 128,
        "total_tokens": 2069
      }
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Disney's strategic focus on cruise ships evolved from a capital investment priority in 2022 to a risk-aware operational consideration in 2023, with significant capital allocation tied to cruise ship expansion (including new vessels like the Disney Wish) while simultaneously acknowledging heightened operational risks from external factors like travel disruptions and regulatory changes. The 2022 10-K explicitly identifies cruise ships as a key component of Parks & Experiences capital investments—funded through theme park/resort expansion budgets—and emphasizes that such investments depend on consumer acceptance of new offerings, whereas the 2023 10-K underscores that cruise operations face amplified risks from uncontrollable events (e.g., hurricanes, health crises, and shifting consumer preferences) that could directly impact profitability and require pausing operations, as seen with Hurricane Milton's closure of Walt Disney World Resort. This progression reflects a strategic shift from aggressive capital deployment toward managing volatility in cruise demand and supply chain dependencies, with both years confirming cruise ships' integration into DPEP's revenue streams (via merchandise, vacations, and licensing) and their vulnerability to macroeconomic and environmental disruptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Operates_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Cruise Ships (PRODUCT)",
        "Cruise Ships (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10941,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3374,
        "completion_tokens": 325,
        "total_tokens": 3700
      }
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard has consistently employed short duration foreign exchange derivative contracts as economic hedges to mitigate foreign exchange risk arising from daily settlement activities, where exposure typically spans only a few days between transaction and customer settlement. This practice, explicitly detailed in both 2022 and 2024 filings, involves entering into such contracts based on anticipated receipts and disbursements to offset currency fluctuations against functional currencies, with resulting gains and losses recorded in general and administrative expenses. The evolution reflects a sustained strategic focus on managing this specific, short-term FX risk through these targeted derivative instruments, as evidenced by their continued use in 2024 to address volatility from daily settlement cycles, while the broader hedging framework for net investment and fair value purposes (e.g., interest rate swaps, euro-denominated debt hedges) remained distinct and unchanged in its core purpose.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Uses]- ORG",
      "triplets_used": [
        "MA (ORG) -> Short Duration Foreign Exchange Derivative Contracts (FIN_INST)",
        "Short Duration Foreign Exchange Derivative Contracts (FIN_INST) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_106",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7805,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2622,
        "completion_tokens": 250,
        "total_tokens": 2872
      }
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce's strategic relationship with enterprise cloud companies has evolved from a focus on foundational investments to active ecosystem integration and AI-driven expansion. In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies through its CRM platform, emphasizing risk management and brand protection amid market volatility (Chunk 1), while 2024 demonstrates a shift toward deeper ecosystem utilization, including the launch of Agentforce AI agents and enhanced collaboration with ISVs and system integrators via the AppExchange marketplace (Chunk 2). This evolution reflects a strategic pivot from passive investment to active partnership, where Salesforce now leverages its platform to integrate third-party innovations—such as AI capabilities and industry-specific solutions—into its core offerings, thereby expanding its solution ecosystem and driving cross-selling opportunities with enterprise customers (Chunk 2). The company continues to prioritize these strategic investments as a growth lever, reinvesting proceeds from exits to further grow its portfolio while aligning with emerging technologies like AI (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "CRM (ORG) -> Enterprise Cloud Companies (COMP)",
        "Enterprise Cloud Companies (COMP) -> CRM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CRM_10k_2023.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CRM_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12605,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3796,
        "completion_tokens": 298,
        "total_tokens": 4095
      }
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "The company's approach to accrual rates for vendor funding programs maintained the same methodology between fiscal 2023 and fiscal 2024, continuing to base accrual rates on vendor agreement provisions and historical purchase trends, while explicitly acknowledging that actual results could differ from projected purchase volumes—particularly for programs with graduated funding tied to volume thresholds—as reflected in both the 2023 and 2024 disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Changes]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Accrual Rates (ACCOUNTING_POLICY)",
        "Accrual Rates (ACCOUNTING_POLICY) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10326,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3233,
        "completion_tokens": 113,
        "total_tokens": 3347
      }
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "From 2022 to 2024, the strategic partnership between LLY and Boehringer Ingelheim has deepened legal entanglement and increased collaborative reliance on Jardiance, particularly through regulatory and litigation developments. The 2022 U.S. patent litigation initiated by Boehringer Ingelheim against generic firms over Jardiance was stayed, but ongoing patent disputes involving other partners (e.g., Novartis/Taltz) reflect a broader pattern of legal vigilance that indirectly affects LLY’s ecosystem. Crucially, the Inflation Reduction Act (IRA) of 2022 directly impacts this relationship: in August 2023, HHS designated Jardiance—central to the LLY-BI collaboration—as one of the first ten drugs subject to government-set Medicare pricing starting in 2026, with an August 2024 announcement confirming a 66% discount off 2023 list prices. This regulatory shift, driven by the IRA’s pricing provisions, creates revenue pressure that directly affects both companies’ business models, as noted in LLY’s 2024 10-K, which explicitly links the IRA’s pricing mechanisms to “accelerating revenue erosion” and altered development strategies. Thus, the relationship has evolved from patent litigation to active regulatory interdependence, where Boehringer Ingelheim’s legal challenges and the IRA’s pricing mandates now jointly shape LLY’s commercial trajectory for Jardiance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Boehringer Ingelheim (COMP)",
        "Boehringer Ingelheim (COMP) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8577,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2793,
        "completion_tokens": 342,
        "total_tokens": 3135
      }
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "Disney's capital investment strategy toward cruise ships evolved significantly from 2022 to 2023 as part of its broader Parks & Experiences expansion, with direct financial ties to cruise operations explicitly documented in both annual filings. While Chunk 1 (2022) highlights economic pressures affecting investment decisions—including inflation and financing costs that could impact cruise-related capital allocation—the 2023 filing (Chunk 2) reveals concrete capital deployment: \"the majority of the Company's capital spend has been at our parks and experiences business, which is principally for... cruise ships\" alongside $2 billion in cruise ticket sales and ancillary revenue from merchandise, food, and beverage on ships (p. 12). This confirms cruise ships are now a strategic pillar within Experiences, directly contributing to revenue streams like merchandise licensing and retail that Chunk 1's broader economic discussion (e.g., \"increase our costs\" and \"shift in consumer demand\") would influence but not detail. Critically, Chunk 2's operational specifics—such as cruise ships being marketed through \"multi-year agreements\" with sponsors and integrated into resort facilities—demonstrate Disney's intentional capital commitment to this asset class, transforming it from a peripheral offering into a core revenue driver within the Experiences segment. Thus, the evolution reflects a deliberate shift from 2022's risk-aware investment context (Chunk 1) to 2023's active capital deployment with measurable financial returns, embedding cruise ships within Disney's Parks & Experiences growth engine.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "DIS (ORG) -> Cruise Ships (PRODUCT)",
        "Cruise Ships (PRODUCT) -> DIS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "DIS_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "DIS_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11460,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3503,
        "completion_tokens": 402,
        "total_tokens": 3905
      }
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Mastercard Foundry's role in fostering innovation has evolved from a conceptual innovation lab to a strategic engine driving blockchain integration and scalable fintech partnerships between 2022 and 2024. While Chunk 1 established its foundational work in 2021 with programs like Digital First Card and early blockchain/cryptocurrency initiatives, Chunk 2 demonstrates its 2024 maturation through concrete blockchain business model development using the Mastercard Multi-Token Network™ and expanded crypto engagement, explicitly building on its 2021 \"experimenting with future technologies\" mandate to now enable programmable payments and secure digital asset integration across the ecosystem. This progression is directly enabled by Mastercard Foundry's core function as the connective tissue (as shown in the KG pattern ORG → Product → Org) that links Mastercard's innovation strategy to emerging technology adoption and fintech collaboration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "MA (ORG) -> Mastercard Foundry (PRODUCT)",
        "Mastercard Foundry (PRODUCT) -> MA (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MA_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MA_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9205,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2947,
        "completion_tokens": 236,
        "total_tokens": 3183
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "The collaboration with Boehringer Ingelheim has evolved from early-stage regulatory designations to direct pricing impacts under U.S. law, as evidenced by the FDA's Breakthrough Therapy designation in 2022 (Chunk 1) and the IRA-mandated government-set pricing for Jardiance—a drug central to the partnership—subject to a 66% discount starting in 2026 (Chunk 2). This progression reflects a strategic shift from accelerating development via regulatory pathways to navigating aggressive U.S. pricing reforms that now directly target collaborative products, with IRA provisions like manufacturer rebates and potential penalties further reshaping the commercial landscape (Chunk 2). Consequently, while regulatory designations initially supported development momentum, the partnership now faces heightened pricing pressures from federal policies that specifically impact their jointly developed assets, signaling a transition from innovation-focused collaboration to cost-containment challenges affecting revenue trajectories (Chunks 1 and 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Boehringer Ingelheim (COMP)",
        "Boehringer Ingelheim (COMP) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6474,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2267,
        "completion_tokens": 259,
        "total_tokens": 2526
      }
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "The strategic positioning of the CH-53K King Stallion heavy lift helicopter within Lockheed Martin's Rotary and Mission Systems (RMS) segment has evolved from a growth pillar highlighted in both 2023 and 2024 disclosures to a core component of the company's 21st Century Security vision, with sustained investment in its development and production phases expected through 2026, as evidenced by its inclusion alongside Patriot PAC-3, HIMARS, GMLRS, and Trident II D5 modernization in RMS's growth portfolio, while the KG triplets confirm the reciprocal organizational relationship between LMT and the CH-53K platform, underscoring its strategic integration within RMS operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "LMT (ORG) -> CH-53K King Stallion Heavy Lift Helicopter (PRODUCT)",
        "CH-53K King Stallion Heavy Lift Helicopter (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11215,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3459,
        "completion_tokens": 169,
        "total_tokens": 3629
      }
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The shift in LLY's diabetes portfolio co-developed with Boehringer Ingelheim—from 2022's inclusion of Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, and Trijardy XR to 2024's focus on Jardiance, Glyxambi, Synjardy, and Trijardy XR—reflects a strategic pivot toward prioritizing high-impact, globally scalable diabetes products with strong reimbursement potential, particularly in markets where anti-obesity therapies face access barriers. This consolidation underscores a deliberate market focus on products aligned with evolving payer dynamics and competitive advantages in cost-effectiveness and patient access, as highlighted by LLY's emphasis on overcoming \"barriers to reimbursable patient access\" for next-generation therapies like anti-obesity medicines, which now represent a significant revenue stream but require strategic navigation of coverage limitations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Diabetes Products (PRODUCT)",
        "Diabetes Products (PRODUCT) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_7",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8483,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2770,
        "completion_tokens": 218,
        "total_tokens": 2989
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "The financial performance and strategic importance of the JASSM program evolved significantly between 2023 and 2024, with production activity directly driving backlog growth and revenue contributions. While JASSM was a key contributor to MFC's $1.4 billion (13%) net sales increase in 2024—specifically cited alongside GMLRS and LRASM as part of tactical and strike missile program ramp-ups—this growth occurred against a backdrop of substantial operating profit decline ($1.1 billion decrease, or 73%), primarily due to $1.2 billion in lower profit booking rate adjustments and $1.4 billion in losses on a classified program. Backlog increased in both years due to JASSM orders, with 2024's growth specifically attributed to higher orders on JASSM alongside PAC-3 and GMLRS, underscoring its sustained strategic importance despite mixed financial impacts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "LMT (ORG) -> JASSM (PRODUCT)",
        "JASSM (PRODUCT) -> LMT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LMT_10k_2023.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LMT_10k_2024.pdf",
          "page_id": "page_40",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3662,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 214,
        "total_tokens": 1770
      }
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPM's credit risk evaluation framework for Business Banking Loans has evolved from a broader consumer loan focus in 2023 to a more refined, indicator-driven approach in 2024 that emphasizes borrower distress signals. In 2023, the bank assessed risk through general loan classifications and delinquency trends, while 2024 explicitly integrates geographic distribution, LTV ratios, and refreshed FICO scores as key predictors of borrower distress—particularly for scored business banking loans—enabling earlier identification of at-risk borrowers through these combined metrics. This shift allows JPM to move beyond simple delinquency tracking to proactively assess credit quality using dynamic, risk-specific indicators tied to borrower behavior and collateral value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG",
      "triplets_used": [
        "JPM (ORG) -> Business Banking Loans (PRODUCT)",
        "Business Banking Loans (PRODUCT) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_242",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_250",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2917,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 191,
        "total_tokens": 1571
      }
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Target Corporation's executive compensation framework demonstrates a clear evolution in its long-term incentive plans across 2022 and 2023 filings, with SPP II transitioning from the 2016 Plan Statement to a 2022 Plan Statement effective May 1, 2022, as evidenced by its incorporation in both Chunk 1 (F*) and Chunk 2 (10.6*). This structural refinement—documented in the KG relationship TGT → SPP II → TGT—reflects a deliberate shift toward updated governance frameworks, while the concurrent introduction of the 2023 Officer EDCP (10.9*) and retention of legacy plans like SPP I (10.5*) and SPP III (10.7*) indicate a tiered approach to aligning executive incentives with strategic objectives. The progression from SPP II’s 2016 foundation to its 2022 restatement, alongside the 2023 EDCP update, suggests Target is systematically modernizing its compensation architecture to enhance flexibility, accountability, and alignment with shareholder interests, ultimately reinforcing a compensation philosophy that prioritizes long-term value creation over short-term gains.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "TGT (ORG) -> SPP II (FIN_INST)",
        "SPP II (FIN_INST) -> TGT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TGT_10k_2022.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TGT_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 16474,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4756,
        "completion_tokens": 267,
        "total_tokens": 5023
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "The financial obligations under the Incyte collaboration for Olumiant have evolved with significant milestone payments and future potential. As of 2022, Incyte was eligible for up to $100 million in additional success‑based regulatory milestones and another $100 million in sales‑based milestones, on top of the $260 million and $210 million milestones already capitalized in 2021 and 2020. By 2024, the collaboration remains governed by the same tiered royalty structure—up to 20 % on worldwide net sales, plus an additional low‑teens royalty on COVID‑19 sales that exceed a specified threshold—while the company continues to record royalty payments to Incyte as cost of sales and to capitalize any new success‑based milestones as intangible assets. Consequently, future milestone payments could still reach the full $200 million of potential regulatory and sales milestones, depending on regulatory approvals and sales performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Incyte (COMP)",
        "Incyte (COMP) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_73",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3391,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 233,
        "total_tokens": 1717
      }
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco's financial exposure in the APJC region increased from $5,360 million in fiscal 2022 to $5,382 million in fiscal 2023, reflecting a net growth of $22 million (approximately 0.4%) in segment assets, as shown by the APJC balance rising from $5,360 million to $5,382 million in the comparative segment‑balance table. This modest expansion aligns with the APJC geographic segment’s role in Cisco’s internal management reporting, where revenue is attributed based on the customer’s ordering location and the segment’s asset balance is tracked separately from other regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> APJC (GPE)",
        "APJC (GPE) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_105",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2324,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 143,
        "total_tokens": 1354
      }
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "The strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance has evolved significantly from 2022 to 2024 in direct response to regulatory changes, particularly the U.S. Inflation Reduction Act (IRA). As noted in Chunk 1, Jardiance (in collaboration with Boehringer Ingelheim) demonstrated strong revenue growth (30% in the U.S., 28% internationally) driven by increased demand and volume, establishing it as a key therapeutic asset. This momentum was directly impacted by the IRA, as detailed in Chunk 2: HHS selected Jardiance in August 2023 as one of the first ten drugs subject to government-set pricing, effective in 2026, with an announced 66% discount off the 2023 U.S. list price in August 2024. This regulatory shift, which applies to drugs approved under a New Drug Application after a nine-year exclusivity period, directly targets Jardiance within LLY's partnership framework (as reflected in the KG triplet \"LLY Partners_With Boehringer Ingelheim\" and \"Boehringer Ingelheim Depends_On LLY\"), fundamentally altering its revenue trajectory and compelling strategic adjustments to R&D and commercial planning ahead of the 2026 pricing implementation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "LLY (ORG) -> Boehringer Ingelheim (COMP)",
        "Boehringer Ingelheim (COMP) -> LLY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LLY_10k_2022.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LLY_10k_2024.pdf",
          "page_id": "page_45",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9048,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2904,
        "completion_tokens": 295,
        "total_tokens": 3200
      }
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "General Motors' focus on the financial and reputational risks of product safety recalls intensified between 2022 and 2023, particularly regarding global platforms like the Chevrolet Bolt EV and its broader EV/AV strategy. Both 2022 and 2023 SEC filings explicitly link product safety recalls to material adverse effects on business operations, reputation, brand equity, and consumer trust, with heightened emphasis on global platform vulnerabilities (e.g., Bolt EV recalls) and advanced technologies like AVs that amplify regulatory and safety scrutiny. The company underscores that concerns about product safety—whether from regulators, consumers, or internal reviews—can trigger delays, recalls, investigations, and significant financial liabilities, directly threatening its positioning in the EV/AV disruption, while also tying these risks to broader challenges in sourcing components and managing supplier-related recall costs across its global operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "GM (ORG) -> Product Safety Recalls (RISK_FACTOR)",
        "Product Safety Recalls (RISK_FACTOR) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2022.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12825,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3873,
        "completion_tokens": 240,
        "total_tokens": 4113
      }
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "The Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolved from approximately $500 in new issuances in November 2023 with maturities extending to 2033-2043, to a reduction of $77 in July 2024 through partial repayment, while the parent company simultaneously retired $1,000 of its 2.750% Senior Notes in May 2024 using cash and short-term investments. This pattern indicates a strategic shift toward optimizing the capital structure by reducing debt obligations through targeted repayments of both domestic and subsidiary-level debt, while maintaining long-term financing through structured note programs with staggered maturities that support Costco's global operations. The use of Level 3 valuations for the Japanese subsidiary's notes and Level 2 for parent debt underscores the complexity of their financing architecture, reflecting a deliberate approach to managing long-term liabilities across international entities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "COST (ORG) -> Guaranteed Senior Notes (FIN_INST)",
        "Guaranteed Senior Notes (FIN_INST) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5193,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1949,
        "completion_tokens": 234,
        "total_tokens": 2183
      }
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "Between 2022 and 2023, Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million to $9,865 million), representing a significant reduction in these holdings. This decline, combined with the $44 million decrease observed from 2021 to 2022 (as shown in Chunk 1), indicates a deliberate strategic shift toward reducing exposure to fixed-income securities, likely to reallocate capital toward other priorities such as cash reserves or equity investments, as evidenced by the $50 million increase in marketable equity securities in 2023. The consistent downward trend across both periods, supported by the KG relationship where Cisco (CSCO) holds and discloses these investments, suggests a conscious portfolio rebalancing rather than passive market-driven changes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reduces]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "CSCO (ORG) -> Available-for-sale debt investments (FIN_INST)",
        "Available-for-sale debt investments (FIN_INST) -> CSCO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CSCO_10k_2022.pdf",
          "page_id": "page_49",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CSCO_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1844,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 198,
        "total_tokens": 1310
      }
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "JPMorgan Chase's exposure to system damage risks has intensified from 2023 to 2024 due to heightened operational complexity and evolving cyber threats, particularly from third-party vendor attacks and data recovery challenges. While both 2023 and 2024 disclosures highlight similar risk categories—including third-party vendor vulnerabilities, ransomware, and data restoration delays—the 2024 filing explicitly emphasizes oversight of third-party vendors and early detection of attacks targeting them, reflecting a more acute focus on supply chain security amid rising incidents. This evolution underscores a deeper integration of vendor risk into JPMorgan's operational fabric, where failures in external systems now directly threaten its own infrastructure resilience, as evidenced by the KG pattern linking \"JPM\" to \"System Damage\" through \"Impacted_By\" and \"Negatively_Impacts\" relationships. Consequently, the company's exposure has not merely persisted but expanded in scope and sophistication, demanding more robust controls to mitigate cascading disruptions from vendor compromises.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "JPM (ORG) -> System Damage (RISK_FACTOR)",
        "System Damage (RISK_FACTOR) -> JPM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "JPM_10k_2023.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "JPM_10k_2024.pdf",
          "page_id": "page_27",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10332,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3228,
        "completion_tokens": 272,
        "total_tokens": 3501
      }
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco has invested in expanding its private-label manufacturing infrastructure, including the production of certain private-label items at its own processing, packaging, and manufacturing facilities, to support its private-label growth strategy by 2024. This operational investment aligns with its 2022 filing’s emphasis on increasing private-label penetration as a key driver of profitability and comparable sales growth, enabling greater control over pricing and margin management amid inflationary pressures. The KG pattern (COST → Private Label Items → COST) confirms this vertical integration, as Costco (COST) both produces and sells private-label items, directly supporting its strategy to leverage private-label growth for enhanced profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "COST (ORG) -> Private Label Items (PRODUCT)",
        "Private Label Items (PRODUCT) -> COST (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "COST_10k_2022.pdf",
          "page_id": "page_22",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "COST_10k_2024.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5775,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2077,
        "completion_tokens": 188,
        "total_tokens": 2265
      }
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "UnitedHealth Group's approach to Medicaid managed care contract bidding evolved significantly between 2022 and 2023, with heightened emphasis on bid accuracy assumptions and associated risks. In both years, bids were fundamentally based on assumptions regarding enrollment, utilization, medical costs, and other factors, but the 2023 filing explicitly highlighted that chronic failure to meet government benchmarks (such as Medicare Part D enrollee premium thresholds) could result in termination of government contracts, underscoring a critical escalation in risk. The company faced persistent pressures from funding volatility, including potential CMS benchmark reductions and recoupments from audits, which directly impacted bid accuracy requirements and necessitated intensified cost management strategies to mitigate adverse effects on results of operations, financial position, and cash flows across all regulatory engagements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_For]-> REGULATORY_REQUIREMENT <-[Bids_On]- ORG",
      "triplets_used": [
        "UNH (ORG) -> State Medicaid Managed Care Contracts (REGULATORY_REQUIREMENT)",
        "State Medicaid Managed Care Contracts (REGULATORY_REQUIREMENT) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_20",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12751,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3855,
        "completion_tokens": 233,
        "total_tokens": 4089
      }
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "MET's investment in Municipals declined from $13,737 million at the end of 2021 to $13,240 million by the end of 2022, reflecting a $497 million reduction in exposure over the two‑year period.  In the 2022 valuation hierarchy disclosed in the 2023 filing, all municipal securities were classified as Level 2 fair‑value measurements, with $159 million in Level 2 and $15 million in Level 3, confirming that the portfolio remained within the Level 2 classification rather than moving to Level 1 or Level 3.  This classification aligns with the KG pattern where ORG (MET) depends on FIN_INST (Municipals) and both entities disclose the fair‑value hierarchy, showing that MET’s municipal holdings continued to be reported as Level 2 assets through 2022‑2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Municipals (FIN_INST)",
        "Municipals (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 18967,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 5371,
        "completion_tokens": 188,
        "total_tokens": 5560
      }
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "Microsoft's approach to Office 365 subscriptions has evolved significantly from fiscal year 2022 to 2024, marked by a strategic shift toward greater licensing flexibility and diversified customer agreement models. By FY2024, Microsoft introduced the Microsoft Customer Agreement (MCA), a non-expiring digital framework designed to support customers over time through simplified, predictable purchasing options across all organization sizes—from small businesses using Microsoft Online Subscription Agreements for monthly/annual cloud subscriptions to large enterprises leveraging Enterprise Agreements for three-year, organization-wide licensing of both perpetual licenses (with optional SA) and cloud services. This evolution reflects a deliberate move away from rigid, one-size-fits-all licensing toward modular, usage-based models that accommodate varying customer needs, as evidenced by the introduction of specialized agreements like Open Value (for small/medium organizations with three-year terms) and Select Plus (for government/academic entities), while maintaining backward compatibility through existing frameworks like the Microsoft Products and Services Agreement for flexible perpetual or subscription licensing without organization-wide commitments. Crucially, this shift aligns with Microsoft’s broader financial strategy of generating recurring revenue through subscriptions, as highlighted by the FY2022 10-K’s emphasis on unearned revenue from volume licensing programs and Office 365 subscriptions being recognized ratably over contract periods, with the MCA and Online Subscription Agreements enabling more granular, scalable revenue recognition models that reduce upfront payment barriers and enhance customer retention through flexible payment terms (typically 30–60 days) and the elimination of financing incentives in favor of predictable, usage-aligned billing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Office 365 Subscriptions (PRODUCT)",
        "Office 365 Subscriptions (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8096,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2667,
        "completion_tokens": 471,
        "total_tokens": 3139
      }
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "The composition of MET's Level 3 Fixed Maturity Securities AFS shifted significantly between 2022 and 2023, with total Level 3 holdings increasing from $64 million to $64 million (stable) but the underlying mix changing: corporate bonds rose from $3 million to $3,029 million, foreign bonds grew from $2 million to $2 million (still small), and other securities such as short‑term investments and other investments expanded markedly, while the “Other (1)” category fell from $686 million to $699 million but remained a minor component. This reallocation—particularly the large increase in corporate and foreign bond positions and the emergence of substantial short‑term and other investment holdings—indicates that MET is moving toward a more diversified, higher‑yielding fixed‑income portfolio and is placing greater emphasis on longer‑duration and higher‑risk assets, reflecting a strategic shift to optimize returns amid changing interest‑rate and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Fixed Maturity Securities AFS (FIN_INST)",
        "Fixed Maturity Securities AFS (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_307",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11012,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3402,
        "completion_tokens": 242,
        "total_tokens": 3644
      }
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Microsoft's strategic positioning of Office 365 has evolved from a standalone productivity suite to a core component of its integrated cloud services portfolio, explicitly positioned as a platform-agnostic foundation for AI-driven offerings across diverse devices. The company actively infuses generative AI capabilities into Office 365 while maintaining its critical role within the broader cloud ecosystem (including Azure and Dynamics 365), directly responding to competitive pressures from AI-native rivals by investing heavily in AI infrastructure and platform-agnostic delivery to ensure utility, compatibility, and security across PCs, smartphones, and gaming consoles. This evolution reflects a deliberate shift toward cloud-based and AI services as central growth drivers, despite the significant operational costs and execution risks inherent in competing against both traditional software license models and advertising-funded open-source alternatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Office 365 (PRODUCT)",
        "Office 365 (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8411,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2757,
        "completion_tokens": 240,
        "total_tokens": 2998
      }
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "UnitedHealth Group's (UNH) evaluation methodology for credit-related impairments remained consistent between 2022 and 2023, continuing to assess available-for-sale debt securities for impairment by comparing the present value of expected cash flows to amortized cost, evaluating issuer credit quality and near-term prospects, and considering specific events affecting the issuer. While the 2022 filing (Chunk 1) noted no significant credit deterioration and deemed unrealized losses temporary due to interest rate-driven market conditions rather than credit issues, the 2023 filing (Chunk 2) expanded on the methodology by detailing the evaluation process for credit-related impairment, including the use of present value of cash flows, fair value versus amortized cost comparisons, and issuer financial condition analysis—though it did not explicitly quantify a change in impairment recognition between years. Both filings confirm that credit-related impairments were recorded as allowances against investment income, with non-credit impairments going to other comprehensive income, and emphasize that the Company actively manages portfolio exposure to limit issuer and sector concentration risks. The 2023 disclosure also clarified that the Company specifically identifies the cost of each investment sold to calculate realized gains/losses, reinforcing the structured approach to impairment assessment that persisted year-over-year without material change in methodology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Records]- ORG",
      "triplets_used": [
        "UNH (ORG) -> Credit-Related Impairment (RISK_FACTOR)",
        "Credit-Related Impairment (RISK_FACTOR) -> UNH (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNH_10k_2022.pdf",
          "page_id": "page_57",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNH_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7738,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2588,
        "completion_tokens": 368,
        "total_tokens": 2956
      }
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "The allocation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans shifted significantly from 2022 to 2023, with the target allocation for Fixed Maturity Securities AFS decreasing from 95% to 95% (stable) but the actual allocation in 2023 showing a notable increase in corporate bonds (from $3,029M to $3,083M) and U.S. government bonds (from $1,537M to $1,575M), while the total fair value of Fixed Maturity Securities AFS rose from $6,714M (2022) to $6,714M (2023) in the pension plan and from $1,274M to $1,334M in other postretirement benefits, reflecting a strategic reallocation toward higher-yielding corporate and government securities within the AFS portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Fixed Maturity Securities AFS (FIN_INST)",
        "Fixed Maturity Securities AFS (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_305",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7540,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2530,
        "completion_tokens": 176,
        "total_tokens": 2706
      }
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Lowe's strategic positioning of the Kitchens & Bath category evolved from being grouped under the broader Home Décor segment in 2022 (as noted in Chunk 1's merchandising breakdown) to being explicitly highlighted as a core category within its full product assortment strategy in 2023 (Chunk 2), reflecting its growing importance in the company's portfolio. This progression is underscored by the company's expanded focus on omnichannel capabilities and supply chain investments specifically supporting big and bulky items like Kitchens & Bath (Chunk 2), while its reclassification of merchandise divisions (Chunk 1) demonstrates a deliberate effort to align product categorization with strategic priorities—evidenced by the inclusion of Kitchens & Bath in the \"Product Selection\" section alongside other key categories like Appliances and Flooring, and its emphasis on private brands and national brands like Klein Tools to strengthen this segment's offering. Consequently, Kitchens & Bath transitioned from a sub-category within Home Décor to a strategically emphasized pillar of Lowe's product portfolio, directly contributing to its Total Home strategy and omnichannel execution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG",
      "triplets_used": [
        "LOW (ORG) -> Kitchens & Bath (PRODUCT)",
        "Kitchens & Bath (PRODUCT) -> LOW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "LOW_10k_2022.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "LOW_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5531,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2030,
        "completion_tokens": 295,
        "total_tokens": 2326
      }
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International's strategic focus on Cheese & Grocery has evolved from a $1,990 million revenue contributor in 2021 (across Latin America, AMEA, Europe, and North America) to a stabilized but non-growing segment, as evidenced by its absence from the 2024 strategic priorities discussion and the company's narrowed focus on core snack categories (chocolate, biscuits, and baked snacks) amid macroeconomic volatility. This shift—highlighted by the 2024 document's emphasis on \"adjacent, locally relevant categories\" like cheese & grocery while explicitly prioritizing \"snacking\" growth through iconic brands and operational excellence—suggests Mondelez is deprioritizing Cheese & Grocery to concentrate resources on higher-growth, globally scalable snack categories, using its core snacking footprint and brand portfolio to drive long-term sustainable growth rather than expanding into adjacent grocery segments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Cheese & Grocery (PRODUCT)",
        "Cheese & Grocery (PRODUCT) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_136",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6866,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2365,
        "completion_tokens": 229,
        "total_tokens": 2594
      }
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, underwent a strategic shift between the 2022 and 2023 10-K filings. In the 2022 filing (Chunk 1), Jevity was explicitly listed within the Nutritional Products segment's enteral feeding products alongside Freego™ (Enteral Pump) and Freego™ sets, indicating they were presented as distinct but complementary product lines. By the 2023 filing (Chunk 2), the language consolidated Jevity under enteral feeding products but omitted explicit mention of Freego™ products in the principal products list, despite retaining Freego™ in the segment description. This repositioning reflects a deliberate emphasis on Jevity as a standalone flagship enteral product while integrating Freego™ into broader operational references without direct comparative emphasis. The KG triplets confirm Jevity (PRODUCT) is produced by ABT (ORG) and Freego™ (PRODUCT) is also produced by ABT (ORG), establishing their shared corporate origin but highlighting the evolving market presentation between filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Jevity (PRODUCT)",
        "Jevity (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_3",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10645,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3301,
        "completion_tokens": 277,
        "total_tokens": 3578
      }
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "MET's investment in municipals increased from $11,761 million in amortized cost at the end of 2022 to $10,982 million in 2023, with gross unrealized gains rising from $2,746 million to $2,464 million and unrealized losses declining from 6 million to 13 million, reflecting a shift toward higher‑rated, lower‑risk securities; the 2023 fair‑value hierarchy places municipals almost entirely in Level 2 (159 million) and Level 3 (0 million) with a total estimated fair value of $159 million, indicating that the company is managing credit risk by reducing exposure to lower‑rated municipal credits and emphasizing higher‑quality, more liquid municipal assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MET (ORG) -> Municipals (FIN_INST)",
        "Municipals (FIN_INST) -> MET (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MET_10k_2022.pdf",
          "page_id": "page_219",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MET_10k_2023.pdf",
          "page_id": "page_308",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9299,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2969,
        "completion_tokens": 164,
        "total_tokens": 3133
      }
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Abbott's interest rate hedge contracts remained designated for managing fixed-rate debt exposure, with notional value held constant at approximately $2.2 billion at the end of 2023 (the same level implied for 2022), and these fair‑value hedges converted portions of fixed‑rate obligations to variable rates, thereby mitigating interest‑rate risk on that debt. The company also continued to use foreign‑currency forward contracts—totaling $13.8 billion in gross notional at year‑end 2023—to hedge both cash‑flow and net‑investment exposures, while maintaining its interest‑rate hedges as a separate mechanism for fixed‑rate debt management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Interest Rate Hedge Contracts (FIN_INST)",
        "Interest Rate Hedge Contracts (FIN_INST) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_64",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5436,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2010,
        "completion_tokens": 159,
        "total_tokens": 2169
      }
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M’s fixed‑rate registered notes strategy combined continued issuance with active repayment and interest‑rate hedging. 3M issued new fixed‑rate registered notes in 2022 (e.g., $1.1 bn of medium‑term notes that matured in 2024) and, after the 2021 interest‑rate swaps that converted portions of its 2049 and 2050 notes to floating rates, it further hedged $500 m and $300 m of those issues through swaps tied to LIBOR/SOFR through mid‑2028.  Repayment activity included the 2022 maturity and redemption of $600 m of euro‑denominated fixed‑rate medium‑term notes, the 2023 redemption of $500 m of fixed‑rate registered notes and $650 m of fixed‑rate medium‑term notes, and the 2024 repayment of $1.1 bn of medium‑term notes that matured, while the 2021‑2022 make‑whole‑call redemptions of $450 m of 2.75 % notes due 2022 and $1 bn of notes due 2021 generated early‑extinguishment charges of roughly $10‑11 m each.  Thus, 3M’s fixed‑rate registered notes program evolved from a pattern of periodic issuances (2019‑2021) to a strategy of managing maturities and interest‑rate exposure through swaps and targeted redemptions, ensuring liquidity while maintaining a stable funding profile across the 2022‑2024 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Decreases]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Fixed Rate Registered Notes (FIN_INST)",
        "Fixed Rate Registered Notes (FIN_INST) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2022.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8588,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2794,
        "completion_tokens": 308,
        "total_tokens": 3103
      }
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "The role of securities issuances in Schwab's capital structure has evolved as a more targeted, strategic source of funding rather than a primary driver of capital growth between 2023 and 2024. While Schwab's primary capital sources remain operational cash flows from subsidiaries and securities issuances in the capital markets (as noted in Chunk 1's capital management discussion), the 2024 filing (Chunk 2) reveals a shift toward using external financing more selectively to support liquidity needs and regulatory capital requirements, with less emphasis on large-scale issuances compared to prior periods. This reflects a capital management strategy focused on maintaining regulatory buffers (e.g., Tier 1 Leverage Ratio minimums of 4% for CSC and 5% for CSB) while returning excess capital to shareholders through dividends and share repurchases, rather than expanding the capital structure through frequent securities issuances.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sources_Capital_From]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> Securities Issuances (FIN_INST)",
        "Securities Issuances (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_59",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_52",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11070,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3420,
        "completion_tokens": 233,
        "total_tokens": 3654
      }
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife, initially estimated at $270 million in 2020, were remeasured quarterly and resulted in charges of $369 million in 2021 and $51 million in 2020 due to fairvalue adjustments, with a $100 million milestone payment made in 2021 upon fairlife meeting 2020 financial targets. The 2024 chunk confirms the remaining milestone payment tied to 2024–2025 targets is still outstanding, indicating fairlife has not yet achieved all required financial goals to trigger the final payments. This ongoing contingent liability remeasurement and lack of full milestone realization demonstrate that fairlife's performance against its financial targets remains incomplete, with future obligations contingent on achieving specified results through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> fairlife (COMP)",
        "fairlife (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_75",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7557,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2529,
        "completion_tokens": 198,
        "total_tokens": 2727
      }
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) has evolved from a nascent offering in 2022 to a core growth driver by 2024, as evidenced by its integration into enterprise IT solutions and measurable market traction. In 2022, OCI contributed to the \"Cloud and license\" segment's 85% revenue share (up from 84% in 2021), with operating margin declining to 26% (from 38% in 2021) due to heavy investment, while 2024 filings highlight OCI's role in enabling hybrid cloud deployments—combining on-premise, cloud, and SaaS models—to address enterprise IT needs through interoperable infrastructure services. This strategic pivot is underscored by OCI's positioning as a critical enabler for customers seeking flexible, integrated solutions, directly tying its growth to Oracle's broader enterprise IT ecosystem and global market expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud Infrastructure (PRODUCT)",
        "Oracle Cloud Infrastructure (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9000,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2906,
        "completion_tokens": 213,
        "total_tokens": 3119
      }
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Between 2023 and 2024, the treatment and risk profile of Principal Account Loans (PALs) evolved significantly, particularly regarding credit loss allowance and collateralization. As noted in Chunk 1, the allowance for credit losses on PALs decreased due to lower projected loss rates and improved credit quality metrics in the bank loan portfolio, reflecting reduced risk in recent periods. This trend continued into 2024, as stated in Chunk 2, where substantially all PALs are now subject to the collateral maintenance practical expedient under ASC 326, are fully collateralized by securities exceeding borrowings in fair value, and therefore required no allowance for credit losses as of December 31, 2024 and 2023. The structural relationship between SCHW (ORG) and PALs (FIN_INST), as captured by the KG triplet pattern ORG -[Increases]-> FIN_INST <-[Depends_On]- ORG, underscores SCHW’s active role in growing and securing PALs, reinforcing their lower risk profile through collateralization and regulatory alignment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> FIN_INST <-[Depends_On]- ORG",
      "triplets_used": [
        "SCHW (ORG) -> PALs (FIN_INST)",
        "PALs (FIN_INST) -> SCHW (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "SCHW_10k_2023.pdf",
          "page_id": "page_146",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "SCHW_10k_2024.pdf",
          "page_id": "page_88",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1519,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1011,
        "completion_tokens": 255,
        "total_tokens": 1267
      }
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Nike's relationship with the Asia Pacific & Latin America (APLA) region has evolved from a distinct geographic operating segment under its global brand structure to a more integrated yet strategically significant unit within the Nike Brand divisions, as evidenced by its inclusion in the reportable segments alongside North America, Europe/Middle East & Africa, and Greater China in the 2024 Form 10-K (Note 15). While APLA's specific financial metrics are not isolated in the provided disclosures, its operational role is defined within the geographic segmentation framework where it participates in Nike Brand sales activity, including transitions of certain businesses to third-party distributors (Note 18), and its performance is evaluated using the same EBIT metric as other regions, reflecting its integration into Nike's global operational structure. This evolution underscores a strategic emphasis on APLA as a key growth market within Nike's global footprint, particularly as the company continues to manage its global brand divisions and corporate functions to support regional innovation and market-specific initiatives, aligning with its broader mission of \"bringing inspiration and innovation to every athlete in the world\" through localized engagement and community investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> APLA (GPE)",
        "APLA (GPE) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9286,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2961,
        "completion_tokens": 322,
        "total_tokens": 3284
      }
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Abbott's strategic emphasis on Pedialyte evolved significantly between 2022 and 2023, with the company expanding its U.S. Pediatric Nutritional business through targeted product portfolio enhancements. In 2021, Pedialyte contributed to a 10.3% sales increase in the U.S. Pediatric Nutritional segment, and by 2023, it was positioned alongside other key brands like Similac and PediaSure within Abbott's broader nutritional portfolio, which included pediatric and adult formulations such as Ensure and Glucerna. The 2023 10-K filing explicitly lists Pedialyte among the principal products in the Nutritional Products segment, highlighting its role in Abbott's strategy to grow pediatric nutritional offerings through direct-to-consumer and institutional marketing, while also expanding its product range to include specialized formulations like Pedialyte SideKicks and Pedialyte Peptide to meet diverse clinical and consumer needs. This expansion reflects a deliberate focus on strengthening Abbott's position in the pediatric nutritional space, leveraging Pedialyte's established market presence to drive growth alongside other core brands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ABT (ORG) -> Pedialyte (PRODUCT)",
        "Pedialyte (PRODUCT) -> ABT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ABT_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ABT_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7632,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2552,
        "completion_tokens": 285,
        "total_tokens": 2837
      }
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX's 7.100% notes due 2027 maintained a consistent aggregate principal balance of $135 million in both 2022 and 2023, indicating stable debt levels for this specific tranche during the period. This consistency, alongside the disclosed repayment of $1,100 million in 2.800% and $2.500% notes due 2022 (as shown in Chunk 1's 2021 repayment data), demonstrates a strategic debt management approach focused on retiring higher-cost near-term obligations while preserving targeted long-term financing structures like the 7.100% notes due 2027.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 7.100% notes due 2027 (FIN_INST)",
        "7.100% notes due 2027 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3585,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 134,
        "total_tokens": 1673
      }
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Nike's relationship with Converse has deteriorated in revenue performance between fiscal 2023 and 2024, with Converse revenues declining 15% on a currency-neutral basis (Chunk 1), driven by a 16% drop in wholesale and 14% decline in direct-to-consumer sales, while reported EBIT fell 30% due to margin contraction and lower revenues (Chunk 1). Strategically, Nike maintains full ownership and operational control over Converse as evidenced by its standalone reporting in the 10-K (Chunk 2), yet this relationship now reflects a strategic shift toward prioritizing Nike Brand growth over Converse's performance, as seen in the 130-basis-point gross margin contraction attributed to unfavorable exchange rates and lower ASPs (Chunk 1), despite Converse's historical role as a wholly-owned subsidiary brand under Nike's portfolio (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Converse (COMP)",
        "Converse (COMP) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6206,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2181,
        "completion_tokens": 209,
        "total_tokens": 2391
      }
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "Coca-Cola's financial risk assessment regarding digital evolution has shifted significantly from 2022 to 2024, with the 2024 filing explicitly linking digital transformation to margin improvement and sales growth as direct financial imperatives—unlike the 2022 version, which only mentioned digital channels as a general risk factor without connecting it to financial outcomes. The 2024 assessment states that failure to successfully digitalize the Coca-Cola system would \"negatively affect our ability to increase sales and improve margins,\" directly tying digital execution to both revenue growth and margin expansion, while also noting that digitalization costs could \"adversely impact our financial performance,\" creating a new layer of financial risk assessment around digital investment ROI. Crucially, the 2024 document connects digital evolution to consumer behavior shifts (\"shopping patterns are being affected by the digital evolution\") that directly threaten market share and revenue, making digital capability a strategic necessity for sustaining the sales growth and margin improvement the company now explicitly targets—demonstrating a clear evolution from passive risk acknowledgment in 2022 to active financial dependency on digital success by 2024, as evidenced by the KG triplet relationship where Digital Evolution (MACRO_CONDITION) now directly impacts KO's financial outcomes through the pathway of sales and margin performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> MACRO_CONDITION <-[Depends_On]- ORG",
      "triplets_used": [
        "KO (ORG) -> Digital Evolution (MACRO_CONDITION)",
        "Digital Evolution (MACRO_CONDITION) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_19",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13142,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3937,
        "completion_tokens": 362,
        "total_tokens": 4300
      }
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Services has evolved from fiscal 2022 to 2024 through increased R&D investment ($7.2B in 2022, up from $6.5B in 2021 and $6.1B in 2020) focused on enhancing cloud-integrated applications and infrastructure, while explicitly positioning these offerings as superior to on-premise solutions through greater flexibility, interoperability, and reduced customer investment requirements; this strategic shift is reinforced by the company's consistent messaging across both 2022 and 2024 disclosures about prioritizing cloud-based innovation and deployment models as central to growth, with fiscal 2024 documentation further emphasizing Oracle Cloud Services' role in enabling customers to leverage integrated SaaS and infrastructure services via cloud deployment, directly building on the foundational strategy described in the 2022 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud Services (PRODUCT)",
        "Oracle Cloud Services (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9682,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3080,
        "completion_tokens": 219,
        "total_tokens": 3300
      }
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors' Formula Stock Award Plan has undergone a definitive transition in share availability between 2023 and 2024, with no future awards or deferrals permitted under the plan. According to the 2023 filing (Chunk 1), the plan allowed directors to defer receipt of stock awards with dividends reinvested, but explicitly stated \"No future stock awards or deferrals may be made under this plan\" (Chunk 1). This is confirmed in the 2024 filing (Chunk 2), which specifies that the plan contributes only 391 shares issuable upon distribution of deferred compensation benefits, reflecting shares previously allocated but not newly authorized. The plan's discontinuation is further contextualized by its classification as a \"Plan not approved by security holders\" in the 2024 filing (Chunk 2, point 5), where it is noted that no future awards will be made, and existing shares are limited to those already credited to participant accounts. Thus, the status of shares under this plan has evolved from active issuance in 2023 to complete cessation of new awards, with only a minimal, exhausted share reserve (391 shares) remaining for distribution in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "WFC (ORG) -> Norwest Corporation Directors' Formula Stock Award Plan (ACCOUNTING_POLICY)",
        "Norwest Corporation Directors' Formula Stock Award Plan (ACCOUNTING_POLICY) -> WFC (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "WFC_10k_2023.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "WFC_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7007,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2414,
        "completion_tokens": 293,
        "total_tokens": 2707
      }
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald's disclosure on food safety concerns shifted from isolated mentions of brand reputation risks in 2022 to explicit linkage with supply chain volatility and commodity cost pressures in 2023. While the 2022 filing highlighted food safety as a standalone reputational risk requiring substantial resource investment to prevent brand damage from contamination or tampering, the 2023 filing integrated food safety concerns within broader commodity market volatility, specifically citing climate conditions, international market fluctuations, and government regulations as drivers of price instability that could disrupt supply chains and elevate costs. This evolution reflects a strategic expansion of the risk narrative: rather than treating food safety in isolation, McDonald's now positions it as one interdependent factor among many (including labor costs and commodity volatility) that collectively threaten operational resilience, with the 2023 disclosure emphasizing how supply chain disruptions directly impact profitability through both cost inflation and heightened safety compliance demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Food Safety Concerns (RISK_FACTOR)",
        "Food Safety Concerns (RISK_FACTOR) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13898,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4120,
        "completion_tokens": 281,
        "total_tokens": 4402
      }
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "Based on the comparative data across both filings, TMO's 1.750% 7-Year Senior Notes due 10/15/2028 maintained its **carrying value of $700 million** throughout both periods, with the **effective interest rate remaining fixed at 1.89%** as reported in both the 2023 and 2024 filings. The notes were issued in 2021 (implied by the 7-year maturity from issuance) and continued to accrue interest at the original contractual rate without modification, reflecting standard debt accounting where the effective interest rate remains constant over the instrument's life unless remeasured. This consistency aligns with the KG relationship where the financial instrument maintains its original terms across reporting periods, with no indicated changes to either the carrying amount or the underlying interest rate structure between December 31, 2023 and December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG",
      "triplets_used": [
        "TMO (ORG) -> 1.750% 7-Year Senior Notes (FIN_INST)",
        "1.750% 7-Year Senior Notes (FIN_INST) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14990,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4380,
        "completion_tokens": 215,
        "total_tokens": 4596
      }
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged at $148 million in both 2023 and 2022, as shown in the comparative tables of both filings. This stability in the specific tranche's balance—despite a significant increase in total long-term debt from $31,249 million (2022) to $43,638 million (2023)—suggests RTX is managing long-term debt maturities by maintaining targeted exposure to specific tranches while aggressively expanding overall debt capacity through new issuances across a broader range of maturities and interest rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "RTX (ORG) -> 7.000% notes due 2038 (FIN_INST)",
        "7.000% notes due 2038 (FIN_INST) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_94",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_85",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5116,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1924,
        "completion_tokens": 136,
        "total_tokens": 2060
      }
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees underwent a significant shift in rent and royalty collection dynamics. While Chunk 1 reveals that in 2020 the Company implemented widespread deferrals of approximately $1 billion in cash rent and royalty payments from franchisees due to COVID-19 impacts—payments that were largely collected by December 31, 2021—Chunk 2 indicates that by 2023, the Company had fully transitioned to operating under its standard franchise model where restaurants are operated by franchisees under conventional franchise arrangements, with rent and royalties structured as a percent of sales. This evolution reflects a return to normalized financial operations post-pandemic, with future gross minimum rent payments under existing conventional franchise agreements now forming the baseline for ongoing revenue collection, as evidenced by the detailed restaurant information by ownership type presented in the 2023 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_5",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1118,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 913,
        "completion_tokens": 245,
        "total_tokens": 1158
      }
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "From 2022 to 2024, The Coca-Cola Company's financial stake in Embotelladora Andina S.A. has been reduced through divestitures, as indicated by the KG pattern **ORG -[Divests]-> COMP** and the explicit mention in Chunk 1 that the company \"continues to account for our remaining ownership interest in Andina as an equity method investment\" following prior sales of portions of its stake. The 2024 data in Chunk 2 confirms this evolution, showing Embotelladora Andina S.A.'s fair value ($168 million) and carrying value ($90 million), reflecting a smaller remaining equity position compared to prior years. This strategic reduction—evidenced by the disposal of ownership interests in 2019 and continued partial exits—demonstrates a deliberate shift toward optimizing its bottling portfolio, likely to focus on higher-margin partnerships or refranchising initiatives, while retaining a minority equity stake to preserve governance influence and strategic alignment with key bottling operations in South America.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Divests]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "KO (ORG) -> Embotelladora Andina S.A. (COMP)",
        "Embotelladora Andina S.A. (COMP) -> KO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "KO_10k_2022.pdf",
          "page_id": "page_76",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "KO_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_6",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5466,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2021,
        "completion_tokens": 251,
        "total_tokens": 2273
      }
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle's strategic investment in cloud infrastructure has evolved from 2022 to 2024 through a deliberate expansion of its Oracle Cloud Infrastructure (OCI) offerings within the product portfolio, as evidenced by its 2022 10-K highlighting dedicated R&D resources and workforce investment to maintain technical control over development, and its 2024 10-K explicitly positioning OCI as a core component of its \"flexible and interoperable IT deployment models\" alongside SaaS, with the company emphasizing its comprehensive integration of applications and infrastructure services to meet enterprise IT needs. This evolution reflects a strategic shift from internal development focus (noted in 2022's R&D emphasis) to a more defined, portfolio-centric approach where OCI is presented as a distinct, value-driven offering—directly connected via the KG pattern ORCL → [Produces] → OCI ←[Introduces]→ ORCL—demonstrating how Oracle has systematically elevated OCI from an internal project to a central, revenue-generating product line within its broader cloud strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Oracle Cloud Infrastructure (PRODUCT)",
        "Oracle Cloud Infrastructure (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6398,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2259,
        "completion_tokens": 265,
        "total_tokens": 2524
      }
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "Between 2023 and 2024, TMO's integration of The Binding Site Group solidified its strategic expansion into specialty diagnostics, particularly in oncology and hematology, as evidenced by its acquisition within the Specialty Diagnostics segment in January 2023 and subsequent operational focus on leveraging this capability for innovation in blood cancer diagnostics. This acquisition, alongside the 2023 purchase of CorEvitas, underscored TMO's post-acquisition strategy of broadening its diagnostic portfolio with high-value, niche technologies to enhance its competitive edge in clinical testing and data-driven solutions. The company's continued investment in capacity (e.g., $1.3–$1.5 billion capital expenditure for 2024) and active capital allocation—such as $3 billion in stock repurchases in early 2024—reflects a strategic emphasis on scaling integrated diagnostic offerings while optimizing financial performance through non-GAAP metrics like organic revenue growth, which excludes acquisition impacts to isolate core operational trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "TMO (ORG) -> The Binding Site Group (COMP)",
        "The Binding Site Group (COMP) -> TMO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "TMO_10k_2023.pdf",
          "page_id": "page_24",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "TMO_10k_2024.pdf",
          "page_id": "page_65",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6525,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2277,
        "completion_tokens": 261,
        "total_tokens": 2539
      }
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the disclosure of BNY Mellon's Directors' Code of Conduct evolved in terms of website accessibility and scope, as reflected in the 10-K filings and KG relationships. In 2022 (Chunk 1), the Directors' Code of Conduct was explicitly described as applying to \"all directors of BNY Mellon\" and was accessible via a dedicated URL on the company's website, with plans to disclose amendments or waivers related to directors. By 2024 (Chunk 2), the scope was updated to apply to \"all directors of BNY\" (reflecting the parent entity name), and the website link was refined to a more specific path under investor relations, while maintaining the same disclosure intent regarding amendments and waivers. The KG pattern confirms this continuity through the ORG-BK's Subject_To relationship with the ACCOUNTING_POLICY (Directors' Code of Conduct), ensuring that all iterations of the code across years are governed by the same disclosure framework, with the 2024 filing refining the website reference and entity naming without altering the core scope or governance intent.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "BK (ORG) -> Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5015,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1908,
        "completion_tokens": 270,
        "total_tokens": 2178
      }
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial reporting relationship with franchisees remained structured around distinct ownership models—company-operated restaurants and franchised locations—without material consolidation of franchisee entities, as noted in both 2022 and 2023 10-K filings where franchisee-operated restaurants' results were not material to consolidated statements. The company maintained its focus on strategic emphasis through detailed accounting disclosures, including variable interest entity evaluations and franchisee-related accounting policies, while continuing to report franchisee financials separately under distinct operational segments rather than integrating them into consolidated results. This consistent approach reflects an ongoing strategic emphasis on franchisee independence within the financial reporting framework, even as regulatory updates like lease accounting (ASU 2021-05) and tax reforms were adopted without altering the fundamental franchisee-company financial separation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MCD (ORG) -> Franchisees (COMP)",
        "Franchisees (COMP) -> MCD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MCD_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MCD_10k_2023.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4296,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1703,
        "completion_tokens": 255,
        "total_tokens": 1958
      }
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "Based on the provided information, the accounting treatment for contingent consideration liabilities related to the Clif Bar acquisition evolved in 2023 and 2024 as follows:  \n\nThe contingent consideration liabilities were initially measured at fair value using a Monte Carlo simulation (Level 3 inputs) at acquisition, with $548 million classified as long-term liabilities and $132 million as current liabilities at December 31, 2023 (per Chunk 1). Subsequent fair value adjustments were recorded in selling, general, and administrative expenses within the consolidated statement of earnings, reflecting ongoing reassessments of forecasted revenue, gross profit, EBITDA targets, discount rates, and volatility assumptions (Chunk 1).  \n\nWhile Chunk 2 references purchase price allocation adjustments for Clif Bar during 2023 and 2024, it does not specify the impact on contingent consideration liabilities; however, the KG triplet relationship (MDLZ → Clif Bar) confirms the acquisition context, and the 2024 reference to \"purchase price allocation adjustments\" implies ongoing refinement of the liability measurements tied to the original contingent consideration framework established in 2023. Thus, the evolution reflects iterative fair value updates driven by updated projections and market inputs, with adjustments consistently impacting SG&A expenses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Clif Bar (COMP)",
        "Clif Bar (COMP) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_99",
          "chunk_id": "chunk_7",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2409,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 339,
        "total_tokens": 1595
      }
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "AMD's strategic emphasis on Vulkan API support has evolved from foundational integration in 2022 to active co-development and ecosystem enablement by 2024, as evidenced by its role as a primary beneficiary of Vulkan in the KG triplets (AMD → Vulkan) and the 2024 disclosure of Vulkan support in current-generation RDNA 3 architecture (Chunk 2). This progression reflects AMD's deliberate effort to maintain competitiveness in the discrete GPU market by deeply embedding Vulkan’s cross-platform capabilities—such as variable rate shading and ray tracing—into its RDNA 2 and RDNA 3 architectures (Chunk 1), while simultaneously advancing FidelityFX Super Resolution and Radeon Software to optimize Vulkan-driven performance and developer adoption (Chunk 1). By aligning Vulkan support with broader ecosystem initiatives like the AMD Advantage Design Framework and professional-grade Radeon PRO drivers, AMD ensures its discrete GPUs remain relevant across gaming, professional workloads, and semi-custom platforms (e.g., PlayStation 5 Pro), demonstrating a sustained focus on API-driven innovation to counter NVIDIA’s dominance and secure market share through software-hardware synergy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Features]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Vulkan (PRODUCT)",
        "Vulkan (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10422,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3246,
        "completion_tokens": 296,
        "total_tokens": 3542
      }
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX's operating profit declined by $1.9 billion in 2023 versus 2022, a drop primarily driven by the $2.9 billion Powder Metal Matter charge and related acquisition accounting adjustments disclosed in the 2023 filing, while the 2022‑2021 profit increase of $0.4 billion was attributed to lower acquisition accounting adjustments and improved segment performance. The disclosed acquisition accounting adjustments of $(2,203) million in 2022 and $(5,100) million in 2021 illustrate how these charges have progressively reduced operating profit, culminating in the substantial 2023 impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Decreases]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Acquisition Accounting Adjustments (ACCOUNTING_POLICY)",
        "Acquisition Accounting Adjustments (ACCOUNTING_POLICY) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2022.pdf",
          "page_id": "page_51",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_7",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 1932,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 146,
        "total_tokens": 1289
      }
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "Based on the provided SEC filings and KG relationships, MDLZ's relationship with Clif Bar evolved significantly between 2023 and 2024 primarily through acquisition-related financial activities. In 2023, MDLZ acquired Clif Bar (noted in Chunk 1 as an August 1, 2022 acquisition), and by 2024, MDLZ was adjusting the purchase price allocation for Clif Bar during 2023 (Chunk 2), indicating ongoing integration and valuation refinements. The 2023 acquisition contributed to increased selling, general, and administrative expenses ($618 million increase, partially driven by acquisition integration costs and contingent consideration adjustments per Chunk 1), while the 2024 adjustments reflect continued financial impact and oversight of this relationship. This evolution demonstrates how MDLZ's post-acquisition integration of Clif Bar directly influenced its 2023 financial performance and ongoing 2024 accounting practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Introduces]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Clif Bar (COMP)",
        "Clif Bar (COMP) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_41",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4963,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1870,
        "completion_tokens": 230,
        "total_tokens": 2101
      }
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "Gulfstream's approach to energy efficient engines has evolved from emphasizing R&D investment in sustainable aviation fuel (SAF) and energy efficient engines in 2023 to advancing specific aircraft developments with new engine technologies in 2024, including the G700's \"superior high-speed performance of all-new engines\" and the G800's introduction as part of a \"nearly two decade effort\" to develop all-new aircraft families. This shift is reflected in the G700's recent FAA certification (March 2024) as the \"ultra-long-range, ultra-large-cabin\" aircraft featuring \"advanced Sym metry Flight Deck\" and \"all-new engines,\" while the G800 and G400 (introduced in 2021) complete the new family lineup that \"consistently broaden customer offerings while raising the bar for safety and performance.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "GD (ORG) -> Energy Efficient Engines (PRODUCT)",
        "Energy Efficient Engines (PRODUCT) -> GD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GD_10k_2023.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GD_10k_2024.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4121,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1669,
        "completion_tokens": 199,
        "total_tokens": 1868
      }
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 to 2024, AMD's semi-custom SoC revenue structure evolved from a model heavily reliant on non-recurring engineering fees and customer-specific design wins (as noted in Chunk 1's disclosure that \"revenue from our semi-custom SoC products is dependent upon... being incorporated into customers' products\") toward a more integrated, product-cycle-driven revenue stream reflected in its 2024 portfolio expansion (Chunk 2's listing of \"semi-custom System-on-Chip (SoC) products\" among core offerings). This strategic shift is underscored by AMD's 2024 emphasis on semi-custom SoCs as key components within its broader product ecosystem—including AI accelerators, EPYC processors, and adaptive SoCs—indicating a move to embed these custom designs into high-growth markets like data center and AI, where revenue is now tied to the success of third-party customers' platform launches rather than direct sales control (Chunk 2's revenue recognition notes that \"revenue... is deriv ed from product sales\" and that semi-custom revenue \"is directly related to sales of the third-party's products\"). Consequently, AMD's 2024 positioning emphasizes securing long-term design wins in semi-custom SoCs for AI and data center applications, transforming what was once a volatile, fee-based revenue stream into a more predictable, volume-driven component of its overall semiconductor business, directly linking product adoption to market success without direct pricing control (Chunk 1's warning that \"we have no control over the marketing efforts of these third parties\" now defines a matured, partnership-dependent revenue model).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AMD (ORG) -> Semi-Custom SoC Products (PRODUCT)",
        "Semi-Custom SoC Products (PRODUCT) -> AMD (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMD_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMD_10k_2024.pdf",
          "page_id": "page_62",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10000,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3141,
        "completion_tokens": 405,
        "total_tokens": 3547
      }
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The company's preferred share authorization remained unchanged between fiscal years 2023 and 2024, with the same $0.20 par value for 127.5 million Preferred Shares and $1.00 par value for 500,000 A Preferred Shares, and no shares issued or outstanding as of April 26, 2024 (Chunk 1 & Chunk 2). This structural stability in preferred share terms—coupled with the company's $11.0 billion total share repurchase authorization (including a $5.0 billion incremental increase in March 2024) and active ordinary share buybacks—indicates a capital strategy focused on returning capital to shareholders through equity repurchases rather than utilizing preferred share mechanisms, while maintaining a conservative stance on preferred share issuance (Chunk 1 & Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "MDT (ORG) -> A Preferred Shares (FIN_INST)",
        "A Preferred Shares (FIN_INST) -> MDT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDT_10k_2023.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDT_10k_2024.pdf",
          "page_id": "page_81",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6020,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2148,
        "completion_tokens": 189,
        "total_tokens": 2337
      }
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "The framing of reputational risk tied to adverse publicity in BK’s disclosures has evolved from a general mention of reputational harm in 2022 to a more integrated linkage with sustainability concerns and climate-related impacts by 2024, reflecting heightened regulatory and stakeholder scrutiny. Both 2022 and 2024 filings explicitly connect adverse publicity to reputational harm affecting business operations, but the 2024 disclosure expands this risk under \"sustainability concerns, including a focus on climate change and diversity, could adversely affect our business... and damage our reputation,\" directly tying reputational exposure to environmental, social, and governance (ESG) factors absent in the 2022 version. This progression underscores a strategic shift toward embedding reputational risk within broader ESG and climate-related vulnerabilities, while maintaining consistent connections to operational and financial consequences across both periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "triplets_used": [
        "BK (ORG) -> Publicity (RISK_FACTOR)",
        "Publicity (RISK_FACTOR) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6618,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2302,
        "completion_tokens": 241,
        "total_tokens": 2544
      }
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "Amazon's financial investment and valuation approach toward Anthropic, PBC evolved significantly from 2023 to 2024, reflecting changes in investment classification and valuation drivers. In 2023, Amazon invested $1.25 billion in Anthropic via a convertible note classified as available-for-sale at fair value (Level 3), with unrealized gains/losses recorded in accumulated other comprehensive income, and held an option to invest up to an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, Amazon's equity investment in Anthropic was reclassified to fair value measurement under the equity method, with valuations subject to market volatility and inherent complexity due to the lack of market data for private companies, as noted in the 2024 10-K. This shift underscores a strategic pivot toward more dynamic fair value assessment, directly influenced by evolving market conditions and operational dependencies, such as AWS cloud services integration, which strengthened the business relationship between AMZN and Anthropic, PBC. Consequently, the valuation of Amazon's stake became increasingly sensitive to external economic factors and private company-specific risks, moving beyond the 2023 framework of cost method accounting with periodic impairment reviews.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "AMZN (ORG) -> Anthropic, PBC (COMP)",
        "Anthropic, PBC (COMP) -> AMZN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AMZN_10k_2023.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AMZN_10k_2024.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9148,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2935,
        "completion_tokens": 321,
        "total_tokens": 3256
      }
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "Between 2023 and 2024, the nature of risks related to protecting MDLZ's intellectual property, including know-how, has evolved from primarily focusing on traditional legal protections (patents, trademarks, trade secrets, licensing agreements, and enforcement against infringement) to explicitly incorporating emerging threats from artificial intelligence developments that could undermine current protections, while simultaneously maintaining the same core concern about inadequate protection diminishing competitiveness and materially harming the business, financial condition, and stock price – a risk consistently highlighted across both years but now with heightened specificity regarding AI-related vulnerabilities in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Protects]-> RISK_FACTOR <-[Discloses]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Know-How (RISK_FACTOR)",
        "Know-How (RISK_FACTOR) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2024.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11318,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3463,
        "completion_tokens": 184,
        "total_tokens": 3648
      }
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements shows continuity in governance structure across filings, with both the 2023 and 2024 SEC documents referencing the same foundational agreements and amendments. The 2023 filing (GS_10k_2023.pdf) discloses historical agreements dating back to 2008 (10.17) and pre-2015 forms (10.31-10.34), while the 2024 filing (GS_10k_2024.pdf) maintains these references (10.9, 10.17, 10.18) and additionally incorporates the Amended and Restated Stock Incentive Plan (2021) as the governing framework for director equity awards, indicating an evolution toward updated, consolidated equity incentive structures without altering the core agreement timelines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "GS (ORG) -> Non-Employee Director Equity Award Agreements (ACCOUNTING_POLICY)",
        "Non-Employee Director Equity Award Agreements (ACCOUNTING_POLICY) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_246",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9417,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3024,
        "completion_tokens": 178,
        "total_tokens": 3203
      }
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in terms of revenue recognition and contractual responsibilities as follows:  \n1. **Revenue Recognition Framework**: BKNG continues to recognize revenue on a net basis for online travel reservation services, where travel service providers (not travelers) are the primary customers. Revenue is measured based on the expected consideration in contracts with providers, including commissions or margins, and is recognized when post-booking services are completed and travelers begin using the arranged services (BKNG_10k_2023.pdf, page_83).  \n2. **Contractual Responsibilities**: Contracts with travel service providers grant them the ability to market reservation availability without transferring responsibility for delivering services to BKNG. This structure ensures BKNG’s revenues are presented net of payments to providers, including merchant revenues (e.g., transaction net revenue, processing fees) and agency revenues (commissions without payment facilitation) (BKNG_10k_2023.pdf, page_83).  \n3. **Global Operational Context**: While BKNG’s revenue streams are heavily driven by international operations (e.g., Booking.com in the Netherlands facilitating U.S. hotel bookings), the core contractual and revenue recognition model remains consistent across regions, underpining its global platform’s interdependency with travel providers (BKNG_10k_2022.pdf, page_48).  \n\nThis evolution underscores a stable, partnership-based model where BKNG’s role is facilitative rather than service-delivery focused, with revenue tied directly to contractual terms with providers rather than direct ownership of travel services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> Travel Service Providers (COMP)",
        "Travel Service Providers (COMP) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_83",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8611,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2794,
        "completion_tokens": 424,
        "total_tokens": 3218
      }
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "Between the 2023 and 2024 10-K filings, Goldman Sachs maintained the same executive life insurance policy disclosure structure without introducing new policy types or substantive changes to existing disclosures. The company continued to reference its original 2006 agreements (Exhibit 10.11 and 10.12 in both filings) that govern the Goldman Sachs & Co. LLC Executive Life Insurance Policy with Metropolitan Life Insurance Company and the parallel Pacific Life & Annuity Company policy, preserving the identical incorporation language and exhibit numbering across filings. This consistency reflects the company's practice of retaining established disclosure frameworks for these long-standing benefit arrangements without structural modifications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Discloses]- ORG",
      "triplets_used": [
        "GS (ORG) -> Executive Life Insurance Policy (FIN_INST)",
        "Executive Life Insurance Policy (FIN_INST) -> GS (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GS_10k_2023.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GS_10k_2024.pdf",
          "page_id": "page_246",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10010,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3146,
        "completion_tokens": 186,
        "total_tokens": 3333
      }
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, AVGO's strategic approach to FBAR filters has evolved from emphasizing internal fabrication for IP protection and time-to-market acceleration (as noted in Chunk 1's disclosure of internal III-V wafer fabrication for FBAR filters in the U.S. and Singapore) to maintaining this capability within a broader, competitive positioning strategy that remains central to its semiconductor differentiation (Chunk 2 reiterates internal fabrication for FBAR filters as a key innovative process amid intensified competition). This consistent manufacturing approach—leveraging internal facilities for proprietary FBAR filters while outsourcing commodity processes—has been critical to sustaining AVGO's competitive edge in wireless communications, particularly as it faces heightened competition from firms like Qorvo and Skyworks in infrastructure markets (Chunk 2's competitive landscape explicitly lists these rivals in the context of semiconductor solutions). Consequently, AVGO's internal fabrication of FBAR filters has not only preserved its IP advantage but also reinforced its ability to meet time-critical customer demands across global supply chains, directly supporting its strategic focus on high-value, system-level partnerships with OEMs requiring specialized technical support and reliability (Chunk 1's emphasis on \"collaborative product development\" and \"system-level knowledge\" for customer retention).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> FBAR Filters (PRODUCT)",
        "FBAR Filters (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11894,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3616,
        "completion_tokens": 357,
        "total_tokens": 3974
      }
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "BMY's strategic positioning of Krazati evolved from a late-stage clinical asset in 2023 (as evidenced by its inclusion in multiple late-line trials like KRYSTAL-17, KRYSTAL-10, and KRYSTAL-12* across 1L/2L NSCLC and CRC indications) to a commercially acquired asset following BMS's January 2024 acquisition of Mirati Therapeutics for $4.8 billion total consideration ($58/share cash + $1B CVR potential), which explicitly granted BMS rights to advance Krazati's first-line NSCLC development (combined with Opdivo) and leverage PRMT5 Inhibitor as a next-stage asset, while the $2.0 billion R&D technology valuation and indefinite-lived IPRD ($1.7B) from the 2024 10-K reflect the acquired Mirati portfolio's fair value that underpins Krazati's enhanced financial and clinical valuation trajectory.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "BMY (ORG) -> Krazati (PRODUCT)",
        "Krazati (PRODUCT) -> BMY (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BMY_10k_2023.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BMY_10k_2024.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2520,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 199,
        "total_tokens": 1462
      }
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in how it manages financial obligations and incentives through structured incentive programs and deferred merchant bookings. BKNG provides incentive programs including referral bonuses, rebates, credits, discounts, and loyalty points, where the estimated value of these incentives and expected redemption of loyalty points is recognized as a reduction of revenue at the time they are granted (Chunk 2). Concurrently, cash payments received from travelers in advance of fulfilling performance obligations are recorded as \"Deferred merchant bookings\" on the balance sheet, representing amounts payable to travel service providers and the Company's estimated future revenue from commissions or fees, primarily subject to refunds for cancellations (Chunk 2). This system ensures BKNG accounts for financial obligations to providers while aligning incentives with revenue recognition, reflecting a strategic approach to managing relationships and financial commitments with travel partners.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Depends_On]- ORG",
      "triplets_used": [
        "BKNG (ORG) -> Travel Service Providers (COMP)",
        "Travel Service Providers (COMP) -> BKNG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BKNG_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BKNG_10k_2023.pdf",
          "page_id": "page_84",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9834,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3112,
        "completion_tokens": 266,
        "total_tokens": 3379
      }
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "Broadcom's involvement in the development of Custom Touch Controllers has evolved from initial design and supply in 2022 to full production and integration by 2024, reflecting a matured role in the product lifecycle. As indicated in Chunk 1, Broadcom develops and supplies custom touch controllers for wireless applications, particularly in mobile devices and STB/Broadband markets, where they are engineered for high performance and integration with broader semiconductor solutions. By 2024, as shown in Chunk 2, these custom touch controllers are explicitly listed under \"Wireless\" major end markets with key product offerings including \"Custom touch controllers,\" confirming their established production and application in Broadcom’s portfolio. Furthermore, the KG triplet relationship—where AVGO (ORG) supplies Custom Touch Controllers (PRODUCT), and those controllers are produced by AVGO—demonstrates a closed-loop, vertically integrated role, underscoring Broadcom’s end-to-end ownership from design through production in support of target markets like mobile connectivity and broadband access.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> Custom Touch Controllers (PRODUCT)",
        "Custom Touch Controllers (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9689,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3067,
        "completion_tokens": 275,
        "total_tokens": 3342
      }
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "Union Pacific's freight car strategy evolved from 2023 to 2024 through a shift from leasing to acquiring assets, as evidenced by $143 million in freight car lease buyouts reported in 2024 (Chunk 2) compared to prior-year lease commitments detailed in 2023 disclosures (Chunk 1). This strategic pivot aligns with their capital plan to \"acquire freight cars to support replacement and growth opportunities\" (Chunk 2), directly reflecting the KG pattern where ORG (UNP) Depends_On PRODUCT (freight cars) through Acquires relationships, while simultaneously reducing reliance on leased assets previously documented in their 2023 lease portfolio (Chunk 1).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Acquires]- ORG",
      "triplets_used": [
        "UNP (ORG) -> Freight Cars (PRODUCT)",
        "Freight Cars (PRODUCT) -> UNP (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "UNP_10k_2023.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "UNP_10k_2024.pdf",
          "page_id": "page_33",
          "chunk_id": "chunk_5",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2124,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 162,
        "total_tokens": 1323
      }
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "The transition of certain NIKE Brand businesses within APLA to third-party distributors generated a non-recurring impairment charge recognized in Corporate for FY2020, reflecting the release of non-cash cumulative foreign currency translation losses (Chunk 1). This structural shift, detailed in Note 15 of the FY2023 filing as part of the APLA geographic segment's operational reorganization, directly impacted financial reporting by altering segment composition and requiring adjustments to revenue recognition and cost allocation across the geographic operating segments (Chunk 2). The change necessitated a strategic realignment of NIKE Brand's geographic footprint, particularly affecting APLA's operational scope and financial disclosures, while maintaining the Company's standardized foreign currency accounting practices that route translation gains/losses through Corporate (Chunks 1 & 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> APLA (GPE)",
        "APLA (GPE) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_90",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6549,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2279,
        "completion_tokens": 224,
        "total_tokens": 2503
      }
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "Broadcom's (AVGO) involvement with InP lasers has evolved from 2022 to 2024 through a strategic shift toward internal fabrication of proprietary InP-based components—specifically vertical-cavity surface emitting lasers and side-emitting lasers for fiber optics—while maintaining outsourced production for commodity processes, as documented in both 2022 and 2024 SEC filings. This internal focus, highlighted in the manufacturing operations sections of both filings, enables IP protection and accelerated time-to-market for high-value optical components, directly supporting competitive positioning against specialized players like Coherent Corp. and Lumentum in the infrastructure software and semiconductor solutions markets. The company’s long-term supplier relationships and Asia-based manufacturing footprint (including Malaysia warehousing) further solidify its ability to meet time-critical customer demands across global OEM networks, as evidenced by its 2022 customer collaboration model and 2024 competitive landscape analysis.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Supplies]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> InP Lasers (PRODUCT)",
        "InP Lasers (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2022.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11894,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3611,
        "completion_tokens": 259,
        "total_tokens": 3870
      }
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, the ownership structure of Swoosh, LLC relative to NIKE's Class A and Class B Common Stock remained materially unchanged, with Swoosh, LLC continuing to beneficially own approximately 77% of the Class A Common Stock as of both June 30, 2022 (Chunk 1) and June 28, 2024 (Chunk 2), which would convert to approximately 16% ownership of Class B Common Stock if converted. This consistent stake—rooted in Swoosh, LLC's formation by Philip H. Knight to hold his majority Class A shares, with Travis Knight playing a significant management role despite the entity lacking voting rights (Chunk 1)—means Swoosh, LLC retains disproportionate influence over NIKE's equity structure, particularly in Class B voting power, thereby preserving concentrated control over key governance decisions despite the nominal conversion ratio to Class B shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Affects_Stock]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> Swoosh,LLC (COMP)",
        "Swoosh,LLC (COMP) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_25",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_26",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11803,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3595,
        "completion_tokens": 214,
        "total_tokens": 3810
      }
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI advanced its Reduced-Risk Products (RRPs) strategy by integrating Swedish Match’s oral nicotine portfolio (notably ZYN) into its global smoke-free offerings, expanding availability to 84 markets by end-2023 while aligning with its broader shift to four geographical segments (including the newly integrated Swedish Match). This consolidation—highlighted in the 2023 10-K’s segment restructuring plans for 2024 reporting—reflects a deliberate evolution from standalone RRP development to a unified, globally distributed portfolio where smoke-free products (including IQOS and ZYN) now constitute a core, widely accessible alternative to combustible tobacco.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "PM (ORG) -> Reduced-Risk Products (PRODUCT)",
        "Reduced-Risk Products (PRODUCT) -> PM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PM_10k_2022.pdf",
          "page_id": "page_97",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PM_10k_2023.pdf",
          "page_id": "page_28",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5657,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2055,
        "completion_tokens": 169,
        "total_tokens": 2225
      }
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "Caterpillar's strategic role in the reciprocating engines business has evolved from being a primary seller and producer of engines through its dealer network (as evidenced by Chunk 1's description of selling reciprocating engines through dealers and to manufacturers like Perkins and MaK) to expanding its aftermarket and remanufacturing footprint, including remanufacturing services for other companies (noted in Chunk 2's \"Financial Products Segment\" and \"Machinery, Energy & Transportation\" sections). This evolution is reflected in its revenue composition, where reciprocating engines now represent a smaller portion of overall revenue but with higher gross margin potential due to value-added services like remanufacturing and parts sales (supported by Chunk 1's \"Order Backlog\" showing engine-related backlog and Chunk 2's \"Manufacturing Costs\" emphasizing volume-adjusted pricing impacts). The shift toward higher-margin aftermarket activities—such as remanufacturing engines and components (Chunk 2, point 1)—directly enhances gross margin potential by leveraging existing production capacity and dealer networks to generate recurring revenue from parts and services rather than just new engine sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Reciprocating Engines (PRODUCT)",
        "Reciprocating Engines (PRODUCT) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_39",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10739,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3331,
        "completion_tokens": 302,
        "total_tokens": 3634
      }
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon maintained its commitment to disclose amendments to or waivers of the Directors' Code of Conduct on its website, as explicitly stated in both the 2022 and 2023 10-K filings. The company consistently communicated its intent to inform stakeholders of changes through website disclosures for both the Directors' Code of Conduct and the broader Code of Conduct, with no evolution in the mechanism—relying solely on website postings for transparency regarding governance policy updates. This approach underscored a stable, proactive disclosure framework without procedural changes between the fiscal years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Announces]- ORG",
      "triplets_used": [
        "BK (ORG) -> Amendments to Directors' Code of Conduct (ACCOUNTING_POLICY)",
        "Amendments to Directors' Code of Conduct (ACCOUNTING_POLICY) -> BK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "BK_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "BK_10k_2023.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4517,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1806,
        "completion_tokens": 158,
        "total_tokens": 1965
      }
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike refined its operational structure in the APLA market by continuing to streamline its organization around the Consumer Direct Acceleration strategy, building on the leadership and operating model changes initiated in FY21 that reduced workforce and incurred $294 million in pre‑tax restructuring charges (Chunk 1). This strategic shift is reflected in the company’s segment reporting, where APLA is treated as a distinct geographic operating segment within the NIKE Brand and is managed through NIKE Direct channels, emphasizing owned stores, digital platforms, and select wholesale partners that align with the marketplace vision (Chunk 2). Consequently, Nike’s participation in APLA evolved from a broader wholesale focus toward a more integrated, digitally‑driven model that leverages localized brand divisions and aligns product creation, inventory management, and pricing actions to meet regional consumer demand while maintaining alignment with its global financial objectives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "NKE (ORG) -> APLA (GPE)",
        "APLA (GPE) -> NKE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "NKE_10k_2022.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "NKE_10k_2023.pdf",
          "page_id": "page_89",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9928,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3112,
        "completion_tokens": 252,
        "total_tokens": 3365
      }
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from being a key driver of revenue growth in 2021 (as documented in Chunk 1, where it contributed to a 22% increase in consolidated sales to $50.971 billion) to partially offsetting lower sales volume in 2024 (Chunk 2), where a $2.251 billion or 3% sales decline was \"more than offset by favorable price realization\" alongside $10.792 billion in profit—demonstrating its critical role in sustaining profitability despite reduced volume. This shift reflects how Caterpillar strategically leveraged pricing power to protect margins during economic headwinds, as evidenced by the KG triplet relationship (CAT → Favorable Price Realization → CAT) consistently enabling positive financial outcomes across all reported periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> MACRO_CONDITION <-[Positively_Impacts]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Favorable Price Realization (MACRO_CONDITION)",
        "Favorable Price Realization (MACRO_CONDITION) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_34",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2024.pdf",
          "page_id": "page_30",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 4628,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1800,
        "completion_tokens": 207,
        "total_tokens": 2007
      }
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "General Motors' EV manufacturing capacity strategy has evolved from a broad, capacity-focused investment in 2023 to a more disciplined, supply chain-integrated approach in 2024, with explicit emphasis on securing North American raw material sources through strategic multi-year agreements to support long-term EV demand amid industry-wide excess capacity and competitive pricing pressures. This shift reflects a strategic pivot toward leveraging ICE vehicle profits to fund EV growth while actively developing a resilient, North America-focused supply chain to mitigate raw material supply constraints and reduce dependency on external sources, as highlighted by GM's 2024 disclosure of \"advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of strategic, multi-year supply agreements.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "GM (ORG) -> EV Manufacturing Capacity (PRODUCT)",
        "EV Manufacturing Capacity (PRODUCT) -> GM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "GM_10k_2023.pdf",
          "page_id": "page_18",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "GM_10k_2024.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12940,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3879,
        "completion_tokens": 213,
        "total_tokens": 4093
      }
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid has declined significantly from 2022 to 2024, as evidenced by remaining performance obligations of approximately $1 billion for Paxlovid as of December 31, 2024 (Chunk 2), down from the $3.5 billion revenue reversal tied to expected returns of 6.5 million treatment courses in 2023 (Chunk 2), while the 2022 filing (Chunk 1) only references Paxlovid's emergency use authorization without disclosing any specific financial commitments or performance obligations. This evolution reflects the transition from pandemic-era emergency use revenue to a more stabilized, though still declining, contractual revenue stream with firm orders expected to be recognized through 2028 (Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9245,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2944,
        "completion_tokens": 180,
        "total_tokens": 3124
      }
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Caterpillar's approach to monitoring supplier financial viability has evolved from 2022 to 2023 by strengthening contractual agreements to specifically address supply chain risks, particularly supplier financial viability and business continuity, while maintaining its global strategic sourcing model to ensure long-term supplier relationships and enterprise spend leverage. In 2022, the company emphasized monitoring supplier financial viability as part of its risk mitigation strategy to prevent business disruptions, and by 2023, this was reinforced through more robust contractual agreements that explicitly protect intellectual property and processes, directly addressing the risks of supply chain disruptions and production constraints observed in both years. The consistent focus across both filings on supplier financial viability as a monitored risk factor—evidenced by the KG triplets linking CAT to Supplier Financial Viability and the risk monitoring framework—demonstrates a targeted evolution in contractual protections to mitigate supply base vulnerabilities, as reflected in the detailed supplier risk management language in both the 2022 and 2023 SEC filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> RISK_FACTOR <-[Monitors]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Supplier Financial Viability (RISK_FACTOR)",
        "Supplier Financial Viability (RISK_FACTOR) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_9",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9716,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3083,
        "completion_tokens": 294,
        "total_tokens": 3377
      }
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Visa's Risk and Identity Solutions have evolved from a core payment infrastructure component into a strategically integrated value-added service, as evidenced by its expanded focus and acquisitions between 2022 and 2024. In 2022, these solutions were positioned as one of five key value-added service categories (alongside issuing, acceptance, open banking, and advisory services) that diversify revenue by providing \"servi ces that go beyond payments\" to optimize client performance and create differentiated customer experiences (Chunk 2). This strategic evolution accelerated with Visa's 2024 acquisition of Pismo, a cloud-native issuer processing platform, which expanded Visa's capabilities to include core banking and card-issuer processing via cloud-native APIs, directly enhancing its Risk and Identity Solutions through deeper integration with emerging payment frameworks and real-time payment networks (Chunk 2). Concurrently, Visa strengthened its Risk and Identity Solutions by embedding them within its broader \"network of networks\" approach, enabling modular, API-driven services like fraud mitigation, dispute management, and tokenization that support both Visa and non-Visa transactions while unifying the complex payments ecosystem (Chunk 1 and Chunk 2). This integration reflects a clear shift from foundational payment facilitation to a comprehensive, network-agnostic suite of solutions designed to drive client retention and revenue diversification across the entire payments value chain.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "V (ORG) -> Risk and Identity Solutions (PRODUCT)",
        "Risk and Identity Solutions (PRODUCT) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_5",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9003,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2901,
        "completion_tokens": 377,
        "total_tokens": 3278
      }
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "The company's exposure to shelf space limitations as a risk factor has intensified between 2022 and 2023 due to evolving retail dynamics, as evidenced by both chunks. In 2022 (Chunk 1), the company explicitly identified \"limitations on access to shelf space\" and \"delisting of our products\" as adverse policy changes from retail trade customers that could \"adversely affect our business,\" while also noting the \"rapidly changing retail landscape\" and \"emergence of alternative retail channels\" as key disruptors. By 2023 (Chunk 2), this exposure became more pronounced as the company detailed how \"changes in the policies and practices of our trade customers\" – specifically \"limitations on access to shelf space,\" \"inventory de-stocking,\" and \"delisting of our products\" – continued to negatively impact operations, with the retail landscape further evolving through \"continued growth of eCommerce\" and \"emergence of alternative retail channels\" like subscription services and direct-to-consumer models. This progression is reinforced by the KG triplet relationship where **CL** (the company) is **Negatively_Impacts** the **Shelf Space Limitations** risk factor, and this risk factor is **Impacted_By** CL's increasing dependence on key retailers and vulnerability to their shifting policies across both reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "CL (ORG) -> Shelf Space Limitations (RISK_FACTOR)",
        "Shelf Space Limitations (RISK_FACTOR) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_31",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 10893,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3386,
        "completion_tokens": 331,
        "total_tokens": 3717
      }
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Oracle's hybrid deployment strategy has evolved from a broad, flexible portfolio of on-premise, cloud, and hybrid options (including Exadata Cloud@Customer, Dedicated Region, and multicloud integrations) emphasized in fiscal 2023 to a more structured, cloud-centric approach in fiscal 2024, where hybrid deployments are positioned as a key differentiator through tightly integrated Oracle Cloud Services (SaaS and OCI) that enable seamless workload mobility and interoperability across environments. This strategic shift is underscored by significant R&D investments ($8.9B in fiscal 2024) focused on enhancing cloud-native offerings and infrastructure, while maintaining support for traditional license and hardware deployments to ensure customer choice and transition flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "ORCL (ORG) -> Hybrid Deployments (PRODUCT)",
        "Hybrid Deployments (PRODUCT) -> ORCL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ORCL_10k_2023.pdf",
          "page_id": "page_6",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ORCL_10k_2024.pdf",
          "page_id": "page_72",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9437,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2999,
        "completion_tokens": 195,
        "total_tokens": 3195
      }
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid has declined significantly from its peak pandemic levels, with remaining contracted revenue expectations now totaling approximately $1 billion for future deliveries through 2028, down from the $3.5 billion revenue reversal recorded in 2023 and the $129 million one‑time settlement adjustment in 2024. This reduction reflects the winding down of pandemic‑era demand, as indicated by the $442 million of revenue recognized in the third quarter of 2024 tied to the U.S. SNS and the overall decrease in remaining performance obligations for Paxlovid relative to the earlier $4 billion commitment for Comirnaty.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_23",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11385,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3481,
        "completion_tokens": 162,
        "total_tokens": 3643
      }
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Caterpillar's relationship with its independent dealers has remained fundamentally contractual and strategically consistent between 2022 and 2023, with both years relying on identical \"standard sales and service agreements\" that establish dealers' rights to purchase, sell, and service products within defined territories while obligating them to actively promote and support Caterpillar's products through dedicated personnel, financial transparency, and intellectual property protection - obligations that persist as non-exclusive, terminable-at-will arrangements requiring 90 days' written notice. The 2023 agreement details explicitly reinforce this structure by requiring dealers to \"develop and promote\" sales, maintain detailed financial records for Caterpillar's review, and provide warranty support, while the 2022 overview confirms this contractual framework as the enduring basis for dealer relationships, emphasizing that these agreements govern the core dynamic of Caterpillar's independent dealer network across both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Partners_With]- ORG",
      "triplets_used": [
        "CAT (ORG) -> Independent Dealers (COMP)",
        "Independent Dealers (COMP) -> CAT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CAT_10k_2022.pdf",
          "page_id": "page_4",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CAT_10k_2023.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9233,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2949,
        "completion_tokens": 259,
        "total_tokens": 3208
      }
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, the company increased its capital allocation to Africa/Eurasia from $13 million to $33 million, reflecting a strategic shift toward growth in this region, while restructuring charges tied to the 2022 Global Productivity Initiative allocated approximately 10% of cumulative pre-tax charges ($20–$24 million) to Africa/Eurasia initiatives, aligning with the ORG–Africa/Eurasia operational focus shown in the KG pattern. This reallocation supports the company’s broader strategy to drive growth in strategic markets, as evidenced by the $33 million capital expenditure in Africa/Eurasia for 2023 (up from $13 million in 2022) and the regional breakdown of productivity initiative charges, which explicitly includes Africa/Eurasia as a key target for operational streamlining and cost reduction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Increases]-> GPE <-[Operates_In]- ORG",
      "triplets_used": [
        "CL (ORG) -> Africa/Eurasia (GPE)",
        "Africa/Eurasia (GPE) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_117",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2873,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 202,
        "total_tokens": 1559
      }
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "From 2022 to 2024, Qualcomm's strategic focus on 5G evolved from foundational investment in core 5G NR technologies and patent licensing (QTL) toward active commercialization and ecosystem expansion, particularly in new verticals like automotive and IoT. Chunk 1 highlights the critical risk of U.S.-China regulatory pressures disrupting supply chains and revenue streams, directly impacting Qualcomm's ability to commercialize 5G products in China—a key market for its 5G revenue concentration. Chunk 2 confirms sustained investment in 5G advancements (e.g., OFDMA-based technologies and foundational patents for 5G NR), while explicitly linking this to commercialization outcomes: \"We have invested and continue to invest in the development of 5G and continue to play a significant role in driving advancements of 5G,\" with licensing revenues heavily tied to OFDMA-based 5G devices like smartphones. Crucially, Chunk 2 also details the transition to new business models via QSI's strategic investments in 5G-adjacent areas (e.g., automotive, AI), acknowledging that \"our growth also depends significantly on our ability to develop and commercialize products using 5G technologies\" despite risks like \"alternate technologies or products may be better.\" Together, these chunks reveal a clear evolution: from securing 5G patent dominance (2022) to monetizing it through licensing and new product ecosystems (2023–2024), while navigating geopolitical risks that could undermine commercialization in critical markets like China.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> 5G Technologies (PRODUCT)",
        "5G Technologies (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_13",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12940,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3873,
        "completion_tokens": 381,
        "total_tokens": 4255
      }
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Pfizer's financial and strategic positioning of Paxlovid has undergone a significant shift between 2022 and 2024, with its revenue contribution declining substantially while contractual commitments for future supply remain. In 2022, Paxlovid generated $76 million in revenue (as shown in Chunk 1's 2021 column for 2022 reporting), but by 2024, it had become a minor component of Pfizer's overall portfolio, with only $1 billion in remaining contracted revenue obligations for future deliveries through 2028 (per Chunk 2's \"Remaining Performance Obligations\" section). The company also recorded a $771 million favorable adjustment to non-cash revenue reversals related to Paxlovid returns in 2024 (Chunk 2), reflecting the winding down of pandemic-era demand, while simultaneously withdrawing Oxbryta (a separate product) due to safety concerns (Chunk 2, point d). This evolution underscores a strategic pivot away from pandemic-driven revenues toward long-term contracts for Comirnaty and Paxlovid, with the latter now contributing minimally to current financials despite ongoing supply commitments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_113",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 13140,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3922,
        "completion_tokens": 274,
        "total_tokens": 4197
      }
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "The company's exposure to credit market tightness as a supply chain risk has evolved from a documented concern in 2022 to a more explicitly emphasized vulnerability in 2023, reflecting increasing sensitivity to external financial conditions. While both filings identify tighter credit or capital markets as a factor impacting suppliers (via the KG relationship ORG → Credit Market Tightness → ORG), the 2023 filing (Chunk 2) expands this risk within a broader \"Operational Risks\" section, directly linking it to supply chain disruptions alongside geopolitical events, pandemics, and logistics issues—highlighting how financial market conditions now intersect with operational vulnerabilities. This progression indicates a growing recognition that external financial pressures, such as restricted credit access for suppliers, are no longer a secondary concern but an integrated component of the company's heightened exposure to macroeconomic volatility, thereby amplifying its overall vulnerability to shifts in global financial conditions beyond traditional operational disruptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "triplets_used": [
        "CL (ORG) -> Credit Market Tightness (RISK_FACTOR)",
        "Credit Market Tightness (RISK_FACTOR) -> CL (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "CL_10k_2022.pdf",
          "page_id": "page_16",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "CL_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7294,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2483,
        "completion_tokens": 270,
        "total_tokens": 2753
      }
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid has significantly evolved from 2022 to 2024, reflecting both the product's peak pandemic-driven revenue and subsequent strategic adjustments. In 2022, Paxlovid received EUAs and approvals across key markets (U.S., EU, Japan), establishing it as a critical COVID-19 treatment, with remaining performance obligations for future supply contracts totaling approximately $1 billion as of December 2024 (Chunk 2). By 2024, the company reported a $442 million revenue adjustment tied to the U.S. Strategic National Stockpile (SNS) and a $771 million favorable adjustment from reduced expected returns of Paxlovid courses (from 6.5 million to 5.1 million), indicating a decline in government procurement but continued contractual obligations for future deliveries through 2028 (Chunk 2). Additionally, while Paxlovid's revenue recognition was tied to EUA-labeled courses and contractual deliveries (Chunk 2), its financial impact was contextualized within broader product revenues, including alliance and royalty streams (Chunk 1), demonstrating a shift from emergency pandemic revenue to long-term, negotiated supply agreements with anticipated deliveries spanning 2025–2028.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "PFE (ORG) -> Paxlovid (PRODUCT)",
        "Paxlovid (PRODUCT) -> PFE (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PFE_10k_2022.pdf",
          "page_id": "page_47",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PFE_10k_2024.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7487,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2505,
        "completion_tokens": 302,
        "total_tokens": 2808
      }
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "From 2023 to 2024, the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation decreased significantly, with the Company's accrual for these liabilities declining from $574 million as of December 31, 2023 to $51 million as of December 31, 2024, reflecting a substantial reduction in estimated future claims and settlement costs. This reduction is partially attributable to the resolution of Aearo Technologies' Chapter 11 bankruptcy stay (dismissed in June 2023), which allowed litigation to resume, and the implementation of a limited liability arrangement where Aearo's exposure is now capped to claims involving exposure to asbestos, silica, or silica products on or after January 1, 1997, under an agreement with Cabot that requires quarterly payments of $100,000 to retain indemnification for pre-1995 claims. However, the Company continues to face ongoing uncertainty regarding potential developments such as changes in claim volumes, legal outcomes, liability allocations among co-defendants in the Payor Group, and the financial viability of insurers, which could significantly alter the ultimate liability beyond the current accruals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Involved_In]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Aearo Holding Corp. (COMP)",
        "Aearo Holding Corp. (COMP) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_82",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_87",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12609,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3787,
        "completion_tokens": 298,
        "total_tokens": 4085
      }
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "Between 2023 and 2024, Skoal's retail share declined from 9.3% to 7.6%, a decrease of 1.7 percentage points, while its shipment volume also decreased from 208.5 million units (2020) to 197.4 million units (2021), reflecting a downward trend of 11.1 million units over the same period. This parallel decline in both retail share and shipment volume across the respective timeframes indicates a consistent reduction in Skoal's market performance and physical output, as evidenced by the data in Chunk 1 (shipment volumes for 2020 and 2021) and Chunk 2 (retail shares for 2023 and 2024), with the KG triplet relationship confirming MO's production and disclosure of Skoal as a core product.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MO (ORG) -> Skoal (PRODUCT)",
        "Skoal (PRODUCT) -> MO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MO_10k_2022.pdf",
          "page_id": "page_46",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MO_10k_2024.pdf",
          "page_id": "page_48",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2145,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 171,
        "total_tokens": 1341
      }
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's engineering focus in multimedia technologies has evolved to emphasize integrated AI capabilities and expanded platform versatility across diverse industries. The company has intensified R&D investments in advanced multimedia processing—including camera, video, display, and computer vision systems—while embedding specialized engines like NPUs for AI acceleration, as highlighted in both 2022 and 2024 filings. This strategic shift supports broader integration into automotive (e.g., ADAS/AD), XR, and IoT applications, with innovations designed to enhance performance and enable new revenue streams through on-device AI and cross-device compatibility, directly aligning with their diversification strategy and global wireless ecosystem vision.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Develops]-> PRODUCT <-[Produces]- ORG",
      "triplets_used": [
        "QCOM (ORG) -> Multimedia Technologies (PRODUCT)",
        "Multimedia Technologies (PRODUCT) -> QCOM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "QCOM_10k_2022.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "QCOM_10k_2024.pdf",
          "page_id": "page_14",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 12269,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3712,
        "completion_tokens": 193,
        "total_tokens": 3906
      }
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly through both equity investment adjustments and intercompany balance reconciliations following reconsolidation. In 2023, 3M had previously deconsolidated the Aearo Entities but reconsolidated them in Q2 2023 after court dismissal of their voluntary bankruptcy proceedings, which eliminated prior intercompany balances ($0.7B equity investment asset and $0.6B net liability for intercompany amounts) from comparative balance sheets. The CAE Settlement initially structured with $1B payable in cash or stock was amended in January 2024 to make the equity portion irrevocably payable in cash, though 3M retained discretion to settle in cash rather than issue stock. By December 31, 2023, 3M had accrued a $5.0B liability for Combat Arms Earplugs-related claims (reflected in contingent liabilities), and the reconsolidation impacted balance sheet presentations by removing prior deconsolidated entity balances while establishing new consolidated intercompany relationships. This restructuring eliminated prior equity investment accounting and reclassified intercompany amounts, fundamentally altering how 3M's financial statements reflected its relationship with the Aearo Entities through both settlement obligations and balance sheet consolidation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Reconsolidates]-> COMP <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "MMM (ORG) -> Aearo Entities (COMP)",
        "Aearo Entities (COMP) -> MMM (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MMM_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MMM_10k_2024.pdf",
          "page_id": "page_50",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11027,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3394,
        "completion_tokens": 335,
        "total_tokens": 3730
      }
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Visa's Risk and Identity Solutions have evolved from a standalone fraud prevention offering into a core component of its broader Value-Added Services portfolio between 2022 and 2024, as evidenced by its expanded strategic positioning within the company's diversified revenue model. In 2022, the solutions were described as transforming data into near real-time insights for fraud prevention and authentication (Chunk 1), but by 2024, they were explicitly integrated into Visa's five-category Value-Added Services strategy—including Open Banking Solutions—and positioned as critical for enabling network-agnostic services beyond payments (Chunk 2). This evolution is further reinforced by strategic acquisitions like Pismo in early 2024, which expanded Visa's core banking and card-issuing capabilities to support real-time payments and emerging frameworks, directly enhancing the scalability and integration of Risk and Identity Solutions within its broader portfolio of over 200 products (Chunk 2). Consequently, these solutions now operate as a foundational layer across Visa's diversified offerings—from Issuing and Acceptance Solutions to Open Banking—driving client retention through features like Visa Consumer Authentication Service and Advanced Identity Score while supporting the company's goal of delivering \"high impact business outcomes\" through interconnected, modular services (Chunk 1 and Chunk 2).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "V (ORG) -> Risk and Identity Solutions (PRODUCT)",
        "Risk and Identity Solutions (PRODUCT) -> V (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "V_10k_2022.pdf",
          "page_id": "page_12",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "V_10k_2024.pdf",
          "page_id": "page_11",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8815,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2854,
        "completion_tokens": 353,
        "total_tokens": 3207
      }
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "RTX's disclosure of Acquisition Accounting Adjustments evolved significantly between 2023 and 2024, with the 2024 10-K (Chunk 2) explicitly quantifying the impact through its FAS/CAS operating adjustment changes. The 2023 10-K (Chunk 1) shows a $1,998 million negative impact on consolidated operating profit from these adjustments, while the 2024 filing details that the $0.3 billion decrease in this adjustment (compared to 2023) was driven by reduced CAS expense due to pension plan changes effective December 31, 2022, as referenced in Note 10. This adjustment, which is excluded from management's segment performance evaluation, directly contributed to the shift in operating profit margins—from 5.2% in 2023 (Chunk 1) to a higher, though not fully quantified, 2024 margin reflecting the $0.3 billion reduction in the adjustment's negative impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "triplets_used": [
        "RTX (ORG) -> Acquisition Accounting Adjustments (ACCOUNTING_POLICY)",
        "Acquisition Accounting Adjustments (ACCOUNTING_POLICY) -> RTX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "RTX_10k_2023.pdf",
          "page_id": "page_109",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "RTX_10k_2024.pdf",
          "page_id": "page_54",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5139,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1936,
        "completion_tokens": 213,
        "total_tokens": 2149
      }
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud grew from $91.4 billion in fiscal 2022 to $111.6 billion in fiscal 2023, reflecting a $20.2 billion increase that helped lift Microsoft Cloud revenue from $91.4 billion to $111.6 billion year‑over‑year. This upward trajectory, highlighted by the Office 365 Commercial segment’s role in driving Microsoft Cloud’s $137.4 billion total in fiscal 2024, demonstrates a strong, accelerating growth pattern for Office 365 within the broader cloud ecosystem and underscores its expanding share of Microsoft’s cloud revenue base.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Discloses]- ORG",
      "triplets_used": [
        "MSFT (ORG) -> Office 365 Commercial (PRODUCT)",
        "Office 365 Commercial (PRODUCT) -> MSFT (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MSFT_10k_2022.pdf",
          "page_id": "page_43",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MSFT_10k_2023.pdf",
          "page_id": "page_93",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3128,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 149,
        "total_tokens": 1589
      }
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Between 2023 and 2024, Merck's alliance revenue related to Lynparza grew by 9%, as explicitly stated in Chunk 2, which attributes this growth to \"higher demand in most international markets.\" This increase is directly tied to the product's expanded approval in China in January 2025 for adjuvant treatment of BRCA-mutated breast cancer (Chunk 2), which preceded the revenue growth and likely drove international demand. Additionally, Chunk 1 clarifies that Lynparza's alliance revenue represents Merck's share of profits from sales net of costs and commercialization expenses (Note 4), confirming the revenue metric used. The growth reflects both the new Chinese indication and sustained international uptake, as evidenced by the 9% increase reported in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2023.pdf",
          "page_id": "page_126",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5336,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1961,
        "completion_tokens": 189,
        "total_tokens": 2150
      }
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The Procter & Gamble 2014 Stock and Incentive Compensation Plan (2014 Plan) remains a key equity compensation vehicle disclosed across multiple regulatory filings, with its governance and terms detailed in both historical and current disclosures. As noted in the 2023 filing (Exhibit 10-25), the 2014 Plan’s regulations were updated alongside the 2019 Plan, reflecting ongoing oversight by the Compensation and Leadership Development Committee, while the 2024 filing (Item 12) confirms its continued inclusion among active equity plans used for equity compensation reporting, maintaining its regulatory relevance in equity disclosures through the KG-linked relationship of ORG discloses ACCOUNTING_POLICY.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PG (ORG) -> 2014 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY)",
        "2014 Stock and Incentive Compensation Plan (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 15608,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4579,
        "completion_tokens": 176,
        "total_tokens": 4756
      }
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan remains a core component of PG’s equity compensation structure, continuing to be adopted and referenced in both the 2023 and 2024 10‑K filings as an active accounting policy governing share‑based awards.  In the 2024 filing (Item 12), the plan is explicitly listed alongside newer plans—including the 2001, 2003, 2009, 2014, and 2019 Stock and Incentive Compensation Plans—demonstrating its ongoing role within the company’s broader equity compensation framework.  This consistent inclusion across the two filings confirms that the 1992 Stock Plan has retained its significance and is still formally adopted as part of PG’s current equity compensation architecture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG",
      "triplets_used": [
        "PG (ORG) -> 1992 Stock Plan (ACCOUNTING_POLICY)",
        "1992 Stock Plan (ACCOUNTING_POLICY) -> PG (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "PG_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "PG_10k_2024.pdf",
          "page_id": "page_68",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 8522,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2781,
        "completion_tokens": 171,
        "total_tokens": 2952
      }
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "The company's emphasis on large-scale transformations has remained strategically consistent between 2023 and 2024, with both years highlighting that clients continue to prioritize these initiatives which convert to revenue over longer periods. While economic volatility impacted shorter-duration and smaller contracts in fiscal 2024, the core pattern of client spending on large-scale transformations—requiring extended revenue conversion timelines—has persisted as a key driver of business activity across both reporting periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Large-Scale Transformations (PRODUCT)",
        "Large-Scale Transformations (PRODUCT) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_21",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 9958,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3139,
        "completion_tokens": 132,
        "total_tokens": 3271
      }
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "From fiscal 2023 to 2024 Accenture’s issuance of Class A ordinary shares for employee compensation shifted from a publicly announced open‑market purchase program (used in 2023 to acquire treasury shares for employee awards) to a share‑withholding approach tied to payroll tax obligations under its employee equity plans; this change is reflected in the 2024 10‑K where the “Purchases/redemptions of Accenture Canada Holdings Inc. exchangeable shares and Class X shares” line shows a net outflow of 5,112 Class X shares, while the “Issuances of Class A ordinary shares for employee share programs” line records **7,970** shares issued with a fair‑value of **$1.943 million**, and the accompanying “Share‑based compensation expense” of **$1.571 million** demonstrates the accounting impact.  \n\nThe equity‑structure tables in the 2024 filing capture the net effect: treasury‑share balances fell from **$(3.4 million)** to **$(6.68 million)**, and the “Total Accenture plc Shareholders’ Equity” increased from **$20.097 billion** (as of Aug 31 2021) to **$22.106 billion** (as of Aug 31 2022), reflecting the dilution from the 7,970 new Class A issuances and the related dividend payouts, which together reduced retained earnings by **$2.558 million** and generated a total dividend expense of **$2.457 million**.  \n\nThus, the shift in how Accenture delivers Class A shares—moving from open‑market treasury purchases to share‑withholding for tax purposes—altered the composition of its equity but did not materially change the overall authorization for share repurchases; instead, the new issuances added **$1.349 million** to shareholders’ equity (after accounting for the $1.943 million fair‑value of the shares and the $1.571 million compensation expense), while the overall treasury‑share position expanded, underscoring a modest dilution of the company’s equity base.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Introduces]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Class A Ordinary Shares (FIN_INST)",
        "Class A Ordinary Shares (FIN_INST) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_101",
          "chunk_id": "chunk_3",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_70",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6373,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2240,
        "completion_tokens": 467,
        "total_tokens": 2707
      }
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ's exposure to Canadian-denominated debt instruments decreased significantly from $7 million (in millions) in 2022 to $8 million (in millions) in 2023, reflecting a net reduction of $16 million in the liability position. This shift aligns with the company's broader strategy of deleveraging foreign‑currency‑denominated debt, as evidenced by the overall decline in euro, British pound sterling, and Swiss franc notes across the same periods. Consequently, the change in Canadian debt mirrors MDLZ's systematic effort to lower its aggregate foreign‑currency exposure throughout 2022‑2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Canadian notes (FIN_INST)",
        "Canadian notes (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_114",
          "chunk_id": "chunk_6",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 2398,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 147,
        "total_tokens": 1402
      }
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "From 2023 to 2024, Accenture's engagement with growth-stage companies has deepened strategically, transitioning from general partnership to active investment and incubation. Both the 2023 and 2024 10-K filings confirm that **Accenture Ventures partners with and invests in growth-stage companies** developing innovative enterprise technologies, with specific emphasis on emerging tech areas like AI, blockchain, and quantum. This is reinforced by the consistent mention of **Accenture Labs incubating and applying emerging technology innovation to business architectures**, demonstrating a sustained, structured approach to fostering innovation through both investment and applied research. The repetition of these initiatives across both filings—particularly the explicit linkage of Accenture Ventures to growth-stage company investment—confirms a deliberate, evolving strategy to integrate these companies into Accenture's innovation ecosystem, moving beyond collaboration to active strategic involvement and capital deployment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Invests_In]- ORG",
      "triplets_used": [
        "ACN (ORG) -> Growth-Stage Companies (COMP)",
        "Growth-Stage Companies (COMP) -> ACN (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "ACN_10k_2023.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "ACN_10k_2024.pdf",
          "page_id": "page_17",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 7716,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2572,
        "completion_tokens": 257,
        "total_tokens": 2829
      }
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "From 2022 to 2024, Merck's financial involvement in the Lynparza collaboration with AstraZeneca evolved through accelerated amortization of the $1.1 billion Lynparza intangible asset—capitalized from sales‑ and regulatory‑based milestones—now being written down over a useful life through 2028, while alliance revenue from Lynparza grew 9% in 2024 driven by higher international demand and a 2025 Chinese NMPA approval for an adjuvant indication. This growth reflects both the expanding commercial footprint of Lynparza and the ongoing recognition of milestone-related revenue, underscoring the deepening strategic and financial integration between Merck and AstraZeneca in the Lynparza partnership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Amortizes_Asset]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "MRK (ORG) -> Lynparza (PRODUCT)",
        "Lynparza (PRODUCT) -> MRK (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MRK_10k_2022.pdf",
          "page_id": "page_102",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MRK_10k_2024.pdf",
          "page_id": "page_55",
          "chunk_id": "chunk_3",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 6379,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 2241,
        "completion_tokens": 174,
        "total_tokens": 2416
      }
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "AVGO's strategic emphasis on ValueOps has evolved from being positioned as a discrete solution within its Distributed Software portfolio in 2023 to becoming a central, integrated pillar of its broader portfolio strategy in 2024. In 2023, ValueOps was explicitly listed as a key offering under the Distributed Software portfolio (Chunk 1), while the 2024 filing elevates it to a foundational domain alongside DevOps and AIOps, explicitly tied to \"end-to-end visibility across all stages of the digital lifecycle\" and linked to business outcomes like innovation and profitability (Chunk 2). This shift indicates AVGO is no longer merely offering ValueOps as a component but is strategically embedding it as the core operational framework driving its entire Distributed Software portfolio, reflecting a deeper integration of DevOps/AIOps practices to optimize software delivery and business impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> ValueOps (PRODUCT)",
        "ValueOps (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_8",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_10",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 14029,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 4145,
        "completion_tokens": 223,
        "total_tokens": 4368
      }
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "FedEx's DRIVE transformation evolution into 2024 shows Network 2.0 progressing from strategic planning (2023) to active implementation risks (2024), with expected cost savings tied to network consolidation and operational efficiencies offset by significant integration challenges. The 2024 10-K explicitly warns that failure to achieve anticipated cost savings—due to integration complexities, regulatory hurdles, or unforeseen expenses—could materially harm future financial results, while simultaneously highlighting that the transformation's success is critical to meeting long-term strategic goals like carbon neutrality by 2040. This progression reflects a shift from conceptual transformation in 2023 to the tangible, high-stakes execution risks documented in the 2024 filing, where the company acknowledges that the path to realizing Network 2.0's promised efficiencies is now fraught with operational, legal, and financial uncertainties that directly impact its ability to control costs and execute its business strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Network 2.0 (PRODUCT)",
        "Network 2.0 (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_32",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_29",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11418,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3498,
        "completion_tokens": 257,
        "total_tokens": 3755
      }
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "The financial impact from equity method investment contracts decreased from a $2 million gain in 2023 to a $7 million gain in 2022 (as shown in Chunk 2), indicating a shift in MDLZ’s engagement with these investments. This change reflects a reduced contribution from equity method investments to earnings, suggesting a less pronounced financial benefit compared with the prior year. Consequently, MDLZ’s involvement with equity method investment contracts appears to be diminishing in its impact on overall earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "triplets_used": [
        "MDLZ (ORG) -> Equity Method Investment Contracts (FIN_INST)",
        "Equity Method Investment Contracts (FIN_INST) -> MDLZ (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "MDLZ_10k_2022.pdf",
          "page_id": "page_111",
          "chunk_id": "chunk_4",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "MDLZ_10k_2023.pdf",
          "page_id": "page_98",
          "chunk_id": "chunk_4",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 5061,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1918,
        "completion_tokens": 129,
        "total_tokens": 2047
      }
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "From fiscal year 2023 to fiscal year 2024, Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million, with the percentage of completion increasing from 67% to 67% (indicating no progress in completion but a stable estimate). This stability in cost and unchanged completion percentage relative to expectations suggests that development for the July 2024 releases is progressing as planned, with no significant budget adjustments or delays reported, aligning with the scheduled release timeline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Announces]- ORG",
      "triplets_used": [
        "AVGO (ORG) -> VMware Cloud Foundation July 2024 Releases (PRODUCT)",
        "VMware Cloud Foundation July 2024 Releases (PRODUCT) -> AVGO (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "AVGO_10k_2023.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "AVGO_10k_2024.pdf",
          "page_id": "page_69",
          "chunk_id": "chunk_2",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 3934,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 1656,
        "completion_tokens": 141,
        "total_tokens": 1797
      }
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "The strategic positioning of FedEx Office's Ship and Go kiosk has evolved from a niche self-service shipping solution to a core component of an integrated e-commerce and returns ecosystem between 2023 and 2024. This evolution is evidenced by its expansion to approximately 1,300 locations (up from earlier coverage) and deeper integration with FedEx Returns Technology and Consolidated Returns, enabling seamless in-store label printing and box-free returns drop-offs that directly support omnichannel retail demands. Critically, this advancement is underpinned by FedEx Dataworks' enterprise data platform—which centralizes machine learning models for reuse and scalability—allowing FedEx Office to optimize logistics operations, enhance returns management efficiency, and deliver cohesive digital solutions across its 2,000-store network, reflecting a deliberate strategy to unify physical retail touchpoints with data-driven e-commerce infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Introduces]- ORG",
      "triplets_used": [
        "FDX (ORG) -> Ship and Go Kiosk (PRODUCT)",
        "Ship and Go Kiosk (PRODUCT) -> FDX (ORG)"
      ],
      "chunks_used": [
        {
          "hop": "hop_1_rel",
          "source_file": "FDX_10k_2023.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        },
        {
          "hop": "hop_2_rel",
          "source_file": "FDX_10k_2024.pdf",
          "page_id": "page_15",
          "chunk_id": "chunk_1",
          "ticker": ""
        }
      ],
      "context_stats": {
        "total_chunks": 2,
        "total_chars": 11897,
        "triplets_count": 2
      },
      "token_usage": {
        "prompt_tokens": 3625,
        "completion_tokens": 238,
        "total_tokens": 3863
      }
    }
  ]
}